Selleck_GPCR
  SciTegic11012412592D

 25 26  0  0  0  0            999 V2000
    9.5862   -3.2909    0.0000 C   0  0
    8.1609   -2.8234    0.0000 C   0  0
    7.8525   -1.3573    0.0000 N   0  0
    8.8523   -0.2390    0.0000 C   0  0
    8.0978    1.0574    0.0000 C   0  0
    6.6317    0.7404    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
    0.0000    3.0008    0.0000 S   0  0
   -1.2993    3.7504    0.0000 O   0  0
   -0.0007    4.5008    0.0000 O   0  0
    1.2993    3.7521    0.0000 C   0  0
    1.2992    5.2521    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
 19 20  1  0
 14 21  1  0
 21 22  2  0
 21 23  2  0
 21 24  1  0
 24 25  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7552

> <plate>
1

> <well>
A03

> <supplier_cmpd_name>
Amisulpride

> <ctcr_id>
2986

> <supplier_cmpd_id>
S1280

> <smiles>
CCN1CCCC1CNC(=O)c2cc(c(N)cc2OC)[S](=O)(=O)CC

> <pd_targets>
{TSHR,ALOX15,FFP,LMNA,DRD2,MAPK1,DRD3,ADRA2A,ADRA2B,ADRA2C,HTR2A,HTR2B,HTR7,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2C,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,HTR4,HTR5A,HTR6}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor",Oxidoreductase,Transferase,Kinase,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)"
,"Protein Kinase","Glycohormone receptor","Monoamine receptor","CMGC protein kinase group","Dopamine receptor","CMGC protein kinase MAPK family","Adrenergic receptor","Serotonin receptor","CMGC protei
n kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Glycoprotein hormone receptors",Lipoxygenases,"Dopamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK 
families","5-Hydroxytryptamine receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Disease,Metabolism,"Cell Cycle","Signal Transduction","Immune System","Infectious disease","Metabolism of lipids",Mitotic,"Signaling by GPCR","Innate Immune System","Leishmania infection","Biosynthes
is of specialized proresolving mediators (SPMs)","M Phase","GPCR ligand binding","Toll-like Receptor Cascades","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","Mitotic Met
aphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Toll Like Receptor 5 (TLR5) Cascade","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","Mi
totic Anaphase","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of DPAn-3-derived protectins and r
esolvins","Nuclear Envelope (NE) Reassembly","Dopamine receptors","MAP kinase activation","Serotonin receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated
 by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{DRD2}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{amisulpride,71675-85-9,71675859,Solian,Aminosultopride,Deniban,Amisulprida,"DAN 2163",Amisulpridum,DAN-2163,DAN2163,C17H27N3O4S,"Amisulpride free base",APD421,4-Amino-N-((1-ethyl-2-pyrrolidinyl)methy
l)-5-(ethylsulfonyl)-o-anisamide,4AminoN((1ethyl2pyrrolidinyl)methyl)5(ethylsulfonyl)oanisamide,CHEBI:64045,"71675-85-9 (fr","71675859 (fr",T0811,S1280,SAM001246639,Prestw-1217,Amisulpride,CPD00044930
9}

> <pdid>
PD001316

> <targets>
{Dopamine Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{2159}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 24  0  0  1  0            999 V2000
    6.4990   -5.2473    0.0000 C   0  0
    6.4987   -3.7473    0.0000 O   0  0
    5.1993   -2.9963    0.0000 C   0  0
    3.9014   -3.7484    0.0000 C   0  0
    2.6012   -3.0004    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    3.8967   -0.7484    0.0000 C   0  0
    5.1969   -1.4963    0.0000 C   0  0
    6.4947   -0.7442    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 O   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 O   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
 10  6  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 14  1  0
 21 22  1  0
 22 10  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7553

> <plate>
1

> <well>
A04

> <supplier_cmpd_name>
Hesperetin

> <ctcr_id>
2860

> <supplier_cmpd_id>
S2308

> <smiles>
COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2

> <pd_targets>
{CYP2C19,HIF1A,CYP2C9,DPP4,KDM1A,CYP3A4,CA4,CA12,ALDH1A1,CYP1A2,MAPK1,HSD17B10,GSK3B,CA7,CYP2D6,REP,CYP1A1,TSHR,ATM,CYP1B1,RAB9A,RORC,AMPC,NPC1,SOAT1,SOAT2,MTTP,MAPT,FTL,SMN1,HPGD}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator","Membrane receptor",Transporter,"Other cytosolic protein","Unclassified protein","Cytochrome P450",Protease,Eraser,Lyase,Oxidoreductase,Kinase,"Fa
mily A G protein-coupled receptor",Hydrolase,"Nuclear receptor",Transferase,Reader,"Cytochrome P450 family 2","Serine protease","Lysine demethylase","Cytochrome P450 family 3","Cytochrome P450 family 
1","Protein Kinase","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Methyl-lysine/arginine binding protein","Cytochrome P450 family 2C","Serine protease SC clan","Lysine-spe
cific demethylase","Cytochrome P450 family 3A","Cytochrome P450 family 1A","CMGC protein kinase group","Cytochrome P450 family 2D","Glycohormone receptor","Atypical protein kinase group","Cytochrome P
450 family 1B","Nuclear hormone receptor subfamily 1 group F","Tudor domain","Cytochrome P450 2C19","Cytochrome P450 2C9","Serine protease S9B subfamily","Cytochrome P450 3A4","Cytochrome P450 1A1","C
MGC protein kinase MAPK family","CMGC protein kinase GSK family","Cytochrome P450 2D6","Atypical protein kinase PIKK family","Cytochrome P450 1B1","Nuclear hormone receptor subfamily 1 group F member 
3","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,Transporters,"Cytochrome P450","Peptidases and proteinases","Chromatin modifying enzymes","Carbonic anhydrases","Kinases (EC 2.7.x.x)","Anti-infective target
s","G protein-coupled receptors","Nuclear hormone receptors","SLC superfamily of solute carriers","Eicosanoid turnover","CYP2 family: drug metabolising subset","SC: Serine (S) Peptidases","1.14.11.- H
istone demethylases","CYP3 family","CYP1 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Viral protein targets","Glycoprotein hormone receptors",Atypical,"1F. Retinoic acid-related orphans","
SLC65 NPC-type cholesterol transporters","Prostaglandin synthases","S9: Prolyl oligopeptidase","Mitogen-activated protein kinases (MAP kinases)","Glycogen synthase kinase (GSK) family","Coronavirus (C
oV) proteins","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","GSK subfamily","Other PIKK family kinases"}

> <pathway_reactome>
{Metabolism,"Cellular responses to external stimuli","Metabolism of proteins","Signal Transduction","Transport of small molecules","Immune System",Disease,"Cell Cycle","Gene expression (Transcription)
","Neuronal System","Vesicle-mediated transport","Metabolism of RNA","Biological oxidations","Cellular responses to stress","Peptide hormone metabolism","Intracellular signaling by second messengers",
"Metabolism of lipids","O2/CO2 exchange in erythrocytes","Reversible hydration of carbon dioxide","Innate Immune System","Metabolism of amino acids and derivatives","Infectious disease","Cell Cycle Ch
eckpoints","Signaling by Rho GTPases","RNA Polymerase II Transcription","Plasma lipoprotein assembly",remodeling,"and clearance","Transmission across Chemical Synapses","Membrane Trafficking","Metabol
ism of non-coding RNA","Phase I - Functionalization of compounds","Cellular response to hypoxia","Incretin synthesis",secretion,"and inactivation","PIP3 activates AKT signaling","Biosynthesis of speci
alized proresolving mediators (SPMs)","Erythrocytes take up carbon dioxide and release oxygen","Toll-like Receptor Cascades","Branched-chain amino acid catabolism","SARS-CoV Infections","Leishmania in
fection","G1/S DNA Damage Checkpoints","Rho GTPase cycle","Generic Transcription Pathway","Plasma lipoprotein clearance","Neurotransmitter receptors and postsynaptic signal transmission","trans-Golgi 
Network Vesicle Budding","snRNP Assembly","Cytochrome P450 - arranged by substrate type","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha",Synthesis,"and inactivation of Gluca
gon-like Peptide-1 (GLP-1)","PTEN Regulation","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","SARS-CoV-1 Infection","Leishmania parasite growth and surviv
al","p53-Dependent G1/S DNA damage checkpoint","RHOBTB GTPase Cycle","Transcriptional regulation by RUNX3","LDL clearance","Chylomicron assembly","Activation of NMDA receptors and postsynaptic events"
,"Golgi Associated Vesicle Biogenesis",Xenobiotics,"Regulation of PTEN gene transcription","Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","SARS-CoV-1 Genome Replication and Tr
anscription","Anti-inflammatory response favouring Leishmania parasite infection","p53-Dependent G1 DNA Damage Response","Endogenous sterols","RHOBTB3 ATPase cycle","RUNX3 Regulates Immune Response an
d Cell Migration","Post NMDA receptor activation events","Biosynthesis of D-series resolvins","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkyl
ated by CYP1A2","MAP kinase activation","Replication of the SARS-CoV-1 genome","ADORA2B mediated anti-inflammatory cytokines production","Stabilization of p53","Activation of AMPK downstream of NMDARs
","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{DGAT1,MTTP,SOAT1,SOAT2}

> <broad_moa>
{"ACAT inhibitor"}

> <synonyms>
{Hesperitin,520-33-2,520332,"3',5,7-Trihydroxy-4'-methoxyflavanone","3',5,7Trihydroxy4'methoxyflavanone",(-)-hesperetin,()hesperetin,YSO2,"Cyanidanon 4'-methyl ether 1626","Cyanidanon 4'methyl ether 1
626","(S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one","(S)5,7dihydroxy2(3hydroxy4methoxyphenyl)chroman4one","NSC 57654",Prestwick_908,Prestwick908,Prestwick-908,"Prestwick 908",UNII-Q9Q3
D557F1,UNIIQ9Q3D557F1,5,7,3'-Trihydroxy-,3'Trihydroxy,T2565,S2308,310012,Hesperetin,HESPERETIN}

> <pdid>
PD001966

> <targets>
{"Histamine Receptor"}

> <classes>
{TGF-beta/Smad}

> <pubchem_cids>
{72281}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 23  0  0  0  0            999 V2000
   11.4915   -1.5060    0.0000 H   0  3
    8.9915   -1.5060    0.0000 Cl  0  5
   -2.6041   -2.9866    0.0000 C   0  0
   -1.3074   -3.7406    0.0000 N   0  0
   -0.0048   -2.9950    0.0000 C   0  0
    1.2926   -3.7495    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5030    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 C   0  0
   -2.5998    3.0004    0.0000 F   0  0
   -3.8976    0.7500    0.0000 F   0  0
   -3.8982    2.2498    0.0000 F   0  0
    3.8934   -3.7569    0.0000 C   0  0
    5.1961   -3.0132    0.0000 C   0  0
    6.4915   -3.7695    0.0000 C   0  0
    6.4843   -5.2694    0.0000 C   0  0
    5.1817   -6.0132    0.0000 C   0  0
    3.8862   -5.2570    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
  7 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7554

> <plate>
1

> <well>
A05

> <supplier_cmpd_name>
Fluoxetine HCl

> <ctcr_id>
5037

> <supplier_cmpd_id>
S1333

> <smiles>
[H+].[Cl-].CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2

> <pd_targets>
{SLC6A4,ACHE,HTT,CYP2C19,ADRA1A,ADRA1B,ADRA1D,SLC6A3,ALB,HRH3,SLC6A2,HTR1A,HTR1B,HTR1D,HTR1F,KCNH2,KCNJ6,HTR2C,SLC29A4,NET,LMNA,SIGMAR1,HTR2B,ADRA2A,ADRA2B,ADRA2C,HTR2A,KCNC1,HTR6,KMT2A,MEN1,FTL,PMP22
,HPGD,GMNN,CYP3A4,CHRM5,KCNK2,MTOR,CHRM3,CACNA1C,CYP2D6,CHRM1,ANO1,CHRNA2,CHRNA3,CHRNB4,APEX1,AMPC,ALDH1A1,KDM4E,LEF,RORC,TP53,TSHR,CYP2C9,CYP1A2,NFKB1,ALOX15,THPO,HRH1,MAPK1,ARRB2}

> <pathway_gtopdb>
{Transporter,"Electrochemical transporter","SLC superfamily of solute carriers","SLC06 neurotransmitter transporter family",Enzyme,"Unclassified protein","Membrane receptor","Secreted protein","Ion ch
annel","Other nuclear protein","Epigenetic regulator",Hydrolase,"Cytochrome P450","Family A G protein-coupled receptor","Voltage-gated ion channel",Reader,Kinase,"Other ion channel","Ligand-gated ion 
channel","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Potassium channels",Bromodomain,"Cytochrome P450 family 3","Protein Kinase","Voltage-gated calcium channel","Chloride cha
nnel","Nicotinic acetylcholine receptor","Cytochrome P450 family 2C","Monoamine receptor","Voltage-gated potassium channel","Inwardly rectifying potassium channel","SLC28 and SLC29 families of nucleos
ide transporters","Cytochrome P450 family 3A","Two-pore domain potassium channel","Atypical protein kinase group","Cytochrome P450 family 2D","Calcium-activated chloride channel","Nicotinic acetylchol
ine receptor alpha subunit","Nicotinic acetylcholine receptor beta subunit","Cytochrome P450 2C19","Adrenergic receptor","Histamine receptor","Serotonin receptor","SLC29 Facilitative nucleoside transp
orter family","Cytochrome P450 3A4","Acetylcholine receptor","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Atypical protein kinase FRAP subfamily","Transcription factor","Other cytosoli
c protein",Oxidoreductase,Eraser,Protease,"Nuclear receptor","Lysine demethylase","Metallo protease","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Cytochrome P450 family 1
","Jumonji domain-containing","Metallo protease MAE clan","Nuclear hormone receptor subfamily 1 group F","Glycohormone receptor","Cytochrome P450 family 1A","CMGC protein kinase group","Metallo protea
se M34 family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C9","Cytochrome P450 1A1","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC6 neurotransmitter transporter family","Monoamine transporter subfamily",Enzymes,Receptors,"Ion channels","Other protein targets","Acetylcholine 
turnover","Cytochrome P450","G protein-coupled receptors","Voltage-gated ion channels","Sigma receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Other ion channels","Ligand-gated ion channels","
CYP2 family: drug metabolising subset","Histamine receptors","Potassium channels","5-Hydroxytryptamine receptors","SLC28 and SLC29 families of nucleoside transporters","Prostaglandin synthases","CYP3 
family",Adrenoceptors,"Acetylcholine receptors (muscarinic)",Atypical,"Voltage-gated calcium channels","Chloride channels","Nicotinic acetylcholine receptors","Voltage-gated potassium channels","Inwar
dly rectifying potassium channels","SLC29 family","Two P domain potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Calcium activated chloride channel","FRAP subfamily
","Chromatin modifying enzymes","Nuclear hormone receptors","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","Glycoprotein hormone receptors","CYP1 family",Lipoxygenases,"CMGC: Con
taining CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter clearance","Serotonin clearance from the synaptic cleft",Metabolism,"Gene expression (Transcription)",Disease,"Signal Trans
duction","Muscle contraction","Transport of small molecules","Cell Cycle","Vesicle-mediated transport","Developmental Biology","Metabolism of lipids","RNA Polymerase II Transcription","Biological oxid
ations","Disorders of transmembrane transporters","Signaling by GPCR","Cardiac conduction","SLC-mediated transmembrane transport",Mitotic,"Infectious disease","Potassium Channels","Membrane Traffickin
g","Nervous system development","Ion channel transport","Phospholipid metabolism","Generic Transcription Pathway","Phase I - Functionalization of compounds","SLC transporter disorders","Metabolism of 
steroids","GPCR ligand binding","Phase 3 - rapid repolarisation","Neurotransmitter receptors and postsynaptic signal transmission","Transport of vitamins",nucleosides,"and related molecules","M Phase"
,"SARS-CoV Infections","Voltage gated Potassium channels","Leishmania infection","trans-Golgi Network Vesicle Budding","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of
 specialized proresolving mediators (SPMs)","Mitotic G1 phase and G1/S transition","Tandem pore domain potassium channels","Axon guidance","Stimuli-sensing channels","Glycerophospholipid biosynthesis"
,"Transcriptional Regulation by MECP2","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Bile acid and bile salt metabolism","Class A/1 
(Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","GABA receptor activation","Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane"
,"Mitotic Metaphase and Anaphase","Potential therapeutics for SARS","Leishmania parasite growth and survival","Golgi Associated Vesicle Biogenesis","Biosynthesis of DHA-derived SPMs","G1/S Transition"
,"TWIK related potassium channel (TREK)","Transcriptional Regulation by TP53","NCAM signaling for neurite out-growth","Acetylcholine binding and downstream events","Synthesis of PC","Regulation of MEC
P2 expression and activity",Xenobiotics,"Recycling of bile acids and salts","Amine ligand-binding receptors","GABA B receptor activation","Mitotic Anaphase","Anti-inflammatory response favouring Leish
mania parasite infection","Biosynthesis of D-series resolvins","Activation of the pre-replicative complex","Biosynthesis of maresins","Regulation of TP53 Activity","NCAM1 interactions","Postsynaptic n
icotinic acetylcholine receptors","CYP2E1 reactions","Histamine receptors","Activation of GABAB receptors","Serotonin receptors","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory 
cytokines production","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Muscarinic acetylcholine receptors","Regulation of TP53 Expression and Degradation","Highly calcium permeable postsynaptic nico
tinic acetylcholine receptors","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","DNA Repair","Im
mune System",Hemostasis,"Base Excision Repair","Cell Cycle Checkpoints","Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Innate Immune System","Resolution of Ab
asic Sites (AP sites)","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints","Signaling by Interleukins","Platelet Aggregation (Plug Formation)","Toll-like Receptor Cascades","Resolut
ion of AP sites via the multiple-nucleotide patch replacement pathway","Ethanol oxidation","Uptake and function of anthrax toxins","Transcriptional regulation by RUNX3","p53-Dependent G1/S DNA damage 
checkpoint","Interleukin-1 family signaling","Biosynthesis of DPA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","PCNA-Dependent Long Patch Base Excision Repair","RUNX3 Regulates Immune Response 
and Cell Migration","p53-Dependent G1 DNA Damage Response","Interleukin-1 signaling","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","Stabilization of p53","Aromatic amines 
can be N-hydroxylated or N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived protectins and resolvins","MAP kinase activation","Autodegradation of the
 E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ANO1,HTR2B,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{"FLUOXETINE HYDROCHLORIDE",56296-78-7,56296787,"Fluoxetine Hcl",Prozac,59333-67-4,59333674,Sarafem,"Fluoxetine (hydrochloride)",Fluoxeren,Adofen,Fluctin,Lovan,Fluctine,Fluoxac,Fludac,Fluxil,Fontex,"L
Y 110140",LY-110140,LY110140,MFCD00214288,Reconcile,Self,T0450,T0450L,S1333,SAM002589965,1504173,Prestw-511,Fluoxetine,"Fluoxetine hydrochloride","Fluoxetine HCl",CPD000058452,FLUOXETINE}

> <pdid>
PD004343

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{62857,657320,11824156}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 16  0  0  0  0            999 V2000
    7.6894   -2.6293    0.0000 Cl  0  0
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1887   -6.0105    0.0000 C   0  0
    3.8883   -6.7578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  3  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 11  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7555

> <plate>
1

> <well>
A06

> <supplier_cmpd_name>
Amfebutamone HCl

> <ctcr_id>
6227

> <supplier_cmpd_id>
S2452

> <smiles>
Cl.CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1

> <pd_targets>
{CHRNA3,CHRNB4,CHRNA4,CHRNB2,SLC6A3,SLC6A4,SLC6A2,CHRNA7,ALDH1A1,ITGA5,CHRNA1,CHRNB1,CHRND,CHRNG,CYP2C19,HTR3A}

> <pathway_gtopdb>
{"Ion channel",Transporter,Enzyme,"Ligand-gated ion channel","Electrochemical transporter",Oxidoreductase,"Cytochrome P450","Nicotinic acetylcholine receptor","SLC superfamily of solute carriers","Cyt
ochrome P450 family 2","5HT3 receptor","Nicotinic acetylcholine receptor alpha subunit","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Cytochrome P450 2C19"}

> <pathway_chembl>
{Transporters,"Ion channels",Enzymes,"SLC superfamily of solute carriers","Ligand-gated ion channels","Cytochrome P450","SLC6 neurotransmitter transporter family","Nicotinic acetylcholine receptors","
CYP2 family: drug metabolising subset","5-HT<sub>3</sub> receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System",Metabolism,"Disorders of transmembrane transporters","Transmission across Chemical Synapses","Biological oxidations","SLC transporter disorders","Neurotransmitter clearance"
,"Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance fro
m the synaptic cleft","Defective SLC6A2 causes orthostatic intolerance (OI)","Acetylcholine binding and downstream events","Ethanol oxidation","Cytochrome P450 - arranged by substrate type","Postsynap
tic nicotinic acetylcholine receptors",Xenobiotics,"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","CYP2E1 reactions"}

> <broad_targets>
{SLC6A2,SLC6A3}

> <broad_moa>
{"dopamine reuptake inhibitor"}

> <synonyms>
{AKOS026750042,"Bupropion hydrochloride",31677-93-7,31677937,"Bupropion Hcl","2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one hydrochloride","2(tertbutylamino)1(3chlorophenyl)propan1one hydrochlori
de",Wellbutrin,"Amfebutamone hydrochloride",Zyban,"Wellbutrin XL","Wellbutrin SR",Budeprion,"Forfivo XL",W,S2452,SAM001246723,1504174,Prestw-249,"Amfebutamone HCl",CPD000058423,BUPROPION}

> <pdid>
PD003148

> <targets>
{"Dopamine Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{657316,62884}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 33 32  0  0  0  0            999 V2000
   24.3060   -2.2455    0.0000 H   0  3
   21.8060   -2.2455    0.0000 H   0  3
   19.3060   -2.2455    0.0000 Cl  0  5
   16.8060   -2.2455    0.0000 Cl  0  5
   14.3053   -0.7442    0.0000 C   0  0
   13.0040   -1.4903    0.0000 O   0  0
   12.9985   -2.9911    0.0000 C   0  0
   14.2964   -3.7431    0.0000 C   0  0
   14.2940   -5.2431    0.0000 C   0  0
   12.9938   -5.9911    0.0000 C   0  0
   11.6959   -5.2391    0.0000 C   0  0
   11.6982   -3.7390    0.0000 C   0  0
   10.3985   -2.9887    0.0000 N   0  0
   10.3984   -1.4887    0.0000 C   0  0
    9.0994   -0.7387    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    7.8004   -2.9887    0.0000 C   0  0
    9.0995   -3.7387    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 24  1  0
 33 28  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7556

> <plate>
1

> <well>
A07

> <supplier_cmpd_name>
Naftopidil DiHCl

> <ctcr_id>
1242

> <supplier_cmpd_id>
S1387

> <smiles>
[H+].[H+].[Cl-].[Cl-].COc1ccccc1N2CCN(CC2)CC(O)COc3cccc4ccccc34

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRA1A,ADRA1B,ADRA1D,CACNA1H,MAPT,MAPK1,LMNA,ADRB2,NFO,GMNN,PMP22,KMT2A,MEN1,HIF1A,HTT,KDM4E,MTOR,CYP2D6,CYP3A4,CYP2C19,ALOX15,CYP1A2,ALDH1A1,CHRM1,TP53,TSHR}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Other cytosolic protein",Enzyme,"Other nuclear protein","Unclassified protein","Epigenetic regulator","Transcription factor","Family A G protein-coupled receptor","
Voltage-gated ion channel",Kinase,Hydrolase,Reader,Eraser,"Cytochrome P450",Oxidoreductase,"Small molecule receptor (family A GPCR)","Voltage-gated calcium channel","Protein Kinase",Bromodomain,"Lysin
e demethylase","Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","Peptide receptor (family A GPCR)","Monoamine receptor","CMGC protein kinase group","Jumonji domain-cont
aining","Atypical protein kinase group","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Glycohormone receptor","Adrenergic receptor","C
MGC protein kinase MAPK family","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 1A1","Acetylcholine receptor","CMGC protein ki
nase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Cytochrome P450","Eicosanoid turnover",Adrenoceptors,
"Voltage-gated calcium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases",Atypical,"CYP2 family: drug metabolising subset","CYP3 family",Lipoxygenases,"CYP1 fam
ily","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subf
amily","FRAP subfamily"}

> <pathway_reactome>
{"Signal Transduction","Developmental Biology","Neuronal System","Immune System","Cell Cycle",Disease,"Cellular responses to external stimuli","Gene expression (Transcription)",Metabolism,"Signaling b
y GPCR","Nervous system development","Transmission across Chemical Synapses","Innate Immune System",Mitotic,"Infectious disease","Cellular responses to stress","RNA Polymerase II Transcription","Biolo
gical oxidations","Metabolism of lipids","Cell Cycle Checkpoints","GPCR ligand binding","Axon guidance","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades",
"M Phase","Leishmania infection","Mitotic G1 phase and G1/S transition","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Cellular response to hypoxia","Generic Transcription Pathway",
"Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","NCAM signaling for neurite 
out-growth","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","G1/S Transition","O
xygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by MECP2","Transcriptional Regulation by TP53","Cytochrome P450 - arranged by substrate type","Bios
ynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Amine ligand-binding receptors","NCAM1 interactions","Post NMDA recepto
r activation events","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Activation of the pre-replicative complex","R
egulation of MECP2 expression and activity","Regulation of TP53 Activity",Xenobiotics,"Biosynthesis of maresins","Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response",Adrenoceptors,"Act
ivation of AMPK downstream of NMDARs","MAP kinase activation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradatio
n","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acety
lcholine receptors","Stabilization of p53","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Autodegradation of
 the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{RESTW97,"RESTW 97","NAFTOPIDIL DIHYDROCHLORIDE",57149-08-3,57149083,"57149 08 3","Naftopidil DiHCl","Naftopidil (dihydrochloride)",Avishot,Flivas,KT-611;BM-15275,KT611;BM15275,"KT 611;BM 15275",C24H3
0Cl2N2O3,SR-01000002977,SR01000002977,"SR 010",S1387,Prestw-975,"Naftopidil dihydrochloride"}

> <pdid>
PD000224

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{11957660}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 24  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0  1  0  0  0
    2.5836   -4.3986    0.0000 O   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15  5  1  0
 15  9  1  0
  6 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  6
 18 20  1  0
 20  2  1  0
 20 21  1  1
M  END
> <name>
Selleck_GPCR

> <id>
7557

> <plate>
1

> <well>
A08

> <supplier_cmpd_name>
Estriol

> <ctcr_id>
1932

> <supplier_cmpd_id>
S2466

> <smiles>
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O

> <pd_targets>
{SHBG,SERPINA6,ESR1,CYP51,ALOX15,ESR2,SLC6A4,NR3C1,OR51E2,SLCO1A1,AMPC,UGT1A10}

> <pathway_gtopdb>
{"Secreted protein","Transcription factor",Enzyme,Transporter,"Unclassified protein","Nuclear receptor","Cytochrome P450",Oxidoreductase,"Electrochemical transporter",Hydrolase,"Nuclear hormone recept
or subfamily 3","Cytochrome P450 family 51","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 3 group A","Cytochrome P450 family 51A","SLC06 neurotransmitter transporter family"
,"Nuclear hormone receptor subfamily 3 group C","SLC21/SLCO family of organic anion transporting polypeptides","Nuclear hormone receptor subfamily 3 group A member 1","Cytochrome P450 51A1","Nuclear h
ormone receptor subfamily 3 group A member 2","Nuclear hormone receptor subfamily 3 group C member 1",Transferase}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Eicosanoid turnover","SLC superfamily of solute carriers","Steroid hormone receptors",Lipoxygenases,"SLC6 neurotransmitter transporter fami
ly","3A. Estrogen receptors","Monoamine transporter subfamily","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Signal Transduction","Neuronal System","Metabolism of lipids","RNA Polymerase II Transcription","Intracellular signaling by second messengers","Transmiss
ion across Chemical Synapses","Signaling by GPCR","Metabolism of steroids","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","PIP3 activates AKT signaling","N
eurotransmitter clearance","GPCR downstream signalling","Metabolism of steroid hormones","Transcriptional regulation by RUNX1","Biosynthesis of DPA-derived SPMs","Negative regulation of the PI3K/AKT n
etwork","Serotonin clearance from the synaptic cleft","FOXO-mediated transcription","G alpha (s) signalling events","Glucocorticoid biosynthesis","RUNX1 regulates estrogen receptor mediated transcript
ion","Biosynthesis of DPAn-3 SPMs",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Olfactory Signaling Pathway","Bios
ynthesis of DPAn-3-derived protectins and resolvins","Biological oxidations","Phase II - Conjugation of compounds",Glucuronidation}

> <broad_targets>
{ESR1,ESR2}

> <broad_moa>
{"estrogen receptor agonist"}

> <synonyms>
{RESTW109,estriol,50-27-1,50271,Oestriol,Trihydroxyestrin,Estratriol,Ovestin,Ovestrion,Destriol,Tridestrin,Theelol,Aacifemine,Oestratriol,Orestin,16alpha-Hydroxyestradiol,16alphaHydroxyestradiol,Ortho
-Gynest,OrthoGynest,Deuslon-A,DeuslonA,Hemostyptanon,Hormomed,Klimoral,Oestriolum,Orgastyptin,Overstin,T,S2466,Prestw-1096,Estriol}

> <pdid>
PD001139

> <targets>
{Estrogen/progestogen Receptor,Endogenous Metabolite,Estrogen Receptor/ERR}

> <classes>
{Endocrinology & Hormones,Metabolic Enzyme/Protease,Others}

> <pubchem_cids>
{5756}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 21  0  0  0  0            999 V2000
    7.5973    1.1128    0.0000 H   0  3
    5.0973    1.1128    0.0000 Cl  0  5
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5006    0.0000 C   0  0
   -3.8969    0.7474    0.0000 C   0  0
   -3.8946   -0.7535    0.0000 N   0  0
   -5.1920   -1.5063    0.0000 C   0  0
   -2.5942   -1.5010    0.0000 C   0  0
   -2.5994    3.0015    0.0000 C   0  0
   -1.3013    3.7531    0.0000 O   0  0
   -3.8616    2.2295    0.0000 C   0  0
   -5.1613    2.9784    0.0000 C   0  0
   -5.1626    4.4784    0.0000 C   0  0
   -3.8642    5.2295    0.0000 C   0  0
   -2.5645    4.4806    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 11 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 16  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7558

> <plate>
1

> <well>
A09

> <supplier_cmpd_name>
Venlafaxine

> <ctcr_id>
6059

> <supplier_cmpd_id>
S1441

> <smiles>
[H+].[Cl-].COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2

> <pd_targets>
{SLC6A3,SLC6A2,NET,SLC6A4,ADRA1A,LMNA}

> <pathway_gtopdb>
{Transporter,"Membrane receptor","Other nuclear protein","Electrochemical transporter","Family A G protein-coupled receptor","SLC superfamily of solute carriers","Small molecule receptor (family A GPC
R)","SLC06 neurotransmitter transporter family","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Transporters,Receptors,"SLC superfamily of solute carriers","G protein-coupled receptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"Monoamine transporter subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction","Cell Cycle","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Signaling by GPCR",Mitotic,"SLC transporter disorders",
"Neurotransmitter clearance","GPCR ligand binding","M Phase","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance from the synaptic cleft","Class A/1 (Rhodopsin-like 
receptors)","Mitotic Metaphase and Anaphase","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine ligand-binding receptors","Mitotic Anaphase",Adrenoceptors,"Nuclear Envelope (NE) Reassembly"
,"Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SLC6A2,SLC6A4}

> <broad_moa>
{"adrenergic inhibitor","norepinephrine reuptake inhibitor","serotoninâ€“norepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{"Venlafaxine hydrochloride",99300-78-4,99300784,"VENLAFAXINE HCl",Effexor,Efexor,"Effexor XR",Trevilor,Dobupal,Vandral,Wy-45030,Wy45030,"Venlafaxine (hydrochloride)","Wy 45030","Wy-45,030","Wy45,030"
,"Wy 45030 hydrochloride",1-(2-(Dimethylamino)-1-(4-met,1(2(Dimethylamino)1(4met,S1441,SAM001246572,Venlafaxine,CPD000469154}

> <pdid>
PD010124

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{62923,25137858}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 22  0  0  0  0            999 V2000
   11.4837   -4.5059    0.0000 H   0  3
    8.9837   -4.5059    0.0000 Cl  0  5
    5.1937   -3.0093    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5917   -6.0086    0.0000 C   0  0
    2.5912   -7.5095    0.0000 C   0  0
    1.2924   -8.2599    0.0000 Cl  0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    6.4837   -8.2663    0.0000 C   0  0
    6.4785   -9.7663    0.0000 C   0  0
    5.1769  -10.5118    0.0000 C   0  0
    3.8804   -9.7573    0.0000 C   0  0
    3.8856   -8.2573    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7559

> <plate>
1

> <well>
A10

> <supplier_cmpd_name>
Phenoxybenzamine HCl

> <ctcr_id>
5741

> <supplier_cmpd_id>
S2499

> <smiles>
[H+].[Cl-].CC(COc1ccccc1)N(CCCl)Cc2ccccc2

> <pd_targets>
{TSHR,ALOX15,GLA,SCN1A,SCN2A,SCN3A,ADRA2B,DRD1,DRD2,DRD3,DRD4,DRD5,ADRA1A,ADRA1B,ADRA1D,ALDH1A1,HIF1A,GROES,GROL,KDM4E,TGR,NPSR1,LMNA,CYP3A4,HSPD1,HSPE1,THRB,LEF,NFO,TDP1,KMT2A,MEN1,SLC22A2,SLC22A1,SL
C22A3,ADRA2A,ADRA2C,CALM1,CYP2C19,CHRM1,CYP2D6,NFKB1,CYP2C9,CYP1A2}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Ion channel","Transcription factor","Unclassified protein","Epigenetic regulator","Other nuclear protein","Other cytosolic protein",Transporter,"Family A G protein-coupled
 receptor",Oxidoreductase,Hydrolase,"Voltage-gated ion channel",Eraser,"Cytochrome P450","Nuclear receptor",Protease,Reader,"Electrochemical transporter","Peptide receptor (family A GPCR)","Voltage-ga
ted sodium channel","Small molecule receptor (family A GPCR)","Lysine demethylase","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","Metallo protease",Bromodomain,"SLC superfamily of 
solute carriers","Glycohormone receptor","Monoamine receptor","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 gro
up A","Metallo protease MAE clan","SLC22 family of organic cation and anion transporters","Adrenergic receptor","Dopamine receptor","Neuropeptide receptor","Cytochrome P450 3A4","Nuclear hormone recep
tor subfamily 1 group A member 2","Metallo protease M34 family","Cytochrome P450 family 2","Cytochrome P450 family 1","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytochrome P450 family 1A
","Cytochrome P450 2C19","Acetylcholine receptor","Cytochrome P450 2D6","Cytochrome P450 2C9","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes","Cytochrome P450","Nuclear hormone receptors","SLC superfamily of solute carriers","Gl
ycoprotein hormone receptors",Lipoxygenases,Adrenoceptors,"1.14.11.- Histone demethylases","Neuropeptide S receptor","CYP3 family","1A. Thyroid hormone receptors","SLC22 family of organic cation and a
nion transporters","Organic cation transporters (OCT)","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","CYP1 family"}

> <pathway_reactome>
{Disease,Metabolism,"Signal Transduction","Cellular responses to external stimuli","Cell Cycle","Metabolism of proteins","DNA Repair","Transport of small molecules","Neuronal System","Infectious disea
se","Metabolism of lipids","Signaling by GPCR","Biological oxidations","Cellular responses to stress",Mitotic,"Post-translational protein modification","DNA Double-Strand Break Repair","SLC-mediated t
ransmembrane transport","Transmission across Chemical Synapses","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Sphingolipid metabolism","GPCR ligand binding","Phas
e I - Functionalization of compounds","Cellular response to hypoxia","M Phase",SUMOylation,"Uptake and actions of bacterial toxins","Nonhomologous End-Joining (NHEJ)","Transport of bile salts and orga
nic acids","metal ions and amine compounds","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","Glycosphingo
lipid metabolism","Class A/1 (Rhodopsin-like receptors)","Ethanol oxidation","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Mitotic Metaphase and Anaphase","Biosynthesis o
f DHA-derived SPMs","SUMO E3 ligases SUMOylate target proteins","Uptake and function of anthrax toxins","Organic cation/anion/zwitterion transport","Activation of NMDA receptors and postsynaptic event
s","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","Amine ligand-binding receptors","Mitotic Anaphase","Biosynthesis of maresins","SUMOylation of int
racellular receptors","Organic cation transport","Post NMDA receptor activation events","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of DPAn-3-derived protectins and resolvi
ns",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Initiation of Nuclear Envel
ope (NE) Reformation","Ras activation upon Ca2+ influx through NMDA receptor","Immune System","Cytokine Signaling in Immune system","Signaling by Interleukins","Cytochrome P450 - arranged by substrate
 type","Interleukin-1 family signaling",Xenobiotics,"Interleukin-1 signaling","CYP2E1 reactions","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can 
be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Dibenzyline,"Bensylyt NEN","Phenoxybenzamine chloride",NCI-C01661,NCIC01661,"Phenoxybenzamine hydrochloride (USP)","N-2-Phenoxyisopropyl-N-benzyl-chloroethylamine hydrochloride","N2PhenoxyisopropylNb
enzylchloroethylamine hydrochloride","Dibenzyline chloride","2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane hydrochl","2(NBenzyl2chloroethylamino)1phenoxypropane hydrochl",T1158,S2499,SAM002564244,2
300176,Prestw-944,"Phenoxybenzamine hydrochloride","Phenoxybenzamine HCl",CPD000058422,"PHENOXYBENZAMINE HYDROCHLORIDE"}

> <pdid>
PD009637

> <targets>
{"Androgen Receptor"}

> <classes>
{"GPCR & G Protein","alpha adrenergic blocker"}

> <pubchem_cids>
{6141,657233,5284441}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 31 32  0  0  1  0            999 V2000
   12.7852   -6.3812    0.0000 Cl  0  5
    6.4897   -5.2632    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0  1  0  0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0  2  0  0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 F   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 O   0  0
    5.1873   -7.5117    0.0000 C   0  0  2  0  0  0
    3.8882   -8.2618    0.0000 C   0  0
    3.8881   -9.7618    0.0000 C   0  0
    5.1871  -10.5118    0.0000 C   0  0
    5.1870  -12.0119    0.0000 C   0  0
    6.4860  -12.7619    0.0000 C   0  0
    6.4859  -14.2619    0.0000 F   0  0
    7.7851  -12.0120    0.0000 C   0  0
    7.7852  -10.5120    0.0000 C   0  0
    6.4862   -9.7619    0.0000 C   0  0
    6.4862   -8.2619    0.0000 O   0  0
   10.2852   -6.3812    0.0000 H   0  3
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
 19  9  1  0
  3 20  1  0
 20 21  1  1
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 27 28  1  0
 28 29  2  0
 29 23  1  0
 29 30  1  0
 30 20  1  0
M  CHG  2   1  -1  31   1
M  END
> <name>
Selleck_GPCR

> <id>
7560

> <plate>
1

> <well>
A11

> <supplier_cmpd_name>
Nebivolol

> <ctcr_id>
8191

> <supplier_cmpd_id>
S1549

> <smiles>
[Cl-].O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]3CCc4cc(F)ccc4O3.[H+]

> <pd_targets>
{ADRB1,ADRB2,KCNH2,ADRB3,KCNE1,KCNQ1,CACNA1C,SCN5A,KCND3}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel","Small molecule receptor (family A GPCR)","Potassium channels","Voltage-gated calcium channel","Vol
tage-gated sodium channel","Monoamine receptor","Voltage-gated potassium channel","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels",Adrenoceptors,"Potassium channels","Voltage-gated calcium channels","Voltage-gated sodium channels","Voltage-gated 
potassium channels"}

> <pathway_reactome>
{Disease,"Muscle contraction","Developmental Biology","Infectious disease","Cardiac conduction","Nervous system development","Leishmania infection","Phase 3 - rapid repolarisation","Axon guidance","Ph
ase 1 - inactivation of fast Na+ channels","Leishmania parasite growth and survival","NCAM signaling for neurite out-growth","L1CAM interactions","Anti-inflammatory response favouring Leishmania paras
ite infection","NCAM1 interactions","Interaction between L1 and Ankyrins","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{ADRB1}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"UNII-JGS34J7L9I component JWEXHQAEWHKGCW-BIISKSHESA-N","UNIIJGS34J7L9I component JWEXHQAEWHKGCWBIISKSHESAN","Nebivolol hydrochloride",152520-56-4,152520564,"rac Nebivolol hydrochloride","Nebivolol (
hydrochloride)",CHEMBL2358570,NCGC00183875-01,NCGC0018387501,DSSTox_CID_28991,DSSToxCID28991,DSSTox-CID-28991,"DSSTox CID 28991",DSSTox_RID_83256,DSSToxRID83256,DSSTox-RID-83256,"DSSTox RID 83256",DSS
Tox_GSID_49065,DSSToxGSID49065,DSSTox-GSID-49065,"DSSTox GSID 49065",CAS-169293-,CAS169293,T0154,S1549,Nebivolol}

> <pdid>
PD009358

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{11626384}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 13 13  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0  2  0  0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  1
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7561

> <plate>
1

> <well>
A12

> <supplier_cmpd_name>
L-Adrenaline

> <ctcr_id>
7830

> <supplier_cmpd_id>
S2522

> <smiles>
CNC[C@H](O)c1ccc(O)c(O)c1

> <pd_targets>
{TDP1,FFP,RORC,ADRA2B,ADRB3,MAPT,HTR7,ADRA1A,SLC6A2,ADRA1B,DRD2,ADRB2,KMT2A,ALD,GRK2,ADRA2C,APEX1,MEN1,ADRA2A,ADRB1,SLC22A1,PMP22,BLM,TGR,KDM4E,NPSR1,CYP2D6,THPO,ADRA1D,HIF1A,MAPK1,CYP3A4,ALDH1A1,CYP1
A2,ABCC1,RECQL,TSHR,HSD17B10,ALOX15,CHRM1,GAA,RXFP1,NFKB1,MTOR,CA1,TNF}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other cytosolic protein",Transporter,"Epigenetic regulator","Unclassified protein",Hydrolase,Transferase,"Nuclear receptor","Family A G protein-coup
led receptor","Electrochemical transporter",Reader,Kinase,Eraser,"Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers",Bromodomain,"Prot
ein Kinase","Lysine demethylase","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","SLC06 neurotransmitter transporter family","AGC protein kinase 
group","SLC22 family of organic cation and anion transporters","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F member 3","Adrenergic 
receptor","Serotonin receptor","Dopamine receptor","AGC protein kinase GRK family","Neuropeptide receptor","AGC protein kinase BARK subfamily","Secreted protein","Cytochrome P450",Oxidoreductase,"Prim
ary active transporter",Lyase,"Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","ATP-binding cassette","Cytochrome P450 family 2D","CMGC protein kinase group","Cytochrom
e P450 family 3A","Cytochrome P450 family 1A","ABCC subfamily","Glycohormone receptor","Relaxin-like peptide receptor (family A GPCR)","Atypical protein kinase group","Cytochrome P450 2D6","CMGC prote
in kinase MAPK family","Cytochrome P450 3A4","Cytochrome P450 1A1","Acetylcholine receptor","Relaxin receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase
 FRAP subfamily"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","SLC superfamily of solute carriers","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","1F. Retinoic acid-r
elated orphans",Adrenoceptors,"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","Dopamine receptors","2.1.1.43 Histone methyltransferases (HMTs)","AGC: Containing PKA",PKG,"PK
C families","SLC22 family of organic cation and anion transporters","1.14.11.- Histone demethylases","Neuropeptide S receptor","Monoamine transporter subfamily","G protein-coupled receptor kinases (GR
Ks)","Organic cation transporters (OCT)","Beta-adrenergic receptor kinases (&beta;ARKs)","Cytochrome P450","ATP-binding cassette transporter family","Eicosanoid turnover","3.2.1.- Glycosidases","Carbo
nic anhydrases","CYP2 family: drug metabolising subset","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","CYP1 family","ABCC subfamily","Glycoprotein hormone receptors",Lipoxygenases,"Ace
tylcholine receptors (muscarinic)","Relaxin family peptide receptors",Atypical,"Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK su
bfamily","FRAP subfamily"}

> <pathway_reactome>
{"DNA Repair","Gene expression (Transcription)","Signal Transduction",Disease,"Neuronal System","Transport of small molecules","Developmental Biology","DNA Double-Strand Break Repair","RNA Polymerase 
II Transcription","Signaling by GPCR","Infectious disease","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Intracellular signaling by second messengers","Base Excisi
on Repair","SLC-mediated transmembrane transport","Nervous system development","Nonhomologous End-Joining (NHEJ)","Generic Transcription Pathway","GPCR ligand binding","Leishmania infection","Neurotra
nsmitter receptors and postsynaptic signal transmission","SLC transporter disorders","DAG and IP3 signaling","Resolution of Abasic Sites (AP sites)","Transport of bile salts and organic acids","metal 
ions and amine compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)","Leis
hmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Defective SLC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","CaM pathway","
Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Organic cation/anion/zwitterion transport","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)",
"RUNX3 Regulates Immune Response and Cell Migration","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","RUNX1
 regulates genes involved in megakaryocyte differentiation and platelet function","Calmodulin induced events","PCNA-Dependent Long Patch Base Excision Repair","Organic cation transport","HDR through H
omologous Recombination (HRR)",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Dopamine receptors","Homologous DNA Pairing and Strand
 Exchange","Presynaptic phase of homologous DNA pairing and strand exchange",Metabolism,Hemostasis,"Cellular responses to external stimuli","Immune System","Biological oxidations","Platelet activation
","signaling and aggregation","Cellular responses to stress","Innate Immune System","Metabolism of lipids","Metabolism of amino acids and derivatives","Diseases of metabolism","Cytokine Signaling in I
mmune system","Phase I - Functionalization of compounds","Platelet Aggregation (Plug Formation)","Cellular response to hypoxia","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving 
mediators (SPMs)","Fatty acid metabolism","Branched-chain amino acid catabolism","Diseases of carbohydrate metabolism","Signaling by Interleukins","Cytochrome P450 - arranged by substrate type","Oxyge
n-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Arachidonic acid metabolism","Biosynt
hesis of DPA-derived SPMs","Glycogen storage diseases","Interleukin-1 family signaling","Transcriptional Regulation by TP53","Interleukin-12 family signaling","Interleukin-10 signaling",Xenobiotics,"M
yD88 cascade initiated on plasma membrane","Biosynthesis of maresins","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Biosynthesis of DPAn-3 SPMs","Glycogen storage disease type II (GAA)","Interleuk
in-1 signaling","Regulation of TP53 Activity","Interleukin-12 signaling","CYP2E1 reactions","MAP kinase activation","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-deal
kylated by CYP1A2","Biosynthesis of DPAn-3-derived protectins and resolvins","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Regulation of TP53 Expression and Degrad
ation","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","
ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,PAH,TNF}

> <broad_moa>
{"adrenergic receptor agonist","carbonic anhydrase activator",neurotransmitter}

> <synonyms>
{ADRENALIN,epinephrine,l-Adrenaline,lAdrenaline,L-epinephrine,Lepinephrine,51-43-4,51434,Adrenalin,adrenaline,Levoepinephrine,Adnephrine,Chelafrin,Epinefrina,Epinephran,Epirenan,(-)-Adrenaline,()Adren
aline,Nephridine,Adrenal,Epifrin,Renoform,Epipen,Vasoconstrictine,Hypernephrin,Renostypticin,Supr,S2522,L-Adrenaline}

> <pdid>
PD003193

> <targets>
{Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5816}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 42 43  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.1981    1.4971    0.0000 C   0  0
   -5.1976    2.9979    0.0000 C   0  0
   -6.4959    3.7492    0.0000 Cl  0  0
   -3.8978   -0.7554    0.0000 C   0  0
   -5.1947   -1.5091    0.0000 C   0  0
   -5.1905   -3.0091    0.0000 C   0  0
   -3.8893   -3.7554    0.0000 C   0  0
   -2.5924   -3.0018    0.0000 C   0  0
   -2.5967   -1.5018    0.0000 C   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -1.3042    3.7491    0.0000 C   0  0
    8.9894    0.7350    0.0000 O   0  0
    8.9894   -0.7650    0.0000 C   0  0
    7.6901   -1.5146    0.0000 O   0  0
   10.2894   -1.5150    0.0000 C   0  0
   11.5894   -0.7650    0.0000 C   0  0
   12.8879   -1.5158    0.0000 O   0  0
   11.5908    0.7358    0.0000 C   0  0
   12.8908    1.4858    0.0000 C   0  0
   14.1894    0.7350    0.0000 O   0  0
   12.8922    2.9858    0.0000 O   0  0
   11.5906   -2.2950    0.0000 C   0  0
   10.2919   -3.0456    0.0000 O   0  0
   12.8897   -3.0447    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 13 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
 34 40  1  0
 40 41  1  0
 40 42  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7562

> <plate>
1

> <well>
A13

> <supplier_cmpd_name>
Toremifene Citrate

> <ctcr_id>
5611

> <supplier_cmpd_id>
S1776

> <smiles>
CN(C)CCOc1ccc(cc1)\C(=C(\CCCl)c2ccccc2)c3ccccc3.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"TOREMIFENE CITRATE",89778-27-8,89778278,Fareston,"Toremifene (Citrate)",UNII-2498Y783QT,UNII2498Y783QT,"89778-27-8 (citrate)","89778278 (citrate)",NSC613680,2498Y783QT,NSC-613680,"Toremifene Citrate
 (Fareston, Acapodene)",DSSTox_CID_1367,DSSToxCID1367,DSSTox-CID-1367,"DSSTox CID 1367",DSSTox_RID_76113,DSSToxRID76113,DSSTox-RID-76113,"DSSTox RID 76113",DSSTox_GSID_21367,DSSToxGSID21367,DSSTox-GSI
D-21367,"DSSTox GSID 21367",FC,T1464,S1776,SAM001246774,1505682,"Toremifene citrate","Toremifene Citrate",CPD000469213,"TOREMIPHENE CITRATE"}

> <pdid>

> <targets>
{Others}

> <classes>
{antineoplastic,anti-estrogen,"Endocrinology & Hormones"}

> <pubchem_cids>
{3005572}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 42 43  0  0  0  0            999 V2000
    5.1873   -7.5109    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5886   -6.0033    0.0000 C   0  0
    1.2919   -5.2492    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 Cl  0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -6.4995    3.7432    0.0000 C   0  0
   -5.2004    2.9933    0.0000 C   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -1.3042    3.7491    0.0000 C   0  0
    8.9894   -0.0154    0.0000 O   0  0
    8.9894   -1.5154    0.0000 C   0  0
    7.6901   -2.2650    0.0000 O   0  0
   10.2894   -2.2654    0.0000 C   0  0
   11.5894   -1.5154    0.0000 C   0  0
   12.8879   -2.2662    0.0000 O   0  0
   11.5908   -0.0146    0.0000 C   0  0
   12.8908    0.7354    0.0000 C   0  0
   14.1894   -0.0154    0.0000 O   0  0
   12.8922    2.2354    0.0000 O   0  0
   11.5906   -3.0454    0.0000 C   0  0
   10.2919   -3.7960    0.0000 O   0  0
   12.8897   -3.7951    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 15 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
 34 40  1  0
 40 41  1  0
 40 42  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7563

> <plate>
1

> <well>
A14

> <supplier_cmpd_name>
Clomifene citrate

> <ctcr_id>
6902

> <supplier_cmpd_id>
S2561

> <smiles>
CCN(CC)CCOc1ccc(cc1)\C(=C(Cl)\c2ccccc2)c3ccccc3.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Clomifene citrate","CLOMIPHENE CITRATE",50-41-9,50419,"Zuclomiphene citrate",Clomid,"Clomiphene citrate salt","Clomiphene A citrate","cis-Clomiphene citrate","cisClomiphene citrate",Milophene,Seroph
ene,Chloramiphene,Omifin,"Clomifene citrate (Serophene)",UNII-UY5,UNIIUY5,S2561,1500196,"Clomifene citrate"}

> <pdid>

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones","gonad stimulating principle"}

> <pubchem_cids>
{3033832,57420540}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 48 47  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.3996    1.4837    0.0000 C   0  0
   -9.0964   -0.7636    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   20.6848   -5.2570    0.0000 C   0  0
   20.6869   -3.7570    0.0000 O   0  0
   19.3887   -3.0039    0.0000 C   0  0
   19.3909   -1.5031    0.0000 C   0  0
   18.0926   -0.7500    0.0000 C   0  0
   18.0926    0.7500    0.0000 C   0  0
   16.7936    1.5000    0.0000 C   0  0
   15.4946    0.7500    0.0000 C   0  0
   14.1933    1.4977    0.0000 O   0  0
   12.8946    0.7455    0.0000 C   0  0
   11.5933    1.4932    0.0000 C   0  0
   11.5907    2.9932    0.0000 O   0  0
   10.2946    0.7409    0.0000 C   0  0
    8.9933    1.4887    0.0000 N   0  0
    7.6946    0.7364    0.0000 C   0  0
    6.3940    1.4837    0.0000 C   0  0
    7.6972   -0.7636    0.0000 C   0  0
   15.4946   -0.7500    0.0000 C   0  0
   16.7936   -1.5000    0.0000 C   0  0
   27.0869    0.7431    0.0000 O   0  0
   27.0869   -0.7569    0.0000 C   0  0  2  0  0  0
   25.7869   -1.5069    0.0000 C   0  0  1  0  0  0
   25.7869   -3.0069    0.0000 O   0  0
   24.4869   -0.7569    0.0000 C   0  0
   24.4869    0.7431    0.0000 O   0  0
   23.1876   -1.5065    0.0000 O   0  0
   28.3869   -1.5069    0.0000 C   0  0
   28.3869   -3.0069    0.0000 O   0  0
   29.6862   -0.7573    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
  8 18  1  0
 18 19  2  0
 19  5  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 27 37  1  0
 37 38  2  0
 38 24  1  0
 40 39  1  1
 40 41  1  0
 41 42  1  1
 41 43  1  0
 43 44  1  0
 43 45  2  0
 40 46  1  0
 46 47  1  0
 46 48  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7564

> <plate>
1

> <well>
A15

> <supplier_cmpd_name>
Metoprolol Tartrate

> <ctcr_id>
3353

> <supplier_cmpd_id>
S1856

> <smiles>
COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc2ccc(OCC(O)CNC(C)C)cc2.O[C@H]([C@@H](O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Metoprolol tartrate",56392-17-7,56392177,Metoproferm,Selectadril,Arbralene,Azumetop,Beprolo,Bloksan,Cardoxone,Jeprolol,Kapodine,Mepolol,Metoberag,Metoberta,Metocard,Metolol,Metomerck,Metoprolin,Prol
aken,Ritmolol,Selopral,Sigaprolol,Topromel,Vasocardin,Bloxa,T0487,S1856,Prestw-733,"Metoprolol Tartrate","Metoprolol-(+,-) (+)-tartrate salt"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{441308}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 31  0  0  1  0            999 V2000
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2973   -2.2519    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0  1  0  0  0
    6.4897   -5.2632    0.0000 O   0  0
    5.1873   -7.5117    0.0000 C   0  0
    6.4855   -8.2648    0.0000 O   0  0
    6.4833   -9.7656    0.0000 C   0  0
    5.1817  -10.5112    0.0000 C   0  0
    5.1765  -12.0112    0.0000 C   0  0
    6.4730  -12.7657    0.0000 C   0  0
    7.7746  -12.0202    0.0000 C   0  0
    9.0710  -12.7747    0.0000 Cl  0  0
    7.7798  -10.5202    0.0000 C   0  0
    9.0821   -9.7743    0.0000 C   0  0
   10.3838   -9.0289    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  8  1  0
 13 14  2  0
 14  5  1  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 27 21  1  0
 27 28  1  0
 28 29  3  0
M  END
> <name>
Selleck_GPCR

> <id>
7565

> <plate>
1

> <well>
A16

> <supplier_cmpd_name>
NPS-2143

> <ctcr_id>
7523

> <supplier_cmpd_id>
S2633

> <smiles>
CC(C)(Cc1ccc2ccccc2c1)NC[C@@H](O)COc3cccc(Cl)c3C#N

> <pd_targets>
{CASR,GRM5,KCNH2,SLC6A2,CYP2D6,ADRB2,GPRC6A,SLC6A3,SLC6A4}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel",Transporter,Enzyme,"Family C G protein-coupled receptor","Voltage-gated ion channel","Electrochemical transporter","Cytochrome P450","Family A G protein-coupled rece
ptor","Ion receptor (family C GPCR)","Small molecule receptor (family C GPCR)","Potassium channels","SLC superfamily of solute carriers","Cytochrome P450 family 2","Small molecule receptor (family A G
PCR)","Calcium sensing receptor","Neurotransmitter receptor (family C GPCR)","Voltage-gated potassium channel","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2D","Monoamine recept
or","Metabotropic glutamate receptor","Cytochrome P450 2D6","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"Ion channels",Transporters,Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","SLC superfamily of solute carriers","Cytochrome P450","Calcium-sensing receptor","Metabotropi
c glutamate receptors","Potassium channels","SLC6 neurotransmitter transporter family","CYP2 family: drug metabolising subset",Adrenoceptors,"Orphan and other 7TM receptors","Voltage-gated potassium c
hannels","Monoamine transporter subfamily","Class C Orphans"}

> <pathway_reactome>
{"Signal Transduction","Muscle contraction",Disease,Metabolism,"Neuronal System","Signaling by GPCR","Cardiac conduction","Disorders of transmembrane transporters","Biological oxidations","Infectious 
disease","Transmission across Chemical Synapses","GPCR downstream signalling","Phase 3 - rapid repolarisation","SLC transporter disorders","Phase I - Functionalization of compounds","Leishmania infect
ion","Neurotransmitter clearance","G alpha (i) signalling events","G alpha (q) signalling events","Defective SLC6A2 causes orthostatic intolerance (OI)","Cytochrome P450 - arranged by substrate type",
"Leishmania parasite growth and survival","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance from the synaptic cleft",Xenobiotics,"Anti-inflammatory response favour
ing Leishmania parasite infection","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{CASR}

> <broad_moa>
{"calcium receptor antagonist"}

> <synonyms>
{NPS-2143,NPS2143,284035-33-2,284035332,"NPS 2143",SB-262470,SB262470,UNII-Z25PJ77W7V,UNIIZ25PJ77W7V,CHEMBL180672,Z25PJ77W7V,C24H25ClN2O2,"284035-33-2 (free base); 324523-20-8 (HCl).","284035332 (free
 base); 324523208 (HCl).",(+)-NPS-2143,(+)NPS2143,GTPL716,cc-312,cc312,SCHEMBL13597018,DTXSID10426075,EX-A017,EXA017,BCPP000077,BCP02421,ZINC,S2633}

> <pdid>
PD010908

> <targets>
{CaSR}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{6918446}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 41 42  0  0  0  0            999 V2000
    5.1965   -1.5117    0.0000 C   0  0
    3.8999   -0.7576    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
    1.2941   -3.7520    0.0000 C   0  0
    1.2894   -5.2521    0.0000 C   0  0
   -0.0120   -5.9981    0.0000 C   0  0
   -1.3087   -5.2440    0.0000 C   0  0
   -2.6123   -5.9877    0.0000 O   0  0
   -3.9086   -5.2314    0.0000 C   0  0
   -5.2123   -5.9751    0.0000 C   0  0
   -6.5086   -5.2188    0.0000 N   0  0
   -7.8115   -5.9621    0.0000 C   0  0
   -6.5013   -3.7189    0.0000 C   0  0
   -1.3040   -3.7440    0.0000 C   0  0
   -0.0027   -2.9981    0.0000 C   0  0
   10.2915   -1.5124    0.0000 O   0  0
   10.2915   -3.0124    0.0000 C   0  0
    8.9922   -3.7620    0.0000 O   0  0
   11.5915   -3.7624    0.0000 C   0  0
   12.8915   -3.0124    0.0000 C   0  0
   14.1900   -3.7632    0.0000 O   0  0
   12.8929   -1.5115    0.0000 C   0  0
   14.1929   -0.7615    0.0000 C   0  0
   15.4914   -1.5124    0.0000 O   0  0
   14.1943    0.7385    0.0000 O   0  0
   12.8927   -4.5423    0.0000 C   0  0
   11.5940   -5.2930    0.0000 O   0  0
   14.1918   -5.2921    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  3 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 10 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 20 27  1  0
 27 28  2  0
 28 17  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
 35 36  1  0
 36 37  1  0
 36 38  2  0
 33 39  1  0
 39 40  1  0
 39 41  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7566

> <plate>
1

> <well>
A17

> <supplier_cmpd_name>
Tamoxifen Citrate

> <ctcr_id>
5844

> <supplier_cmpd_id>
S1972

> <smiles>
CC/C(c1ccccc1)=C(c2ccccc2)/c3ccc(OCCN(C)C)cc3.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"RESTW 14",Tamoxan,Tamoxene,Tamoxin,Tamox,MLS001055370,"Tamoxifen citrate",54965-24-1,54965241,"54965 24 1",Istubal,"Tamoxifen (Citrate)","Tamoxifen citrate salt",UNII-7FRV7310N6,UNII7FRV7310N6,"UNII
 7FRV7310N6",C32H37NO8,"ICI 46474","ICI 46,474","Tamoxifen Citrate (Nolvadex)","54965-24-1 (citrate)","54965241 (citrate)","54965 24 1 (citrate)",7FRV7310N,T0835,180973,S1972,NSC180973,1500557,Prestw-
146,"NSC 180973
NSC 180973","Tamoxifen Z-isomer citrate","Tamoxifen Citrate","TAMOXIFEN CITRATE"}

> <pdid>

> <targets>
{Estrogen/progestogen Receptor,Apoptosis,Autophagy,Estrogen Receptor/ERR,HSP}

> <classes>
{antineoplastic,Endocrinology & Hormones,SERM,estrogen antagonist,Apoptosis,Autophagy,Cell Cycle/DNA Damage,Metabolic Enzyme/Protease,Others}

> <pubchem_cids>
{25010734,2733525}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 33 34  0  0  0  0            999 V2000
   11.4915   -4.5069    0.0000 H   0  3
    8.9915   -4.5069    0.0000 Cl  0  5
   -3.8983   -9.7601    0.0000 C   0  0
   -2.6003  -10.5119    0.0000 C   0  0
   -1.2990   -9.7642    0.0000 C   0  0
    0.0001  -10.5141    0.0000 C   0  0
    1.2991   -9.7641    0.0000 C   0  0
    1.2991   -8.2640    0.0000 C   0  0
    2.5973   -7.5109    0.0000 O   0  0
    2.5952   -6.0101    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -7.5141    0.0000 C   0  0
   -1.2990   -8.2642    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 23  1  0
 30 31  2  0
 31 20  1  0
  8 32  1  0
 32 33  2  0
 33  5  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7567

> <plate>
1

> <well>
A18

> <supplier_cmpd_name>
JTC-801

> <ctcr_id>
3850

> <supplier_cmpd_id>
S2722

> <smiles>
[H+].[Cl-].CCc1ccc(OCc2ccccc2C(=O)Nc3ccc4nc(C)cc(N)c4c3)cc1

> <pd_targets>
{OPRK1,MAPT,FFP,OPRL1,RORC,OPRM1,OPRD1}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Transcription factor","Family A G protein-coupled receptor",Transferase,"Nuclear receptor","Peptide receptor (family A GPCR)","Nuclear hormone re
ceptor subfamily 1","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Opioid receptor","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Nuclear hormone receptors","Opioid receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System","Signal Transduction","RNA Polymerase II Transcription","Transmission across Chemical Synapses","Signaling by GPCR","Generic Transcription Pathway"
,"Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","GPCR downstream signalling","Transcriptional Regulation by MECP2","Activation of NMDA receptors and postsynapt
ic events","Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX3","G alpha (i) signalling events","MECP2 regulates neuronal receptors and channels","Post NMDA receptor activation
 events","Peptide ligand-binding receptors","RUNX3 Regulates Immune Response and Cell Migration","Opioid Signalling","Activation of AMPK downstream of NMDARs","G-protein activation"}

> <broad_targets>
{OPRL1}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{TC80,JTC-801,JTC801,244218-51-7,244218517,"JTC 801","JTC-801 HCl","JTC801 HCl",UNII-7I21WLZ2FP,UNII7I21WLZ2FP,TCMDC-125882,TCMDC125882,7I21WLZ2FP,MFCD06198707,"244218-51-7 (free base).","244218517 (f
ree base).",C26H26ClN3O2,cc-187,cc187,MLS006011235,CHEMBL531742,SCHEMBL2240337,DTXSID10415525,EX-A084,EXA084,AOB33759,BCP02544,ABP000782,s272,S2722}

> <pdid>
PD048896

> <targets>
{Opioid Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{5311339}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 15  0  0  0  0            999 V2000
    7.4300    0.2350    0.0000 H   0  3
    4.9300    0.2350    0.0000 Cl  0  5
    2.4768   -0.6464    0.0000 C   0  0
    1.1700    0.0900    0.0000 C   0  0
    1.1700    1.5200    0.0000 C   0  0
    0.0000    2.2400    0.0000 C   0  0
   -1.3200    1.5200    0.0000 C   0  0
   -1.3200    0.0900    0.0000 C   0  0
   -2.7075    0.6600    0.0000 C   0  0
    0.0000   -0.6200    0.0000 C   0  0
   -2.1100   -0.8400    0.0000 C   0  0
   -1.0400   -0.3900    0.0000 C   0  0
   -1.3177   -1.8641    0.0000 N   0  0
   -1.0400    1.1000    0.0000 C   0  0
    0.0400   -1.0200    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10  4  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14  6  1  0
 12 15  1  0
 15  4  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7568

> <plate>
1

> <well>
A19

> <supplier_cmpd_name>
Memantine HCl

> <ctcr_id>
5993

> <supplier_cmpd_id>
S2043

> <smiles>
[H+].[Cl-].CC12CC3CC(C)(C1)CC(N)(C3)C2

> <pd_targets>
{GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,HTT,LMNA,AMPC,NPSR1,PMP22,MTOR,SLC22A1,HTR3A,CHRNA7,DRD2,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG
3,GABRP,GABRQ,GLRA1,GLRA2,GLRA3,GLRB}

> <pathway_gtopdb>
{"Ion channel","Unclassified protein","Other nuclear protein",Enzyme,"Membrane receptor",Transporter,"Ligand-gated ion channel",Hydrolase,"Family A G protein-coupled receptor",Kinase,"Electrochemical 
transporter","Ionotropic glutamate receptor","Peptide receptor (family A GPCR)","Protein Kinase","SLC superfamily of solute carriers","5HT3 receptor","Small molecule receptor (family A GPCR)","GABA-A 
receptor","Glycine receptor","NMDA receptor","Short peptide receptor (family A GPCR)","Atypical protein kinase group","SLC22 family of organic cation and anion transporters","Monoamine receptor","Neur
opeptide receptor","Atypical protein kinase PIKK family","Dopamine receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,Transporters,"Ligand-gated ion channels","G protein-coupled receptors","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","Ionotropic glutamate receptors","N
europeptide S receptor",Atypical,"SLC22 family of organic cation and anion transporters","5-HT<sub>3</sub> receptors","Dopamine receptors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) famil
y","Organic cation transporters (OCT)","FRAP subfamily"}

> <pathway_reactome>
{"Neuronal System","Gene expression (Transcription)","Cell Cycle",Disease,"Developmental Biology","Transport of small molecules","Signal Transduction","Transmission across Chemical Synapses","RNA Poly
merase II Transcription",Mitotic,"Infectious disease","Nervous system development","SLC-mediated transmembrane transport","Signaling by GPCR","Neurotransmitter receptors and postsynaptic signal transm
ission","Generic Transcription Pathway","M Phase","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Transport of bile salts and organic acids","metal ions and am
ine compounds","GPCR ligand binding","Activation of NMDA receptors and postsynaptic events","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survi
val","Transcriptional Regulation by TP53","Organic cation/anion/zwitterion transport","Class A/1 (Rhodopsin-like receptors)","Post NMDA receptor activation events","Regulation of MECP2 expression and 
activity","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Regulation of TP53 Activity","Organic cation transport","Amine ligand-binding receptors","Long-term p
otentiation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Dopamine receptors","CREB1 phosphorylation th
rough NMDA receptor-mediated activation of RAS signaling","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{"MEMANTINE HYDROCHLORIDE",41100-52-1,41100521,"41100 52 1","Memantine HCL","3,5-Dimethyl-1-adamantanamine hydrochloride","3,5Dimethyl1adamantanamine hydrochloride","3,5 Dimethyl 1 adamantanamine hydr
ochloride",3,5-dimethyladaman,5dimethyladaman,S2043,SAM002699890,1501121,Prestw-978,"Memantine HCl",CPD000875213,"Memantine Hydrochloride"}

> <pdid>
PD009581

> <targets>
{"AMPA Receptor-kainate Receptor-NMDA Receptor"}

> <classes>
{"muscle relaxant (skeletal)","Neuronal Signaling"}

> <pubchem_cids>
{43834392,181458,66766747}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 19  0  0  0  0            999 V2000
   -3.9477   -7.1844    0.0000 C   0  0
   -2.8628   -6.1485    0.0000 N   0  0
   -1.4233   -6.5700    0.0000 C   0  0
   -0.3384   -5.5341    0.0000 C   0  0
   -0.6928   -4.0817    0.0000 C   0  0
   -2.1327   -3.6551    0.0000 C   0  0
   -3.2175   -4.6910    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17  8  1  0
 17 11  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7569

> <plate>
1

> <well>
A20

> <supplier_cmpd_name>
BRL-54443

> <ctcr_id>
939

> <supplier_cmpd_id>
S2852

> <smiles>
CN1CCC(CC1)c2c[nH]c3ccc(O)cc23

> <pd_targets>
{BLM,CYP1A2,HTR1F,HTR1E,THPO,CYP2D6,CYP3A4,CYP2C9,CHRM1,MAPT,NFO,ALD,NPSR1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Unclassified protein","Other cytosolic protein","Cytochrome P450","Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450 family 1","Small molecule receptor (fami
ly A GPCR)","Cytochrome P450 family 2","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Cytochrome P450 family 1A","Monoamine receptor","Cytochrome P450 family 2D","Cytochrome P450 famil
y 3A","Cytochrome P450 family 2C","Short peptide receptor (family A GPCR)","Cytochrome P450 1A1","Serotonin receptor","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C9","Acetylcholine r
eceptor","Neuropeptide receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","CYP1 family","5-Hydroxytryptamine receptors","CYP2 family: drug metabolising subset","CYP3 family","Acetylcholine receptors (muscari
nic)","Neuropeptide S receptor"}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Signal Transduction",Hemostasis,"Neuronal System",Disease,"DNA Double-Strand Break Repair","Biological oxidations","Signaling by GPCR","Platelet activation","signaling and ag
gregation","Metabolism of lipids","Transmission across Chemical Synapses","Infectious disease","Homology Directed Repair","Phase I - Functionalization of compounds","GPCR ligand binding","Platelet Agg
regation (Plug Formation)","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","HDR through Homologous 
Recombination (HRR) or Single Strand Annealing (SSA)","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Activation of NMDA recep
tors and postsynaptic events","Leishmania parasite growth and survival","HDR through Homologous Recombination (HRR)",Xenobiotics,"Amine ligand-binding receptors","Biosynthesis of maresins","Post NMDA 
receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection","Homologous DNA Pairing and Strand Exchange","Aromatic amines can be N-hydroxylated or N-dealkylated by
 CYP1A2","Serotonin receptors","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Muscarinic acetylcholine receptors","Activation of AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory
 cytokines production","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{HTR1E,HTR1F}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{57477-39-1,57477391,"BRL 54443",BRL-54443,BRL54443,3-(1-methylpiperidin-4-yl)-1H-indol-5-ol,3(1methylpiperidin4yl)1Hindol5ol,UNII-Q2DH1CHI0Y,UNIIQ2DH1CHI0Y,"1H-Indol-5-ol, 3-(1-methyl-4-piperidinyl)-
","1HIndol5ol, 3(1methyl4piperidinyl)",5-Hydroxy-3-(1-methylpiperidin-4-yl)-1H-indole,5Hydroxy3(1methylpiperidin4yl)1Hindole,Q2DH1CHI0Y,C14H18N2O,5-Hydroxy-3-(1-methylpiperidine-4-yl),5Hydroxy3(1methy
lpiperidine4yl),T2459,S2852}

> <pdid>
PD010549

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{2438}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 29  0  0  0  0            999 V2000
    5.1893   -7.5096    0.0000 C   0  0
    5.1901   -6.0096    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3032    3.7490    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8983    0.7459    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 O   0  0
   -2.5951   -3.0031    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.2153   -4.4912    0.0000 N   0  0
    5.2143   -2.9912    0.0000 C   0  0
    6.5150   -5.2400    0.0000 C   0  0
    2.5909   -6.0072    0.0000 C   0  0
    2.5897   -7.5072    0.0000 C   0  0
    1.2900   -8.2562    0.0000 C   0  0
   -0.0084   -7.5052    0.0000 C   0  0
   -0.0072   -6.0052    0.0000 C   0  0
    1.2924   -5.2562    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  2  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 19  8  1  0
  3 20  1  0
 20 21  1  0
 20 22  1  0
  3 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7570

> <plate>
1

> <well>
A21

> <supplier_cmpd_name>
Trimebutine

> <ctcr_id>
4103

> <supplier_cmpd_id>
S2085

> <smiles>
CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c2ccccc2

> <pd_targets>
{OPRD1,MAPT,MAPK1,KMT2A,MEN1,CYP3A4,LMNA,HIF1A,ALDH1A1,OPRM1,CACNA1A,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNB1,CACNB2,CACNB3,CACNB4,KCNMA1,KCNMB1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN3,KCNN4,CACNA1G,CACN
A1H,CACNA1I,CHRM1,CHRM2,CHRM3,CHRM4}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Epigenetic regulator","Other nuclear protein","Transcription factor","Ion channel","Family A G protein-coupled receptor",Kinase,Reader,"Cytochrom
e P450",Oxidoreductase,"Voltage-gated ion channel","Peptide receptor (family A GPCR)","Protein Kinase",Bromodomain,"Cytochrome P450 family 3","Voltage-gated calcium channel","Small molecule receptor (
family A GPCR)","Short peptide receptor (family A GPCR)","CMGC protein kinase group","Cytochrome P450 family 3A","Monoamine receptor","Opioid receptor","CMGC protein kinase MAPK family","Cytochrome P4
50 3A4","Acetylcholine receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cytochrome P450","Opioid receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","Acetylcholine receptors (mus
carinic)","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System","Immune System",Metabolism,"Cell Cycle","Cellular responses to external stimuli","Signaling by GPCR","Transmission across Chemical Synapses","Innate Immune Sys
tem","Metabolism of lipids",Mitotic,"Cellular responses to stress","Biological oxidations","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor C
ascades","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Cellular response to hypoxia","Phase I - Functionalization of compounds","GPCR downstream signalling","Class A/1 (Rhodop
sin-like receptors)","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Oxygen-dependent 
proline hydroxylation of Hypoxia-inducible Factor Alpha","Ethanol oxidation","G alpha (i) signalling events","Peptide ligand-binding receptors","Post NMDA receptor activation events","MyD88 cascade in
itiated on plasma membrane","Biosynthesis of maresins","Mitotic Anaphase","Opioid Signalling","Amine ligand-binding receptors","Activation of AMPK downstream of NMDARs","MAP kinase activation","Biosyn
thesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","G-protein activation","Muscarinic acetylcholine receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclea
r Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{OPRD1,OPRK1,OPRM1}

> <broad_moa>
{"opioid receptor agonist"}

> <synonyms>
{trimebutine,39133-31-8,39133318,"2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate","2(Dimethylamino)2phenylbutyl 3,4,5trimethoxybenzoate","Benzoic acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2
-phenylbutyl ester","Benzoic acid, 3,4,5trimethoxy, 2(dimethylamino)2phenylbutyl ester","TRIMEBUTINE FREE BASE",3,4,"5-Trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl es","5Trimethoxybenzoic ac
id 2(dimethylamino)2phenylbutyl es",T0918,S2085,Trimebutine}

> <pdid>
PD009062

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5573}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 20  0  0  0  0            999 V2000
    6.4924   -3.7566    0.0000 C   0  0
    5.1945   -3.0045    0.0000 N   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 N   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  2  0
 17  8  1  0
 17 18  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7571

> <plate>
1

> <well>
A22

> <supplier_cmpd_name>
VUF 10166

> <ctcr_id>
4848

> <supplier_cmpd_id>
S2865

> <smiles>
CN1CCN(CC1)c2nc3ccccc3nc2Cl

> <pd_targets>
{HRH4,HTR3A,HTR3B}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Family A G protein-coupled receptor","Ligand-gated ion channel","Small molecule receptor (family A GPCR)","5HT3 receptor","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Ligand-gated ion channels","Histamine receptors","5-HT<sub>3</sub> receptors"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System","Signaling by GPCR","Transmission across Chemical Synapses","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Class A/1 
(Rhodopsin-like receptors)","Amine ligand-binding receptors","Histamine receptors"}

> <broad_targets>
{HTR3A,HTR3B}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{155584-74-0,155584740,"VUF 10166",2-chloro-3-(4-methylpiperazin-1-yl)quinoxaline,2chloro3(4methylpiperazin1yl)quinoxaline,CHEMBL261010,"Quinoxaline, 2-chloro-3-(4-methyl-1-piperazinyl)-","Quinoxaline
, 2chloro3(4methyl1piperazinyl)",VUF10166;VUF-10166,VUF10166;VUF10166,VUF-10166,VUF10166,SCHEMBL404203,DTXSID60640663,HMS3651F21,HMS3884N20,EX-A4554,EXA4554,7806AA,BDBM5045,T6728,S2865}

> <pdid>
PD010540

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{24278976}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 13  0  0  1  0            999 V2000
    8.8982   -1.8787    0.0000 Cl  0  5
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0  2  0  0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3982   -1.8787    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  1
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  2  0
 14  7  1  0
M  CHG  2   1  -1  15   1
M  END
> <name>
Selleck_GPCR

> <id>
7572

> <plate>
1

> <well>
B03

> <supplier_cmpd_name>
Epinephrine HCl

> <ctcr_id>
7535

> <supplier_cmpd_id>
S3061

> <smiles>
[Cl-].CNC[C@H](O)c1ccc(O)c(O)c1.[H+]

> <pd_targets>
{TDP1,FFP,RORC,ADRA2B,ADRB3,MAPT,HTR7,ADRA1A,SLC6A2,ADRA1B,DRD2,ADRB2,KMT2A,ALD,GRK2,ADRA2C,APEX1,MEN1,ADRA2A,ADRB1,SLC22A1,PMP22,BLM,TGR,KDM4E,NPSR1,CYP2D6,THPO,ADRA1D,HIF1A,MAPK1,CYP3A4,ALDH1A1,CYP1
A2,ABCC1,RECQL,TSHR,HSD17B10,ALOX15,CHRM1,GAA,RXFP1,NFKB1,MTOR,CA1,TNF}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other cytosolic protein",Transporter,"Epigenetic regulator","Unclassified protein",Hydrolase,Transferase,"Nuclear receptor","Family A G protein-coup
led receptor","Electrochemical transporter",Reader,Kinase,Eraser,"Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers",Bromodomain,"Prot
ein Kinase","Lysine demethylase","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","SLC06 neurotransmitter transporter family","AGC protein kinase 
group","SLC22 family of organic cation and anion transporters","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F member 3","Adrenergic 
receptor","Serotonin receptor","Dopamine receptor","AGC protein kinase GRK family","Neuropeptide receptor","AGC protein kinase BARK subfamily","Secreted protein","Cytochrome P450",Oxidoreductase,"Prim
ary active transporter",Lyase,"Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","ATP-binding cassette","Cytochrome P450 family 2D","CMGC protein kinase group","Cytochrom
e P450 family 3A","Cytochrome P450 family 1A","ABCC subfamily","Glycohormone receptor","Relaxin-like peptide receptor (family A GPCR)","Atypical protein kinase group","Cytochrome P450 2D6","CMGC prote
in kinase MAPK family","Cytochrome P450 3A4","Cytochrome P450 1A1","Acetylcholine receptor","Relaxin receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase
 FRAP subfamily"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","SLC superfamily of solute carriers","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","1F. Retinoic acid-r
elated orphans",Adrenoceptors,"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","Dopamine receptors","2.1.1.43 Histone methyltransferases (HMTs)","AGC: Containing PKA",PKG,"PK
C families","SLC22 family of organic cation and anion transporters","1.14.11.- Histone demethylases","Neuropeptide S receptor","Monoamine transporter subfamily","G protein-coupled receptor kinases (GR
Ks)","Organic cation transporters (OCT)","Beta-adrenergic receptor kinases (&beta;ARKs)","Cytochrome P450","ATP-binding cassette transporter family","Eicosanoid turnover","3.2.1.- Glycosidases","Carbo
nic anhydrases","CYP2 family: drug metabolising subset","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","CYP1 family","ABCC subfamily","Glycoprotein hormone receptors",Lipoxygenases,"Ace
tylcholine receptors (muscarinic)","Relaxin family peptide receptors",Atypical,"Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK su
bfamily","FRAP subfamily"}

> <pathway_reactome>
{"DNA Repair","Gene expression (Transcription)","Signal Transduction",Disease,"Neuronal System","Transport of small molecules","Developmental Biology","DNA Double-Strand Break Repair","RNA Polymerase 
II Transcription","Signaling by GPCR","Infectious disease","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Intracellular signaling by second messengers","Base Excisi
on Repair","SLC-mediated transmembrane transport","Nervous system development","Nonhomologous End-Joining (NHEJ)","Generic Transcription Pathway","GPCR ligand binding","Leishmania infection","Neurotra
nsmitter receptors and postsynaptic signal transmission","SLC transporter disorders","DAG and IP3 signaling","Resolution of Abasic Sites (AP sites)","Transport of bile salts and organic acids","metal 
ions and amine compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)","Leis
hmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Defective SLC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","CaM pathway","
Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Organic cation/anion/zwitterion transport","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)",
"RUNX3 Regulates Immune Response and Cell Migration","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","RUNX1
 regulates genes involved in megakaryocyte differentiation and platelet function","Calmodulin induced events","PCNA-Dependent Long Patch Base Excision Repair","Organic cation transport","HDR through H
omologous Recombination (HRR)",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Dopamine receptors","Homologous DNA Pairing and Strand
 Exchange","Presynaptic phase of homologous DNA pairing and strand exchange",Metabolism,Hemostasis,"Cellular responses to external stimuli","Immune System","Biological oxidations","Platelet activation
","signaling and aggregation","Cellular responses to stress","Innate Immune System","Metabolism of lipids","Metabolism of amino acids and derivatives","Diseases of metabolism","Cytokine Signaling in I
mmune system","Phase I - Functionalization of compounds","Platelet Aggregation (Plug Formation)","Cellular response to hypoxia","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving 
mediators (SPMs)","Fatty acid metabolism","Branched-chain amino acid catabolism","Diseases of carbohydrate metabolism","Signaling by Interleukins","Cytochrome P450 - arranged by substrate type","Oxyge
n-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Arachidonic acid metabolism","Biosynt
hesis of DPA-derived SPMs","Glycogen storage diseases","Interleukin-1 family signaling","Transcriptional Regulation by TP53","Interleukin-12 family signaling","Interleukin-10 signaling",Xenobiotics,"M
yD88 cascade initiated on plasma membrane","Biosynthesis of maresins","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Biosynthesis of DPAn-3 SPMs","Glycogen storage disease type II (GAA)","Interleuk
in-1 signaling","Regulation of TP53 Activity","Interleukin-12 signaling","CYP2E1 reactions","MAP kinase activation","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-deal
kylated by CYP1A2","Biosynthesis of DPAn-3-derived protectins and resolvins","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Regulation of TP53 Expression and Degrad
ation","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","
ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,PAH,TNF}

> <broad_moa>
{"adrenergic receptor agonist","carbonic anhydrase activator",neurotransmitter}

> <synonyms>
{"Epinephrine hydrochloride","l-Adrenaline hydrochloride","lAdrenaline hydrochloride","(R)-adrenaline hydrochloride","(R)adrenaline hydrochloride",CHEBI:6213,"Epinephrine HCl","l-Epinephrine hydrochlo
ride","lEpinephrine hydrochloride",55-31-2,55312,"Adrenaline hydrochloride",GELATIN,"Adrenalin chloride",UNII-WBB047OO38,UNIIWBB047OO38,4-((1R)-1-hydroxy-2-(,4((1R)1hydroxy2(,S3061}

> <pdid>
PD003193

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{24906312,441411}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 25  0  0  0  0            999 V2000
   10.1943   -2.7559    0.0000 H   0  3
    7.6943   -2.7559    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 S   0  0
    5.1937   -3.0093    0.0000 O   0  0
    5.1912   -4.5090    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1884   -2.6409    0.0000 C   0  0
   -4.6234   -3.0602    0.0000 C   0  0
   -4.9781   -4.5176    0.0000 C   0  0
   -3.8933   -5.5536    0.0000 N   0  0
   -4.2480   -7.0110    0.0000 C   0  0
   -2.4537   -5.1320    0.0000 C   0  0
   -2.0990   -3.6745    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 17  1  0
 16 24  1  0
 24 13  1  0
 24 25  2  0
 25 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7573

> <plate>
1

> <well>
B04

> <supplier_cmpd_name>
Perindopril Erbumine

> <ctcr_id>
1837

> <supplier_cmpd_id>
S1506

> <smiles>
[H+].[Cl-].CN[S](=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1

> <pd_targets>
{HTR1B,HTR1D,HTR1F,HTR1A,HTR1E}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Serotonin receptors"}

> <broad_targets>
{HTR1A,HTR1B,HTR1D,HTR1E,HTR1F}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{"NARATRIPTAN HYDROCHLORIDE",143388-64-1,143388641,Amerge,"Naratriptan HCl",Naramig,GR-85548A,GR85548A,"GR 85548A","Naratriptan (hydrochloride)",UNII-10X8X4P12Z,UNII10X8X4P12Z,"GR-85548A hydrochloride
","GR85548A hydrochloride",10X8X4P12Z,MFCD08141821,DSSTox_CID_28990,DSSToxCID28990,DSSTox-CID-28990,"DSSTox CID 28990",DSSTox_RID_83255,DSSToxRID83255,DSSTox-RID-83255,"DSSTox RID 83255",DSSTox_GSID_4
9064,DSSToxGSID49064,DSSTox-GSID-49064,"DSSTox GSID 49064",CHEBI:,T6602,S1488,S1506,Naratriptan,Naratriptan,"Perindopril Erbumine"}

> <pdid>
PD009622

> <targets>
{"5-HT Receptor",RAAS}

> <classes>
{"Endocrinology & Hormones","Neuronal Signaling"}

> <pubchem_cids>
{60875,25137850}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 30  0  0  1  0            999 V2000
   -1.8778    2.7573    0.0000 C   0  0
   -1.0947    1.4779    0.0000 N   0  3
    0.0000    0.6568    0.0000 C   0  0  2  0  0  0
   -0.6568   -0.6386    0.0000 C   0  0
   -1.8063   -1.3319    0.0000 C   0  0
   -0.8393    0.0000    0.0000 C   0  0  1  0  0  0
    0.9488    0.0000    0.0000 C   0  0
    1.8975   -0.8028    0.0000 C   0  0  2  0  0  0
    1.6421    0.6933    0.0000 C   0  0
    2.6599   -2.0832    0.0000 O   0  0
    1.9266   -3.3927    0.0000 C   0  0
    2.6932   -4.6829    0.0000 C   0  0
    1.9623   -5.9928    0.0000 C   0  0
    2.7311   -7.2808    0.0000 C   0  0
    4.2309   -7.2590    0.0000 C   0  0
    4.9619   -5.9492    0.0000 C   0  0
    4.1931   -4.6612    0.0000 C   0  0
    0.4260   -3.4119    0.0000 C   0  0
   -0.3092   -4.7195    0.0000 C   0  0
   -1.8091   -4.7367    0.0000 C   0  0
   -2.5740   -3.4463    0.0000 C   0  0
   -1.8389   -2.1388    0.0000 C   0  0
   -0.3390   -2.1216    0.0000 C   0  0
    8.7619   -0.7614    0.0000 C   0  0
    8.7619   -2.2614    0.0000 S   0  0
    7.4627   -3.0110    0.0000 O   0  0
   10.0612   -3.0110    0.0000 O   0  0
    8.7619   -3.7614    0.0000 O   0  5
  1  2  1  0
  2  3  1  0
  3  4  1  1
  4  5  1  0
  6  5  1  6
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  8 10  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 11 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 24 25  1  0
 25 26  2  0
 25 27  2  0
 25 28  1  0
M  CHG  2   2   1  28  -1
M  END
> <name>
Selleck_GPCR

> <id>
7574

> <plate>
1

> <well>
B05

> <supplier_cmpd_name>
Benztropine mesylate

> <ctcr_id>
4750

> <supplier_cmpd_id>
S3163

> <smiles>
C[NH+]1[C@@H]2CC[C@H]1C[C@H](C2)OC(c3ccccc3)c4ccccc4.CS(=O)(=O)[O-]

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW123,"RESTW 123","BENZTROPINE MESYLATE",Cogentin,132-17-2,132172,"132 17 2","Benztropine mesilate","Benztropine methanesulfonate","benzatropine mesylate","Benzatropine mesilate",UNII-WMJ8TL7510,U
NIIWMJ8TL7510,"UNII WMJ8TL7510",Benztropine,S3163,Prestw-1236,"Benztropine mesylate"}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{3246155}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 29  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 C   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -3.8976    0.7553    0.0000 O   0  0
   -2.5951    3.0039    0.0000 N   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -3.8934    5.2570    0.0000 C   0  0
   -5.1924    6.0070    0.0000 C   0  0
   -6.4915    5.2571    0.0000 C   0  0
   -7.7905    6.0071    0.0000 Cl  0  0
   -6.4915    3.7571    0.0000 C   0  0
   -5.1925    3.0070    0.0000 C   0  0
   -7.7912    3.0067    0.0000 C   0  0
   -9.0915    3.7546    0.0000 C   0  0
  -10.3894    3.0026    0.0000 C   0  0
  -10.3870    1.5026    0.0000 C   0  0
   -9.0868    0.7546    0.0000 C   0  0
   -7.7890    1.5067    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11  5  1  0
  8 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7575

> <plate>
1

> <well>
B06

> <supplier_cmpd_name>
Vismodegib (GDC-0449)

> <ctcr_id>
5334

> <supplier_cmpd_id>
S1082

> <smiles>
C[S](=O)(=O)c1ccc(c(Cl)c1)C(=O)Nc2ccc(Cl)c(c2)c3ccccn3

> <pd_targets>
{ALB,SMO,SHH}

> <pathway_gtopdb>
{"Secreted protein","Membrane receptor","Unclassified protein","Frizzled family G protein-coupled receptor","Smoothened receptor (frizzled family GPCR)"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Class Frizzled GPCRs"}

> <pathway_reactome>
{Metabolism,"Organelle biogenesis and maintenance",Disease,"Metabolism of lipids","Cilium Assembly","Diseases of signal transduction by growth factor receptors and second messengers","Metabolism of st
eroids","Cargo trafficking to the periciliary membrane","Hh mutants abrogate ligand secretion","Bile acid and bile salt metabolism","BBSome-mediated cargo-targeting to cilium","HHAT G278V doesn't palm
itoylate Hh-Np","Recycling of bile acids and salts"}

> <broad_targets>
{SMO}

> <broad_moa>
{"hedgehog pathway inhibitor","smoothened receptor antagonist"}

> <synonyms>
{DC044,Vismodegib,879085-55-9,879085559,GDC-0449,GDC0449,Erivedge,2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide,2chloroN(4chloro3(pyridin2yl)phenyl)4(methylsulfonyl)benzamid
e,"Vismodegib (GDC-0449)","Vismodegib (GDC0449)",HhAntag691,"GDC 0449","GDC-0449 (Vismodegib)","GDC0449 (Vismodegib)",UNII-25X868M3DS,UNII25X868M3DS,NSC-747691,NSC747691,2-Chloro-N-(4-chloro-3-(2-p,2C
hloroN(4chloro3(2p,T2590,755986,S1082,"NSC 755986"}

> <pdid>
PD004109

> <targets>
{Hedgehog,P-gp,Hedgehog Signaling Pathway,Autophagy}

> <classes>
{Smoothened Receptor Antagonist,Neuronal Signaling,Autophagy,Stem Cell/Wnt}

> <pubchem_cids>
{24776445}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 29  0  0  1  0            999 V2000
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0031    3.0008    0.0000 C   0  0
    1.3039    3.7494    0.0000 S   0  0
    1.3070    5.2494    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.8481   -5.2205    0.0000 C   0  0
   -3.3481   -5.2205    0.0000 N   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 C   0  0
   -5.1962   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
    9.0003    1.5149    0.0000 C   0  0
    9.0003    0.0149    0.0000 S   0  0
    9.0003   -1.4851    0.0000 O   0  0
    7.7010   -0.7347    0.0000 O   0  0
   10.2996   -0.7347    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  7  8  1  0
  8  9  1  0
  6 10  1  0
 11 10  1  1
 11 12  1  0
 12  4  1  0
 12 13  1  6
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 11  1  0
 21 22  2  0
 22 14  1  0
 22 17  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 24 27  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7576

> <plate>
1

> <well>
B07

> <supplier_cmpd_name>
Pergolide mesylate

> <ctcr_id>
4632

> <supplier_cmpd_id>
S4000

> <smiles>
CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34.C[S](O)(=O)=O

> <pd_targets>
{DRD2,HTR1B,DRD3,HTR7,HTR1A,ADRA1B,ADRA2A,DRD1,ADRA2B,ADRA2C,ADRA1A,KCNH2,DRD5,HTR2A,HTR2B,HTR6,ADRA1D,DRD4,HTR2C,FFP,CYP3A4,HTR1D,HTR1F,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HRH1,BLM,CYP2D6}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel",Enzyme,"Family A G protein-coupled receptor","Voltage-gated ion channel",Transferase,"Cytochrome P450","Small molecule receptor (family A GPCR)","Potassium channels"
,"Cytochrome P450 family 3","Cytochrome P450 family 2","Monoamine receptor","Voltage-gated potassium channel","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Dopamine receptor","Serotonin rec
eptor","Adrenergic receptor","Cytochrome P450 3A4","Histamine receptor","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Cytochrome P450","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"Potassium channels","
CYP3 family","Histamine receptors","CYP2 family: drug metabolising subset","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Muscle contraction",Metabolism,"DNA Repair","Signaling by GPCR","Infectious disease","Cardiac conduction","Metabolism of lipids","DNA Double-Strand Break Repair","Biolo
gical oxidations","GPCR ligand binding","Leishmania infection","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","Homology Directed Repair","Phase I - Functi
onalization of compounds","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Stra
nd Annealing (SSA)","Cytochrome P450 - arranged by substrate type","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","HDR
 through Homologous Recombination (HRR)",Xenobiotics,"Dopamine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Biosynthesis of maresin-like SP
Ms","Histamine receptors","Homologous DNA Pairing and Strand Exchange","CYP2E1 reactions","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A,HTR1B,HTR1D,HTR2A,HTR2B,HTR2C}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{"PERGOLIDE MESYLATE",66104-23-2,66104232,"Pergolide Methanesulfonate","PERGOLIDE MESYLATE SALT","Pergolide (mesylate)","Pergolide mesilate",LY127809,UNII-55B9HQY616,UNII55B9HQY616,"8-beta-((Methylthi
o)methyl)-6-propylergoline methanesulfonate","8beta((Methylthio)methyl)6propylergoline methanesulfonate",MLS000069837,CHEBI:8021,55B9H,S4000,SAM001247070,1503269,Prestw-295,"Pergolide mesylate",CPD000
058504}

> <pdid>
PD009755

> <targets>
{"Dopamine Receptor"}

> <classes>
{"dopamine receptor agonist","Neuronal Signaling"}

> <pubchem_cids>
{47812,11292791}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 87 92  0  0  1  0            999 V2000
    9.0912    0.7685    0.0000 C   0  0
    7.7907    1.5158    0.0000 O   0  0
    6.4920    0.7636    0.0000 C   0  0
    6.4972   -0.7364    0.0000 C   0  0
    5.2007   -1.4909    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6015   -2.9986    0.0000 C   0  0  2  0  0  0
    3.9027   -3.7449    0.0000 C   0  0
    5.1996   -2.9912    0.0000 C   0  0
    6.5008   -3.7375    0.0000 C   0  0
    7.7968   -2.9807    0.0000 O   0  0
    7.7904   -1.4807    0.0000 C   0  0
    6.5050   -5.2375    0.0000 C   0  0
    7.8054   -5.9869    0.0000 O   0  0
    7.8075   -7.4869    0.0000 C   0  0
    5.2081   -5.9912    0.0000 C   0  0
    3.9070   -5.2449    0.0000 C   0  0
    2.6101   -5.9986    0.0000 C   0  0
    1.3089   -5.2523    0.0000 C   0  0
    1.3046   -3.7523    0.0000 N   0  3  1  0  0  0
    0.0266   -4.5375    0.0000 C   0  0
    1.3369   -2.2722    0.0000 C   0  0
    0.0737   -1.4618    0.0000 C   0  0
    0.1430    0.0375    0.0000 C   0  0
    1.4755    0.7263    0.0000 O   0  0
   -1.1202    0.8479    0.0000 O   0  0
   -1.0509    2.3471    0.0000 C   0  0
   -2.3141    3.1576    0.0000 C   0  0
   -2.2448    4.6568    0.0000 C   0  0
   -3.5080    5.4672    0.0000 C   0  0
   -3.4387    6.9664    0.0000 C   0  0
   -4.7019    7.7769    0.0000 O   0  0
   -4.6326    9.2761    0.0000 C   0  0
   -3.3001    9.9649    0.0000 O   0  0
   -5.8958   10.0865    0.0000 C   0  0
   -5.8265   11.5857    0.0000 C   0  0
   -7.0897   12.3962    0.0000 N   0  3  1  0  0  0
   -7.0200   13.8946    0.0000 C   0  0
   -7.1226   10.9169    0.0000 C   0  0
   -8.4552   10.2284    0.0000 C   0  0
   -9.7179   11.0382    0.0000 C   0  0
  -11.0505   10.3496    0.0000 C   0  0
  -12.3131   11.1594    0.0000 C   0  0
  -13.6451   10.4677    0.0000 O   0  0
  -13.7129    8.9692    0.0000 C   0  0
  -12.2431   12.6577    0.0000 C   0  0
  -13.5048   13.4706    0.0000 O   0  0
  -14.8393   12.7856    0.0000 C   0  0
  -10.9105   13.3463    0.0000 C   0  0
   -9.6479   12.5365    0.0000 C   0  0
   -8.3153   13.2251    0.0000 C   0  0  1  0  0  0
   -8.2247   14.7230    0.0000 C   0  0
   -6.8825   15.3945    0.0000 C   0  0
   -6.7898   16.8917    0.0000 C   0  0
   -5.4469   17.5600    0.0000 C   0  0
   -4.1967   16.7313    0.0000 C   0  0
   -2.8544   17.4028    0.0000 O   0  0
   -2.7639   18.9000    0.0000 C   0  0
   -4.2893   15.2341    0.0000 C   0  0
   -3.0400   14.4023    0.0000 O   0  0
   -3.1348   12.9053    0.0000 C   0  0
   -5.6321   14.5658    0.0000 C   0  0
    3.8939    0.7546    0.0000 C   0  0
    5.1903    1.5091    0.0000 C   0  0
    5.1821    3.0099    0.0000 O   0  0
    3.8794    3.7535    0.0000 C   0  0
   33.7127   -1.1054    0.0000 O   0  5
   33.7131    0.3946    0.0000 S   0  0
   35.0126    1.1438    0.0000 O   0  0
   35.0118   -0.3560    0.0000 O   0  0
   32.4134    1.1450    0.0000 C   0  0
   32.4134    2.6450    0.0000 C   0  0
   31.1143    3.3950    0.0000 C   0  0
   29.8153    2.6450    0.0000 C   0  0
   29.8153    1.1450    0.0000 C   0  0
   31.1143    0.3950    0.0000 C   0  0
   41.4107   -1.1054    0.0000 O   0  5
   41.4112    0.3946    0.0000 S   0  0
   42.7107    1.1438    0.0000 O   0  0
   42.7099   -0.3560    0.0000 O   0  0
   40.1114    1.1450    0.0000 C   0  0
   40.1114    2.6450    0.0000 C   0  0
   38.8124    3.3950    0.0000 C   0  0
   37.5134    2.6450    0.0000 C   0  0
   37.5134    1.1450    0.0000 C   0  0
   38.8124    0.3950    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  2  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 18  9  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  6
 38 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 44 47  2  0
 47 48  1  0
 48 49  1  0
 47 50  1  0
 50 51  2  0
 51 42  1  0
 51 52  1  0
 52 38  1  0
 52 53  1  1
 53 54  1  0
 54 55  2  0
 55 56  1  0
 56 57  2  0
 57 58  1  0
 58 59  1  0
 57 60  1  0
 60 61  1  0
 61 62  1  0
 60 63  2  0
 63 54  1  0
  6 64  1  0
 64 65  2  0
 65  3  1  0
 65 66  1  0
 66 67  1  0
 68 69  1  0
 69 70  2  0
 69 71  2  0
 69 72  1  0
 72 73  2  0
 73 74  1  0
 74 75  2  0
 75 76  1  0
 76 77  2  0
 77 72  1  0
 78 79  1  0
 79 80  2  0
 79 81  2  0
 79 82  1  0
 82 83  2  0
 83 84  1  0
 84 85  2  0
 85 86  1  0
 86 87  2  0
 87 82  1  0
M  CHG  4  21   1  38   1  68  -1  78  -1
M  END
> <name>
Selleck_GPCR

> <id>
7577

> <plate>
1

> <well>
B08

> <supplier_cmpd_name>
Cisatracurium Besylate

> <ctcr_id>
7439

> <supplier_cmpd_id>
S2113

> <smiles>
COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]4(C)CCc5cc(OC)c(OC)cc5[C@H]4Cc6ccc(OC)c(OC)c6)cc1OC.[O-][S](=O)(=O)c7ccccc7.[O-][S](=O)(=O)c8ccccc8

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{CHRNA2}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Cisatracurium besylate",Nimbex,96946-42-8,96946428,"Cisatracurium besilate","Cisatracurium (besylate)",UNII-80YS8O1MBS,UNII80YS8O1MBS,51W89,80YS8O1MBS,CHEBI:3721,"96946-42-8 (besylate)","96946428 (b
esylate)","(1R-cis,1'R-cis)-Atracurium besylate","(1Rcis,1'Rcis)Atracurium besylate","Cisatracurium besilate (INN)","NIMBEX PRESERVA",S2113,"Cisatracurium Besylate"}

> <pdid>
PD013187

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{62886}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 28  0  0  0  0            999 V2000
    0.0007    0.0004    0.0000 C   0  0
    1.3000    0.7500    0.0000 O   0  0
    2.6000    0.0000    0.0000 S   0  0
    2.6000   -1.5000    0.0000 O   0  5
    3.8993    0.7496    0.0000 O   0  0
    3.8989   -0.7502    0.0000 O   0  0
   15.4771   -2.2291    0.0000 C   0  0
   14.1962   -3.0096    0.0000 N   0  3
   14.1609   -4.5092    0.0000 C   0  0
   14.1962   -1.5096    0.0000 C   0  0
   12.8971   -0.7596    0.0000 C   0  0
   11.5981   -1.5096    0.0000 C   0  0
   11.5981   -3.0096    0.0000 C   0  0
   12.8971   -3.7596    0.0000 C   0  0
   10.2968   -0.7618    0.0000 C   0  0
    8.9981   -1.5141    0.0000 C   0  0
    7.6964   -0.7687    0.0000 C   0  0
    6.4000   -1.5232    0.0000 C   0  0
    6.4052   -3.0232    0.0000 C   0  0
    7.7068   -3.7687    0.0000 C   0  0
    9.0032   -3.0142    0.0000 C   0  0
   10.2942    0.7389    0.0000 C   0  0
    8.9948    1.4885    0.0000 C   0  0
    8.9943    2.9885    0.0000 C   0  0
   10.2930    3.7390    0.0000 C   0  0
   11.5923    2.9895    0.0000 C   0  0
   11.5929    1.4895    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  3  6  2  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  8  1  0
 12 15  2  3
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 15 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  CHG  2   4  -1   8   1
M  END
> <name>
Selleck_GPCR

> <id>
7578

> <plate>
1

> <well>
B09

> <supplier_cmpd_name>
Diphemanil Methylsulfate

> <ctcr_id>
675

> <supplier_cmpd_id>
S4034

> <smiles>
CO[S]([O-])(=O)=O.C[N+]1(C)CCC(CC1)=C(c2ccccc2)c3ccccc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"DIPHEMANIL METHYLSULFATE",62-97-5,62975,"Diphemanil metilsulfate",Prantal,"Diphenmanil methylsulfate","Diphemanil mesylate",Diphenmethanil,Demotil,Nivelon,Nivelona,Talpran,Variton,"Diphenmanil (meth
ylsulfate)","Diphemanil methosulfat",T0594,S4034,Prestw-79,"Diphemanil Methylsulfate","Diphemanil methylsulfate"}

> <pdid>

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{6126}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 21  0  0  0  0            999 V2000
    2.6030   -2.9977    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    3.8983   -0.7459    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -3.9020   -3.7404    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
   -5.1992   -2.9856    0.0000 C   0  0
   -6.5013   -3.7302    0.0000 F   0  0
   -5.1935   -1.4856    0.0000 F   0  0
   -6.4953   -2.2305    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7579

> <plate>
1

> <well>
B10

> <supplier_cmpd_name>
Niflumic acid

> <ctcr_id>
3764

> <supplier_cmpd_id>
S3018

> <smiles>
OC(=O)c1cccnc1Nc2cccc(c2)C(F)(F)F

> <pd_targets>
{ALDH1A1,KMT2A,MEN1,CYP2C9,KCNT2,TTR,PTGS2,NFKB1,LEF,GMNN,PKM,LMNA,TEAD4,GPR35,HIF1A,CYP3A4,CYP1A2,DHODH,PMP22,RORC,SOX18,UGT1A1,PTGS1,TRPC4,TRPA1,ANO1,CLCNKA,CLCNKB,KCNQ1,CLCN1,PLA2G1B}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Secreted protein","Other cytosolic protein","Unclassified protein","Other nuclear protein","Membrane receptor","Transcription factor","Ion channel",Oxidoreductase,Reade
r,"Cytochrome P450",Protease,"Family A G protein-coupled receptor","Nuclear receptor",Transferase,"Voltage-gated ion channel","Other ion channel",Hydrolase,Bromodomain,"Cytochrome P450 family 2","Meta
llo protease","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Transient receptor potential channel","Chloride ch
annel","Potassium channels","Cytochrome P450 family 2C","Metallo protease MAE clan","Carboxylic acid receptor","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Nuclear hormone receptor subfami
ly 1 group F","Calcium-activated chloride channel","Voltage-gated potassium channel","Cytochrome P450 2C9","Metallo protease M34 family","Kynurenic acid receptor","Cytochrome P450 3A4","Cytochrome P45
0 1A1","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,"Ion channels","Other protein targets",Receptors,"Cytochrome P450","Voltage-gated ion channels",Transthyretin,"Eicosanoid turnover","2.7.1.40 Pyruvate kinases","G protein-coupled receptors","
1.-.-.- Oxidoreductases","Nuclear hormone receptors","UDP glucuronosyltransferases (UGT)","Other ion channels","Glycerophospholipid turnover","CYP2 family: drug metabolising subset","Potassium channel
s",Cyclooxygenase,"Orphan and other 7TM receptors","CYP3 family","CYP1 family","1F. Retinoic acid-related orphans","Transient Receptor Potential channels","Chloride channels","Phospholipase A<sub>2</s
ub>","Calcium- and sodium-activated potassium channels","Class A Orphans","Calcium activated chloride channel","ClC family","Voltage-gated potassium channels"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Immune System",Disease,"Cell Cycle","Gene expression (Transcription)","Cellular responses to external stimuli","Developmental Biology","Transport of small molecules"
,"Muscle contraction","Biological oxidations","Signaling by GPCR","Metabolism of lipids","Cytokine Signaling in Immune system","Infectious disease",Mitotic,"Metabolism of carbohydrates","RNA Polymeras
e II Transcription","Cellular responses to stress","Metabolism of nucleotides","Nervous system development","Diseases of metabolism","Ion channel transport","Cardiac conduction","Phase I - Functionali
zation of compounds","GPCR downstream signalling","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins","Uptake and actions of bacterial toxins","Mitotic G1 phase and
 G1/S transition","Glucose metabolism","M Phase","Generic Transcription Pathway","GPCR ligand binding","Cellular response to hypoxia","Nucleobase biosynthesis","EGR2 and SOX10-mediated initiation of S
chwann cell myelination","Metabolic disorders of biological oxidation enzymes","Fatty acid metabolism","Axon guidance","Stimuli-sensing channels","Phase 2 - plateau phase","Phospholipid metabolism","E
thanol oxidation","Cytochrome P450 - arranged by substrate type","G alpha (i) signalling events","Biosynthesis of DPA-derived SPMs","Interleukin-1 family signaling","Uptake and function of anthrax tox
ins","G1/S Transition",Glycolysis,"Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-induc
ible Factor Alpha","Biosynthesis of DHA-derived SPMs","Pyrimidine biosynthesis","Defective UGT1A1 causes hyperbilirubinemia","Arachidonic acid metabolism","Netrin-1 signaling","TRP channels","Glycerop
hospholipid biosynthesis",Xenobiotics,"Visual phototransduction","Biosynthesis of DPAn-3 SPMs","Interleukin-1 signaling","Activation of the pre-replicative complex","Mitotic Anaphase","RUNX3 regulates
 YAP1-mediated transcription","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Role of second messengers in net
rin-1 signaling","Acyl chain remodelling of PC","CYP2E1 reactions","The canonical retinoid cycle in rods (twilight vision)","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Nuclear Envelope (NE) Reassemb
ly","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ANO1,CLCN1,CLCNKA,CLCNKB,KCNQ1,PLA2G1B,PLA2G4A,PTGS1,PTGS2,UGT1A9}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{4394-00-7,4394007,Nifluril,Forenol,Landruma,"Nifluminic acid","Acido niflumico","Acide niflumique","Acide niflumique (INN-French)","Acide niflumique (INNFrench)","Acido niflumico (INN-Spanish)","Acid
o niflumico (INNSpanish)","Acidum niflumicum (INN-Latin)","Acidum niflumicum (INNLatin)","UP 83",2-((3-(trifluoromethyl)phen,2((3(trifluoromethyl)phen,T0693,S3018,1502015,Prestw-255,"Niflumic acid","N
IFLUMIC ACID"}

> <pdid>
PD001431

> <targets>
{GABA Receptor,Chloride Channel}

> <classes>
{Neuronal Signaling,analgesic,antiinflammatory,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{4488}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 58 61  0  0  1  0            999 V2000
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
    7.7928   -6.0048    0.0000 C   0  0
    9.0914   -5.2526    0.0000 C   0  0
   10.3931   -5.9981    0.0000 C   0  0
   11.6896   -5.2436    0.0000 C   0  0
   11.6844   -3.7436    0.0000 C   0  0
   10.3828   -2.9981    0.0000 C   0  0
    9.0864   -3.7526    0.0000 C   0  0
   18.0831   -3.7516    0.0000 C   0  0
   19.3834   -3.0039    0.0000 C   0  0
   19.3856   -1.5031    0.0000 C   0  0
   20.6859   -0.7553    0.0000 O   0  0
   18.0874   -0.7500    0.0000 C   0  0
   18.0873    0.7500    0.0000 C   0  0
   16.7883    1.5000    0.0000 C   0  0
   15.4893    0.7500    0.0000 C   0  0
   14.1902    1.5000    0.0000 O   0  0
   15.4893   -0.7500    0.0000 C   0  0
   16.7883   -1.5000    0.0000 C   0  0
   20.6816   -3.7570    0.0000 N   0  0
   20.6817   -5.2570    0.0000 C   0  0
   21.9807   -6.0070    0.0000 C   0  0
   23.2798   -5.2571    0.0000 C   0  0
   23.2798   -3.7571    0.0000 C   0  0
   21.9808   -3.0070    0.0000 C   0  0
   24.5811   -6.0048    0.0000 C   0  0
   25.8798   -5.2526    0.0000 C   0  0
   27.1814   -5.9981    0.0000 C   0  0
   28.4779   -5.2436    0.0000 C   0  0
   28.4727   -3.7436    0.0000 C   0  0
   27.1711   -2.9981    0.0000 C   0  0
   25.8747   -3.7526    0.0000 C   0  0
   34.8779   -0.3783    0.0000 O   0  0
   34.8779   -1.8783    0.0000 C   0  0  2  0  0  0
   33.5779   -2.6283    0.0000 C   0  0  1  0  0  0
   33.5779   -4.1283    0.0000 O   0  0
   32.2779   -1.8783    0.0000 C   0  0
   32.2779   -0.3783    0.0000 O   0  0
   30.9786   -2.6279    0.0000 O   0  0
   36.1779   -2.6283    0.0000 C   0  0
   36.1779   -4.1283    0.0000 O   0  0
   37.4771   -1.8788    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11  5  1  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 32 34  1  0
 34 35  2  0
 35 29  1  0
 26 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 36  1  0
 39 42  1  0
 42 43  1  0
 43 44  2  0
 44 45  1  0
 45 46  2  0
 46 47  1  0
 47 48  2  0
 48 43  1  0
 50 49  1  1
 50 51  1  0
 51 52  1  1
 51 53  1  0
 53 54  1  0
 53 55  2  0
 50 56  1  0
 56 57  1  0
 56 58  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7580

> <plate>
1

> <well>
B11

> <supplier_cmpd_name>
Ifenprodil Tartrate

> <ctcr_id>
7281

> <supplier_cmpd_id>
S4091

> <smiles>
CC(C(O)c1ccc(O)cc1)N2CCC(CC2)Cc3ccccc3.CC(C(O)c4ccc(O)cc4)N5CCC(CC5)Cc6ccccc6.O[C@H]([C@@H](O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"ifenprodil tartrate",23210-58-4,23210584,"Ifenprodil (tartrate)",UNII-89CTB4XUF7,UNII89CTB4XUF7,89CTB4XUF7,"23210-58-4 (tartrate)","23210584 (tartrate)","IFENPRODIL HEMITARTRATE","Cerocral (TN)","EI
NECS 245-493-5","EINECS 2454935","Ifenprodil tartrate (JAN)","Ifenprodil tartrate (JP17)",SCHEMBL1650040,CHEBI:31,T1186,S4091,"Ifenprodil Tartrate"}

> <pdid>

> <targets>
{Others,iGluR,Potassium Channel}

> <classes>
{Neuronal Signaling,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{656586}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 40  0  0  1  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 C   0  0  1  0  0  0
   -5.3229    1.2135    0.0000 C   0  0  1  0  0  0
   -5.7863    2.6401    0.0000 C   0  0
   -6.2045    0.0000    0.0000 O   0  0
   -5.3229   -1.2135    0.0000 C   0  0
   -5.7862   -2.6402    0.0000 O   0  0
   -2.5981    1.5000    0.0000 C   0  0  1  0  0  0
   -2.6012    3.0008    0.0000 C   0  0
   -3.9020    3.7494    0.0000 C   0  0
   -3.9051    5.2502    0.0000 C   0  0
   -5.2041    6.0003    0.0000 C   0  0
   -5.2042    7.5003    0.0000 C   0  0
   -3.9052    8.2503    0.0000 C   0  0
   -2.6061    7.5003    0.0000 C   0  0
   -2.6061    6.0003    0.0000 N   0  0
   -3.9052    9.7510    0.0000 C   0  0
   -5.2031   10.5032    0.0000 C   0  0
   -5.2007   12.0032    0.0000 C   0  0
   -3.9005   12.7512    0.0000 C   0  0
   -2.6027   11.9991    0.0000 C   0  0
   -1.3025   12.7471    0.0000 F   0  0
   -2.6050   10.4991    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  7  6  1  1
  7  8  1  0
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  1
 12  7  1  0
 11 13  1  0
 14 13  1  1
 15 14  1  1
 15 16  1  0
 16 17  1  6
 16 18  1  0
 18 19  1  0
 19 14  1  0
 19 20  2  0
 15 21  1  0
 21 10  1  0
 21 22  1  1
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 27 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  1  0
 34 36  2  0
 36 30  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7581

> <plate>
1

> <well>
B12

> <supplier_cmpd_name>
Vorapaxar

> <ctcr_id>
8192

> <supplier_cmpd_id>
S8067

> <smiles>
CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c4ccc(cn4)c5cccc(F)c5

> <pd_targets>
{F2R}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Protease-activated receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Proteinase-activated receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors"}

> <broad_targets>
{F2R}

> <broad_moa>
{"thrombin inhibitor"}

> <synonyms>
{Vorapaxar,618385-01-6,618385016,Zontivity,"Sch 530348",SCH-530348,SCH530348,"Vorapaxar free base",UNII-ZCE93644N2,UNIIZCE93644N2,MK-5348,MK5348,CHEMBL493982,CHEBI:82702,ZCE93644N2,"705260-08-8 (sulfa
te)","705260088 (sulfate)","618385-01-6 (free base)","618385016 (free base)","Vorapaxar (USAN:INN)",an-6-yl)carbamate,an6yl)carbamate,Vorap,T7013,T3098,1755,S8067,"Vorapaxar sulfate",vorapaxar,"SCH 53
0348"}

> <pdid>
PD003611

> <targets>
{Protease-activated Receptor,Protease-Activated Receptor (PAR)}

> <classes>
{GPCR & G Protein,GPCR/G Protein}

> <pubchem_cids>
{10077130}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 22  0  0  0  0            999 V2000
   12.5987    2.2480    0.0000 H   0  3
   10.0987    2.2480    0.0000 H   0  3
    7.5987    2.2480    0.0000 Cl  0  5
    5.0987    2.2480    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5998    1.4986    0.0000 C   0  0
   -3.8983    0.7460    0.0000 C   0  0
   -3.8989   -0.7540    0.0000 C   0  0
   -5.1982   -1.5035    0.0000 C   0  0
   -6.4970   -0.7530    0.0000 C   0  0
   -6.4964    0.7470    0.0000 C   0  0
   -5.1971    1.4965    0.0000 C   0  0
   -2.6013    2.9994    0.0000 C   0  0
   -1.3046    3.7535    0.0000 C   0  0
   -1.3092    5.2535    0.0000 C   0  0
   -2.6105    5.9995    0.0000 C   0  0
   -3.9073    5.2455    0.0000 C   0  0
   -3.9027    3.7455    0.0000 C   0  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 12 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7582

> <plate>
1

> <well>
B13

> <supplier_cmpd_name>
Cyclizine 2HCl

> <ctcr_id>
115

> <supplier_cmpd_id>
S4139

> <smiles>
[H+].[H+].[Cl-].[Cl-].CN1CCN(CC1)C(c2ccccc2)c3ccccc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{HRH1,SULT1E1}

> <broad_moa>
{"histamine receptor modulator"}

> <synonyms>
{"Cyclizine 2HCl","Cyclizine dihydrochloride",5897-18-7,5897187,UNII-VF601QVZ67,UNIIVF601QVZ67,"Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride","Piperazine, 1diphenylmethyl4methyl, dihydrochl
oride",VF601QVZ67,DSSTox_CID_27753,DSSToxCID27753,DSSTox-CID-27753,"DSSTox CID 27753",DSSTox_RID_82530,DSSToxRID82530,DSSTox-RID-82530,"DSSTox RID 82530",DSSTox_GSID_47773,DSSToxGSID47773,DSSTox-GSID-
47773,"DSSTox GSID 47773",NCGC00016421-01,NCGC0001642101,CAS-303-25-3,CAS303253,1-Diphenylmethyl,1Diphenylmethyl,S4139}

> <pdid>
PD002402

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{67533,91992352}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 27  0  0  1  0            999 V2000
   -0.2670   -5.4825    0.0000 C   0  0
    0.7500   -4.3800    0.0000 C   0  0
    2.2133   -4.7099    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
   -0.6870   -2.7320    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  1
  4  6  1  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 12  1  0
 18 19  1  6
 18 20  1  0
 20  9  1  0
 20 21  1  6
 21 22  1  0
 22 23  1  0
 23  4  1  0
 23  8  1  0
 23 24  1  6
M  END
> <name>
Selleck_GPCR

> <id>
7583

> <plate>
1

> <well>
B15

> <supplier_cmpd_name>
17-Hydroxyprogesterone

> <ctcr_id>
8193

> <supplier_cmpd_id>
S4507

> <smiles>
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{SERPINA6,LMNA,MAPT,PGR,BLM,AR,KMT2A,MEN1,SHBG,MAPK3,NFO,REP,SLC6A3,NR3C1,ADORA3}

> <pathway_gtopdb>
{"Secreted protein","Other nuclear protein","Other cytosolic protein","Transcription factor",Enzyme,"Epigenetic regulator",Transporter,"Membrane receptor","Nuclear receptor",Reader,Kinase,Hydrolase,Tr
ansferase,"Electrochemical transporter","Family A G protein-coupled receptor","Nuclear hormone receptor subfamily 3",Bromodomain,"Protein Kinase","SLC superfamily of solute carriers","Small molecule r
eceptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group C","CMGC protein kinase group","SLC06 neurotransmitter transporter family","Nucleotide-like receptor (family A GPCR)","Nuclear horm
one receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 3 group C member 1","Adenosine 
receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets",Transporters,"Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Anti-infective targets","SLC superfamily of solute carriers","G protein-coupled receptors","
Steroid hormone receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Viral protein targets","SLC6 neurotransmitter transporter family","Adenosine receptors","3C. 3-Ketosteroid receptors","Mitog
en-activated protein kinases (MAP kinases)","Coronavirus (CoV) proteins","Monoamine transporter subfamily","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Neuronal System","DNA Repair","Gene expression (Transcription)","Immune System",Disease,"Signal Transduction","Metabolism of lipids",Mitotic,"Transmission across Chemical Syn
apses","DNA Double-Strand Break Repair","RNA Polymerase II Transcription","Innate Immune System","Infectious disease","Disorders of transmembrane transporters","Signaling by GPCR","Metabolism of stero
ids","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Homology Directed Repair","Generic Transcription Pathway","Toll-like Receptor Cascades","SARS-CoV Infections","SLC tra
nsporter disorders","GPCR ligand binding","Metabolism of steroid hormones","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination
 (HRR) or Single Strand Annealing (SSA)","Transcriptional regulation by RUNX2","Toll Like Receptor 5 (TLR5) Cascade","SARS-CoV-2 Infection","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PK
DYS)","FOXO-mediated transcription","Class A/1 (Rhodopsin-like receptors)","Glucocorticoid biosynthesis","Mitotic Anaphase","Post NMDA receptor activation events","HDR through Homologous Recombination
 (HRR)","RUNX2 regulates bone development","MyD88 cascade initiated on plasma membrane","SARS-CoV-2 Genome Replication and Transcription","FOXO-mediated transcription of oxidative stress","metabolic a
nd neuronal genes","Nucleotide-like (purinergic) receptors","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","RUNX2 regulates o
steoblast differentiation","MAP kinase activation","Replication of the SARS-CoV-2 genome","Adenosine P1 receptors","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DN
A pairing and strand exchange","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{7HYDROXYPROGESTERON,hydroxyprogesterone,17ALPHA-HYDROXYPROGESTERONE,17ALPHAHYDROXYPROGESTERONE,17-Hydroxyprogesterone,17Hydroxyprogesterone,68-96-2,68962,17a-Hydroxyprogesterone,17aHydroxyprogesteron
e,Prodix,Prodox,"Gestageno gador",17-alpha-Hydroxyprogesterone,17alphaHydroxyprogesterone,"17-Hydroxypregn-4-ene-3,20-dione","17Hydroxypregn4ene3,20dione",Setaderm,Oxiprogesteronum,17alph,S4507}

> <pdid>
PD000437

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{6238}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 31  0  0  0  0            999 V2000
    8.8990    4.2667    0.0000 H   0  3
    6.3990    4.2667    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.2991    5.2507    0.0000 N   0  0
   -0.0012    6.0029    0.0000 C   0  0
   -0.0036    7.5029    0.0000 C   0  0
   -1.3039    8.2509    0.0000 N   0  0
   -2.6017    7.4988    0.0000 C   0  0
   -2.5993    5.9988    0.0000 C   0  0
   -1.3093    9.7517    0.0000 C   0  0
   -0.0128   10.5060    0.0000 O   0  0
   -2.6114   10.4982    0.0000 C   0  0
   -2.7567   11.9783    0.0000 C   0  0
   -4.2255   12.2827    0.0000 C   0  0
   -4.9689   10.9799    0.0000 C   0  0
   -3.9596    9.8703    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13  7  1  0
 13 14  1  0
 14 15  2  0
 15  5  1  0
 15 16  1  0
 16 17  1  0
  9 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
 21 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 26  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7584

> <plate>
1

> <well>
B17

> <supplier_cmpd_name>
Terazosin

> <ctcr_id>
6752

> <supplier_cmpd_id>
S4679

> <smiles>
[H+].[Cl-].COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4

> <pd_targets>
{ADRA1A,ADRA1D,ADRA2A,ADRA2C,NFO,KMT2A,MEN1,FFP,ADRA1B,ADRA2B,KDM4E,GLA,GAA,ALDH1A1,KCNH2,HPGD,HTT,SMN1,AMPC,LMNA,HSD17B10,MAPK1,ALD,SLC22A1,ABCC4,KCNH6,KCNH7,TGFB1,TSHR,LEF,TP53,CHRM1,RORC}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Ion channel","Unclassified protein","Other nuclear protein",Transporter,"Secreted protein","Transcription factor","Family A G protein-coupled recept
or",Hydrolase,Reader,Transferase,Eraser,Oxidoreductase,"Voltage-gated ion channel",Kinase,"Electrochemical transporter","Primary active transporter",Protease,"Small molecule receptor (family A GPCR)",
Bromodomain,"Lysine demethylase","Potassium channels","Methyl-lysine/arginine binding protein","Protein Kinase","SLC superfamily of solute carriers","ATP-binding cassette","Peptide receptor (family A 
GPCR)","Metallo protease","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium channel","Tudor domain","CMGC protein kinase group","SLC22 family of organic cation and anion transp
orters","ABCC subfamily","Glycohormone receptor","Metallo protease MAE clan","Adrenergic receptor","CMGC protein kinase MAPK family","Metallo protease M34 family","Acetylcholine receptor","CMGC protei
n kinase ERK1","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Chromatin modifying enzymes","3.2.1.- Glycosidases","Voltage-gated ion channels","Eicosanoid turnover","Kinases (EC 2.7.x.
x)","SLC superfamily of solute carriers","ATP-binding cassette transporter family",Adrenoceptors,"1.14.11.- Histone demethylases","Potassium channels","Prostaglandin synthases","CMGC: Containing CDK",
MAPK,GSK3,"CLK families","SLC22 family of organic cation and anion transporters","ABCC subfamily","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Voltage-gated potassium chann
els","Mitogen-activated protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily","Nuclear hormone receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Muscle contraction","Gene expression (Transcription)","Metabolism of RNA","Cell Cycle","Immune System","Transport of small molecules",Hemostasis,"Neuronal Sy
stem","Signaling by GPCR","Metabolism of lipids","Diseases of metabolism","Biological oxidations","Cardiac conduction","RNA Polymerase II Transcription","Metabolism of non-coding RNA",Mitotic,"Metabol
ism of amino acids and derivatives","Innate Immune System","SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Potassium Channels","Diseases of signal transductio
n by growth factor receptors and second messengers","Infectious disease","Cell Cycle Checkpoints","GPCR ligand binding","Sphingolipid metabolism","Diseases of carbohydrate metabolism","Phase I - Funct
ionalization of compounds","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","snRNP Assembly","M Phase","Branched-chain amino
 acid catabolism","Toll-like Receptor Cascades","Transport of bile salts and organic acids","metal ions and amine compounds","Response to elevated platelet cytosolic Ca2+","Voltage gated Potassium cha
nnels","Signaling by TGF-beta Receptor Complex in Cancer","Leishmania infection","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","Glycosph
ingolipid metabolism","Glycogen storage diseases","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (T
LR5) Cascade","Organic cation/anion/zwitterion transport","Platelet degranulation","Loss of Function of SMAD2/3 in Cancer","Leishmania parasite growth and survival","Uptake and function of anthrax tox
ins","p53-Dependent G1/S DNA damage checkpoint","Amine ligand-binding receptors","Glycogen storage disease type II (GAA)","Biosynthesis of D-series resolvins","Regulation of MECP2 expression and activ
ity","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Organic cation transport","SMAD2/3 Phosphorylation Motif Mutants in Cancer","Anti-inflammatory response favouring Leishmania paras
ite infection","p53-Dependent G1 DNA Damage Response",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Stabilization 
of p53","Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1",
"ERK/MAPK targets","ERKs are inactivated","Transcriptional regulation by RUNX3","RUNX3 Regulates Immune Response and Cell Migration"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{AKOS026749822,"Terazosin hydrochloride",63074-08-8,63074088,"Terazosin HCl",Hytrin,Flumarc,Fosfomic,Vasocard,Blavin,Abbott-45975,Abbott45975,"Terazosin hydrochloride anhydrous",Zayasel,"Terazocin Hyd
rochloride (anhydrous)",MLS000040261,"Terazosin (hydrochloride)",SM,S4679,1505576,Prestw-751,Terazosin,"TERAZOSIN HYDROCHLORIDE"}

> <pdid>
PD002848

> <targets>
{"Adrenergic receptor"}

> <classes>
{"GPCR & G Protein",antihypertensive}

> <pubchem_cids>
{663211,44383,44662380}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 36  0  0  1  0            999 V2000
    5.8361   -8.0013    0.0000 C   0  0
    4.6617   -7.0682    0.0000 C   0  0  2  0  0  0
    4.9930   -5.6052    0.0000 C   0  0
    4.0557   -4.4341    0.0000 C   0  0
    2.5536   -4.4230    0.0000 N   0  0
    1.6225   -5.6111    0.0000 C   0  0
    1.9588   -7.0729    0.0000 C   0  0
    3.3114   -7.7214    0.0000 N   0  0
    3.3110   -9.2241    0.0000 C   0  0
    4.6100   -9.9741    0.0000 O   0  0
    2.0115   -9.9750    0.0000 C   0  0
    0.7136   -9.2228    0.0000 C   0  0
   -0.5867   -9.9706    0.0000 C   0  0
   -1.8844   -9.2184    0.0000 C   0  0
   -0.5892  -11.4706    0.0000 C   0  0
    0.7086  -12.2228    0.0000 C   0  0
    2.0089  -11.4750    0.0000 C   0  0
    3.3073  -12.2276    0.0000 N   0  0
    4.6607  -11.6110    0.0000 N   0  0
    5.6607  -12.7291    0.0000 C   0  0
    4.9065  -14.0256    0.0000 C   0  0
    3.4403  -13.7089    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  2  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 18  1  0
  5 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 31 25  1  0
 31 32  1  0
 32 23  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7585

> <plate>
1

> <well>
B19

> <supplier_cmpd_name>
Suvorexant (MK-4305)

> <ctcr_id>
7406

> <supplier_cmpd_id>
S7279

> <smiles>
C[C@@H]1CCN(CCN1C(=O)c2cc(C)ccc2n3nccn3)c4oc5ccc(Cl)cc5n4

> <pd_targets>
{HCRTR1,HCRTR2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Orexin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Orexin receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors","Orexin and neuropeptides FF and QRFP bind to their respectiv
e receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"UVOREXANT (MK4305","UVOREXANT (MK 4305",Suvorexant,1030377-33-3,1030377333,"1030377 33 3",MK-4305,MK4305,"MK 4305",BELSOMRA,UNII-081L192FO9,UNII081L192FO9,"UNII 081L192FO9","Suvorexant (MK-4305)","S
uvorexant (MK4305)","Suvorexant (",S7279}

> <pdid>
PD009398

> <targets>
{"OX Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{24965990}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  1  0            999 V2000
    8.2992  -10.5861    0.0000 C   0  0
    7.7933   -9.1740    0.0000 C   0  0
    8.7636   -8.0301    0.0000 C   0  0
    6.3168   -8.9050    0.0000 O   0  0
    5.8106   -7.4921    0.0000 C   0  0
    6.7829   -6.3499    0.0000 C   0  0
    6.2798   -4.9368    0.0000 C   0  0
    4.8092   -4.6676    0.0000 C   0  0
    3.8322   -5.8080    0.0000 C   0  0
    4.3352   -7.2212    0.0000 C   0  0
    3.3624   -8.3640    0.0000 C   0  0
    2.3901   -9.5062    0.0000 N   0  0
    4.2010   -3.2956    0.0000 C   0  0
    4.9531   -1.9978    0.0000 O   0  0
    3.9511   -0.8815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.7343   -2.9815    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 C   0  0  2  0  0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8781   -1.4381    0.0000 N   0  0
   -4.3396   -0.0100    0.0000 C   0  0
   -5.8069    0.3054    0.0000 C   0  0
   -6.2681    1.7327    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  3  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 18  1  0
 26 22  2  0
 23 27  1  6
 27 28  1  0
 28 29  1  0
 29 30  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7586

> <plate>
1

> <well>
B21

> <supplier_cmpd_name>
Ozanimod (RPC1063)

> <ctcr_id>
8194

> <supplier_cmpd_id>
S7952

> <smiles>
CC(C)Oc1ccc(cc1C#N)c2onc(n2)c3cccc4[C@H](CCc34)NCCO

> <pd_targets>
{S1PR3,S1PR4,S1PR5,S1PR1,S1PR2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","EDG receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Lysophospholipid (S1P) receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Lysosphingolipid and LPA receptors"}

> <broad_targets>
{S1PR1}

> <broad_moa>
{"sphingosine 1-phosphate receptor agonist"}

> <synonyms>
{Ozanimod,1306760-87-1,1306760871,RPC1063,"Ozanimod (RPC1063)",RPC-1063,UNII-Z80293URPV,UNIIZ80293URPV,Z80293URPV,"Ozanimod (USAN:INN)",Zeposia,"RPC 1063","Ozanimod; RPC1063","Ozanimod (USAN/INN)",GTP
L8709,SCHEMBL2195490,CHEMBL3707247,AMY3373,BCP16513,EX-A1316,EXA1316,RPC1063:RPC-106,RPC1063:RPC106,T6923,S7952}

> <pdid>
PD049163

> <targets>
{S1P Receptor,LPL Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein}

> <pubchem_cids>
{52938427}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 16 17  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -4.0317   -0.7359    0.0000 C   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -6.2524    0.2436    0.0000 C   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -5.5608    2.8298    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
 15 16  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7587

> <plate>
1

> <well>
C03

> <supplier_cmpd_name>
Aniracetam

> <ctcr_id>
4317

> <supplier_cmpd_id>
S1281

> <smiles>
COc1ccc(cc1)C(=O)N2CCCC2=O

> <pd_targets>
{CYP1A2,KMT2A,MEN1,CYP2C19,BLM,CYP2C9,THRB,MAPT,KDM4E,CYP2D6,RECQL,GRIA4,GRIA3,GRIA2,GRIA1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Transcription factor","Other cytosolic protein","Ion channel","Cytochrome P450",Reader,"Nuclear receptor",Eraser,"Ligand-gated ion channel","Cytochrome P450 family 1",B
romodomain,"Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1","Lysine demethylase","Ionotropic glutamate receptor","Cytochrome P450 family 1A","Cytochrome P450 family 2C","Nuclear hormo
ne receptor subfamily 1 group A","Jumonji domain-containing","Cytochrome P450 family 2D","AMPA receptor","Cytochrome P450 1A1","Cytochrome P450 2C19","Cytochrome P450 2C9","Nuclear hormone receptor su
bfamily 1 group A member 2","Cytochrome P450 2D6"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Cytochrome P450","Nuclear hormone receptors","Chromatin modifying enzymes","Ligand-gated ion channels","CYP1 family","CYP2 family: drug metabolising subset","1A. Thy
roid hormone receptors","1.14.11.- Histone demethylases","Ionotropic glutamate receptors"}

> <pathway_reactome>
{Metabolism,"DNA Repair","Metabolism of proteins","Neuronal System","Biological oxidations","DNA Double-Strand Break Repair","Post-translational protein modification","Transmission across Chemical Syn
apses","Phase I - Functionalization of compounds","Homology Directed Repair",SUMOylation,"Neurotransmitter receptors and postsynaptic signal transmission","Asparagine N-linked glycosylation","Cytochro
me P450 - arranged by substrate type","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","SUMO E3 ligases SUMOylate target proteins","Activation of NMDA receptors and postsy
naptic events","Glutamate binding","activation of AMPA receptors and synaptic plasticity","Transport to the Golgi and subsequent modification",Xenobiotics,"HDR through Homologous Recombination (HRR)",
"SUMOylation of intracellular receptors","Post NMDA receptor activation events","Trafficking of AMPA receptors","ER to Golgi Anterograde Transport","Aromatic amines can be N-hydroxylated or N-dealkyla
ted by CYP1A2","CYP2E1 reactions","Homologous DNA Pairing and Strand Exchange","Activation of AMPK downstream of NMDARs","Trafficking of GluR2-containing AMPA receptors","Long-term potentiation","Carg
o concentration in the ER","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{DRD2,GRIA1,GRIA2,GRIA3,GRIA4,HTR2A}

> <broad_moa>
{"glutamate receptor agonist"}

> <synonyms>
{RESTW117,aniracetam,72432-10-1,72432101,Draganon,Sarpul,1-(4-Methoxybenzoyl)-2-pyrrolidinone,1(4Methoxybenzoyl)2pyrrolidinone,1-(4-methoxybenzoyl)pyrrolidin-2-one,1(4methoxybenzoyl)pyrrolidin2one,Amp
amet,"Ro 13-5057","Ro 135057",1-p-Anisoyl-2-pyrrolidinone,1pAnisoyl2pyrrolidinone,1-p-anisoylpyrrolidin-2-one,1panisoylpyrrolidin2one,UNII-5L16LKN964,UNII5L16LKN964,2-Pyrrolidinone,2Pyrrolidinone,1-(4
-methoxybenzoyl),1(4methoxybenzoyl),T0333,S1281,Prestw-1178,Aniracetam}

> <pdid>
PD001087

> <targets>
{"AMPA Receptor-kainate Receptor-NMDA Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{2196}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 21  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0  1  0  0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1962   -1.5000    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 N   0  0
   -3.8971   -5.2500    0.0000 C   0  0
   -2.5980   -6.0000    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5981   -3.0000    0.0000 C   0  0  1  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  6
 15 16  1  0
 16 17  1  0
 17  2  1  0
 17  6  1  0
 15 18  1  0
 18  7  1  0
 18 11  1  6
M  END
> <name>
Selleck_GPCR

> <id>
7588

> <plate>
1

> <well>
C04

> <supplier_cmpd_name>
(+)-Matrine

> <ctcr_id>
7497

> <supplier_cmpd_id>
S2322

> <smiles>
O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{OPRK1}

> <broad_moa>
{"opioid receptor agonist"}

> <synonyms>
{alpha-Matrine,alphaMatrine,Matrine,519-02-8,519028,(+)-Matrine,(+)Matrine,Matrinium,Matridin-15-one,Matridin15one,UNII-N390W430AC,UNIIN390W430AC,CHEBI:6700,"Matrene, (+)-","Matrene, (+)",N390W430AC,"
NSC 146051","BRN 0085851",cis-Neomatrine,cisNeomatrine,trans-Neomatrine,transNeomatrine,"Matrine,(S)","Matrine ((+)-Matrine)","Matrine ((+)Matrine)","Matridin-15-one (9CI)","Matridin15one (9CI)",5-24,
524,S2322}

> <pdid>
PD001186

> <targets>
{Opioid Receptor,Autophagy,Ferroptosis,Mitophagy}

> <classes>
{Neuronal Signaling,Apoptosis,Autophagy,GPCR/G Protein}

> <pubchem_cids>
{91466}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 29  0  0  0  0            999 V2000
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8999   -0.7576    0.0000 N   0  0
    5.1972   -1.5121    0.0000 O   0  0
    6.4998   -0.7667    0.0000 C   0  0
    7.7972   -1.5212    0.0000 C   0  0
    9.0991   -0.7761    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 C   0  0
   -2.5998    3.0004    0.0000 F   0  0
   -3.8976    0.7500    0.0000 F   0  0
   -3.8982    2.2498    0.0000 F   0  0
   12.8998   -0.7568    0.0000 O   0  0
   12.8998   -2.2568    0.0000 C   0  0
   11.6005   -3.0064    0.0000 O   0  0
   14.1998   -3.0068    0.0000 C   0  0
   15.4998   -2.2568    0.0000 C   0  0
   15.5012   -0.7560    0.0000 C   0  0
   14.2026   -0.0051    0.0000 O   0  0
   16.8005   -0.0064    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7589

> <plate>
1

> <well>
C05

> <supplier_cmpd_name>
Fluvoxamine maleate

> <ctcr_id>
2189

> <supplier_cmpd_id>
S1336

> <smiles>
COCCCC\C(=N/OCCN)c1ccc(cc1)C(F)(F)F.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"FLUVOXAMINE MALEATE",Luvox,61718-82-9,61718829,"61718 82 9",Fevarin,"Luvox CR","Fluvoxamine (maleate)",DU23000,UNII-5LGN83G74V,UNII5LGN83G74V,"UNII 5LGN83G74V",5LGN83G74V,C19H25F3N2O6,54739-20-7,547
39207,"54739 20 7",DU-23000,"DU 23000",54739-18-3,54739183,T1077,S1336,1505604,Prestw-995,"Fluvoxamine maleate"}

> <pdid>

> <targets>
{5-HT Receptor,Serotonin Transporter}

> <classes>
{Neuronal Signaling,antiobsessional agent}

> <pubchem_cids>
{9560989}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 19 18  0  0  0  0            999 V2000
   12.9003   -0.7502    0.0000 Cl  0  0
    7.8029   -2.9887    0.0000 N   0  0
    7.8003   -1.4887    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
   10.3996   -1.4837    0.0000 O   0  0
    6.4990   -0.7409    0.0000 C   0  0
    6.4964    0.7591    0.0000 O   0  0
    5.2003   -1.4932    0.0000 N   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  2  0
 18 11  1  0
 18 19  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7590

> <plate>
1

> <well>
C06

> <supplier_cmpd_name>
Benserazide HCl

> <ctcr_id>
5953

> <supplier_cmpd_id>
S2453

> <smiles>
Cl.NC(CO)C(=O)NNCc1ccc(O)c(O)c1O

> <pd_targets>
{ESR2,UBE2I,ALPI,ALPG,CBS,SAE1,HK2,REP,MEX-5,TDP1,ALD,POLB,UBA2,FFP,AMPC,KDM4E,MAPT,PMP22,NPSR1,ALDH1A1,KMT2A,MEN1,LMNA,TGR,NS1,GAA,POS-1,MTOR,DDC}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Unclassified protein","Epigenetic regulator","Other cytosolic protein","Membrane receptor","Other nuclear protein","Nuclear receptor",Aminoacyltransferase,Phosphatase,T
ransferase,Hydrolase,Eraser,"Family A G protein-coupled receptor",Oxidoreductase,Reader,Kinase,Lyase,"Nuclear hormone receptor subfamily 3","Lysine demethylase","Peptide receptor (family A GPCR)",Brom
odomain,"Protein Kinase","Nuclear hormone receptor subfamily 3 group A","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Nuclear hormone receptor s
ubfamily 3 group A member 2","Neuropeptide receptor","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets","Nuclear hormone receptors","Hydrogen sulphide synthesis","Anti-infective targets","Chromatin modifying enzymes","G protein-coupled receptors","3.2.1.- Glyco
sidases","Kinases (EC 2.7.x.x)","Carboxylases and decarboxylases","Steroid hormone receptors","Viral protein targets","1.14.11.- Histone demethylases","Neuropeptide S receptor",Atypical,Decarboxylases
,"3A. Estrogen receptors","Coronavirus (CoV) proteins","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Signal Transduction","Cell Cycle","Metabolism of proteins",Metabolism,Disease,"DNA Repair","Neuronal System","Developmental Biology","Gene expression (Transcription)","Intracellular signaling by sec
ond messengers",Mitotic,"Post-translational protein modification","Metabolism of amino acids and derivatives","Metabolism of lipids","Metabolism of carbohydrates","Infectious disease","DNA Double-Stra
nd Break Repair","Base Excision Repair","Transmission across Chemical Synapses","Nervous system development","Biological oxidations","Diseases of metabolism","RNA Polymerase II Transcription","PIP3 ac
tivates AKT signaling","M Phase","Post-translational modification: synthesis of GPI-anchored proteins","Selenoamino acid metabolism",SUMOylation,"Phospholipid metabolism","Glucose metabolism","SARS-Co
V Infections","Nonhomologous End-Joining (NHEJ)","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and postsynaptic signal transmission","EGR2 and SOX10-mediated initiation of Schwan
n cell myelination","Leishmania infection","Phase I - Functionalization of compounds","Diseases of carbohydrate metabolism","Generic Transcription Pathway","Metabolism of amine-derived hormones","Nega
tive regulation of the PI3K/AKT network","Mitotic Metaphase and Anaphase","Metabolism of ingested SeMet",Sec,"MeSec into H2Se","Processing and activation of SUMO","Glycerophospholipid biosynthesis",Gl
ycolysis,"SARS-CoV-2 Infection","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Activation of NMDA receptors and postsynaptic events","Leishmania parasite growth and su
rvival","Ethanol oxidation","Glycogen storage diseases","Transcriptional Regulation by TP53","Catecholamine biosynthesis",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Mitotic Anaphase","SUMO is c
onjugated to E1 (UBA2:SAE1)","Synthesis of PA","SARS-CoV-2 Genome Replication and Transcription","PCNA-Dependent Long Patch Base Excision Repair","Post NMDA receptor activation events","Anti-inflammat
ory response favouring Leishmania parasite infection","Glycogen storage disease type II (GAA)","Regulation of TP53 Activity","Nuclear Envelope (NE) Reassembly","Replication of the SARS-CoV-2 genome","
Activation of AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Postmitotic nuclear pore complex (NPC) reformation",
"Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{DDC}

> <broad_moa>
{"DOPA decarboxylase inhibitor"}

> <synonyms>
{SCHEMBL16516192,AKOS026750132,"BENSERAZIDE HYDROCHLORIDE",14919-77-8,14919778,"Benserazide HCl","2-amino-3-hydroxy-N'-(2,3,4-trihydroxybenzyl)propanehydrazide hydrochloride","2amino3hydroxyN'(2,3,4tr
ihydroxybenzyl)propanehydrazide hydrochloride","Benzerazide hydrochloride","Benserazide (hydrochloride)",2'-,2',T1517,S2453,1500137,Prestw-938,"Benserazide hydrochloride"}

> <pdid>
PD013354

> <targets>
{"Dopamine Receptor"}

> <classes>
{"decarboxylase inhibitor",Others}

> <pubchem_cids>
{657280,26964}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 25  0  0  0  0            999 V2000
    8.8813   -0.2065    0.0000 H   0  3
    6.3813   -0.2065    0.0000 Cl  0  5
    3.8805   -1.4410    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 N   0  0
   -1.3786    3.8595    0.0000 C   0  0
   -1.8372    5.2877    0.0000 C   0  0
   -3.3372    5.2929    0.0000 N   0  0
   -3.8056    3.8679    0.0000 C   0  0
   -5.2311    3.4009    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.5701   -4.1788    0.0000 C   0  0
    0.0400   -5.5491    0.0000 C   0  0
    1.5318   -5.7059    0.0000 C   0  0
    2.4135   -4.4923    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 16 18  1  0
 18  5  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24  4  1  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7591

> <plate>
1

> <well>
C07

> <supplier_cmpd_name>
Ondansetron HCl

> <ctcr_id>
6325

> <supplier_cmpd_id>
S1390

> <smiles>
[H+].[Cl-].Cn1c2CCC(Cn3ccnc3C)C(=O)c2c4ccccc14

> <pd_targets>
{HTR3A,HTR3B,HTR2C,HTR4,CCKBR,KCNH2,HTR3C,HTR3D,HTR3E,OPRM1,CHRNA7,HTR1D,HTR2A,HTR2B,CHRM1,SIGMAR1,CHRNA4,CHRNB2,CYP3A4,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG
1,GABRG2,GABRG3,GABRP,GABRQ,HTR1B,CHRNA3,CHRNB4,SLC47A2,SLC22A1,SLC22A2,SLC47A1,SLC22A3,HTR1A}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Enzyme,Transporter,"Ligand-gated ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel","Cytochrome P450","Electrochemical transporter","5HT3
 receptor","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Potassium channels","Nicotinic acetylcholine receptor","Cytochrome P450 family 3","GABA-A receptor","SLC superf
amily of solute carriers","Monoamine receptor","Short peptide receptor (family A GPCR)","Voltage-gated potassium channel","Nicotinic acetylcholine receptor alpha subunit","Cytochrome P450 family 3A","
SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Serotonin receptor","Cholecystokinin receptor","Opioid receptor","Acetylcholine rec
eptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{"Ion channels",Receptors,"Other protein targets",Enzymes,Transporters,"Ligand-gated ion channels","G protein-coupled receptors","Voltage-gated ion channels","Sigma receptors","Cytochrome P450","SLC s
uperfamily of solute carriers","5-HT<sub>3</sub> receptors","5-Hydroxytryptamine receptors","Cholecystokinin receptors","Potassium channels","Opioid receptors","Nicotinic acetylcholine receptors","Ace
tylcholine receptors (muscarinic)","CYP3 family","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channels"
,"Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction",Disease,"Muscle contraction",Metabolism,"Transport of small molecules","Transmission across Chemical Synapses","Signaling by GPCR","Infectious disease","Cardia
c conduction","Metabolism of lipids","SLC-mediated transmembrane transport","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Leishmania infection","GPCR downstr
eam signalling","Phase 3 - rapid repolarisation","SARS-CoV Infections","Biosynthesis of specialized proresolving mediators (SPMs)","Transport of bile salts and organic acids","metal ions and amine com
pounds","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","G alpha (q) signalling events","G alpha (i) signalling events","Acetylcholine binding and downstream events","
Potential therapeutics for SARS","Biosynthesis of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasi
te infection","Gastrin-CREB signalling pathway via PKC and MAPK","Opioid Signalling","Postsynaptic nicotinic acetylcholine receptors","Biosynthesis of maresins","Organic cation transport","Serotonin r
eceptors","ADORA2B mediated anti-inflammatory cytokines production","G-protein activation","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Muscarinic acetylcholine receptors
","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{HTR3A,HTR3B}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{MCULE-4423935922,MCULE4423935922,"MCULE 4423935922",FT-0659335,FT0659335,"FT 0659335","ONDANSETRON HYDROCHLORIDE","ONDANSETRON HCl",99614-01-4,99614014,"99614 01 4",Zofran,Zophren,"Ondansetron (Hydro
chloride)","SN 307","Ondansetron hydrochloride hyd",S1390,SAM001246631,Prestw-1058,"Ondansetron HCl",CPD000469179,"Ondansetron Hydrochloride"}

> <pdid>
PD002938

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{44661392,66766733,68647}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 39 36  0  0  0  0            999 V2000
   16.5990   -3.3702    0.0000 I   0  5
   14.0990   -3.3702    0.0000 I   0  5
   11.5990   -3.3702    0.0000 I   0  5
    9.0983   -0.7368    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 N   0  3
    6.4964    0.7598    0.0000 C   0  0
    7.3612    1.2619    0.0000 C   0  0
    7.8216    0.0282    0.0000 C   0  0
    7.8190    1.0282    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 O   0  0
   -3.8990   -0.7455    0.0000 C   0  0
   -5.2003   -1.4932    0.0000 C   0  0
   -6.4990   -0.7410    0.0000 N   0  3
   -7.8003   -1.4887    0.0000 C   0  0
   -9.0983   -0.7369    0.0000 C   0  0
   -6.4964    0.7598    0.0000 C   0  0
   -5.1965    1.5083    0.0000 C   0  0
   -6.5045   -2.2709    0.0000 C   0  0
   -7.8058   -3.0170    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 O   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.3070   -5.2502    0.0000 C   0  0
    2.6078   -5.9988    0.0000 N   0  3
    2.6109   -7.4996    0.0000 C   0  0
    3.9110   -8.2477    0.0000 C   0  0
    3.9062   -5.2461    0.0000 C   0  0
    3.9045   -3.7461    0.0000 C   0  0
    1.2856   -6.7685    0.0000 C   0  0
    1.2901   -8.2685    0.0000 C   0  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  1  0
  6 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 22 25  1  0
 25 26  1  0
 22 27  1  0
 27 28  1  0
 18 29  2  0
 29 14  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 33 36  1  0
 36 37  1  0
 33 38  1  0
 38 39  1  0
M  CHG  6   1  -1   2  -1   3  -1   6   1  22   1  33   1
M  END
> <name>
Selleck_GPCR

> <id>
7592

> <plate>
1

> <well>
C08

> <supplier_cmpd_name>
Gallamine Triethiodide

> <ctcr_id>
902

> <supplier_cmpd_id>
S2471

> <smiles>
[I-].[I-].[I-].CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC

> <pd_targets>
{CHRM2,TSHR,HIF1A,ACHE,CHRM1,FFP,LMNA,ALOX15,CHRNA1,CHRNB1,CHRND,CHRNE,CHRNG,CHRNA2}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor",Enzyme,"Other nuclear protein","Ion channel","Family A G protein-coupled receptor",Hydrolase,Transferase,Oxidoreductase,"Ligand-gated ion channel","Small mo
lecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Nicotinic acetylcholine receptor","Monoamine receptor","Glycohormone receptor","Nicotinic acetylcholine receptor alpha subunit","Ac
etylcholine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Acetylcholine turnover","Eicosanoid turnover","Ligand-gated ion channels","Acetylcholine receptors (muscarinic)","Glycoprotein hormone 
receptors",Lipoxygenases,"Nicotinic acetylcholine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Cellular responses to external stimuli",Metabolism,"Cell Cycle","Neuronal System","Signaling by GPCR","Infectious disease","Cellular responses to stress","Metabolism of
 lipids",Mitotic,"Transmission across Chemical Synapses","GPCR ligand binding","Leishmania infection","Cellular response to hypoxia","Phospholipid metabolism","M Phase","Biosynthesis of specialized pr
oresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Oxygen-dependent prolin
e hydroxylation of Hypoxia-inducible Factor Alpha","Glycerophospholipid biosynthesis","Mitotic Metaphase and Anaphase","Biosynthesis of DPA-derived SPMs","Acetylcholine binding and downstream events",
"Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of PC","Mitotic Anaphase","Biosynthesis of DPAn-3 SPMs","Postsynaptic nicotinic acetylc
holine receptors","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resol
vins","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CHRM2,CHRNA1}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"GALLAMINE TRIETHIODIDE",65-29-2,65292,Flaxedil,Benzkurin,Pirolakson,Sincurarine,Syncurarine,Gallaflex,Parexyl,Pyrolaxon,Relaxan,Remyolan,Retensin,Tricuran,"Gallamone triethiodide","Gallamine iodide"
,"Benzcurine iodide","Miowas G",Galla,T0720,S2471,1500312,Prestw-157,"Gallamine triethiodide","Gallamine Triethiodide"}

> <pdid>
PD013256

> <targets>
{AChR}

> <classes>
{"muscle relaxant (skeletal)","Neuronal Signaling"}

> <pubchem_cids>
{6172}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 S   0  0
   -2.6016   -2.9971    0.0000 O   0  0
   -1.3015   -2.2494    0.0000 O   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -0.0095   -6.0029    0.0000 C   0  0
   -0.0126   -7.5029    0.0000 C   0  0
   -1.3132   -8.2502    0.0000 C   0  0
   -2.6106   -7.4975    0.0000 N   0  0
   -2.6076   -5.9975    0.0000 C   0  0
   -3.9057   -5.2445    0.0000 C   0  0
   -3.9051   -3.7444    0.0000 C   0  0
   -5.2038   -2.9938    0.0000 C   0  0
   -6.5032   -3.7432    0.0000 C   0  0
   -6.5039   -5.2432    0.0000 C   0  0
   -5.2052   -5.9938    0.0000 C   0  0
   -7.8025   -2.9922    0.0000 C   0  0
   -7.9420   -1.5115    0.0000 O   0  0
   -9.4096   -1.2013    0.0000 C   0  0
  -10.1582   -2.5012    0.0000 N   0  0
   -9.1532   -3.6148    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  2  0
  9  3  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 26  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7593

> <plate>
1

> <well>
C09

> <supplier_cmpd_name>
Zibotentan (ZD4054)

> <ctcr_id>
3168

> <supplier_cmpd_id>
S1456

> <smiles>
COc1nc(C)cnc1N[S](=O)(=O)c2cccnc2c3ccc(cc3)c4ocnn4

> <pd_targets>
{EDNRA}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Endothelin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Endothelin receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors"}

> <broad_targets>
{EDNRA}

> <broad_moa>
{"endothelin receptor antagonist"}

> <synonyms>
{Zibotentan,186497-07-4,186497074,ZD4054,"Zibotentan (ZD4054)",ZD-4054,"Zibotentan (ZD4054 )",UNII-8054MM4902,UNII8054MM4902,"Zd 4054",8054MM4902,"Zibotentan (USAN:INN:JAN)",ZibotentanZD4054,"Zibotent
an,ZD4054",Zibotentan(ZD4054)/,"Zibotentan (ZD 4054)",ZD40,S1456}

> <pdid>
PD011185

> <targets>
{Endothelin Receptor,ETA Receptor,Apoptosis}

> <classes>
{GPCR & G Protein,Apoptosis,GPCR/G Protein}

> <pubchem_cids>
{9910224}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 28  0  0  0  0            999 V2000
   -1.3127   -5.2403    0.0000 C   0  0
   -1.3074   -3.7403    0.0000 C   0  0
   -2.6041   -2.9862    0.0000 O   0  0
   -0.0048   -2.9949    0.0000 S   0  0
    1.2925   -3.7494    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2578    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    6.4855   -8.2648    0.0000 O   0  0
    6.4833   -9.7656    0.0000 C   0  0
    7.7815  -10.5187    0.0000 C   0  0
    7.7816  -12.0187    0.0000 C   0  0
    9.0806  -12.7688    0.0000 C   0  0
   10.3797  -12.0188    0.0000 C   0  0
   10.3797  -10.5188    0.0000 C   0  0
    9.0807   -9.7688    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  6 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7594

> <plate>
1

> <well>
C10

> <supplier_cmpd_name>
Racecadotril

> <ctcr_id>
1172

> <supplier_cmpd_id>
S2503

> <smiles>
CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2

> <pd_targets>
{ABCB11,ABCC3,CYP2C9,CYP2C19,CYP2D6,CYP3A4,CYP1A2}

> <pathway_gtopdb>
{Transporter,"Primary active transporter","ATP-binding cassette","ABCB subfamily","ABCC subfamily",Enzyme,"Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 famil
y 1","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Cytochrome P450 2C9","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochrome P450
 3A4","Cytochrome P450 1A1"}

> <pathway_chembl>
{Transporters,"ATP-binding cassette transporter family","ABCB subfamily","ABCC subfamily",Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subset","CYP3 family","CYP1 family"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Metabolism of steroids","Bile acid and bile salt metabolism","Synthesis of bile acids and bile salts","Recycling of bile acids and salts","Synthesis of bile acids a
nd bile salts via 7alpha-hydroxycholesterol","Biological oxidations","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Cytochrome P450 - arranged 
by substrate type","Biosynthesis of DHA-derived SPMs",Xenobiotics,"Biosynthesis of maresins","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkyla
ted by CYP1A2"}

> <broad_targets>
{MME}

> <broad_moa>
{"enkephalinase inhibitor"}

> <synonyms>
{Racecadotril,81110-73-8,81110738,Acetorphan,"Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate","Benzyl 2(3(acetylthio)2benzylpropanamido)acetate","S049; Sinorphan","Racecadotril (Acetorphan)","be
nzyl (3-(acetylthio)-2-benzylpropanoyl)glycinate","benzyl (3(acetylthio)2benzylpropanoyl)glycinate",MFCD00865520,Tiorfan,"benzyl 2-((2-(acetylsulfanylmethyl)-3-","benzyl 2((2(acetylsulfanylmethyl)3",T
1176,S2503,SAM001247060,Prestw-626,Racecadotril,CPD000449320}

> <pdid>
PD001681

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{107751}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 14 13  0  0  0  0            999 V2000
    7.6943   -1.8789    0.0000 Br  0  5
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    5.1937   -3.0093    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  3
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14  8  1  0
M  CHG  2   1  -1  12   1
M  END
> <name>
Selleck_GPCR

> <id>
7595

> <plate>
1

> <well>
C11

> <supplier_cmpd_name>
Pyridostigmine Bromide

> <ctcr_id>
2588

> <supplier_cmpd_id>
S1608

> <smiles>
[Br-].CN(C)C(=O)Oc1ccc[n+](C)c1

> <pd_targets>
{BCHE,ACHE,TSHR,CHRM1,IMPA1,GLA,NFO,RORC,LMNA}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Transcription factor","Other nuclear protein",Hydrolase,"Family A G protein-coupled receptor","Nuclear receptor","Peptide receptor (family A GPCR)","Small molecule recepto
r (family A GPCR)","Nuclear hormone receptor subfamily 1","Glycohormone receptor","Monoamine receptor","Nuclear hormone receptor subfamily 1 group F","Acetylcholine receptor","Nuclear hormone receptor
 subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Acetylcholine turnover","G protein-coupled receptors","Inositol phosphate turnover","Nuclear hormone receptors","Glycoprotein hormone receptors","Acetylcholine receptors (muscarini
c)","Inositol monophosphatase","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{Metabolism,Disease,"Signal Transduction","Gene expression (Transcription)","Cell Cycle","Metabolism of lipids","Infectious disease","Signaling by GPCR","Inositol phosphate metabolism","RNA Polymerase
 II Transcription",Mitotic,"Phospholipid metabolism","Leishmania infection","GPCR ligand binding","Synthesis of IP2",IP,"and Ins in the cytosol","Sphingolipid metabolism","Generic Transcription Pathwa
y","M Phase","Glycerophospholipid biosynthesis","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Glycosphingolipid metabolism","Transcriptional regulation by RUNX3","M
itotic Metaphase and Anaphase","Synthesis of PC","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","RUNX3 Regulates Immune Response and Cell Migrati
on","Mitotic Anaphase","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformatio
n"}

> <broad_targets>
{ACHE,BCHE}

> <broad_moa>
{"cholinesterase inhibitor"}

> <synonyms>
{Kalimin,Kalymin,Mestinon,Regonal,"Mestinon bromide","Ro 1-5130","Ro 15130","3-(Dimethylcarbamyloxy)-1-methylpyridinium bromide","3(Dimethylcarbamyloxy)1methylpyridinium bromide","1-Methyl-3-hydroxypy
ridinium bromide dimethylcarbamate","1Methyl3hydroxypyridinium bromide dimethylcarbamate","3-Hydroxy-1-methylpyridinium bromide dimethylcarbamate","3Hydroxy1methylpyridinium bromide dimethylcarbamate"
,Dimethylca,S1608,SAM002564227,1503240,"Pyridostigmine Bromide",CPD000058605,"PYRIDOSTIGMINE BROMIDE"}

> <pdid>
PD010140

> <targets>
{Others}

> <classes>
{cholinergic,"Neuronal Signaling"}

> <pubchem_cids>
{91696191,7550}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 13 11  0  0  0  0            999 V2000
    8.8933   -1.1283    0.0000 H   0  3
    6.3933   -1.1283    0.0000 Cl  0  5
    3.8926   -3.7566    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7596

> <plate>
1

> <well>
C12

> <supplier_cmpd_name>
Dopamine HCl

> <ctcr_id>
5016

> <supplier_cmpd_id>
S2529

> <smiles>
[H+].[Cl-].NCCc1ccc(O)c(O)c1

> <pd_targets>
{ALOX5}

> <pathway_gtopdb>
{Enzyme,Oxidoreductase}

> <pathway_chembl>
{Enzymes,"Eicosanoid turnover",Lipoxygenases}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Biosynthesis of specialized proresolving mediators (SPMs)","Biosynthesis of DPA-derived SPMs","Biosynthesis of DPAn-3 SPMs","Biosynthesis of DPAn-3-derived 13-serie
s resolvins"}

> <broad_targets>
{DBH,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A,HTR7,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{"Dopamine hydrochloride",62-31-7,62317,"62 31 7","3-Hydroxytyramine hydrochloride","3Hydroxytyramine hydrochloride","3 Hydroxytyramine hydrochloride","Dopamine HCl","4-(2-aminoethyl)benzene-1,2-diol 
hydrochloride","4(2aminoethyl)benzene1,2diol hydrochloride",4(2aminoethyl)benzene1,2d,S2529,SAM002554938,1500263,Prestw-1398,"Dopamine HCl",CPD000059081,"DOPAMINE HYDROCHLORIDE"}

> <pdid>
PD000596

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling",cardiotonic,antihypotensive}

> <pubchem_cids>
{65340,46911794,517540}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 21  0  0  0  0            999 V2000
    7.6971   -3.7837    0.0000 H   0  3
    5.1971   -3.7837    0.0000 Cl  0  5
   -0.5529  -10.3163    0.0000 C   0  0
    0.0576   -8.9462    0.0000 N   0  0
    1.5502   -8.7888    0.0000 C   0  0
    2.1626   -7.4186    0.0000 N   0  0
    1.2830   -6.2026    0.0000 C   0  0
    1.8954   -4.8324    0.0000 C   0  0
    1.0157   -3.6164    0.0000 S   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 O   0  0
    0.0000    1.2760    0.0000 C   0  0
   -0.0031    2.7742    0.0000 C   0  0
   -1.3040    3.5228    0.0000 N   0  0
   -1.3071    5.0228    0.0000 C   0  0
   -2.6017    2.7705    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0
    2.4298  -10.0049    0.0000 C   0  0
    1.8174  -11.3750    0.0000 N   0  3
    0.3254  -11.5292    0.0000 O   0  5
    2.6966  -12.5904    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 13 18  2  0
 18 19  1  0
 19 11  2  0
  5 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
M  CHG  4   1   1   2  -1  21   1  22  -1
M  END
> <name>
Selleck_GPCR

> <id>
7597

> <plate>
1

> <well>
C13

> <supplier_cmpd_name>
Ranitidine

> <ctcr_id>
7007

> <supplier_cmpd_id>
S1801

> <smiles>
[H+].[Cl-].CNC(/NCCSCc1oc(CN(C)C)cc1)=C\[N+]([O-])=O

> <pd_targets>
{CA2,CA1,HRH2,RAD52,BLM,MAPT,AMPC,NFKB1,TSHR,ATP4A,ATP4B,HIF1A,KMT2A,MEN1,LMNA,CHRM1,ACHE,HSD17B10,SLC47A1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other nuclear protein","Other cytosolic protein",Transporter,"Transcription factor","Epigenetic regulator",Lyase,"Family A G protein-coupled receptor",Hydrolase,"Primary a
ctive transporter",Reader,Oxidoreductase,"Electrochemical transporter","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","P-type ATPase",Bromodomain,"SLC superfamily of solu
te carriers","Monoamine receptor","Glycohormone receptor","Hydrogen potassium ATPase","SLC47 family of multidrug and toxin extrusion transporters","Histamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Carbonic anhydrases","G protein-coupled receptors","Acetylcholine turnover","SLC superfamily of solute carriers","Histamine receptors","Glycoprotein hormone receptors"
,"Acetylcholine receptors (muscarinic)","SLC47 family of multidrug and toxin extrusion transporters"}

> <pathway_reactome>
{"Transport of small molecules","Immune System",Disease,"DNA Repair","Neuronal System","Cellular responses to external stimuli","Cell Cycle","Signal Transduction",Metabolism,"O2/CO2 exchange in erythr
ocytes","Cytokine Signaling in Immune system","Infectious disease","DNA Double-Strand Break Repair","Transmission across Chemical Synapses","Cellular responses to stress",Mitotic,"Signaling by GPCR","
Metabolism of lipids","Metabolism of amino acids and derivatives","SLC-mediated transmembrane transport","Erythrocytes take up carbon dioxide and release oxygen","Signaling by Interleukins","Leishmani
a infection","Homology Directed Repair","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to hypoxia","M Phase","GPCR ligand binding","Phospholipid metabolism","Bran
ched-chain amino acid catabolism","Transport of bile salts and organic acids","metal ions and amine compounds","Interleukin-12 family signaling","Leishmania parasite growth and survival","HDR through 
Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Activation of NMDA receptors and postsynaptic events","Interleukin-1 family signaling","Oxygen-dependent proline hydroxylation of Hypo
xia-inducible Factor Alpha","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Glycerophospholipid biosynthesis","Interleukin-12 signaling","Anti-inflammatory response favouring 
Leishmania parasite infection","HDR through Single Strand Annealing (SSA)","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events","Interleukin-1 signaling","Mitotic Anapha
se","Amine ligand-binding receptors","Synthesis of PC","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","ADORA2B mediated anti-inflammatory cytokines production","H
omologous DNA Pairing and Strand Exchange","Activation of AMPK downstream of NMDARs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors
","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"ranitidine hydrochloride","Ranitidine HCL",66357-59-3,66357593,ZANTAC,Fendibina,Gastridina,Gastrolav,Kuracid,Raniberl,Ranibloc,Alquen,Rani-nerton,Raninerton,Nu-Ranit,NuRanit,Rani-Q,RaniQ,"Ranitidine
 (hydrochloride)",71130-06-8,71130068,Santanol,Tanidina,Toriol,Coralen,Quantor,Radin,Noctone,S1801,SAM002264645,Ranitidine,CPD000653467}

> <pdid>
PD009680

> <targets>
{Bacterial,Cytochrome P450,Histamine Receptor}

> <classes>
{Neuronal Signaling,Anti-infection,GPCR/G Protein,Immunology/Inflammation,Metabolic Enzyme/Protease}

> <pubchem_cids>
{3033332,24883424,43835200}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 15  0  0  0  0            999 V2000
   10.1894   -2.2553    0.0000 H   0  3
    7.6894   -2.2553    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7598

> <plate>
1

> <well>
C14

> <supplier_cmpd_name>
Isoprenaline HCl

> <ctcr_id>
33

> <supplier_cmpd_id>
S2566

> <smiles>
[H+].[Cl-].CC(C)NCC(O)c1ccc(O)c(O)c1

> <pd_targets>
{TSHR,ALDOA,ADRB3,ADRB1,ADRB2,FFP,ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,MAPT,ALOX15,ALD,HSD17B10,KDM4E,TDP1,PMP22,RXFP1,MAPK1,AMPC,BLM,POLB,NS1,GAA,TAS2R46,TAS2R31,TAS2R50,TAS2R10,TAS2R41,DRD3,TAS
2R45,MTOR,DRD4,TAS2R14,TAS2R4,DRD2,TAS2R3,TAS2R40,TAS2R39,TAS2R9,TAS2R8,TAS2R13,TAS2R43,TAS2R16,TAS2R19,TAS2R7,TAS2R42,TAS2R60,TAS2R38,TAS2R30,TAS2R1,TAS2R5,TAS2R20,PIK3R1,PIK3R2,PIK3R3,PDE4,MPI,TGR,N
FKB1,HIF1A,CYP3A4,CYP1A2,KMT2A,MEN1,HPGD,LMNA,CYP2C19,ALDH1A1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other cytosolic protein","Epigenetic regulator","Unclassified protein","Family A G protein-coupled receptor",Lyase,Transferase,Oxidoreductase,Eraser,Hydrolase,Kinase,"Tast
e family G protein-coupled receptor",Isomerase,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Lysine demethylase","Protein Kinase","Taste receptor (taste family GPCR)","
Glycohormone receptor","Monoamine receptor","Jumonji domain-containing","Relaxin-like peptide receptor (family A GPCR)","CMGC protein kinase group","Atypical protein kinase group","Adrenergic receptor
","Relaxin receptor","CMGC protein kinase MAPK family","Dopamine receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily","Transcription fact
or","Other nuclear protein","Cytochrome P450",Reader,"Cytochrome P450 family 3","Cytochrome P450 family 1",Bromodomain,"Cytochrome P450 family 2","Cytochrome P450 family 3A","Cytochrome P450 family 1A
","Cytochrome P450 family 2C","Cytochrome P450 3A4","Cytochrome P450 1A1","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","3.2.1.- Glycosidases","Glycerophospholipid turnover","Glycoprotein hormone 
receptors",Adrenoceptors,Lipoxygenases,"1.14.11.- Histone demethylases","Relaxin family peptide receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Orphan and other 7TM receptors","Dopamine re
ceptors",Atypical,"Phosphatidylinositol kinases","Mitogen-activated protein kinases (MAP kinases)","Taste 2 receptors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","
FRAP subfamily","Cytochrome P450","CYP3 family","CYP1 family","Prostaglandin synthases","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{Disease,Hemostasis,"Neuronal System",Metabolism,"DNA Repair","Developmental Biology","Immune System","Signal Transduction","Gene expression (Transcription)","Metabolism of proteins","Infectious disea
se","Platelet activation","signaling and aggregation","Transmission across Chemical Synapses","Metabolism of lipids","Metabolism of amino acids and derivatives","DNA Double-Strand Break Repair","Nervo
us system development","Innate Immune System","Base Excision Repair","Diseases of metabolism","Signaling by GPCR","RNA Polymerase II Transcription","Diseases of signal transduction by growth factor re
ceptors and second messengers","Signaling by Receptor Tyrosine Kinases","Adaptive Immune System","Post-translational protein modification","Leishmania infection","Response to elevated platelet cytosol
ic Ca2+","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Nonhomologous End-Joining
 (NHEJ)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Receptor Cascades","Homology Directed Repair","Resolution of Abasic Sites (AP sites)","Diseases of carbohydrate met
abolism","GPCR downstream signalling","GPCR ligand binding","Generic Transcription Pathway","Signaling by FGFR in disease","Signaling by Insulin receptor","Costimulation by the CD28 family","Asparagin
e N-linked glycosylation","Leishmania parasite growth and survival","Platelet degranulation","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","Toll Like Recept
or 5 (TLR5) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Glycogen storage dise
ases","G alpha (i) signalling events","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by TP53","Signaling by FGFR1 in disease","Insulin receptor signalling cascade","CD28 co-stimula
tion","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide","LLO) and transfer to a nascent protein","Anti-inflammatory response favouring Leishmania parasite infection","Pos
t NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision Repa
ir","Glycogen storage disease type II (GAA)","Amine ligand-binding receptors","Regulation of TP53 Activity","FGFR1 mutant receptor activation","IRS-mediated signalling","CD28 dependent PI3K/Akt signal
ing","Synthesis of substrates in N-glycan biosythesis","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins an
d resolvins","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","Dopamine receptors","Regulation of TP53 Expression and Degradation","Signaling by cytosolic FGFR1 fusion mutants","PI
3K Cascade",Adrenoceptors,"Synthesis of GDP-mannose","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degrad
ation","ERK/MAPK targets","ERKs are inactivated","Cellular responses to external stimuli","Cell Cycle","Cytokine Signaling in Immune system","Cellular responses to stress","Biological oxidations",Mito
tic,"Signaling by Interleukins","Cellular response to hypoxia","Phase I - Functionalization of compounds","M Phase","Interleukin-1 family signaling","Oxygen-dependent proline hydroxylation of Hypoxia-
inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Ethanol oxidation","Interleukin-1 signaling","Biosynthesis o
f maresins",Xenobiotics,"Biosynthesis of D-series resolvins","Mitotic Anaphase","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated 
or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{AKOS026750017,"l-Isoprenaline hydrochloride","lIsoprenaline hydrochloride",MCULE-1456958404,MCULE1456958404,"(2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)-propan-2-ylazanium;chloride","(2(3,4dihydroxyphen
yl)2hydroxyethyl)propan2ylazanium;chloride","Isoprenaline hydrochloride","ISOPROTERENOL HYDROCHLORIDE",51-30-9,51309,Isuprel,"Isoprenaline HCl",Euspiran,Aerolo,S2566,SAM002554906,1500357,CPD000058267}

> <pdid>
PD009570

> <targets>
{"Adrenergic Receptor"}

> <classes>
{bronchodilator,"Neuronal Signaling"}

> <pubchem_cids>
{57513594,13701,5807}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 25  0  0  1  0            999 V2000
   15.3985   -1.1176    0.0000 Cl  0  5
    5.1919    1.5058    0.0000 C   0  0
    6.4933    0.7599    0.0000 N   0  0
    7.7897    1.5144    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0  1  0  0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    9.0994   -0.7387    0.0000 C   0  0
   10.3984   -1.4887    0.0000 C   0  0
   10.3985   -2.9887    0.0000 C   0  0
    9.0995   -3.7387    0.0000 C   0  0
    7.8004   -2.9887    0.0000 C   0  0
   12.8985   -1.1176    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18  9  1  0
 18 13  1  0
  5 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  2   1  -1  25   1
M  END
> <name>
Selleck_GPCR

> <id>
7599

> <plate>
1

> <well>
C15

> <supplier_cmpd_name>
Dapoxetine HCl

> <ctcr_id>
7575

> <supplier_cmpd_id>
S1869

> <smiles>
[Cl-].CN(C)[C@@H](CCOc1cccc2ccccc12)c3ccccc3.[H+]

> <pd_targets>
{SLC6A4}

> <pathway_gtopdb>
{Transporter,"Electrochemical transporter","SLC superfamily of solute carriers","SLC06 neurotransmitter transporter family"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC6 neurotransmitter transporter family","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter clearance","Serotonin clearance from the synaptic cleft"}

> <broad_targets>
{HTR1A,HTR1B,HTR2C,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{"Dapoxetine hydrochloride",129938-20-1,129938201,"129938 20 1","Dapoxetine HCl",Priligy,UNII-U4OHT63MRI,UNIIU4OHT63MRI,"UNII U4OHT63MRI","Dapoxetine (hydrochloride)",U4OHT63MRI,"(+)-Dapoxetine hydroc
hloride","(+)Dapoxetine hydrochloride",S1869,"Dapoxetine HCl"}

> <pdid>
PD008691

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{67108443,71352}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 26  0  0  1  0            999 V2000
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 C   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0  2  0  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    7.7960   -1.5190    0.0000 C   0  0
    9.0965   -0.7716    0.0000 O   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 O   0  0
    2.5893   -6.0044    0.0000 C   0  0
    1.2924   -5.2507    0.0000 C   0  0
    2.5845   -7.5044    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 19 20  1  0
 20 21  2  0
 21 14  1  0
 21 22  1  0
  4 23  1  0
 23 24  1  0
 23 25  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7600

> <plate>
1

> <well>
C16

> <supplier_cmpd_name>
5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM)

> <ctcr_id>
7432

> <supplier_cmpd_id>
S2659

> <smiles>
CC(C)N(CC[C@H](c1ccccc1)c2cc(CO)ccc2O)C(C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{CHRM3}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{Desfesoterodine,207679-81-0,207679810,"(R)-5-Hydroxymethyl tolterodine","(R)5Hydroxymethyl tolterodine","5-Hydroxymethyl Tolterodine","5Hydroxymethyl Tolterodine",(R)-2-(3-(Diisopropylamino)-1-phenyl
propyl)-4-(hydroxymethyl)phenol,(R)2(3(Diisopropylamino)1phenylpropyl)4(hydroxymethyl)phenol,PNU-200577,PNU200577,5-Hydroxymethyltolterodine,5Hydroxymethyltolterodine,UNII-YU871O78GR,UNIIYU871O78GR,"P
NU 200577","Desfesoterodine (INN)",S2659,"5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM)"}

> <pdid>
PD010900

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9819382}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  0  0            999 V2000
    7.7546  -15.0257    0.0000 Cl  0  0
    6.4594  -14.2692    0.0000 C   0  0
    5.1566  -15.0126    0.0000 C   0  0
    3.8613  -14.2561    0.0000 C   0  0
    3.8689  -12.7561    0.0000 C   0  0
    5.1717  -12.0125    0.0000 C   0  0
    5.1769  -10.5118    0.0000 N   0  0
    6.4785   -9.7663    0.0000 C   0  0
    6.4837   -8.2663    0.0000 C   0  0
    5.1873   -7.5117    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 O   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8856   -8.2573    0.0000 C   0  0
    3.8804   -9.7573    0.0000 C   0  0
    6.4669  -12.7692    0.0000 C   0  0
    7.7698  -12.0258    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 19  1  0
 25 26  2  0
 26 16  1  0
 10 27  1  0
 27 28  1  0
 28  7  1  0
  6 29  2  0
 29  2  1  0
 29 30  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7601

> <plate>
1

> <well>
C17

> <supplier_cmpd_name>
Aripiprazole

> <ctcr_id>
4649

> <supplier_cmpd_id>
S1975

> <smiles>
Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl

> <pd_targets>
{RORC,HTR3A,DRD4,HTR1A,HTR2C,KCNH2,HRH1,HTR2A,ADRA2A,ADRA2B,HTR1D,DRD3,ADRB1,GSC2,ADRA1A,HTR7,DRD2,HTR2B,SLC6A3,H1-0,HTR1B,GAA,HTR6,MAPT,ADRA2C,ADRA1B,ADRA1D,DRD5,ADRB2,CHRM1,SLC6A4,CHRM5,KMT2A,MEN1,N
PSR1,HTR5A,CHRM4,GRIN1,CHRM2,SLC6A2,CHRM3,HRH3,PRKCG,HTR1E,ABCB1,HTR3B,HTR3C,HTR3D,HTR3E}

> <pathway_gtopdb>
{"Transcription factor","Ion channel","Membrane receptor",Enzyme,Transporter,"Other nuclear protein","Other cytosolic protein","Epigenetic regulator","Nuclear receptor","Ligand-gated ion channel","Fam
ily A G protein-coupled receptor","Voltage-gated ion channel",Transferase,"Electrochemical transporter",Hydrolase,Reader,Kinase,"Primary active transporter","Nuclear hormone receptor subfamily 1","5HT
3 receptor","Small molecule receptor (family A GPCR)","Potassium channels","SLC superfamily of solute carriers",Bromodomain,"Peptide receptor (family A GPCR)","Ionotropic glutamate receptor","Protein 
Kinase","ATP-binding cassette","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Voltage-gated potassium channel","SLC06 neurotransmitter transporter family","Short peptide receptor
 (family A GPCR)","NMDA receptor","AGC protein kinase group","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F member 3","Dopamine receptor","Serotonin receptor","Histamine receptor","Adr
energic receptor","Acetylcholine receptor","Neuropeptide receptor","AGC protein kinase PKC family","AGC protein kinase PKC alpha subfamily"}

> <pathway_chembl>
{Receptors,"Ion channels",Transporters,Enzymes,"Nuclear hormone receptors","Ligand-gated ion channels","G protein-coupled receptors","Voltage-gated ion channels","SLC superfamily of solute carriers","
3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","ATP-binding cassette transporter family","1F. Retinoic acid-related orphans","5-HT<sub>3</sub> receptors","Dopamine receptors","5-Hydroxytryptamine recept
ors","Potassium channels","Histamine receptors",Adrenoceptors,"SLC6 neurotransmitter transporter family","Acetylcholine receptors (muscarinic)","Neuropeptide S receptor","Ionotropic glutamate receptor
s","AGC: Containing PKA",PKG,"PKC families","ABCB subfamily","Voltage-gated potassium channels","Monoamine transporter subfamily","Protein kinase C (PKC) family","Alpha subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System","Signal Transduction","Muscle contraction",Disease,"Cellular responses to external stimuli",Metabolism,"RNA Polymerase II Transcription","Transmiss
ion across Chemical Synapses","Signaling by GPCR","Cardiac conduction","Infectious disease","Disorders of transmembrane transporters","Cellular responses to stress","Diseases of metabolism","Abacavir 
transport and metabolism","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Phase 3 - rapid repolarisation","Leishmania infection
","SLC transporter disorders","Cellular Senescence","Diseases of carbohydrate metabolism","Neurotransmitter clearance","Abacavir transmembrane transport","Transcriptional regulation by RUNX3","Class A
/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","DNA Damage/Telomere Stress Induced Senescence","Glycogen sto
rage diseases","Activation of NMDA receptors and postsynaptic events","Serotonin clearance from the synaptic cleft","Defective SLC6A2 causes orthostatic intolerance (OI)","Glutamate binding","activati
on of AMPA receptors and synaptic plasticity","RUNX3 Regulates Immune Response and Cell Migration","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection"
,"Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","Trafficking of AMPA receptors","Dopamine receptors","
Serotonin receptors","Histamine receptors",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors","CREB1
 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Trafficking of GluR2-containing AMPA receptors","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA2A,ADRA2B,ADRA2C,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,DRD4,DRD5,HRH1,HTR1A,HTR1B,HTR1D,HTR1E,HTR2A,HTR2C,HTR3A,HTR6,HTR7}

> <broad_moa>
{"serotonin receptor agonist","serotonin receptor antagonist"}

> <synonyms>
{RESTW122,Aripiprazole,"7-(4-(-4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril","7(4(4(2,3dichlorophenyl)1piperazinyl)butoxy)3,4dihydrocarbostyril","7-(4-(4-(2,3-dichlorophenyl)-1-
piperazinyl)butoxy)-3, 4-dihydrocarbostyril","7(4(4(2,3dichlorophenyl)1piperazinyl)butoxy)3, 4dihydrocarbostyril",1026778-41-5,1026778415,24-29-3,24293,129722-12-9,129722129,Abilify,Abilitat,"Abilify 
Discmelt",OPC-145,OPC145,T1566,S1975,SAM001246750,1505851,Prestw-1229,CPD000466383,ARIPIPRAZOLE}

> <pdid>
PD000697

> <targets>
{"5-HT Receptor"}

> <classes>
{antipsychotic,"5HT2A antagonist","Neuronal Signaling"}

> <pubchem_cids>
{60795}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 31 34  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.4469   -5.2298    0.0000 C   0  0
   -2.9152   -5.5365    0.0000 C   0  0
   -3.6607   -4.2349    0.0000 C   0  0
   -2.6531   -3.1237    0.0000 S   0  0
   -5.1527   -4.0728    0.0000 C   0  0
   -6.1232   -5.2100    0.0000 C   0  0
   -7.5980   -4.9363    0.0000 C   0  0
   -8.0984   -3.5222    0.0000 C   0  0
   -9.5732   -3.2485    0.0000 F   0  0
   -7.1239   -2.3818    0.0000 C   0  0
   -5.6491   -2.6555    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0  2  0  0  0
   -3.8967    0.7484    0.0000 O   0  0
   -5.1969    1.4963    0.0000 C   0  0  2  0  0  0
   -6.4939    0.7411    0.0000 C   0  0
   -6.4894   -0.7588    0.0000 O   0  0
   -5.1993    2.9963    0.0000 C   0  0  1  0  0  0
   -6.4995    3.7442    0.0000 O   0  0
   -3.9014    3.7484    0.0000 C   0  0  2  0  0  0
   -3.9038    5.2484    0.0000 O   0  0
   -2.6012    3.0004    0.0000 C   0  0  1  0  0  0
   -1.3034    3.7525    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 14  1  0
 21  5  1  6
 21 22  1  0
 22 23  1  0
 23 24  1  6
 24 25  1  0
 23 26  1  0
 26 27  1  1
 26 28  1  0
 28 29  1  6
 28 30  1  0
 30 21  1  0
 30 31  1  1
M  END
> <name>
Selleck_GPCR

> <id>
7602

> <plate>
1

> <well>
C18

> <supplier_cmpd_name>
Canagliflozin

> <ctcr_id>
7252

> <supplier_cmpd_id>
S2760

> <smiles>
Cc1ccc(cc1Cc2ccc(s2)c3ccc(F)cc3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O

> <pd_targets>
{SLC5A2,SLC5A1,PROTEASE}

> <pathway_gtopdb>
{Transporter,Enzyme,"Electrochemical transporter",Protease,"SLC superfamily of solute carriers","Cysteine protease","SLC05 family of sodium-dependent glucose transporters","Cysteine protease PAC clan"
,"Cysteine protease C3A subfamily"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC5 family of sodium-dependent glucose transporters","Hexose transporter family"}

> <pathway_reactome>
{Disease,"Disorders of transmembrane transporters","SLC transporter disorders","Defective SLC5A2 causes renal glucosuria (GLYS1)","Defective SLC5A1 causes congenital glucose/galactose malabsorption (G
GM)"}

> <broad_targets>
{SLC5A1,SLC5A2}

> <broad_moa>
{"sodium/glucose cotransporter inhibitor"}

> <synonyms>
{Canagliflozin,842133-18-0,842133180,"Canagliflozin anhydrous","canagliflozin hemihydrate",TA-7284,TA7284,JNJ-28431754,JNJ28431754,UNII-6S49DGR869,UNII6S49DGR869,"JNJ 24831754ZAE","Canagliflozin hydra
te",1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene,1(Glucopyranosyl)4methyl3(5(4fluorophenyl)2thienylmethyl)benzene,CHEBI:73274,6S49,S2760}

> <pdid>
PD000132

> <targets>
{SGLT}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{24812758}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 25  0  0  0  0            999 V2000
   12.5852   -0.0431    0.0000 H   0  3
   10.0852   -0.0431    0.0000 Cl  0  5
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  7 10  2  3
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  3
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 10  1  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7603

> <plate>
1

> <well>
C19

> <supplier_cmpd_name>
Cyproheptadine HCl

> <ctcr_id>
1615

> <supplier_cmpd_id>
S2044

> <smiles>
[H+].[Cl-].CN1CCC(CC1)=C2c3ccccc3C=Cc4ccccc24

> <pd_targets>
{HTR1A,HTR1B,HTR1D,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HTR6,HTR7,CYP2C19,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HRH4,SLC6A2,SETD7,ADRA1A,HRH1,TSHR,ALDH1A1,TP53,CYP2D6,DRD2,DRD3,SCN1A,SCN2A,SCN
3A,FFP,LEF,ADRA1B,SLC6A4,HTT,ADRA1D,DRD1,DRD4,DRD5,CYP1A2,HSD17B10,PMP22,RORC,LMNA,MAPT,KMT2A,MEN1,ADRA2B,HRH2,KCNH2,ADRA2C,CACNA1C,ADRA2A,MTOR}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Transporter,"Epigenetic regulator","Transcription factor","Ion channel","Unclassified protein","Other nuclear protein","Other cytosolic protein","Family A G protein-coupled
 receptor","Cytochrome P450","Electrochemical transporter",Writer,Oxidoreductase,"Voltage-gated ion channel",Transferase,Protease,"Ligand-gated ion channel","Nuclear receptor",Reader,Kinase,"Small mol
ecule receptor (family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute carriers","Protein methyltransferase","Peptide receptor (family A GPCR)","Voltage-gated sodium channel","Metallo p
rotease","5HT3 receptor","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1",Bromodomain,"Potassium channels","Voltage-gated calcium channel","Protein Kinase","Monoamine receptor","Cytoc
hrome P450 family 2C","SLC06 neurotransmitter transporter family","SET domain","Glycohormone receptor","Cytochrome P450 family 2D","Metallo protease MAE clan","Cytochrome P450 family 1A","Nuclear horm
one receptor subfamily 1 group F","Voltage-gated potassium channel","Atypical protein kinase group","Serotonin receptor","Cytochrome P450 2C19","Acetylcholine receptor","Histamine receptor","Adrenergi
c receptor","Cytochrome P450 2D6","Dopamine receptor","Metallo protease M34 family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Atypical protein kinase PIKK family",
"Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Chromatin modifying enzymes","Ligand-gated ion channels","Nuclear h
ormone receptors","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","Histamine receptors","SLC6 neurotransmitter transporter f
amily","2.1.1.43 Histone methyltransferases (HMTs)",Adrenoceptors,"Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Dopamine receptors","5-HT<sub>3</sub> receptors","CYP1 family
","1F. Retinoic acid-related orphans","Potassium channels","Voltage-gated calcium channels",Atypical,"Monoamine transporter subfamily","Voltage-gated potassium channels","Phosphatidyl inositol 3' kina
se-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Signal Transduction","Chromatin organization","Cell Cycle","Neuronal System","Gene expression (Transcription)","Developmental Biology","Muscle contraction","Biological oxidations"
,"Infectious disease","Signaling by GPCR","Disorders of transmembrane transporters","Chromatin modifying enzymes","Cell Cycle Checkpoints","Transmission across Chemical Synapses","RNA Polymerase II Tr
anscription","Metabolism of amino acids and derivatives","Nervous system development",Mitotic,"Cardiac conduction","Phase I - Functionalization of compounds","Leishmania infection","GPCR ligand bindin
g","SLC transporter disorders","PKMTs methylate histone lysines","G1/S DNA Damage Checkpoints","Uptake and actions of bacterial toxins","Neurotransmitter clearance","Neurotransmitter receptors and pos
tsynaptic signal transmission","Generic Transcription Pathway","Branched-chain amino acid catabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Phase 3 - rapid repola
risation","Axon guidance","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intoleran
ce (OI)","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Uptake and function of anthrax toxins","Serotonin clearance from the synaptic cleft","Transcriptional Regulation by MECP2","Tra
nscriptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","NCAM signaling for neurite out-growth","Transcriptional Regulation by TP53",X
enobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","p53-Dependent G1 DNA Damage Response","Regulation of MECP2 expression and activity","R
UNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","Post NMDA receptor activation events","NCAM1 interactions","Regulation of TP53 Activity","CYP2E1 reactions","ADORA2B mediated ant
i-inflammatory cytokines production","Serotonin receptors","Histamine receptors",Adrenoceptors,"Muscarinic acetylcholine receptors","Stabilization of p53","Dopamine receptors","Aromatic amines can be 
N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Regulation of TP53 Expression and Degradation","Autodegradation of the E3 ubiqu
itin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,CHRM1,CHRM2,CHRM3,HRH1,HTR2A,HTR2C,HTR6,HTR7}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{RESTW10,"RESTW 10",AKOS024366257,MCULE-4137922083,MCULE4137922083,"MCULE 4137922083",ST50999681,"4-dibenzo(b,f)(7)annulen-5-ylidene-1-methylpiperidine, chloride","4dibenzo(b,f)(7)annulen5ylidene1meth
ylpiperidine, chloride","4 dibenzo(b",f)(7)ann,S2044,SAM001246883,1505973,Prestw-103,"Cyproheptadine HCl",CPD000058431,"CYPROHEPTADINE HYDROCHLORIDE","Cyproheptadine hydrochloride"}

> <pdid>
PD010029

> <targets>
{"Histamine Receptor"}

> <classes>
{antipruritic,H1-antihistamine,"Neuronal Signaling"}

> <pubchem_cids>
{43834424,657241,13770}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.6608   -1.8315    0.0000 O   0  0
   -5.1253   -4.3743    0.0000 N   0  0
   -6.5925   -4.6865    0.0000 C   0  0
   -7.0558   -6.1132    0.0000 C   0  0
   -6.0519   -7.2277    0.0000 O   0  0
   -4.5847   -6.9156    0.0000 C   0  0
   -4.1214   -5.4890    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.1905    2.6376    0.0000 C   0  0
   -2.1885    3.7539    0.0000 O   0  0
   -4.6589    2.9478    0.0000 C   0  0
   -5.1272    4.3728    0.0000 C   0  0
   -6.5954    4.6799    0.0000 C   0  0
   -7.5955    3.5619    0.0000 C   0  0
   -9.0637    3.8689    0.0000 Cl  0  0
   -7.1272    2.1368    0.0000 C   0  0
   -5.6590    1.8298    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 14  1  0
 10 20  1  0
 20  6  1  0
 20 21  2  0
 21  3  1  0
  7 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 30 24  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7604

> <plate>
1

> <well>
C20

> <supplier_cmpd_name>
BML-190

> <ctcr_id>
3745

> <supplier_cmpd_id>
S2854

> <smiles>
COc1ccc2n(c(C)c(CC(=O)N3CCOCC3)c2c1)C(=O)c4ccc(Cl)cc4

> <pd_targets>
{FTL,CYP2C19,CYP2C9,PMP22,CNR2,CYP3A4,TSHR,KMT2A,MEN1,BLM,CYP1A2,NFKB1,GMNN,PKM,RORC,CHRM1}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Membrane receptor","Epigenetic regulator","Other cytosolic protein","Transcription factor","Cytochrome P450","Family A G protein-coupled receptor",Protease,Reader,"Nucl
ear receptor","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Cysteine protease",Bromodomain,"Cytochrome P450 family
 1","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2C","Lipid-like ligand receptor (family A GPCR)","Cytochrome P450 family 3A","Glycohormone receptor","Cysteine protease CA clan","Cyt
ochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Cytochrome P450 2C19","Cytochrome P450 2C9","Cannabinoid receptor","Cytochrome P450 3A4","Cysteine protease
 C1A family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","2.7.1.40 Pyruvate kinases","Nuclear hormone receptors","CYP2 family: drug metabolising subset","Cannabinoid receptors","CYP3 family"
,"Glycoprotein hormone receptors","CYP1 family","1F. Retinoic acid-related orphans","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Vesicle-mediated transport",Metabolism,"Developmental Biology","Signal Transduction",Disease,"DNA Repair","Immune System","Cell Cycle","Gene expression (Transcription)","Membrane Trafficking","Biolo
gical oxidations","Nervous system development","Signaling by GPCR","Metabolism of lipids","Infectious disease","DNA Double-Strand Break Repair","Cytokine Signaling in Immune system",Mitotic,"Metabolis
m of carbohydrates","RNA Polymerase II Transcription","trans-Golgi Network Vesicle Budding","Phase I - Functionalization of compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination",
"GPCR downstream signalling","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Homology Directed Repair","Signaling by Interleukins","Mitotic G1 phase and G1/S transi
tion","Glucose metabolism","Generic Transcription Pathway","GPCR ligand binding","Golgi Associated Vesicle Biogenesis","Cytochrome P450 - arranged by substrate type","G alpha (i) signalling events","B
iosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interleukin-1 family signaling","G1/S Transiti
on",Glycolysis,"Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)",Xenobiotics,"Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection",
"HDR through Homologous Recombination (HRR)","Interleukin-1 signaling","Activation of the pre-replicative complex","RUNX3 Regulates Immune Response and Cell Migration","Amine ligand-binding receptors"
,"CYP2E1 reactions","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Homologous DNA Pairing and Strand Exchange","Aromatic amines can be N-hydroxylated or
 N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Muscarinic acetylcholine receptors","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CNR2}

> <broad_moa>
{"cannabinoid receptor inverse agonist"}

> <synonyms>
{ML19,BML-190,BML190,2854-32-2,2854322,"Indomethacin morpholinylamide","BML 190",CHEMBL72631,SR-01000075946,SR01000075946,Bio2_000763,Bio2000763,Bio2-000763,"Bio2 000763",Tocris-1383,Tocris1383,Lopac-
I-151,LopacI151,"Indomethacin morpholinamide",CBiol_001726,CBiol001726,CBiol-001726,"CBiol 001726",Lopac0_000685,Lopac0000685,Lopac0-000685,"Lopac0 000685",BSPBio_001563,BSPBio001563,BSPBio-001563,"BS
PBio 001563",KBioGR_000283,KBioGR000283,KBioGR-000283,"KBioGR 000283",KBioSS_000283,KBioSS000283,KBioSS-000283,"KBioSS 000283","3-AMINO BENZONITRILE?","3AMINO BENZONITRILE?",B,T6417,S2854}

> <pdid>
PD010548

> <targets>
{Cannabinoid Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{2415}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 37  0  0  1  0            999 V2000
   11.1361    4.5567    0.0000 Cl  0  5
    6.1356   -1.0519    0.0000 C   0  0
    5.2020   -2.2259    0.0000 O   0  0
    3.7175   -2.0053    0.0000 C   0  0
    3.1695   -0.6090    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 N   0  0
   -2.5245    2.0171    0.0000 C   0  0
   -2.2987    3.5008    0.0000 C   0  0
   -3.4702    4.4390    0.0000 C   0  0
   -3.2444    5.9227    0.0000 N   0  0
   -1.8472    6.4683    0.0000 C   0  0
   -4.4159    6.8609    0.0000 C   0  0
   -4.1901    8.3446    0.0000 C   0  0  1  0  0  0
   -2.9882    9.1803    0.0000 C   0  0
   -3.8734   10.3883    0.0000 C   0  0
   -4.0362   11.8795    0.0000 C   0  0
   -5.4090   12.4840    0.0000 C   0  0
   -5.5689   13.9763    0.0000 O   0  0
   -4.3577   14.8612    0.0000 C   0  0
   -6.6190   11.5974    0.0000 C   0  0
   -7.9938   12.1994    0.0000 O   0  0
   -9.2024   11.3111    0.0000 C   0  0
   -6.4561   10.1062    0.0000 C   0  0
   -5.0833    9.5017    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1476   -0.7184    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.2990   -2.9545    0.0000 C   0  0
    2.7822   -3.1780    0.0000 C   0  0
    3.3277   -4.5763    0.0000 O   0  0
    2.3908   -5.7477    0.0000 C   0  0
    8.6361    4.5567    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 16 15  1  6
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  2  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  2  0
 27 16  1  0
 27 18  1  0
  9 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31  6  2  0
 31 32  1  0
 32 33  2  0
 33  4  1  0
 33 34  1  0
 34 35  1  0
M  CHG  2   1  -1  36   1
M  END
> <name>
Selleck_GPCR

> <id>
7605

> <plate>
1

> <well>
C21

> <supplier_cmpd_name>
Ivabradine HCl

> <ctcr_id>
7480

> <supplier_cmpd_id>
S2086

> <smiles>
[Cl-].COc1cc2CCN(CCCN(C)C[C@H]3Cc4cc(OC)c(OC)cc34)C(=O)Cc2cc1OC.[H+]

> <pd_targets>
{HCN1,HCN4,HCN2,HCN3}

> <pathway_gtopdb>
{"Ion channel","Voltage-gated ion channel","Cyclic nucleotide-regulated channel"}

> <pathway_chembl>
{"Ion channels","Voltage-gated ion channels","Cyclic nucleotide-regulated channels"}

> <pathway_reactome>
{"Neuronal System","Potassium Channels","HCN channels"}

> <broad_targets>
{HCN1,HCN3,HCN4}

> <broad_moa>
{"HCN channel blocker","potassium channel blocker","sodium channel blocker"}

> <synonyms>
{148849-67-6,148849676,"Ivabradine HCl",Procoralan,"Ivabradine (hydrochloride)",UNII-TP19837BZK,UNIITP19837BZK,Corlanor,TP19837BZK,CHEBI:85969,NCGC00181343-01,NCGC0018134301,"148849-67-6 (HCl)","14884
9676 (HCl)",Ivabradinehydrochloride,"Ivabradine HCl (Procoralan)",s16257,Corlent,S2086}

> <pdid>
PD000477

> <targets>
{Adrenergic Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{3045381,46856313}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 27  0  0  0  0            999 V2000
   11.6883   -8.2536    0.0000 C   0  0
   10.3908   -7.5010    0.0000 O   0  0
   10.3929   -6.0001    0.0000 C   0  0
    9.0946   -5.2471    0.0000 C   0  0
    9.0967   -3.7463    0.0000 C   0  0
    7.7985   -2.9932    0.0000 N   0  0
    7.7985   -1.4932    0.0000 C   0  0
    6.4994   -0.7432    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2004   -2.9933    0.0000 C   0  0
    6.4995   -3.7432    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 C   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 15  1  0
 25 21  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7606

> <plate>
1

> <well>
C22

> <supplier_cmpd_name>
Prucalopride

> <ctcr_id>
1371

> <supplier_cmpd_id>
S2875

> <smiles>
COCCCN1CCC(CC1)NC(=O)c2cc(Cl)c(N)c3CCOc23

> <pd_targets>
{AP4S1,HTR4,HTR3A}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Family A G protein-coupled receptor","Ligand-gated ion channel","Small molecule receptor (family A GPCR)","5HT3 receptor","Monoamine receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Ligand-gated ion channels","5-Hydroxytryptamine receptors","5-HT<sub>3</sub> receptors"}

> <pathway_reactome>
{"Vesicle-mediated transport",Disease,"Neuronal System","Membrane Trafficking","Infectious disease","Transmission across Chemical Synapses","trans-Golgi Network Vesicle Budding","Leishmania infection"
,"Neurotransmitter receptors and postsynaptic signal transmission","Lysosome Vesicle Biogenesis","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite inf
ection","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{HTR4}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{Prucalopride,179474-81-8,179474818,Motegrity,UNII-0A09IUW5TP,UNII0A09IUW5TP,0A09IUW5TP,C18H26ClN3O3,CHEMBL117287,R-093877,R093877,"179474-81-8 (free base)","179474818 (free base)",resotrans,"Prucalop
ride (USAN:INN:BAN)",PubChem22481,"Prucalopride (USAN/INN)",DSSTox_CID_31459,DSSToxCID31459,DSSTox-CID-31459,"DSSTox CID 31459",DSSTox_RID_9734,DSSToxRID9734,DSSTox-RID-9734,"DSSTox RID 9734",T2542,S2
875}

> <pdid>
PD009298

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{3052762}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 28  0  0  1  0            999 V2000
   12.2327    0.2674    0.0000 Cl  0  5
   -2.6395    3.8685    0.0000 O   0  0
   -1.3618    3.0827    0.0000 C   0  0
    0.0000    3.7710    0.0000 C   0  0
    1.0625    3.0827    0.0000 C   0  0
    1.0625    1.6760    0.0000 C   0  0
    2.3045    0.9727    0.0000 C   0  0
    2.3045   -0.4040    0.0000 C   0  0  1  0  0  0
    3.2622   -1.0625    0.0000 N   0  0
    3.2622   -1.9005    0.0000 C   0  0
    0.0000   -1.9005    0.0000 C   0  0
    0.0000   -0.4040    0.0000 C   0  0  1  0  0  0
   -1.3618   -1.1223    0.0000 C   0  0  1  0  0  0
   -2.5589    0.2394    0.0000 O   0  0
   -1.3618    1.6760    0.0000 C   0  0
    0.0000    0.9727    0.0000 C   0  0
   -1.3618   -2.5589    0.0000 C   0  0
   -2.6462   -3.3336    0.0000 O   0  0
    0.0000   -3.2772    0.0000 C   0  0
    1.0774   -2.5589    0.0000 C   0  0
    1.0774   -1.1373    0.0000 C   0  0  1  0  0  0
    2.3821   -1.8775    0.0000 O   0  0
    4.6577   -0.4958    0.0000 C   0  0
    5.8415   -1.4184    0.0000 C   0  0
    7.2320   -0.8558    0.0000 C   0  0
    9.7327    0.2674    0.0000 H   0  3
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  1
 12 13  1  0
 13 14  1  6
 14 15  1  0
 15  3  1  0
 15 16  2  0
 16  6  1  0
 16 12  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 12  1  0
 21 22  1  1
  9 23  1  0
 23 24  1  0
 24 25  2  0
M  CHG  2   1  -1  26   1
M  END
> <name>
Selleck_GPCR

> <id>
7607

> <plate>
1

> <well>
D03

> <supplier_cmpd_name>
Naloxone HCl

> <ctcr_id>
4880

> <supplier_cmpd_id>
S3066

> <smiles>
[Cl-].Oc1ccc2C[C@H]3N(CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O)CC=C.[H+]

> <pd_targets>
{LMNA,MAPT,BLM,OPRK1,OPRD1,OPRM1,CCR5,TGR,CYP2D6,CREB1,ESR1,TLR4}

> <pathway_gtopdb>
{"Other nuclear protein","Other cytosolic protein",Enzyme,"Membrane receptor","Unclassified protein","Transcription factor","Family A G protein-coupled receptor","Cytochrome P450","Nuclear receptor",H
ydrolase,"Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 3","Short peptide receptor (family A GPCR)","Chemokine receptor","Cytochrome P450 family 2D",
"Nuclear hormone receptor subfamily 3 group A","Opioid receptor","CC chemokine receptor","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 3 group A member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Nuclear hormone receptors","Catalytic receptors","Opioid receptors","Chemokine receptors","CYP2 family: drug metabolising subset","S
teroid hormone receptors","Pattern recognition receptors","3A. Estrogen receptors","Toll-like receptor family"}

> <pathway_reactome>
{"Cell Cycle","Neuronal System","DNA Repair",Mitotic,"Transmission across Chemical Synapses","DNA Double-Strand Break Repair","M Phase","Neurotransmitter receptors and postsynaptic signal transmission
","Homology Directed Repair","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mito
tic Anaphase","Post NMDA receptor activation events","HDR through Homologous Recombination (HRR)","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing a
nd Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","Gene expression (Transcription)","Signal Transduction",Disease,
Metabolism,"Immune System","RNA Polymerase II Transcription","Signaling by GPCR","Infectious disease","Biological oxidations","Innate Immune System","Generic Transcription Pathway","GPCR ligand bindin
g","GPCR downstream signalling","HIV Infection","Phase I - Functionalization of compounds","Toll-like Receptor Cascades","Transcriptional Regulation by MECP2","Class A/1 (Rhodopsin-like receptors)","G
 alpha (i) signalling events","HIV Life Cycle","Cytochrome P450 - arranged by substrate type","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional regulation by RUNX1","Toll Like Receptor 4 (TLR4) C
ascade","MECP2 regulates neuronal receptors and channels","Peptide ligand-binding receptors","Opioid Signalling","Early Phase of HIV Life Cycle",Xenobiotics,"MyD88 cascade initiated on plasma membrane
","RUNX1 regulates estrogen receptor mediated transcription","MyD88-independent TLR4 cascade","G-protein activation","Binding and entry of HIV virion","CYP2E1 reactions","MAP kinase activation","TRIF(
TICAM1)-mediated TLR4 signaling","MAPK targets/ Nuclear events mediated by MAP kinases","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon","CREB phosphorylation"}

> <broad_targets>
{CREB1,ESR1,OPRD1,OPRK1,OPRM1,TLR4}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{RESTW11,"Naloxone hydrochloride","Naloxone HCl",357-08-4,357084,Narcan,"Naloxone (hydrochloride)","NIH 7890",UNII-F850569PQR,UNIIF850569PQR,EN-15304,EN15304,CHEBI:31892,F850569PQR,MFCD00069322,"357-0
8-4 (HCl)","357084 (HCl)",Narcanti,17-Allyl-4,17Allyl4,5alpha-epoxy-3,5alphaepoxy3,"14-dihydroxymorphinan-6-one hydrochl","14dihydroxymorphinan6one hydrochl",S3066,SAM002703137,Prestw-111,CPD000058766
}

> <pdid>
PD007525

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{44666320,5464092,46911858}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 32  0  0  0  0            999 V2000
    7.7858   -7.5171    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    6.4833   -9.7656    0.0000 C   0  0
    7.7815  -10.5187    0.0000 S   0  0
    9.0819   -9.7710    0.0000 O   0  0
    7.7794  -12.0195    0.0000 C   0  0
    9.0776  -12.7726    0.0000 C   0  0
    9.2155  -14.2535    0.0000 O   0  0
   10.6827  -14.5653    0.0000 C   0  0
   11.4327  -13.2663    0.0000 C   0  0
   10.4290  -12.1516    0.0000 C   0  0
    5.1873   -7.5117    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0076    0.0000 C   0  0
    5.1958   -1.5068    0.0000 O   0  0
    6.4962   -0.7574    0.0000 C   0  0
    6.5004    0.7426    0.0000 C   0  0
    7.8016    1.4889    0.0000 C   0  0
    7.8090    2.9897    0.0000 C   0  0
    9.1119    3.7346    0.0000 N   0  0
    9.1215    5.2346    0.0000 C   0  0
   10.4252    5.9764    0.0000 C   0  0
   11.7195    5.2182    0.0000 C   0  0
   11.7100    3.7182    0.0000 C   0  0
   10.4063    2.9764    0.0000 C   0  0
    9.0985    0.7352    0.0000 C   0  0
    9.0942   -0.7648    0.0000 C   0  0
    7.7931   -1.5111    0.0000 N   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  2  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 22  1  0
 20 28  2  0
 28 29  1  0
 29 30  2  0
 30 18  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7608

> <plate>
1

> <well>
D04

> <supplier_cmpd_name>
Lisinopril

> <ctcr_id>
7164

> <supplier_cmpd_id>
S2076

> <smiles>
O=C(C[S](=O)Cc1occc1)NC\C=C/COc2cc(CN3CCCCC3)ccn2

> <pd_targets>
{HRH2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{HRH2}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{lafutidine,118288-08-7,118288087,"118288 08 7",FRG-8813,FRG8813,"FRG 8813","Lafutidine (INN)","Lafutidine free base",206449-93-6,206449936,"206449 93 6","118288-08-7 (free base)","118288087 (free bas
e)","118288 08 7 (free base)",DSSTox_CID_26434,DSSToxCID26434,DSSTox-CID-26434,"DSSTox CID 26434",DSS,S2065,S2076,Lafutidine,Lisinopril}

> <pdid>
PD010868

> <targets>
{"Histamine Receptor",RAAS}

> <classes>
{"Endocrinology & Hormones","Neuronal Signaling"}

> <pubchem_cids>
{5282136}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 26  0  0  1  0            999 V2000
    2.2090   -0.3353    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8972    3.7500    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    2.7095   -0.7710    0.0000 O   0  0
    3.4182   -2.8395    0.0000 C   0  0
    2.9720   -4.2725    0.0000 C   0  0
    3.9887   -5.3754    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  3
 12  6  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  6
 15  5  1  0
 15 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19  2  1  0
 19 20  1  1
 19 21  1  0
 21 22  1  0
 22 23  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7609

> <plate>
1

> <well>
D05

> <supplier_cmpd_name>
Altrenogest

> <ctcr_id>
7277

> <supplier_cmpd_id>
S3167

> <smiles>
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC=C

> <pd_targets>
{FFP}

> <pathway_gtopdb>
{Enzyme,Transferase}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{PGR}

> <broad_moa>
{"progestogen hormone"}

> <synonyms>
{Altrenogest,850-52-2,850522,Allyltrenbolone,Regumate,"Allyl trenbolone",UNII-2U0X0JA2NB,UNII2U0X0JA2NB,RU-2267,RU2267,A-35957,A35957,2U0X0JA2NB,"17-alpha-Allyl-estratriene-4,9,11,17-beta-ol-3-one","1
7alphaAllylestratriene4,9,11,17betaol3one",DSSTox_CID_28789,DSSToxCID28789,DSSTox-CID-28789,"DSSTox CID 28789",DSSTox_RID_83058,DSSToxRID83058,DSSTox-RID-83058,"DSSTox RID 83058",DSSTox_GSID_48863,DSS
ToxGSID48863,DSSTox-GSID-48863,"DSSTox GSID 48863",Altrenogestum,CAS-850-52-2,CAS850522,Es,S3167}

> <pdid>
PD000329

> <targets>
{Estrogen/progestogen Receptor,Progesterone Receptor}

> <classes>
{Endocrinology & Hormones,Others}

> <pubchem_cids>
{10041070}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 32  0  0  0  0            999 V2000
   10.2937   -1.6696    0.0000 Cl  0  0
    7.7795   -7.5156    0.0000 C   0  0
    7.7840   -6.0157    0.0000 C   0  0
    6.4870   -5.2605    0.0000 N   0  0
    5.1863   -6.0093    0.0000 C   0  0
    5.1835   -7.5093    0.0000 C   0  0
    6.4915   -3.7597    0.0000 C   0  0
    7.7931   -3.0140    0.0000 O   0  0
    5.1945   -3.0045    0.0000 C   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.7042    2.8783    0.0000 C   0  0
   -0.0458    4.1773    0.0000 C   0  0
   -1.5458    4.1773    0.0000 N   0  0
   -2.2958    2.8783    0.0000 C   0  0
   -1.5458    1.5792    0.0000 C   0  0
   -1.2990    0.7500    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2991   -3.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 17  1  0
 17 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 30 15  1  0
 30 24  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7610

> <plate>
1

> <well>
D06

> <supplier_cmpd_name>
ADL5859 HCl

> <ctcr_id>
5739

> <supplier_cmpd_id>
S1139

> <smiles>
Cl.CCN(CC)C(=O)c1ccc(cc1)C2=CC3(CCNCC3)Oc4cccc(O)c24

> <pd_targets>
{OPRD1,MRGPRX2,OPRK1,OPRM1,KCNH2}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel","Peptide receptor (family A GPCR)","Potassium channels","Short peptide receptor (family A GPCR)","V
oltage-gated potassium channel","Opioid receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels","Opioid receptors","Orphan and other 7TM receptors","Potassium channels","Class A Orphans","Voltage-gated potassium
 channels"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)","Muscle contraction","Signaling by GPCR","RNA Polymerase II Transcription","Cardiac conduction","GPCR ligand binding","Generic Transcription Pa
thway","GPCR downstream signalling","Phase 3 - rapid repolarisation","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by MECP2","G alpha (i) signalling events","Peptide ligand-bindin
g receptors","MECP2 regulates neuronal receptors and channels","Opioid Signalling","G-protein activation"}

> <broad_targets>
{OPRD1}

> <broad_moa>
{"opioid receptor agonist"}

> <synonyms>
{850173-95-4,850173954,"ADL5859 HCl",ADL-5859,ADL5859,"ADL5859 Hydrochloride","850173-95-4 (ADL 5859 HCl)","850173954 (ADL 5859 HCl)","ADL 5859",C24H29ClN2O3,"ADL-5859 Hydrochloride","Adl-5859 HCl","A
dl5859 HCl",cc-30,cc30,MLS006010290,DTXSID20677374,EX-A433,EXA433,QCR-190,QCR190,AOB87750,BCP01728,ADL-5859/ADL5859,ADL5859/ADL5859,ABP0,T6175,S1139}

> <pdid>
PD050133

> <targets>
{Opioid Receptor}

> <classes>
{Others,Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{46931003}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 30  0  0  1  0            999 V2000
    2.2473   -8.7521    0.0000 N   0  0
    3.1332   -7.5416    0.0000 C   0  0
    4.6332   -7.5468    0.0000 S   0  0
    5.1017   -6.1218    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 N   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0  2  0  0  0
   -7.8029    2.9887    0.0000 O   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4007    1.4818    0.0000 C   0  0
  -11.6971    0.7273    0.0000 C   0  0
  -11.6919   -0.7727    0.0000 C   0  0
  -10.3903   -1.5182    0.0000 C   0  0
   -9.0939   -0.7637    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.6747   -6.1134    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  1
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 13 26  1  0
 26 27  2  0
 27 10  1  0
  5 28  1  0
 28  2  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7611

> <plate>
1

> <well>
D07

> <supplier_cmpd_name>
Mirabegron

> <ctcr_id>
7542

> <supplier_cmpd_id>
S4009

> <smiles>
Nc1scc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)n1

> <pd_targets>
{ADRB1,ADRB2,ADRB3}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{Mirabegron,223673-61-8,223673618,Myrbetriq,Betanis,Betmiga,"Mirabegron (YM178)","YM 178",YM178,YM-178,UNII-MVR3JL3B2V,UNIIMVR3JL3B2V,MVR3JL3B2V,CHEBI:65349,"Myrbetriq (TN)","Mirabegron (USAN:INN)","M
irabegron (USAN/JAN)",SCHEMBL904788,GTPL7445,CHEMBL2095212,AMY1800,HMS3714I,S4009}

> <pdid>
PD009179

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9865528}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 32  0  0  0  0            999 V2000
   14.3053   -0.7442    0.0000 C   0  0
   13.0040   -1.4903    0.0000 O   0  0
   12.9985   -2.9911    0.0000 C   0  0
   14.2964   -3.7431    0.0000 C   0  0
   14.2940   -5.2431    0.0000 C   0  0
   12.9938   -5.9911    0.0000 C   0  0
   11.6959   -5.2391    0.0000 C   0  0
   11.6982   -3.7390    0.0000 C   0  0
   10.3985   -2.9887    0.0000 N   0  0
   10.3984   -1.4887    0.0000 C   0  0
    9.0994   -0.7387    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    7.8004   -2.9887    0.0000 C   0  0
    9.0995   -3.7387    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 20  1  0
 29 24  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7612

> <plate>
1

> <well>
D08

> <supplier_cmpd_name>
Naftopidil

> <ctcr_id>
398

> <supplier_cmpd_id>
S2126

> <smiles>
COc1ccccc1N2CCN(CC2)CC(O)COc3cccc4ccccc34

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRA1A,ADRA1B,ADRA1D,CACNA1H,MAPT,MAPK1,LMNA,ADRB2,NFO,GMNN,PMP22,KMT2A,MEN1,HIF1A,HTT,KDM4E,MTOR,CYP2D6,CYP3A4,CYP2C19,ALOX15,CYP1A2,ALDH1A1,CHRM1,TP53,TSHR}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Other cytosolic protein",Enzyme,"Other nuclear protein","Unclassified protein","Epigenetic regulator","Transcription factor","Family A G protein-coupled receptor","
Voltage-gated ion channel",Kinase,Hydrolase,Reader,Eraser,"Cytochrome P450",Oxidoreductase,"Small molecule receptor (family A GPCR)","Voltage-gated calcium channel","Protein Kinase",Bromodomain,"Lysin
e demethylase","Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","Peptide receptor (family A GPCR)","Monoamine receptor","CMGC protein kinase group","Jumonji domain-cont
aining","Atypical protein kinase group","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Glycohormone receptor","Adrenergic receptor","C
MGC protein kinase MAPK family","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 1A1","Acetylcholine receptor","CMGC protein ki
nase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Cytochrome P450","Eicosanoid turnover",Adrenoceptors,
"Voltage-gated calcium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases",Atypical,"CYP2 family: drug metabolising subset","CYP3 family",Lipoxygenases,"CYP1 fam
ily","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subf
amily","FRAP subfamily"}

> <pathway_reactome>
{"Signal Transduction","Developmental Biology","Neuronal System","Immune System","Cell Cycle",Disease,"Cellular responses to external stimuli","Gene expression (Transcription)",Metabolism,"Signaling b
y GPCR","Nervous system development","Transmission across Chemical Synapses","Innate Immune System",Mitotic,"Infectious disease","Cellular responses to stress","RNA Polymerase II Transcription","Biolo
gical oxidations","Metabolism of lipids","Cell Cycle Checkpoints","GPCR ligand binding","Axon guidance","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades",
"M Phase","Leishmania infection","Mitotic G1 phase and G1/S transition","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Cellular response to hypoxia","Generic Transcription Pathway",
"Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","NCAM signaling for neurite 
out-growth","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","G1/S Transition","O
xygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by MECP2","Transcriptional Regulation by TP53","Cytochrome P450 - arranged by substrate type","Bios
ynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Amine ligand-binding receptors","NCAM1 interactions","Post NMDA recepto
r activation events","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Activation of the pre-replicative complex","R
egulation of MECP2 expression and activity","Regulation of TP53 Activity",Xenobiotics,"Biosynthesis of maresins","Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response",Adrenoceptors,"Act
ivation of AMPK downstream of NMDARs","MAP kinase activation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradatio
n","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acety
lcholine receptors","Stabilization of p53","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Autodegradation of
 the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{naftopidil,57149-07-2,57149072,KT-611,KT611,Flivas,Avishot,1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol,1(4(2methoxyphenyl)piperazin1yl)3(naphthalen1yloxy)propan2ol,"Naftop
idil (Flivas)",BM-15275,BM15275,CHEMBL142635,4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-piperazineethanol,4(2methoxyphenyl)alpha((1naphthalenyloxy)methyl)1piperazineethanol,NCGC000157,T06
96,S2126,SAM001246658,Naftopidil,Naftopidil,CPD000466346}

> <pdid>
PD000224

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{4418}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 17  0  0  0  0            999 V2000
    6.2990    1.8942    0.0000 H   0  3
    3.7990    1.8942    0.0000 Cl  0  5
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2121    3.8625    0.0000 N   0  0
    0.7463    5.2884    0.0000 C   0  0
   -0.7537    5.2860    0.0000 C   0  0
   -1.2149    3.8587    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
  5 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17  3  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7613

> <plate>
1

> <well>
D09

> <supplier_cmpd_name>
Tetrahydrozoline HCl

> <ctcr_id>
2105

> <supplier_cmpd_id>
S4043

> <smiles>
[H+].[Cl-].C1CC(C2=NCCN2)c3ccccc3C1

> <pd_targets>
{AMPC,BLM,ADRA2A,ADRA2B,ADRA2C,ADRA1A,ADRA1B,ADRA1D,TAAR1,CYP2D6}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Hydrolase,"Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor","Trace amine receptor","Cytochrome P450
","Cytochrome P450 family 2","Cytochrome P450 family 2D","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Trace amine receptor",Adrenoceptors,Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{"DNA Repair",Disease,"Signal Transduction","DNA Double-Strand Break Repair","Infectious disease","Signaling by GPCR","Homology Directed Repair","Leishmania infection","GPCR ligand binding","HDR throu
gh Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR)","Anti-
inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production",A
drenoceptors,"Presynaptic phase of homologous DNA pairing and strand exchange",Metabolism,"Biological oxidations","Phase I - Functionalization of compounds","Cytochrome P450 - arranged by substrate ty
pe",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"Tetrahydrozoline hydrochloride",522-48-5,522485,"Tetrahydrozoline HCl","Tetryzoline hydrochloride",Tyzine,Visine,"Murine Plus",Vasopos,"Tyzanol hydrochloride","Tetrahydrozoline (hydrochloride)",MLS0
00069739,2-(1,2(1,2,3,4-Tetrahydr,4Tetrahydr,T0397,S4043,SAM002264650,1500567,Prestw-698,Tetryzoline,CPD000058219,"TETRAHYDROZOLINE HYDROCHLORIDE"}

> <pdid>
PD009236

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"adrenergic agonist","nasal decongestant","Neuronal Signaling"}

> <pubchem_cids>
{10648,657258,57506628}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  0  0            999 V2000
    6.4451   -1.8434    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    2.7343   -2.9815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2567    0.5878    0.0000 C   0  0
    3.2235    1.6679    0.0000 C   0  0
    3.6446    3.1076    0.0000 C   0  0
    5.1019    3.4627    0.0000 C   0  0
    5.5231    4.9024    0.0000 Cl  0  0
    6.1382    2.3782    0.0000 C   0  0
    5.7171    0.9385    0.0000 C   0  0
    4.8054   -4.6666    0.0000 C   0  0
    6.2966   -4.8284    0.0000 O   0  0
    3.9195   -5.8781    0.0000 N   0  0
    4.5250   -7.2514    0.0000 N   0  0
    3.6414   -8.4636    0.0000 C   0  0
    4.2492   -9.8349    0.0000 C   0  0
    5.7408   -9.9941    0.0000 C   0  0
    6.6244   -8.7820    0.0000 C   0  0
    6.0165   -7.4107    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
 12 13  1  0
  5 14  1  0
 14  2  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 25  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7614

> <plate>
1

> <well>
D10

> <supplier_cmpd_name>
Rimonabant

> <ctcr_id>
2590

> <supplier_cmpd_id>
S3021

> <smiles>
Cc1c(nn(c2ccc(Cl)cc2Cl)c1c3ccc(Cl)cc3)C(=O)NN4CCCCC4

> <pd_targets>
{GPR18,CNR1,CNR2,CYP1A2,LMNA,CYP2D6,CYP2C9,MAPT,CYP2C19,GPR55,NPSR1,CYP3A4,GSP1,KCNH2,FABP1,GSP2,ABCC4,ABCB11,ABCC1,ACHE}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Other cytosolic protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 
1","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Lipid-like ligand receptor (family A GPCR)","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Cytoch
rome P450 family 2C","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Cannabinoid receptor","Cytochrome P450 1A1","Cytochrome P450 2D6","Cytochrome P450 2C9","Cytochrome P450 2C19
","Lysophosphatidylinositol receptor","Neuropeptide receptor","Cytochrome P450 3A4","Ion channel","Auxiliary transport protein",Transporter,"Voltage-gated ion channel","Fatty acid binding protein fami
ly","Primary active transporter",Hydrolase,"Potassium channels","ATP-binding cassette","Voltage-gated potassium channel","ABCC subfamily","ABCB subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Orphan and other 7TM receptors","Cannabinoid receptors","CYP1 family","CYP2 family: drug metabolising subset","Neuropeptide S recept
or","CYP3 family","Class A Orphans","Ion channels","Other protein targets",Transporters,"Voltage-gated ion channels","Fatty acid-binding proteins","ATP-binding cassette transporter family","Acetylchol
ine turnover","Potassium channels","ABCC subfamily","ABCB subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Cell Cycle","Neuronal System",Disease,"Signaling by GPCR","Biological oxidations",Mitotic,"Transmission across Chemical Synapses","Infectious disease","Metabolism of
 lipids","GPCR downstream signalling","Phase I - Functionalization of compounds","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","Biosynthesis of spe
cialized proresolving mediators (SPMs)","G alpha (i) signalling events","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic e
vents","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs",Xenobiotics,"Mitotic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishman
ia parasite infection","Biosynthesis of maresins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Activation of AMPK downstrea
m of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation","Muscle contraction",Hemostasis,"Cardiac co
nduction","Platelet activation","signaling and aggregation","Phase 3 - rapid repolarisation","Regulation of lipid metabolism by PPARalpha","Response to elevated platelet cytosolic Ca2+","Metabolism of
 steroids","Fatty acid metabolism","Phospholipid metabolism","PPARA activates gene expression","Platelet degranulation","Bile acid and bile salt metabolism","Arachidonic acid metabolism","Glycerophosp
holipid biosynthesis","Synthesis of bile acids and bile salts","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Synthesis of PC","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"
}

> <broad_targets>
{CNR1,GPR55}

> <broad_moa>
{"cannabinoid receptor antagonist"}

> <synonyms>
{Rimonabant,168273-06-1,168273061,Acomplia,Zimulti,SR141716,"SR 141716",SR141716A,UNII-RML78EN3XE,UNIIRML78EN3XE,"A 281","Rimonabant free base","SR 141716A",SR-141716A,RML78EN3XE,CHEMBL111,"Rimonabant
 (SR141716)",SR-141716,Rimoslim,CHEBI:34967,NCGC00164572-01,NCGC0016457201,(3H)SR141716A,T1519L,T1915,T1519,S3021,AM251,"Rimonabant hydrochloride"}

> <pdid>
PD003150

> <targets>
{"Cannabinoid Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{104850}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 14  0  0  1  0            999 V2000
    8.1484   -1.8639    0.0000 Cl  0  5
    3.1476   -0.7184    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0  1  0  0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 N   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -5.4558    0.0000 Cl  0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    5.6484   -1.8639    0.0000 H   0  3
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  3  1  0
 14  8  1  0
M  CHG  2   1  -1  15   1
M  END
> <name>
Selleck_GPCR

> <id>
7615

> <plate>
1

> <well>
D11

> <supplier_cmpd_name>
Lorcaserin HCl

> <ctcr_id>
7276

> <supplier_cmpd_id>
S4109

> <smiles>
[Cl-].C[C@H]1CNCCc2ccc(Cl)cc12.[H+]

> <pd_targets>
{HTR2C,HTR2B,HTR2A,SLC6A4}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Family A G protein-coupled receptor","Electrochemical transporter","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Monoamine receptor"
,"SLC06 neurotransmitter transporter family","Serotonin receptor"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","SLC superfamily of solute carriers","5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System","Signaling by GPCR","Transmission across Chemical Synapses","GPCR ligand binding","Neurotransmitter clearance","Class A/1 (Rhodopsin-like receptors)","Serotoni
n clearance from the synaptic cleft","Amine ligand-binding receptors","Serotonin receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{PD35,AKOS015899958,AKOS015900847,SCHEMBL16672993,SW219573-1,SW2195731,D06613,"Lorcaserin hydrochloride","Lorcaserin HCl",846589-98-8,846589988,Belviq,"Lorcaserin (Hydrochloride)",APD-356,APD356,UNII-
0QJF08GDPE,UNII0QJF08GDPE,(R)-8-chloro-1-methyl-2,(R)8chloro1methyl2,3,4,"5-tetrahydro-1H-benzo(d)azepine h","5tetrahydro1Hbenzo(d)azepine h",S4109}

> <pdid>
PD009356

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{53302095,118040193,11673085}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 30  0  0  1  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8939   -0.7546    0.0000 C   0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -5.2060    2.9909    0.0000 Cl  0  0
   -5.1852   -3.0098    0.0000 C   0  0  2  0  0  0
   -6.4828   -3.7624    0.0000 O   0  0
   -6.4800   -5.2624    0.0000 C   0  0  2  0  0  0
   -7.7799   -6.0126    0.0000 S   0  0
   -9.0793   -5.2631    0.0000 C   0  0
   -5.1795   -6.0099    0.0000 C   0  0  1  0  0  0
   -5.1767   -7.5099    0.0000 O   0  0
   -3.8819   -5.2575    0.0000 C   0  0  2  0  0  0
   -2.5815   -6.0051    0.0000 O   0  0
   -3.8847   -3.7575    0.0000 C   0  0  1  0  0  0
   -2.5871   -3.0051    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 16 11  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  1
 19 20  1  0
 18 21  1  0
 21 22  1  6
 21 23  1  0
 23 24  1  1
 23 25  1  0
 25 16  1  0
 25 26  1  6
  7 27  1  0
 27 28  2  0
 28  4  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7616

> <plate>
1

> <well>
D12

> <supplier_cmpd_name>
Sotagliflozin (LX4211)

> <ctcr_id>
8195

> <supplier_cmpd_id>
S8103

> <smiles>
CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)cc1

> <pd_targets>
{SLC5A1,SLC5A2}

> <pathway_gtopdb>
{Transporter,"Electrochemical transporter","SLC superfamily of solute carriers","SLC05 family of sodium-dependent glucose transporters"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC5 family of sodium-dependent glucose transporters","Hexose transporter family"}

> <pathway_reactome>
{Disease,"Disorders of transmembrane transporters","SLC transporter disorders","Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)","Defective SLC5A2 causes renal glucosuria (GLY
S1)"}

> <broad_targets>
{SLC5A1,SLC5A2}

> <broad_moa>
{"sodium/glucose cotransporter inhibitor"}

> <synonyms>
{Sotagliflozin,1018899-04-1,1018899041,LX-4211,LX4211,UNII-6B4ZBS263Y,UNII6B4ZBS263Y,LP-802034,LP802034,6B4ZBS263Y,MFCD22493506,"Sotagliflozin (LX4211)","Sotagliflozin (USAN:INN)",Zynquista,"LX 4211",
Tube103,"LP 802034","Sotagliflozin (USAN/INN)",C21H25ClO5S,"Sotagliflozin (LX-4211)",T3547,S8103}

> <pdid>
PD016991

> <targets>
{SGLT}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{24831714}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 39 42  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -0.0136   -6.0070    0.0000 N   0  0
   -0.0210   -7.5078    0.0000 S   0  0
   -1.3239   -8.2510    0.0000 O   0  0
   -1.3162   -6.7513    0.0000 O   0  0
    1.2746   -8.2655    0.0000 C   0  0
    1.2663   -9.7654    0.0000 C   0  0
    2.5611  -10.5226    0.0000 C   0  0
    3.8643   -9.7799    0.0000 C   0  0
    3.8726   -8.2799    0.0000 C   0  0
    2.5778   -7.5227    0.0000 C   0  0
    5.1599  -10.5375    0.0000 C   0  0
    5.1525  -12.0375    0.0000 C   0  0
    6.4628   -9.7943    0.0000 C   0  0
    6.4551  -11.2940    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 N   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -3.9020   -3.7404    0.0000 N   0  0
   -2.6004   -2.9949    0.0000 C   0  0
   -2.5984   -1.4941    0.0000 O   0  0
   -3.8966   -0.7411    0.0000 C   0  0
   -3.8946    0.7597    0.0000 C   0  0
   -5.1921    1.5123    0.0000 O   0  0
   -5.2095   -5.9863    0.0000 C   0  0
   -5.2172   -7.4864    0.0000 N   0  0
   -6.5200   -8.2298    0.0000 C   0  0
   -7.8152   -7.4733    0.0000 C   0  0
   -7.8076   -5.9733    0.0000 C   0  0
   -6.5048   -5.2298    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
 11 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 10  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 27 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7617

> <plate>
1

> <well>
D13

> <supplier_cmpd_name>
Bosentan

> <ctcr_id>
6598

> <supplier_cmpd_id>
S4220

> <smiles>
COc1ccccc1Oc2c(N[S](=O)(=O)c3ccc(cc3)C(C)(C)C)nc(nc2OCCO)c4ncccn4

> <pd_targets>
{EDNRB,EDNRA,ABCB11,NR1I2,RORC,FFP,ABCC4,ABCC3}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Transcription factor",Enzyme,"Family A G protein-coupled receptor","Primary active transporter","Nuclear receptor",Transferase,"Peptide receptor (family A GPCR)","ATP
-binding cassette","Nuclear hormone receptor subfamily 1","Short peptide receptor (family A GPCR)","ABCB subfamily","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1
 group F","ABCC subfamily","Endothelin receptor","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","ATP-binding cassette transporter family","Nuclear hormone receptors","Endothelin receptors","ABCB subfamily","1I. Vitamin D receptor-like recepto
rs","1F. Retinoic acid-related orphans","ABCC subfamily"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Metabolism of proteins","Gene expression (Transcription)",Hemostasis,"Signaling by GPCR","Metabolism of lipids","Post-translational protein modification","RNA Polyme
rase II Transcription","Platelet activation","signaling and aggregation","GPCR ligand binding","Metabolism of steroids",SUMOylation,"Generic Transcription Pathway","Response to elevated platelet cytos
olic Ca2+","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX3","Platelet degranulation","Pepti
de ligand-binding receptors","Synthesis of bile acids and bile salts","SUMOylation of intracellular receptors","RUNX3 Regulates Immune Response and Cell Migration","Recycling of bile acids and salts",
"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{EDNRA,EDNRB}

> <broad_moa>
{"endothelin receptor antagonist"}

> <synonyms>
{Bosentan,147536-97-8,147536978,Tracleer,"Ro 47-0203","Ro 470203",Ro-47-0203,Ro470203,C27H29N5O6S,"Bosentan (USAN:INN:BAN)",UNII-XUL93R30K2,UNIIXUL93R30K2,CHEMBL957,XUL93R30K2,Actelion,CHEBI:51450,"14
7536-97-8 (free)","147536978 (free)",NCGC00167440-01,NCGC0016744001,"bosentan anhydrous",DSSTox_CID_26627,DSSToxCID26627,DSSTox-CID-26627,"DSSTox CID 26627",DSSTox_RID_81776,DSSToxRID81776,DSSTox-RID-
81776,"DSSTox RID 81776",DSST,S4220,Prestw-1244}

> <pdid>
PD009964

> <targets>
{Others,Endothelin Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein}

> <pubchem_cids>
{104865}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 19 20  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 Cl  0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 S   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
   -3.9021   -3.7405    0.0000 C   0  0
   -5.1985   -2.9860    0.0000 Cl  0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -2.6160   -7.4949    0.0000 Cl  0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -0.0127   -6.0039    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9  2  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 11  1  0
 18 19  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7618

> <plate>
1

> <well>
D15

> <supplier_cmpd_name>
Bithionol

> <ctcr_id>
8196

> <supplier_cmpd_id>
S4552

> <smiles>
Oc1c(Cl)cc(Cl)cc1Sc2cc(Cl)cc(Cl)c2O

> <pd_targets>
{CASP7,KMT2A,MEN1,RECQL,KDM4E,HSD17B10,RORC,FTL,TP53,CYP3A4,MAPK1,ALOX12,CASP1,LEF,MAPT,ALOX15,HPGD,HIF1A,TSHR,ALDH1A1,NR1I2,LMNA,MCL1,THRB,KCNT1,ESR2,AMPC,BLM,MAPK14,HTT,ESR1,ENV,GROES,GROL,S1PR1,POL
B,HSPD1,HSPE1,NAPEPLD,ADRA2B,SLC6A2,HTR2B,HTR2C,ADORA3,ADORA2A,ADRA2A,LCK,HTR1A,SLC22A1,SLC47A2,ADRA2C,OPRM1,SLC22A3,SLC47A1,DRD3,ERBB2,TACR2,SLC6A3,SLC22A2,EGFR,TBXAS1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Transcription factor","Unclassified protein","Other cytosolic protein","Membrane receptor","Other nuclear protein","Surface antigen",Transporter,Protease,Reader,Eraser,
Oxidoreductase,"Nuclear receptor","Cytochrome P450",Kinase,"Family A G protein-coupled receptor",Hydrolase,Phosphodiesterase,"Electrochemical transporter","Cysteine protease",Bromodomain,"Lysine demet
hylase","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Protein Kinase","Metallo protease","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 3","Small molecule 
receptor (family A GPCR)","SLC superfamily of solute carriers","Cytochrome P450 family 5","Cysteine protease CD clan","Jumonji domain-containing","Cysteine protease CA clan","Nuclear hormone receptor 
subfamily 1 group F","Cytochrome P450 family 3A","CMGC protein kinase group","Metallo protease MAE clan","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone recepto
r subfamily 1 group A","Nuclear hormone receptor subfamily 3 group A","Lipid-like ligand receptor (family A GPCR)","Monoamine receptor","SLC06 neurotransmitter transporter family","Nucleotide-like rec
eptor (family A GPCR)","TK protein kinase group","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Short peptide receptor (family A 
GPCR)","Cytochrome P450 family 5A","Cysteine protease C14 family","Cysteine protease C1A family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","CMGC protein kinase MAPK
 family","Metallo protease M34 family","Nuclear hormone receptor subfamily 1 group I member 2","Metallo protease M1 family","Nuclear hormone receptor subfamily 1 group A member 2","Nuclear hormone rec
eptor subfamily 3 group A member 2","Nuclear hormone receptor subfamily 3 group A member 1","EDG receptor","Adrenergic receptor","Serotonin receptor","Adenosine receptor","Tyrosine protein kinase Src 
family","Opioid receptor","Dopamine receptor","Tyrosine protein kinase EGFR family","Neurokinin receptor","Cytochrome P450 5A1","CMGC protein kinase ERK1","CMGC protein kinase p38 subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Ion channels",Transporters,"Peptidases and proteinases","Chromatin modifying enzymes","Nuclear hormone receptors","Cytochrome P450","Kinases (EC 2.7.x.x)","
Eicosanoid turnover","G protein-coupled receptors","B-cell lymphoma 2 (Bcl-2) protein family","Voltage-gated ion channels","Anti-infective targets","Endocannabinoid turnover","SLC superfamily of solut
e carriers","Catalytic receptors","CD: Cysteine (C) Peptidases","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Lipox
ygenases,"Prostaglandin synthases","Glycoprotein hormone receptors","1I. Vitamin D receptor-like receptors","1A. Thyroid hormone receptors","Potassium channels","Steroid hormone receptors","Lysophosph
olipid (S1P) receptors","Viral protein targets","<i>N</i>-Acylethanolamine turnover",Adrenoceptors,"SLC6 neurotransmitter transporter family","5-Hydroxytryptamine receptors","Adenosine receptors","Rec
eptor kinases","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Opioid receptors","Dopamine receptors","Tachykinin receptors",CYP5,
"CYP7 and CYP8 families","C14: Caspase","Mitogen-activated protein kinases (MAP kinases)","Calcium- and sodium-activated potassium channels","3A. Estrogen receptors","Coronavirus (CoV) proteins","Mono
amine transporter subfamily","TK: Tyrosine kinase","Organic cation transporters (OCT)","ERK subfamily","p38 subfamily","Non-receptor tyrosine kinases (nRTKs)","Receptor tyrosine kinases (RTKs)","Src f
amily","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{"Programmed Cell Death",Metabolism,"Gene expression (Transcription)","Vesicle-mediated transport","Cell Cycle","Immune System",Disease,"Neuronal System","Cellular responses to external stimuli","Meta
bolism of proteins","Signal Transduction","DNA Repair","Transport of small molecules","Developmental Biology",Apoptosis,"Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","M
embrane Trafficking","Cell Cycle Checkpoints","Metabolism of lipids","Innate Immune System","Infectious disease","Transmission across Chemical Synapses","Cellular responses to stress","Biological oxid
ations","Post-translational protein modification",Mitotic,"Cytokine Signaling in Immune system","Intracellular signaling by second messengers","DNA Double-Strand Break Repair","Signaling by GPCR","Bas
e Excision Repair","Disorders of transmembrane transporters","SLC-mediated transmembrane transport","Nervous system development","Intrinsic Pathway for Apoptosis","Branched-chain amino acid catabolism
","Generic Transcription Pathway","trans-Golgi Network Vesicle Budding","G1/S DNA Damage Checkpoints","Biosynthesis of specialized proresolving mediators (SPMs)","Toll-like Receptor Cascades","Uptake 
and actions of bacterial toxins","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to hypoxia","Leishmania infection","Phase I - Functionalization of compounds",SUMO
ylation,"M Phase","Signaling by Interleukins","PIP3 activates AKT signaling","Homology Directed Repair","GPCR ligand binding","SARS-CoV Infections","Resolution of Abasic Sites (AP sites)","GPCR downst
ream signalling","SLC transporter disorders","HIV Infection","Transport of bile salts and organic acids","metal ions and amine compounds","Axon guidance","Apoptotic factor-mediated response","Transcri
ptional regulation by RUNX3","Golgi Associated Vesicle Biogenesis","p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of 
DPA-derived SPMs","Transcriptional Regulation by TP53","Uptake and function of anthrax toxins","Activation of NMDA receptors and postsynaptic events","Oxygen-dependent proline hydroxylation of Hypoxia
-inducible Factor Alpha","Leishmania parasite growth and survival","Ethanol oxidation","SUMO E3 ligases SUMOylate target proteins","Mitotic Metaphase and Anaphase","Interleukin-4 and Interleukin-13 si
gnaling","Negative regulation of the PI3K/AKT network","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional Regulation by MECP2","Transcriptional regulation b
y RUNX1","Class A/1 (Rhodopsin-like receptors)","SARS-CoV-1 Infection","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","G alpha (i) signalling events","Defective SLC6A2 
causes orthostatic intolerance (OI)","Host Interactions of HIV factors","Organic cation/anion/zwitterion transport","Semaphorin interactions","Defective SLC6A3 causes Parkinsonism-dystonia infantile (
PKDYS)","G alpha (q) signalling events","Cytochrome P450 - arranged by substrate type","Cytochrome c-mediated apoptotic response","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1
 DNA Damage Response","Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","Biosynthesis of DPAn-3 SPMs","TP53 Regulates Transcription of Cell Death Genes","Post NMDA receptor activ
ation events","Biosynthesis of D-series resolvins","Anti-inflammatory response favouring Leishmania parasite infection","SUMOylation of intracellular receptors","Mitotic Anaphase",PI5P,"PP2A and IER3 
Regulate PI3K/AKT Signaling","HDR through Homologous Recombination (HRR)","Regulation of MECP2 expression and activity","RUNX1 regulates estrogen receptor mediated transcription","Lysosphingolipid and
 LPA receptors","SARS-CoV-1 Genome Replication and Transcription","PCNA-Dependent Long Patch Base Excision Repair","Visual phototransduction","Amine ligand-binding receptors","Nucleotide-like (puriner
gic) receptors","The role of Nef in HIV-1 replication and disease pathogenesis","Organic cation transport","Opioid Signalling","Sema4D in semaphorin signaling","Peptide ligand-binding receptors","Gast
rin-CREB signalling pathway via PKC and MAPK",Eicosanoids,"Activation of caspases through apoptosome-mediated cleavage","Stabilization of p53","Biosynthesis of maresin-like SPMs","MAP kinase activatio
n","Biosynthesis of DPAn-3-derived maresins","TP53 Regulates Transcription of Caspase Activators and Caspases","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and 
resolvins","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Replication of the SARS-CoV-1 genome","The canonic
al retinoid cycle in rods (twilight vision)",Adrenoceptors,"Serotonin receptors","Adenosine P1 receptors","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapter
s","G-protein activation","Dopamine receptors","Sema4D induced cell migration and growth-cone collapse","Tachykinin receptors bind tachykinins","EGFR Transactivation by Gastrin","Autodegradation of th
e E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","
Biosynthesis of A2E","implicated in retinal degradation","Nef Mediated CD4 Down-regulation","ERK/MAPK targets","Activation of the AP-1 family of transcription factors","ERKs are inactivated"}

> <broad_targets>
{ESR1,ESR2,MCL1}

> <broad_moa>
{"autotaxin inhibitor"}

> <synonyms>
{bithionol,97-18-7,97187,Actamer,"2,2'-Thiobis(4,6-dichlorophenol)","2,2'Thiobis(4,6dichlorophenol)",Lorothidol,Bithin,Bitin,"Bithionol sulfide",Bithionolate,Bidiphen,Bisoxyphen,Bitionol,Lorothiodol,N
eopellis,Nobacter,"Vancide BL","Usaf B-22","Usaf B22","Bis(2-hydroxy-3,5-dichlorophenyl) sulfide","Bis(2hydroxy3,5dichlorophenyl) sulfide",Bi,T0830,S4552,Bithionol}

> <pdid>
PD002451

> <targets>
{cAMP}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{2406}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 22  0  0  0  0            999 V2000
    8.9855   -3.0012    0.0000 Cl  0  5
    6.4833   -9.7648    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 N   0  3
   -6.4990    0.7409    0.0000 C   0  0
   -7.7996    1.4882    0.0000 O   0  0
   -3.8778    2.2624    0.0000 C   0  0
   -3.8816    3.7624    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 16 20  1  0
 20 21  1  0
 13 22  1  0
 22 23  2  0
 23 10  1  0
M  CHG  2   1  -1  17   1
M  END
> <name>
Selleck_GPCR

> <id>
7619

> <plate>
1

> <well>
D17

> <supplier_cmpd_name>
Fingolimod (FTY720) HCl

> <ctcr_id>
1137

> <supplier_cmpd_id>
S5002

> <smiles>
[Cl-].CCCCCCCCc1ccc(CCC([NH3+])(CO)CO)cc1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Fingolimod hydrochloride",162359-56-0,FTY720,"Fingolimod HCl",Gilenya,Gilenia,"Fty 720",Fty-720,"Fingolimod (hydrochloride)","Fingolimod (FTY720) HCl","2-Amino-2-(4-octylphenethyl)propane-1,3-diol h
ydrochloride","2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride",UNII-G926EC510T,"FTY720 free base",CHEBI:63112,"2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol hydrochloride","2-am
ino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol;hydrochloride",G926EC510T,MFCD00939512,"Gilenya (TN)","1,3-Propanediol, 2-amino-2-(2-(4-octylphenyl)ethyl)-, hydrochloride","2-AMINO-2-(2-(4-OCTYL-PHENYL
)-ETHYL)-PROPANE-1,3-DIOL HCL","FTY720 hydrochloride","Fingolimod-d4 Hydrochloride","2-amino-2-(4-octylphenethyl)propane-1,3-diol hydrochloride.","2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol, h
ydrochloride","1,3-Propanediol, 2-amino-2-(2-(4-octylphenyl)ethyl)-, hydrochloride (1:1)","Fingolimod hydrochloride (USAN)","Fingolimod (FTY720)",Imusera,"Fingolimod, HCl","FTY720,Fingolimod",1346604-
90-7,"Fin;limod hydrochloride",PubChem23815,"FTY720 - Fingolimod","Fingolimod HClFTY-720","Epitope ID:156573",SCHEMBL81362,cc-329,MLS006010179,"Fingolimod (FTY-720 HCl)","FTY-720 HYDROCHLORIDE",CHEMBL
544665,FTY-720A,"Fingolimod hydrochloride FTY720",AOB7477,DTXSID00167364,EX-A960,TDI-132,"2-Amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol, HCl",BCPP000225,BCP01808,"Fingolimod hydrochloride (JAN/US
AN)",s5002,AKOS005145784,AC-1929,AM84549,BCP9000705,CCG-265016,CS-0114,KS-1172,AK-33554,HY-12005,SMR004701287,SY057854,AB0018286,DB-014816,A8548,F1018,FT-0643569,SW219384-1,"162359-56-0 (HCl)",EC-000.
2314,A25158,D04187,J10426,W-5231,359F560,SR-01000942237,Q-101363,SR-01000942237-2,Q27132395,"2-(4-octylphenethyl)-2-aminopropane-1,3-diol hydrochloride","2-amino-2-(2-(4-octylphenyl) ethyl)-1,3-propan
ediol hydrochloride","2-Amino-2-(2-(4-octylphenyl)-ethyl)-1,3-propanediol hydrochloride","2-Amino-2-(2-(4-n-octylphenyl)ethyl)propane-1,3-diol Hydrochloride","2-Amino-2-(2-(4-octyl-phenyl)-ethyl)-prop
ane -1,3-diol hydrochloride","2-Amino-2-(2-(4-octyl-phenyl)-ethyl)-propane-1,3-diol hydrochloride",S5002,Fingolimod,"Fingolimod (FTY720) HCl"}

> <pdid>

> <targets>
{S1P Receptor,Bcr-Abl,PKC,S1P,LPL Receptor,PAK}

> <classes>
{GPCR & G Protein,Cell Cycle/DNA Damage,Cytoskeleton,GPCR/G Protein}

> <pubchem_cids>
{57516011,11824109,107969}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 35  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2978    3.7529    0.0000 C   0  0
    1.2954    5.2529    0.0000 C   0  0
   -0.0048    6.0009    0.0000 C   0  0
   -1.3026    5.2488    0.0000 C   0  0
   -1.3002    3.7488    0.0000 C   0  0
   -0.0103    7.5017    0.0000 N   0  3
    1.2863    8.2560    0.0000 O   0  5
   -1.3116    8.2478    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8617   -2.2496    0.0000 C   0  0
   -5.1782    0.0303    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 N   0  0
    2.5972    1.5031    0.0000 C   0  0
    3.8976    0.7554    0.0000 O   0  0
    2.5951    3.0039    0.0000 O   0  0
    3.8933    3.7570    0.0000 C   0  0
    3.8933    5.2571    0.0000 C   0  0
    5.1924    6.0071    0.0000 C   0  0
    6.4914    5.2571    0.0000 C   0  0
    6.4915    3.7571    0.0000 C   0  0
    5.1925    3.0071    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 11 13  2  0
  4 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 20 21  1  0
 21 14  1  0
 21 22  2  0
 15 23  1  0
 23  2  1  0
  3 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 27  1  0
M  CHG  2  11   1  12  -1
M  END
> <name>
Selleck_GPCR

> <id>
7620

> <plate>
1

> <well>
D19

> <supplier_cmpd_name>
FLI-06

> <ctcr_id>
7870

> <supplier_cmpd_id>
S7399

> <smiles>
CC1=C(C(c2ccc(cc2)[N+]([O-])=O)C3=C(CC(C)(C)CC3=O)N1)C(=O)OC4CCCCC4

> <pd_targets>
{CCNA1,CCNA2,CDK2,APH1A,APH1B,NCSTN,PSEN1,PSEN2,PSENEN,NOTCH1}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein",Kinase,Protease,"Protein Kinase","Aspartic protease","CMGC protein kinase group","Aspartic protease AD clan","CMGC protein kinase CDK family","Aspartic protease A22A sub
family","CMGC protein kinase CDC2 subfamily","Aspartic protease A22A regulatory subfamily"}

> <pathway_chembl>
{"Other protein targets","Notch receptors"}

> <pathway_reactome>
{Disease,"Diseases of metabolism","Diseases of glycosylation","Diseases associated with O-glycosylation of proteins","Defective LFNG causes SCDO3"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{FLI-06,FLI06,313967-18-9,313967189,"FLI 06",CHEMBL3604460,C25H30N2O5,Oprea1_143746,Oprea1143746,Oprea1-143746,"Oprea1 143746",Oprea1_499413,Oprea1499413,Oprea1-499413,"Oprea1 499413",SCHEMBL15536952,
AOB2707,EX-A294,EXA294,SYN5099,HMS3653A22,HMS3886B15,BCP09289,2412AH,BDBM50110176,MFCD00330996,s7399,STK368879,AKOS000650664,CCG-269112,CCG269112,MCULE-5112819342,MCULE5112819342,T3075,S7399}

> <pdid>
PD010323

> <targets>
{Gamma-secretase,Notch}

> <classes>
{Stem Cells & Wnt,Neuronal Signaling,Stem Cell/Wnt}

> <pubchem_cids>
{3103157}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 28  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 C   0  0
    2.5988   -1.5004    0.0000 C   0  0
    1.2996   -2.2502    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.7996    1.4882    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7508    0.0000 C   0  0
    5.1976   -1.5016    0.0000 C   0  0
    6.4971   -0.7525    0.0000 C   0  0
    6.4980    0.7475    0.0000 C   0  0
    7.7967    1.4998    0.0000 O   0  0
    7.7955    3.0006    0.0000 C   0  0
    9.0942    3.7529    0.0000 C   0  0
   10.3941    3.0043    0.0000 O   0  0
    9.0930    5.2537    0.0000 C   0  0
   10.3910    6.0056    0.0000 Cl  0  0
    5.1995    1.4984    0.0000 C   0  0
    3.9000    0.7492    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
  7 14  1  0
 14 15  2  0
 15  4  1  0
  2 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 19 26  1  0
 26 27  2  0
 27 16  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7621

> <plate>
1

> <well>
D21

> <supplier_cmpd_name>
EPI-001

> <ctcr_id>
8197

> <supplier_cmpd_id>
S7955

> <smiles>
CC(C)(c1ccc(OCC(O)CO)cc1)c2ccc(OCC(O)CCl)cc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{PI00,"Ralaniten (EPI-001)","Ralaniten (EPI001)",EPI-001,EPI001,227947-06-0,227947060,"Bisphenol A (3-chloro-2-hydroxypropyl) (2,3-dihydroxypropyl) ether","Bisphenol A (3chloro2hydroxypropyl) (2,3dihy
droxypropyl) ether",BADGE-HCl-H2O,BADGEHClH2O,"EPI 001",SCHEMBL12267194,CHEBI:59642,DTXSID30400170,BCP18361,EX-A2389,EXA2389,MFCD02683414,s7955,CCG-268596,CCG268596,1,2,3,4-Tetrahydroqu,4Tetrahydroqu,
S7955}

> <pdid>
PD071541

> <targets>
{Androgen Receptor,Apoptosis,PPAR}

> <classes>
{Endocrinology & Hormones,Apoptosis,Cell Cycle/DNA Damage,Others}

> <pubchem_cids>
{4166922}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 30  0  0  1  0            999 V2000
    5.2315    1.1941    0.0000 C   0  0
    3.7691    0.8603    0.0000 N   0  0
    3.1796   -0.5190    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0  1  0  0  0
    1.3514    1.0778    0.0000 C   0  0  2  0  0  0
    2.6395    1.8472    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -1.0157    5.5663    0.0000 Cl  0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    9.0322    2.5802    0.0000 O   0  0
    9.0322    1.0802    0.0000 C   0  0
    7.7330    0.3306    0.0000 O   0  0
   10.3322    0.3302    0.0000 C   0  0
   11.6322    1.0802    0.0000 C   0  0
   11.6336    2.5810    0.0000 C   0  0
   10.3351    3.3318    0.0000 O   0  0
   12.9329    3.3306    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  2  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13  7  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  4  1  0
 20 15  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7622

> <plate>
1

> <well>
E03

> <supplier_cmpd_name>
Asenapine

> <ctcr_id>
7104

> <supplier_cmpd_id>
S1283

> <smiles>
CN1C[C@H]2[C@H](C1)c3cc(Cl)ccc3Oc4ccccc24.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Asenapine maleate",85650-56-2,85650562,Saphris,"Asenapine (maleate)","85650-56-2 (maleate)","85650562 (maleate)",Sycrest,Org-5222,Org5222,"Asenapine maleate (USAN)",Asenapine/,C17H16ClNO.C4H4O4,"EIN
ECS 288-064-8","EINECS 2880648","Saphris (TN)","Asenapine maleate solution","(S,S)-Asenapine Maleate","(S,S)Asenapine Maleate",S,S1283,Asenapine}

> <pdid>

> <targets>
{Adrenergic Receptor,5-HT Receptor,Dopamine Receptor,Histamine Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{6917875}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 12 12  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7623

> <plate>
1

> <well>
E04

> <supplier_cmpd_name>
Synephrine

> <ctcr_id>
3322

> <supplier_cmpd_id>
S2362

> <smiles>
CNCC(O)c1ccc(O)cc1

> <pd_targets>
{AMPC,THPO,ALDH1A1,BLM,CHRM1,SMN1,HTR1A,NMUR2,HIF1A,CYP2C9}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor","Epigenetic regulator",Hydrolase,Oxidoreductase,"Family A G protein-coupled receptor",Reader,"Small molecule receptor (family A GPCR)","Methyl-lysine
/arginine binding protein","Peptide receptor (family A GPCR)","Monoamine receptor","Tudor domain","Short peptide receptor (family A GPCR)","Acetylcholine receptor","Serotonin receptor","Neuromedin U r
eceptor","Transcription factor","Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2C","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","Neuromedin U receptors",Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subse
t"}

> <pathway_reactome>
{Hemostasis,Metabolism,"DNA Repair","Signal Transduction","Metabolism of RNA","Platelet activation","signaling and aggregation","Biological oxidations","DNA Double-Strand Break Repair","Signaling by G
PCR","Metabolism of non-coding RNA","Platelet Aggregation (Plug Formation)","Phase I - Functionalization of compounds","Homology Directed Repair","GPCR ligand binding","snRNP Assembly","Ethanol oxidat
ion","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR)","Amine ligand-binding receptors",
"Peptide ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","Serotonin receptors","Presynaptic phase of homologous DNA pairing and strand excha
nge","Cellular responses to external stimuli","Cellular responses to stress","Cellular response to hypoxia","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 
- arranged by substrate type",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{Synephrine,Oxedrine,94-07-5,94075,p-Synephrine,pSynephrine,Parasympatol,Sympaethamine,Sympatol,Sympaethamin,Analeptin,Simpatol,Simpalon,Synephrin,Synthenate,(+/-)-Synephrine,(+/)Synephrine,Sympathol,
p-Oxedrine,pOxedrine,4-(1-Hydroxy-2-(methylamino)ethyl)phenol,4(1Hydroxy2(methylamino)ethyl)phenol,Ethaphene,DL-SYNEPHRINE,DLSYNEPHRINE,T1287,S2362,SAM001246896,Prestw-1088,CPD000059111,"(+,-)-Synephr
ine"}

> <pdid>
PD000201

> <targets>
{Androgen Receptor,Adrenergic Receptor,Endogenous Metabolite}

> <classes>
{GPCR & G Protein,GPCR/G Protein,Metabolic Enzyme/Protease,Neuronal Signaling}

> <pubchem_cids>
{7172}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 17  0  0  0  0            999 V2000
    5.1873   -7.5109    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5886   -6.0033    0.0000 C   0  0
    1.2919   -5.2492    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
 16 17  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7624

> <plate>
1

> <well>
E05

> <supplier_cmpd_name>
Lidocaine

> <ctcr_id>
4905

> <supplier_cmpd_id>
S1357

> <smiles>
CCN(CC)CC(=O)Nc1c(C)cccc1C

> <pd_targets>
{SCN2A,AMPC,SCN1A,SCN3A,MAPK1,SCN9A,SCN5A,MAPT,LMNA,CHRM1,SCN4A,SCN10A,ALDH1A1,CYP3A4,GAA,BLM,SCN11A,SCN7A,SCN8A,EGFR}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Other cytosolic protein","Other nuclear protein","Membrane receptor","Voltage-gated ion channel",Hydrolase,Kinase,"Family A G protein-coupled receptor",Oxidoreductase,"Cytochrom
e P450","Voltage-gated sodium channel","Protein Kinase","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","CMGC protein kinase group","Monoamine receptor","Cytochrome P450 family 3A
","TK protein kinase group","CMGC protein kinase MAPK family","Acetylcholine receptor","Cytochrome P450 3A4","Tyrosine protein kinase EGFR family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Voltage-gated ion channels","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","3.2.1.- Glycosidases","Catalytic receptors","Voltage-gated sodium
 channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","CYP3 family","Receptor kinases","Mitogen-activated protein kinases (MAP kinases)","TK: Tyrosine kinas
e","ERK subfamily","Receptor tyrosine kinases (RTKs)","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{"Developmental Biology","Immune System","Neuronal System","Cell Cycle","Signal Transduction",Metabolism,Disease,"DNA Repair","Nervous system development","Innate Immune System","Transmission across C
hemical Synapses",Mitotic,"Signaling by GPCR","Biological oxidations","Metabolism of lipids","Diseases of metabolism","DNA Double-Strand Break Repair","Axon guidance","Toll-like Receptor Cascades","Ne
urotransmitter receptors and postsynaptic signal transmission","M Phase","GPCR ligand binding","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","D
iseases of carbohydrate metabolism","Homology Directed Repair","GPCR downstream signalling","L1CAM interactions","Toll Like Receptor 5 (TLR5) Cascade","Activation of NMDA receptors and postsynaptic ev
ents","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Glycogen storage diseases","HDR through Homologous Recombination (
HRR) or Single Strand Annealing (SSA)","G alpha (q) signalling events","Interaction between L1 and Ankyrins","MyD88 cascade initiated on plasma membrane","Post NMDA receptor activation events","Mitoti
c Anaphase","Amine ligand-binding receptors","Biosynthesis of maresins","Glycogen storage disease type II (GAA)","HDR through Homologous Recombination (HRR)","Gastrin-CREB signalling pathway via PKC a
nd MAPK","MAP kinase activation","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","Homologous DNA P
airing and Strand Exchange","EGFR Transactivation by Gastrin","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous 
DNA pairing and strand exchange","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{EGFR,SCN10A,SCN5A,SCN9A}

> <broad_moa>
{"histamine receptor agonist"}

> <synonyms>
{lidocaine,137-58-6,137586,Lignocaine,Xylocaine,"2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide","2(Diethylamino)N(2,6dimethylphenyl)acetamide",Lidoderm,Anestacon,Esracaine,Duncaine,Alphacaine,Cappi
caine,Gravocain,Isicaina,L-Caine,LCaine,Leostesin,Maricaine,Xylocain,Xylocitin,Solcain,Isicaine,Xylestes,T0468,S1357,SAM001247018,Lidocaine,CPD000058189}

> <pdid>
PD003120

> <targets>
{"Histamine Receptor",Apoptosis,ERK,MEK,NF-ºB,"Sodium Channel"}

> <classes>
{Neuronal Signaling,Apoptosis,MAPK/ERK Pathway,Membrane Transporter/Ion Channel,NF-ºB,Stem Cell/Wnt}

> <pubchem_cids>
{3676}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 22  0  0  0  0            999 V2000
    8.9990   -3.3752    0.0000 Cl  0  5
    6.4983   -0.7414    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  3
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6060   -6.0003    0.0000 C   0  0
   -3.9051   -5.2503    0.0000 C   0  0
   -2.6060   -7.5003    0.0000 C   0  0
   -1.3070   -8.2503    0.0000 C   0  0
   -0.0080   -7.5003    0.0000 C   0  0
   -0.0079   -6.0003    0.0000 C   0  0
    1.2911   -5.2504    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
M  CHG  2   1  -1  14   1
M  END
> <name>
Selleck_GPCR

> <id>
7625

> <plate>
1

> <well>
E06

> <supplier_cmpd_name>
Bupivacaine HCl

> <ctcr_id>
3392

> <supplier_cmpd_id>
S2454

> <smiles>
[Cl-].CCCCN1CCCCC1C(=O)[NH2+]c2c(C)cccc2C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Bupivacaine HCL",18010-40-7,14252-80-3,Vivacaine,"Bupivacaine (hydrochloride)","1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride",Marcain,AH-2250,"Win 11,318",CHEBI:31322,"1-Buty
l-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide monohydrochloride",Bloqueina,LAC-43,"(S)-Bupivacaine hydrochloride",Bicain,"Marcaine Spinal","1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hy
drochloride",SMR000058218,"(+-)-Bupivacaine hydrochloride","Bupivacaine hydrochloride (JAN)",WIN-11318,"MNarcaine hydrochloride","EINECS 241-917-8","14252-80-3 (HCl)","73360-54-0 (HCl.H2O)","Bupivacai
ne hydrochloride kit","LAC 43",SR-05000001874,"Bupivacaine hydrochloride anhydrous","levobupivacaine hydrochloride (anhydrous)","2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride","SKY 0302",Prestwick_8
94,"2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride","2',6'-Pipecoloxylidide, 1-butyl-, monohydrochloride","AH 2250","Marcaine hydrochloride preservation free","(S)-Bupivac
aine HCl","bupivacain hydrochloride","Bupivacaine hydrochloride preservation free","Bupivacaine hydrochloride rs","bupivacaine monohydrochloride","Win 11318 HCl",SCHEMBL34374,MLS001361336,MLS002154259
,SPECTRUM1503818,"Bupivacaine-(d9) Hydrochloride",CHEMBL1200396,DTXSID0030877,CHEBI:77441,HY-B0405A,AOB6341,HMS1568N12,HMS1922I12,Pharmakon1600-01503818,"Bupivacaine hydrochloride (Marcain)",ACT04725,
BCP22697,BCP22708,"bupivacaine hydrochloride (anhydrous)",CCG-39367,MFCD00078956,NSC119660,NSC758631,s2454,AKOS015889322,BCP9000461,FD-0235,MCULE-5414144502,NSC-119660,NSC-758631,NCGC00095072-01,NCGC0
0095072-02,H875,ST013772,B3925,FT-0607564,FT-0623287,FT-0658830,FT-0663897,FT-0663899,SW197015-3,52B803,K-4565,J-011502,Q-100158,SR-05000001874-3,Q27888209,"1-butyl-2-piperidylformo-2',6'-xylidide hyd
rochloride","2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (+-)-","2-Piperidinecarboxamide,6-dimethylphenyl)-, hydrochloride","1-butyl-2-((2,6-dimethylphenyl)carbamoyl)piperidinium chloride","N-(2,
6-dimethylphenyl)(1-butyl(2-piperidyl))carboxamide, chloride","rac-1-butyl-2-((2,6-dimethylphenyl)carbamoyl)piperidinium chloride","2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-,monohydroch
loride","rac-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride",15233-43-9,AKOS026749767,FT-0651247,S2454,1503818,Prestw-305,"Bupivacaine HCl","BUPIVACAINE HYDROCHLORIDE","Bupivacai
ne HCl","Bupivacaine hydrochloride"}

> <pdid>

> <targets>
{Others}

> <classes>
{"anesthetic (local)","GPCR & G Protein"}

> <pubchem_cids>
{49852290,43834309,64737,68509175}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 39 43  0  0  1  0            999 V2000
    8.7657    0.7508    0.0000 Br  0  5
   -2.4932   -2.7883    0.0000 C   0  0
   -2.1940   -3.7425    0.0000 C   0  0
   -3.2095   -4.8465    0.0000 O   0  0
   -0.7292   -4.0692    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  1  0  0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0  2  0  0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0  2  0  0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
   -2.5988    6.0004    0.0000 N   0  0
   -3.8991    5.2525    0.0000 C   0  0
   -5.1969    6.0045    0.0000 C   0  0
   -5.1946    7.5045    0.0000 O   0  0
   -3.8944    8.2525    0.0000 C   0  0
   -2.5965    7.5004    0.0000 C   0  0
    2.5192   -4.4342    0.0000 N   0  3
    1.0588   -4.5290    0.0000 C   0  0
    0.7400   -5.9948    0.0000 C   0  0
    2.0355   -6.7509    0.0000 C   0  0
    3.1550   -5.7524    0.0000 C   0  0
    4.0201   -4.4415    0.0000 C   0  0
    4.7649   -5.7445    0.0000 C   0  0
    6.2649   -5.7518    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  9  8  1  6
  9 10  1  0
 10 11  1  1
 11 12  1  0
 13 12  1  6
 13 14  1  0
 14 15  1  0
 15 16  1  1
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 13  1  0
 19 20  1  6
 19 21  1  0
 21 10  1  0
 21 22  1  6
 22 23  1  0
 23 24  1  0
 24  6  1  0
 24  9  1  0
 24 25  1  6
 17 26  1  6
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 26  1  0
  7 32  1  6
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 32  1  0
 32 37  1  0
 37 38  1  0
 38 39  2  0
M  CHG  2   1  -1  32   1
M  END
> <name>
Selleck_GPCR

> <id>
7626

> <plate>
1

> <well>
E07

> <supplier_cmpd_name>
Rocuronium Bromide

> <ctcr_id>
7113

> <supplier_cmpd_id>
S1397

> <smiles>
[Br-].CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCOCC5)[N+]6(CCCC6)CC=C

> <pd_targets>
{CHRNA1,CHRNB1,CHRND,CHRNE,CHRNG,CHRNA2,CHRM2,HTR3A}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor","Ligand-gated ion channel","Family A G protein-coupled receptor","Nicotinic acetylcholine receptor","Small molecule receptor (family A GPCR)","5HT3 receptor","Nicoti
nic acetylcholine receptor alpha subunit","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{"Ion channels",Receptors,"Ligand-gated ion channels","G protein-coupled receptors","Nicotinic acetylcholine receptors","Acetylcholine receptors (muscarinic)","5-HT<sub>3</sub> receptors"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction","Transmission across Chemical Synapses","Signaling by GPCR","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Acetylchol
ine binding and downstream events","Class A/1 (Rhodopsin-like receptors)","Postsynaptic nicotinic acetylcholine receptors","Amine ligand-binding receptors","Highly calcium permeable postsynaptic nicot
inic acetylcholine receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM2,CHRNA2,HTR3A}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"ROCURONIUM BROMIDE",119302-91-9,119302919,Zemuron,Esmeron,"Rocuronium (Bromide)",UNII-I65MW4OFHZ,UNIII65MW4OFHZ,"ORG 9426",Org-9426,Org9426,CHEBI:8885,I65MW4OFHZ,"Rocuronium hydrobromide",NCGC001674
33-01,NCGC0016743301,org9426,Eslax,RocuroniumBromide,"Rocuroium Bromide","Zemuron (TN)",BROMOROC,S1397,"Rocuronium Bromide"}

> <pdid>
PD010055

> <targets>
{AChR,Others}

> <classes>
{Neuronal Signaling,Others}

> <pubchem_cids>
{441351}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 21  0  0  1  0            999 V2000
   -0.0041   -2.9953    0.0000 C   0  0
    1.2925   -3.7494    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0  1  0  0  0
    2.5973   -1.5031    0.0000 C   0  0  1  0  0  0
    3.8999   -0.7576    0.0000 C   0  0
    5.1965   -1.5117    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    7.7905   -6.0071    0.0000 O   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  6
  5  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
  3 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 14  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7627

> <plate>
1

> <well>
E08

> <supplier_cmpd_name>
Hexestrol

> <ctcr_id>
7504

> <supplier_cmpd_id>
S2473

> <smiles>
CC[C@@H]([C@@H](CC)c1ccc(O)cc1)c2ccc(O)cc2

> <pd_targets>
{CYP3A4,MAPT,AMPC,ALOX15,ESR1,FTL,CYP2C19,CYP2D6,CYP2C9,ESR2,LMNA,CYP1A2}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Transcription factor","Unclassified protein","Other nuclear protein","Cytochrome P450",Hydrolase,Oxidoreductase,"Nuclear receptor","Cytochrome P450 family 3","Nuclea
r hormone receptor subfamily 3","Cytochrome P450 family 2","Cytochrome P450 family 1","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 3 group A","Cytochrome P450 family 2C","Cytochrome
 P450 family 2D","Cytochrome P450 family 1A","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group A member 1","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochrome P450 2C9","Cytochrom
e P450 1A1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","Eicosanoid turnover","Nuclear hormone receptors","CYP3 family",Lipoxygenases,"Steroid hormone receptors","CYP2 family: drug metabolising subset","CYP1 family","3A
. Estrogen receptors"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Gene expression (Transcription)","Vesicle-mediated transport","Cell Cycle","Metabolism of lipids","Transmission across Chemical Synapses","RNA Polymerase II Transcriptio
n","Membrane Trafficking","Biological oxidations",Mitotic,"Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcr
iption Pathway","trans-Golgi Network Vesicle Budding","Phase I - Functionalization of compounds","M Phase","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","Bi
osynthesis of DPA-derived SPMs","Transcriptional regulation by RUNX1","Golgi Associated Vesicle Biogenesis","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Biosynthesi
s of maresins","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","RUNX1 regulates estrogen receptor mediated transcription",Xenobiotics,"Mitotic Anaphase","Biosynthesis of maresin-l
ike SPMs","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Aromatic amines can be N-hydroxylat
ed or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{AKR1C1,ESR1,ESR2}

> <broad_moa>
{"synthetic estrogen"}

> <synonyms>
{hexestrol,meso-Hexestrol,mesoHexestrol,84-16-2,84162,Hexoestrol,Hexanoestrol,Hexestrofen,Estra-Plex,EstraPlex,Cycloestrol,Mesohexestrol,Synestrol,Erythrohexestrol,Estrifar,Estronal,Extra-plex,Extrapl
ex,Hormoestrol,Dihydrostilbestrol,Sinestrol,Synthovo,Syntrogene,"meso hexestrol",me,S2473,Hexestrol}

> <pdid>
PD001710

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{192197}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 25  0  0  0  0            999 V2000
   10.1943   -2.7559    0.0000 H   0  3
    7.6943   -2.7559    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 S   0  0
    5.1937   -3.0093    0.0000 O   0  0
    5.1912   -4.5090    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1884   -2.6409    0.0000 C   0  0
   -4.6234   -3.0602    0.0000 C   0  0
   -4.9781   -4.5176    0.0000 C   0  0
   -3.8933   -5.5536    0.0000 N   0  0
   -4.2480   -7.0110    0.0000 C   0  0
   -2.4537   -5.1320    0.0000 C   0  0
   -2.0990   -3.6745    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 17  1  0
 16 24  1  0
 24 13  1  0
 24 25  2  0
 25 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7628

> <plate>
1

> <well>
E09

> <supplier_cmpd_name>
Naratriptan

> <ctcr_id>
1837

> <supplier_cmpd_id>
S1488

> <smiles>
[H+].[Cl-].CN[S](=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1

> <pd_targets>
{HTR1B,HTR1D,HTR1F,HTR1A,HTR1E}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Serotonin receptors"}

> <broad_targets>
{HTR1A,HTR1B,HTR1D,HTR1E,HTR1F}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{"NARATRIPTAN HYDROCHLORIDE",143388-64-1,143388641,Amerge,"Naratriptan HCl",Naramig,GR-85548A,GR85548A,"GR 85548A","Naratriptan (hydrochloride)",UNII-10X8X4P12Z,UNII10X8X4P12Z,"GR-85548A hydrochloride
","GR85548A hydrochloride",10X8X4P12Z,MFCD08141821,DSSTox_CID_28990,DSSToxCID28990,DSSTox-CID-28990,"DSSTox CID 28990",DSSTox_RID_83255,DSSToxRID83255,DSSTox-RID-83255,"DSSTox RID 83255",DSSTox_GSID_4
9064,DSSToxGSID49064,DSSTox-GSID-49064,"DSSTox GSID 49064",CHEBI:,T6602,S1488,S1506,Naratriptan,Naratriptan,"Perindopril Erbumine"}

> <pdid>
PD009622

> <targets>
{"5-HT Receptor",RAAS}

> <classes>
{"Endocrinology & Hormones","Neuronal Signaling"}

> <pubchem_cids>
{60875,25137850}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 25  0  0  0  0            999 V2000
   -5.1750    2.4141    0.0000 C   0  0
   -3.7106    2.0893    0.0000 N   0  0
   -2.7244    3.5602    0.0000 C   0  0
   -1.3873    2.9083    0.0000 C   0  0
   -1.0864    1.5043    0.0000 C   0  0
   -1.9890    0.3677    0.0000 C   0  0
   -3.4432    0.3677    0.0000 C   0  0
   -4.3959    1.5043    0.0000 C   0  0
   -4.0616    2.9083    0.0000 C   0  0
   -5.3820    2.3902    0.0000 O   0  0
    0.3779    1.1636    0.0000 O   0  0
    0.8153   -0.2720    0.0000 C   0  0
   -0.2091   -1.3677    0.0000 O   0  0
    2.2771   -0.6120    0.0000 C   0  0
    3.2999    0.4864    0.0000 C   0  0
    2.8611    1.9208    0.0000 O   0  0
    2.7145   -2.0477    0.0000 C   0  0
    4.1751   -2.3896    0.0000 C   0  0
    4.6093   -3.8253    0.0000 C   0  0
    3.5830   -4.9193    0.0000 C   0  0
    2.1225   -4.5775    0.0000 C   0  0
    1.6883   -3.1417    0.0000 C   0  0
    7.1093   -0.6796    0.0000 Br  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  9 10  1  0
 10  8  1  0
  5 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  3
 18 19  1  0
 19 20  2  3
 20 21  1  0
 21 22  2  3
 22 17  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7629

> <plate>
1

> <well>
E10

> <supplier_cmpd_name>
Scopolamine HBr

> <ctcr_id>
7588

> <supplier_cmpd_id>
S2508

> <smiles>
CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br

> <pd_targets>
{MACHR-A,CHRM2,CHRM4,CHRM3,CHRM5,CHRM1,SI,RORC,NFO,KMT2A,MEN1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Transcription factor","Epigenetic regulator","Family A G protein-coupled receptor","Nuclear receptor",Hydrolase,Reader,"Small molecule receptor (family A GPCR)","Nuclear h
ormone receptor subfamily 1",Bromodomain,"Monoamine receptor","Nuclear hormone receptor subfamily 1 group F","Acetylcholine receptor","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Nuclear hormone receptors","Acetylcholine receptors (muscarinic)","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Gene expression (Transcription)","Signaling by GPCR","Diseases of metabolism","RNA Polymerase II Transcription","GPCR ligand binding","Diseases of carbohydrate metaboli
sm","Generic Transcription Pathway","Class A/1 (Rhodopsin-like receptors)","Intestinal saccharidase deficiencies","Transcriptional regulation by RUNX3","Amine ligand-binding receptors","RUNX3 Regulate
s Immune Response and Cell Migration","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,SI}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Scopolamine hydrobromide",114-49-8,114498,"Scopolamine HBr",Scopos,Beldavrin,Scopamin,Tranaxine,Hyosol,"Hyoscine bromide","(-)-Scopolamine hydrobromide","()Scopolamine hydrobromide","Scopolamine (hy
drobromide)","Scopolaminium bromide",UNII-R3K67DRL3J,UNIIR3K67DRL3J,"Scopolammonium bromi",S2508}

> <pdid>
PD008411

> <targets>
{AChR,Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{6603108}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 35 37  0  0  1  0            999 V2000
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0  2  0  0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.3115    2.9665    0.0000 C   0  0
   -1.8032    3.1233    0.0000 C   0  0
   -2.4133    1.7530    0.0000 N   0  0
   -3.8794    1.4442    0.0000 C   0  0
   -4.8823    2.5608    0.0000 C   0  0
   -6.3509    2.2515    0.0000 C   0  0
   -7.3532    3.3674    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 N   0  0
   -2.5951   -3.0031    0.0000 O   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    7.7846   -7.5149    0.0000 C   0  0
    9.0836   -8.2649    0.0000 C   0  0
    9.0836   -9.7649    0.0000 C   0  0
    7.7845  -10.5149    0.0000 C   0  0
    6.4855   -9.7648    0.0000 C   0  0
    5.1873  -10.5179    0.0000 O   0  0
    5.1895  -12.0188    0.0000 C   0  0
    3.8913  -12.7719    0.0000 C   0  0
    3.8934  -14.2719    0.0000 F   0  0
    2.5909  -12.0241    0.0000 F   0  0
    2.5934  -13.5239    0.0000 F   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  9 14  1  0
 14  6  2  0
 14 15  1  0
 15 16  2  0
 16  4  1  0
 15 17  1  0
 17 18  1  0
 17 19  2  0
  2 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7630

> <plate>
1

> <well>
E11

> <supplier_cmpd_name>
Silodosin

> <ctcr_id>
8198

> <supplier_cmpd_id>
S1613

> <smiles>
C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(N)=O)NCCOc3ccccc3OCC(F)(F)F

> <pd_targets>
{ADRA1A,GSC2,ADRA1B,ADRA1D,KCNH2,SCN5A}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Ion channel","Family A G protein-coupled receptor",Transferase,"Voltage-gated ion channel","Small molecule receptor (family A GPCR)","Potassium channels","Voltage-gated so
dium channel","Monoamine receptor","Voltage-gated potassium channel","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels",Adrenoceptors,"Potassium channels","Voltage-gated sodium channels","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction","Muscle contraction","Developmental Biology","Signaling by GPCR","Cardiac conduction","Nervous system development","GPCR ligand binding","Phase 3 - rapid repolarisation","Axon g
uidance","Class A/1 (Rhodopsin-like receptors)","L1CAM interactions","Amine ligand-binding receptors","Interaction between L1 and Ankyrins",Adrenoceptors}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Silodosin,160970-54-7,160970547,Rapaflo,Urief,Silodyx,KMD-3213,KMD3213,Urorec,"KMD 3213",UNII-CUZ39LUY82,UNIICUZ39LUY82,KAD-3213,KAD3213,CUZ39LUY82,CHEMBL24778,Silodosin-d6,Silodosind6,Rapflo,"KAD 32
13","Silodosin (INN:BAN)","Rapaflo (TN)","Silodosin (Rapaflo)","Urief (TN)","Silodosin (JP17/INN)",S1613}

> <pdid>
PD009321

> <targets>
{"Adrenergic Recepto"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5312125}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 22  0  0  1  0            999 V2000
   11.4904   -5.2561    0.0000 Cl  0  5
    2.5909   -6.0056    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0  1  0  0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0  1  0  0  0
    6.4897   -5.2632    0.0000 O   0  0
    5.1873   -7.5117    0.0000 C   0  0
    6.4837   -8.2663    0.0000 C   0  0
    6.4785   -9.7663    0.0000 C   0  0
    5.1769  -10.5118    0.0000 C   0  0
    5.1717  -12.0118    0.0000 O   0  0
    3.8804   -9.7573    0.0000 C   0  0
    3.8856   -8.2573    0.0000 C   0  0
    8.9904   -5.2561    0.0000 H   0  3
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
  3 14  1  0
 14 15  1  1
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 16  1  0
M  CHG  2   1  -1  23   1
M  END
> <name>
Selleck_GPCR

> <id>
7631

> <plate>
1

> <well>
E12

> <supplier_cmpd_name>
Ritodrine HCl

> <ctcr_id>
7613

> <supplier_cmpd_id>
S2533

> <smiles>
[Cl-].C[C@@H](NCCc1ccc(O)cc1)[C@@H](O)c2ccc(O)cc2.[H+]

> <pd_targets>
{GALR3,ADRB2,ADRB3,HIF1A,LMNA}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor","Other nuclear protein","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Short peptide re
ceptor (family A GPCR)","Monoamine receptor","Galanin receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Galanin receptors",Adrenoceptors}

> <pathway_reactome>
{"Signal Transduction",Disease,"Cellular responses to external stimuli","Cell Cycle","Signaling by GPCR","Infectious disease","Cellular responses to stress",Mitotic,"GPCR ligand binding","Leishmania i
nfection","Cellular response to hypoxia","M Phase","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor 
Alpha","Mitotic Metaphase and Anaphase","Peptide ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","ADORA2B mediated anti-inflammatory c
ytokines production","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"Ritodrine hydrochloride","Ritodrine (hydrochloride)","Ritodrine hydrochloride (Yutopar)",52447-11-7,52447117,Yutopar,SMR000326750,"(+-)-Ritodrine hydrochloride","(+)Ritodrine hydrochloride",SR-01000
076101,SR01000076101,Utopar,Pre-Par,PrePar,"NSC 291565","DU 21220; Miolene; NSC 291565",N-(p-Hydro,N(pHydro,S2533,"Ritodrine HCl","Ritodrine HCl"}

> <pdid>
PD009677

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{3040551}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 11  9  0  0  0  0            999 V2000
   10.2999    1.1254    0.0000 Cl  0  5
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 O   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 N   0  3
    7.7992    0.0004    0.0000 C   0  0
    7.7989    1.5002    0.0000 C   0  0
    6.5000    2.2500    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
M  CHG  2   1  -1   8   1
M  END
> <name>
Selleck_GPCR

> <id>
7632

> <plate>
1

> <well>
E13

> <supplier_cmpd_name>
Acetylcholine Chloride

> <ctcr_id>
4120

> <supplier_cmpd_id>
S1805

> <smiles>
[Cl-].CC(=O)OCC[N+](C)(C)C

> <pd_targets>
{POLB,NFO,CHRNA4,BLM}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Hydrolase,"Ligand-gated ion channel","Nicotinic acetylcholine receptor","Nicotinic acetylcholine receptor alpha subunit"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","Nicotinic acetylcholine receptors"}

> <pathway_reactome>
{"DNA Repair","Neuronal System","Base Excision Repair","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and 
postsynaptic signal transmission","Homology Directed Repair","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Acetylcholine binding and downstream events","HDR through H
omologous Recombination (HRR) or Single Strand Annealing (SSA)","PCNA-Dependent Long Patch Base Excision Repair","Postsynaptic nicotinic acetylcholine receptors","HDR through Homologous Recombination 
(HRR)","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Homologous DNA Pairing and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ACHE,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,CHRNA2}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{"ACETYLCHOLINE CHLORIDE",60-31-1,60311,Miochol,Acecoline,"ACH chloride",Chloroacetylcholine,Arterocoline,Acecholin,Ovisot,Azetylcholinchlorid,"Acetylcholine (chloride)","2-(Acetyloxy)-N,N,N-trimethyl
ethanaminium chloride","2(Acetyloxy)N,N,Ntrimethylethanaminium chloride",MIOCHOL-E,MIOCHOLE,Acetylcholinium,T1221,S1805,SAM002548945,1500104,"Acetylcholine chloride","Acetylcholine Chloride",CPD000059
182,ACETYLCHOLINE}

> <pdid>
PD009386

> <targets>
{AChR,Calcium Channel,Endogenous Metabolite,nAChR}

> <classes>
{Neuronal Signaling,vasodilator (peripheral),antiarrhythmic,miotic,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease}

> <pubchem_cids>
{6060}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 31  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0  1  0  0  0
   -2.1132    4.3307    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
    1.0956    4.0166    0.0000 C   0  0
    0.4768    5.3830    0.0000 C   0  0
   -1.0140    5.2166    0.0000 C   0  0  1  0  0  0
   -2.4603    4.8674    0.0000 O   0  0
   -3.5120    5.9380    0.0000 C   0  0
   -3.1105    7.3833    0.0000 C   0  0
   -4.9646    5.5636    0.0000 O   0  0
   -0.5492    6.6304    0.0000 C   0  0
    0.9144    6.9591    0.0000 C   0  0
   -1.5653    7.7338    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  1
  8 10  1  0
 10  4  1  0
 10 11  1  1
 11 12  1  0
 12 13  1  0
 13  8  1  0
 13 14  1  6
 14 15  1  0
 15 16  1  0
 15 17  2  0
 13 18  1  0
 18 19  1  0
 18 20  2  0
  5 21  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  3
 28  2  1  0
 28 21  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7633

> <plate>
1

> <well>
E14

> <supplier_cmpd_name>
Medroxyprogesterone acetate

> <ctcr_id>
7024

> <supplier_cmpd_id>
S2567

> <smiles>
C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(C)=O)C(C)=O)[C@@]4(C)CCC(=O)C=C14

> <pd_targets>
{NR3C2,PGR,SHBG,AKR1C2,AR,NR3C1,ALDH1A1,ESR1,ESR2,AKR1C3,AKR1C1,LMNA,NPSR1,CYP3A4,ABCC4,ABCB11,HRH2,ABCB1,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG
3,GABRP,GABRQ}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Secreted protein","Other nuclear protein","Membrane receptor",Transporter,"Ion channel","Nuclear receptor",Protease,Oxidoreductase,"Family A G protein-coupled receptor"
,"Cytochrome P450","Primary active transporter","Ligand-gated ion channel","Nuclear hormone receptor subfamily 3","Cysteine protease","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","ATP
-binding cassette","Small molecule receptor (family A GPCR)","GABA-A receptor","Nuclear hormone receptor subfamily 3 group C","Cysteine protease CA clan","Nuclear hormone receptor subfamily 3 group A"
,"Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","ABCC subfamily","ABCB subfamily","Monoamine receptor","Nuclear hormone receptor subfamily 3 group C member 2","Cysteine protease 
C1A family","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone rec
eptor subfamily 3 group A member 1","Neuropeptide receptor","Cytochrome P450 3A4","Histamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Eicosanoid turnover","G protein-coupled receptors","Cytochrome P450","ATP-binding cassette transporter family","Steroid hormone receptors",
"Prostaglandin synthases","Neuropeptide S receptor","CYP3 family","ABCC subfamily","ABCB subfamily","Histamine receptors","3C. 3-Ketosteroid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Gene expression (Transcription)","Cell Cycle",Disease,Hemostasis,"Post-translational protein modification","Metabolism of lipids","RNA Polymerase II Transcription
","Biological oxidations",Mitotic,"Infectious disease","Platelet activation","signaling and aggregation","Abacavir transport and metabolism",SUMOylation,"Metabolism of steroids","Generic Transcription
 Pathway","Phase I - Functionalization of compounds","M Phase","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Response to elevated platelet cytosolic Ca2+","Abacav
ir transmembrane transport","SUMO E3 ligases SUMOylate target proteins","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX2","FOXO-mediated transcription","Ethanol oxidation","Mi
totic Metaphase and Anaphase","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Platelet degranulation","Transcriptional regulation by RUNX1","SUMOylation of intracellular 
receptors","Synthesis of bile acids and bile salts","RUNX2 regulates bone development","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Mitotic Anaphase","Anti-inflamm
atory response favouring Leishmania parasite infection","Biosynthesis of maresins","RUNX1 regulates estrogen receptor mediated transcription","Synthesis of bile acids and bile salts via 24-hydroxychol
esterol","RUNX2 regulates osteoblast differentiation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Synthesis of bil
e acids and bile salts via 7alpha-hydroxycholesterol","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ESR1,PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{"Medroxyprogesterone acetate",71-58-9,71589,"Medroxyprogesterone 17-acetate","Medroxyprogesterone 17acetate",Metigestrona,Provera,Farlutin,Gestapuran,Perlutex,Veramix,Methylacetoxyprogesterone,"Medro
xyacetate progesterone",Depo-Provera,DepoProvera,Depcorlutin,Deporone,Lutopolar,Nadigest,Prodasone,P,S2567,SAM002564220,CPD000653524}

> <pdid>
PD001874

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{6279}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 26  0  0  0  0            999 V2000
   14.0825   -5.2598    0.0000 H   0  3
   11.5825   -5.2598    0.0000 Cl  0  5
    9.0819   -9.7710    0.0000 C   0  0
    7.7815  -10.5187    0.0000 C   0  0
    7.7794  -12.0187    0.0000 O   0  0
    6.4833   -9.7656    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0039    0.0000 N   0  0
   -3.8915   -3.7585    0.0000 C   0  0
   -3.8863   -5.2585    0.0000 C   0  0
   -2.5847   -6.0040    0.0000 C   0  0
   -1.2883   -5.2495    0.0000 C   0  0
   -1.2935   -3.7495    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 21  1  0
 19 27  2  0
 27 15  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7634

> <plate>
1

> <well>
E15

> <supplier_cmpd_name>
Roxatidine Acetate HCl

> <ctcr_id>
5802

> <supplier_cmpd_id>
S1880

> <smiles>
[H+].[Cl-].CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1

> <pd_targets>
{HRH2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{HRH2}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{AKOS026749808,AKOS005067597,"roxatidine acetate hydrochloride",93793-83-0,93793830,"ROXATIDINE ACETATE HCl",Roxit,Gastralgin,Altat,"HOE 760",TZU-0460,TZU0460,"Roxatidine (Acetate Hydrochloride)",Hoe-
760,Hoe760,UNII-60426GOR1E,UNII60426GOR1E,2-Acetoxy-N-(3-(3-(1-piperi,2AcetoxyN(3(3(1piperi,T0157,S1880,SAM001246547,Prestw-428,"Roxatidine Acetate hydrochloride","Roxatidine Acetate HCl",CPD000469144
}

> <pdid>
PD009203

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{67108342,16640927,10949026,56704}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 39 41  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 N   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 N   0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
    0.0102   -7.5017    0.0000 C   0  0
    1.3123   -8.2482    0.0000 C   0  0
    1.3177   -9.7490    0.0000 N   0  0
    2.6197  -10.4955    0.0000 C   0  0
    3.9163   -9.7412    0.0000 O   0  0
    2.6252  -11.9963    0.0000 C   0  0
    3.9254  -12.7443    0.0000 C   0  0
    3.9279  -14.2443    0.0000 C   0  0
    2.6300  -14.9964    0.0000 C   0  0
    1.3298  -14.2485    0.0000 C   0  0
    1.3274  -12.7485    0.0000 C   0  0
    0.0206  -10.5037    0.0000 C   0  0
    0.0234  -12.0038    0.0000 C   0  0
   -1.2742  -12.7563    0.0000 C   0  0
   -2.5747  -12.0089    0.0000 C   0  0
   -2.5776  -10.5089    0.0000 C   0  0
   -1.2801   -9.7563    0.0000 N   0  0
    7.7279   -4.8732    0.0000 O   0  0
    7.7279   -6.3732    0.0000 C   0  0
    6.4286   -7.1228    0.0000 O   0  0
    9.0278   -7.1232    0.0000 C   0  0
   10.3278   -6.3732    0.0000 C   0  0
   10.3293   -4.8724    0.0000 C   0  0
    9.0307   -4.1215    0.0000 O   0  0
   11.6285   -4.1228    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
 17 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7635

> <plate>
1

> <well>
E16

> <supplier_cmpd_name>
WAY-100635 Maleate

> <ctcr_id>
8199

> <supplier_cmpd_id>
S2663

> <smiles>
COc1ccccc1N2CCN(CC2)CCN(C(=O)C3CCCCC3)c4ccccn4.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"AY100635 MALEAT",SCHEMBL4077972,CHEMBL1256924,AOB6812,DTXSID60474703,QCR-206,QCR206,C29H38N4O6,HMS2233G03,HMS3263F20,HMS3884D14,EX-A2180,EXA2180,Tox21_501229,Tox21501229,Tox21-501229,"Tox21 501229",
"WAY-100635 maleate salt, powder","WAY100635 maleate salt, powder",AKOS024458129,CCG-222533,CCG222533,CS-0417,CS0417,LP01229,NCGC00094471-01,NCGC0009447101,NCGC00261914-01,NCGC0026191401,A,T3453,T2631
,S2663,"WAY-100635 maleate salt","WAY-100635 Maleate"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{11957721}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 26  0  0  0  0            999 V2000
   -1.8948    4.3802    0.0000 C   0  0
   -2.9996    3.3656    0.0000 N   0  3
   -2.9996    0.5981    0.0000 C   0  0
   -1.7408    0.1428    0.0000 C   0  0
   -0.5981    0.5356    0.0000 C   0  0
   -1.1338    1.6158    0.0000 C   0  0
   -2.4550    2.0265    0.0000 C   0  0
   -3.8209    1.2230    0.0000 C   0  0
   -4.1780   -0.1875    0.0000 C   0  0
   -5.2493    0.8035    0.0000 O   0  0
    0.6817   -0.2152    0.0000 O   0  0
    1.9863    0.5268    0.0000 C   0  0
    1.9956    2.0267    0.0000 O   0  0
    3.2816   -0.2313    0.0000 C   0  0
    3.2693   -1.7321    0.0000 C   0  0
    1.9645   -2.4721    0.0000 O   0  0
    4.5863    0.5106    0.0000 C   0  0
    5.8820   -0.2451    0.0000 C   0  0
    7.1844    0.4991    0.0000 C   0  0
    7.1911    1.9990    0.0000 C   0  0
    5.8954    2.7549    0.0000 C   0  0
    4.5931    2.0107    0.0000 C   0  0
   -4.4042    3.8919    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  9 10  1  0
 10  8  1  0
  5 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  3
 18 19  1  0
 19 20  2  3
 20 21  1  0
 21 22  2  3
 22 17  1  0
  2 23  1  0
M  CHG  1   2   1
M  END
> <name>
Selleck_GPCR

> <id>
7636

> <plate>
1

> <well>
E17

> <supplier_cmpd_name>
Methscopolamine

> <ctcr_id>
7479

> <supplier_cmpd_id>
S1978

> <smiles>
C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C

> <pd_targets>
{CHRM2,GPM3,CYP3A4,HSD17B10,GPM4,TSHR,HIF1A,CHRM1,CHRM4,GPM2,CHRM3,CHRM5,RORC,AMPC,BLM}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Transcription factor","Family A G protein-coupled receptor","Cytochrome P450",Oxidoreductase,"Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Peptide 
receptor (family A GPCR)","Monoamine receptor","Cytochrome P450 family 3A","Glycohormone receptor","Acetylcholine receptor","Cytochrome P450 3A4","Nuclear receptor",Hydrolase,"Nuclear hormone receptor
 subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Acetylcholine receptors (muscarinic)","CYP3 family","Glycoprotein hormone receptors","Nuclear hormone receptors","1F. Retinoic acid-
related orphans"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Cellular responses to external stimuli","Signaling by GPCR","Metabolism of lipids","Metabolism of amino acids and derivatives","Infectious disease","Cellular
 responses to stress","GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Leishmania infection","Cellular response to hypoxia","Cl
ass A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Amine ligan
d-binding receptors","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","ADORA2B m
ediated anti-inflammatory cytokines production","Gene expression (Transcription)","DNA Repair","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Generic Transcription Pathway","Homol
ogy Directed Repair","Transcriptional regulation by RUNX3","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","RUNX3 Regulates Immune Response and Cell Migration","HDR throu
gh Homologous Recombination (HRR)","Homologous DNA Pairing and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{methscopolamine,Methylscopolamine,N-Methylscopolamine,NMethylscopolamine,"N-methyl scopolamine","Nmethyl scopolamine",UNII-VDR09VTQ8U,UNIIVDR09VTQ8U,CHEMBL376897,VDR09VTQ8U,13265-10-6,13265106,Pamine
,Metylskopolamin,"Methscopolamine (bromide)","Methyl scopolamine",(3H)N-methylscopolamine,(3H)Nmethylscopolamine,"(3H)N-methyl s","(3H)Nmethyl s",S1978,Methscopolamine}

> <pdid>
PD013671

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{71183}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 31  0  0  0  0            999 V2000
    3.8983   -0.7512    0.0000 F   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.5983   -3.0004    0.0000 F   0  0
    3.8975   -2.2510    0.0000 F   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 N   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -2.6005    2.9949    0.0000 C   0  0
   -3.9021    3.7404    0.0000 C   0  0
   -3.9073    5.2404    0.0000 C   0  0
   -5.2089    5.9859    0.0000 Cl  0  0
   -2.6108    5.9949    0.0000 C   0  0
   -1.3092    5.2494    0.0000 C   0  0
   -0.0128    6.0039    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6131   -7.4988    0.0000 C   0  0
   -3.9147   -8.2443    0.0000 C   0  0
   -5.2111   -7.4898    0.0000 O   0  0
   -5.2060   -5.9898    0.0000 C   0  0
   -3.9043   -5.2443    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15  9  1  0
 15 16  1  0
  7 17  2  0
 17 18  1  0
 18 19  2  0
 19  5  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 24  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7637

> <plate>
1

> <well>
E18

> <supplier_cmpd_name>
GW842166X

> <ctcr_id>
5240

> <supplier_cmpd_id>
S2778

> <smiles>
FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC3CCOCC3

> <pd_targets>
{CNR2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","Cannabinoid receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Cannabinoid receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (i) signalling events"}

> <broad_targets>
{CNR2}

> <broad_moa>
{"cannabinoid receptor agonist"}

> <synonyms>
{2455AH,BDBM50211843,s2778,BCP9000755,666260-75-9,666260759,GW842166X,"GW 842166X",GW-842166X,GW842166,"GW 842166",UNII-VL1I6P2DZ8,UNIIVL1I6P2DZ8,VL1I6P2DZ8,GW-842166,CHEMBL225411,842166X,"GW-842,166X
","GW842,166X",cc-723,cc723,MLS006010287,C18H17Cl2F3N4O2,SCHEMBL3015040,DTXSID60216786,HMS,T6527,S2778}

> <pdid>
PD010578

> <targets>
{Cannabinoid Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{10253143}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 33 33  0  0  0  0            999 V2000
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 N   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 C   0  0
   10.3023   -2.2649    0.0000 O   0  0
   10.3023   -3.7649    0.0000 C   0  0
    9.0030   -4.5145    0.0000 O   0  0
   11.6023   -4.5149    0.0000 C   0  0
   12.9023   -3.7649    0.0000 C   0  0
   14.2008   -4.5157    0.0000 O   0  0
   12.9037   -2.2641    0.0000 C   0  0
   14.2037   -1.5141    0.0000 C   0  0
   15.5023   -2.2649    0.0000 O   0  0
   14.2051   -0.0141    0.0000 O   0  0
   12.9035   -5.2948    0.0000 C   0  0
   11.6048   -6.0455    0.0000 O   0  0
   14.2026   -6.0446    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 25 31  1  0
 31 32  1  0
 31 33  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7638

> <plate>
1

> <well>
E19

> <supplier_cmpd_name>
Orphenadrine Citrate

> <ctcr_id>
287

> <supplier_cmpd_id>
S2054

> <smiles>
CN(C)CCOC(c1ccccc1)c2ccccc2C.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"N,N-Dimethyl-2-((o-methyl-alpha-phenyl-benzyl)oxy)-ethylamine citrate","ETHYLAMINE, N,N-DIMETHYL-2-((o-METHYL-alpha-PHENYLBENZYL)OXY)-, CITRATE",4724-58-7,"N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzy
loxy)ethylamine citrate","Orphenadrine citrate",4682-36-4,Banflex,Flexon,"Orphenadrine (Citrate)","Orphenadrine dihydrogen citrate",X-Otag,"Orphenadrine citrate salt","Orphenadrine citrate (USP)","Orp
henadrine citrate (Norflex)",CHEBI:7790,Flexoject,C24H31NO8,4596-23-0,NCGC00094745-01,Plenactol,Euflex,Flexor,Tega-Flex,DSSTox_CID_24678,DSSTox_RID_80390,DSSTox_GSID_44678,"Norflex (pharmaceutical)",O
rphenadrinecitrate,CAS-4682-36-4,"EINECS 225-137-5","Norflex (TN)","ORPHENADINE CITRATE","N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1)",MLS000069549,SCHEMBL119470,SPECTRUM
1500447,CHEMBL1200395,DTXSID8044678,HMS502K15,HY-B0369A,HMS1920D10,HMS2091L10,HMS2231J06,HMS3259M21,HMS3370M12,HMS3651A10,HMS3884M22,Pharmakon1600-01500447,Tox21_111323,Tox21_113543,Tox21_301079,CCG-4
0242,NSC757238,AKOS008132385,Tox21_111323_1,MCULE-5864907407,NC00525,NE62567,NSC-757238,NCGC00015771-13,NCGC00094745-02,NCGC00094745-03,NCGC00254980-01,AK117797,AS-74807,SMR000058817,FT-0655842,FT-067
3305,S2054,SW102176-4,EN300-53019,D00774,A826945,SR-01000002975-5,Q27107584,"N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate","(+-)-N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy
)ethylamine citrate",SAM002554918,1500447,"Orphenadrine Citrate",CPD000058817,"ORPHENADRINE CITRATE","Orphenadrine Citrate"}

> <pdid>

> <targets>
{AChR,iGluR}

> <classes>
{antihistaminic,muscle relaxant (skeletal),Neuronal Signaling,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{20846,83823}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 31  0  0  0  0            999 V2000
    2.5930   -4.5039    0.0000 S   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 N   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -1.2948   -3.7517    0.0000 S   0  0
   -3.8933   -3.7570    0.0000 N   0  0
   -3.8912   -5.2578    0.0000 C   0  0
   -5.1894   -6.0109    0.0000 C   0  0
   -5.1872   -7.5117    0.0000 C   0  0
   -6.4854   -8.2648    0.0000 C   0  0
   -6.4833   -9.7657    0.0000 N   0  0
   -7.7815  -10.5188    0.0000 C   0  0
   -9.0818   -9.7710    0.0000 S   0  0
   -7.7793  -12.0196    0.0000 N   0  0
   -9.0775  -12.7727    0.0000 C   0  0
   -9.0776  -14.2727    0.0000 C   0  0
  -10.3766  -15.0227    0.0000 C   0  0
  -11.6757  -14.2728    0.0000 C   0  0
  -11.6757  -12.7728    0.0000 C   0  0
  -10.3767  -12.0227    0.0000 C   0  0
  -12.9740  -12.0197    0.0000 N   0  0
  -12.9719  -10.5189    0.0000 C   0  0
  -12.9698   -9.0189    0.0000 S   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 25 27  1  0
 27 28  2  0
 28 29  2  0
  8 30  2  0
 30  4  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7639

> <plate>
1

> <well>
E20

> <supplier_cmpd_name>
MRS 2578

> <ctcr_id>
5483

> <supplier_cmpd_id>
S2855

> <smiles>
S=C=Nc1cccc(NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S)c1

> <pd_targets>
{MAPT,KMT2A,MEN1,CYP3A4,ALDH1A1,P2RY6,ALOX15}

> <pathway_gtopdb>
{"Other cytosolic protein","Epigenetic regulator",Enzyme,"Membrane receptor",Reader,"Cytochrome P450",Oxidoreductase,"Family A G protein-coupled receptor",Bromodomain,"Cytochrome P450 family 3","Small
 molecule receptor (family A GPCR)","Cytochrome P450 family 3A","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 3A4","Purine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","Eicosanoid turnover","CYP3 family","P2Y receptors",Lipoxygenases}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Signal Transduction","Transmission across Chemical Synapses","Metabolism of lipids","Biological oxidations","Signaling by GPCR","Neurotransmitter receptors and postsynap
tic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","GPCR ligand binding","Activation of NMDA receptors and postsynaptic eve
nts","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DPA-derived SPMs","Post NMDA receptor activation events","Biosynthesis of maresins",
"Nucleotide-like (purinergic) receptors","Biosynthesis of DPAn-3 SPMs","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SPMs","P2Y receptors","Biosynthesis of DPAn-3-derived pro
tectins and resolvins"}

> <broad_targets>
{P2RY6}

> <broad_moa>
{"purinergic receptor antagonist"}

> <synonyms>
{"MRS 2578",711019-86-2,711019862,MRS-2578,MRS2578,"1,1'-(butane-1,4-diyl)bis(3-(3-isothiocyanatophenyl)thiourea)","1,1'(butane1,4diyl)bis(3(3isothiocyanatophenyl)thiourea)","1,4-Di(3-(3-isothiocyanat
ophenyl)thioureido)butane","1,4Di(3(3isothiocyanatophenyl)thioureido)butane",CHEMBL1321988,C20H20N6S4,GTPL1753,SCHEMBL17644288,DTXSID90582027,BCPP000156,HMS3651B19,HMS37,T6172,S2855}

> <pdid>
PD010547

> <targets>
{P2 Receptor,Apoptosis,P2Y Receptor}

> <classes>
{Neuronal Signaling,Apoptosis,GPCR/G Protein}

> <pubchem_cids>
{16078986}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 27  0  0  1  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    5.1937   -3.0093    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5978   -1.5022    0.0000 C   0  0  2  0  0  0
   -2.5953   -3.0022    0.0000 C   0  0
   -3.8990   -0.7544    0.0000 N   0  0
   -5.1970   -1.5061    0.0000 C   0  0
   -3.9015    0.7456    0.0000 C   0  0
   11.5943   -0.3804    0.0000 O   0  0
   11.5943   -1.8804    0.0000 C   0  0  2  0  0  0
   10.2943   -2.6304    0.0000 C   0  0  1  0  0  0
   10.2943   -4.1304    0.0000 O   0  0
    8.9943   -1.8804    0.0000 C   0  0
    8.9943   -0.3804    0.0000 O   0  0
    7.6950   -2.6300    0.0000 O   0  0
   12.8943   -2.6304    0.0000 C   0  0
   12.8943   -4.1304    0.0000 O   0  0
   14.1936   -1.8809    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 12 14  1  0
 14 15  1  6
 14 16  1  0
 16 17  1  0
 16 18  1  0
 20 19  1  1
 20 21  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 23 25  2  0
 20 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7640

> <plate>
1

> <well>
E21

> <supplier_cmpd_name>
Rivastigmine Tartrate

> <ctcr_id>
7420

> <supplier_cmpd_id>
S2087

> <smiles>
CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C.O[C@H]([C@@H](O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Rivastigmine tartrate",129101-54-8,129101548,"SDZ-ENA 713","SDZENA 713","Rivastigmine Hydrogen Tartrate","Rivastigmine (tartrate)",UNII-9IY2357JPE,UNII9IY2357JPE,"ENA 713","Rivastigmine tartrate (Ex
elon)",9IY2357JPE,"Rivastigmine bitartrate",Rivastach,3-((1S)-1-(Dime,3((1S)1(Dime,T1628,S2087,"Rivastigmine Tartrate"}

> <pdid>

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{6918078}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 27  0  0  1  0            999 V2000
    1.0813    1.8186    0.0000 C   0  0
    0.0600    0.7200    0.0000 C   0  0  1  0  0  0
   -0.5400    2.2100    0.0000 N   0  0
   -0.5400   -0.8500    0.0000 C   0  0  1  0  0  0
    0.8500   -1.3700    0.0000 C   0  0
    2.1100   -0.9300    0.0000 C   0  0
    3.4600   -1.0200    0.0000 C   0  0
    4.2100    0.0900    0.0000 C   0  0
    3.6100    1.3000    0.0000 C   0  0
    2.2700    1.3800    0.0000 C   0  0
    1.5200    0.2600    0.0000 C   0  0
   -1.8500   -1.7700    0.0000 C   0  0
   -3.4300   -2.2400    0.0000 C   0  0
   -4.6300   -1.1000    0.0000 C   0  0
   -4.2400    0.5000    0.0000 C   0  0
   -2.6500    0.9600    0.0000 C   0  0
   -1.4500   -0.1700    0.0000 C   0  0
    8.0100    1.8600    0.0000 O   0  0
    8.0100    0.3600    0.0000 C   0  0
    6.7107   -0.3896    0.0000 O   0  0
    9.3100   -0.3900    0.0000 C   0  0
   10.6100    0.3600    0.0000 C   0  0
   10.6114    1.8608    0.0000 C   0  0
    9.3128    2.6116    0.0000 O   0  0
   11.9107    2.6104    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  4  3  1  1
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  2  1  0
 11  6  1  0
  4 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  2  1  0
 17 12  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7641

> <plate>
1

> <well>
E22

> <supplier_cmpd_name>
(-)-MK 801 Maleate

> <ctcr_id>
3599

> <supplier_cmpd_id>
S2876

> <smiles>
C[C@@]12N[C@@H](Cc3ccccc13)c4ccccc24.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW93,"(-)-MK 801 Maleate","()MK 801 Maleate",121917-57-5,121917575,UNII-EF13O02IV0,UNIIEF13O02IV0,"(-)-MK 801 hydrogen maleate","()MK 801 hydrogen maleate","(-)-dizocilpine maleate","()dizocilpine
 maleate",EF13O02IV0,"(-)-MK 801 (Maleate)","()MK 801 (Maleate)","(-)-MK-801 MALEATE","()MK801 MALEATE","(+)-MK 801 Maleate","(+)MK 801 Maleate","(-)-Dizocilpine (Maleate)","()Dizocilpine (Maleate)",7
7086-19-2,77086192,77086-22-7,77086227,(-)-MK801,()MK801,DI,T3320,T6352,S2876,Prestw-935,"Dizocilpine Maleate"}

> <pdid>

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{16219612}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 16  0  0  1  0            999 V2000
    3.8976   -0.7465    0.0000 C   0  0
    2.5998   -1.4987    0.0000 C   0  0  2  0  0  0
    2.6028   -2.9995    0.0000 C   0  0
    1.3921   -3.8634    0.0000 C   0  0
    1.8604   -5.2884    0.0000 N   0  0
    3.3604   -5.2834    0.0000 C   0  0
    3.8192   -3.8553    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  3  1  0
  2  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14  8  1  0
 14 15  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7642

> <plate>
1

> <well>
F03

> <supplier_cmpd_name>
Dexmedetomidine

> <ctcr_id>
7379

> <supplier_cmpd_id>
S3075

> <smiles>
C[C@H](c1c[nH]cn1)c2cccc(C)c2C

> <pd_targets>
{ADRA2B,ADRA2A,ADRA1A,ADRA1D,ADRA2C,NISCH,SLC6A2,MAOB,ADRA1B,MAOA}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Transporter,Enzyme,"Family A G protein-coupled receptor","Electrochemical transporter",Oxidoreductase,"Small molecule receptor (family A GPCR)","SLC supe
rfamily of solute carriers","Monoamine receptor","SLC06 neurotransmitter transporter family","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"G protein-coupled receptors","SLC superfamily of solute carriers","Catecholamine turnover",Adrenoceptors,"SLC6 neurotransmitter transporter family","Monoamine transpor
ter subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,Metabolism,"Signaling by GPCR","Disorders of transmembrane transporters","Biological oxidations","GPCR ligand binding","SLC transporter disorders","Phase I - Functionali
zation of compounds","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine Oxidase reactions","Amine ligand-binding receptors","Biogenic amines are oxida
tively deaminated to aldehydes by MAOA and MAOB",Adrenoceptors}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"(S)-4-(1-(2,3-Dimethylphenyl)ethyl)-1H-imidazole","(S)4(1(2,3Dimethylphenyl)ethyl)1Himidazole",DEXMEDETOMIDINE,113775-47-6,113775476,Dexmedetomidinum,"MPV 1440",Dexmedetomidina,"5-((1S)-1-(2,3-dimet
hylphenyl)ethyl)-1H-imidazole","5((1S)1(2,3dimethylphenyl)ethyl)1Himidazole","(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole","(+)4((S)alpha,2,3Trimethylbenzyl)imidazole",UNII-67VB76HONO,UNII67VB76HON
O,MPV-1440,MPV1440,S3075,Dexmedetomidine,"Dexmedetomidine HCl"}

> <pdid>
PD013841

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5311068}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 15  0  0  0  0            999 V2000
    5.0987   -0.7504    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -3.8990   -0.7455    0.0000 C   0  0
   -5.2526   -1.3618    0.0000 N   0  0
   -6.2524   -0.2436    0.0000 C   0  0
   -5.4979    1.0528    0.0000 N   0  0
   -4.0317    0.7358    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  7 14  2  0
 14  3  1  0
 14 15  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7643

> <plate>
1

> <well>
F04

> <supplier_cmpd_name>
Fosinopril Sodium

> <ctcr_id>
3869

> <supplier_cmpd_id>
S2095

> <smiles>
Cl.Cc1cccc(Cc2[nH]cnc2)c1C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{ADRA2A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"DETOMIDINE HYDROCHLORIDE",90038-01-0,90038010,"Detomidine HCl",Domosedan,"MPV-253 AII","MPV253 AII","Detomidine (hydrochloride)",UNII-95K4LKB6QE,UNII95K4LKB6QE,"Detomidine hydrochloride (USAN)","5-(
2,3-Dimethylbenzyl)-1H-imidazole Hydrochloride","5(2,3Dimethylbenzyl)1Himidazole Hydrochloride",95K4LKB6QE,5-((2,5((2,3-dimet,3dimet,S2092,S2095,"Fosinopril Sodium"}

> <pdid>

> <targets>
{Adrenergic Receptor,RAAS}

> <classes>
{Endocrinology & Hormones,Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{56031,50986730}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 20  0  0  1  0            999 V2000
   10.3056    0.0059    0.0000 Cl  0  5
    1.2844    3.7485    0.0000 C   0  0
    2.5857    3.0025    0.0000 N   0  3
    2.5914    1.5017    0.0000 C   0  0
    3.8934    0.7553    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0  1  0  0  0
    2.6003   -1.4978    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    5.2003   -1.4933    0.0000 C   0  0
    5.2076   -2.9933    0.0000 C   0  0
    6.5102   -3.7370    0.0000 C   0  0
    7.8056   -2.9808    0.0000 C   0  0
    7.7984   -1.4808    0.0000 C   0  0
    6.4958   -0.7371    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
  6 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
Selleck_GPCR

> <id>
7644

> <plate>
1

> <well>
F05

> <supplier_cmpd_name>
Atomoxetine HCl

> <ctcr_id>
1715

> <supplier_cmpd_id>
S3175

> <smiles>
[Cl-].C[NH2+]CC[C@@H](Oc1ccccc1C)c2ccccc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{AKOS015896138,"Atomoxetine hydrochloride","Atomoxetine HCL",82248-59-7,82248597,Strattera,"TOMOXETINE HYDROCHLORIDE","(R)-Tomoxetine hydrochloride","(R)Tomoxetine hydrochloride","(R)-N-Methyl-3-pheny
l-3-(o-tolyloxy)propan-1-amine hydrochloride","(R)NMethyl3phenyl3(otolyloxy)propan1amine hydrochloride","(R)-(-)-Tomoxetine h","(R)()Tomoxetine h",S3175,SAM001246626,Prestw-1463,"Atomoxetine HCl",CPD0
00469177,"Tomoxetine hydrochloride"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{45108252,54840,11426336}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 41 44  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0  2  0  0  0
   -2.5950   -3.0008    0.0000 C   0  0
   -1.2942   -3.7494    0.0000 C   0  0
   -1.2911   -5.2502    0.0000 C   0  0
    0.0098   -5.9988    0.0000 C   0  0
    0.0129   -7.4996    0.0000 C   0  0
    1.3137   -8.2482    0.0000 C   0  0
    1.3168   -9.7490    0.0000 C   0  0
    2.6176  -10.4975    0.0000 C   0  0
    2.6207  -11.9984    0.0000 C   0  0
    3.9215  -12.7469    0.0000 S   0  0
    5.2192  -11.9946    0.0000 O   0  0
    3.9246  -14.2477    0.0000 C   0  0
    5.2254  -14.9963    0.0000 C   0  0
    5.2285  -16.4971    0.0000 C   0  0
    6.5293  -17.2457    0.0000 C   0  0
    6.5270  -15.7457    0.0000 F   0  0
    7.8271  -16.4934    0.0000 F   0  0
    6.5324  -18.7465    0.0000 C   0  0
    7.8325  -19.4946    0.0000 F   0  0
    6.5348  -20.2465    0.0000 F   0  0
    5.2347  -19.4988    0.0000 F   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  6  5  1  6
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
  7 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
 34 35  1  0
 35 36  2  0
 36  5  1  0
 36 30  1  0
  6 37  1  0
 37  2  1  0
 37 38  1  1
 38 39  1  0
 39 40  1  0
 40  2  1  0
 40 41  1  1
M  END
> <name>
Selleck_GPCR

> <id>
7645

> <plate>
1

> <well>
F06

> <supplier_cmpd_name>
Fulvestrant

> <ctcr_id>
4559

> <supplier_cmpd_id>
S1191

> <smiles>
C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCC[S](=O)CCCC(F)(F)C(F)(F)F)Cc4cc(O)ccc34)[C@@H]1CC[C@@H]2O

> <pd_targets>
{GPER1,ESR1,ESR2,NR1H4,EPHX2,BLA,PGR,NR1I2,ESRRA}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor",Enzyme,"Family A G protein-coupled receptor","Nuclear receptor",Protease,Hydrolase,"Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfa
mily 3","Nuclear hormone receptor subfamily 1","Serine protease","Lipid-like ligand receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subfamily 1 group
 H","Serine protease SC clan","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 3 group B","Steroid-like ligand receptor
","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group A member 2","Nuclear hormone receptor subfamily 1 group H member 4","Serine protease S33 family","
Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily 3 group B member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Nuclear hormone receptors",Hydrolases,"G protein-coupled estrogen receptor","Steroid hormone receptors","1H. Liver X receptor-like receptors","1I. Vit
amin D receptor-like receptors","3B. Estrogen-related receptors","3A. Estrogen receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)",Metabolism,"Metabolism of proteins","Signaling by GPCR","RNA Polymerase II Transcription","Intracellular signaling by second messengers","Metab
olism of lipids","Post-translational protein modification","GPCR ligand binding","Generic Transcription Pathway","PIP3 activates AKT signaling","Metabolism of steroids","Biosynthesis of specialized pr
oresolving mediators (SPMs)",SUMOylation,"Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX1","Negative regulation of the PI3K/AKT network","Bile acid and bile salt metabolism"
,"Biosynthesis of DHA-derived SPMs","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX2","Peptide ligand-binding receptors","RUNX1 regulates estrogen receptor mediated tra
nscription",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Synthesis of bile acids and bile salts","Biosynthesis of maresins","SUMOylation of intracellular receptors","Regulation of RUNX2 expressio
n and activity","Synthesis of bile acids and bile salts via 27-hydroxycholesterol"}

> <broad_targets>
{ESR1,ESR2,GPER1}

> <broad_moa>
{"estrogen receptor antagonist"}

> <synonyms>
{RESTW142,Fulvestrant,129453-61-8,129453618,Faslodex,"Ici 182780",ICI-182780,ICI182780,"ICI 182,780","ZM 182780",ZM-182780,ZM182780,ZD-9238,ZD9238,"ZD 182780","Fulvestrant (Faslodex)","ZD 9238",CHEMBL
1358,C32H47F5O3S,CHEBI:31638,DSSTox_CID_2369,DSSToxCID2369,DSSTox-CID-2369,"DSSTox CID 2369",DSSTox_RID_76561,DSSToxRID76561,DSSTox-RID-76561,"DSSTox RID 76561",DSSTox_GSID_22369,DSSToxGSID22369,DSSTo
x-GSID-22369,"DSSTox GSID 22369",F,T2146,719276,S1191,nan,Prestw-1424,"NSC 719276",fulvestrant}

> <pdid>
PD002815

> <targets>
{"","Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones","Estrogen Receptor Antagonists"}

> <pubchem_cids>
{104741}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 24  0  0  0  0            999 V2000
   10.1894    1.1269    0.0000 H   0  3
    7.6894    1.1269    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 O   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -5.1937    3.0092    0.0000 O   0  0
   -3.8912    5.2578    0.0000 C   0  0
   -5.1894    6.0109    0.0000 N   0  0
   -5.1873    7.5117    0.0000 C   0  0
   -6.4848    8.2644    0.0000 C   0  0
   -3.8869    8.2595    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 C   0  0
   -2.5951   -3.0031    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 12 22  1  0
 22 23  2  0
 23  9  1  0
 22 24  1  0
 24 25  1  0
 24 26  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7646

> <plate>
1

> <well>
F07

> <supplier_cmpd_name>
Acebutolol HCl

> <ctcr_id>
6599

> <supplier_cmpd_id>
S4010

> <smiles>
[H+].[Cl-].CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O

> <pd_targets>
{KDM4E,ADRB1,HTR1A,SLC22A1,ADRB2}

> <pathway_gtopdb>
{"Epigenetic regulator","Membrane receptor",Transporter,Eraser,"Family A G protein-coupled receptor","Electrochemical transporter","Lysine demethylase","Small molecule receptor (family A GPCR)","SLC s
uperfamily of solute carriers","Jumonji domain-containing","Monoamine receptor","SLC22 family of organic cation and anion transporters","Adrenergic receptor","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Chromatin modifying enzymes","G protein-coupled receptors","SLC superfamily of solute carriers","1.14.11.- Histone demethylases",Adrenoceptors,"5-Hydroxytryptamine rec
eptors","SLC22 family of organic cation and anion transporters","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Disease,"Signal Transduction","Transport of small molecules","Infectious disease","Signaling by GPCR","SLC-mediated transmembrane transport","Leishmania infection","GPCR ligand binding","Transport of
 bile salts and organic acids","metal ions and amine compounds","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Organic cation/anion/zwitterion transport","Anti-infla
mmatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Organic cation transport","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors"}

> <broad_targets>
{ADRB1}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{NCGC00018215-06,NCGC0001821506,NCGC00094830-01,NCGC0009483001,"Acebutolol hydrochloride",34381-68-5,34381685,"Acebutolol HCL",Sectral,"Acebutolol (hydrochloride)",Prent,C18H29ClN2O4,MLS000069553,CHEB
I:2380,IL-17803A,IL17803A,"M&B 17803A",SMR000058800,DSSTox_CID_25461,DSSToxCID25461,DSSTox-CID-25461,"DSSTox CID 25461",DSSTox_R,DSSToxR,DSSTox-R,"DSSTox R",T1012,S4010,SAM002264591,1500665,Prestw-69,
"Acebutolol HCl",CPD000058800,"ACEBUTOLOL HYDROCHLORIDE"}

> <pdid>
PD009749

> <targets>
{"Adrenergic Receptor"}

> <classes>
{antianginal,"Neuronal Signaling",antiarrhythmic,antihypertensive}

> <pubchem_cids>
{441307,36816,657184}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 37 39  0  0  0  0            999 V2000
   12.9807   -5.4488    0.0000 H   0  3
   10.4807   -5.4488    0.0000 Cl  0  5
    3.8805   -1.4410    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
   -0.6890   -4.0818    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -1.2234   -6.6267    0.0000 C   0  0
   -0.7552   -8.0517    0.0000 C   0  0
    0.7130   -8.3588    0.0000 C   0  0
    1.1844   -9.7837    0.0000 O   0  0
    2.6539  -10.0888    0.0000 C   0  0
    3.1253  -11.5137    0.0000 C   0  0
    4.5948  -11.8188    0.0000 N   0  0
    4.9765  -13.2769    0.0000 C   0  0
    6.3417  -13.8983    0.0000 C   0  0
    7.6787  -13.2183    0.0000 C   0  0
    7.9807  -11.7490    0.0000 C   0  0
    7.0203  -10.5968    0.0000 C   0  0
    5.5206  -10.6294    0.0000 C   0  0
    1.7131   -7.2408    0.0000 C   0  0
    1.2449   -5.8157    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    1.9048   -5.7699    0.0000 C   0  0
    2.7504   -7.0088    0.0000 C   0  0
    4.2462   -6.8960    0.0000 C   0  0
    5.0918   -8.1349    0.0000 O   0  0
    4.8963   -5.5442    0.0000 C   0  0
    4.0507   -4.3052    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  2  0
 11  5  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 21  1  0
 17 28  1  0
 28 29  2  0
 29 14  1  0
 12 30  1  0
 30  4  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 34 36  1  0
 36 37  2  0
 37 31  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7647

> <plate>
1

> <well>
F08

> <supplier_cmpd_name>
Bazedoxifene HCl

> <ctcr_id>
1148

> <supplier_cmpd_id>
S2128

> <smiles>
[H+].[Cl-].Cc1c2cc(O)ccc2n(Cc3ccc(OCCN4CCCCCC4)cc3)c1c5ccc(O)cc5

> <pd_targets>
{ESR1,ESR2,REP}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormon
e receptor subfamily 3 group A member 2",Enzyme,Transferase}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3A. Estrogen receptors","Other protein targets","Anti-infective targets","Viral protein targets","Coronavirus (CoV) proteins"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction","RNA Polymerase II Transcription","Intracellular signaling by second messengers","Generic Transcription Pathway","PIP3 activates AKT signaling"
,"Transcriptional regulation by RUNX1","Negative regulation of the PI3K/AKT network","RUNX1 regulates estrogen receptor mediated transcription",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling",Disease
,"Infectious disease","SARS-CoV Infections","SARS-CoV-2 Infection","SARS-CoV-2 Genome Replication and Transcription","Replication of the SARS-CoV-2 genome"}

> <broad_targets>
{ESR1,ESR2}

> <broad_moa>
{"selective estrogen receptor modulator (SERM)"}

> <synonyms>
{"Bazedoxifene HCl",198480-56-7,198480567,"Bazedoxifene hydrochloride","TSE-424 (hydrochloride)","TSE424 (hydrochloride)","Bazedoxifene (hydrochloride)","WAY 140424","TSE 424 hydrochloride",C30H34N2O3
.ClH,SCHEMBL5157977,DTXSID80433034,BCP28606,"PF-05208749 HCl","PF05208749 HCl",2256AH,s21,S2128}

> <pdid>
PD008610

> <targets>
{"Estrogen/progestin receptor","Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{9936012}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 22  0  0  1  0            999 V2000
    8.8990    0.7516    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8991    0.7525    0.0000 C   0  0
   -5.1969    1.5045    0.0000 C   0  0
   -5.1945    3.0045    0.0000 C   0  0
   -6.4924    3.7566    0.0000 Cl  0  0
   -3.8943    3.7525    0.0000 C   0  0
   -3.8919    5.2525    0.0000 Cl  0  0
   -2.5965    3.0004    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3990    0.7516    0.0000 H   0  3
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  6
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15  8  1  0
  7 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  4  1  0
 21 16  1  0
M  CHG  2   1  -1  22   1
M  END
> <name>
Selleck_GPCR

> <id>
7648

> <plate>
1

> <well>
F09

> <supplier_cmpd_name>
Sertraline HCl

> <ctcr_id>
412

> <supplier_cmpd_id>
S4053

> <smiles>
[Cl-].CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13.[H+]

> <pd_targets>
{MAPT,LEF,TP53,LMNA,NFKB1,THPO,CYP3A4,SLC6A3,FTL,RORC,PMP22,ALOX15,MAPK1,SLC6A2,CHRM1,SLC6A4,TSHR,KMT2A,MEN1,GMNN,ADRA1B,CYP1A2,AMPC,ABCB11,CYP2J2,CYP2C19,FFP,LUXR,CYP2D6,SIGMAR1,ADRA2B,ADRA2C,MC5R,CH
RM4,HTR2B,ABCB1,MTOR,HTR2A,CACNA1C,CHRM5,KCNH2,HTR2C,ADRA2A,CHRM2,PGRMC1,HRH1,HTR1A,CHRM3,NET,ADRA1A}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein",Transporter,"Membrane receptor","Epigenetic regulator","Ion channel",Protease,"Cytochrome P450",
"Electrochemical transporter","Nuclear receptor",Oxidoreductase,Kinase,"Family A G protein-coupled receptor",Reader,Hydrolase,"Primary active transporter",Transferase,"Voltage-gated ion channel","Meta
llo protease","Cytochrome P450 family 3","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1","Protein Kinase","Small molecule receptor (family A GPCR)","Peptide receptor (famil
y A GPCR)",Bromodomain,"Cytochrome P450 family 1","ATP-binding cassette","Cytochrome P450 family 2","Voltage-gated calcium channel","Potassium channels","Metallo protease MAE clan","Cytochrome P450 fa
mily 3A","SLC06 neurotransmitter transporter family","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 1A"
,"ABCB subfamily","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Voltage-gated potassium channel","Metallo protease M
34 family","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Acetylcholine receptor","Adrenergic receptor","Cytochrome P450 1A1","Cytochr
ome P450 2C19","Cytochrome P450 2D6","Melanocortin receptor","Serotonin receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily","Histamine r
eceptor","Dopamine receptor"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Other protein targets","Ion channels","Cytochrome P450","SLC superfamily of solute carriers","Nuclear hormone receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","
G protein-coupled receptors","Chromatin modifying enzymes","ATP-binding cassette transporter family","Sigma receptors","Voltage-gated ion channels","CYP3 family","SLC6 neurotransmitter transporter fam
ily","1F. Retinoic acid-related orphans",Lipoxygenases,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","2.1.1.43 Histone methylt
ransferases (HMTs)",Adrenoceptors,"CYP1 family","ABCB subfamily","CYP2 family: drug metabolising subset","Melanocortin receptors","5-Hydroxytryptamine receptors",Atypical,"Voltage-gated calcium channe
ls","Potassium channels","Monoamine transporter subfamily","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Voltage-gated potassium ch
annels","ERK subfamily","FRAP subfamily","Histamine receptors","Dopamine receptors"}

> <pathway_reactome>
{"Neuronal System",Disease,"Cell Cycle","Immune System",Hemostasis,Metabolism,"Vesicle-mediated transport","Gene expression (Transcription)","Developmental Biology","Signal Transduction","Muscle contr
action","Transmission across Chemical Synapses","Infectious disease","Cell Cycle Checkpoints",Mitotic,"Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Metabolis
m of lipids","Disorders of transmembrane transporters","Membrane Trafficking","RNA Polymerase II Transcription","Nervous system development","Innate Immune System","Signaling by GPCR","Biological oxid
ations","Abacavir transport and metabolism","Cardiac conduction","Neurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints
","M Phase","Signaling by Interleukins","Platelet Aggregation (Plug Formation)","Biosynthesis of specialized proresolving mediators (SPMs)","SLC transporter disorders","trans-Golgi Network Vesicle Bud
ding","Generic Transcription Pathway","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Receptor Cascades","GPCR ligand binding","Neurotransmitter clearance","Leishmania infe
ction","Mitotic G1 phase and G1/S transition","Phase I - Functionalization of compounds","Metabolism of steroids","SARS-CoV Infections","Abacavir transmembrane transport","Axon guidance","Phase 3 - ra
pid repolarisation","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Interleu
kin-1 family signaling","Biosynthesis of DHA-derived SPMs","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX3"
,"Biosynthesis of DPA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","Leishmania parasite growth and survival"
,"G1/S Transition","Defective SLC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Pot
ential therapeutics for SARS","Transcriptional Regulation by TP53","NCAM signaling for neurite out-growth","Post NMDA receptor activation events","p53-Dependent G1 DNA Damage Response","Mitotic Anapha
se","Interleukin-1 signaling","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","Amine ligand-b
inding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Activation of the pre-replicative complex","RUNX1 regulates genes involved in megakaryocyte differentiation and 
platelet function",Xenobiotics,"Synthesis of bile acids and bile salts","Fatty acids","Regulation of TP53 Activity","NCAM1 interactions","Activation of AMPK downstream of NMDARs","Stabilization of p53
","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","MAP kinase activation",
"Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Synthesis of bile acids
 and bile salts via 7alpha-hydroxycholesterol","CYP2E1 reactions","Serotonin receptors","Regulation of TP53 Expression and Degradation","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of
 Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated","Histamine receptors"}

> <broad_targets>
{SLC6A3,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{AKOS015896266,Zoloft,Lustral,"Cp 51,974-1",Seserine,"Sertraline hydrochloride",79559-97-0,"Sertraline HCl",Gladem,Serad,"Sertraline (hydrochloride)",UNII-UTI8907Y6X,"(+)-sertraline hydrochloride",CHE
BI:9124,UTI8907Y6X,"rac-cis-Sertraline Hydrochloride",C17H18Cl3N,MFCD00895772,Atruline,Tresleen,"Cp-51,974-1",Tatig,CP-51974-1,DSSTox_CID_20243,DSSTox_RID_79456,DSSTox_GSID_40243,79617-95-1,Adjuvin,Ar
emis,MLS001401398,"(+)-cis-(1S,4S)-1-methylamino-4-(3,4-dichlorophenyl)tetralin hydrochloride",CAS-79559-97-0,NCGC00092386-03,SMR000466298,C17H17Cl2N.HCl,Serlift,Sertraline.HCl,79617-99-5,"Sertraline,
 HCl","Sertraline hydrochloride (USAN:USP)","Zoloft (TN)",CPD000466298,CHEMBL1709,SCHEMBL23230,MLS000758929,ARONIS24360,SPECTRUM1505262,"SERTRALINE HYDRECHLORIDE",Methyl2-(Hydroxymethyl)Acrylate,DTXSI
D1040243,"(+/-)-Sertraline Hydrochloride",HY-B0176A,"(1R,4R)-SERTRALINE HCL","(1R,4S)-SERTRALINE HCL",AOB2376,HMS1922P09,Pharmakon1600-01505262,"Sertraline hydrochloride (JAN/USP)",Tox21_111199,Tox21_
500870,AC-740,CCG-39575,CS0024,NSC746308,NSC758948,SBB080777,AKOS005267232,AKOS015846322,Tox21_111199_1,AB07662,CS-2052,KS-1111,LP00870,MCULE-1681469163,NC00198,NC00726,NE57257,NSC-746308,NSC-758948,N
CGC00092386-01,NCGC00092386-13,NCGC00261555-01,"Sertraline hydrochloride Related Compound A","Sertraline hydrochloride, >=98 (HPLC)",CP-5197401,EU-0100870,S4053,D00825,J10439,559S970,Q27108281,"Sertra
line hydrochloride 100 microg/mL in Acetonitrile","Sertraline Hydrochloride 1.0 mg/ml in Methanol (as free base)","Sertraline hydrochloride, British Pharmacopoeia (BP) Reference Standard","Sertraline 
hydrochloride, European Pharmacopoeia (EP) Reference Standard",SAM002700175,SAM001246666,1505262,"SERTRALINE HYDROCHLORIDE"}

> <pdid>
PD004322

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"5HT uptake inhibitor","Neuronal Signaling"}

> <pubchem_cids>
{50986904,11078406,63009}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 32  0  0  0  0            999 V2000
    5.0987   -2.7052    0.0000 Na  0  3
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.3115    2.9665    0.0000 O   0  0
   -1.8032    3.1233    0.0000 C   0  0
   -2.4133    1.7530    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -2.6016   -2.9971    0.0000 O   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -0.0934   -6.1101    0.0000 S   0  0
   -0.5570   -7.5366    0.0000 C   0  0
   -2.0570   -7.5366    0.0000 C   0  0
   -2.5205   -6.1100    0.0000 C   0  0
   -3.9417   -5.6362    0.0000 S   0  0
   -4.2418   -4.1665    0.0000 O   0  0
   -5.3645   -5.1610    0.0000 O   0  0
   -5.0654   -6.6311    0.0000 N   0  5
   -6.4892   -6.1563    0.0000 C   0  0
   -6.9180   -4.7322    0.0000 O   0  0
   -8.4179   -4.7175    0.0000 N   0  0
   -8.8954   -6.1395    0.0000 C   0  0
  -10.3264   -6.5891    0.0000 C   0  0
   -7.6905   -7.0330    0.0000 C   0  0
   -7.6963   -8.5330    0.0000 Cl  0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  2  0
  9 10  1  0
 10 11  2  0
 11  3  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 15  2  0
 19 20  1  0
 20 21  2  0
 20 22  2  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 24  2  0
 29 30  1  0
M  CHG  2   1   1  23  -1
M  END
> <name>
Selleck_GPCR

> <id>
7649

> <plate>
1

> <well>
F10

> <supplier_cmpd_name>
Sitaxentan sodium

> <ctcr_id>
1213

> <supplier_cmpd_id>
S3034

> <smiles>
[Na+].Cc1cc2OCOc2cc1CC(=O)c3sccc3[S](=O)(=O)[N-]c4onc(C)c4Cl

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Sitaxsentan sodium","Sitaxentan sodium",210421-74-2,210421742,Thelin,"Sitaxsentan (sodium)",UNII-6V9JH46E20,UNII6V9JH46E20,TBC-11251NA,TBC11251NA,6V9JH46E20,TBC-11251Z,TBC11251Z,"210421-74-2  (sodiu
m salt)","210421742  (sodium salt)","IPI 1040 (sodium);TBC11251 (sodium)","Sitaxentan sodium (USAN)",SITAXSEN,T6672,S3034}

> <pdid>

> <targets>
{"Endothelin Receptor","ETA Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{11477084,101185768}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 27  0  0  0  0            999 V2000
    1.2916   -5.2495    0.0000 C   0  0
    1.2948   -3.7495    0.0000 N   0  0
   -0.0028   -2.9971    0.0000 C   0  0
    2.5957   -3.0011    0.0000 C   0  0
    2.5990   -1.5003    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7504    0.0000 C   0  0
    3.9010    0.7496    0.0000 O   0  0
    3.8617   -2.2295    0.0000 C   0  0
    5.1601   -2.9806    0.0000 C   0  0
    6.4597   -2.2317    0.0000 C   0  0
    6.4610   -0.7317    0.0000 C   0  0
    5.1626    0.0194    0.0000 C   0  0
   10.2610    0.0000    0.0000 O   0  0
   10.2610   -1.5000    0.0000 C   0  0
    8.9617   -2.2496    0.0000 O   0  0
   11.5610   -2.2500    0.0000 C   0  0
   12.8610   -1.5000    0.0000 C   0  0
   14.1609   -2.2500    0.0000 C   0  0
   14.1609   -3.7500    0.0000 O   0  0
   15.4602   -1.5004    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
  5 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 13  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7650

> <plate>
1

> <well>
F11

> <supplier_cmpd_name>
Desvenlafaxine Succinate

> <ctcr_id>
250

> <supplier_cmpd_id>
S4112

> <smiles>
CN(C)CC(c1ccc(O)cc1)C2(O)CCCCC2.OC(=O)CCC(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Desvenlafaxine Succinate","WY 45233 succinate",448904-47-0,448904470,"Desvenlafaxine succinate anhydrous","O-Desmethylvenlafaxine succinate","ODesmethylvenlafaxine succinate",C16H25NO2.C4H6O4,"4-(2-
(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol succinate","4(2(dimethylamino)1(1hydroxycyclohexyl)ethyl)phenol succinate","Ventab DX",T6188,S4112,"Desvenlafaxine succinate hydrate"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9800068}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 30  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.3115    2.9665    0.0000 N   0  0
    0.6890    4.0818    0.0000 C   0  0
    0.2234    5.5086    0.0000 C   0  0
    1.2255    6.6258    0.0000 C   0  0
    0.7623    8.0525    0.0000 C   0  0
    1.7662    9.1671    0.0000 C   0  0
    3.2334    8.8550    0.0000 C   0  0
    3.6967    7.4283    0.0000 C   0  0
    2.6928    6.3138    0.0000 C   0  0
   -1.8032    3.1233    0.0000 N   0  0
   -2.4133    1.7530    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5536   -4.4230    0.0000 C   0  0
   -4.0145   -4.6748    0.0000 O   0  0
   -4.2107   -6.1619    0.0000 C   0  0
   -2.8569   -6.8080    0.0000 C   0  0
   -1.8241   -5.7201    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  5 14  1  0
 14 15  2  0
 15 16  1  0
 16  4  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21  2  1  0
 21 17  1  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7651

> <plate>
1

> <well>
F12

> <supplier_cmpd_name>
SCH58261

> <ctcr_id>
8200

> <supplier_cmpd_id>
S8104

> <smiles>
Nc1nc2n(CCc3ccccc3)ncc2c4nc(nn14)c5occc5

> <pd_targets>
{RAB9A,IMPA1,HSD17B10,KDM4E,ALDH1A1,ADORA1,ADORA2A,NPC1,ADORA2B,ALOX15,HPGD,TP53,ADORA3,SMN1,MAPK1,CYP3A4}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor",Transporter,"Transcription factor",Hydrolase,Oxidoreductase,Eraser,"Family A G protein-coupled receptor",Reader,Kinase,"Cytochrome P450","Lysine deme
thylase","Small molecule receptor (family A GPCR)","Methyl-lysine/arginine binding protein","Protein Kinase","Cytochrome P450 family 3","Jumonji domain-containing","Nucleotide-like receptor (family A 
GPCR)","Tudor domain","CMGC protein kinase group","Cytochrome P450 family 3A","Adenosine receptor","CMGC protein kinase MAPK family","Cytochrome P450 3A4","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Inositol phosphate turnover","Chromatin modifying enzymes","G protein-coupled receptors","SLC superfamily of solute carriers","Eicosanoid turnover","Kinases (EC 2.7.x.
x)","Cytochrome P450","Inositol monophosphatase","1.14.11.- Histone demethylases","Adenosine receptors","SLC65 NPC-type cholesterol transporters",Lipoxygenases,"Prostaglandin synthases","CMGC: Contain
ing CDK",MAPK,GSK3,"CLK families","CYP3 family","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Transport of small molecules","Cell Cycle","Metabolism of RNA","Immune System","Signaling by Rho GTPases","Inositol phosphate metabolism","Metabolism of amin
o acids and derivatives","Biological oxidations","Signaling by GPCR","Infectious disease","Plasma lipoprotein assembly",remodeling,"and clearance","Metabolism of lipids","Cell Cycle Checkpoints","Meta
bolism of non-coding RNA","Innate Immune System","Rho GTPase cycle","Synthesis of IP2",IP,"and Ins in the cytosol","Branched-chain amino acid catabolism","Phase I - Functionalization of compounds","GP
CR ligand binding","Leishmania infection","Plasma lipoprotein clearance","Biosynthesis of specialized proresolving mediators (SPMs)","G1/S DNA Damage Checkpoints","snRNP Assembly","Toll-like Receptor 
Cascades","RHOBTB GTPase Cycle","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","LDL clearance","Biosynthesis of DPA-derived SPMs","Biosynthesis of
 DHA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","Toll Like Receptor 5 (TLR5) Cascade","RHOBTB3 ATPase cycle","Nucleotide-like (purinergic) receptors","Anti-inflammatory response favourin
g Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","Biosynthesis of D-series resolvins","p53-Dependent G1 DNA Damage Response","MyD88 cascade initiated on plasma membrane","Biosynthesis of
 maresins","Adenosine P1 receptors","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of DPAn-3-derived protectins and resolvins","Stabilization of p53","MAP kinase activation","
Biosynthesis of maresin-like SPMs","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADORA1,ADORA2A,ADORA2B,ADORA3}

> <broad_moa>
{"adenosine receptor antagonist"}

> <synonyms>
{"Sch 58261",160098-96-4,160098964,Sch-58261,Sch58261,UNII-4309023MAH,UNII4309023MAH,CHEMBL17127,MFCD00933778,4309023MAH,"(3H)SCH 58261",GTPL403,GTPL431,SCHEMBL537287,ZINC6170,CHEBI:93424,AOB5053,DTXS
ID80166799,HMS3263L20,HMS3268F20,HMS3413A10,HMS3677A10,HMS3748I07,HMS3886N0,T6979,S8104,SCH58261}

> <pdid>
PD016768

> <targets>
{"Adenosine Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{176408}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 24  0  0  1  0            999 V2000
    6.4991   -0.7671    0.0000 C   0  0
    5.1972   -1.5121    0.0000 C   0  0
    3.8999   -0.7576    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1017   -6.1219    0.0000 S   0  0
    4.6332   -7.5468    0.0000 C   0  0
    3.1332   -7.5416    0.0000 C   0  0
    2.6747   -6.1134    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 O   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  2  0
 12  4  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
 22 12  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7652

> <plate>
1

> <well>
F13

> <supplier_cmpd_name>
Rotigotine

> <ctcr_id>
8201

> <supplier_cmpd_id>
S4274

> <smiles>
CCCN(CCc1sccc1)[C@H]2CCc3c(O)cccc3C2

> <pd_targets>
{DRD3,DRD5,DRD2,DRD4,HTR1A,ADRA2B}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Dopamine receptor","Serotonin receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","A
mine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Dopamine receptors","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors"
,Adrenoceptors}

> <broad_targets>
{ADRA2B,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{Rotigotine,99755-59-6,99755596,Neupro,Leganto,"SPM 962",(6S)-rotigotine,(6S)rotigotine,UNII-87T4T8BO2E,UNII87T4T8BO2E,SPM-962,SPM962,"N 0923",CHEMBL1303,87T4T8BO2E,"99755-59-6 (free base)","99755596 
(free base)","(6S)-6-(Propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol","(6S)6(Propyl(2(2thienyl)ethyl)amino)5,6,7,8tetrahydro1naphthalenol",NCGC00168748-01,NCGC0016874801,Rotigot,T6
647,S4274}

> <pdid>
PD004258

> <targets>
{Dopamine Receptor,5-HT Receptor,Adrenergic Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{59227}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 34 33  0  0  0  0            999 V2000
   15.1876   -4.1268    0.0000 H   0  3
   12.6876   -4.1268    0.0000 H   0  3
   10.1876   -4.1268    0.0000 Cl  0  5
    7.6876   -4.1268    0.0000 Cl  0  5
    2.5608  -12.0027    0.0000 O   0  0
    2.5691  -10.5028    0.0000 C   0  0
    3.8725   -9.7587    0.0000 C   0  0
    3.8808   -8.2579    0.0000 N   0  0
    5.1824   -7.5124    0.0000 C   0  0
    5.1876   -6.0124    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -5.2508    0.0000 C   0  0
   -2.5976   -6.0017    0.0000 F   0  0
    0.0003   -6.0004    0.0000 F   0  0
   -1.2983   -6.7508    0.0000 F   0  0
    2.5895   -6.0034    0.0000 C   0  0
    2.5844   -7.5034    0.0000 C   0  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 15  1  0
 28 23  1  0
 26 29  1  0
 29 30  1  0
 29 31  1  0
 29 32  1  0
 11 33  1  0
 33 34  1  0
 34  8  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7653

> <plate>
1

> <well>
F15

> <supplier_cmpd_name>
Fluphenazine (dihydrochloride)

> <ctcr_id>
1797

> <supplier_cmpd_id>
S4569

> <smiles>
[H+].[H+].[Cl-].[Cl-].OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1

> <pd_targets>
{RORC,UBE2N,RAD52,LMNA,MAPT,RECQL,NPSR1,TIM10,GAA,GLA,MAPK1,GMNN,CYP3A4,NFO,KMT2A,MEN1,PMP22,ADRA2C,HTR7,SCN1A,SCN2A,SCN3A,NFKB1,CYP2D6,CYP1A2,ADRA1A,HRH1,DRD2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY
8,HTR2C,HTR6,HTR2A,ATP2A1,TPR,AR,ADRA2A,DRD3,S,ALB,CHRM1,TP53,PDR5,ADRA1B,SIGMAR1,LEF,THPO,HTR1B,CHRM2,DRD4,ADRA2B,CHRM3,ABCB11,FFP,DRD5,HTR1A,KCNK2,REP,ADRA1D,ADRB3,HRH2,HTR2B,TACR2,ABCB1,ADORA3,SLC6
A3,SLC6A2,OPRK1,MTOR,OPRD1,OPRM1,KCNH2,EGFR,ERBB2,SLC6A4,MC5R,CHRM4,FYN,CALM1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other nuclear protein","Other cytosolic protein","Membrane receptor","Unclassified protein","Epigenetic regulator","Ion channel",Transporter,"Secreted protein","Nuclear
 receptor",Aminoacyltransferase,"Family A G protein-coupled receptor",Hydrolase,Kinase,"Cytochrome P450",Reader,"Voltage-gated ion channel",Lyase,"Primary active transporter",Oxidoreductase,Protease,T
ransferase,"Electrochemical transporter","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Protein Kinase","Cytochrome P450 family 3",Bromodomain,"Small molecule receptor (fam
ily A GPCR)","Voltage-gated sodium channel","Cytochrome P450 family 2","Cytochrome P450 family 1","P-type ATPase","Nuclear hormone receptor subfamily 3","Metallo protease","ATP-binding cassette","Pota
ssium channels","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","CMGC protein kinase group","Cytochrome P450 family 3A","Mo
noamine receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Calcium ATPase","Nuclear hormone receptor subfamily 3 group C","Metallo protease MAE clan","ABCB subfamily","Two-pore domain 
potassium channel","Nucleotide-like receptor (family A GPCR)","SLC06 neurotransmitter transporter family","Atypical protein kinase group","Voltage-gated potassium channel","TK protein kinase group","N
uclear hormone receptor subfamily 1 group F member 3","Neuropeptide receptor","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Adrenergic receptor","Serotonin receptor","Cytochrome P450 2D6","
Cytochrome P450 1A1","Histamine receptor","Dopamine receptor","Nuclear hormone receptor subfamily 3 group C member 4","Acetylcholine receptor","Metallo protease M34 family","Neurokinin receptor","Aden
osine receptor","Opioid receptor","Atypical protein kinase PIKK family","Tyrosine protein kinase EGFR family","Melanocortin receptor","Tyrosine protein kinase Src family","CMGC protein kinase ERK1","A
typical protein kinase FRAP subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","Ion channels","Nuclear hormone receptors","G protein-coupled receptors","3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","Cytochrome P450","P-type
 ATPases","Sigma receptors","Anti-infective targets","ATP-binding cassette transporter family","Voltage-gated ion channels","SLC superfamily of solute carriers","Catalytic receptors","1F. Retinoic aci
d-related orphans","Neuropeptide S receptor","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family",Adrenoceptors,"5-Hydroxytryptamine receptors","CYP2 family: drug metabolising subset","CYP1 f
amily","Histamine receptors","Dopamine receptors","P2A P-type ATPases: Ca<sup>2+</sup>-ATPases","Steroid hormone receptors","Acetylcholine receptors (muscarinic)","Viral protein targets","ABCB subfami
ly","Potassium channels","Tachykinin receptors","Adenosine receptors","SLC6 neurotransmitter transporter family","Opioid receptors",Atypical,"Receptor kinases","Melanocortin receptors","Mitogen-activa
ted protein kinases (MAP kinases)","3C. 3-Ketosteroid receptors","Coronavirus (CoV) proteins","Two P domain potassium channels","Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-relat
ed kinases (PIKK) family","Voltage-gated potassium channels","TK: Tyrosine kinase","ERK subfamily","FRAP subfamily","Receptor tyrosine kinases (RTKs)","Non-receptor tyrosine kinases (nRTKs)","Type I R
TKs: ErbB (epidermal growth factor) receptor family","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Immune System","DNA Repair","Cell Cycle","Neuronal System",Disease,Metabolism,"Developmental Biology","Signal Transduction",Hemostasis,"Muscle contraction","RNA Pol
ymerase II Transcription","Innate Immune System","DNA Double-Strand Break Repair",Mitotic,"Transmission across Chemical Synapses","Infectious disease","Diseases of metabolism","Metabolism of lipids","
Nervous system development","Signaling by GPCR","Cytokine Signaling in Immune system","Biological oxidations","Platelet homeostasis","Cell Cycle Checkpoints","Platelet activation","signaling and aggre
gation","Potassium Channels","Abacavir transport and metabolism","Disorders of transmembrane transporters","Cardiac conduction","Generic Transcription Pathway","Toll-like Receptor Cascades","Homology 
Directed Repair","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","Diseases of carbohydrate metabolism","Sphingolipid metabolism","Mitotic G1 phase an
d G1/S transition","Biosynthesis of specialized proresolving mediators (SPMs)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR ligand binding","Signaling by Interleukins","Phase
 I - Functionalization of compounds","Platelet calcium homeostasis","Metabolism of steroids","G1/S DNA Damage Checkpoints","SARS-CoV Infections","Uptake and actions of bacterial toxins","Platelet Aggr
egation (Plug Formation)","Tandem pore domain potassium channels","Abacavir transmembrane transport","SLC transporter disorders","GPCR downstream signalling","Phase 3 - rapid repolarisation","Axon gui
dance","Neurotransmitter clearance","HIV Infection","Transcriptional regulation by RUNX3","Toll Like Receptor 4 (TLR4) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (
SSA)","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","Leishmania parasite growth and survival","Glycogen storage diseases","Glycosphingolipid metabolism","Toll
 Like Receptor 5 (TLR5) Cascade","G1/S Transition","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","Cytochrome P450 - arranged by substrate t
ype","Reduction of cytosolic Ca++ levels","Transcriptional regulation by RUNX2","Bile acid and bile salt metabolism","p53-Dependent G1/S DNA damage checkpoint","Potential therapeutics for SARS","SARS-
CoV-1 Infection","Uptake and function of anthrax toxins","TWIK related potassium channel (TREK)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Defective SLC6A2 causes orthostatic 
intolerance (OI)","Transcriptional Regulation by MECP2","Transcriptional Regulation by TP53","G alpha (i) signalling events","G alpha (q) signalling events","Semaphorin interactions","Serotonin cleara
nce from the synaptic cleft","Host Interactions of HIV factors","RUNX3 Regulates Immune Response and Cell Migration","MyD88-independent TLR4 cascade","HDR through Single Strand Annealing (SSA)","Mitot
ic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection","Glycogen storage disease type II (GAA)","MyD88 cascade initiated on plasma mem
brane","Activation of the pre-replicative complex","Biosynthesis of maresins","Amine ligand-binding receptors","Interleukin-1 signaling",Xenobiotics,"RUNX2 regulates bone development","Recycling of bi
le acids and salts","p53-Dependent G1 DNA Damage Response","Translation of structural proteins","Synthesis of bile acids and bile salts","SARS-CoV-1 Genome Replication and Transcription","Peptide liga
nd-binding receptors","Nucleotide-like (purinergic) receptors","MECP2 regulates neuronal receptors and channels","Regulation of TP53 Activity","Opioid Signalling","Gastrin-CREB signalling pathway via 
PKC and MAPK","Sema4D in semaphorin signaling","The role of Nef in HIV-1 replication and disease pathogenesis","TRIF(TICAM1)-mediated TLR4 signaling","Nuclear Envelope (NE) Reassembly","Activation of 
AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","Biosynthesis of maresin-like SPMs",Adrenoceptors,"MAP3K8 (TPL2)-dependent MAPK1/3 activati
on","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Histamine receptors","Dopamine receptors","Serotonin receptors","RUNX2 regulates osteoblast differentiation",
"Muscarinic acetylcholine receptors","Stabilization of p53","Maturation of spike protein","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Replication of the SARS-CoV-1 genome",
"Tachykinin receptors bind tachykinins","Adenosine P1 receptors","Regulation of TP53 Expression and Degradation","G-protein activation","EGFR Transactivation by Gastrin","Sema4D induced cell migration
 and growth-cone collapse","Nef and signal transduction","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","IKK complex recruitment mediated by RIP1","Initiation of Nu
clear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","Ras activation upon Ca2+ inf
lux through NMDA receptor","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CALM1,DRD1,DRD2,DRD5,HRH1,HTR2A,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{AKOS024366260,MCULE-5539512526,MCULE5539512526,"MCULE 5539512526",ST50999687,"Fluphenazine dihydrochloride","Fluphenazine hydrochloride",146-56-5,146565,"146 56 5",Prolixin,Anatensol,Moditen,Permitil
,"Fluphenazine (dihydroch",S4569,Prestw-320,"Fluphenazine (dihydrochloride)"}

> <pdid>
PD009883

> <targets>
{Dopamine Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{43834425,67356,71777408}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 10  9  0  0  1  0            999 V2000
    2.5968    2.9990    0.0000 C   0  0
    3.8969    2.2508    0.0000 N   0  0
    3.9000    0.7500    0.0000 C   0  0  2  0  0  0
    2.6000    0.0000    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    1.3000    2.2500    0.0000 O   0  0
    0.0007    0.0004    0.0000 O   0  0
    5.2000    0.0000    0.0000 C   0  0
    5.2000   -1.5000    0.0000 O   0  0
    6.4992    0.7496    0.0000 O   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  3  8  1  0
  8  9  1  0
  8 10  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7654

> <plate>
1

> <well>
F17

> <supplier_cmpd_name>
NMDA (N-Methyl-D-aspartic acid)

> <ctcr_id>
2964

> <supplier_cmpd_id>
S7072

> <smiles>
CN[C@H](CC(O)=O)C(O)=O

> <pd_targets>
{GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,HSD17B10,TSHR,CYP1A2,ALDH1A1,FFP,KDM4E,CHRM1,HPN}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Membrane receptor","Epigenetic regulator","Ligand-gated ion channel",Oxidoreductase,"Family A G protein-coupled receptor","Cytochrome P450",Transferase,Eraser,Protease,"Ionotrop
ic glutamate receptor","Peptide receptor (family A GPCR)","Cytochrome P450 family 1","Lysine demethylase","Small molecule receptor (family A GPCR)","Serine protease","NMDA receptor","Glycohormone rece
ptor","Cytochrome P450 family 1A","Jumonji domain-containing","Monoamine receptor","Serine protease PA clan","Cytochrome P450 1A1","Acetylcholine receptor","Serine protease S1A subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Cytochrome P450","Chromatin modifying enzymes","Ligand-gated ion channels","Glycoprotein hormone receptors","CYP1 family","1.14.11.- Hi
stone demethylases","Acetylcholine receptors (muscarinic)","Ionotropic glutamate receptors"}

> <pathway_reactome>
{Metabolism,Disease,"Signal Transduction","Neuronal System","Metabolism of amino acids and derivatives","Infectious disease","Biological oxidations","Signaling by GPCR","Signaling by Receptor Tyrosine
 Kinases","Transmission across Chemical Synapses","Branched-chain amino acid catabolism","Leishmania infection","Phase I - Functionalization of compounds","GPCR ligand binding","Signaling by MET","Neu
rotransmitter receptors and postsynaptic signal transmission","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Ethanol oxidation","Class A/1 (Rhodopsin-like re
ceptors)","MET Receptor Activation","Activation of NMDA receptors and postsynaptic events","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Amine ligand-binding recept
ors","Post NMDA receptor activation events","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine recep
tors","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Long-term potentiation","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D}

> <broad_moa>
{"glutamate receptor agonist"}

> <synonyms>
{"NmethylDaspartic acid",NMDA,6384-92-5,6384925,N-Methylaspartate,NMethylaspartate,N-Methyl-D-aspartate,NMethylDaspartate,"D-Aspartic acid, N-methyl-","DAspartic acid, Nmethyl","Methyl aspartic acid",
"n-methyl-d-aspartic acid (nmda)","nmethyldaspartic acid (nmda)","(R)-2-(Methylamino)succinic acid","(R)2(Methylamino)succinic acid","NMDA (N-Methyl-D-aspartic acid)","NMDA (NMethylDaspartic acid)",UN
II-1903B9Q6,UNII1903B9Q6,T6608,S7072,1503636,"N-METHYL-D-ASPARTIC ACID (NMDA)"}

> <pdid>
PD000968

> <targets>
{GluR,Endogenous Metabolite,iGluR}

> <classes>
{NMDA agonist,Neuronal Signaling,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease}

> <pubchem_cids>
{22880}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 27  0  0  0  0            999 V2000
   12.9019    0.0313    0.0000 C   0  0
   11.4019    0.0261    0.0000 C   0  0
   10.5245   -1.1905    0.0000 O   0  0
    9.0971   -0.7319    0.0000 C   0  0
    7.8007   -1.4864    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 N   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.4939    0.7591    0.0000 C   0  0
    7.7903    1.5136    0.0000 C   0  0
    9.0919    0.7681    0.0000 C   0  0
   10.5161    1.2366    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 11  1  0
 20 15  1  0
  6 21  2  0
 21 22  1  0
 22 23  2  0
 23  4  1  0
 23 24  1  0
 24  2  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7655

> <plate>
1

> <well>
F19

> <supplier_cmpd_name>
SB-334867

> <ctcr_id>
8202

> <supplier_cmpd_id>
S7585

> <smiles>
Cc1oc2cc(NC(=O)Nc3ccnc4cccnc34)ccc2n1

> <pd_targets>
{HCRTR2,HTR2C,MAPT,MAPK1,CYP3A4,CYP1A2,HTR2B,ADORA2A,HCRTR1,KMT2A,MEN1,CYP2C19,CYP2D6,ALDH1A1,TP53}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Epigenetic regulator","Transcription factor","Family A G protein-coupled receptor",Kinase,"Cytochrome P450",Reader,Oxidoreductase,"Peptide recept
or (family A GPCR)","Small molecule receptor (family A GPCR)","Protein Kinase","Cytochrome P450 family 3","Cytochrome P450 family 1",Bromodomain,"Cytochrome P450 family 2","Short peptide receptor (fam
ily A GPCR)","Monoamine receptor","CMGC protein kinase group","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 family 2C","Cytochrome
 P450 family 2D","Orexin receptor","Serotonin receptor","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Cytochrome P450 1A1","Adenosine receptor","Cytochrome P450 2C19","Cytochrome P450 2D6",
"CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cytochrome P450","Orexin receptors","5-Hydroxytryptamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 famil
y","CYP1 family","Adenosine receptors","CYP2 family: drug metabolising subset","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System","Immune System",Metabolism,Disease,"Cell Cycle","Signaling by GPCR","Transmission across Chemical Synapses","Innate Immune System","Metabolism of lipids","Biol
ogical oxidations","Infectious disease","Cell Cycle Checkpoints","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades","Biosynthesis of 
specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Leishmania infection","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","Activation of NMDA re
ceptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Etha
nol oxidation","p53-Dependent G1/S DNA damage checkpoint","Peptide ligand-binding receptors","Amine ligand-binding receptors","Post NMDA receptor activation events","MyD88 cascade initiated on plasma 
membrane","Biosynthesis of maresins",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","p53-Dependent G1 DNA Damage Response","Orexin and neuropeptides FF and QRFP bind 
to their respective receptors","Serotonin receptors","Activation of AMPK downstream of NMDARs","MAP kinase activation","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-d
ealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Stabilization of p53","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the
 E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{HCRTR1,HCRTR2}

> <broad_moa>
{"orexin receptor antagonist"}

> <synonyms>
{B33486,792173-99-0,792173990,SB-334867,SB334867,"1-(2-methylbenzo(d)oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea","1(2methylbenzo(d)oxazol6yl)3(1,5naphthyridin4yl)urea",249889-64-3,249889643,"SB-334867
 free base","SB334867 free base","SB 334867","SB-334867 (free base)","SB334867 (free base)","SB334867A free base",N-(2-methyl-6-benzoxazolyl)-N'-1,N(2methyl6benzoxazolyl)N'1,5-naphthyridin-4-yl-Urea,5
naphthyridin4ylUrea,T6140,S7585}

> <pdid>
PD012915

> <targets>
{"OX Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{6604926}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 41 43  0  0  1  0            999 V2000
    7.7808  -10.5183    0.0000 C   0  0
    6.4833   -9.7656    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 S   0  0
   -3.8976    0.7500    0.0000 O   0  0
   -3.8982    2.2498    0.0000 O   0  0
   -2.5998    3.0012    0.0000 N   0  0
   -3.8995    3.7516    0.0000 C   0  0
   -3.9027    5.2517    0.0000 C   0  0
   -5.2032    5.9990    0.0000 C   0  0
   -6.5007    5.2464    0.0000 C   0  0
   -7.8036    5.9914    0.0000 C   0  0
   -9.1007    5.2365    0.0000 C   0  0
  -10.4035    5.9816    0.0000 N   0  0
  -11.7007    5.2267    0.0000 C   0  0
  -13.0035    5.9718    0.0000 C   0  0  2  0  0  0
  -13.0092    7.4718    0.0000 O   0  0
  -14.3006    5.2169    0.0000 C   0  0
  -15.6034    5.9620    0.0000 O   0  0
  -16.9006    5.2070    0.0000 C   0  0
  -18.2038    5.9498    0.0000 C   0  0
  -19.4987    5.1927    0.0000 C   0  0
  -19.4904    3.6927    0.0000 C   0  0
  -20.7853    2.9356    0.0000 O   0  0
  -18.1873    2.9499    0.0000 C   0  0
  -16.8924    3.7070    0.0000 C   0  0
   -6.4977    3.7464    0.0000 C   0  0
   -5.1971    2.9990    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  2  0
 17 19  2  0
 17 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  1
 29 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 36 38  1  0
 38 39  2  0
 39 33  1  0
 24 40  1  0
 40 41  2  0
 41 21  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7656

> <plate>
1

> <well>
F21

> <supplier_cmpd_name>
L755507

> <ctcr_id>
8203

> <supplier_cmpd_id>
S7974

> <smiles>
CCCCCCNC(=O)Nc1ccc(cc1)[S](=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{159182-43-1,159182431,L755507,L-755507,"L-755,507","L755,507","L 755507",CHEMBL12998,GTPL3931,SCHEMBL5165122,HMS3413M07,HMS3677M07,HMS3886B21,EX-A2397,EXA2397,ZINC3939153,BDBM50070156,s7974,AKOS02445
6983,CCG-270146,CCG270146,CP-0074,CP0074,CS-7782,CS7782,NCGC00092331-01,NCGC0009233101,AC-32762,AC32762,HY-19334,HY19334,F10055,L75,T6872,S7974}

> <pdid>
PD017083

> <targets>
{adrenergic receptor,Adrenergic Receptor,CRISPR/Cas9}

> <classes>
{GPCR & G Protein,Cell Cycle/DNA Damage,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{9829836}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 31 29  0  0  0  0            999 V2000
   16.4904   -0.0057    0.0000 H   0  3
   13.9904   -0.0057    0.0000 H   0  3
   11.4904   -0.0057    0.0000 Cl  0  5
    8.9904   -0.0057    0.0000 Cl  0  5
    6.4897   -5.2632    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5109    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5998    1.4986    0.0000 C   0  0
   -3.8983    0.7460    0.0000 C   0  0
   -3.8989   -0.7540    0.0000 C   0  0
   -5.1982   -1.5035    0.0000 C   0  0
   -6.4970   -0.7530    0.0000 C   0  0
   -6.4964    0.7470    0.0000 C   0  0
   -5.1971    1.4965    0.0000 C   0  0
   -2.6013    2.9994    0.0000 C   0  0
   -1.3046    3.7535    0.0000 C   0  0
   -1.3092    5.2535    0.0000 C   0  0
   -2.6105    5.9995    0.0000 C   0  0
   -2.6152    7.4995    0.0000 Cl  0  0
   -3.9073    5.2455    0.0000 C   0  0
   -3.9027    3.7455    0.0000 C   0  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 18 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 31 25  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7657

> <plate>
1

> <well>
G03

> <supplier_cmpd_name>
Cetirizine DiHCl

> <ctcr_id>
5318

> <supplier_cmpd_id>
S1291

> <smiles>
[H+].[H+].[Cl-].[Cl-].OC(=O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3

> <pd_targets>
{HRH1,TEK,KCNH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel",Protease,"Family A G protein-coupled receptor",Kinase,"Voltage-gated ion channel","Cysteine protease","Small molecule receptor (family A GPCR)","Protein Kinas
e","Potassium channels","Cysteine protease CA clan","Monoamine receptor","TK protein kinase group","Voltage-gated potassium channel","Cysteine protease C1A family","Histamine receptor","Tyrosine prote
in kinase Tie family"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Catalytic receptors","Voltage-gated ion channels","Histamine receptors","Receptor kinases","Potassium channels","TK: Tyrosine kinase","Voltage-
gated potassium channels","Receptor tyrosine kinases (RTKs)","Type XII RTKs: TIE family of angiopoietin receptors"}

> <pathway_reactome>
{"Signal Transduction","Muscle contraction","Signaling by GPCR","MAPK family signaling cascades","Cardiac conduction","GPCR ligand binding","MAPK1/MAPK3 signaling","Phase 3 - rapid repolarisation","Cl
ass A/1 (Rhodopsin-like receptors)","RAF/MAP kinase cascade","Amine ligand-binding receptors","Histamine receptors"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{"Cetirizine dihydrochloride",83881-52-1,83881521,"CETIRIZINE HYDROCHLORIDE",Zyrtec,Reactine,"Cetirizine diHCl",Alerlisin,Virlix,Zirtek,"P 071",P-071,P071,"Cetirizine (dihydrochloride)","83881-52-1 (H
Cl)","83881521 (HCl)",C21H27Cl3N2O3,Zerviate,Cetirigamma,A,S1291,1505371,Prestw-503,"Cetirizine DiHCl"}

> <pdid>
PD003052

> <targets>
{Histamine Receptor}

> <classes>
{H1 antihistamine,Neuronal Signaling,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{55182,44659863,57515953}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 29  0  0  1  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -6.4952    0.7500    0.0000 C   0  0
   -7.7942    1.4999    0.0000 C   0  0
   -7.7943    2.9999    0.0000 C   0  0
   -9.0956    3.7477    0.0000 O   0  0
  -10.3935    2.9958    0.0000 C   0  0
   -6.4952    3.7500    0.0000 C   0  0
   -6.4983    5.2508    0.0000 O   0  0
   -7.7984    5.9989    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 13 12  1  6
 13  8  1  0
 13 14  1  0
 14  5  2  0
 14 15  1  0
 15 16  2  0
 16  3  1  0
 16 17  1  0
 17 18  1  0
 11 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 21 24  2  0
 24 10  1  0
 24 25  1  0
 25 26  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7658

> <plate>
1

> <well>
G04

> <supplier_cmpd_name>
Rotundine

> <ctcr_id>
7214

> <supplier_cmpd_id>
S2437

> <smiles>
COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC

> <pd_targets>
{TSHR,LMNA,LEF,SIGMAR1,CYP3A4,F3,DRD3,DRD2,DRD5}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein",Enzyme,"Family A G protein-coupled receptor",Protease,"Cytochrome P450","Peptide receptor (family A GPCR)","Metallo protease","Cytochrome P450 family 3","S
mall molecule receptor (family A GPCR)","Glycohormone receptor","Metallo protease MAE clan","Cytochrome P450 family 3A","Monoamine receptor","Metallo protease M34 family","Cytochrome P450 3A4","Dopami
ne receptor"}

> <pathway_chembl>
{Receptors,"Other protein targets",Enzymes,"G protein-coupled receptors","Sigma receptors","Cytochrome P450","Glycoprotein hormone receptors","CYP3 family","Dopamine receptors"}

> <pathway_reactome>
{Disease,"Cell Cycle",Metabolism,"Signal Transduction","Infectious disease",Mitotic,"Metabolism of lipids","Signaling by Receptor Tyrosine Kinases","Signaling by GPCR","Leishmania infection","M Phase"
,"Uptake and actions of bacterial toxins","SARS-CoV Infections","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by NTRKs","GPCR ligand binding","Leishmania parasite growth and s
urvival","Mitotic Metaphase and Anaphase","Uptake and function of anthrax toxins","Potential therapeutics for SARS","Biosynthesis of DHA-derived SPMs","Signaling by NTRK1 (TRKA)","Class A/1 (Rhodopsin
-like receptors)","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Biosynthesis of maresins","Nuclear Events (kinase and transcription factor activation)","Amin
e ligand-binding receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","NGF-stimulated transcription","Dopamine re
ceptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{DRD1,DRD2,DRD3,HTR1A}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{tetrahydropalmatine,Rotundine,l-Tetrahydropalmatine,lTetrahydropalmatine,483-14-7,483147,(-)-Tetrahydropalmatine,()Tetrahydropalmatine,(S)-Tetrahydropalmatine,(S)Tetrahydropalmatine,Gindarine,Hyndari
ne,Caseanine,(S)-(-)-tetrahydropalmatine,(S)()tetrahydropalmatine,UNII-3X69CO5I79,UNII3X69CO5I79,CHEBI:16563,3X69CO5I79,2,3,9,10-tetramethoxy-13aalpha-berbine,10tetramethoxy13aalphaberbine,T2917,T2714
,T2793,S2437,"Tetrahydropalmatine hydrochloride",Tetrahydropalmatine}

> <pdid>
PD001244

> <targets>
{Dopamine Receptor,Apoptosis}

> <classes>
{Neuronal Signaling,Apoptosis,GPCR/G Protein}

> <pubchem_cids>
{72301}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 30  0  0  0  0            999 V2000
   10.0885   -4.5769    0.0000 C   0  0
    9.5757   -3.1673    0.0000 C   0  0
    8.0979   -2.9056    0.0000 O   0  0
    7.5847   -1.4952    0.0000 C   0  0
    8.5494   -0.3466    0.0000 O   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
    1.0157    5.5663    0.0000 Cl  0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  2  3
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 13  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 12  1  0
 27 22  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7659

> <plate>
1

> <well>
G05

> <supplier_cmpd_name>
Loratadine

> <ctcr_id>
2087

> <supplier_cmpd_id>
S1358

> <smiles>
CCOC(=O)N1CCC(CC1)=C2c3ccc(Cl)cc3CCc4cccnc24

> <pd_targets>
{MAPK1,HRH1,CYP2C19,BLM,NPSR1,KCNH2,KMT2A,MEN1,LMNA,PMP22,TP53,CYP2C9,GMNN,CYP2C8,MAPT,ALOX15,THPO,TSHR,NR1H4,SLC6A15,CYP3A4,HIF1A,CHRM1,CYP2D6,RORC,NR1I2,ABCB1,MTOR,ABCB11,KCNK9,CACNA1C,CACNA1D,CACNA
1F,CACNA1S,HTR2B}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel","Epigenetic regulator","Other nuclear protein","Unclassified protein","Transcription factor","Other cytosolic protein",Transporter,Kinase,"Family A G protein-
coupled receptor",Protease,"Cytochrome P450","Voltage-gated ion channel",Reader,Oxidoreductase,"Nuclear receptor","Electrochemical transporter","Primary active transporter","Protein Kinase","Small mol
ecule receptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Potassium channels",Bromodomain,"Nuclear hormone receptor subfamily 1","SLC superfami
ly of solute carriers","Cytochrome P450 family 3","ATP-binding cassette","Voltage-gated calcium channel","CMGC protein kinase group","Monoamine receptor","Cysteine protease CA clan","Cytochrome P450 f
amily 2C","Short peptide receptor (family A GPCR)","Voltage-gated potassium channel","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group H","SLC06 neurotransmitter transporter family",
"Cytochrome P450 family 3A","Cytochrome P450 family 2D","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group I","ABCB subfamily","Atypical protein kinase group","
Two-pore domain potassium channel","CMGC protein kinase MAPK family","Histamine receptor","Cysteine protease C1A family","Cytochrome P450 2C19","Neuropeptide receptor","Cytochrome P450 2C9","Cytochrom
e P450 2C8","Nuclear hormone receptor subfamily 1 group H member 4","Cytochrome P450 3A4","Acetylcholine receptor","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 1 group F member 3","Nuclea
r hormone receptor subfamily 1 group I member 2","Atypical protein kinase PIKK family","Serotonin receptor","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","Voltage-gated ion channels","Eicosanoid turnover","Nuclear hormone receptors","SL
C superfamily of solute carriers","ATP-binding cassette transporter family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Histamine receptors","CYP2 family: drug metabolising subset","Neuropeptide 
S receptor","Potassium channels",Lipoxygenases,"Glycoprotein hormone receptors","1H. Liver X receptor-like receptors","SLC6 neurotransmitter transporter family","CYP3 family","Acetylcholine receptors 
(muscarinic)","1F. Retinoic acid-related orphans","1I. Vitamin D receptor-like receptors","ABCB subfamily",Atypical,"5-Hydroxytryptamine receptors","Mitogen-activated protein kinases (MAP kinases)","V
oltage-gated potassium channels","Neutral amino acid transporter subfamily","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Two P domain potassium channels","ERK subfamily","FRAP subf
amily"}

> <pathway_reactome>
{"Immune System","Signal Transduction",Metabolism,"DNA Repair",Disease,"Muscle contraction","Cell Cycle","Developmental Biology","Neuronal System",Hemostasis,"Transport of small molecules","Cellular r
esponses to external stimuli","Gene expression (Transcription)","Metabolism of proteins","Innate Immune System","Signaling by GPCR","Biological oxidations","DNA Double-Strand Break Repair","Infectious
 disease","Cardiac conduction",Mitotic,"Nervous system development","Cell Cycle Checkpoints","Transmission across Chemical Synapses","Metabolism of lipids","Platelet activation","signaling and aggrega
tion","SLC-mediated transmembrane transport","Cellular responses to stress","RNA Polymerase II Transcription","Post-translational protein modification","Abacavir transport and metabolism","Potassium C
hannels","Toll-like Receptor Cascades","GPCR ligand binding","Phase I - Functionalization of compounds","Homology Directed Repair","Leishmania infection","Phase 3 - rapid repolarisation","M Phase","EG
R2 and SOX10-mediated initiation of Schwann cell myelination","G1/S DNA Damage Checkpoints","Mitotic G1 phase and G1/S transition","Neurotransmitter receptors and postsynaptic signal transmission","Bi
osynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug Formation)","Metabolism of steroids","Transport of bile salts and organic acids","metal ions and amine compounds","
Cellular response to hypoxia","Generic Transcription Pathway",SUMOylation,"Abacavir transmembrane transport","Tandem pore domain potassium channels","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (R
hodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Mitoti
c Metaphase and Anaphase","p53-Dependent G1/S DNA damage checkpoint","G1/S Transition","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","Bile acid and bile sal
t metabolism","Na+/Cl- dependent neurotransmitter transporters","Biosynthesis of DHA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional regulatio
n by RUNX3","SUMO E3 ligases SUMOylate target proteins","Transcriptional Regulation by TP53","TWIK-releated acid-sensitive K+ channel (TASK)","MyD88 cascade initiated on plasma membrane","Amine ligand
-binding receptors",Xenobiotics,"HDR through Homologous Recombination (HRR)","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","p53-Dependent G1 DNA Damage Respon
se","Activation of the pre-replicative complex","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","Synthesis of bile acids and bile salts","Biosynthesis of maresins","RUNX3 Regulate
s Immune Response and Cell Migration","SUMOylation of intracellular receptors","Regulation of TP53 Activity","MAP kinase activation","Histamine receptors","CYP2E1 reactions","Homologous DNA Pairing an
d Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Stabilization of p53","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3
-derived protectins and resolvins","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Biosynthesis of maresin-like SPMs","Muscarinic acetylcholine receptors","Regulation of TP53 Expre
ssion and Degradation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Serotonin receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homolog
ous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are i
nactivated"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{loratadine,79794-75-5,79794755,Claritin,Loratidine,Alavert,Clarityn,Lisino,Clarityne,Loracert,Loradex,Bonalerg,Claritine,Fristamin,Histaloran,Lertamine,Lorastine,Civeran,Loranox,Versal,"Sch 29851",An
hissen,Sch-29851,Sch29851,UNII-7AJO3BO7QN,UNII7AJO3BO7QN,MFCD00672869,C22H23Cl,T1097,S1358,SAM001246987,1503712,Prestw-1432,Loratadine,CPD000058255,LORATADINE}

> <pdid>
PD000883

> <targets>
{Histamine Receptor,Influenza Virus}

> <classes>
{H1 antihistamine,Neuronal Signaling,Anti-infection,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{3957}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 12 10  0  0  0  0            999 V2000
   10.2999    1.1254    0.0000 Cl  0  5
    3.9000    2.2500    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    1.3000    0.7500    0.0000 N   0  3
    0.0007    0.0004    0.0000 C   0  0
    0.0011    1.5002    0.0000 C   0  0
    1.3000    2.2500    0.0000 C   0  0
    5.2000    0.0000    0.0000 O   0  0
    6.5000    0.7500    0.0000 C   0  0
    6.5000    2.2500    0.0000 N   0  0
    7.7992    0.0004    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
M  CHG  2   1  -1   5   1
M  END
> <name>
Selleck_GPCR

> <id>
7660

> <plate>
1

> <well>
G06

> <supplier_cmpd_name>
Bethanechol chloride

> <ctcr_id>
5050

> <supplier_cmpd_id>
S2455

> <smiles>
[Cl-].CC(C[N+](C)(C)C)OC(N)=O

> <pd_targets>
{CHRM2,LMNA,MAPT,CHRM1,CHRM3,CHRM4,CHRM5,GPM2,GPM3,TSHR}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein","Other cytosolic protein","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Monoamine rec
eptor","Glycohormone receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Signal Transduction","Cell Cycle","Neuronal System",Disease,"Signaling by GPCR",Mitotic,"Transmission across Chemical Synapses","Infectious disease","GPCR ligand binding","M Phase","Neurotransmitter
 receptors and postsynaptic signal transmission","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","
Leishmania parasite growth and survival","Amine ligand-binding receptors","Mitotic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection"
,"Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Enve
lope (NE) Reformation"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{"Bethanechol chloride",590-63-6,590636,Urecholine,Myocholine,"Carbamyl-beta-methylcholine chloride","Carbamylbetamethylcholine chloride",Besacholine,Mechotane,Mechothane,Mecothane,Mictone,Mictrol,Duv
oid,"Bethanechol (chloride)",Uro-Carb,UroCarb,"Urecholine chloride","Carbamylmethylcholine chlori",T3126,S2455,SAM002548931,1500146,Prestw-1073,CPD000058680,"BETHANECHOL CHLORIDE"}

> <pdid>
PD009590

> <targets>
{AChR,mAChR}

> <classes>
{cholinergic,Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{11548}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 30  0  0  0  0            999 V2000
    8.8990    5.2680    0.0000 H   0  3
    6.3990    5.2680    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.3022    5.2508    0.0000 N   0  0
   -0.0044    6.0031    0.0000 C   0  0
   -2.6030    5.9994    0.0000 C   0  0
   -2.6061    7.5002    0.0000 C   0  0
   -3.9069    8.2488    0.0000 C   0  0
   -3.9100    9.7496    0.0000 N   0  0
   -5.2108   10.4981    0.0000 C   0  0
   -6.5086    9.7459    0.0000 O   0  0
   -5.2139   11.9989    0.0000 C   0  0
   -6.4275   12.8588    0.0000 C   0  0
   -5.9640   14.2853    0.0000 C   0  0
   -4.4640   14.2854    0.0000 C   0  0
   -4.0004   12.8588    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13  7  1  0
 13 14  1  0
 14 15  2  0
 15  5  1  0
 15 16  1  0
 16 17  1  0
  9 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 26  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7661

> <plate>
1

> <well>
G07

> <supplier_cmpd_name>
Alfuzosin HCl

> <ctcr_id>
1816

> <supplier_cmpd_id>
S1409

> <smiles>
[H+].[Cl-].COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3

> <pd_targets>
{ADRA1B,ADRA1A,HSD17B10,GLA,GAA,ADRA1D,KDM4E,ACHE,ALDH1A1,HPGD,KCNH2,SLC22A1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Ion channel",Transporter,"Family A G protein-coupled receptor",Oxidoreductase,Hydrolase,Eraser,"Voltage-gated ion channel","Electrochemical transpor
ter","Small molecule receptor (family A GPCR)","Lysine demethylase","Potassium channels","SLC superfamily of solute carriers","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium 
channel","SLC22 family of organic cation and anion transporters","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","3.2.1.- Glycosidases","Chromatin modifying enzymes","Acetylcholine turnover","Eicosanoid turnover","Voltage-gated ion chan
nels","SLC superfamily of solute carriers",Adrenoceptors,"1.14.11.- Histone demethylases","Prostaglandin synthases","Potassium channels","SLC22 family of organic cation and anion transporters","Voltag
e-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Muscle contraction","Transport of small molecules","Signaling by GPCR","Metabolism of amino acids and derivatives","Metabolism of lipids","Diseases of metabo
lism","Biological oxidations","Cardiac conduction","SLC-mediated transmembrane transport","GPCR ligand binding","Branched-chain amino acid catabolism","Sphingolipid metabolism","Diseases of carbohydra
te metabolism","Phospholipid metabolism","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Phase 3 - rapid repolarisation","Transport of bile salt
s and organic acids","metal ions and amine compounds","Class A/1 (Rhodopsin-like receptors)","Glycosphingolipid metabolism","Glycogen storage diseases","Glycerophospholipid biosynthesis","Ethanol oxid
ation","Biosynthesis of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Amine ligand-binding receptors","Glycogen storage disease type II (GAA)","Synthesis of PC","Biosynthesis of D-ser
ies resolvins","Organic cation transport",Adrenoceptors}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Uroxatral,CHEBI:32286,AKOS026749786,"Alfuzosin Hydrochloride",81403-68-1,81403681,"81403 68 1","Alfuzosin HCl",Xatral,Urion,Alfoten,"Alfuzosin (hydrochloride)","SL 77 499-10","SL 77 49910","SL 77 499
 10","Alfuzosin hydrochloride",S1409,Prestw-322,"Alfuzosin HCl"}

> <pdid>
PD003155

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{25137863,71764}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 37  0  0  0  0            999 V2000
   12.7943   -3.0140    0.0000 H   0  3
   10.2943   -3.0140    0.0000 Cl  0  5
    6.4876   -5.2643    0.0000 C   0  0
    6.4912   -3.7643    0.0000 N   0  0
    7.7922   -3.0178    0.0000 C   0  0
    5.1937   -3.0100    0.0000 C   0  0
    4.3263   -3.5077    0.0000 O   0  0
    5.1972   -1.5092    0.0000 C   0  0
    3.8990   -0.7562    0.0000 C   0  0
    3.9012    0.7447    0.0000 C   0  0
    2.6029    1.4977    0.0000 N   0  0
    1.3008    0.7531    0.0000 C   0  0
    0.0049    1.5084    0.0000 C   0  0
    0.0110    3.0084    0.0000 C   0  0
   -1.2731    2.2332    0.0000 O   0  0
    1.3132    3.7531    0.0000 C   0  0
    2.6091    2.9977    0.0000 C   0  0
    0.0519    4.4885    0.0000 C   0  0
    1.3711    5.2023    0.0000 C   0  0
    1.4125    6.7018    0.0000 C   0  0
    0.1347    7.4873    0.0000 C   0  0
    0.1761    8.9868    0.0000 Cl  0  0
   -1.1846    6.7735    0.0000 C   0  0
   -1.2259    5.2740    0.0000 C   0  0
    6.4990   -0.7623    0.0000 C   0  0
    7.7960   -1.5158    0.0000 C   0  0
    9.0971   -0.7693    0.0000 C   0  0
    9.1011    0.7307    0.0000 C   0  0
    7.8041    1.4842    0.0000 C   0  0
    6.5030    0.7377    0.0000 C   0  0
    3.8959   -2.2567    0.0000 C   0  0
    3.8926   -3.7567    0.0000 C   0  0
    2.5919   -4.5039    0.0000 C   0  0
    1.2945   -3.7510    0.0000 C   0  0
    1.2978   -2.2510    0.0000 C   0  0
    2.5985   -1.5039    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 11  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
  8 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
  8 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7662

> <plate>
1

> <well>
G08

> <supplier_cmpd_name>
Loperamide HCl

> <ctcr_id>
1861

> <supplier_cmpd_id>
S2480

> <smiles>
[H+].[Cl-].CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4

> <pd_targets>
{TSHR,THPO,ADRA1B,ABCB11,CES2,KMT2A,MEN1,HTT,ALOX15,CYP2D6,ALOX12,CHRM1,ADRA1A,OPRD1,CALM,CYP3A4,OPRM1,SLC22A1,TEK,LMNA,REP,OPRK1,CYP1A2,CACNA1C,SCN1A,SCN2A,SCN3A,RORC,TP53,FTL,PMP22,BLM,NPSR1,NFO,GMN
N,ADRB2,DRD3,MTOR,SIGMAR1,SCN5A,HTR2B,KCNH2,SLC6A4,HRH2,ABCB1,POMC,CALM1}

> <pathway_gtopdb>
{"Membrane receptor","Unclassified protein",Transporter,Enzyme,"Epigenetic regulator","Other nuclear protein","Ion channel","Transcription factor","Family A G protein-coupled receptor","Primary active
 transporter",Hydrolase,Reader,Oxidoreductase,"Cytochrome P450","Electrochemical transporter",Kinase,Transferase,"Voltage-gated ion channel","Nuclear receptor","Peptide receptor (family A GPCR)","Smal
l molecule receptor (family A GPCR)","ATP-binding cassette",Bromodomain,"Cytochrome P450 family 2","Cytochrome P450 family 3","SLC superfamily of solute carriers","Protein Kinase","Cytochrome P450 fam
ily 1","Voltage-gated calcium channel","Voltage-gated sodium channel","Nuclear hormone receptor subfamily 1","Potassium channels","Glycohormone receptor","Monoamine receptor","ABCB subfamily","Cytochr
ome P450 family 2D","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","SLC22 family of organic cation and anion transporters","TK protein kinase group","Cytochrome P450 family 1A","
Nuclear hormone receptor subfamily 1 group F","Atypical protein kinase group","Voltage-gated potassium channel","SLC06 neurotransmitter transporter family","Adrenergic receptor","Cytochrome P450 2D6",
"Acetylcholine receptor","Opioid receptor","Cytochrome P450 3A4","Tyrosine protein kinase Tie family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Neuropeptide recept
or","Dopamine receptor","Atypical protein kinase PIKK family","Serotonin receptor","Histamine receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Other protein targets","Ion channels","G protein-coupled receptors","ATP-binding cassette transporter family","Eicosanoid turnover","Cytochrome P450","SLC superfamily 
of solute carriers","Catalytic receptors","Anti-infective targets","Voltage-gated ion channels","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Sigma receptors","Glycoprotein hormone receptors",Ad
renoceptors,"ABCB subfamily",Lipoxygenases,"CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","Opioid receptors","CYP3 family","SLC22 family of organic cation and anion tra
nsporters","Receptor kinases","Viral protein targets","CYP1 family","Voltage-gated calcium channels","1F. Retinoic acid-related orphans","Neuropeptide S receptor","Dopamine receptors",Atypical,"Voltag
e-gated sodium channels","5-Hydroxytryptamine receptors","Potassium channels","SLC6 neurotransmitter transporter family","Histamine receptors","Organic cation transporters (OCT)","TK: Tyrosine kinase"
,"Coronavirus (CoV) proteins","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Voltage-gated potassium channels","Monoamine transporter subfamily","Receptor tyrosine kinases (RTKs)","F
RAP subfamily","Type XII RTKs: TIE family of angiopoietin receptors"}

> <pathway_reactome>
{Disease,Hemostasis,"Signal Transduction",Metabolism,"Gene expression (Transcription)","Transport of small molecules","Cell Cycle","Developmental Biology","Vesicle-mediated transport","DNA Repair","Mu
scle contraction","Neuronal System","Infectious disease","Platelet activation","signaling and aggregation","Signaling by GPCR","Metabolism of lipids","Biological oxidations","RNA Polymerase II Transcr
iption","SLC-mediated transmembrane transport","MAPK family signaling cascades",Mitotic,"Nervous system development","Cell Cycle Checkpoints","Membrane Trafficking","DNA Double-Strand Break Repair","C
ardiac conduction","Transmission across Chemical Synapses","Abacavir transport and metabolism","Leishmania infection","Platelet Aggregation (Plug Formation)","GPCR ligand binding","Metabolism of stero
ids","Phase I - Functionalization of compounds","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR downstream signalling","Transport of bile salts and or
ganic acids","metal ions and amine compounds","MAPK1/MAPK3 signaling","M Phase","SARS-CoV Infections","Axon guidance","G1/S DNA Damage Checkpoints","trans-Golgi Network Vesicle Budding","EGR2 and SOX1
0-mediated initiation of Schwann cell myelination","Homology Directed Repair","Mitotic G1 phase and G1/S transition","Phase 3 - rapid repolarisation","Neurotransmitter clearance","Abacavir transmembra
ne transport","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","T
ranscriptional Regulation by MECP2","Biosynthesis of DPA-derived SPMs","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","G alpha (i) signalling events","Organic cation
/anion/zwitterion transport","RAF/MAP kinase cascade","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","Mitotic Metaphase and Anaphase","SARS-CoV-2 Infection","NCAM signaling for neurite o
ut-growth","SARS-CoV-1 Infection","Transcriptional regulation by RUNX3","p53-Dependent G1/S DNA damage checkpoint","Golgi Associated Vesicle Biogenesis","HDR through Homologous Recombination (HRR) or 
Single Strand Annealing (SSA)","G1/S Transition","Transcriptional Regulation by TP53","Potential therapeutics for SARS","L1CAM interactions","Serotonin clearance from the synaptic cleft","Activation o
f NMDA receptors and postsynaptic events","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Synthesis of bile acids and bile salts","Regulation of 
MECP2 expression and activity","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"Peptide ligand-binding receptors","Biosynthesis of maresins","Opioid Signalling","Organic cation transport","SMAD2/SMAD3:SMAD4
 heterotrimer regulates transcription","Mitotic Anaphase","SARS-CoV-2 Genome Replication and Transcription","MECP2 regulates neuronal receptors and channels","NCAM1 interactions","SARS-CoV-1 Genome Re
plication and Transcription","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1 DNA Damage Response","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative
 complex","Regulation of TP53 Activity","Interaction between L1 and Ankyrins","Post NMDA receptor activation events","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Synthesis 
of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Biosynthesis of DPAn-3-derived maresins","Muscarinic acetylcho
line receptors","Biosynthesis of maresin-like SPMs","G-protein activation","Nuclear Envelope (NE) Reassembly","Replication of the SARS-CoV-2 genome","Aromatic amines can be N-hydroxylated or N-dealkyl
ated by CYP1A2","Replication of the SARS-CoV-1 genome","Stabilization of p53","Homologous DNA Pairing and Strand Exchange","Dopamine receptors","Regulation of TP53 Expression and Degradation","Seroton
in receptors","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Pr
esynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degradation","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{CACNA1A,CALM1,OPRD1,OPRK1,OPRM1,POMC}

> <broad_moa>
{"opioid receptor agonist"}

> <synonyms>
{"Loperamide hydrochloride",34552-83-5,34552835,"Loperamide HCl",Imodium,Suprasec,Fortasec,"Imodium A-D","Imodium AD","Loperamide (hydrochloride)",UNII-77TI35393C,UNII77TI35393C,"Maalox Anti-Diarrheal
","Maalox AntiDiarrheal",MLS000069779,CHEBI:6533,MFCD00058581,77TI35393C,NSC-696356,NSC696356,Dissenten,Lopemid,Lopemin,T0209,S2480,SAM002564218,Prestw-144,CPD000058466}

> <pdid>
PD009698

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{71420,57516049,43833345}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 36  0  0  0  0            999 V2000
    0.5586   -5.1668    0.0000 C   0  0
    1.1640   -3.7944    0.0000 C   0  0
    0.2783   -2.5827    0.0000 C   0  0
    0.8840   -1.2095    0.0000 C   0  0
    0.0000    0.0000    0.0000 C   0  0
   -1.5043    0.0000    0.0000 N   0  0
   -1.9556    1.4291    0.0000 C   0  0
   -2.4219    2.8581    0.0000 C   0  0
   -3.9262    2.8581    0.0000 C   0  0
   -4.3925    1.4291    0.0000 C   0  0
   -3.1740    0.5415    0.0000 C   0  0
   -0.7521    2.3016    0.0000 C   0  0
   -0.7521    3.8016    0.0000 O   0  0
    0.4513    1.4291    0.0000 N   0  0
    1.8744    1.8982    0.0000 C   0  0
    2.9947    0.8995    0.0000 C   0  0
    4.4200    1.3670    0.0000 C   0  0
    5.5376    0.3665    0.0000 C   0  0
    5.2299   -1.1016    0.0000 C   0  0
    3.8047   -1.5692    0.0000 C   0  0
    2.6871   -0.5687    0.0000 C   0  0
    6.3481   -2.1025    0.0000 C   0  0
    6.0382   -3.5703    0.0000 C   0  0
    7.1542   -4.5725    0.0000 C   0  0
    8.5802   -4.1071    0.0000 C   0  0
    8.8902   -2.6395    0.0000 C   0  0
    7.7742   -1.6372    0.0000 C   0  0
    8.0843   -0.1689    0.0000 C   0  0
    7.0764    0.9248    0.0000 N   0  0
    7.8268    2.2236    0.0000 N   0  0
    9.2939    1.9113    0.0000 N   0  0
    9.4503    0.4195    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
  7 12  1  0
 12 13  2  0
 12 14  1  0
 14  5  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 28  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7663

> <plate>
1

> <well>
G09

> <supplier_cmpd_name>
Irbesartan

> <ctcr_id>
2839

> <supplier_cmpd_id>
S1507

> <smiles>
CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5

> <pd_targets>
{AGTR1,CYP3A4,EDNRA,AGTR1B,AGTR2,GAA,ABCB11,SLC10A1,LMNA,MAPK1,ABCC4,ABCC3,JUN}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Transporter,"Other nuclear protein","Transcription factor","Family A G protein-coupled receptor",Protease,"Cytochrome P450",Hydrolase,"Primary active transporter","Electroc
hemical transporter",Kinase,"Peptide receptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 3","ATP-binding cassette","SLC superfamily of solute carriers","Protein Kinase","Short peptid
e receptor (family A GPCR)","Cysteine protease CA clan","Cytochrome P450 family 3A","ABCB subfamily","SLC10 family of sodium-bile acid co-transporters","CMGC protein kinase group","ABCC subfamily","An
giotensin receptor","Cysteine protease C1A family","Cytochrome P450 3A4","Endothelin receptor","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Cytochrome P450","3.2.1.- Glycosidases","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Kinases (EC 2.7.x
.x)","Angiotensin receptors","CYP3 family","Endothelin receptors","ABCB subfamily","SLC10 family of sodium-bile acid co-transporters","CMGC: Containing CDK",MAPK,GSK3,"CLK families","ABCC subfamily","
Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Cell Cycle","Immune System",Hemostasis,"Signaling by GPCR","Metabolism of lipids","Diseases of metabolism",Mitotic,"Innate Immune System","Platelet activatio
n","signaling and aggregation","GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Diseases of carbohydrate metabolism","Metabolism of steroids","M Phase","Toll-like Rec
eptor Cascades","Response to elevated platelet cytosolic Ca2+","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Glycogen storage diseases","Bile acid and bile salt metabolism
","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade","Platelet degranulation","Peptide ligand-binding receptors","Biosynthesis of maresins","Glycogen storage disease type II (GAA)"
,"Synthesis of bile acids and bile salts","Recycling of bile acids and salts","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresin-like SPMs","Synthesis of bile aci
ds and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","MAP kinase activation","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by 
MAP kinases","ERK/MAPK targets","Activation of the AP-1 family of transcription factors","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{irbesartan,138402-11-6,138402116,Avapro,Aprovel,Karvea,SR-47436,SR47436,BMS-186295,BMS186295,"BMS 186295","SR 47436","Irbesartan free base",UNII-J0E2756Z7N,UNIIJ0E2756Z7N,CHEMBL1513,CHEBI:5959,J0E275
6Z7N,"138402-11-6 (free base)","138402116 (free base)",MFCD00864464,NCGC00095122-01,NCGC0009512201,DSSTox_CID_3169,DSSToxCID3169,DSSTox-CID-3169,"DSSTox CID 3169",DSSTox_RID_7,DSSToxRID7,DSSTox-RID-7,
"DSSTox RID 7",S1507,SAM001246548,1504259,Irbesartan,CPD000466306,IRBESARTAN}

> <pdid>
PD001208

> <targets>
{RAAS,Angiotensin Receptor,Apoptosis}

> <classes>
{angiotensin 2 receptor antagonist,Endocrinology & Hormones,Apoptosis,GPCR/G Protein}

> <pubchem_cids>
{3749}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 18  0  0  0  0            999 V2000
   10.1894   -2.2554    0.0000 H   0  3
    7.6894   -2.2554    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 S   0  0
   -3.8964   -0.7545    0.0000 C   0  0
   -5.1996    1.4928    0.0000 O   0  0
   -5.1966   -0.0070    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 15 18  2  0
 13 19  1  0
 19 20  2  0
 20 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7664

> <plate>
1

> <well>
G10

> <supplier_cmpd_name>
Sotalol

> <ctcr_id>
6494

> <supplier_cmpd_id>
S2509

> <smiles>
[H+].[Cl-].CC(C)NCC(O)c1ccc(N[S](C)(=O)=O)cc1

> <pd_targets>
{BLM,GLA,ADRB1,ADRB2,ADRB3,LMNA,KCNH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other nuclear protein","Ion channel",Hydrolase,"Family A G protein-coupled receptor","Voltage-gated ion channel","Small molecule receptor (family A GPCR)","Potassium chann
els","Monoamine receptor","Voltage-gated potassium channel","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels",Adrenoceptors,"Potassium channels","Voltage-gated potassium channels"}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Cell Cycle",Disease,"Muscle contraction","DNA Double-Strand Break Repair","Metabolism of lipids",Mitotic,"Infectious disease","Cardiac conduction","Homology Directed Repair",
"Sphingolipid metabolism","M Phase","Leishmania infection","Phase 3 - rapid repolarisation","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Glycosphingolipid metabolism"
,"Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite in
fection","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Presynaptic phase of homologous DNA pairing and stra
nd exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB1,ADRB2,KCNH2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{MCULE-8589076631,MCULE8589076631,"Sotalol hydrochloride",959-24-0,959240,"Sotalol HCL",Betapace,"Betapace AF",Sotalex,Sotacor,"Sotalol (hydrochloride)","MJ 1999","Mead johnson 1999",Sorine,"(+/-)-Sot
alol hydrochloride","(+/)Sotalol hydrochloride","Betapace (TN)","Sotalol (Betapace)",S2509,SAM001246725,Prestw-966,Sotalol,CPD000326828}

> <pdid>
PD009998

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{45371387,66245,67108155}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 10 11  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 N   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  2  1  0
 10  6  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7665

> <plate>
1

> <well>
G11

> <supplier_cmpd_name>
Allopurinol

> <ctcr_id>
6943

> <supplier_cmpd_id>
S1630

> <smiles>
O=C1NC=Nc2[nH]ncc12

> <pd_targets>
{XDH,RAB9A,BLM,LMNA,TSHR,STXA}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor",Oxidoreductase,Hydrolase,"Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Glycohormone receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"1.-.-.- Oxidoreductases","G protein-coupled receptors","Glycoprotein hormone receptors"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","DNA Repair","Cell Cycle",Disease,"Metabolism of nucleotides","Signaling by Rho GTPases","DNA Double-Strand Break Repair",Mitotic,"Infectious disease","Nucleobase cat
abolism","Rho GTPase cycle","Homology Directed Repair","M Phase","Leishmania infection","Purine catabolism","RHOBTB GTPase Cycle","HDR through Homologous Recombination (HRR) or Single Strand Annealing
 (SSA)","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","RHOBTB3 ATPase cycle","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Anti-inflammatory response fa
vouring Leishmania parasite infection","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Presynaptic phase of h
omologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Aloprim,Allopurinol,Prestw-1213,Prestw1213,ALLOPURINOL,CPD000059083,S1630,SAM002554884,1390,1500108,"NSC 1390",Allopurinol}

> <pdid>
PD002486

> <targets>
{Others,OX Receptor,Xanthine Oxidase}

> <classes>
{antihyperuricemia,Xanthine Oxidase Inhibitor,antiurolithic,antigout,GPCR & G Protein,Metabolic Enzyme/Protease}

> <pubchem_cids>
{2094}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 11 13  0  0  1  0            999 V2000
   -5.1750    2.4141    0.0000 C   0  0
   -3.7106    2.0893    0.0000 N   0  0
   -2.7244    3.5602    0.0000 C   0  0  2  0  0  0
   -1.3873    2.9083    0.0000 C   0  0
   -1.0864    1.5043    0.0000 C   0  0
    0.3741    1.1623    0.0000 O   0  0
   -1.9890    0.3677    0.0000 C   0  0
   -3.4432    0.3677    0.0000 C   0  0  1  0  0  0
   -4.3959    1.5043    0.0000 C   0  0  2  0  0  0
   -5.3820    2.3902    0.0000 O   0  0
   -4.0616    2.9083    0.0000 C   0  0  2  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  1
  4  5  1  0
  5  6  1  0
  5  7  1  0
  8  7  1  1
  8  2  1  0
  8  9  1  0
  9 10  1  6
 11 10  1  6
 11  3  1  0
 11  9  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7666

> <plate>
1

> <well>
G12

> <supplier_cmpd_name>
Scopine

> <ctcr_id>
7222

> <supplier_cmpd_id>
S2545

> <smiles>
CN1[C@@H]2CC(O)C[C@H]1[C@@H]3O[C@H]23

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{}

> <broad_moa>
{}

> <synonyms>
{Scopine,498-45-3,498453,"(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo(3.3.1.02,4)nonan-7-ol","(1R,2R,4S,5S,7s)9Methyl3oxa9azatricyclo(3.3.1.02,4)nonan7ol","6,7-Epoxytropine","6,7Epoxytropine",Pseudo
scopine,"rel-(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo(3.3.1.02,4)nonan-7-ol","rel(1R,2R,4S,5S,7s)9Methyl3oxa9azatricyclo(3.3.1.02,4)nonan7ol",PubChem11613,SCHEMBL9889341,CHEMBL4303435,CHEMBL43035
36,T6662,S2545}

> <pdid>
PD010698

> <targets>
{Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{1274465}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 27  0  0  0  0            999 V2000
    5.1894   -6.0108    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    2.5915   -6.0067    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 N   0  0
   10.3023   -0.3804    0.0000 O   0  0
   10.3023   -1.8804    0.0000 C   0  0
    9.0030   -2.6300    0.0000 O   0  0
   11.6023   -2.6304    0.0000 C   0  0
   12.9023   -1.8804    0.0000 C   0  0
   12.9037   -0.3796    0.0000 C   0  0
   11.6051    0.3712    0.0000 O   0  0
   14.2030    0.3700    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7667

> <plate>
1

> <well>
G13

> <supplier_cmpd_name>
Chlorpheniramine Maleate

> <ctcr_id>
6680

> <supplier_cmpd_id>
S1816

> <smiles>
CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Chlorpheniramine maleate",113-92-8,113928,Piriton,"Chlorphenamine Maleate",Antagonate,Kloromin,"Chlorphenamine hydrogen maleate","Chlorpheniramine (maleate)",MFCD00069225,Polaronil,C16H19ClN2.C4H4O4
,"Chlorphenamine maleates","Chloropheniramine male",T1553,T0785,T0205,S1816,SAM001247022,Prestw-117,"Dexchlorpheniramine Maleate","Brompheniramine hydrogen maleate","Chlorpheniramine Maleate",CPD00046
6271}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5281068,5284366}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 14 12  0  0  1  0            999 V2000
    8.8982   -1.8789    0.0000 Cl  0  5
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0  2  0  0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3982   -1.8789    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  1
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13  7  1  0
M  CHG  2   1  -1  14   1
M  END
> <name>
Selleck_GPCR

> <id>
7668

> <plate>
1

> <well>
G14

> <supplier_cmpd_name>
Phenylephrine HCl

> <ctcr_id>
1116

> <supplier_cmpd_id>
S2569

> <smiles>
[Cl-].CNC[C@H](O)c1cccc(O)c1.[H+]

> <pd_targets>
{HIF1A,ADRA1A,ADRA1D,ADRA1B,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,NFKB1,TSHR,GAA,BLM,LMNA,KDM4E}

> <pathway_gtopdb>
{"Transcription factor","Membrane receptor","Other cytosolic protein",Enzyme,"Other nuclear protein","Epigenetic regulator","Family A G protein-coupled receptor",Hydrolase,Eraser,"Small molecule recep
tor (family A GPCR)","Peptide receptor (family A GPCR)","Lysine demethylase","Monoamine receptor","Glycohormone receptor","Jumonji domain-containing","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","3.2.1.- Glycosidases","Chromatin modifying enzymes",Adrenoceptors,"Glycoprotein hormone receptors","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Signal Transduction",Disease,"Immune System","DNA Repair","Cell Cycle","Cellular responses to stress","Signaling by GPCR","Infectious disease","Cytokine Sign
aling in Immune system","Diseases of metabolism","DNA Double-Strand Break Repair",Mitotic,"Cellular response to hypoxia","GPCR ligand binding","Leishmania infection","Signaling by Interleukins","Disea
ses of carbohydrate metabolism","Homology Directed Repair","M Phase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Class A/1 (Rhodopsin-like receptors)","Leishmania paras
ite growth and survival","Interleukin-1 family signaling","Glycogen storage diseases","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Am
ine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Interleukin-1 signaling","Glycogen storage disease type II (GAA)","HDR through Homologous Recombinat
ion (HRR)","Mitotic Anaphase",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Homologous DNA Pairing and Strand Exchange","Nuclear
 Envelope (NE) Reassembly","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{Mydfrin,Neo-Synephrine,NeoSynephrine,Dionephrine,CHEBI:8094,61-76-7,61767,"3-((1R)-1-hydroxy-2-(methylamino)ethyl)phenol hydrochloride","3((1R)1hydroxy2(methylamino)ethyl)phenol hydrochloride","PHENY
LEPHRINE HYDROCHLORIDE","Phenylephrine HCl","L-PHENYLEPHRINE HYDROCHLORIDE","LPHENYLEPHRINE HYDROCHLORIDE","Metaoxedrine chloride",Adrianol,Biom,S2569,1500483}

> <pdid>
PD010076

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein",mydriatic,decongestant}

> <pubchem_cids>
{657210,5284443,441279}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 21  0  0  0  0            999 V2000
   -0.5529  -10.3163    0.0000 C   0  0
    0.0576   -8.9462    0.0000 N   0  0
    1.5502   -8.7888    0.0000 C   0  0
    2.1626   -7.4186    0.0000 N   0  0
    1.2830   -6.2026    0.0000 C   0  0
    1.8954   -4.8324    0.0000 C   0  0
    1.0157   -3.6164    0.0000 S   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 S   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -2.6394    0.8543    0.0000 C   0  0
   -3.7533   -0.1515    0.0000 N   0  0
   -5.1808    0.3090    0.0000 C   0  0
   -3.4388   -1.6182    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 N   0  0
    2.4298  -10.0049    0.0000 C   0  0
    3.9228   -9.8520    0.0000 N   0  3
    4.5362   -8.4832    0.0000 O   0  5
    4.8020  -11.0674    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 12 17  2  0
 17  9  1  0
  3 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
M  CHG  2  19   1  20  -1
M  END
> <name>
Selleck_GPCR

> <id>
7669

> <plate>
1

> <well>
G15

> <supplier_cmpd_name>
Nizatidine

> <ctcr_id>
2353

> <supplier_cmpd_id>
S1890

> <smiles>
CN\C(NCCSCc1csc(CN(C)C)n1)=C\[N+]([O-])=O

> <pd_targets>
{ACHE,HRH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Hydrolase,"Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Acetylcholine turnover","G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{Metabolism,Disease,"Metabolism of lipids","Infectious disease","Phospholipid metabolism","Leishmania infection","Glycerophospholipid biosynthesis","Leishmania parasite growth and survival","Synthesis
 of PC","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{HRH2}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{Prestwick3_000921,Prestwick3000921,Prestwick3-000921,"Prestwick3 000921",BSPBio_000822,BSPBio000822,BSPBio-000822,"BSPBio 000822",MLS002154062,BPBio1_000906,BPBio1000906,BPBio1-000906,"BPBio1 000906"
,CHEMBL2358532,SCHEMBL13575816,C12H21N5O2S2,HMS2097J04,HMS2233M09,HMS3714J04,HMS3884K14,ZINC1530737,CCG-220921,CCG220921,NCGC00179412-01,NCGC0017941201,AS-13317,AS13317,H884,SMR001233377,AB00513965,S1
890,SW196508-3,SW1965083,AB0051396,T1575,Prestw-921,Nizatidine}

> <pdid>
PD003067

> <targets>
{Others,Histamine Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{5353831}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 33 32  0  0  0  0            999 V2000
   17.7931   -2.2548    0.0000 H   0  3
   15.2931   -2.2548    0.0000 H   0  3
   12.7931   -2.2548    0.0000 Cl  0  5
   10.2931   -2.2548    0.0000 Cl  0  5
    1.2948   -3.7516    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -6.4947    0.7442    0.0000 Cl  0  0
   -3.8967    0.7484    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1876   -6.0124    0.0000 C   0  0
    5.1824   -7.5124    0.0000 C   0  0
    3.8808   -8.2579    0.0000 C   0  0
    2.5844   -7.5034    0.0000 C   0  0
    2.5895   -6.0034    0.0000 C   0  0
    5.1943   -3.0089    0.0000 C   0  0
    6.4932   -3.7593    0.0000 C   0  0
    7.7925   -3.0098    0.0000 C   0  0
    7.7931   -1.5098    0.0000 C   0  0
    6.4943   -0.7593    0.0000 C   0  0
    5.1950   -1.5088    0.0000 C   0  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 14  1  0
  6 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 21 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7670

> <plate>
1

> <well>
G16

> <supplier_cmpd_name>
BRL-15572

> <ctcr_id>
5421

> <supplier_cmpd_id>
S2677

> <smiles>
[H+].[H+].[Cl-].[Cl-].OC(CN1CCN(CC1)c2cccc(Cl)c2)C(c3ccccc3)c4ccccc4

> <pd_targets>
{NPSR1,LMNA,KMT2A,MEN1,BLM,GMNN,PMP22,NFO,HTR1E,HTR1B,HTR1A,HTR1D,HTR1F,HTR2B,HTR6,HTR2A,HTR2C}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein","Epigenetic regulator",Enzyme,"Unclassified protein","Family A G protein-coupled receptor",Reader,Hydrolase,"Peptide receptor (family A GPCR)",Bromodomain,
"Small molecule receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Monoamine receptor","Neuropeptide receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Neuropeptide S receptor","5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{Disease,"Cell Cycle","DNA Repair","Developmental Biology","Signal Transduction","Infectious disease",Mitotic,"DNA Double-Strand Break Repair","Nervous system development","Signaling by GPCR","Leishma
nia infection","M Phase","Homology Directed Repair","Mitotic G1 phase and G1/S transition","EGR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR ligand binding","Leishmania parasite g
rowth and survival","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Class A/1 (Rhodopsin-like receptors)","Anti-inflam
matory response favouring Leishmania parasite infection","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative complex","Amine ligand-binding receptors","A
DORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Serotonin receptors","Initiation of Nuclear Envelope (NE) Refor
mation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR6}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{193611-72-2,193611722,"BRL-15572 dihydrochloride","BRL15572 dihydrochloride",BRL-15572,BRL15572,"BRL-15572 (dihydrochloride)","BRL15572 (dihydrochloride)","BRL-15572 2HCl","BRL15572 2HCl","BRL 15572 
dihydrochloride",C25H27ClN2O.2ClH,cc-253,cc253,DTXSID70872473,BCP03480,s2677,CCG-269542,CCG269542,CS-0423,CS0423,AK468697,HY-13200,HY13200,SW219375-1,SW2193751,X7597,W-5294,W5294,T6423,S2677}

> <pdid>
PD051723

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9891303}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 58 59  0  0  1  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0  2  0  0  0
   -3.8964   -0.7545    0.0000 C   0  0
   -5.2003    1.4932    0.0000 N   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0  1  0  0  0
   -7.8029    2.9887    0.0000 O   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4007    1.4818    0.0000 C   0  0
  -11.6971    0.7273    0.0000 C   0  0
  -11.6919   -0.7727    0.0000 C   0  0
  -12.9883   -1.5272    0.0000 O   0  0
  -10.3903   -1.5182    0.0000 C   0  0
  -10.3820   -3.0190    0.0000 N   0  0
   -9.0786   -3.7630    0.0000 C   0  0
   -9.0703   -5.2630    0.0000 O   0  0
   -9.0939   -0.7637    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   20.6814   -3.0031    0.0000 C   0  0
   20.6835   -1.5031    0.0000 O   0  0
   19.3853   -0.7500    0.0000 C   0  0
   19.3853    0.7500    0.0000 C   0  0
   18.0862    1.5000    0.0000 C   0  0
   16.7872    0.7500    0.0000 C   0  0
   15.4859    1.4977    0.0000 C   0  0
   14.1872    0.7455    0.0000 C   0  0  2  0  0  0
   14.1898   -0.7545    0.0000 C   0  0
   12.8859    1.4932    0.0000 N   0  0
   11.5872    0.7409    0.0000 C   0  0
   10.2860    1.4887    0.0000 C   0  0  1  0  0  0
   10.2833    2.9887    0.0000 O   0  0
    8.9873    0.7364    0.0000 C   0  0
    7.6856    1.4818    0.0000 C   0  0
    6.3891    0.7273    0.0000 C   0  0
    6.3943   -0.7727    0.0000 C   0  0
    5.0979   -1.5272    0.0000 O   0  0
    7.6960   -1.5182    0.0000 C   0  0
    7.7042   -3.0190    0.0000 N   0  0
    9.0077   -3.7630    0.0000 C   0  0
    9.0159   -5.2630    0.0000 O   0  0
    8.9924   -0.7637    0.0000 C   0  0
   16.7872   -0.7500    0.0000 C   0  0
   18.0863   -1.5000    0.0000 C   0  0
   24.4835    0.7378    0.0000 O   0  0
   24.4835   -0.7622    0.0000 C   0  0
   23.1842   -1.5118    0.0000 O   0  0
   25.7835   -1.5122    0.0000 C   0  0
   27.0835   -0.7622    0.0000 C   0  0
   28.3835   -1.5122    0.0000 C   0  0
   28.3835   -3.0122    0.0000 O   0  0
   29.6827   -0.7626    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  6
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 19 23  2  0
 23 14  1  0
  6 24  1  0
 24 25  2  0
 25  3  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  6
 33 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  6
 37 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 42 44  1  0
 44 45  1  0
 45 46  1  0
 46 47  2  0
 44 48  2  0
 48 39  1  0
 31 49  1  0
 49 50  2  0
 50 28  1  0
 51 52  1  0
 52 53  2  0
 52 54  1  0
 54 55  2  0
 55 56  1  0
 56 57  1  0
 56 58  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7671

> <plate>
1

> <well>
G17

> <supplier_cmpd_name>
Formoterol Hemifumarate

> <ctcr_id>
855

> <supplier_cmpd_id>
S2020

> <smiles>
COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1.COc3ccc(C[C@H](C)NC[C@@H](O)c4ccc(O)c(NC=O)c4)cc3.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{43229-80-7,43229807,"FORMOTEROL FUMARATE","Formoterol hemifumarate","(S,S)-formoterol fumarate","(S,S)formoterol fumarate","Formoterol (Fumarate)","YM 08316","BD 40A","Formoterol Fumarate,(S)",CHEMBL
4303430,CHEBI:63109,"ethyl)phenyl)formamide hemifumarate",HMS3267L,T6505,S2020,Prestw-1421,"Formoterol Hemifumarate","Formoterol fumarate"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9832292}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 23  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2004    2.9933    0.0000 C   0  0
   -6.4995    3.7432    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -9.0976    3.7431    0.0000 F   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -6.4994   -0.7568    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7672

> <plate>
1

> <well>
G18

> <supplier_cmpd_name>
VU 0357121

> <ctcr_id>
1587

> <supplier_cmpd_id>
S2795

> <smiles>
CCCCOc1ccc(cc1)C(=O)Nc2ccc(F)cc2F

> <pd_targets>
{GRM5}

> <pathway_gtopdb>
{"Membrane receptor","Family C G protein-coupled receptor","Small molecule receptor (family C GPCR)","Neurotransmitter receptor (family C GPCR)","Metabotropic glutamate receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Metabotropic glutamate receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (q) signalling events"}

> <broad_targets>
{GRM5}

> <broad_moa>
{"glutamate receptor positive allosteric modulator"}

> <synonyms>
{"VU 0357121",433967-28-3,433967283,"4-butoxy-N-(2,4-difluorophenyl)benzamide","4butoxyN(2,4difluorophenyl)benzamide",VU0357121,CHEMBL2151790,VU-0357121,"Cambridge id 6991768",cc-377,cc377,MLS00601179
3,GTPL6399,DTXSID10367833,EX-A195,EXA195,HMS3656J10,HMS3884B18,BCP04788,ZINC2999928,BDBM50392425,MFCD03243692,s2,T6725,S2795}

> <pdid>
PD010568

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{2296132}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 31  0  0  0  0            999 V2000
   13.8990    4.2667    0.0000 H   0  3
   11.3990    4.2667    0.0000 O   0  0
    8.8990    4.2667    0.0000 O   0  0
    6.3990    4.2667    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.2991    5.2507    0.0000 N   0  0
   -0.0012    6.0029    0.0000 C   0  0
   -0.0036    7.5029    0.0000 C   0  0
   -1.3039    8.2509    0.0000 N   0  0
   -2.6017    7.4988    0.0000 C   0  0
   -2.5993    5.9988    0.0000 C   0  0
   -1.3093    9.7517    0.0000 C   0  0
   -0.0128   10.5060    0.0000 O   0  0
   -2.6114   10.4982    0.0000 C   0  0
   -2.7567   11.9783    0.0000 C   0  0
   -4.2255   12.2827    0.0000 C   0  0
   -4.9689   10.9799    0.0000 C   0  0
   -3.9596    9.8703    0.0000 O   0  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15  9  1  0
 15 16  1  0
 16 17  2  0
 17  7  1  0
 17 18  1  0
 18 19  1  0
 11 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
 23 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 28  1  0
M  CHG  2   1   1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7673

> <plate>
1

> <well>
G19

> <supplier_cmpd_name>
Terazosin HCl

> <ctcr_id>
568

> <supplier_cmpd_id>
S2059

> <smiles>
[H+].O.O.[Cl-].COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4

> <pd_targets>
{ADRA1A,ADRA1D,ADRA2A,ADRA2C,NFO,KMT2A,MEN1,FFP,ADRA1B,ADRA2B,KDM4E,GLA,GAA,ALDH1A1,KCNH2,HPGD,HTT,SMN1,AMPC,LMNA,HSD17B10,MAPK1,ALD,SLC22A1,ABCC4,KCNH6,KCNH7,TGFB1,TSHR,LEF,TP53,CHRM1,RORC}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Ion channel","Unclassified protein","Other nuclear protein",Transporter,"Secreted protein","Transcription factor","Family A G protein-coupled recept
or",Hydrolase,Reader,Transferase,Eraser,Oxidoreductase,"Voltage-gated ion channel",Kinase,"Electrochemical transporter","Primary active transporter",Protease,"Small molecule receptor (family A GPCR)",
Bromodomain,"Lysine demethylase","Potassium channels","Methyl-lysine/arginine binding protein","Protein Kinase","SLC superfamily of solute carriers","ATP-binding cassette","Peptide receptor (family A 
GPCR)","Metallo protease","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium channel","Tudor domain","CMGC protein kinase group","SLC22 family of organic cation and anion transp
orters","ABCC subfamily","Glycohormone receptor","Metallo protease MAE clan","Adrenergic receptor","CMGC protein kinase MAPK family","Metallo protease M34 family","Acetylcholine receptor","CMGC protei
n kinase ERK1","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Chromatin modifying enzymes","3.2.1.- Glycosidases","Voltage-gated ion channels","Eicosanoid turnover","Kinases (EC 2.7.x.
x)","SLC superfamily of solute carriers","ATP-binding cassette transporter family",Adrenoceptors,"1.14.11.- Histone demethylases","Potassium channels","Prostaglandin synthases","CMGC: Containing CDK",
MAPK,GSK3,"CLK families","SLC22 family of organic cation and anion transporters","ABCC subfamily","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Voltage-gated potassium chann
els","Mitogen-activated protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily","Nuclear hormone receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Muscle contraction","Gene expression (Transcription)","Metabolism of RNA","Cell Cycle","Immune System","Transport of small molecules",Hemostasis,"Neuronal Sy
stem","Signaling by GPCR","Metabolism of lipids","Diseases of metabolism","Biological oxidations","Cardiac conduction","RNA Polymerase II Transcription","Metabolism of non-coding RNA",Mitotic,"Metabol
ism of amino acids and derivatives","Innate Immune System","SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Potassium Channels","Diseases of signal transductio
n by growth factor receptors and second messengers","Infectious disease","Cell Cycle Checkpoints","GPCR ligand binding","Sphingolipid metabolism","Diseases of carbohydrate metabolism","Phase I - Funct
ionalization of compounds","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","snRNP Assembly","M Phase","Branched-chain amino
 acid catabolism","Toll-like Receptor Cascades","Transport of bile salts and organic acids","metal ions and amine compounds","Response to elevated platelet cytosolic Ca2+","Voltage gated Potassium cha
nnels","Signaling by TGF-beta Receptor Complex in Cancer","Leishmania infection","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","Glycosph
ingolipid metabolism","Glycogen storage diseases","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (T
LR5) Cascade","Organic cation/anion/zwitterion transport","Platelet degranulation","Loss of Function of SMAD2/3 in Cancer","Leishmania parasite growth and survival","Uptake and function of anthrax tox
ins","p53-Dependent G1/S DNA damage checkpoint","Amine ligand-binding receptors","Glycogen storage disease type II (GAA)","Biosynthesis of D-series resolvins","Regulation of MECP2 expression and activ
ity","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Organic cation transport","SMAD2/3 Phosphorylation Motif Mutants in Cancer","Anti-inflammatory response favouring Leishmania paras
ite infection","p53-Dependent G1 DNA Damage Response",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Stabilization 
of p53","Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1",
"ERK/MAPK targets","ERKs are inactivated","Transcriptional regulation by RUNX3","RUNX3 Regulates Immune Response and Cell Migration"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Terazosin monohydrochloride dihydrate",CHEBI:9446,"Terazosin hydrochloride dihydrate",70024-40-7,70024407,"70024 40 7",Magnurol,"Terazosin HCl",Flotrin,Heitrin,Hytrine,"Terazosin HCl dihydrate",Hytr
in,Urodie,"Terazosin (hydrochloride dihy",S2059,"Terazosin HCl"}

> <pdid>
PD002848

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{25137846,63016}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 32  0  0  0  0            999 V2000
    4.0597  -12.2151    0.0000 C   0  0
    4.8089  -10.9156    0.0000 O   0  0
    4.0585   -9.6159    0.0000 C   0  0
    2.5585   -9.6189    0.0000 C   0  0
    1.8059   -8.3214    0.0000 C   0  0
    2.5532   -7.0208    0.0000 C   0  0
    1.8028   -5.7210    0.0000 N   0  0
    2.5524   -4.4208    0.0000 S   0  0
    4.0524   -4.4203    0.0000 O   0  0
    3.3030   -5.7195    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6923   -4.0811    0.0000 C   0  0
    4.0532   -7.0178    0.0000 C   0  0
    4.8059   -8.3153    0.0000 C   0  0
    6.3066   -8.3123    0.0000 N   0  0
    7.0562   -7.0129    0.0000 C   0  0
    8.5562   -7.0122    0.0000 C   0  0
    9.3067   -8.3109    0.0000 N   0  0
    8.5573   -9.6103    0.0000 C   0  0
    7.0573   -9.6110    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 13  1  0
 19 20  1  0
 20 11  2  0
 20 21  1  0
  6 22  1  0
 22 23  2  0
 23  3  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 24  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7674

> <plate>
1

> <well>
G20

> <supplier_cmpd_name>
SB271046

> <ctcr_id>
4485

> <supplier_cmpd_id>
S2856

> <smiles>
COc1ccc(N[S](=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N4CCNCC4

> <pd_targets>
{HTR4,ADRA1B,CYP1A2,CYP3A4,CYP2D6,CYP2C19,HTR6,DRD3,HTR2C,HTR7,DRD2,DRD4,HTR1A,HTR2A,HTR1B,HTR1D}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Cytochrome P450 family 3","Cytochrome P450 fam
ily 2","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 2C","Serotonin receptor","Adrenergic receptor","Cytochrome P450 
1A1","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 2C19","Dopamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","5-Hydroxytryptamine receptors",Adrenoceptors,"CYP1 family","CYP3 family","CYP2 family: drug metabolising subset","Dopamine receptors
"}

> <pathway_reactome>
{Disease,"Signal Transduction",Metabolism,"Infectious disease","Signaling by GPCR","Biological oxidations","Metabolism of lipids","Leishmania infection","GPCR ligand binding","Phase I - Functionalizat
ion of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate 
type","Biosynthesis of DHA-derived SPMs","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors",Xenobiotics,"Biosynthesis of maresins","ADORA2B mediated 
anti-inflammatory cytokines production",Adrenoceptors,"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Dopamine receptors","Se
rotonin receptors"}

> <broad_targets>
{HTR6}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{209481-20-9,209481209,"Sb 271046",SB-271046,SB271046,UNII-L3SK5KX24S,UNIIL3SK5KX24S,L3SK5KX24S,CHEMBL431298,"SB 737050",C20H22ClN3O3S2,"SB-271,046","SB271,046",GTPL276,SCHEMBL194700,"SB271046 HCl",BD
BM28583,"SB 271046 HCl",HMS3651D19,HMS3884D20,BCP03713,EX-A2155,EXA2155,ZINC1489208,2704AH,P,T4118,S2856,"SB 271046 hydrochloride"}

> <pdid>
PD010546

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5312149}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 23  0  0  0  0            999 V2000
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.2211    1.4430    0.0000 C   0  0
   -8.4711    2.7420    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 18  1  0
 13 21  1  0
 21 22  2  0
 22 10  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7675

> <plate>
1

> <well>
G21

> <supplier_cmpd_name>
Betaxolol

> <ctcr_id>
603

> <supplier_cmpd_id>
S2091

> <smiles>
CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1

> <pd_targets>
{ADRB1,ADRB3,ADRB2,BLM,LMNA,GAA,AMPC,CYP2D6,CYP1A2,CHRM1,CYP2C9,KMT2A,MEN1,LEF}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor",Enzyme,"Other nuclear protein","Epigenetic regulator",Hy
drolase,"Cytochrome P450",Reader,Protease,"Cytochrome P450 family 2","Cytochrome P450 family 1",Bromodomain,"Metallo protease","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Cytochrome P450 
family 2C","Metallo protease MAE clan","Cytochrome P450 2D6","Cytochrome P450 1A1","Acetylcholine receptor","Cytochrome P450 2C9","Metallo protease M34 family"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors,Enzymes,"3.2.1.- Glycosidases","Cytochrome P450","CYP2 family: drug metabolising subset","CYP1 family","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production","DNA Repair","Cell Cycle",Metabolism,"Signal Transduction","DNA Double-Strand Break Repair",Mitotic,"Diseases of metabolism","Biological oxidations","Signaling by GPCR","Homology
 Directed Repair","M Phase","Diseases of carbohydrate metabolism","Phase I - Functionalization of compounds","GPCR ligand binding","Uptake and actions of bacterial toxins","HDR through Homologous Reco
mbination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Glycogen storage diseases","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Up
take and function of anthrax toxins","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Glycogen storage disease type II (GAA)",Xenobiotics,"Amine ligand-binding receptors","Homologous D
NA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","Presynapt
ic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB1,ADRB2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{betaxolol,63659-18-7,63659187,Betaxololum,Betoptic,Kerlone,"Betaxololum (INN-Latin)","Betaxololum (INNLatin)","SL 75212",Dextrobetaxolol,1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(propan-2-ylamino
)propan-2-ol,1(4(2(cyclopropylmethoxy)ethyl)phenoxy)3(propan2ylamino)propan2ol,CHEBI:3082,"(R)-Betaxolol; (+)-Betaxolol","(R)Betaxolol; (+)Betaxolol",ALO-1401-02,ALO140102,KERLEDEX,NCGC0001,T0226,S209
1,"Betaxolol hydrochloride",Betaxolol,"Betaxolol (Betoptic)"}

> <pdid>
PD008960

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{2369}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 19  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 N   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -2.6017    2.9971    0.0000 O   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6061    6.0003    0.0000 C   0  0
   -2.6061    7.5003    0.0000 C   0  0
   -1.3071    8.2503    0.0000 C   0  0
   -0.0080    7.5003    0.0000 C   0  0
   -0.0080    6.0003    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  5 15  2  0
 15 16  1  0
 16 17  2  0
 17  3  1  0
 17 18  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7676

> <plate>
1

> <well>
G22

> <supplier_cmpd_name>
VU 0361737

> <ctcr_id>
2497

> <supplier_cmpd_id>
S2892

> <smiles>
COc1cc(NC(=O)c2ccccn2)ccc1Cl

> <pd_targets>
{GRM4,GRM2,GRM1,GRM8}

> <pathway_gtopdb>
{"Membrane receptor","Family C G protein-coupled receptor","Small molecule receptor (family C GPCR)","Neurotransmitter receptor (family C GPCR)","Metabotropic glutamate receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Metabotropic glutamate receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (i) signalling events","G alpha (q) signalling events"}

> <broad_targets>
{GRM4}

> <broad_moa>
{"glutamate receptor positive allosteric modulator"}

> <synonyms>
{1161205-04-4,1161205044,"VU 0361737",VU0361737,N-(4-chloro-3-methoxyphenyl)picolinamide,N(4chloro3methoxyphenyl)picolinamide,N-(4-CHLORO-3-METHOXYPHENYL)-2-PYRIDINECARBOXAMIDE,N(4CHLORO3METHOXYPHENYL
)2PYRIDINECARBOXAMIDE,N-(4-chloro-3-methoxyphenyl)pyridine-2-carboxamide,N(4chloro3methoxyphenyl)pyridine2carboxamide,C13H11ClN2O2,CHEMBL562551,2-Pyridinecarboxamide,2Pyridinecarboxamide,N-(4-chloro-3
-methox,N(4chloro3methox,T6726,S2892}

> <pdid>
PD010247

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{44191096}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 37 39  0  0  1  0            999 V2000
   13.3506   -0.2280    0.0000 C   0  0
   12.5979    1.0695    0.0000 C   0  0
   11.0971    1.0674    0.0000 C   0  0
   10.3516   -0.2343    0.0000 C   0  0
    8.8516   -0.2395    0.0000 C   0  0
    7.8525   -1.3573    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    6.6317    0.7404    0.0000 C   0  0
    8.0971    1.0569    0.0000 C   0  0
    8.8426    2.3586    0.0000 C   0  0
   10.3426    2.3638    0.0000 C   0  0
   11.0858    3.6677    0.0000 C   0  0
   10.3294    4.9630    0.0000 C   0  0
    5.2003   -1.4932    0.0000 N   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0  2  0  0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   17.1510    2.4817    0.0000 O   0  0
   17.1510    0.9817    0.0000 C   0  0
   15.8517    0.2321    0.0000 O   0  0
   18.4510    0.2317    0.0000 C   0  0
   19.7510    0.9817    0.0000 C   0  0
   19.7524    2.4825    0.0000 C   0  0
   18.4538    3.2333    0.0000 O   0  0
   21.0517    3.2321    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  2  0
  9 10  1  0
 10 11  2  0
 11  3  1  0
 11 12  1  0
 12 13  1  0
  7 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  6
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  3
 28 29  1  0
 29 18  1  0
 29 23  2  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  1  0
 35 37  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7677

> <plate>
1

> <well>
H03

> <supplier_cmpd_name>
Indacaterol Maleate

> <ctcr_id>
7388

> <supplier_cmpd_id>
S3083

> <smiles>
CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c3ccc(O)c4NC(=O)C=Cc34.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{753498-25-8,"Arcapta Neohaler","Indacaterol (maleate)",UNII-2JEC1ITX7R,Onbrez,2JEC1ITX7R,QAB149-AFA,QAB-149-AFA,CHEBI:68573,"753498-25-8 (malate)","Indacaterol maleate (USAN)","QAB 149AFA","Oslif Bre
ezhaler","Onbrez Breezhaler","Hirobriz Breezhaler","QAB-149 maleate","Arcapta neohaler (TN)","Onbrez Inhalation Capsules","Indacaterol Maleic Acid Salt",SCHEMBL523627,CHEMBL1789842,"Indacaterol maleat
e (JAN/USAN)",HMS3885O07,C24H28N2O3.C4H4O4,2474AH,HY-14299A,MFCD20526769,CCG-269764,AC-30121,AK163936,AS-10152,AB0073003,I0927,S3083,D09319,Q-4501,Q27137018,"Indacaterol Maleate"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9827599}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 27  0  0  1  0            999 V2000
   11.4915   -3.3820    0.0000 Cl  0  5
   -1.3000   -8.2636    0.0000 F   0  0
   -0.0021   -7.5115    0.0000 C   0  0
   -0.0045   -6.0115    0.0000 C   0  0
    1.2934   -5.2595    0.0000 C   0  0
    2.5937   -6.0074    0.0000 C   0  0
    2.5960   -7.5075    0.0000 C   0  0
    1.2981   -8.2595    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0  2  0  0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 N   0  0
    5.1925   -3.0070    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0  1  0  0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    8.9915   -3.3820    0.0000 H   0  3
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  9  6  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 14 15  1  6
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
 24 25  2  0
 25 17  1  0
M  CHG  2   1  -1  26   1
M  END
> <name>
Selleck_GPCR

> <id>
7678

> <plate>
1

> <well>
H04

> <supplier_cmpd_name>
Plerixafor 8HCl (AMD3100 8HCl)

> <ctcr_id>
4681

> <supplier_cmpd_id>
S3013

> <smiles>
[Cl-].Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3.[H+]

> <pd_targets>
{KMT2A,MEN1,TGR,KCNH2,SLC6A2,HTR1A,HTR2A,HTR3A,SLC6A4,SLC6A3,ADRA1A,CYP3A4,P2RX4,GRK2,MPO,ADRA2A,ADRA2C,CHRM2,CHRM1,CHRM5,ADRA2B,CHRM3,ADRA1B,ADRA1D,NORA,CYP2D6,CHRM4,THPO,CYP1A2,NFKB1,MAPK1,LMNA,TP53
,NET,PMP22,ABCB11,RORC,TACR1,MTOR,SIGMAR1,CACNA1C,CACNA1D,CACNA1F,CACNA1S,ABCB1,ADRB1,ADRB2,ADRB3,DRD2,HRH1,HTR2B,DRD1,DRD5}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Ion channel",Transporter,"Membrane receptor","Unclassified protein","Other cytosolic protein","Other nuclear protein","Transcription factor",Reader,"Voltage-gated ion c
hannel","Electrochemical transporter","Family A G protein-coupled receptor","Ligand-gated ion channel","Cytochrome P450",Kinase,Oxidoreductase,"Primary active transporter","Nuclear receptor",Bromodoma
in,"Potassium channels","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","5HT3 receptor","Cytochrome P450 family 3","P2X receptor","Protein Kinase","Cytochrome P450 famil
y 2","Cytochrome P450 family 1","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","Voltage-gated potassium channel","SLC0
6 neurotransmitter transporter family","Monoamine receptor","Cytochrome P450 family 3A","AGC protein kinase group","Cytochrome P450 family 2D","Cytochrome P450 family 1A","CMGC protein kinase group","
ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Serotonin receptor","Adrenergic receptor","Cytochrome P450 3A4"
,"AGC protein kinase GRK family","Acetylcholine receptor","Cytochrome P450 2D6","Cytochrome P450 1A1","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Neuroki
nin receptor","Atypical protein kinase PIKK family","Dopamine receptor","Histamine receptor","AGC protein kinase BARK subfamily","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Ion channels",Receptors,Transporters,Enzymes,"Other protein targets","Voltage-gated ion channels","G protein-coupled receptors","Ligand-gated ion channels","SLC superfamily of solute carriers","Cyto
chrome P450","Kinases (EC 2.7.x.x)","1.-.-.- Oxidoreductases","ATP-binding cassette transporter family","Nuclear hormone receptors","Sigma receptors","Potassium channels","5-Hydroxytryptamine receptor
s","5-HT<sub>3</sub> receptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"CYP3 family","P2X receptors","AGC: Containing PKA",PKG,"PKC families","Acetylcholine receptors (muscarinic)","
CYP2 family: drug metabolising subset","CYP1 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","ABCB subfamily","1F. Retinoic acid-related orphans","Tachykinin receptors",Atypical,"Dopamine rece
ptors","Histamine receptors","Voltage-gated potassium channels","Monoamine transporter subfamily","G protein-coupled receptor kinases (GRKs)","Mitogen-activated protein kinases (MAP kinases)","Phospha
tidyl inositol 3' kinase-related kinases (PIKK) family","Beta-adrenergic receptor kinases (&beta;ARKs)","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{"Muscle contraction","Signal Transduction","Neuronal System",Disease,Metabolism,"Immune System",Hemostasis,"Cell Cycle","Developmental Biology","Gene expression (Transcription)","Cardiac conduction",
"Signaling by GPCR","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Metabolism of lipids","Infectious disease","Intracellular signaling by second messengers","Innate
 Immune System","Biological oxidations","Platelet activation","signaling and aggregation","Cytokine Signaling in Immune system",Mitotic,"Cell Cycle Checkpoints","Nervous system development","RNA Polym
erase II Transcription","Abacavir transport and metabolism","Phase 3 - rapid repolarisation","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Neurotransmitter c
learance","SLC transporter disorders","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","DAG and IP3 signaling","ROS and RNS production in phagocytes","Phase I - Funct
ionalization of compounds","Platelet Aggregation (Plug Formation)","Signaling by Interleukins","Toll-like Receptor Cascades","M Phase","G1/S DNA Damage Checkpoints","EGR2 and SOX10-mediated initiation
 of Schwann cell myelination","Metabolism of steroids","Generic Transcription Pathway","SARS-CoV Infections","Abacavir transmembrane transport","Class A/1 (Rhodopsin-like receptors)","Serotonin cleara
nce from the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Biosynthesis of DHA-derived SPMs","Cell recruitment (pro-inflammatory response)","CaM pathway","Events a
ssociated with phagocytolytic activity of PMN cells","Defective SLC6A2 causes orthostatic intolerance (OI)","Cytochrome P450 - arranged by substrate type","Interleukin-1 family signaling","Toll Like R
eceptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","p53-Dependent G1/S DNA damage checkpoint","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX3","Transcriptional Regula
tion by TP53","Potential therapeutics for SARS","Amine ligand-binding receptors","Biosynthesis of maresins","Purinergic signaling in leishmaniasis infection","Calmodulin induced events",Xenobiotics,"I
nterleukin-1 signaling","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","p53-Dependent G1 DNA Damage Response","Synthesis of bile acids and bile salts","RUNX3 Regulates Immune Response
 and Cell Migration","Peptide ligand-binding receptors","Regulation of TP53 Activity","Serotonin receptors",Adrenoceptors,"Biosynthesis of maresin-like SPMs","Muscarinic acetylcholine receptors","CYP2
E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","MAP kinase activation","Nuclear Envelope (NE) Reassembly","Stabilization 
of p53","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Tachykinin receptors bind tachykinins","Regulation of TP53 Expression and Degradation","Dopamine receptors","Histamine r
eceptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","E
RK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HTR2A,SLC6A2,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{RESTW85,"Paroxetine hydrochloride","Paroxetine Hcl",78246-49-8,78246498,Paroxat,Paxil,Seroxat,"paroxetine (hydrochloride)",110429-35-1,110429351,Aropax,"Paroxetine hydrochloride (USP)",C19H21ClFNO3,U
NII-3I3T11UD2S,UNII3I3T11UD2S,"Paroxetine hydrochloride hemihydrate",3I3T11UD2S,Paroxe,S3005,S3013,1504085,Prestw-851,"Paroxetine HCl","Plerixafor 8HCl (AMD3100 8HCl)","PAROXETINE HYDROCHLORIDE","Paro
xetine Hydrochloride"}

> <pdid>
PD002925

> <targets>
{CXCR,"5-HT Receptor"}

> <classes>
{"Neuronal Signaling",antidepressant,"GPCR & G Protein"}

> <pubchem_cids>
{10915512,62878,68492682}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 30  0  0  1  0            999 V2000
    4.9133   -2.4605    0.0000 Br  0  5
   -2.6079   -6.7003    0.0000 C   0  0
   -1.1079   -6.7042    0.0000 N   0  0
   -0.2222   -7.9149    0.0000 C   0  0
    1.2028   -7.4466    0.0000 C   0  0
    1.1979   -5.9466    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0  2  0  0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  3
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 S   0  0
   -5.2029    2.9932    0.0000 O   0  0
   -3.9027    2.2457    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -6.4969   -0.7591    0.0000 C   0  0
   -7.7948   -1.5109    0.0000 C   0  0
   -9.0949   -0.7628    0.0000 C   0  0
   -9.0971    0.7372    0.0000 C   0  0
   -7.7991    1.4891    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  1
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  2  0
 18 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 15 27  1  0
 27 28  2  0
 28  9  1  0
 28 12  1  0
M  CHG  2   1  -1  11   1
M  END
> <name>
Selleck_GPCR

> <id>
7679

> <plate>
1

> <well>
H05

> <supplier_cmpd_name>
Eletriptan HBr

> <ctcr_id>
7287

> <supplier_cmpd_id>
S3180

> <smiles>
[Br-].CN1CCC[C@@H]1CC2=C[NH2+]c3ccc(CC[S](=O)(=O)c4ccccc4)cc23

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Eletriptan hydrobromide",177834-92-3,177834923,"Eletriptan HBr",Relpax,UNII-M41W832TA3,UNIIM41W832TA3,"Eletriptan (hydrobromide)","eletriptan monohydrobromide","UK 116044-04","UK 11604404",C22H26N2O
2S.HBr,CHEBI:61176,M41W832TA3,"UK-116,044-04","UK116,04404","Eletriptan Hydrobromide (USAN)",S3180,"Eletriptan HBr"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{656631,67075126,11397100}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 38  0  0  0  0            999 V2000
   12.5334   -5.2717    0.0000 H   0  3
   10.0334   -5.2717    0.0000 Cl  0  5
    4.4991   -8.4771    0.0000 O   0  0
    3.8490   -7.1253    0.0000 C   0  0
    4.6946   -5.8864    0.0000 C   0  0
    4.0445   -4.5346    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    1.7031   -5.6606    0.0000 C   0  0
    2.3532   -7.0124    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    0.3114   -2.9665    0.0000 S   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    3.8794   -1.4442    0.0000 C   0  0
    4.3452   -0.0184    0.0000 O   0  0
    4.8823   -2.5608    0.0000 C   0  0
    6.3506   -2.2538    0.0000 C   0  0
    7.3506   -3.3718    0.0000 C   0  0
    6.8824   -4.7969    0.0000 C   0  0
    7.8807   -5.9176    0.0000 O   0  0
    7.4102   -7.3427    0.0000 C   0  0
    8.4085   -8.4634    0.0000 C   0  0
    7.9380   -9.8886    0.0000 N   0  0
    8.9341  -11.0101    0.0000 C   0  0
    8.4610  -12.4335    0.0000 C   0  0
    6.9917  -12.7355    0.0000 C   0  0
    5.9956  -11.6141    0.0000 C   0  0
    6.4687  -10.1906    0.0000 C   0  0
    5.4142   -5.1039    0.0000 C   0  0
    4.4141   -3.9859    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
 19 10  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 29  1  0
 25 35  1  0
 35 36  2  0
 36 22  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7680

> <plate>
1

> <well>
H06

> <supplier_cmpd_name>
Raloxifene HCl

> <ctcr_id>
6458

> <supplier_cmpd_id>
S1227

> <smiles>
[H+].[Cl-].Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4

> <pd_targets>
{ESR1,MAPT,FFP,ALOX15,TP53,UBE2N,ESR2,LMNA,ALDH1A1,AMPC,NPSR1,FTL,HTT,LEF,BLM,NFO,NS1,HSD17B10,RORC,PMP22,GMNN,KMT2A,CYP3A4,HLA-A,MEN1,AOX1,PLD1,CYP2D6,ADRA1A,C5,CYP2C19,CYP2C9,NFKB1,HTR1B,GPER1,EBP,T
HPO,SIGMAR1,ERG2,TSHR,CHRM1,PLD2,ADRA1B,RECQL,NR1H4,HTR2B,ADRA2B,DRD3,TACR2,MTOR,SLC6A3,OPRD1,FYN,SLC6A4,NR1I2,ACHE,ADRA1D,OPRK1,OPRM1,HTR2C,ADRA2A,ADRA2C,HTR2A,SLC6A2,DRD2,HTR6,ADORA2A}

> <pathway_gtopdb>
{"Transcription factor","Other cytosolic protein",Enzyme,"Other nuclear protein","Membrane receptor","Unclassified protein","Epigenetic regulator","Surface antigen","Secreted protein",Transporter,"Nuc
lear receptor",Transferase,Oxidoreductase,Aminoacyltransferase,Hydrolase,"Family A G protein-coupled receptor",Protease,Reader,"Cytochrome P450",Isomerase,Kinase,"Electrochemical transporter","Nuclear
 hormone receptor subfamily 3","Peptide receptor (family A GPCR)","Metallo protease","Nuclear hormone receptor subfamily 1",Bromodomain,"Cytochrome P450 family 3","Cytochrome P450 family 2","Small mol
ecule receptor (family A GPCR)","Cysteine protease","Protein Kinase","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 3 group A","Short peptide receptor (family A GPCR)","Metal
lo protease MAE clan","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Monoamine receptor","Cytochrome P450 family 2C","Cysteine protease CA clan
","Lipid-like ligand receptor (family A GPCR)","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group H","Atypical protein kinase group","SLC06 neurotransmitter transporter family","TK pr
otein kinase group","Nuclear hormone receptor subfamily 1 group I","Nucleotide-like receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamil
y 3 group A member 2","Neuropeptide receptor","Metallo protease M34 family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P450 2D6","Adrenergic receptor","C
ytochrome P450 2C19","Cytochrome P450 2C9","Cysteine protease C1A family","Serotonin receptor","Steroid-like ligand receptor","Acetylcholine receptor","Nuclear hormone receptor subfamily 1 group H mem
ber 4","Dopamine receptor","Neurokinin receptor","Atypical protein kinase PIKK family","Opioid receptor","Tyrosine protein kinase Src family","Nuclear hormone receptor subfamily 1 group I member 2","A
denosine receptor","Atypical protein kinase FRAP subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets",Transporters,"Nuclear hormone receptors","Eicosanoid turnover","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","Glycerophosphol
ipid turnover","Sigma receptors","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","Catalytic receptors","Acetylcholine turnover","Steroid hormone receptors",Lipoxygenases,"Neuropeptide S re
ceptor","1F. Retinoic acid-related orphans","2.1.1.43 Histone methyltransferases (HMTs)","CYP3 family","Phosphatidylcholine-specific phospholipase D","CYP2 family: drug metabolising subset",Adrenocept
ors,"5-Hydroxytryptamine receptors","G protein-coupled estrogen receptor","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","1H. Liver X receptor-like receptors","Dopamine recept
ors","Tachykinin receptors",Atypical,"SLC6 neurotransmitter transporter family","Opioid receptors","Receptor kinases","1I. Vitamin D receptor-like receptors","Adenosine receptors","3A. Estrogen recept
ors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Monoamine transporter subfamily","TK: Tyrosine kinase","FRAP subfamily","Non-receptor tyrosine kinases (nRTKs)","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System",Metabolism,"Cell Cycle","Immune System","Signal Transduction",Disease,"Vesicle-mediated transport","DNA Repair","Developmental Biology",Hemostasis,
"Metabolism of proteins","RNA Polymerase II Transcription","Transmission across Chemical Synapses","Metabolism of lipids","Cell Cycle Checkpoints","Innate Immune System","Intracellular signaling by se
cond messengers",Mitotic,"Biological oxidations","Infectious disease","Membrane Trafficking","DNA Double-Strand Break Repair","Metabolism of amino acids and derivatives","Nervous system development","
Adaptive Immune System","Metabolism of vitamins and cofactors","Signaling by GPCR","Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Disorders of transmembrane t
ransporters","Post-translational protein modification","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving media
tors (SPMs)","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","PIP3 activates AKT signaling","M Phase","Phase I - Functionalization of compounds","Leishmania infection","trans-Golgi Network
 Vesicle Budding","Uptake and actions of bacterial toxins","Homology Directed Repair","Branched-chain amino acid catabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Mitotic G
1 phase and G1/S transition","Class I MHC mediated antigen processing & presentation","Metabolism of water-soluble vitamins and cofactors","Phospholipid metabolism","GPCR ligand binding","Signaling by
 Interleukins","Metabolism of steroids","Platelet Aggregation (Plug Formation)","SARS-CoV Infections","SLC transporter disorders","HIV Infection","Neurotransmitter clearance",SUMOylation,"GPCR downstr
eam signalling","Transcriptional regulation by RUNX1","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","Toll Like Re
ceptor 4 (TLR4) Cascade","Negative regulation of the PI3K/AKT network","Mitotic Metaphase and Anaphase","Ethanol oxidation","Leishmania parasite growth and survival","Golgi Associated Vesicle Biogenes
is","Transcriptional Regulation by MECP2","Uptake and function of anthrax toxins","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional regulation by RUNX3","G
1/S Transition","Biosynthesis of DHA-derived SPMs","Antigen processing-Cross presentation","Vitamins B6 activation to pyridoxal phosphate","Glycerophospholipid biosynthesis","Cytochrome P450 - arrange
d by substrate type","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","Cholesterol biosynthesis","Potential therapeutics for SARS","Bile acid and bile salt metabolism","Transcri
ptional Regulation by TP53","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Host Interactions of HIV factors","Serotonin clearance from the synaptic cleft","SUMO E3 ligases SUMOylat
e target proteins","G alpha (i) signalling events","Defective SLC6A2 causes orthostatic intolerance (OI)","RUNX1 regulates estrogen receptor mediated transcription","Post NMDA receptor activation even
ts","Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response","MyD88-independent TLR4 cascade",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Mitotic Anaphase","Anti-inflammatory respons
e favouring Leishmania parasite infection","Regulation of MECP2 expression and activity","HDR through Homologous Recombination (HRR)","RUNX3 Regulates Immune Response and Cell Migration","Activation o
f the pre-replicative complex","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Biosynthesis of maresins","Endosomal/Vacuolar pathway","Synthesis of PA",Xenobio
tics,"Amine ligand-binding receptors","Peptide ligand-binding receptors","Interleukin-1 signaling","Cholesterol biosynthesis via desmosterol","Synthesis of bile acids and bile salts","Regulation of TP
53 Activity","The role of Nef in HIV-1 replication and disease pathogenesis","SUMOylation of intracellular receptors","Synthesis of PC","MECP2 regulates neuronal receptors and channels","Opioid Signal
ling","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and resolvins","Stabilization of p53","TRIF(TICAM1)-mediated TLR4 signaling","Nuclear Envelope (NE) Reassembl
y","ADORA2B mediated anti-inflammatory cytokines production","Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","CYP2E1 reactions",Adrenoceptors,"MAP3K8 (TPL2)-dependent 
MAPK1/3 activation","Serotonin receptors","Muscarinic acetylcholine receptors","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Dopamine receptors","Tachykinin receptors bind tachyk
inins","Regulation of TP53 Expression and Degradation","Nef and signal transduction","G-protein activation","Autodegradation of the E3 ubiquitin ligase COP1","IKK complex recruitment mediated by RIP1"
,"Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degradation"}

> <broad_targets>
{ESR1,ESR2}

> <broad_moa>
{"estrogen receptor antagonist","selective estrogen receptor modulator (SERM)"}

> <synonyms>
{MLS001304731,HMS2233M16,HMS3372E10,AKOS015960340,SMR000752510,"RALOXIFENE HYDROCHLORIDE",82640-04-8,"Raloxifene Hcl",Evista,"Keoxifene hydrochloride",Keoxifene,"LY 156758","Raloxifene (hydrochloride)
",UNII-4F86W47BR6,C28H28ClNO4S,LY156758,LY-156758,CHEBI:50740,"Evista (Raloxifene Hydrochloride)",4F86W47BR6,Optruma,MFCD01938233,"82640-04-8 (HCl)",DSSTox_CID_14181,DSSTox_RID_79119,DSSTox_GSID_34181
,SMR000058508,NCGC00015889-05,CAS-82640-04-8,C28H27NO4S.HCl,Loxifen,SR-01000076102,CDT-Raloxifene,"Raloxifene-d4 HCl","Evista (TN)",Prestwick_1035,"Raloxifene hydrochloride (USAN:USP)","Methanone, hyd
rochloride",CHEMBL1116,SCHEMBL19077,cc-148,MLS000859902,MLS001332533,MLS001332534,MLS002222293,"Raloxifene hydrochloride, solid","Evista, Raloxifene hydrochloride",DTXSID1034181,"LY-139481 HCl",HMS157
0N05,Pharmakon1600-01505622,AMY23426,BCP05713,"Raloxifene hydrochloride (JAN/USP)",Tox21_110255,Tox21_302369,Tox21_501051,ANW-54600,HY-13738A,NSC706725,NSC759285,s1227,AKOS008131940,Tox21_110255_1,AC-
8390,CCG-213497,CS-1775,DS-2162,KS-1102,LP01051,MCULE-7336063262,NC00665,NSC-706725,NSC-759285,VA11647,NCGC00015889-03,NCGC00015889-11,NCGC00092353-01,NCGC00092353-03,NCGC00094334-01,NCGC00094334-02,N
CGC00255153-01,NCGC00261736-01,AK-54611,AB0020647,EU-0101051,FT-0630912,R0109,SW197106-5,V1611,EN300-52517,D02217,J90021,M-8965,"R 1402",68523-EP2270008A1,68523-EP2292617A1,68523-EP2298768A1,68523-EP2
308855A1,640R048,Q-201656,SR-01000076102-2,SR-01000076102-9,Q27122215,"(6-OXO-1,6-DIHYDRO-PYRIDAZIN-3-YLOXY)-ACETICACID","Raloxifene hydrochloride, European Pharmacopoeia (EP) Reference Standard",AKOS
026750144,S1227,SAM002548975,1505622,Prestw-862,"Raloxifene HCl",CPD000058508,"Raloxifene hydrochloride"}

> <pdid>
PD004108

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{antiestrogen,"Endocrinology & Hormones"}

> <pubchem_cids>
{11071264,54900,25010765}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 25  0  0  0  0            999 V2000
    4.9852    2.6764    0.0000 Cl  0  0
    3.8856    1.6562    0.0000 C   0  0
    4.2194    0.1938    0.0000 C   0  0
    3.1198   -0.8265    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1695   -0.6090    0.0000 C   0  0
   -3.7175   -2.0053    0.0000 C   0  0
   -2.7822   -3.1781    0.0000 C   0  0
   -1.2990   -2.9545    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.4012   -2.9095    0.0000 C   0  0
    0.4925   -4.1079    0.0000 C   0  0
    1.0734   -5.4909    0.0000 C   0  0
    2.5615   -5.6793    0.0000 N   0  0
    3.4687   -4.4848    0.0000 C   0  0
    2.8879   -3.1018    0.0000 C   0  0
    2.4522    2.0983    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15  5  1  0
 15 16  2  3
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
  6 22  2  0
 22  2  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7681

> <plate>
1

> <well>
H07

> <supplier_cmpd_name>
Desloratadine

> <ctcr_id>
6488

> <supplier_cmpd_id>
S4012

> <smiles>
Clc1ccc2c(CCc3cccnc3C2=C4CCNCC4)c1

> <pd_targets>
{KMT2A,MEN1,GLRA1,GLRA2,GLRA3,GLRB,HRH1,HRH4,ADRA1B,LMNA,AMPC,TGR,SLC6A2,CHRM2,HTR2A,HRH2,CHRM4,CHRM5,SLC6A4,ABCB1,DRD3,CHRM3,HTR2C,ADRA2B,HTR2B,SLC6A3,CHRM1,HTR6}

> <pathway_gtopdb>
{"Epigenetic regulator","Ion channel","Membrane receptor","Other nuclear protein",Enzyme,Transporter,Reader,"Ligand-gated ion channel","Family A G protein-coupled receptor",Hydrolase,"Electrochemical 
transporter","Primary active transporter",Bromodomain,"Glycine receptor","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","ATP-binding cassette","Monoamine receptor","SLC
06 neurotransmitter transporter family","ABCB subfamily","Histamine receptor","Adrenergic receptor","Acetylcholine receptor","Serotonin receptor","Dopamine receptor"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Histamine receptors",Adrenoceptors,"SLC6 neurotransmitter transpor
ter family","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","ABCB subfamily","Dopamine receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Signal Transduction","Cell Cycle",Disease,"Neuronal System",Metabolism,"Signaling by GPCR",Mitotic,"Disorders of transmembrane transporters","Infectious disease","Transmission across Chemical Synaps
es","Abacavir transport and metabolism","GPCR ligand binding","M Phase","SLC transporter disorders","Leishmania infection","Neurotransmitter clearance","Abacavir transmembrane transport","Class A/1 (R
hodopsin-like receptors)","Mitotic Metaphase and Anaphase","Defective SLC6A2 causes orthostatic intolerance (OI)","Leishmania parasite growth and survival","Serotonin clearance from the synaptic cleft
","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Amine ligand-binding receptors","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Histamine 
receptors",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Dopamine receptors","I
nitiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{Desloratadine,100643-71-8,100643718,Clarinex,Descarboethoxyloratadine,Desloratidine,Neoclarityn,Sch-34117,Sch34117,Aerius,Azomyr,Denosin,"Sch 34117",Descarboethoxyoratidine,UNII-FVF865388R,UNIIFVF865
388R,MFCD00871949,CHEMBL1172,"Loratadine related compound a",C19H19ClN2,MLS000559042,S4012,SAM001246545,1505393,Prestw-1390,CPD000149358,DESLORATIDINE}

> <pdid>
PD000515

> <targets>
{"Histamine Receptor"}

> <classes>
{H1-antihistamine,"Neuronal Signaling"}

> <pubchem_cids>
{124087}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 48 50  0  0  1  0            999 V2000
   21.8295   -2.9246    0.0000 O   0  0
   -1.8778    2.7573    0.0000 C   0  0
   -1.0947    1.4779    0.0000 N   0  0
    0.0000    0.6568    0.0000 C   0  0  2  0  0  0
   -0.6568   -0.6386    0.0000 C   0  0
   -1.8063   -1.3319    0.0000 C   0  0
   -0.8393    0.0000    0.0000 C   0  0  1  0  0  0
    0.9488    0.0000    0.0000 C   0  0
    1.8975   -0.8028    0.0000 C   0  0  2  0  0  0
    1.6421    0.6933    0.0000 C   0  0
    2.6599   -2.0832    0.0000 O   0  0
    1.9266   -3.3927    0.0000 C   0  0
    0.4267   -3.4119    0.0000 O   0  0
    2.6932   -4.6829    0.0000 C   0  0
    4.1939   -4.6606    0.0000 C   0  0
    4.9253   -3.3510    0.0000 O   0  0
    1.9600   -5.9924    0.0000 C   0  0
    2.7243   -7.2831    0.0000 C   0  0
    1.9888   -8.5904    0.0000 C   0  0
    0.4888   -8.6071    0.0000 C   0  0
   -0.2755   -7.3164    0.0000 C   0  0
    0.4600   -6.0092    0.0000 C   0  0
    7.4261    2.7573    0.0000 C   0  0
    8.2091    1.4779    0.0000 N   0  0
    9.3038    0.6568    0.0000 C   0  0  2  0  0  0
    8.6470   -0.6386    0.0000 C   0  0
    7.4976   -1.3319    0.0000 C   0  0
    8.4646    0.0000    0.0000 C   0  0  1  0  0  0
   10.2526    0.0000    0.0000 C   0  0
   11.2014   -0.8028    0.0000 C   0  0  2  0  0  0
   10.9459    0.6933    0.0000 C   0  0
   11.9637   -2.0832    0.0000 O   0  0
   11.2304   -3.3927    0.0000 C   0  0
    9.7306   -3.4119    0.0000 O   0  0
   11.9971   -4.6829    0.0000 C   0  0
   13.4977   -4.6606    0.0000 C   0  0
   14.2291   -3.3510    0.0000 O   0  0
   11.2638   -5.9924    0.0000 C   0  0
   12.0281   -7.2831    0.0000 C   0  0
   11.2926   -8.5904    0.0000 C   0  0
    9.7927   -8.6071    0.0000 C   0  0
    9.0283   -7.3164    0.0000 C   0  0
    9.7638   -6.0092    0.0000 C   0  0
   18.0295   -1.4246    0.0000 O   0  0
   18.0295   -2.9246    0.0000 S   0  0
   18.0295   -4.4246    0.0000 O   0  0
   16.7303   -3.6742    0.0000 O   0  0
   19.3288   -3.6742    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  1
  5  6  1  0
  7  6  1  6
  7  3  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  4  1  0
  9 11  1  6
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  1
 26 27  1  0
 28 27  1  6
 28 24  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 25  1  0
 30 32  1  6
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  1  0
 36 37  1  0
 35 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 38  1  0
 44 45  1  0
 45 46  1  0
 45 47  2  0
 45 48  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7682

> <plate>
1

> <well>
H08

> <supplier_cmpd_name>
Atropine

> <ctcr_id>
7174

> <supplier_cmpd_id>
S2130

> <smiles>
O.CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3.CN4[C@@H]5CC[C@H]4C[C@H](C5)OC(=O)C(CO)c6ccccc6.O[S](O)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Tropine,Pseudotropine,8-Methyl-8-azabicyclo(3.2.1)octan-3-ol,8Methyl8azabicyclo(3.2.1)octan3ol,120-29-6,120296,3-Tropanol,3Tropanol,endo-8-methyl-8-azabicyclo(3.2.1)octan-3-ol,endo8methyl8azabicyclo(
3.2.1)octan3ol,Tropanol,7432-10-2,7432102,3.alpha.-Tropanol,3.alpha.Tropanol,Tropin,"N-Tropine (trans)","NTropine (trans)","8-Azabicyclo(3.2.1)octan-3-ol, 8-methyl-, endo-","8Azabicyclo(3.2.1)octan3ol
, 8methyl, endo",NSC43870,T0375L,T4S1619,T0375L2,S2130,"Atropine sulfate monohydrate","Hyoscyamine sulfate hydrate","Atropine sulfate",Atropine}

> <pdid>
PD002296

> <targets>
{Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{8424}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 31  0  0  0  0            999 V2000
   -5.0019    0.8454    0.0000 C   0  0
   -3.5348    0.5331    0.0000 N   0  0
   -2.5311    1.6478    0.0000 C   0  0
   -3.0705   -0.8941    0.0000 C   0  0
   -1.6026   -1.2066    0.0000 C   0  0
   -1.1384   -2.6339    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 O   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    0.0000    4.5008    0.0000 N   0  0
    0.7935   -4.3741    0.0000 C   0  0
   -0.1925   -5.5045    0.0000 C   0  0
    0.2934   -6.9236    0.0000 C   0  0
    1.7654   -7.2123    0.0000 C   0  0
    2.2513   -8.6314    0.0000 F   0  0
    2.7514   -6.0819    0.0000 C   0  0
    2.2654   -4.6628    0.0000 C   0  0
    6.5514   -0.1902    0.0000 O   0  0
    6.5514   -1.6902    0.0000 C   0  0
    5.2521   -2.4398    0.0000 O   0  0
    7.8514   -2.4402    0.0000 C   0  0
    7.8514   -3.9402    0.0000 O   0  0
    9.1506   -1.6906    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15  7  1  0
 15 10  1  0
 12 16  1  0
 16 17  3  0
  7 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7683

> <plate>
1

> <well>
H09

> <supplier_cmpd_name>
Escitalopram Oxalate

> <ctcr_id>
3809

> <supplier_cmpd_id>
S4064

> <smiles>
CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3.OC(=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Citalopram Oxalate",1246819-94-2,1246819942,"S-(+)-Citalopram oxalate","S(+)Citalopram oxalate",Cipralex;Lexapro,MFCD06407826,"Citalopram oxalate D6",207559-01-1,207559011,"(+/-)-Citalopram oxalate"
,"(+/)Citalopram oxalate","(R)-Citalopram Oxalate-(d6)","(R)Citalopram Oxalate(d6)","(S)-Citalopram-(d6) Oxalate","(S)Citalopram(d6) Oxalate",SCHEMBL2010566,HMS,T6493,S4064,"Escitalopram Oxalate"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{21871605}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 37 39  0  0  1  0            999 V2000
    2.5909   -6.0056    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1887   -6.0105    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0  1  0  0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -9.0976    3.7432    0.0000 Cl  0  0
   -6.4995    3.7432    0.0000 C   0  0
   -5.2004    2.9933    0.0000 C   0  0
   -3.8964   -0.7553    0.0000 C   0  0
   -5.1931   -1.5094    0.0000 C   0  0
   -5.1885   -3.0094    0.0000 C   0  0
   -3.8871   -3.7554    0.0000 C   0  0
   -2.5904   -3.0014    0.0000 C   0  0
   -2.5951   -1.5014    0.0000 N   0  0
   11.5868   -3.3835    0.0000 O   0  0
   11.5872   -1.8835    0.0000 S   0  0
   12.8867   -1.1343    0.0000 O   0  0
   12.8859   -2.6341    0.0000 O   0  0
   10.2875   -1.1331    0.0000 C   0  0
   10.2875    0.3669    0.0000 C   0  0
    8.9884    1.1169    0.0000 C   0  0
    7.6894    0.3669    0.0000 C   0  0
    7.6894   -1.1331    0.0000 C   0  0
    8.9884   -1.8831    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  1  0
 10 13  1  0
 14 13  1  6
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 14 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 28 29  1  0
 29 30  2  0
 29 31  2  0
 29 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 32  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7684

> <plate>
1

> <well>
H10

> <supplier_cmpd_name>
Bepotastine Besilate

> <ctcr_id>
7267

> <supplier_cmpd_id>
S3037

> <smiles>
OC(=O)CCCN1CCC(CC1)O[C@@H](c2ccc(Cl)cc2)c3ccccn3.O[S](=O)(=O)c4ccccc4

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Bepotastine besilate",190786-44-8,190786448,"Bepotastine besylate",Bepreve,Talion,"Betotastine besilate","Bepotastine benzenesulfonate","Bepotastine (Beslilate)",UNII-6W18MO1QR3,UNII6W18MO1QR3,TAU-2
84,TAU284,"Bepotastine besylate (USAN)",6W18MO1QR3,CHEBI:31281,"190786-44-8 (besyl","190786448 (besyl",S3037,"Bepotastine Besilate"}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{164521}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 19 20  0  0  0  0            999 V2000
    1.2916   -5.2495    0.0000 C   0  0
    1.2948   -3.7495    0.0000 N   0  0
   -0.0028   -2.9971    0.0000 C   0  0
    2.5957   -3.0011    0.0000 C   0  0
    2.5990   -1.5003    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7504    0.0000 C   0  0
    3.9010    0.7496    0.0000 O   0  0
    3.8617   -2.2295    0.0000 C   0  0
    5.1601   -2.9806    0.0000 C   0  0
    6.4597   -2.2317    0.0000 C   0  0
    6.4610   -0.7317    0.0000 C   0  0
    5.1626    0.0194    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
  5 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 13  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7685

> <plate>
1

> <well>
H11

> <supplier_cmpd_name>
Desvenlafaxine

> <ctcr_id>
5177

> <supplier_cmpd_id>
S4113

> <smiles>
CN(C)CC(c1ccc(O)cc1)C2(O)CCCCC2

> <pd_targets>
{SLC6A2,SLC6A4,SLC6A3,ADRA1A}

> <pathway_gtopdb>
{Transporter,"Membrane receptor","Electrochemical transporter","Family A G protein-coupled receptor","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","SLC06 neurotransmit
ter transporter family","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Transporters,Receptors,"SLC superfamily of solute carriers","G protein-coupled receptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"Monoamine transporter subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Signaling by GPCR","SLC transporter disorders","Neurotransmitter cle
arance","GPCR ligand binding","Defective SLC6A2 causes orthostatic intolerance (OI)","Serotonin clearance from the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Cl
ass A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors",Adrenoceptors}

> <broad_targets>
{SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"serotoninâ€“norepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{Desvenlafaxine,93413-62-8,93413628,O-Desmethylvenlafaxine,ODesmethylvenlafaxine,4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol,4(2(Dimethylamino)1(1hydroxycyclohexyl)ethyl)phenol,"O-desmeth
yl venlafaxine","Odesmethyl venlafaxine",O-Desvenlafaxine,ODesvenlafaxine,"d,l-O-Desmethylvenlafaxine","d,lODesmethylvenlafaxine",CHEBI:83527,"93413-62-8 (free base)","93413628 (free base)","Desvenlaf
axine, 97",1-(2,1(2,T1580,S4113}

> <pdid>
PD009285

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{125017}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 28  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 N   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6078    5.9988    0.0000 C   0  0
   -2.6131    7.4988    0.0000 C   0  0
   -3.9148    8.2443    0.0000 C   0  0
   -5.2112    7.4898    0.0000 C   0  0
   -6.5128    8.2353    0.0000 O   0  0
   -5.2060    5.9898    0.0000 C   0  0
   -3.9044    5.2443    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5536   -4.4230    0.0000 C   0  0
   -4.0145   -4.6748    0.0000 O   0  0
   -4.2107   -6.1619    0.0000 C   0  0
   -2.8569   -6.8080    0.0000 C   0  0
   -1.8241   -5.7201    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
  4 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20  2  1  0
 20 16  1  0
 18 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7686

> <plate>
1

> <well>
H12

> <supplier_cmpd_name>
ZM241385

> <ctcr_id>
8204

> <supplier_cmpd_id>
S8105

> <smiles>
Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4

> <pd_targets>
{ADORA2B,ADORA2A,ADORA1,CYP2D6,CYP3A4,ALDH1A1,ADORA3,FFP,HSD17B10,CYP2C9,CYP1A2,SMN1,MAPK1,LEF}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Family A G protein-coupled receptor","Cytochrome P450",Oxidoreductase,Transferase,Reader,Kinase,Protease,"Small molecule receptor (family A GPCR)","
Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","Methyl-lysine/arginine binding protein","Protein Kinase","Metallo protease","Nucleotide-like receptor (family A GPCR)",
"Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Tudor domain","CMGC protein kinase group","Metallo protease MAE clan","Adenosine recept
or","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450 1A1","CMGC protein kinase MAPK family","Metallo protease M34 family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Kinases (EC 2.7.x.x)","Adenosine receptors","CYP2 family: drug metabolising subset","CYP3 family","CYP1 family","CMGC: Containing CD
K",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Disease,"Signal Transduction",Metabolism,"Metabolism of RNA","Immune System","Infectious disease","Signaling by GPCR","Biological oxidations","Metabolism of lipids","Metabolism of amino acids and der
ivatives","Metabolism of non-coding RNA","Innate Immune System","Leishmania infection","GPCR ligand binding","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediat
ors (SPMs)","Branched-chain amino acid catabolism","snRNP Assembly","Toll-like Receptor Cascades","Uptake and actions of bacterial toxins","Leishmania parasite growth and survival","Class A/1 (Rhodops
in-like receptors)","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","Uptake and function of anthrax toxins",
"Anti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors",Xenobiotics,"Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","ADORA
2B mediated anti-inflammatory cytokines production","Adenosine P1 receptors","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","
MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADORA1,ADORA2A,ADORA2B,ADORA3}

> <broad_moa>
{"adenosine receptor antagonist"}

> <synonyms>
{139180-30-6,139180306,ZM241385,"ZM 241385",ZM-241385,UNII-5NIC36BO71,UNII5NIC36BO71,5NIC36BO71,CHEMBL113142,"ZM-241,385","ZM241,385",C16H15N7O2,(3H)-ZM241385,(3H)ZM241385,3eml,3pwh,PubChem16764,Tocri
s-1036,Tocris1036,GTPL405,SCHEMBL194966,ZINC5258,BDBM21190,CHEBI:92361,DTXSID80160954,EX-A944,EXA944,BCPP000003,HMS326,T7021,S8105}

> <pdid>
PD004548

> <targets>
{"Adenosine Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{176407}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 26  0  0  0  0            999 V2000
   10.1943   -0.3779    0.0000 H   0  3
    7.6943   -0.3779    0.0000 Cl  0  5
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    5.1937   -3.0093    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 O   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -2.6017    2.9971    0.0000 O   0  0
   -1.3070    5.2502    0.0000 N   0  0
   -2.6071    5.9984    0.0000 C   0  0
   -0.0093    6.0025    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8933   -3.7570    0.0000 N   0  0
   -3.8912   -5.2578    0.0000 C   0  0
   -5.1887   -6.0105    0.0000 C   0  0
   -3.8883   -6.7578    0.0000 C   0  0
   -2.5908   -6.0056    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 15 17  1  0
 11 18  2  0
 18 19  1  0
 19 20  2  0
 20  9  1  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7687

> <plate>
1

> <well>
H13

> <supplier_cmpd_name>
Bambuterol HCl

> <ctcr_id>
4789

> <supplier_cmpd_id>
S4277

> <smiles>
[H+].[Cl-].CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(c1)C(O)CNC(C)(C)C

> <pd_targets>
{AMPC,BCHE,ACHE,CYP2D6,ADRB2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Hydrolase,"Cytochrome P450","Family A G protein-coupled receptor","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2D","Monoamin
e receptor","Cytochrome P450 2D6","Adrenergic receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Acetylcholine turnover","Cytochrome P450","G protein-coupled receptors","CYP2 family: drug metabolising subset",Adrenoceptors}

> <pathway_reactome>
{Metabolism,Disease,"Metabolism of lipids","Biological oxidations","Infectious disease","Phospholipid metabolism","Phase I - Functionalization of compounds","Leishmania infection","Glycerophospholipid
 biosynthesis","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Synthesis of PC",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infectio
n","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{ADRB2,BCHE}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"BAMBUTEROL HYDROCHLORIDE",81732-46-9,81732469,"Bambuterol HCl","Bambuterol (hydrochloride)",CHEBI:59167,MFCD03427293,DSSTox_CID_25515,DSSToxCID25515,DSSTox-CID-25515,"DSSTox CID 25515",DSSTox_RID_80
925,DSSToxRID80925,DSSTox-RID-80925,"DSSTox RID 80925",DSSTox_GSID_45515,DSSToxGSID45515,DSSTox-GSID-45515,"DSSTox GSID 45515","Bambuterol-d9 Hydrochloride","Bambuterold9 Hydrochloride","(+/-)-Bambute
rol hydrochloride;KWD-2183 hydrochloride","(+/)Bambuterol hydrochloride;KWD2183 hydrochloride",Pr,T1446,S4277,1505173,Prestw-361,"Bambuterol hydrochloride"}

> <pdid>
PD009511

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"beta adrenergic agonist",bronchodilator,"cholinesterase inhibitor","GPCR & G Protein"}

> <pubchem_cids>
{54765,57515921}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 29  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 Cl  0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -9.0967    3.7462    0.0000 O   0  0
   -9.0947    5.2462    0.0000 C   0  0
   -6.4995    3.7432    0.0000 C   0  0
   -5.2004    2.9933    0.0000 C   0  0
   -3.8964   -0.7553    0.0000 C   0  0
   -5.1931   -1.5094    0.0000 C   0  0
   -5.1885   -3.0094    0.0000 C   0  0
   -3.8871   -3.7554    0.0000 C   0  0
   -3.8793   -5.2562    0.0000 O   0  0
   -2.5769   -6.0003    0.0000 C   0  0
   -2.5904   -3.0014    0.0000 C   0  0
   -2.5951   -1.5014    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  6  9  1  0
  9 10  1  0
  9 11  2  3
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 15 18  1  0
 18 19  2  0
 19 12  1  0
 11 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  2  0
 27 20  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7688

> <plate>
1

> <well>
H15

> <supplier_cmpd_name>
Chlorotrianisene

> <ctcr_id>
6579

> <supplier_cmpd_id>
S4629

> <smiles>
COc1ccc(cc1)C(Cl)=C(c2ccc(OC)cc2)c3ccc(OC)cc3

> <pd_targets>
{CYP2C19,HIF1A,LMNA,TSHR,LEF,NPSR1,KDM4E,MAPT,HSD17B10,ALDH1A1,HPGD,ESR2,ESR1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Other nuclear protein","Membrane receptor","Epigenetic regulator","Other cytosolic protein","Cytochrome P450","Family A G protein-coupled receptor",Protease,Eraser,Oxid
oreductase,"Nuclear receptor","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cysteine protease","Metallo protease","Lysine demethylase","Nuclear hormone receptor subfamily 3","Cytochro
me P450 family 2C","Glycohormone receptor","Cysteine protease CA clan","Metallo protease MAE clan","Short peptide receptor (family A GPCR)","Jumonji domain-containing","Nuclear hormone receptor subfam
ily 3 group A","Cytochrome P450 2C19","Cysteine protease C1A family","Metallo protease M34 family","Neuropeptide receptor","Nuclear hormone receptor subfamily 3 group A member 2","Nuclear hormone rece
ptor subfamily 3 group A member 1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","Chromatin modifying enzymes","Eicosanoid turnover","Nuclear hormone receptors","CYP2 family: drug metabolising subset","Glycoprotein
 hormone receptors","Neuropeptide S receptor","1.14.11.- Histone demethylases","Prostaglandin synthases","Steroid hormone receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{Metabolism,"Cellular responses to external stimuli","Cell Cycle",Disease,"Neuronal System","Signal Transduction","Gene expression (Transcription)","Biological oxidations","Cellular responses to stres
s",Mitotic,"Infectious disease","Transmission across Chemical Synapses","Metabolism of amino acids and derivatives","Metabolism of lipids","Intracellular signaling by second messengers","RNA Polymeras
e II Transcription","Phase I - Functionalization of compounds","Cellular response to hypoxia","M Phase","Leishmania infection","Uptake and actions of bacterial toxins","Neurotransmitter receptors and 
postsynaptic signal transmission","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","PIP3 activates AKT signaling","Generic Transcription Pathway","Cyt
ochrome P450 - arranged by substrate type","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Uptake
 and function of anthrax toxins","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Negative regulation of the PI3K/AKT network","Transcript
ional regulation by RUNX1",Xenobiotics,"Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","Biosynthesis of D-series resolvin
s",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","RUNX1 regulates estrogen receptor mediated transcription","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory
 cytokines production","Activation of AMPK downstream of NMDARs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ESR1,ESR2}

> <broad_moa>
{"estrogenic hormone"}

> <synonyms>
{chlorotrianisene,569-57-3,569573,Chlortrianizen,Chlortrianisestrol,TACE,Chlorotrianisine,Chlorestrolo,Chlorotrianizen,Chlortrianisen,Chloortrianisestrol,Clorotrisin,Hormonisene,Khlortrianizen,Clorest
rolo,Merbentul,Anisene,Metace,Rianil,Chlortrianisoestrolu,T2569,S4629,1500181,Prestw-757,Chlorotrianisene,CHLOROTRIANISENE}

> <pdid>
PD009120

> <targets>
{Estrogen/progestogen Receptor,COX,Estrogen Receptor/ERR}

> <classes>
{Endocrinology & Hormones,estrogen,Immunology/Inflammation,Others}

> <pubchem_cids>
{11289}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 31  0  0  0  0            999 V2000
    4.8089   -4.6669    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    2.7343   -2.9815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2566    0.5871    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    6.4437   -1.8466    0.0000 C   0  0
    7.3222   -3.0635    0.0000 N   0  0
    8.8153   -2.9121    0.0000 N   0  0
    9.6951   -4.1270    0.0000 C   0  0
   11.1872   -3.9726    0.0000 C   0  0
   11.7995   -2.6033    0.0000 N   0  0
   10.9198   -1.3883    0.0000 C   0  0
    9.4277   -1.5427    0.0000 C   0  0
   13.2920   -2.4458    0.0000 C   0  0
   13.9027   -1.0748    0.0000 C   0  0
   15.3943   -0.9152    0.0000 C   0  0
   16.0018    0.4562    0.0000 C   0  0
   15.1179    1.6682    0.0000 C   0  0
   13.6264    1.5086    0.0000 C   0  0
   13.0188    0.1372    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4 11  1  0
 11 12  1  0
 11 13  2  0
 13  2  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7689

> <plate>
1

> <well>
H17

> <supplier_cmpd_name>
SANT-1

> <ctcr_id>
7343

> <supplier_cmpd_id>
S7092

> <smiles>
Cc1nn(c2ccccc2)c(C)c1/C=N/N3CCN(CC3)Cc4ccccc4

> <pd_targets>
{LEF,SMO,MAPK1,FTL,CYP3A4,SHH}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Unclassified protein",Protease,"Frizzled family G protein-coupled receptor",Kinase,"Cytochrome P450","Metallo protease","Smoothened receptor (frizzled family GPCR)","Prote
in Kinase","Cytochrome P450 family 3","Metallo protease MAE clan","CMGC protein kinase group","Cytochrome P450 family 3A","Metallo protease M34 family","CMGC protein kinase MAPK family","Cytochrome P4
50 3A4","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cytochrome P450","Class Frizzled GPCRs","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","Mitogen-activated protei
n kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Disease,"Organelle biogenesis and maintenance","Immune System","Vesicle-mediated transport",Metabolism,"Infectious disease","Cilium Assembly","Innate Immune System","Membrane Trafficking","Metabolism
 of lipids","Diseases of signal transduction by growth factor receptors and second messengers","Uptake and actions of bacterial toxins","Cargo trafficking to the periciliary membrane","Toll-like Recep
tor Cascades","trans-Golgi Network Vesicle Budding","Biosynthesis of specialized proresolving mediators (SPMs)","Hh mutants abrogate ligand secretion","Uptake and function of anthrax toxins","BBSome-m
ediated cargo-targeting to cilium","Toll Like Receptor 5 (TLR5) Cascade","Golgi Associated Vesicle Biogenesis","Biosynthesis of DHA-derived SPMs","HHAT G278V doesn't palmitoylate Hh-Np","MyD88 cascade
 initiated on plasma membrane","Biosynthesis of maresins","MAP kinase activation","Biosynthesis of maresin-like SPMs","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs ar
e inactivated"}

> <broad_targets>
{SHH,SMO}

> <broad_moa>
{"smoothened receptor antagonist"}

> <synonyms>
{SANT-1,SANT1,304909-07-7,304909077,MFCD01827306,CHEMBL515916,"Shh Signaling Antagonist V",SCHEMBL1503099,SCHEMBL10063651,CHEBI:93466,DTXSID90425965,HMS3412P14,HMS3676P14,C23H27N5,EX-A1250,EXA1250,Tox
21_500396,Tox21500396,Tox21-500396,"Tox21 500396",2700AH,BDBM50249488,NSC731871,s7092,STL361943,ZINC12372218,AKOS0,S7092}

> <pdid>
PD010627

> <targets>
{Smoothened,Hedgehog,Smo}

> <classes>
{Stem Cells & Wnt,Stem Cell/Wnt}

> <pubchem_cids>
{6878030}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 33  0  0  0  0            999 V2000
    6.4920    0.7636    0.0000 C   0  0
    6.4972   -0.7364    0.0000 C   0  0
    5.2007   -1.4909    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8939    0.7546    0.0000 C   0  0
    5.1903    1.5091    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 N   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -1.3092    5.2494    0.0000 C   0  0
   -2.6108    5.9949    0.0000 C   0  0
   -3.9073    5.2404    0.0000 C   0  0
   -3.9021    3.7404    0.0000 C   0  0
   -2.6005    2.9949    0.0000 C   0  0
   -5.2096    5.9863    0.0000 N   0  0
   -5.2172    7.4863    0.0000 C   0  0
   -6.5200    8.2297    0.0000 C   0  0
   -7.8153    7.4732    0.0000 O   0  0
   -7.8077    5.9732    0.0000 C   0  0
   -6.5049    5.2298    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
 10 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29  8  1  0
 29 25  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7690

> <plate>
1

> <well>
H19

> <supplier_cmpd_name>
Reversine

> <ctcr_id>
5474

> <supplier_cmpd_id>
S7588

> <smiles>
C1CCC(CC1)Nc2nc(Nc3ccc(cc3)N4CCOCC4)nc5[nH]cnc25

> <pd_targets>
{MAP2K1,FFP,RORC,AURKB,TTK,AURKA,KMT2A,MEN1,ADORA3}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator","Membrane receptor",Kinase,Transferase,"Nuclear receptor",Reader,"Family A G protein-coupled receptor","Protein Kinase","Nuclear hormone receptor 
subfamily 1",Bromodomain,"Small molecule receptor (family A GPCR)","STE protein kinase group","Nuclear hormone receptor subfamily 1 group F","Other protein kinase group","Nucleotide-like receptor (fam
ily A GPCR)","STE protein kinase STE7 family","Nuclear hormone receptor subfamily 1 group F member 3","Other protein kinase AUR family","Other protein kinase TTK family","Adenosine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Catalytic receptors","G protein-coupled receptors","STE: Homologs of yeast Sterile 7","Sterile 11","Sterile 20 kinases","1F. Reti
noic acid-related orphans","Receptor kinases","Adenosine receptors","STE7 family","Other protein kinases","Aurora kinase (Aur) family","TTK family"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)","Cell Cycle","Signaling by Receptor Tyrosine Kinases","RNA Polymerase II Transcription",Mitotic,"Signaling by GPCR","Signaling by NTRKs","Gener
ic Transcription Pathway","M Phase","GPCR ligand binding","Signaling by NTRK1 (TRKA)","Transcriptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Transcriptional Regulation by TP53","Class
 A/1 (Rhodopsin-like receptors)","Signalling to ERKs","RUNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","Regulation of TP53 Activity","Nucleotide-like (purinergic) receptors","Pr
olonged ERK activation events","Separation of Sister Chromatids","Regulation of TP53 Activity through Phosphorylation","Adenosine P1 receptors","Frs2-mediated activation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Reversine,656820-32-5,656820325,"656820 32 5",2-(4-Morpholinoanilino)-6-cyclohexylaminopurine,2(4Morpholinoanilino)6cyclohexylaminopurine,"2 (4 Morpholinoanilino) 6 cyclohexylaminopurine",UNII-Z499CL
J023,UNIIZ499CLJ023,"UNII Z499CLJ023",CHEMBL18834,S7588,"EMD 554717",554717}

> <pdid>
PD005329

> <targets>
{Reversine,"Adenosine Receptor","Aurora Kinase",Autophagy}

> <classes>
{GPCR & G Protein,Autophagy,Cell Cycle/DNA Damage,Epigenetics}

> <pubchem_cids>
{210332}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 35 37  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 O   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    3.9014    2.2508    0.0000 C   0  0
    5.2007    3.0004    0.0000 O   0  0
    2.6028    3.0016    0.0000 O   0  0
   19.3026    6.3471    0.0000 F   0  0
   19.3130    4.8471    0.0000 C   0  0
   20.6172    4.1061    0.0000 C   0  0
   20.6276    2.6062    0.0000 C   0  0
   19.3338    1.8471    0.0000 C   0  0
   19.3411    0.3463    0.0000 C   0  0
   18.0455   -0.4113    0.0000 N   0  0
   18.0507   -1.9113    0.0000 C   0  0
   16.7542   -2.6658    0.0000 C   0  0
   15.4526   -1.9203    0.0000 C   0  0
   15.4474   -0.4203    0.0000 C   0  0
   16.7439    0.3342    0.0000 C   0  0
   14.1539   -2.6726    0.0000 N   0  0
   12.8526   -1.9249    0.0000 C   0  0
   12.8526   -0.4248    0.0000 N   0  0
   11.5535    0.3251    0.0000 C   0  0
   10.2545   -0.4249    0.0000 N   0  0
   10.2545   -1.9249    0.0000 C   0  0
    9.1402   -2.9278    0.0000 S   0  0
    9.7503   -4.2981    0.0000 C   0  0
    9.0003   -5.5972    0.0000 Cl  0  0
   11.2421   -4.1413    0.0000 C   0  0
   11.5535   -2.6749    0.0000 C   0  0
   18.0296    2.5882    0.0000 C   0  0
   18.0192    4.0882    0.0000 C   0  0
   16.7143    4.8296    0.0000 C   0  0
   15.4101    5.5706    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 15  1  0
 18 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 30 31  1  0
 31 22  1  0
 31 26  2  0
 13 32  1  0
 32 33  2  0
 33 10  1  0
 33 34  1  0
 34 35  3  0
M  END
> <name>
Selleck_GPCR

> <id>
7691

> <plate>
1

> <well>
H21

> <supplier_cmpd_name>
PRX-08066 Maleic acid

> <ctcr_id>
7553

> <supplier_cmpd_id>
S8010

> <smiles>
OC(=O)\C=C/C(=O)O.Fc1ccc(CN2CCC(CC2)Nc3ncnc4sc(Cl)cc34)cc1C#N

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"RX08066 MALEIC ACI","PRX-08066 Maleic acid","PRX08066 Maleic acid",866206-55-5,866206555,"PRX-08066 Maleate","PRX08066 Maleate","PRX08066 maleate",C19H17ClFN5S.C4H4O4,HMS3886N21,EX-A1246,EXA1246,226
1AH,CCG-269838,CCG269838,AC-32771,AC32771,S8010,SW219157-1,SW2191571}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{51348293}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 31  0  0  1  0            999 V2000
   -1.8114   -5.1333    0.0000 C   0  0
   -2.2130   -3.6880    0.0000 C   0  0
   -3.6655   -3.3136    0.0000 O   0  0
   -1.1612   -2.6174    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    3.8971    3.7500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.7499   -4.3804    0.0000 C   0  0
   -0.2673   -5.4828    0.0000 C   0  0
    2.2131   -4.7105    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
 10 11  2  3
 11 12  1  0
 11 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 13  1  0
 19 20  1  6
 19 21  1  0
 21  9  1  0
 21 22  1  6
 22 23  1  0
 23 24  1  0
 24  5  1  0
 24  8  1  0
 24 25  1  6
  5 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7692

> <plate>
1

> <well>
I03

> <supplier_cmpd_name>
Megestrol Acetate

> <ctcr_id>
5247

> <supplier_cmpd_id>
S1304

> <smiles>
CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O

> <pd_targets>
{POLB,AR,HIF1A,NPSR1,PGR,LMNA,NR3C1,ABCB11,CYP2C9}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other nuclear protein",Transporter,Protease,"Nuclear receptor","Family A G protein-coupled receptor","Primary active transporter","Cytochrome P450",
"Cysteine protease","Nuclear hormone receptor subfamily 3","Peptide receptor (family A GPCR)","ATP-binding cassette","Cytochrome P450 family 2","Cysteine protease CA clan","Nuclear hormone receptor su
bfamily 3 group C","Short peptide receptor (family A GPCR)","ABCB subfamily","Cytochrome P450 family 2C","Cysteine protease C1A family","Nuclear hormone receptor subfamily 3 group C member 4","Neurope
ptide receptor","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 1","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","ATP-binding cassette transporter family","Cytochrome P450","Steroid hormone receptors","Neuropeptide S recept
or","ABCB subfamily","CYP2 family: drug metabolising subset","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"DNA Repair","Gene expression (Transcription)","Cellular responses to external stimuli",Disease,"Cell Cycle",Metabolism,"Metabolism of proteins","Base Excision Repair","RNA Polymerase II Transcriptio
n","Cellular responses to stress","Infectious disease",Mitotic,"Metabolism of lipids","Biological oxidations","Post-translational protein modification","Resolution of Abasic Sites (AP sites)","Generic
 Transcription Pathway","Cellular response to hypoxia","Leishmania infection","M Phase","Metabolism of steroids","Phase I - Functionalization of compounds",SUMOylation,"Resolution of AP sites via the 
multiple-nucleotide patch replacement pathway","Transcriptional regulation by RUNX2","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Leishmania parasite growth and survival
","Mitotic Metaphase and Anaphase","FOXO-mediated transcription","Bile acid and bile salt metabolism","Cytochrome P450 - arranged by substrate type","SUMO E3 ligases SUMOylate target proteins","PCNA-D
ependent Long Patch Base Excision Repair","RUNX2 regulates bone development","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","FOXO-mediated transcription of oxi
dative stress","metabolic and neuronal genes","Synthesis of bile acids and bile salts",Xenobiotics,"SUMOylation of intracellular receptors","RUNX2 regulates osteoblast differentiation","ADORA2B mediat
ed anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","CYP2E1 reactions","Initiation of Nuclear Envelope 
(NE) Reformation"}

> <broad_targets>
{NR3C1,PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{"MEGESTROL ACETATE",595-33-5,595335,Megace,"Megace ES",Magestin,Niagestin,"Megestryl acetate",Megeron,Megestat,Ovaban,Ovarid,Maygace,Pallace,"BDH 1298","SC 10363",Megestrol-17-acetate,Megestrol17acet
ate,NSC-71423,NSC71423,Volidan,SC10363,UNII-TJ2M0FR8ES,UNIITJ2M0FR8ES,17alpha-Hydroxy-6-methylpregn,17alphaHydroxy6methylpregn,T1284,71423,S1304,SAM001246722,Prestw-956,"NSC 71423","Megestrol acetate"
,"Megestrol Acetate",CPD000058691}

> <pdid>
PD001872

> <targets>
{"Androgen Receptor"}

> <classes>
{"synthetic progestin","Endocrinology & Hormones"}

> <pubchem_cids>
{11683}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 13 12  0  0  0  0            999 V2000
    6.3982   -1.8787    0.0000 Cl  0  0
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7693

> <plate>
1

> <well>
I04

> <supplier_cmpd_name>
Synephrine HCl

> <ctcr_id>
3511

> <supplier_cmpd_id>
S2438

> <smiles>
Cl.CNCC(O)c1ccc(O)cc1

> <pd_targets>
{AMPC,THPO,ALDH1A1,BLM,CHRM1,SMN1,HTR1A,NMUR2,HIF1A,CYP2C9}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor","Epigenetic regulator",Hydrolase,Oxidoreductase,"Family A G protein-coupled receptor",Reader,"Small molecule receptor (family A GPCR)","Methyl-lysine
/arginine binding protein","Peptide receptor (family A GPCR)","Monoamine receptor","Tudor domain","Short peptide receptor (family A GPCR)","Acetylcholine receptor","Serotonin receptor","Neuromedin U r
eceptor","Transcription factor","Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2C","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","Neuromedin U receptors",Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subse
t"}

> <pathway_reactome>
{Hemostasis,Metabolism,"DNA Repair","Signal Transduction","Metabolism of RNA","Platelet activation","signaling and aggregation","Biological oxidations","DNA Double-Strand Break Repair","Signaling by G
PCR","Metabolism of non-coding RNA","Platelet Aggregation (Plug Formation)","Phase I - Functionalization of compounds","Homology Directed Repair","GPCR ligand binding","snRNP Assembly","Ethanol oxidat
ion","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR)","Amine ligand-binding receptors",
"Peptide ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","Serotonin receptors","Presynaptic phase of homologous DNA pairing and strand excha
nge","Cellular responses to external stimuli","Cellular responses to stress","Cellular response to hypoxia","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 
- arranged by substrate type",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"Synephrine hydrochloride",5985-28-4,5985284,"Synephrine HCl","4-(1-Hydroxy-2-(methylamino)ethyl)phenol hydrochloride","4(1Hydroxy2(methylamino)ethyl)phenol hydrochloride","Oxedrine hydrochloride","4
-(1-hydroxy-2-(methylamino)ethyl)phenol hydrochloride","4(1hydroxy2(methylamino)ethyl)phenol hydrochloride","Synephrine (hydrochloride)","Synephrine  HCl",MFCD00050,T6688,S2438}

> <pdid>
PD000201

> <targets>
{"Adrenergic Receptor",Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{42609626,22302}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 26  0  0  1  0            999 V2000
    0.1423    1.5763    0.0000 C   0  0
    0.0479    0.0793    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    2.8524   -0.2919    0.0000 O   0  0
    3.4192   -2.8384    0.0000 C   0  0
    4.4371   -3.9401    0.0000 C   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 16 15  1  6
 16  6  1  0
 16 10  1  0
  7 17  1  0
 17  3  1  0
 17 18  1  1
 18 19  2  3
 19 20  1  0
 20  3  1  0
 20 21  1  1
 20 22  1  0
 22 23  3  0
M  END
> <name>
Selleck_GPCR

> <id>
7694

> <plate>
1

> <well>
I05

> <supplier_cmpd_name>
Gestodene

> <ctcr_id>
7133

> <supplier_cmpd_id>
S1376

> <smiles>
CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C

> <pd_targets>
{PGR,LMNA,FFP}

> <pathway_gtopdb>
{"Transcription factor","Other nuclear protein",Enzyme,"Nuclear receptor",Transferase,"Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor su
bfamily 3 group C member 3"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Metabolism of proteins","Cell Cycle","Post-translational protein modification",Mitotic,SUMOylation,"M Phase","SUMO E3 ligases SUMOylate target proteins","Mitotic Metaphase and Anaphase","SUMOylation
 of intracellular receptors","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"contraceptive agent"}

> <synonyms>
{GESTODENE,60282-87-3,60282873,Gestoden,"Gestodenum (INN-Latin)","Gestodenum (INNLatin)","Gestodeno (INN-Spanish)","Gestodeno (INNSpanish)","SH B 331",UNII-1664P6E6MI,UNII1664P6E6MI,1664P6E6MI,SH-B-33
1,SHB331,Gestinol,"18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17a)-","18,19Dinorpregna4,15dien20yn3one, 13ethyl17hydroxy, (17a)",DSSTox_CID_26478,DSSToxCID26478,DSSTox-CID-26478,"
DSSTox CID 26478",DSSTox_RID_81649,DSSToxRID81649,DSSTox-RID-81649,"DSSTox RID 81649",DS,T1490,S1376,Gestodene}

> <pdid>
PD000497

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{3033968}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 15  0  0  0  0            999 V2000
    6.1607   -2.0183    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 N   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.4469   -5.2297    0.0000 N   0  0
    2.9152   -5.5365    0.0000 C   0  0
    3.6607   -4.2349    0.0000 C   0  0
    2.6532   -3.1236    0.0000 N   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9  3  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7695

> <plate>
1

> <well>
I06

> <supplier_cmpd_name>
Clonidine HCl

> <ctcr_id>
2184

> <supplier_cmpd_id>
S2458

> <smiles>
Cl.Clc1cccc(Cl)c1N=C2NCCN2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Clonidine HCI","2-((2,6-Dichlorophenyl)imino)imidazolidine monohydrochloride","2((2,6Dichlorophenyl)imino)imidazolidine monohydrochloride",AKOS026750072,"CLONIDINE HYDROCHLORIDE",4205-91-8,4205918,"
Clonidine HCl","2-(2,6-Dichloroanilino)-2-imidazoline hydrochloride","2(2,6Dichloroanilino)2imidazoline hydrochloride",Kapvay,N-(2,N(2,6-dichlorophenyl)-4,6dichlorophenyl)4,5-dihyd,5dihyd,S2458,SAM001
247073,1500198,Prestw-248,"Clonidine HCl",CPD000466276,"Clonidine hydrochloride"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling",antihypertensive}

> <pubchem_cids>
{91824207,50986872,20179}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 27  0  0  1  0            999 V2000
    3.8917   -5.2577    0.0000 C   0  0
    3.8934   -3.7577    0.0000 O   0  0
    2.5949   -3.0050    0.0000 C   0  0
    1.2948   -3.7531    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 S   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 Cl  0  0
   10.3023   -0.3793    0.0000 O   0  0
   10.3023   -1.8793    0.0000 S   0  0
   10.3023   -3.3793    0.0000 O   0  0
    9.0030   -2.6289    0.0000 O   0  0
   11.6016   -2.6289    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  5  3  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
 13 14  1  0
 14  6  1  0
  5 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 20 21  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 23 26  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7696

> <plate>
1

> <well>
I07

> <supplier_cmpd_name>
Clopidogrel

> <ctcr_id>
1368

> <supplier_cmpd_id>
S1415

> <smiles>
COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl.O[S](O)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Clopidogrel bisulfate",120202-66-6,120202666,"Clopidogrel hydrogen sulfate","CLOPIDOGREL SULFATE",Iscover,Plavix,135046-48-9,135046489,"Clopidogrel bisulphate","Clopidogrel hemisulfate","Clopidogrel
 sulphate","clopidogrel hydrogen sulphate","Clopidogrel (hydrogen sulf",T0182L,T0182L2,S1415,1503710,"(S)-(+)-Clopidogrel hydrogen sulfate","(±) Clopidogrel hydrogen sulfate",Clopidogrel}

> <pdid>

> <targets>
{"P2 Receptor"}

> <classes>
{"platelet aggregation inhibitor","Neuronal Signaling"}

> <pubchem_cids>
{115366,24883467}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 25  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.2135   -2.9844    0.0000 S   0  0
    0.0000   -3.8661    0.0000 C   0  0
    0.0000   -5.3661    0.0000 C   0  0
    1.2135   -2.9844    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 22  1  0
 22  8  1  0
 22 17  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7697

> <plate>
1

> <well>
I08

> <supplier_cmpd_name>
Olanzapine

> <ctcr_id>
363

> <supplier_cmpd_id>
S2493

> <smiles>
CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24

> <pd_targets>
{DRD2,HRH1,HTR2A,HTR2B,HTR2C,ADRA2A,ADRA2B,ADRA2C,DRD3,DRD4,HTR1A,KCNH2,CHRM3,LMNA,KMT2A,MEN1,GFER,ALOX15,HTR1B,ADRA1A,HTR6,ABCB11,NET,CHRM5,GAA,CHRM2,CHRM1,SLC6A2,CHRM4,ADRA1B,DRD5,H1-0,ADRA1D,HTR7,M
APK1,HTR3A,SLC6A4,HTR3B,HTR3C,HTR3D,HTR3E,DRD1,ADRB1,ADRB2,ADRB3,HTR1D,HTR1E,HTR1F,GABRA1,GABRA2,GABRA3,GABRA5,GABRG1,GABRG2,GABRG3,CCKBR,OPRD1,OPRK1,SLC6A3,CYSLTR1,SCN10A,CACNA1C,CCK,ARRB1,SIGMAR1,TB
XA2R,OPRM1,TAC1}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Other nuclear protein","Epigenetic regulator",Enzyme,Transporter,"Secreted protein","Unclassified protein","Family A G protein-coupled receptor","Voltage-gated ion 
channel",Reader,Oxidoreductase,"Primary active transporter","Electrochemical transporter",Hydrolase,Kinase,"Ligand-gated ion channel","Small molecule receptor (family A GPCR)","Potassium channels",Bro
modomain,"ATP-binding cassette","SLC superfamily of solute carriers","Protein Kinase","5HT3 receptor","Peptide receptor (family A GPCR)","GABA-A receptor","Voltage-gated sodium channel","Voltage-gated
 calcium channel","Monoamine receptor","Voltage-gated potassium channel","ABCB subfamily","SLC06 neurotransmitter transporter family","CMGC protein kinase group","Short peptide receptor (family A GPCR
)","Lipid-like ligand receptor (family A GPCR)","Dopamine receptor","Histamine receptor","Serotonin receptor","Adrenergic receptor","Acetylcholine receptor","CMGC protein kinase MAPK family","Cholecys
tokinin receptor","Opioid receptor","Leukotriene receptor","Prostanoid receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,Transporters,"Other protein targets","G protein-coupled receptors","Voltage-gated ion channels","Eicosanoid turnover","ATP-binding cassette transporter family","3.2.1
.- Glycosidases","Kinases (EC 2.7.x.x)","Ligand-gated ion channels","SLC superfamily of solute carriers","Sigma receptors","Dopamine receptors","Histamine receptors","5-Hydroxytryptamine receptors","P
otassium channels","Acetylcholine receptors (muscarinic)",Adrenoceptors,Lipoxygenases,"ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","5-HT<sub>3</sub> receptors","SLC6 neurotransmitt
er transporter family","Cholecystokinin receptors","Opioid receptors","GABA<sub>A</sub> receptors","Leukotriene receptors","Voltage-gated sodium channels","Voltage-gated calcium channels","Prostanoid 
receptors","Voltage-gated potassium channels","Mitogen-activated protein kinases (MAP kinases)","Monoamine transporter subfamily","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Muscle contraction","Cell Cycle","Protein localization",Metabolism,"Cellular responses to external stimuli","Immune System","Neuronal System","Gene expression (Transcri
ption)","Developmental Biology","Signaling by GPCR","Infectious disease","Cardiac conduction",Mitotic,"Mitochondrial protein import","Metabolism of lipids","Diseases of metabolism","Cellular responses
 to stress","Innate Immune System","Transmission across Chemical Synapses","RNA Polymerase II Transcription","Disorders of transmembrane transporters","Nervous system development","Diseases of signal 
transduction by growth factor receptors and second messengers","GPCR ligand binding","Leishmania infection","Phase 3 - rapid repolarisation","M Phase","Biosynthesis of specialized proresolving mediato
rs (SPMs)","Metabolism of steroids","Diseases of carbohydrate metabolism","Cellular Senescence","Toll-like Receptor Cascades","Neurotransmitter receptors and postsynaptic signal transmission","Neurotr
ansmitter clearance","GPCR downstream signalling","Generic Transcription Pathway","SLC transporter disorders","Axon guidance","Oncogenic MAPK signaling","SARS-CoV Infections","Class A/1 (Rhodopsin-lik
e receptors)","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Biosynthesis of DPA-derived SPMs","Bile acid and bile salt metabolism","Glycogen storage diseases","DNA Damage
/Telomere Stress Induced Senescence","Toll Like Receptor 5 (TLR5) Cascade","Serotonin clearance from the synaptic cleft","G alpha (q) signalling events","Transcriptional Regulation by MECP2","GABA rec
eptor activation","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","L1CAM interactions","NCAM signaling for neurite out-growth","Signaling by RAS mutants","Potential therapeutics for 
SARS","G alpha (i) signalling events","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Biosynthesis of DPAn-3 SPMs","Synthesis 
of bile acids and bile salts","Glycogen storage disease type II (GAA)","Formation of Senescence-Associated Heterochromatin Foci (SAHF)","MyD88 cascade initiated on plasma membrane","Gastrin-CREB signa
lling pathway via PKC and MAPK","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and channels","Interaction between L1 and Ankyrins","NCAM1 interactions","Signaling downstream of
 RAS mutants","Eicosanoid ligand-binding receptors","Opioid Signalling","Dopamine receptors","Histamine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Musc
arinic acetylcholine receptors",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resolvins","Synthesis of bile acids and bile salts via 7alpha-hydroxycho
lesterol","MAP kinase activation","LTC4-CYSLTR mediated IL4 production","Prostanoid ligand receptors","G-protein activation","Tachykinin receptors bind tachykinins","Initiation of Nuclear Envelope (NE
) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,DRD4,DRD5,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GA
BRG3,GABRP,GABRQ,HRH1,HRH2,HRH4,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR5A,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{AB00639907-07,AB0063990707,AB00639907_08,AB0063990708,AB00639907-08,"AB00639907 08",olanzapine,132539-06-1,132539061,Zyprexa,"Zyprexa Zydis",Olansek,Zalasta,"Zyprexa Intramuscular",Zolafren,Zypadhera
,"Zyprexa Velotab",LY-170053,LY170053,"2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo(b)thieno(2,3-e)(1,4)diazepine","2Methyl4(4methylpiperazin1yl)10Hbenzo(b)thieno(2,3e)(1,4)diazepine",Ol,T1567,S2493,
SAM001246652,1505024,Prestw-1455,Olanzapine,CPD000466345,OLANZAPINE}

> <pdid>
PD000646

> <targets>
{"Dopamine Receptor","5-HT Receptor"}

> <classes>
{antipsychotic,"Neuronal Signaling"}

> <pubchem_cids>
{135398745}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 32  0  0  0  0            999 V2000
   -0.2237   -5.5078    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5551   -4.4192    0.0000 C   0  0
    1.8074   -5.7196    0.0000 O   0  0
    4.0559   -4.4171    0.0000 N   0  0
    4.8090   -5.7153    0.0000 C   0  0
    6.3098   -5.7131    0.0000 C   0  0
    7.0629   -7.0113    0.0000 C   0  0
    8.5630   -7.0113    0.0000 C   0  0
    9.3130   -8.3103    0.0000 C   0  0
    8.5631   -9.6094    0.0000 C   0  0
    7.0631   -9.6094    0.0000 C   0  0
    6.3130   -8.3104    0.0000 C   0  0
    9.3135  -10.9090    0.0000 N   0  0
   10.8136  -10.9114    0.0000 C   0  0
   11.5616  -12.2116    0.0000 C   0  0
   10.8096  -13.5095    0.0000 C   0  0
    9.3096  -13.5072    0.0000 C   0  0
    8.5616  -12.2070    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  3  1  0
 12  6  1  0
  4 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 24  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7698

> <plate>
1

> <well>
I09

> <supplier_cmpd_name>
Org 27569

> <ctcr_id>
5613

> <supplier_cmpd_id>
S1534

> <smiles>
CCc1c([nH]c2ccc(Cl)cc12)C(=O)NCCc3ccc(cc3)N4CCCCC4

> <pd_targets>
{CNR1}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","Cannabinoid receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Cannabinoid receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (i) signalling events"}

> <broad_targets>
{CNR1}

> <broad_moa>
{"cannabinoid receptor modulator"}

> <synonyms>
{"Org 27569",868273-06-7,868273067,Org27569,ORG-27569,ORG27569,5-Chloro-3-ethyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide,5Chloro3ethylN(4(piperidin1yl)phenethyl)1Hindole2carboxamide,ab1
20342,CHEMBL1553629,C24H28ClN3O,cc-477,cc477,GTPL7851,SCHEMBL18958918,DTXSID00660764,HMS3651O11,BCP08021,EX-A2224,EXA2224,BDBM50389939,MFC,T2635,S1534}

> <pdid>
PD002684

> <targets>
{"Cannabinoid Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{44828492}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 16  0  0  0  0            999 V2000
    8.9073   -2.2475    0.0000 H   0  3
    6.4073   -2.2475    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 N   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.3092   -5.2494    0.0000 N   0  0
    2.6108   -5.9949    0.0000 C   0  0
    3.9073   -5.2404    0.0000 C   0  0
    3.9021   -3.7404    0.0000 C   0  0
    2.6004   -2.9949    0.0000 S   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10  4  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7699

> <plate>
1

> <well>
I10

> <supplier_cmpd_name>
Xylazine HCl

> <ctcr_id>
34

> <supplier_cmpd_id>
S2516

> <smiles>
[H+].[Cl-].Cc1cccc(C)c1NC2=NCCCS2

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,TSHR,CYP3A4,CYP2D6,ADRA1A,ADRA1B,ADRA1D,RORC,CHRM1,LMNA,PMP22,MAPT,BLM}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein","Other cytosolic protein","Family A G protein-coupled receptor","Cytochrome P450","Nuclear receptor","
Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1","Monoamine receptor","Glycohorm
one receptor","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Nuclear hormone receptor subfamily 1 group F","Adrenergic receptor","Cytochrome P450 3A4","Cytochrome P450 2D6","Nuclear hormone 
receptor subfamily 1 group F member 3","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Nuclear hormone receptors","Glycoprotein hormone receptors","CYP3 family",Adrenoceptors,"CYP2 family: drug metabolising subset","1F.
 Retinoic acid-related orphans","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Disease,Metabolism,"Signal Transduction","Gene expression (Transcription)","Cell Cycle","Developmental Biology","Neuronal System","DNA Repair","Infectious disease","Metabolism of lipids","Signaling b
y GPCR","Biological oxidations","RNA Polymerase II Transcription",Mitotic,"Nervous system development","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Leishmania infection","
Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand binding","Phase I - Functionalization of compounds","Generic Transcription Pathway","M Phase","EGR2 and SOX10-mediated initiatio
n of Schwann cell myelination","Neurotransmitter receptors and postsynaptic signal transmission","Homology Directed Repair","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs"
,"Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Transcriptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsyna
ptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","Amine ligand
-binding receptors",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","Post NMDA receptor activation events","HDR through Homologous Recombination (HRR)","ADORA2B med
iated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs",Adrenoceptors,"CYP2E1 reactions","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Activation o
f AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{23076-35-9,23076359,"Xylazine HCl","N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine hydrochloride","N(2,6Dimethylphenyl)5,6dihydro4H1,3thiazin2amine hydrochloride",Celactal,"Xylazine chlori
de","BAY 1470 hydrochloride",Rompun,Tranquived,Xylamed,"BAY VA 1470",Anased,"Xylazine (hyd",S2516}

> <pdid>
PD001454

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{68554,51358427}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 23  0  0  1  0            999 V2000
   -0.7603   -8.0518    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 N   0  0
   -2.6933   -6.3162    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0  1  0  0  0
   -5.2526    1.3618    0.0000 C   0  0
   -6.2524    0.2436    0.0000 O   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -6.1032   -2.4253    0.0000 O   0  0
   -4.0317   -0.7359    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 14 13  1  6
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 14  1  0
 12 20  1  0
 20 21  2  0
 21  6  1  0
 21  9  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7700

> <plate>
1

> <well>
I11

> <supplier_cmpd_name>
Zolmitriptan

> <ctcr_id>
3086

> <supplier_cmpd_id>
S1649

> <smiles>
CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12

> <pd_targets>
{HTR1E,HTR1F,HTR1A,HTR1D,HTR1B,ADRA2A,ADRA2B,ADRA2C,DRD2,HTR7,HTR2A,HTR2B,KMT2A}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Family A G protein-coupled receptor",Reader,"Small molecule receptor (family A GPCR)",Bromodomain,"Monoamine receptor","Serotonin receptor","Adrenergic rec
eptor","Dopamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Chromatin modifying enzymes","5-Hydroxytryptamine receptors","Dopamine receptors","2.1.1.43 Histone methyltransferases (HMTs)"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Gene expression (Transcription)","Signaling by GPCR","Infectious disease","RNA Polymerase II Transcription","GPCR ligand binding","Leishmania infection","Generic Transc
ription Pathway","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Transcriptional regulation by RUNX1","Amine ligand-binding receptors","Anti-inflammatory response fav
ouring Leishmania parasite infection","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines produc
tion","Dopamine receptors"}

> <broad_targets>
{HTR1A,HTR1B,HTR1D,HTR1E,HTR1F}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{zolmitriptan,139264-17-8,139264178,Zomig,Zomigoro,Zomigon,Flezol,311C90,Zomig-ZMT,ZomigZMT,C16H21N3O2,UNII-2FS66TH3YW,UNII2FS66TH3YW,(S)-4-(3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl)-oxazolidin-2
-one,(S)4(3(2Dimethylaminoethyl)1Hindol5ylmethyl)oxazolidin2one,"Zolmitriptan (Zomig)",(S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl),(S)4((3(2(dimethylamino)ethyl)1Hindol5yl),T1092,S1649,SAM001246
841,1505281,Zolmitriptan,Zolmitriptan,CPD000449310,ZOLMITRIPTAN}

> <pdid>
PD000525

> <targets>
{Others}

> <classes>
{"Neuronal Signaling",antimigraine,"5HT[1B/1D] agonist"}

> <pubchem_cids>
{60857}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 30  0  0  1  0            999 V2000
   11.9444    0.1869    0.0000 O   0  0
    9.4444    0.1869    0.0000 Br  0  5
   -1.8948    4.3802    0.0000 C   0  0
   -2.9996    3.3656    0.0000 N   0  3
   -4.4042    3.8919    0.0000 C   0  0
   -2.9996    0.5981    0.0000 C   0  0  2  0  0  0
   -1.7408    0.1428    0.0000 C   0  0
   -0.5981    0.5356    0.0000 C   0  0
   -1.1338    1.6158    0.0000 C   0  0
   -2.4550    2.0265    0.0000 C   0  0  1  0  0  0
   -3.8209    1.2230    0.0000 C   0  0
   -5.2493    0.8035    0.0000 O   0  0
   -4.1780   -0.1875    0.0000 C   0  0
    0.6817   -0.2152    0.0000 O   0  0
    1.9863    0.5268    0.0000 C   0  0
    1.9956    2.0267    0.0000 O   0  0
    3.2816   -0.2313    0.0000 C   0  0
    3.2909    1.2687    0.0000 O   0  0
    4.5863    0.5106    0.0000 C   0  0
    5.9335   -0.1192    0.0000 C   0  0
    6.9444    0.9889    0.0000 C   0  0
    6.2029    2.2928    0.0000 C   0  0
    4.7337    1.9905    0.0000 S   0  0
    3.2723   -1.7320    0.0000 C   0  0
    4.4805   -2.5992    0.0000 C   0  0
    4.0082   -4.0229    0.0000 C   0  0
    2.5082   -4.0136    0.0000 C   0  0
    2.0535   -2.5842    0.0000 S   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
 10  9  1  1
 10  4  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  6  1  0
 13 11  1  0
  8 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 19  1  0
 17 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  1  0
M  CHG  2   2  -1   4   1
M  END
> <name>
Selleck_GPCR

> <id>
7701

> <plate>
1

> <well>
I12

> <supplier_cmpd_name>
Tiotropium Bromide hydrate

> <ctcr_id>
7226

> <supplier_cmpd_id>
S2547

> <smiles>
O.[Br-].C[N+]1(C)[C@@H]2CC(C[C@H]1C3OC23)OC(=O)C(O)(c4cccs4)c5cccs5

> <pd_targets>
{CHRM4,CHRM3,CHRM5,CHRM2,CHRM1,GPM3}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{HMS3656O14,S2547,"Tiotropium Bromide hydrate"}

> <pdid>
PD014401

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{656610}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 23  0  0  0  0            999 V2000
   11.4855   -2.7614    0.0000 H   0  3
    8.9855   -2.7614    0.0000 Cl  0  5
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.2211    1.4430    0.0000 C   0  0
   -8.4711    2.7420    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 20  1  0
 15 23  1  0
 23 24  2  0
 24 12  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7702

> <plate>
1

> <well>
I13

> <supplier_cmpd_name>
Betaxolol hydrochloride (Betoptic)

> <ctcr_id>
6508

> <supplier_cmpd_id>
S1827

> <smiles>
[H+].[Cl-].CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1

> <pd_targets>
{ADRB1,ADRB3,ADRB2,BLM,LMNA,GAA,AMPC,CYP2D6,CYP1A2,CHRM1,CYP2C9,KMT2A,MEN1,LEF}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor",Enzyme,"Other nuclear protein","Epigenetic regulator",Hy
drolase,"Cytochrome P450",Reader,Protease,"Cytochrome P450 family 2","Cytochrome P450 family 1",Bromodomain,"Metallo protease","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Cytochrome P450 
family 2C","Metallo protease MAE clan","Cytochrome P450 2D6","Cytochrome P450 1A1","Acetylcholine receptor","Cytochrome P450 2C9","Metallo protease M34 family"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors,Enzymes,"3.2.1.- Glycosidases","Cytochrome P450","CYP2 family: drug metabolising subset","CYP1 family","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production","DNA Repair","Cell Cycle",Metabolism,"Signal Transduction","DNA Double-Strand Break Repair",Mitotic,"Diseases of metabolism","Biological oxidations","Signaling by GPCR","Homology
 Directed Repair","M Phase","Diseases of carbohydrate metabolism","Phase I - Functionalization of compounds","GPCR ligand binding","Uptake and actions of bacterial toxins","HDR through Homologous Reco
mbination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Glycogen storage diseases","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Up
take and function of anthrax toxins","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Glycogen storage disease type II (GAA)",Xenobiotics,"Amine ligand-binding receptors","Homologous D
NA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","Presynapt
ic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB1,ADRB2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Betaxolol hydrochloride",63659-19-8,63659198,"Betaxolol HCL",Betoptima,Betoptic,Kerlone,Lokren,"Betaxolol (hydrochloride)","Betaxolo Hydrochloride","alo 1401-02","alo 140102","Betaxolol hydrochlorid
e (Betoptic)",MFCD00242959,SL75212,"Betoptic S",MLS0,S1827,SAM001247084,Prestw-382,S4085,Betaxolol,CPD000058420,"Levobetaxolol HCl"}

> <pdid>
PD008960

> <targets>
{"Adrenergic Receptor",Others}

> <classes>
{Others,"Neuronal Signaling"}

> <pubchem_cids>
{107952,45259220,657296}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 27  0  0  0  0            999 V2000
    5.1894   -6.0108    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    2.5915   -6.0067    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Br  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 N   0  0
   10.3023   -0.3804    0.0000 O   0  0
   10.3023   -1.8804    0.0000 C   0  0
    9.0030   -2.6300    0.0000 O   0  0
   11.6023   -2.6304    0.0000 C   0  0
   12.9023   -1.8804    0.0000 C   0  0
   12.9037   -0.3796    0.0000 C   0  0
   11.6051    0.3712    0.0000 O   0  0
   14.2030    0.3700    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7703

> <plate>
1

> <well>
I14

> <supplier_cmpd_name>
Brompheniramine hydrogen maleate

> <ctcr_id>
952

> <supplier_cmpd_id>
S2585

> <smiles>
CN(C)CCC(c1ccc(Br)cc1)c2ccccn2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Brompheniramine maleate",980-71-2,980712,"Brompheniramine hydrogen maleate","Parabromdylamine maleate",Veltane,Dimetane-ten,Dimetaneten,"Brompheniramine (maleate)",Lodrane,"980-71-2 (maleate)","9807
12 (maleate)","Brompheniramine maleate (USP)","Dimetapp Allergy",MLS,S2585,1505530,1503985,Prestw-475,"DEXCHLORPHENIRAMINE MALEATE","BROMPHENIRAMINE MALEATE"}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{antihistamine,"H1 antihistamine","Neuronal Signaling"}

> <pubchem_cids>
{5281067}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 24  0  0  1  0            999 V2000
    7.4133   -4.8441    0.0000 Cl  0  5
   -3.5185  -11.1877    0.0000 C   0  0
   -2.5084  -10.0787    0.0000 N   0  0
   -2.0255   -8.7984    0.0000 C   0  0  2  0  0  0
   -0.5982   -9.0676    0.0000 C   0  0
    0.3883   -9.9779    0.0000 C   0  0
   -1.1605   -9.4210    0.0000 C   0  0  1  0  0  0
   -1.6595   -7.7040    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 C   0  0
   -2.5188   -7.2317    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 O   0  0
   -0.6890   -4.0818    0.0000 C   0  0
   -2.1567   -3.7722    0.0000 O   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    4.9133   -4.8441    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  1
  5  6  1  0
  7  6  1  6
  7  3  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  4  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 14  1  0
 22 17  1  0
M  CHG  2   1  -1  23   1
M  END
> <name>
Selleck_GPCR

> <id>
7704

> <plate>
1

> <well>
I15

> <supplier_cmpd_name>
Tropisetron

> <ctcr_id>
1725

> <supplier_cmpd_id>
S1898

> <smiles>
[Cl-].CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3C=Nc4ccccc34.[H+]

> <pd_targets>
{HIF1A,AMPC,LMNA}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other nuclear protein",Hydrolase}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cellular responses to external stimuli","Cell Cycle","Cellular responses to stress",Mitotic,"Cellular response to hypoxia","M Phase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Fact
or Alpha","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SMR000058944,MLS000069379,PubChem15848,Opera_ID_638,OperaID638,Opera-ID-638,"Opera ID 638",C17H20N2O2.HCl,CHEMBL1304237,s1898,CCG-220461,CCG220461,"ICS-205,930","ICS205,930",AB0008471,SW198927-2,SW19
89272,"3-Tropanylindole-3-carboxylate monohydrochloride","3Tropanylindole3carboxylate monohydrochloride",826N924,SR-01000002995,SR01000002995,SR-01000002995-3,SR010000029953,S1898,Prestw-461,Tropisetr
on,"Tropisetron HCl"}

> <pdid>
PD013151

> <targets>
{Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{6603067,657379}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 30  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 F   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -5.1903   -1.5091    0.0000 C   0  0  1  0  0  0
   -3.8939   -0.7546    0.0000 C   0  0
   -5.1851   -3.0098    0.0000 C   0  0
   -3.9700   -3.8674    0.0000 O   0  0
   -4.4309   -5.2948    0.0000 N   0  0
   -5.9309   -5.2977    0.0000 C   0  0
   -6.3971   -3.8719    0.0000 N   0  0
   -6.8107   -6.5134    0.0000 C   0  0
   -6.3036   -7.9199    0.0000 C   0  0
   -7.2720   -9.0654    0.0000 C   0  0
   -8.7482   -8.7996    0.0000 C   0  0
   -9.7166   -9.9452    0.0000 F   0  0
   -9.2561   -7.3882    0.0000 C   0  0
   -8.2878   -6.2426    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
 14 16  1  1
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 21  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7705

> <plate>
1

> <well>
I16

> <supplier_cmpd_name>
ADX-47273

> <ctcr_id>
7228

> <supplier_cmpd_id>
S2690

> <smiles>
Fc1ccc(cc1)C(=O)N2CCC[C@@H](C2)c3onc(n3)c4ccc(F)cc4

> <pd_targets>
{GRM5}

> <pathway_gtopdb>
{"Membrane receptor","Family C G protein-coupled receptor","Small molecule receptor (family C GPCR)","Neurotransmitter receptor (family C GPCR)","Metabotropic glutamate receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Metabotropic glutamate receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (q) signalling events"}

> <broad_targets>
{GRM5}

> <broad_moa>
{"glutamate receptor modulator"}

> <synonyms>
{DX4727,ADX-47273,ADX47273,851881-60-2,851881602,"ADX 47273",UNII-4C4P7L0W63,UNII4C4P7L0W63,CHEMBL381055,4C4P7L0W63,cc-252,cc252,SCHEMBL193680,GTPL1420,AOB2848,DTXSID80234386,HMS3884J14,BCP03476,EX-A1
123,EXA1123,ZINC9576498,ABP001172,BDBM50187649,MFCD17167026,s2690,AKOS027255083,ACN-001372,ACN001372,B,T2053,S2690}

> <pdid>
PD010885

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{11383075}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 32  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1476   -0.7184    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.2135   -2.9844    0.0000 S   0  0
    0.0000   -3.8661    0.0000 C   0  0
    1.2135   -2.9844    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   11.3852    1.9772    0.0000 O   0  0
   11.3852    0.4772    0.0000 C   0  0
   10.0859   -0.2724    0.0000 O   0  0
   12.6852   -0.2728    0.0000 C   0  0
   13.9852    0.4772    0.0000 C   0  0
   15.2851   -0.2728    0.0000 C   0  0
   15.2851   -1.7728    0.0000 O   0  0
   16.5844    0.4768    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  2  3
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22  8  1  0
 22 18  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7706

> <plate>
1

> <well>
I17

> <supplier_cmpd_name>
Ketotifen Fumarate

> <ctcr_id>
4499

> <supplier_cmpd_id>
S2024

> <smiles>
CN1CCC(CC1)=C2c3ccccc3CC(=O)c4sccc24.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW37,"KETOTIFEN FUMARATE",34580-14-8,34580148,Zaditen,"Ketotifen hydrogen fumarate","HC 20,511 fumarate","Ketotifen (fumarate)","Ketotifen fumarate salt",UNII-HBD503WORO,UNIIHBD503WORO,"Ketotifen 
fumarate (Zaditor)",HBD503WORO,MLS000069701,C23H23NO5S,MFCD00079394,SMR000058,T0994,S2024,SAM001246984,1500668,Prestw-371,"Ketotifen fumarate","Ketotifen Fumarate",CPD000058462}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{antiasthmatic,"Neuronal Signaling"}

> <pubchem_cids>
{5282408}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 16  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5988   -1.5004    0.0000 C   0  0
   -3.8985   -2.2508    0.0000 C   0  0
   -5.1983   -3.0013    0.0000 C   0  0
   -5.1983   -4.5013    0.0000 C   0  0
   -6.4973   -5.2513    0.0000 C   0  0
   -7.7964   -4.5013    0.0000 C   0  0
   -7.7964   -3.0013    0.0000 C   0  0
   -6.4973   -2.2513    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  6  8  1  0
  8  9  3  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7707

> <plate>
1

> <well>
I18

> <supplier_cmpd_name>
MPEP

> <ctcr_id>
1135

> <supplier_cmpd_id>
S2809

> <smiles>
Cc1cccc(n1)C#Cc2ccccc2

> <pd_targets>
{THPO,SMN1,TGR,NPC1,AMPC,RAB9A,LMNA,FTL,PMP22,GRM1,GRM5,PYK,RORC,CHRM1,FFP,TP53,CYP3A4,MAOA,GRM4,GRIN2B,KMT2A,MEN1,ALOX15,CYP2C9,ALDH1A1,HPGD,PKM,CYP1A2,CYP2D6,KDM4E,CYP2C19}

> <pathway_gtopdb>
{"Unclassified protein","Epigenetic regulator",Enzyme,Transporter,"Other nuclear protein","Membrane receptor","Transcription factor","Ion channel",Reader,Hydrolase,"Family C G protein-coupled receptor
",Transferase,"Nuclear receptor","Family A G protein-coupled receptor","Cytochrome P450",Oxidoreductase,"Ligand-gated ion channel",Eraser,"Methyl-lysine/arginine binding protein","Small molecule recep
tor (family C GPCR)","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Ionotropic glutamate receptor",Bromodomain,"Cytochrome P450 family 2",
"Cytochrome P450 family 1","Lysine demethylase","Tudor domain","Neurotransmitter receptor (family C GPCR)","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Cytochrome P450 family 3
A","NMDA receptor","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Jumonji domain-containing","Metabotropic glutamate receptor","Nuclear hormone receptor subfamily
 1 group F member 3","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450 1A1","Cytochrome P450 2D6","Cytochrome P450 2C19"}

> <pathway_chembl>
{Transporters,Receptors,Enzymes,"Ion channels","SLC superfamily of solute carriers","G protein-coupled receptors","Nuclear hormone receptors","Cytochrome P450","Catecholamine turnover","Ligand-gated i
on channels","Eicosanoid turnover","2.7.1.40 Pyruvate kinases","Chromatin modifying enzymes","SLC65 NPC-type cholesterol transporters","Metabotropic glutamate receptors","1F. Retinoic acid-related orp
hans","Acetylcholine receptors (muscarinic)","CYP3 family","Ionotropic glutamate receptors",Lipoxygenases,"CYP2 family: drug metabolising subset","Prostaglandin synthases","CYP1 family","1.14.11.- His
tone demethylases"}

> <pathway_reactome>
{Hemostasis,"Metabolism of RNA","Transport of small molecules","Signal Transduction","Cell Cycle","Vesicle-mediated transport","Developmental Biology","Gene expression (Transcription)",Metabolism,"Neu
ronal System","Platelet activation","signaling and aggregation","Metabolism of non-coding RNA","Plasma lipoprotein assembly",remodeling,"and clearance","Signaling by Rho GTPases",Mitotic,"Membrane Tra
fficking","Nervous system development","Signaling by GPCR","RNA Polymerase II Transcription","Cell Cycle Checkpoints","Metabolism of lipids","Biological oxidations","Transmission across Chemical Synap
ses","Metabolism of carbohydrates","Platelet Aggregation (Plug Formation)","snRNP Assembly","Plasma lipoprotein clearance","Rho GTPase cycle","M Phase","trans-Golgi Network Vesicle Budding","EGR2 and 
SOX10-mediated initiation of Schwann cell myelination","GPCR downstream signalling","Generic Transcription Pathway","GPCR ligand binding","G1/S DNA Damage Checkpoints","Biosynthesis of specialized pro
resolving mediators (SPMs)","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Glucose metabolism","LDL clearance","RHOBTB GTPase Cycle","Mit
otic Metaphase and Anaphase","Golgi Associated Vesicle Biogenesis","G alpha (q) signalling events","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)","p53-Dependent G1/S DNA 
damage checkpoint","Biosynthesis of DHA-derived SPMs","Amine Oxidase reactions","G alpha (i) signalling events","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs
","Cytochrome P450 - arranged by substrate type","Ethanol oxidation",Glycolysis,"RHOBTB3 ATPase cycle","Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","Amine ligand-binding rec
eptors","p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Post NMDA receptor activation events","Biosynthesi
s of DPAn-3 SPMs",Xenobiotics,"Biosynthesis of D-series resolvins","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Stabilization of p53","Biosynthesis of maresin-like SPMs","C
REB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Biosynthesis of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or 
N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{GRM1,GRM4,GRM5}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{MPEP,2-Methyl-6-(phenylethynyl)pyridine,2Methyl6(phenylethynyl)pyridine,96206-92-7,96206927,6-Methyl-2-(phenylethynyl)pyridine,6Methyl2(phenylethynyl)pyridine,2-methyl-6-(2-phenylethynyl)pyridine,2me
thyl6(2phenylethynyl)pyridine,UNII-7VC0YVI27Y,UNII7VC0YVI27Y,"Pyridine, 2-methyl-6-(phenylethynyl)-","Pyridine, 2methyl6(phenylethynyl)",7VC0YVI27Y,CHEMBL66654,CHEBI:64159,2-methyl-6-(phenylethynyl)-p
yridine,2methyl6(phenylethynyl)pyridine,T2497,S2809,"MPEP hydrochloride"}

> <pdid>
PD010561

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{3025961}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 32  0  0  0  0            999 V2000
    7.7858   -7.5171    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    6.4833   -9.7656    0.0000 C   0  0
    7.7815  -10.5187    0.0000 S   0  0
    9.0819   -9.7710    0.0000 O   0  0
    7.7794  -12.0195    0.0000 C   0  0
    9.0776  -12.7726    0.0000 C   0  0
    9.2155  -14.2535    0.0000 O   0  0
   10.6827  -14.5653    0.0000 C   0  0
   11.4327  -13.2663    0.0000 C   0  0
   10.4290  -12.1516    0.0000 C   0  0
    5.1873   -7.5117    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0076    0.0000 C   0  0
    5.1958   -1.5068    0.0000 O   0  0
    6.4962   -0.7574    0.0000 C   0  0
    6.5004    0.7426    0.0000 C   0  0
    7.8016    1.4889    0.0000 C   0  0
    7.8090    2.9897    0.0000 C   0  0
    9.1119    3.7346    0.0000 N   0  0
    9.1215    5.2346    0.0000 C   0  0
   10.4252    5.9764    0.0000 C   0  0
   11.7195    5.2182    0.0000 C   0  0
   11.7100    3.7182    0.0000 C   0  0
   10.4063    2.9764    0.0000 C   0  0
    9.0985    0.7352    0.0000 C   0  0
    9.0942   -0.7648    0.0000 C   0  0
    7.7931   -1.5111    0.0000 N   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  2  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 22  1  0
 20 28  2  0
 28 29  1  0
 29 30  2  0
 30 18  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7708

> <plate>
1

> <well>
I19

> <supplier_cmpd_name>
Lafutidine

> <ctcr_id>
7164

> <supplier_cmpd_id>
S2065

> <smiles>
O=C(C[S](=O)Cc1occc1)NC\C=C/COc2cc(CN3CCCCC3)ccn2

> <pd_targets>
{HRH2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{HRH2}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{lafutidine,118288-08-7,118288087,"118288 08 7",FRG-8813,FRG8813,"FRG 8813","Lafutidine (INN)","Lafutidine free base",206449-93-6,206449936,"206449 93 6","118288-08-7 (free base)","118288087 (free bas
e)","118288 08 7 (free base)",DSSTox_CID_26434,DSSToxCID26434,DSSTox-CID-26434,"DSSTox CID 26434",DSS,S2065,S2076,Lafutidine,Lisinopril}

> <pdid>
PD010868

> <targets>
{"Histamine Receptor",RAAS}

> <classes>
{"Endocrinology & Hormones","Neuronal Signaling"}

> <pubchem_cids>
{5282136}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 20  0  0  1  0            999 V2000
    1.0813    1.8186    0.0000 C   0  0
    0.0600    0.7200    0.0000 C   0  0  2  0  0  0
   -0.5400    2.2100    0.0000 N   0  0
   -0.5400   -0.8500    0.0000 C   0  0  2  0  0  0
    0.8500   -1.3700    0.0000 C   0  0
    2.1100   -0.9300    0.0000 C   0  0
    3.4600   -1.0200    0.0000 C   0  0
    4.2100    0.0900    0.0000 C   0  0
    3.6100    1.3000    0.0000 C   0  0
    2.2700    1.3800    0.0000 C   0  0
    1.5200    0.2600    0.0000 C   0  0
   -1.8500   -1.7700    0.0000 C   0  0
   -3.4300   -2.2400    0.0000 C   0  0
   -4.6300   -1.1000    0.0000 C   0  0
   -4.2400    0.5000    0.0000 C   0  0
   -2.6500    0.9600    0.0000 C   0  0
   -1.4500   -0.1700    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  2  1  0
 11  6  1  0
  4 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  2  1  0
 17 12  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7709

> <plate>
1

> <well>
I20

> <supplier_cmpd_name>
MK-801 (Dizocilpine)

> <ctcr_id>
7441

> <supplier_cmpd_id>
S2857

> <smiles>
C[C@]12N[C@H](Cc3ccccc13)c4ccccc24

> <pd_targets>
{TSHR,CHRM1,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,HSD17B10,CYP3A4,NFKB1,PRCP,GABRA2,SIGMAR1,ALOX12,CHRM5,KCNJ6,BLM,LMNA}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel",Enzyme,"Other cytosolic protein","Other nuclear protein","Family A G protein-coupled receptor","Ligand-gated ion channel",Oxidoreductase,"Cytochrome P450",Protease,"
Voltage-gated ion channel","Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Ionotropic glutamate receptor","Cytochrome P450 family 3","Serine protease","GABA-A receptor","
Potassium channels","Glycohormone receptor","Monoamine receptor","NMDA receptor","Cytochrome P450 family 3A","Serine protease SC clan","Inwardly rectifying potassium channel","Acetylcholine receptor",
"Cytochrome P450 3A4","Serine protease S28 family"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"Other protein targets","G protein-coupled receptors","Ligand-gated ion channels","Cytochrome P450","Peptidases and proteinases","Sigma receptors","Eicosanoid turnove
r","Voltage-gated ion channels","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Ionotropic glutamate receptors","CYP3 family","SC: Serine (S) Peptidases","GABA<sub>A</sub> rec
eptors",Lipoxygenases,"Potassium channels","S28: Lysosomal Pro-Xaa carboxypeptidase","Inwardly rectifying potassium channels"}

> <pathway_reactome>
{Disease,"Signal Transduction","Neuronal System",Metabolism,"Immune System",Hemostasis,"DNA Repair","Cell Cycle","Infectious disease","Signaling by GPCR","Transmission across Chemical Synapses","Metab
olism of amino acids and derivatives","Metabolism of lipids","Cytokine Signaling in Immune system","Formation of Fibrin Clot (Clotting Cascade)","DNA Double-Strand Break Repair",Mitotic,"Leishmania in
fection","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Sig
naling by Interleukins","Intrinsic Pathway of Fibrin Clot Formation","SARS-CoV Infections","Homology Directed Repair","M Phase","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like rec
eptors)","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","Interleukin-1 family signaling","GABA receptor activation","Potential therapeutics for SARS","Biosyn
thesis of DPA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Anti-inflammatory response favouring Leishmania parasite inf
ection","Amine ligand-binding receptors","Post NMDA receptor activation events","Biosynthesis of maresins","Interleukin-1 signaling","Biosynthesis of DPAn-3 SPMs","GABA B receptor activation","HDR thr
ough Homologous Recombination (HRR)","Mitotic Anaphase","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","CREB1 phosphorylation through NMDA receptor-medi
ated activation of RAS signaling","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived maresins","Long-term potentiation","Activation of GAB
AB receptors","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","Ras activation upon Ca2+ influx through NMDA receptor","Inhibition  of voltage gated Ca2+ channels via Gb
eta/gamma subunits","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{DIZOCILPINE,77086-21-6,77086216,MK-801,MK801,UNII-7PY8KH681I,UNII7PY8KH681I,"MK 801","(5S,10R)-5-methyl-10,11-dihydro-5H-5,10-epiminodibenzo(a,d)(7)annulene","(5S,10R)5methyl10,11dihydro5H5,10epimino
dibenzo(a,d)(7)annulene",Lopac-M-107,LopacM107,Lopac-M-108,LopacM108,"MK-801 (Dizocilpine)","MK801 (Dizocilpine)",Prestwick0_000109,Prestwick0000109,Prestwick0-000109,"Prestwick0 000109",7PY8KH681I,CH
EMBL284237,CHEBI:34725,Dizocilpina,Di,S2857}

> <pdid>
PD010545

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{180081}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 15 15  0  0  0  0            999 V2000
    5.0987   -0.7504    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -3.8990   -0.7455    0.0000 C   0  0
   -5.2526   -1.3618    0.0000 N   0  0
   -6.2524   -0.2436    0.0000 C   0  0
   -5.4979    1.0528    0.0000 N   0  0
   -4.0317    0.7358    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  7 14  2  0
 14  3  1  0
 14 15  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7710

> <plate>
1

> <well>
I21

> <supplier_cmpd_name>
Detomidine HCl

> <ctcr_id>
3869

> <supplier_cmpd_id>
S2092

> <smiles>
Cl.Cc1cccc(Cc2[nH]cnc2)c1C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{ADRA2A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"DETOMIDINE HYDROCHLORIDE",90038-01-0,90038010,"Detomidine HCl",Domosedan,"MPV-253 AII","MPV253 AII","Detomidine (hydrochloride)",UNII-95K4LKB6QE,UNII95K4LKB6QE,"Detomidine hydrochloride (USAN)","5-(
2,3-Dimethylbenzyl)-1H-imidazole Hydrochloride","5(2,3Dimethylbenzyl)1Himidazole Hydrochloride",95K4LKB6QE,5-((2,5((2,3-dimet,3dimet,S2092,S2095,"Fosinopril Sodium"}

> <pdid>

> <targets>
{Adrenergic Receptor,RAAS}

> <classes>
{Endocrinology & Hormones,Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{56031,50986730}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 28  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 O   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8975   -2.2510    0.0000 O   0  0
    3.8990   -0.7508    0.0000 C   0  0
    5.1976   -1.5016    0.0000 C   0  0
    6.4971   -0.7525    0.0000 C   0  0
    6.4980    0.7475    0.0000 C   0  0
    5.1995    1.4984    0.0000 C   0  0
    3.9000    0.7492    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0007    0.0000 N   0  0
   -3.8959    3.7529    0.0000 C   0  0
   -3.8936    5.2529    0.0000 C   0  0
   -2.5933    6.0009    0.0000 N   0  0
   -1.2955    5.2488    0.0000 C   0  0
   -1.2979    3.7488    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  2  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 19  1  0
 14 25  2  0
 25 10  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7711

> <plate>
1

> <well>
I22

> <supplier_cmpd_name>
SB742457

> <ctcr_id>
2581

> <supplier_cmpd_id>
S2894

> <smiles>
O=[S](=O)(c1ccccc1)c2cnc3c(cccc3N4CCNCC4)c2

> <pd_targets>
{HTR6,HTR1A,HTR2A,HTR7,DRD2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Serotonin receptor","Dopamine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","5-Hydroxytryptamine receptors","Dopamine receptors"}

> <pathway_reactome>
{Disease,"Signal Transduction","Infectious disease","Signaling by GPCR","Leishmania infection","GPCR ligand binding","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","A
nti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","Dopamine receptors"
}

> <broad_targets>
{HTR6}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{SK74245,607742-69-8,607742698,Intepirdine,SB-742457,SB742457,GSK-742457,GSK742457,"SB 742457",RVT-101,RVT101,3-(PHENYLSULFONYL)-8-(PIPERAZIN-1-YL)QUINOLINE,3(PHENYLSULFONYL)8(PIPERAZIN1YL)QUINOLINE,"
Quinoline, 3-(phenylsulfonyl)-8-(1-piperazinyl)-","Quinoline, 3(phenylsulfonyl)8(1piperazinyl)","GSK 742457",UNII-2IOB2M82HY,UNII2IOB2M82HY,3-Phenylsulfonyl-8-(piperazin-1-yl)quinolin,3Phenylsulfonyl8
(piperazin1yl)quinolin,T1774,S2894}

> <pdid>
PD010528

> <targets>
{5-HT Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{11256720}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 27  0  0  0  0            999 V2000
   19.2976   -2.2507    0.0000 H   0  3
   16.7976   -2.2507    0.0000 Cl  0  5
   14.2969   -2.2679    0.0000 C   0  0
   12.9965   -3.0156    0.0000 C   0  0
   11.6976   -2.2637    0.0000 N   0  0
   11.6967   -0.7629    0.0000 C   0  0
   10.3977   -0.0128    0.0000 C   0  0
   10.3966   -3.0118    0.0000 C   0  0
    9.0977   -2.2599    0.0000 C   0  0
    7.7988   -1.5080    0.0000 C   0  0
    6.4999   -0.7561    0.0000 C   0  0
    5.1988   -1.5042    0.0000 O   0  0
    3.8999   -0.7523    0.0000 C   0  0
    3.9021    0.7477    0.0000 O   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.6001   -0.0004    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5996   -3.0013    0.0000 C   0  0
    1.3010   -3.7520    0.0000 C   0  0
    1.3018   -5.2520    0.0000 C   0  0
    2.6012   -6.0013    0.0000 C   0  0
    3.8998   -5.2506    0.0000 C   0  0
    3.8990   -3.7506    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  3  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 17  1  0
 15 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7712

> <plate>
1

> <well>
J03

> <supplier_cmpd_name>
Oxybutynin chloride

> <ctcr_id>
2504

> <supplier_cmpd_id>
S3117

> <smiles>
[H+].[Cl-].CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2

> <pd_targets>
{KMT2A,MEN1,PMP22,NPSR1,RECQL,CHRM1,GPM3,CHRM2,CHRM5,CHRM4,ABCB11,CHRM3,DRD3,SLC6A3,SLC6A2,SIGMAR1,CYP2C19,HTR2B,CACNA1C,NFKB1,CYP3A4,CYP2C9,CYP1A2,THPO,CYP2D6,PKM,KCNH2}

> <pathway_gtopdb>
{"Epigenetic regulator","Unclassified protein","Membrane receptor",Enzyme,Transporter,"Ion channel","Other cytosolic protein",Reader,"Family A G protein-coupled receptor","Primary active transporter",
"Electrochemical transporter","Cytochrome P450","Voltage-gated ion channel",Bromodomain,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","ATP-binding cassette","SLC superfa
mily of solute carriers","Cytochrome P450 family 2","Voltage-gated calcium channel","Cytochrome P450 family 3","Cytochrome P450 family 1","Potassium channels","Short peptide receptor (family A GPCR)",
"Monoamine receptor","ABCB subfamily","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Volta
ge-gated potassium channel","Neuropeptide receptor","Acetylcholine receptor","Dopamine receptor","Cytochrome P450 2C19","Serotonin receptor","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P45
0 1A1","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,Transporters,"Other protein targets",Enzymes,"Ion channels","G protein-coupled receptors","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Sigma receptors","C
ytochrome P450","Voltage-gated ion channels","2.7.1.40 Pyruvate kinases","Neuropeptide S receptor","Acetylcholine receptors (muscarinic)","ABCB subfamily","Dopamine receptors","SLC6 neurotransmitter t
ransporter family","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","Voltage-gated calcium channels","CYP3 family","CYP1 family","Potassium channels","Monoamine transporter subf
amily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Developmental Biology",Disease,"Signal Transduction",Metabolism,"Immune System",Hemostasis,"Muscle contraction","Nervous system development","Infectious disease","Signaling by GPCR","Metabolism of l
ipids","Disorders of transmembrane transporters","Biological oxidations","Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Metabolism of carbohydrates","Cardiac 
conduction","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Leishmania infection","GPCR ligand binding","Metabolism of steroids","SLC transporter disorders","SARS-CoV Infections","Ph
ase I - Functionalization of compounds","Axon guidance","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug Formation)","Glucose metabol
ism","Phase 3 - rapid repolarisation","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Defective SLC6A3 causes Parkinsonism-dyston
ia infantile (PKDYS)","Defective SLC6A2 causes orthostatic intolerance (OI)","Potential therapeutics for SARS","Cytochrome P450 - arranged by substrate type","NCAM signaling for neurite out-growth","I
nterleukin-1 family signaling","Biosynthesis of DHA-derived SPMs",Glycolysis,"Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Synthesis of bile ac
ids and bile salts",Xenobiotics,"NCAM1 interactions","Interleukin-1 signaling","Biosynthesis of maresins","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors"
,"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Dopamine receptors","CYP2E1 reactions","Serotonin receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of mare
sin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Oxybutynin chloride","Oxybutynin hydrochloride",1508-65-2,1508652,"Oxybutynin HCl","Oxybutynin (chloride)","Ditropan Xl","MJ 4309-1","MJ 43091",C22H32ClNO3,MLS000069688,MFCD00072150,Dridase,SMR00005
8490,Tropax,"(R)-Oxybutynin Chloride","(R)Oxybutynin Chloride",4-Diethylamino-2-butyny,4Diethylamino2butyny,S3117,SAM002564226,1505399,Prestw-287,CPD000058490,"OXYBUTYNIN CHLORIDE"}

> <pdid>
PD009572

> <targets>
{AChR}

> <classes>
{anticholinergic,"Neuronal Signaling"}

> <pubchem_cids>
{91505,43835207,657224}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 36  0  0  0  0            999 V2000
   15.5002   -7.5017    0.0000 Br  0  5
   12.9995   -1.4792    0.0000 C   0  0
   11.6990   -0.7319    0.0000 C   0  0
   10.4003   -1.4841    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6060   -6.0003    0.0000 C   0  0
   -2.6060   -7.5003    0.0000 C   0  0
   -1.3070   -8.2503    0.0000 C   0  0
   -0.0080   -7.5003    0.0000 C   0  0
   -0.0079   -6.0003    0.0000 C   0  0
   -1.3040   -9.7511    0.0000 C   0  0
   -2.6017  -10.5034    0.0000 O   0  0
   -0.0032  -10.4997    0.0000 O   0  0
   -0.0001  -12.0006    0.0000 C   0  0
    1.3007  -12.7491    0.0000 C   0  0
    1.3038  -14.2500    0.0000 N   0  3
    2.6015  -13.4977    0.0000 C   0  0
    2.6046  -14.9985    0.0000 C   0  0
    2.6076  -16.4985    0.0000 C   0  0
    0.0054  -15.0026    0.0000 C   0  0
    0.0070  -16.5026    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
 33 34  1  0
 31 35  1  0
 35 36  1  0
M  CHG  2   1  -1  31   1
M  END
> <name>
Selleck_GPCR

> <id>
7713

> <plate>
1

> <well>
J04

> <supplier_cmpd_name>
Solifenacin succinate

> <ctcr_id>
6628

> <supplier_cmpd_id>
S3048

> <smiles>
[Br-].CCCCCCCCOc1ccccc1C(=O)Nc2ccc(cc2)C(=O)OCC[N+](C)(CC)CC

> <pd_targets>
{KMT2A,FFP}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Reader,Transferase,Bromodomain}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","2.1.1.43 Histone methyltransferases (HMTs)"}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","Transcriptional regulation by RUNX1","RUNX1 regulates genes involved in megakaryocyte differentiat
ion and platelet function"}

> <broad_targets>
{CACNA1C}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{26095-59-0,26095590,"26095 59 0","Octylonium bromide",Octylonium,"Otilonium (bromide)",SP63,UNII-21HN3N72PV,UNII21HN3N72PV,"UNII 21HN3N72PV",21HN3N72PV,Spasmomen,DSSTox_CID_26357,DSSToxCID26357,DSSTo
x-CID-26357,"DSSTox CID 26357",DSSTox_RID_81559,DSSToxRID81559,DSSTox-RID-81559,"DSSTox RID 81559",DSSTox_GSID_46357,DSSToxGSID46357,DSSTox-GSID-46357,"DSSTox GSID 46357","Otilonii bromidum","Ottiloni
o bromuro","Ottilonio bromuro (Italian)",T1474,S3047,S3048,"Otilonium bromide","Solifenacin succinate","Otilonium Bromide"}

> <pdid>
PD014241

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{72092}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 23  0  0  0  0            999 V2000
   11.9554   -0.4782    0.0000 H   0  3
    9.4554   -0.4782    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  9  1  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7714

> <plate>
1

> <well>
J05

> <supplier_cmpd_name>
Amitriptyline HCl

> <ctcr_id>
3305

> <supplier_cmpd_id>
S3183

> <smiles>
[H+].[Cl-].CN(C)CCC=C1c2ccccc2CCc3ccccc13

> <pd_targets>
{MAPT,ALDH1A1,TP53,LEF,LMNA,PMP22,FFP,KMT2A,MEN1,NFO,TGR,ALD,KDM4E,CYP3A4,HTR2C,LPAR1,NFKB1,CYP2D6,ADRA1B,ADRA1A,CHRM2,HTR6,ADRA2A,HTR7,SLC6A2,SLC6A3,CACNA1C,CACNA1D,CACNA1F,CACNA1S,ADRA2C,HRH1,CHRM1,
SIGMAR1,CHRM3,HTR2A,SLC6A4,KCNH2,HRH2,SCN7A,CYP1A2,RET,DRD2,CHRM4,CHRM5,HTR1B,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN8A,SCN9A,ALB,KCNJ6,HSD17B10,HRH4,HTR1A,GSC2,HTR1D,HTR1F,HTR2B,HTR3A,HTR3B,H
TR4,HTR5A,HTR5B,DRD3,MTOR,DRD5,ADRA1D,ADRA2B,NTRK1,SLC22A1,KCNJ5,OPRD1,OPRK1,NTRK2,KCNQ2,KCNA1,OPRM1,KCNQ3,KCNH6,KCNH7}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein","Epigenetic regulator","Membrane receptor",Transporter,"Ion channel","Secreted protein",Oxidored
uctase,Protease,Transferase,Reader,Hydrolase,Eraser,"Cytochrome P450","Family A G protein-coupled receptor","Electrochemical transporter","Voltage-gated ion channel",Kinase,"Metallo protease",Bromodom
ain,"Lysine demethylase","Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute carriers","Voltage-gated calcium channel","Potassium
 channels","Voltage-gated sodium channel","Cytochrome P450 family 1","Protein Kinase","Peptide receptor (family A GPCR)","Metallo protease MAE clan","Jumonji domain-containing","Cytochrome P450 family
 3A","Monoamine receptor","Lipid-like ligand receptor (family A GPCR)","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Voltage-gated potassium channel","Cytochrome P450 family
 1A","TK protein kinase group","Inwardly rectifying potassium channel","Atypical protein kinase group","SLC22 family of organic cation and anion transporters","Short peptide receptor (family A GPCR)",
"Metallo protease M34 family","Cytochrome P450 3A4","Serotonin receptor","EDG receptor","Cytochrome P450 2D6","Adrenergic receptor","Acetylcholine receptor","Histamine receptor","Cytochrome P450 1A1",
"Tyrosine protein kinase Ret family","Dopamine receptor","Atypical protein kinase PIKK family","Tyrosine protein kinase Trk family","Opioid receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Ion channels","Chromatin modifying enzymes","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Sigma recepto
rs","Voltage-gated ion channels","Catalytic receptors","Kinases (EC 2.7.x.x)","1.14.11.- Histone demethylases","CYP3 family","5-Hydroxytryptamine receptors","Lysophospholipid (LPA) receptors","CYP2 fa
mily: drug metabolising subset",Adrenoceptors,"Acetylcholine receptors (muscarinic)","SLC6 neurotransmitter transporter family","Histamine receptors","Potassium channels","CYP1 family","Receptor kinas
es","Dopamine receptors","Voltage-gated sodium channels",Atypical,"Voltage-gated calcium channels","SLC22 family of organic cation and anion transporters","Opioid receptors","Monoamine transporter sub
family","Voltage-gated potassium channels","TK: Tyrosine kinase","Inwardly rectifying potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Organic cation transporters (
OCT)","Receptor tyrosine kinases (RTKs)","FRAP subfamily","Type XIV RTKs: RET","Type VII RTKs: Neurotrophin receptor/Trk family"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Cell Cycle",Disease,"Developmental Biology","Signal Transduction","Immune System","Muscle contraction","Gene expression (Transcription)","Transport of small molecules","
Transmission across Chemical Synapses","Biological oxidations","Cell Cycle Checkpoints","Infectious disease",Mitotic,"Nervous system development","Metabolism of lipids","Signaling by GPCR","Cytokine S
ignaling in Immune system","Disorders of transmembrane transporters","Cardiac conduction","Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Signaling by Receptor Tyrosine 
Kinases","SLC-mediated transmembrane transport","Potassium Channels","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","G1/S DNA Damage Check
points","Uptake and actions of bacterial toxins","M Phase","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand bin
ding","Signaling by Interleukins","Leishmania infection","SLC transporter disorders","SARS-CoV Infections","Neurotransmitter clearance","Phase 3 - rapid repolarisation","Axon guidance","Metabolism of 
steroids","Branched-chain amino acid catabolism","Generic Transcription Pathway","Signaling by NTRKs","Transport of bile salts and organic acids","metal ions and amine compounds","Voltage gated Potass
ium channels","GPCR downstream signalling","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Uptake and function of anthrax toxins"
,"Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","Cytochrome P450 - arranged by substrate type","Leishmania 
parasite growth and survival","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Potential therapeutics for SARS","Serotonin clea
rance from the synaptic cleft","L1CAM interactions","RET signaling","Bile acid and bile salt metabolism","GABA receptor activation","Transcriptional Regulation by TP53","NCAM signaling for neurite out
-growth","Signaling by NTRK1 (TRKA)","Organic cation/anion/zwitterion transport","Transcriptional Regulation by MECP2","G alpha (i) signalling events","Post NMDA receptor activation events","p53-Depen
dent G1 DNA Damage Response","Mitotic Anaphase","Biosynthesis of maresins","Amine ligand-binding receptors","Lysosphingolipid and LPA receptors","Interleukin-1 signaling",Xenobiotics,"Anti-inflammator
y response favouring Leishmania parasite infection","Interaction between L1 and Ankyrins","Recycling of bile acids and salts","GABA B receptor activation","Regulation of TP53 Activity","NCAM1 interact
ions","Signalling to ERKs","Organic cation transport","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and channels","Activation of TRKA receptors","Opioid Signalling","Activatio
n of AMPK downstream of NMDARs","Stabilization of p53","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Serotonin receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","CYP2E1
 reactions",Adrenoceptors,"Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Histamine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated b
y CYP1A2","Dopamine receptors","Activation of GABAB receptors","Regulation of TP53 Expression and Degradation","Prolonged ERK activation events","NGF-independant TRKA activation","G-protein activation
","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Regulation of TP53 Degradat
ion","ARMS-mediated activation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRB1,ADRB2,ADRB3,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HRH1,HRH2,HRH4,HTR1A,HTR1B,HTR1D,HTR2A,HTR2C,HTR6,HTR7,KCNA1,KCND2,KCND3,KCNQ2,KCNQ3,NTRK1,NTRK2,OPRD1,OPRK1,OPRM1,SIGMAR1,
SLC6A2,SLC6A4}

> <broad_moa>
{"norepinephrine inhibitor","norepinephrine reuptake inhibitor","serotonin receptor antagonist","serotoninâ€“norepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{RESTW7,AKOS015917367,SBB057420,AKOS024366256,MCULE-6119641097,MCULE6119641097,"Amitriptyline Amitriptyline hydrochloride",ST50999679,"Amitriptyline hydrochloride",549-18-8,549188,"Amitriptyline HCl",
Annoyltin,Tryptizol,Domical,Lentizol,Saroten,Endep,"Elavil hydrochloride",Am,S3183,SAM002554886,1500117,Prestw-74,"Amitriptyline HCl",CPD000058368,"AMITRIPTYLINE HYDROCHLORIDE","Amitryptiline hydrochl
oride"}

> <pdid>
PD010103

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{657376,43833356,11065}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 26  0  0  1  0            999 V2000
    2.2090   -0.3353    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8972    3.7500    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    2.7095   -0.7710    0.0000 O   0  0
    3.4182   -2.8395    0.0000 C   0  0
    2.9720   -4.2725    0.0000 C   0  0
    2.5261   -5.7047    0.0000 N   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  3
 12  6  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  6
 15  5  1  0
 15 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19  2  1  0
 19 20  1  1
 19 21  1  0
 21 22  1  0
 22 23  3  0
M  END
> <name>
Selleck_GPCR

> <id>
7715

> <plate>
1

> <well>
J06

> <supplier_cmpd_name>
Dienogest

> <ctcr_id>
7123

> <supplier_cmpd_id>
S1251

> <smiles>
C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N

> <pd_targets>
{PGR,AR}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormon
e receptor subfamily 3 group C member 4"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Metabolism of proteins","Gene expression (Transcription)","Post-translational protein modification","RNA Polymerase II Transcription",SUMOylation,"Generic Transcription Pathway","SUMO E3 ligases SUM
Oylate target proteins","Transcriptional regulation by RUNX2","SUMOylation of intracellular receptors","RUNX2 regulates bone development","RUNX2 regulates osteoblast differentiation"}

> <broad_targets>
{PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{Dienogest,"19-Norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17-alpha)-","19Norpregna4,9diene21nitrile, 17hydroxy3oxo, (17alpha)","19 Norpregna 4,9 diene 21 nitrile, 17 hydroxy 3 oxo , (17 alpha
)",AKOS015840152,AKOS015896680,AC-2166,AC2166,"AC 2166",ACN-037291,ACN037291,"ACN 037291",CCG-267594,CCG267594,"CCG 267594",CS-1782,CS1782,"CS 1782",DB09123,NCGC00346502-04,NCGC0034650204,"NCGC0034650
2 04",ZK-37659,ZK37659,"ZK 37659",D5230,X4651,D03799,AB01566807_01,AB0156680701,AB01566807-01,"AB01566807 01",928D587,Q139160,SR-01000942230,SR01000942230,"SR 01000942230",SR-01000,SR01000,"SR 01000",
T2577,S1251}

> <pdid>
PD009046

> <targets>
{Estrogen/progestogen Receptor,Apoptosis,Autophagy,Progesterone Receptor}

> <classes>
{Endocrinology & Hormones,Apoptosis,Autophagy,Others}

> <pubchem_cids>
{68861}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 23  0  0  1  0            999 V2000
   -1.8778    2.7573    0.0000 C   0  0
   -1.0947    1.4779    0.0000 N   0  0
    0.0000    0.6568    0.0000 C   0  0
   -0.6568   -0.6386    0.0000 C   0  0
   -1.8063   -1.3319    0.0000 C   0  0
   -0.8393    0.0000    0.0000 C   0  0
    0.9488    0.0000    0.0000 C   0  0
    1.8975   -0.8028    0.0000 C   0  0
    1.6421    0.6933    0.0000 C   0  0
    2.6654   -2.0798    0.0000 O   0  0
    4.1661   -2.0555    0.0000 C   0  0
    4.8945   -0.7443    0.0000 O   0  0
    4.9382   -3.3425    0.0000 C   0  0  2  0  0  0
    4.2067   -4.6529    0.0000 C   0  0
    2.7069   -4.6756    0.0000 O   0  0
    6.4389   -3.3181    0.0000 C   0  0
    7.2125   -4.6033    0.0000 C   0  0
    8.7123   -4.5759    0.0000 C   0  0
    9.4385   -3.2634    0.0000 C   0  0
    8.6649   -1.9783    0.0000 C   0  0
    7.1652   -2.0056    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  1
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7716

> <plate>
1

> <well>
J07

> <supplier_cmpd_name>
Hyoscyamine

> <ctcr_id>
7543

> <supplier_cmpd_id>
S4014

> <smiles>
CN1C2CCC1CC(C2)OC(=O)[C@H](CO)c3ccccc3

> <pd_targets>
{CFTR,CHRM3,CHRM2,GPM3,CHRM4,CHRM1,CHRM5,MAPT,ACHE,ADRA2A,NACHRALPHA5,ADRA1D,HTR2C,SLC22A1,GLRA1,AMPC,LMNA,KDM4E,BLM,POLB}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor","Other ion channel","Family A G protein-coupled receptor","Chloride channel","Small molecule receptor (family A GPCR)","Cystic fibrosis transmembrane conductance reg
ulator","Monoamine receptor","Acetylcholine receptor","Other cytosolic protein",Enzyme,Transporter,Hydrolase,"Ligand-gated ion channel","Electrochemical transporter","Nicotinic acetylcholine receptor"
,"SLC superfamily of solute carriers","Glycine receptor","SLC22 family of organic cation and anion transporters","Adrenergic receptor","Serotonin receptor","Other nuclear protein","Epigenetic regulato
r",Eraser,"Lysine demethylase","Jumonji domain-containing"}

> <pathway_chembl>
{"Ion channels",Receptors,"Other ion channels","G protein-coupled receptors","Chloride channels","Acetylcholine receptors (muscarinic)",CFTR,Enzymes,Transporters,"Acetylcholine turnover","SLC superfam
ily of solute carriers","Ligand-gated ion channels",Adrenoceptors,"5-Hydroxytryptamine receptors","SLC22 family of organic cation and anion transporters","Glycine receptors","Organic cation transporte
rs (OCT)","Chromatin modifying enzymes","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{Autophagy,"Signal Transduction",Macroautophagy,"Signaling by GPCR","Selective autophagy","GPCR ligand binding",Aggrephagy,"Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Musc
arinic acetylcholine receptors","Neuronal System",Metabolism,"Transport of small molecules","Transmission across Chemical Synapses","Metabolism of lipids","SLC-mediated transmembrane transport","Neuro
transmitter receptors and postsynaptic signal transmission","Phospholipid metabolism","Transport of bile salts and organic acids","metal ions and amine compounds","Activation of NMDA receptors and pos
tsynaptic events","Glycerophospholipid biosynthesis","Organic cation/anion/zwitterion transport","Post NMDA receptor activation events","Synthesis of PC","Organic cation transport","Activation of AMPK
 downstream of NMDARs",Adrenoceptors,"Serotonin receptors","Cell Cycle","DNA Repair",Mitotic,"DNA Double-Strand Break Repair","Base Excision Repair","M Phase","Homology Directed Repair","Resolution of
 Abasic Sites (AP sites)","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch repla
cement pathway","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision Repair","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand E
xchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{hyoscyamine,Levsin,L-Hyoscyamine,LHyoscyamine,Cystospaz,1-Hyoscyamine,1Hyoscyamine,"Hyoscyamine (Daturine)",l-Hyopscyamine,lHyopscyamine,L-Hyoscamine,LHyoscamine,"Levsinex SR",101-31-5,101315,"(8-met
hyl-8-azabicyclo(3.2.1)octan-3-yl) (2S)-3-hydroxy-2-phenylpropanoate","(8methyl8azabicyclo(3.2.1)octan3yl) (2S)3hydroxy2phenylpropanoate","Tropic acid, (-)-, ester with tropine","Tropic acid, (), este
r with tropine",S4014,Hyoscyamine}

> <pdid>
PD002296

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{64692}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 35 38  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 O   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2978    3.7529    0.0000 C   0  0
    1.2954    5.2529    0.0000 C   0  0
   -0.0048    6.0009    0.0000 C   0  0
   -0.0103    7.5017    0.0000 N   0  0
   -1.3123    8.2482    0.0000 C   0  0
   -2.6088    7.4938    0.0000 O   0  0
   -1.3178    9.7490    0.0000 C   0  0
   -0.0199   10.5012    0.0000 C   0  0
   -0.0223   12.0012    0.0000 C   0  0
   -1.3226   12.7491    0.0000 C   0  0
   -2.6204   11.9970    0.0000 C   0  0
   -2.6180   10.4970    0.0000 C   0  0
   -3.9158    9.7449    0.0000 C   0  0
   -3.9213   12.7452    0.0000 C   0  0
   -3.9262   14.2453    0.0000 C   0  0
   -5.2277   14.9911    0.0000 C   0  0
   -6.5243   14.2370    0.0000 C   0  0
   -7.8280   14.9805    0.0000 O   0  0
   -9.1242   14.2241    0.0000 C   0  0
  -10.4272   14.9673    0.0000 F   0  0
   -9.1168   12.7241    0.0000 F   0  0
  -10.4194   13.4675    0.0000 F   0  0
   -6.5195   12.7370    0.0000 C   0  0
   -5.2180   11.9911    0.0000 C   0  0
   -1.3026    5.2488    0.0000 C   0  0
   -1.3002    3.7488    0.0000 N   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  6
  6  8  1  0
  8  2  1  0
  4  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
 26 32  1  0
 32 33  2  0
 33 23  1  0
 12 34  1  0
 34 35  2  0
 35  9  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7717

> <plate>
1

> <well>
J08

> <supplier_cmpd_name>
LDE225 (NVP-LDE225,Erismodegib)

> <ctcr_id>
7404

> <supplier_cmpd_id>
S2151

> <smiles>
C[C@H]1CN(C[C@@H](C)O1)c2ccc(NC(=O)c3cccc(c3C)c4ccc(OC(F)(F)F)cc4)cn2

> <pd_targets>
{SMO,SHH}

> <pathway_gtopdb>
{"Membrane receptor","Unclassified protein","Frizzled family G protein-coupled receptor","Smoothened receptor (frizzled family GPCR)"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Class Frizzled GPCRs"}

> <pathway_reactome>
{"Organelle biogenesis and maintenance",Disease,"Cilium Assembly","Diseases of signal transduction by growth factor receptors and second messengers","Cargo trafficking to the periciliary membrane","Hh
 mutants abrogate ligand secretion","BBSome-mediated cargo-targeting to cilium","HHAT G278V doesn't palmitoylate Hh-Np"}

> <broad_targets>
{SMO}

> <broad_moa>
{"smoothened receptor antagonist"}

> <synonyms>
{cc-76,cc76,NVP-LDE225(Erismodegib),NVPLDE225(Erismodegib),Erismodegib,Sonidegib,956697-53-3,956697533,LDE225,NVP-LDE225,NVPLDE225,Odomzo,LDE-225,"NVP-LDE 225","NVPLDE 225","LDE 225",UNII-0RLU3VTK5M,U
NII0RLU3VTK5M,"LDE225 (NVP-LDE225,Erismodegib)","LDE225 (NVPLDE225,Erismodegib)",0RLU3VTK5M,"Sonidegib (LDE-225)","Sonidegib (LDE225)","956697-53-3 (free base)","956697533 (free base)",Odomozo,761385,
S2151,erismodegib}

> <pdid>
PD003504

> <targets>
{Smoothened}

> <classes>
{"Stem Cells & Wnt"}

> <pubchem_cids>
{24775005}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 17  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.5993    0.0004    0.0000 O   0  0
    8.9899   -2.6249    0.0000 N   0  0
   10.2902   -1.8772    0.0000 C   0  0
   11.5877   -2.6299    0.0000 N   0  0
   10.2924   -0.3764    0.0000 N   0  0
    8.9941    0.3767    0.0000 N   0  0
    8.9963    1.8775    0.0000 C   0  0
    7.6981    2.6306    0.0000 C   0  0
    7.6981    4.1306    0.0000 C   0  0
    8.9971    4.8806    0.0000 Cl  0  0
    6.3990    4.8806    0.0000 C   0  0
    5.1000    4.1306    0.0000 C   0  0
    5.1000    2.6306    0.0000 C   0  0
    6.3990    1.8806    0.0000 C   0  0
    6.3990    0.3806    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 17 18  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7718

> <plate>
1

> <well>
J09

> <supplier_cmpd_name>
Guanabenz Acetate

> <ctcr_id>
1180

> <supplier_cmpd_id>
S4065

> <smiles>
CC(O)=O.NC(=N)N/N=C/c1c(Cl)cccc1Cl

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Guanabenz acetate",23256-50-0,23256500,Wytensin,"Guanabenz acetate salt","WY-8678 acetate","WY8678 acetate","Guanabenz (Acetate)",Wy-8678,Wy8678,UNII-443O19GK1A,UNII443O19GK1A,MLS000028717,"Guanaben
z (WY-8678) Acetate","Guanabenz (WY8678) Acetate",443O19GK1A,MFCD00153801,SMR000058454,60329-04-6,60329046,"WY 8678 acetat",T6522,S4065,Prestw-96,"Guanabenz Acetate"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9570374,5702062}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 36  0  0  0  0            999 V2000
   15.5002   -7.5017    0.0000 Br  0  5
   12.9995   -1.4792    0.0000 C   0  0
   11.6990   -0.7319    0.0000 C   0  0
   10.4003   -1.4841    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6060   -6.0003    0.0000 C   0  0
   -2.6060   -7.5003    0.0000 C   0  0
   -1.3070   -8.2503    0.0000 C   0  0
   -0.0080   -7.5003    0.0000 C   0  0
   -0.0079   -6.0003    0.0000 C   0  0
   -1.3040   -9.7511    0.0000 C   0  0
   -2.6017  -10.5034    0.0000 O   0  0
   -0.0032  -10.4997    0.0000 O   0  0
   -0.0001  -12.0006    0.0000 C   0  0
    1.3007  -12.7491    0.0000 C   0  0
    1.3038  -14.2500    0.0000 N   0  3
    2.6015  -13.4977    0.0000 C   0  0
    2.6046  -14.9985    0.0000 C   0  0
    2.6076  -16.4985    0.0000 C   0  0
    0.0054  -15.0026    0.0000 C   0  0
    0.0070  -16.5026    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
 33 34  1  0
 31 35  1  0
 35 36  1  0
M  CHG  2   1  -1  31   1
M  END
> <name>
Selleck_GPCR

> <id>
7719

> <plate>
1

> <well>
J10

> <supplier_cmpd_name>
Otilonium Bromide

> <ctcr_id>
6628

> <supplier_cmpd_id>
S3047

> <smiles>
[Br-].CCCCCCCCOc1ccccc1C(=O)Nc2ccc(cc2)C(=O)OCC[N+](C)(CC)CC

> <pd_targets>
{KMT2A,FFP}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Reader,Transferase,Bromodomain}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","2.1.1.43 Histone methyltransferases (HMTs)"}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","Transcriptional regulation by RUNX1","RUNX1 regulates genes involved in megakaryocyte differentiat
ion and platelet function"}

> <broad_targets>
{CACNA1C}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{26095-59-0,26095590,"26095 59 0","Octylonium bromide",Octylonium,"Otilonium (bromide)",SP63,UNII-21HN3N72PV,UNII21HN3N72PV,"UNII 21HN3N72PV",21HN3N72PV,Spasmomen,DSSTox_CID_26357,DSSToxCID26357,DSSTo
x-CID-26357,"DSSTox CID 26357",DSSTox_RID_81559,DSSToxRID81559,DSSTox-RID-81559,"DSSTox RID 81559",DSSTox_GSID_46357,DSSToxGSID46357,DSSTox-GSID-46357,"DSSTox GSID 46357","Otilonii bromidum","Ottiloni
o bromuro","Ottilonio bromuro (Italian)",T1474,S3047,S3048,"Otilonium bromide","Solifenacin succinate","Otilonium Bromide"}

> <pdid>
PD014241

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{72092}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 10  8  0  0  0  0            999 V2000
    6.8954   -1.7782    0.0000 Cl  0  0
    4.3954   -1.7782    0.0000 Cl  0  0
    1.8949   -4.8318    0.0000 N   0  0
    1.0157   -3.6164    0.0000 C   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 N   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  6  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7720

> <plate>
1

> <well>
J11

> <supplier_cmpd_name>
Histamine 2HCl

> <ctcr_id>
1227

> <supplier_cmpd_id>
S4118

> <smiles>
Cl.Cl.NCCc1[nH]cnc1

> <pd_targets>
{HRH2,HRH4,HRH3,HRH1,TSHR,FFP,HTR7,TAAR1,LMNA,CA1,CA7,CA5A}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor",Transferase,Lyase,"Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Monoamine rece
ptor","Glycohormone receptor","Histamine receptor","Serotonin receptor","Trace amine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Carbonic anhydrases","Histamine receptors","Glycoprotein hormone receptors","5-Hydroxytryptamine receptors","Trace amine receptor"}

> <pathway_reactome>
{Disease,"Signal Transduction","Cell Cycle","Immune System",Metabolism,"Infectious disease","Signaling by GPCR",Mitotic,"Cytokine Signaling in Immune system","Reversible hydration of carbon dioxide","
Leishmania infection","GPCR ligand binding","M Phase","Signaling by Interleukins","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Int
erleukin-12 family signaling","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Mitotic Anaphase","Interleukin-12 signaling","ADORA2B mediated anti
-inflammatory cytokines production","Histamine receptors","Nuclear Envelope (NE) Reassembly","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Initiation of Nuclear
 Envelope (NE) Reformation"}

> <broad_targets>
{HRH1,HRH2,HRH3,HRH4}

> <broad_moa>
{"histamine receptor agonist"}

> <synonyms>
{"histamine dihcl",Bichlorhydrated'Histamine,"Histamine dihydrochloride",56-92-8,56928,"Histamine 2HCl","2-(1H-Imidazol-4-yl)ethanamine dihydrochloride","2(1HImidazol4yl)ethanamine dihydrochloride","1
H-Imidazole-4-ethanamine dihydrochloride","1HImidazole4ethanamine dihydrochloride","1H-Imidazole-4-ethanamine, dihydrochloride","1HImidazole4ethanamine, dihydrochloride",per,T6534,T0965,S4118,1500331,
Histamine,"HISTAMINE DIHYDROCHLORIDE"}

> <pdid>
PD012019

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling","H receptor agonist","induces edema in mammalian tissues; gastric secretion stimulant"}

> <pubchem_cids>
{57504843,11309913,5818,57501470}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 21  0  0  0  0            999 V2000
   15.4003   -0.8115    0.0000 H   0  3
   12.9003   -0.8115    0.0000 Cl  0  5
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    9.0964    0.7636    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    6.4964    0.7591    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 C   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 13  1  0
 22 18  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7721

> <plate>
1

> <well>
J12

> <supplier_cmpd_name>
ICI-118551

> <ctcr_id>
8205

> <supplier_cmpd_id>
S8114

> <smiles>
[H+].[Cl-].CC(C)NC(C)C(O)COc1ccc(C)c2CCCc12

> <pd_targets>
{ADRB2,ADRB3,RORC,NFKB1,HIF1A,TP53,CYP3A4,TSHR,LEF,CYP1A2,KDM4E,CYP2D6,ADRB1,ADRA2A,IMPA1,PMP22,NPSR1,KMT2A,MEN1,LMNA}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor","Other cytosolic protein",Enzyme,"Epigenetic regulator","Family A G protein-coupled receptor","Nuclear receptor","Cytochrome P450",Protease,Eraser,"Small mo
lecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Metallo protease","Cytochrome P450 family 1","Lysine demethylase"
,"Cytochrome P450 family 2","Monoamine receptor","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Glycohormone receptor","Metallo protease MAE clan","Cytochrome P450 family 
1A","Jumonji domain-containing","Cytochrome P450 family 2D","Adrenergic receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Metallo protease M34 family","Cytochrom
e P450 1A1","Cytochrome P450 2D6","Unclassified protein","Other nuclear protein",Hydrolase,Reader,Bromodomain,"Short peptide receptor (family A GPCR)","Neuropeptide receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Nuclear hormone receptors","Cytochrome P450","Chromatin modifying enzymes",Adrenoceptors,"1F. Retinoic acid-related orphans","CYP3 family","Glycoprote
in hormone receptors","CYP1 family","1.14.11.- Histone demethylases","CYP2 family: drug metabolising subset","Inositol phosphate turnover","Inositol monophosphatase","Neuropeptide S receptor"}

> <pathway_reactome>
{Disease,"Gene expression (Transcription)","Immune System","Cellular responses to external stimuli","Cell Cycle",Metabolism,"Infectious disease","RNA Polymerase II Transcription","Cytokine Signaling i
n Immune system","Cellular responses to stress","Cell Cycle Checkpoints","Metabolism of lipids","Biological oxidations","Leishmania infection","Generic Transcription Pathway","Signaling by Interleukin
s","Cellular response to hypoxia","G1/S DNA Damage Checkpoints","Biosynthesis of specialized proresolving mediators (SPMs)","Uptake and actions of bacterial toxins","Phase I - Functionalization of com
pounds","Leishmania parasite growth and survival","Transcriptional regulation by RUNX3","Interleukin-1 family signaling","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","p53
-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Uptake and function of anthrax toxins","Cytochrome P450 - arranged by substrate type","Anti-inflammatory response favouring L
eishmania parasite infection","RUNX3 Regulates Immune Response and Cell Migration","Interleukin-1 signaling","p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins",Xenobiotics,"ADORA2B medi
ated anti-inflammatory cytokines production","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Stabilization of p53","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkyl
ated by CYP1A2","CYP2E1 reactions","Autodegradation of the E3 ubiquitin ligase COP1","Signal Transduction","Developmental Biology","Signaling by GPCR","Inositol phosphate metabolism","Nervous system d
evelopment",Mitotic,"GPCR ligand binding","Synthesis of IP2",IP,"and Ins in the cytosol","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Class A/1 (Rhodopsin-like receptors
)","Mitotic Metaphase and Anaphase","Amine ligand-binding receptors","Mitotic Anaphase",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{CI11855,"ICI 118551 Hydrochloride","ICI 118,551 hydrochloride",72795-01-8,72795018,1217094-53-5,1217094535,SR-01000075274,SR01000075274,EU-0100714,EU0100714,SCHEMBL5485188,CHEMBL1256784,ICI-118,ICI11
8,s8114,CCG-267620,CCG267620,NCGC00094064-01,NCGC0009406401,AC-32761,AC32761,AK547937,FT-0670268,FT0670268,FT-0670269,FT0670269,I-127,I127,"( inverted question ma",S8114,ICI-118551}

> <pdid>
PD041535

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{11957590}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 22  0  0  0  0            999 V2000
   15.4003   -1.1252    0.0000 H   0  3
   12.9003   -1.1252    0.0000 Cl  0  5
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    9.0964    0.7636    0.0000 C   0  0
   10.3966    0.0161    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 13  1  0
 23 17  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7722

> <plate>
1

> <well>
J13

> <supplier_cmpd_name>
Carteolol HCl

> <ctcr_id>
1542

> <supplier_cmpd_id>
S4278

> <smiles>
[H+].[Cl-].CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12

> <pd_targets>
{ADRB1,ADRB2,ADRB3}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{RESTW44,AKOS026750076,CHEBI:3438,"5-(2-Hydroxy-3-tert-butylamino)propoxy-3,4-dihydrocarbostyril hydrochloride","5(2Hydroxy3tertbutylamino)propoxy3,4dihydrocarbostyril hydrochloride","carteolol hydroc
hloride",51781-21-6,51781216,"Carteolol HCl",Arteoptic,Mikelan,Cartrol,Abbott-43326,Abbott43326,"Endak hydrochloride",Ocupress,OPC-1085,OPC1085,Carteolo,T1282,S4278,Prestw-446,"Carteolol hydrochloride
"}

> <pdid>
PD009980

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{25137857,49852288,40127}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 18  0  0  0  0            999 V2000
    9.0415   -2.6234    0.0000 H   0  3
    6.5415   -2.6234    0.0000 Cl  0  5
    4.0411   -1.8007    0.0000 C   0  0
    3.2905   -3.0995    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.0390   -4.3998    0.0000 C   0  0
    1.6386   -5.7608    0.0000 N   0  0
    0.5081   -6.7467    0.0000 C   0  0
   -0.7789   -5.9762    0.0000 N   0  0
   -0.4438   -4.5141    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13  5  1  0
  5 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7723

> <plate>
1

> <well>
J15

> <supplier_cmpd_name>
Atipamezole hydrochloride

> <ctcr_id>
8206

> <supplier_cmpd_id>
S4649

> <smiles>
[H+].[Cl-].CCC1(Cc2ccccc2C1)c3[nH]cnc3

> <pd_targets>
{ADRA2B,ADRA2A,ADRA2C,ADRA1A,ADRA1B,ADRA1D}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors",Adrenoceptors}

> <broad_targets>
{}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Atipamezole hydrochloride",104075-48-1,104075481,"Atipamezole HCl","Atipamezole (hydrochloride)","4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole hydrochloride","4(2Ethyl2,3dihydro1Hinden2yl)1Him
idazole hydrochloride","MPV-1248 hydrochloride","MPV1248 hydrochloride",1H-Imidazole,1HImidazole,4-(2-ethyl-2,4(2ethyl2,3-dihydro-1H-inden-2-yl)-,3dihydro1Hinden2yl),monohydrochlor,S4649}

> <pdid>
PD013951

> <targets>
{Adrenergic receptor,Adrenergic Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{13649426}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 40  0  0  0  0            999 V2000
    6.4540  -12.7606    0.0000 C   0  0
    5.1560  -12.0088    0.0000 N   0  0
    3.8547  -12.7565    0.0000 C   0  0
    2.5560  -12.0043    0.0000 C   0  0
    1.2544  -12.7497    0.0000 C   0  0
   -0.0421  -11.9952    0.0000 C   0  0
   -0.0368  -10.4952    0.0000 C   0  0
   -1.3333   -9.7407    0.0000 C   0  0
    1.2648   -9.7497    0.0000 C   0  0
    1.2731   -8.2489    0.0000 N   0  0
    2.5765   -7.5048    0.0000 C   0  0
    3.8716   -8.2615    0.0000 O   0  0
    2.5847   -6.0040    0.0000 C   0  0
    3.8864   -5.2585    0.0000 C   0  0
    3.8915   -3.7585    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2978    3.7529    0.0000 C   0  0
    1.2954    5.2529    0.0000 C   0  0
   -0.0048    6.0009    0.0000 C   0  0
   -1.3026    5.2488    0.0000 C   0  0
   -1.3002    3.7488    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    1.2935   -3.7495    0.0000 C   0  0
    1.2883   -5.2495    0.0000 C   0  0
    2.5612  -10.5043    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 20 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 27  1  0
 32 33  2  0
 33 18  1  0
 16 34  1  0
 34 35  2  0
 35 13  1  0
  9 36  2  0
 36  4  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7724

> <plate>
1

> <well>
J17

> <supplier_cmpd_name>
BMS-833923

> <ctcr_id>
6097

> <supplier_cmpd_id>
S7138

> <smiles>
CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(c4ccccc4)c5ccccc5n3)cc2)c1

> <pd_targets>
{SMO}

> <pathway_gtopdb>
{"Membrane receptor","Frizzled family G protein-coupled receptor","Smoothened receptor (frizzled family GPCR)"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Class Frizzled GPCRs"}

> <pathway_reactome>
{"Organelle biogenesis and maintenance","Cilium Assembly","Cargo trafficking to the periciliary membrane","BBSome-mediated cargo-targeting to cilium"}

> <broad_targets>
{SMO}

> <broad_moa>
{"smoothened receptor antagonist"}

> <synonyms>
{MS83392,BMS-833923,BMS833923,1059734-66-5,1059734665,"BMS 833923",XL139,"XL 139",XL-139,UNII-41J7ZJ239R,UNII41J7ZJ239R,"BMS-833923 (XL-139)","BMS833923 (XL139)",41J7ZJ239R,C30H27N5O,"BMS-833923 free 
base anhydrous","BMS833923 free base anhydrous","XL139 mesylate",GTPL8202,SCHEMBL4138073,CHEMBL3545403,EX-A789,EXA789,HMS3653O09,AOB87352,T2299,S7138}

> <pdid>
PD010603

> <targets>
{Hedgehog/Smoothened,Apoptosis,Smo}

> <classes>
{GPCR & G Protein,Apoptosis,Stem Cell/Wnt}

> <pubchem_cids>
{57662985}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 22  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -2.6016   -2.9971    0.0000 O   0  0
   -1.3070   -5.2502    0.0000 N   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -3.9043   -5.2443    0.0000 C   0  0
   -5.2060   -5.9898    0.0000 C   0  0
   -5.2111   -7.4898    0.0000 C   0  0
   -3.9147   -8.2443    0.0000 C   0  0
   -2.6131   -7.4988    0.0000 C   0  0
   -1.3167   -8.2533    0.0000 Br  0  0
   -0.0031    3.0008    0.0000 N   0  3
    1.2946    3.7531    0.0000 O   0  5
   -1.3032    3.7490    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
  4 19  1  0
 19 20  1  0
 19 21  2  0
M  CHG  2  19   1  20  -1
M  END
> <name>
Selleck_GPCR

> <id>
7725

> <plate>
1

> <well>
J19

> <supplier_cmpd_name>
SB225002

> <ctcr_id>
8207

> <supplier_cmpd_id>
S7651

> <smiles>
Oc1cc(ccc1NC(=O)Nc2ccccc2Br)[N+]([O-])=O

> <pd_targets>
{CXCR2,KMT2A,MEN1,CXCR1}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Family A G protein-coupled receptor",Reader,"Peptide receptor (family A GPCR)",Bromodomain,"Chemokine receptor","CXC chemokine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Chemokine receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors","Chemokine receptors bind chemokines"}

> <broad_targets>
{CXCR2}

> <broad_moa>
{"CC chemokine receptor antagonist"}

> <synonyms>
{182498-32-4,182498324,"sb 225002",SB225002,SB-225002,1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea,1(2bromophenyl)3(2hydroxy4nitrophenyl)urea,N-(2-Bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)urea,N(
2Bromophenyl)N'(2hydroxy4nitrophenyl)urea,CHEMBL239767,MFCD00954637,C13H10BrN3O4,1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea.,1(2bromophenyl)3(2hydroxy4nitrophenyl)urea.,Urea,N-(2-bro,N(2bro,T19
55,2725,S7651,"SB 225002"}

> <pdid>
PD003397

> <targets>
{CXCR}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{3854666}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 37 39  0  0  0  0            999 V2000
   12.7630   -2.8127    0.0000 H   0  3
   10.2630   -2.8127    0.0000 Cl  0  5
    7.7623    0.0141    0.0000 C   0  0
    6.4622   -0.7342    0.0000 C   0  0
    6.4592   -2.2350    0.0000 N   0  0
    5.1945   -3.0045    0.0000 C   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 N   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -3.8813   -1.4408    0.0000 C   0  0
   -4.4481   -0.0574    0.0000 C   0  0
   -5.9346    0.1432    0.0000 C   0  0
   -6.8516   -1.0439    0.0000 C   0  0
   -8.3381   -0.8433    0.0000 Cl  0  0
   -6.2821   -2.4315    0.0000 C   0  0
   -4.7955   -2.6322    0.0000 C   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5536   -4.4230    0.0000 C   0  0
   -1.7031   -5.6606    0.0000 C   0  0
   -2.3532   -7.0124    0.0000 C   0  0
   -3.8489   -7.1253    0.0000 C   0  0
   -4.6946   -5.8864    0.0000 C   0  0
   -4.0444   -4.5346    0.0000 C   0  0
   -4.8897   -3.2954    0.0000 Cl  0  0
    5.1559   -4.4848    0.0000 C   0  0
    6.4539   -5.2366    0.0000 N   0  0
    3.8561   -5.2335    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
 17 25  1  0
 25 26  2  0
 26 27  1  0
 27 12  1  0
 27 16  2  0
 25 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 33 34  1  0
  6 35  1  0
 35 36  1  0
 35 37  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7726

> <plate>
1

> <well>
J21

> <supplier_cmpd_name>
Otenabant (CP-945598) HCl

> <ctcr_id>
8208

> <supplier_cmpd_id>
S8012

> <smiles>
[H+].[Cl-].CCNC1(CCN(CC1)c2ncnc3n(c4ccc(Cl)cc4)c(nc23)c5ccccc5Cl)C(N)=O

> <pd_targets>
{CNR1,CNR2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","Cannabinoid receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Cannabinoid receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (i) signalling events"}

> <broad_targets>
{CNR1}

> <broad_moa>
{"cannabinoid receptor antagonist"}

> <synonyms>
{"TENABANT (CP945598) HC","Otenabant hydrochloride",686347-12-6,686347126,"CP 945598 Hydrochloride","Otenabant (Hydrochloride)","CP-945598 HCl","CP945598 HCl","Otenabant  HCl",UNII-X2166Z319O,UNIIX216
6Z319O,"Otenabant hydrochloride (USAN)","686347-12-6 (HCl)","686347126 (HCl)",X2166Z319O,919516-56-6,919516566,Otenabant,T3530,T1796,S8012,"Otenabant (CP-945598) HCl"}

> <pdid>
PD012916

> <targets>
{"Cannabinoid Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{16223963}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 38 41  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.2991    5.2507    0.0000 N   0  0
   -0.0012    6.0029    0.0000 C   0  0
   -0.0036    7.5029    0.0000 C   0  0
   -1.3039    8.2509    0.0000 N   0  0
   -2.6017    7.4988    0.0000 C   0  0
   -2.5993    5.9988    0.0000 C   0  0
   -1.3093    9.7517    0.0000 C   0  0
   -0.0128   10.5060    0.0000 O   0  0
   -2.6114   10.4982    0.0000 C   0  0
   -2.6190   11.9982    0.0000 C   0  0
   -3.9218   12.7416    0.0000 O   0  0
   -5.2171   11.9850    0.0000 C   0  0
   -6.5199   12.7285    0.0000 C   0  0
   -7.8151   11.9719    0.0000 C   0  0
   -7.8075   10.4719    0.0000 C   0  0
   -6.5047    9.7285    0.0000 C   0  0
   -5.2095   10.4851    0.0000 C   0  0
   -3.9067    9.7416    0.0000 O   0  0
    7.6990    5.9961    0.0000 C   0  0
    7.6990    4.4961    0.0000 S   0  0
    7.6990    2.9961    0.0000 O   0  0
    6.3997    3.7465    0.0000 O   0  0
    8.9983    3.7465    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 13  3  1  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 32 33  1  0
 33 24  1  0
 34 35  1  0
 35 36  1  0
 35 37  2  0
 35 38  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7727

> <plate>
1

> <well>
K03

> <supplier_cmpd_name>
Doxazosin Mesylate

> <ctcr_id>
3185

> <supplier_cmpd_id>
S1324

> <smiles>
COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4.C[S](O)(=O)=O

> <pd_targets>
{GLA,GAA,MAPT,KMT2A,MEN1,ALDH1A1,HPGD,LMNA,KDM4E,FTL,POLB,PMP22,RORC,FFP,BLM,GMNN,NS1,HLA-A,ADRA1D,ADRA1A,ADRA1B,KCNH2,ADRA2C,HTR4,ADRA2A,MMP1,ABCC4,ABCB11,ADRB2,HTR2B,SLC6A4,MTOR,HTR2C,SLC6A3,KCNH6,K
CNH7}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Epigenetic regulator","Other nuclear protein","Unclassified protein","Transcription factor","Surface antigen","Membrane receptor","Ion channel",Transporter,Hydrolase
,Reader,Oxidoreductase,Eraser,"Nuclear receptor",Transferase,"Family A G protein-coupled receptor","Voltage-gated ion channel",Protease,"Primary active transporter","Electrochemical transporter",Kinas
e,Bromodomain,"Lysine demethylase","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Potassium channels","Metallo protease","ATP-binding cassette","SLC superfamily of s
olute carriers","Protein Kinase","Jumonji domain-containing","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Voltage-gated potassium channel","Metallo protease MAM clan","ABCC sub
family","ABCB subfamily","SLC06 neurotransmitter transporter family","Atypical protein kinase group","Nuclear hormone receptor subfamily 1 group F member 3","Adrenergic receptor","Serotonin receptor",
"Metallo protease M10A subfamily","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"3.2.1.- Glycosidases","Eicosanoid turnover","Chromatin modifying enzymes","Nuclear hormone receptors","G protein-coupled receptors","Voltage-gated ion c
hannels","Peptidases and proteinases","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Kinases (EC 2.7.x.x)","Prostaglandin synthases","1.14.11.- Histone demethylases","
1F. Retinoic acid-related orphans",Adrenoceptors,"Potassium channels","5-Hydroxytryptamine receptors","MA: Metallo (M) Peptidases","ABCC subfamily","ABCB subfamily","SLC6 neurotransmitter transporter 
family",Atypical,"2.1.1.43 Histone methyltransferases (HMTs)","Voltage-gated potassium channels","M10: Matrix metallopeptidase","Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-relat
ed kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Neuronal System","Cell Cycle","Vesicle-mediated transport","DNA Repair","Developmental Biology","Gene expression (Transcription)","Immune System","Signal Transduction","Muscle con
traction",Hemostasis,"Metabolism of lipids","Diseases of metabolism","Transmission across Chemical Synapses","Biological oxidations",Mitotic,"Membrane Trafficking","Base Excision Repair","Nervous syst
em development","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Adaptive Immune System","Signaling by GPCR","Cardiac conduction","Infectious disease","Cytokine Signaling in Immune 
system","Platelet activation","signaling and aggregation","Disorders of transmembrane transporters","Sphingolipid metabolism","Diseases of carbohydrate metabolism","Neurotransmitter receptors and post
synaptic signal transmission","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","trans-Golgi Network Vesicle Budding","Resolution of Abas
ic Sites (AP sites)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Generic Transcription Pathway","Homology Directed Repair","Mitotic G1 phase and G1/S transition","Class I MHC med
iated antigen processing & presentation","GPCR ligand binding","Phase 3 - rapid repolarisation","Leishmania infection","Signaling by Interleukins","Response to elevated platelet cytosolic Ca2+","Metab
olism of steroids","Neurotransmitter clearance","SLC transporter disorders","Glycosphingolipid metabolism","Glycogen storage diseases","Activation of NMDA receptors and postsynaptic events","Ethanol o
xidation","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Golgi Associated Vesicle Biogenesis","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Tran
scriptional regulation by RUNX3","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Antigen processing-Cross presentation","Class A/1 (Rhodopsin-like rece
ptors)","Leishmania parasite growth and survival","Interleukin-4 and Interleukin-13 signaling","Platelet degranulation","Bile acid and bile salt metabolism","Serotonin clearance from the synaptic clef
t","Transcriptional Regulation by TP53","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Transcriptional regulation by RUNX1","Glycogen storage disease type II (GAA)","Post NMDA rece
ptor activation events","Biosynthesis of D-series resolvins","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Repair","RUNX3 Regulates Immune Response and Cell Migration","HDR through Homol
ogous Recombination (HRR)","Activation of the pre-replicative complex","Endosomal/Vacuolar pathway","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection
","Synthesis of bile acids and bile salts","Regulation of TP53 Activity","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Activation of AMPK downstream of NMDAR
s","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Synthesis of bile acids and bile salts via 7
alpha-hydroxycholesterol","Serotonin receptors","Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and stran
d exchange","Regulation of TP53 Degradation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{CHEBI:4709,EU-0100474,EU0100474,"EU 0100474",FT-0625592,FT0625592,"FT 0625592",SW197099-3,SW1970993,"SW197099 3","Doxazosin mesylate",77883-43-3,77883433,"77883 43 3",Cardura,Carduran,Cardular,"Cardu
ra XL",Cardenalin,Dedralen,Progandol,Tensiobas,"Doxazosin (mesylate)","Doxazosin mesilate","UK 33274 mesylate",MLS000028455,Do,T0101,S1324,1505976,Prestw-858,"Doxazosin Mesylate","DOXAZOSIN MESYLATE"}

> <pdid>
PD003016

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling",antihypertensive}

> <pubchem_cids>
{25137856,45039113,62978}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 31  0  0  1  0            999 V2000
    3.8964    0.7545    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    5.1996   -1.4928    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  1  0  0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0
    1.2810    2.2196    0.0000 C   0  0
   -0.0353    4.4996    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -2.2500    0.0000 O   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  1  0  0  0
    0.0180   -4.4679    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    1.2990   -2.2500    0.0000 C   0  0
   -2.5990   -4.4584    0.0000 C   0  0
   -3.8983   -3.7090    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  6
  6  8  1  0
  8  9  1  6
  9 10  1  0
  9 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  1
 14 16  1  0
 16  8  1  0
 16 17  1  6
 16 18  1  0
 18 19  1  1
 18 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  6
 23 25  1  0
 25 26  1  0
 26  5  1  0
 26 18  1  0
 26 27  1  6
 23 28  1  0
 28 29  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7728

> <plate>
1

> <well>
K04

> <supplier_cmpd_name>
Forskolin

> <ctcr_id>
7204

> <supplier_cmpd_id>
S2449

> <smiles>
CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C

> <pd_targets>
{NR1I2,ADCY1,SCN1A,SCN2A,SCN3A,SLC2A1,KMT2A,NR0B1,ABCB1,RXFP1,CFTR,PMP22,BLM,GMNN,MAPK1,NPSR1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Ion channel",Transporter,"Epigenetic regulator","Membrane receptor","Nuclear receptor","Voltage-gated ion channel","Electrochemical transporter",Reader,"Primary active 
transporter","Family A G protein-coupled receptor","Other ion channel","Nuclear hormone receptor subfamily 1","Voltage-gated sodium channel","SLC superfamily of solute carriers",Bromodomain,"Nuclear h
ormone receptor subfamily 0","ATP-binding cassette","Peptide receptor (family A GPCR)","Chloride channel","Nuclear hormone receptor subfamily 1 group I","SLC02 family of hexose and sugar alcohol trans
porters","Nuclear hormone receptor subfamily 0 group B","ABCB subfamily","Relaxin-like peptide receptor (family A GPCR)","Cystic fibrosis transmembrane conductance regulator","Nuclear hormone receptor
 subfamily 1 group I member 2","Nuclear hormone receptor subfamily 0 group B member 1","Relaxin receptor","Unclassified protein",Kinase,"Protein Kinase","CMGC protein kinase group","Short peptide rece
ptor (family A GPCR)","CMGC protein kinase MAPK family","Neuropeptide receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","Nuclear hormone receptors","Cyclic nucleotide turnover/signalling","SLC superfamily of solute carriers","Chromatin modifying enzymes","ATP-binding casse
tte transporter family","G protein-coupled receptors","Other ion channels","1I. Vitamin D receptor-like receptors","Adenylyl cyclases (ACs)","SLC2 family of hexose and sugar alcohol transporters","2.1
.1.43 Histone methyltransferases (HMTs)","0B. DAX-like receptors","ABCB subfamily","Relaxin family peptide receptors","Chloride channels","Class I transporters",CFTR,"Kinases (EC 2.7.x.x)","CMGC: Cont
aining CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Metabolism of proteins","Neuronal System",Disease,"Gene expression (Transcription)",Metabolism,Autophagy,"Post-translational protein modification","Transmission across Chemical Synapses","Disorders 
of transmembrane transporters","RNA Polymerase II Transcription","Abacavir transport and metabolism","Infectious disease",Macroautophagy,SUMOylation,"Neurotransmitter receptors and postsynaptic signal
 transmission","SLC transporter disorders","Generic Transcription Pathway","Abacavir transmembrane transport","Leishmania infection","Selective autophagy","SUMO E3 ligases SUMOylate target proteins","
GABA receptor activation","Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)","Transcriptional regulation by RUNX1","Nuclear Receptor transcription pathway","Leishmania parasite growth an
d survival",Aggrephagy,"SUMOylation of intracellular receptors","GABA B receptor activation","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Anti-inflammatory 
response favouring Leishmania parasite infection","Activation of GABAB receptors","ADORA2B mediated anti-inflammatory cytokines production","Adenylate cyclase inhibitory pathway","Developmental Biolog
y","DNA Repair","Cell Cycle","Immune System","Nervous system development","DNA Double-Strand Break Repair",Mitotic,"Innate Immune System","EGR2 and SOX10-mediated initiation of Schwann cell myelinatio
n","Homology Directed Repair","Mitotic G1 phase and G1/S transition","Toll-like Receptor Cascades","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Toll
 Like Receptor 5 (TLR5) Cascade","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative complex","MyD88 cascade initiated on plasma membrane","Homologous DNA Pairing and Stran
d Exchange","MAP kinase activation","Presynaptic phase of homologous DNA pairing and strand exchange","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADCY2,ADCY5,GNAS}

> <broad_moa>
{"adenylyl cyclase activator"}

> <synonyms>
{forskolin,Colforsin,66575-29-9,66575299,Coleonol,colforsina,colforsine,colforsinum,Boforsin,Coleonolk,UNII-1F7A44V6OU,UNII1F7A44V6OU,"HL 362","7beta-Acetoxy-8,13-epoxy-1alpha,6beta,9alpha-trihydroxyl
abd-14-en-11-one","7betaAcetoxy8,13epoxy1alpha,6beta,9alphatrihydroxylabd14en11one","L 75 1362B",C22H34O7,66428-89-5,66428895,CHEMBL52606,1F7A44V6,T2939,S2449,Forskolin}

> <pdid>
PD000867

> <targets>
{cAMP}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{47936}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 33  0  0  1  0            999 V2000
    2.5981    0.0000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0  2  0  0  0
    0.0027   -4.4953    0.0000 C   0  0
    1.2990   -3.7500    0.0000 C   0  0  2  0  0  0
    2.5981   -3.0000    0.0000 C   0  0  2  0  0  0
    2.5981   -1.5000    0.0000 C   0  0  2  0  0  0
    3.8971   -0.7500    0.0000 C   0  0
    5.1962   -1.5000    0.0000 C   0  0
    5.1962   -3.0000    0.0000 C   0  0  1  0  0  0
    6.5611   -2.3779    0.0000 C   0  0
    3.8971   -3.7500    0.0000 C   0  0  1  0  0  0
    4.2297   -5.2071    0.0000 C   0  0  2  0  0  0
    4.8491   -6.5669    0.0000 C   0  0
    5.7224   -5.3544    0.0000 C   0  0  2  0  0  0
    6.3238   -3.9802    0.0000 C   0  0  1  0  0  0
    7.6134   -3.1390    0.0000 C   0  0
    8.8130   -4.0395    0.0000 C   0  0
    8.3272   -5.4587    0.0000 C   0  0
    9.1898   -6.6858    0.0000 O   0  0
    6.8274   -5.4352    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  2  1  0
  8  9  1  0
  9 10  1  1
 11 10  1  1
 11  9  1  0
 12 11  1  6
 12 13  1  0
 13  2  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  1  1
 18 16  1  1
 18 12  1  0
 18 19  1  0
 19 20  1  1
 21 20  1  1
 21 19  1  0
 22 21  1  6
 22 16  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 22  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7729

> <plate>
1

> <well>
K05

> <supplier_cmpd_name>
Drospirenone

> <ctcr_id>
7106

> <supplier_cmpd_id>
S1377

> <smiles>
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7

> <pd_targets>
{PGR,AR,ABCB11,ABCC4,NR3C2,NR3C1}

> <pathway_gtopdb>
{"Transcription factor",Transporter,"Nuclear receptor","Primary active transporter","Nuclear hormone receptor subfamily 3","ATP-binding cassette","Nuclear hormone receptor subfamily 3 group C","ABCB s
ubfamily","ABCC subfamily","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 2","Nucl
ear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,Transporters,"Nuclear hormone receptors","ATP-binding cassette transporter family","Steroid hormone receptors","ABCB subfamily","ABCC subfamily","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Metabolism of proteins","Gene expression (Transcription)",Metabolism,Hemostasis,"Post-translational protein modification","RNA Polymerase II Transcription","Metabolism of lipids","Platelet activatio
n","signaling and aggregation",SUMOylation,"Generic Transcription Pathway","Metabolism of steroids","Response to elevated platelet cytosolic Ca2+","SUMO E3 ligases SUMOylate target proteins","Transcri
ptional regulation by RUNX2","Bile acid and bile salt metabolism","Platelet degranulation","FOXO-mediated transcription","SUMOylation of intracellular receptors","RUNX2 regulates bone development","Sy
nthesis of bile acids and bile salts","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","RUNX2 regulates osteoblast differentiation","Synthesis of bile acids and bile sa
lts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{AR,NR3C2,PGR}

> <broad_moa>
{"mineralocorticoid receptor antagonist"}

> <synonyms>
{BCPP000250,BDBM150275,BCP27035,EX-A3153,EXA3153,Drospirenone,67392-87-4,67392874,Dihydrospirorenone,Dehydrospirorenone,Drospirenona,"1,2-Dihydrospirorenone","1,2Dihydrospirorenone",Drospirenonum,DRSP
,"Drospirenonum (INN-Latin)","Drospirenonum (INNLatin)","Drospirenona (INN-Spanish)","Drospirenona (INNSpanish)","ZK 30595",UNII-N295J34A25,UNIIN295J34A25,S1377}

> <pdid>
PD000859

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{68873}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 26  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -1.0157    5.5663    0.0000 Cl  0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  8  1  0
 23 18  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7730

> <plate>
1

> <well>
K06

> <supplier_cmpd_name>
Clozapine

> <ctcr_id>
3976

> <supplier_cmpd_id>
S2459

> <smiles>
CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24

> <pd_targets>
{ADRA1A,ADRA1B,ADRA1D,DRD2,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,HTR1B,LMNA,LEF,NET,MAPT,CYP2C19,HTR7,DRD3,DRD4,HRH4,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,ADRA2A,ADRA2B,ADRA2C,KCNH2,HTR3A,CYP3A4,HRH1,ADRB1,HTR1E,HTR1F
,HTR5A,DRD5,SIGMAR1,AOX1,CALM1,DRD1,CYP2C9,CYP2D6,CALM,NFKB1,PMP22,KMT2A,MEN1,BLM,HSD17B10,POLB,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY8,HTR1D,HRH3,CYP1A2,SLC6A4,H1-0,ABCB11,ALB,RORC,CYP2J2,IMPA1,HTR
3B,ADORA3,SLC6A2,TSHR,HTR3C,HTR3D,HTR3E,HRH2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,KCNJ6,SLC6A3,OPRM1,CCK,GABRA1,CYSLTR1,GRIN1,ADRB2,OPRD1,OPRK1,TAC1,SCN10A,CCKBR,ARRB1,TBXA2R}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein",Enzyme,Transporter,"Other cytosolic protein","Ion channel","Unclassified protein","Epigenetic regulator","Secreted protein","Transcription factor","Family 
A G protein-coupled receptor",Protease,"Electrochemical transporter","Cytochrome P450","Voltage-gated ion channel","Ligand-gated ion channel",Oxidoreductase,Reader,Lyase,"Primary active transporter","
Nuclear receptor",Hydrolase,"Small molecule receptor (family A GPCR)","Metallo protease","SLC superfamily of solute carriers","Cytochrome P450 family 2","Potassium channels","5HT3 receptor","Cytochrom
e P450 family 3",Bromodomain,"Cytochrome P450 family 1","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","GABA-A recepto
r","Ionotropic glutamate receptor","Voltage-gated sodium channel","Monoamine receptor","Metallo protease MAE clan","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Voltage-gate
d potassium channel","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 1A","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Nucleotide-like receptor (fami
ly A GPCR)","Glycohormone receptor","Inwardly rectifying potassium channel","Short peptide receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","NMDA receptor","Adrenergic receptor",
"Dopamine receptor","Serotonin receptor","Metallo protease M34 family","Cytochrome P450 2C19","Histamine receptor","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450
 2D6","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Adenosine receptor","Opioid receptor","Leukotriene receptor","Cholecystokinin receptor","Prostanoid receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","Other protein targets",Transporters,"G protein-coupled receptors","Cytochrome P450","Voltage-gated ion channels","Ligand-gated ion channels","Sigma receptors","SLC s
uperfamily of solute carriers","ATP-binding cassette transporter family","Nuclear hormone receptors","Inositol phosphate turnover","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"C
YP2 family: drug metabolising subset","Histamine receptors","Potassium channels","Acetylcholine receptors (muscarinic)","5-HT<sub>3</sub> receptors","CYP3 family","CYP1 family","SLC6 neurotransmitter 
transporter family","ABCB subfamily","1F. Retinoic acid-related orphans","Inositol monophosphatase","Adenosine receptors","Glycoprotein hormone receptors","Opioid receptors","GABA<sub>A</sub> receptor
s","Leukotriene receptors","Ionotropic glutamate receptors","Voltage-gated calcium channels","Voltage-gated sodium channels","Cholecystokinin receptors","Prostanoid receptors","Voltage-gated potassium
 channels","Monoamine transporter subfamily","Inwardly rectifying potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Cell Cycle","Neuronal System",Metabolism,"Muscle contraction","Immune System","Developmental Biology","DNA Repair","Cellular responses to external stimuli","Gene expres
sion (Transcription)","Signaling by GPCR","Infectious disease",Mitotic,"Transmission across Chemical Synapses","Biological oxidations","Cardiac conduction","Metabolism of lipids","Metabolism of vitami
ns and cofactors","Cytokine Signaling in Immune system","Nervous system development","DNA Double-Strand Break Repair","Metabolism of amino acids and derivatives","Base Excision Repair","Cellular respo
nses to stress","RNA Polymerase II Transcription","Inositol phosphate metabolism","Disorders of transmembrane transporters","Diseases of signal transduction by growth factor receptors and second messe
ngers","GPCR ligand binding","Leishmania infection","M Phase","Uptake and actions of bacterial toxins","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of
 compounds","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","SARS-CoV Infections","Metabolism of water-soluble vitamins and cofactors","Signaling by Interl
eukins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Branched-chain amino acid catabolism","Resolution of Abasic Sites (AP sites)","Neurotransmitter cle
arance","Cellular Senescence","Metabolism of steroids","Generic Transcription Pathway","Synthesis of IP2",IP,"and Ins in the cytosol","SLC transporter disorders","GPCR downstream signalling","Axon gui
dance","Oncogenic MAPK signaling","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Uptake and function of anthrax toxins","Activation 
of NMDA receptors and postsynaptic events","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Potential therapeutics for SARS","Vitamins B6 activation to pyridoxal phos
phate","Interleukin-1 family signaling","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Se
rotonin clearance from the synaptic cleft","DNA Damage/Telomere Stress Induced Senescence","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX3","Defective SLC6A2 causes orthostat
ic intolerance (OI)","GABA receptor activation","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","G alpha (i) signalling events","Transcriptional Regulation by MECP2","NCAM signaling 
for neurite out-growth","L1CAM interactions","G alpha (q) signalling events","Signaling by RAS mutants","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infec
tion","Mitotic Anaphase","Post NMDA receptor activation events",Xenobiotics,"Biosynthesis of maresins","Interleukin-1 signaling","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch
 Base Excision Repair","Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Synthesis of bile acids and bile salts","Recycling of bile acids and salts","RUNX3 Regulates Immune Response an
d Cell Migration","Fatty acids","Nucleotide-like (purinergic) receptors","GABA B receptor activation","Opioid Signalling","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and cha
nnels","NCAM1 interactions","Interaction between L1 and Ankyrins","Gastrin-CREB signalling pathway via PKC and MAPK","Signaling downstream of RAS mutants","Eicosanoid ligand-binding receptors","Dopami
ne receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly",Adrenoceptors,"Activation of AMPK downstream of NMDARs","CYP2E1 reactio
ns","Histamine receptors","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","MAP3K8 (TPL2)-dep
endent MAPK1/3 activation","Homologous DNA Pairing and Strand Exchange","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Synthesis of bile acids and bile salts via 7alpha-hydroxycho
lesterol","Adenosine P1 receptors","Activation of GABAB receptors","G-protein activation","LTC4-CYSLTR mediated IL4 production","Tachykinin receptors bind tachykinins","Prostanoid ligand receptors","I
nitiation of Nuclear Envelope (NE) Reformation","Ras activation upon Ca2+ influx through NMDA receptor","Presynaptic phase of homologous DNA pairing and strand exchange","Inhibition  of voltage gated 
Ca2+ channels via Gbeta/gamma subunits"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,CALY,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,DRD4,DRD5,HRH1,HRH4,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR5A,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{5786-21-0,5786210,Leponex,Clozapin,CLOZARIL,Fazaclo,Clorazil,Iprox,Clozapina,Clozapinum,"HF 1854",HF-1854,HF1854,"8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine","8Chloro11(4methy
l1piperazinyl)5Hdibenzo(b,e)(1,4)diazepine",W-801,W801,8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo(b,8chloro11(4methylpiperazin1yl)5Hdibenzo(b,e)(1,4)diaz,T0455,S2459,SAM002548976,1500685,Prestw-3
50,Clozapine,CPD000058365,CLOZAPINE,Clozapine}

> <pdid>
PD001633

> <targets>
{"5-HT Receptor"}

> <classes>
{antipsychotic,"Neuronal Signaling"}

> <pubchem_cids>
{135398737}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 28  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 S   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5923   -4.5039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.1253   -4.3743    0.0000 N   0  0
   -6.5929   -4.6844    0.0000 C   0  0
   -4.1233   -5.4906    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    7.6933   -0.1206    0.0000 O   0  0
    7.6933   -1.6206    0.0000 C   0  0
    6.3940   -2.3702    0.0000 O   0  0
    8.9933   -2.3706    0.0000 C   0  0
   10.2933   -1.6206    0.0000 C   0  0
   11.5933   -2.3706    0.0000 C   0  0
   11.5933   -3.8706    0.0000 O   0  0
   12.8926   -1.6210    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 13 19  1  0
 19 10  1  0
 19 20  2  0
 20  7  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7731

> <plate>
1

> <well>
K07

> <supplier_cmpd_name>
Sumatriptan Succinate

> <ctcr_id>
1770

> <supplier_cmpd_id>
S1432

> <smiles>
CN[S](=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1.OC(=O)CCC(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"SUMATRIPTAN SUCCINATE",103628-48-4,103628484,Imitrex,Imigran,Suminat,"Sumavel DosePro",Alsuma,"Sumatriptan (succinate)","GR 43175C",UNII-J8BDZ68989,UNIIJ8BDZ68989,MFCD00902856,"GR 43175","sumatripta
n hydrogen succinate",C18H27N3O6S,CHEBI:64359,J8BDZ68989,"103628-48-4 (succ","103628484 (succ",T0203,S1432,SAM001246579,Prestw-1346,"Sumatriptan succinate","Sumatriptan Succinate",CPD000469158}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{59772}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 27  0  0  0  0            999 V2000
    9.4554   -1.3402    0.0000 Cl  0  0
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5031   -5.4549    0.0000 C   0  0
    3.0039   -5.4528    0.0000 C   0  0
    3.7517   -4.1524    0.0000 O   0  0
    3.7566   -6.7503    0.0000 O   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 20 25  1  0
 25 26  2  0
 26  8  1  0
 26 17  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7732

> <plate>
1

> <well>
K08

> <supplier_cmpd_name>
Olopatadine HCl

> <ctcr_id>
5705

> <supplier_cmpd_id>
S2494

> <smiles>
Cl.CN(C)CC\C=C/1c2ccccc2COc3ccc(CC(O)=O)cc13

> <pd_targets>
{HRH1,HRH2,HRH3,S100A1,S100A12,S100B,S100A13,S100A2,LMNA}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor","Other nuclear protein"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Immune System","Signaling by GPCR","Infectious disease","Innate Immune System","GPCR ligand binding","Leishmania infection","Toll-like Receptor Cascades","Class A/1 (Rh
odopsin-like receptors)","Leishmania parasite growth and survival","Regulation of TLR by endogenous ligand","Toll Like Receptor 5 (TLR5) Cascade","Amine ligand-binding receptors","Anti-inflammatory re
sponse favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","Histamine receptors","ADORA2B mediated anti-inflammatory cytokines production","TAK1 activates NFkB by pho
sphorylation and activation of IKKs complex","Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) 
Reformation"}

> <broad_targets>
{HRH1,S100A1,S100A12,S100A13,S100A2,S100B}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{AKOS026750048,"OLOPATADINE HYDROCHLORIDE","OLOPATADINE HCl",140462-76-6,140462766,Pataday,Allelock,Patanase,Opatanol,ALO4943A,"Olopatadine (hydrochloride)",UNII-2XG66W44KF,UNII2XG66W44KF,Pazeo,KW-467
9,KW4679,2XG66W44KF,AL-4943A,AL4943A,MFCD00875716,ALO-4943A,DSSTox_CID_26486,DSSToxCID26486,DSSTox-CID-26486,"DSSTox CID 26486",S2494,SAM001246802,Prestw-1307,"Olopatadine HCl",CPD000469220,"Olopatadi
ne hydrochloride"}

> <pdid>
PD009730

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{67108011,5282402}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 32  0  0  0  0            999 V2000
   -2.6917   -6.3197    0.0000 C   0  0
   -1.2234   -6.6267    0.0000 N   0  0
   -0.7552   -8.0517    0.0000 C   0  0
    0.7130   -8.3588    0.0000 C   0  0
    1.7131   -7.2408    0.0000 C   0  0
    1.2449   -5.8157    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    3.8794   -1.4442    0.0000 C   0  0
    4.3452   -0.0183    0.0000 O   0  0
    4.8823   -2.5608    0.0000 C   0  0
    4.4142   -3.9859    0.0000 C   0  0
    5.4142   -5.1039    0.0000 C   0  0
    6.8824   -4.7969    0.0000 C   0  0
    7.3506   -3.3718    0.0000 C   0  0
    6.3506   -2.2538    0.0000 C   0  0
    6.8188   -0.8287    0.0000 I   0  0
    4.9487   -6.5307    0.0000 N   0  3
    3.4810   -6.8404    0.0000 O   0  5
    5.9503   -7.6473    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 16 21  1  0
 21 22  1  0
 21 23  2  0
 11 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29  9  1  0
 29 24  1  0
M  CHG  2  21   1  22  -1
M  END
> <name>
Selleck_GPCR

> <id>
7733

> <plate>
1

> <well>
K09

> <supplier_cmpd_name>
AM1241

> <ctcr_id>
1232

> <supplier_cmpd_id>
S1544

> <smiles>
CN1CCCCC1Cn2cc(C(=O)c3cc(ccc3I)[N+]([O-])=O)c4ccccc24

> <pd_targets>
{CNR2,CNR1}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","Cannabinoid receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Cannabinoid receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (i) signalling events"}

> <broad_targets>
{CNR1,CNR2}

> <broad_moa>
{"cannabinoid receptor agonist"}

> <synonyms>
{444912-48-5,444912485,AM1241,AM-1241,"(R,S)-AM1241","(R,S)AM1241",(1-(Methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole),(1(Methylpiperidin2ylmethyl)3(2iodo5nitrobenzoyl)indole),"AM 1241",C
HEMBL408430,GTPL3316,SCHEMBL2030690,BDBM21283,DTXSID301017015,HMS3650F09,HMS3651A13,HMS3884M19,ANW-62168,ANW62168,MFCD11045986,s1544,AM_124,AM124,AM-124,"AM 124",S1544}

> <pdid>
PD010977

> <targets>
{"Cannabinoid Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{10141893}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 24  0  0  0  0            999 V2000
    8.6400   -1.0822    0.0000 H   0  3
    6.1400   -1.0822    0.0000 Cl  0  5
   -2.9790   -5.5336    0.0000 C   0  0
   -2.9537   -4.0338    0.0000 N   0  0
   -1.6420   -3.3046    0.0000 C   0  0
   -1.6167   -1.8039    0.0000 C   0  0
   -0.3049   -1.0747    0.0000 C   0  0
   -0.2800    0.4200    0.0000 C   0  0
    0.0000    2.2500    0.0000 C   0  0
   -0.4900    3.3700    0.0000 C   0  0
   -0.5500    1.7600    0.0000 C   0  0
   -2.0000    1.1200    0.0000 C   0  0
   -3.4200    1.7700    0.0000 C   0  0
   -4.6300    0.8200    0.0000 C   0  0
   -4.4000   -0.6700    0.0000 C   0  0
   -2.9800   -1.2400    0.0000 C   0  0
   -1.7900   -0.2300    0.0000 C   0  0
    0.7800    1.1200    0.0000 C   0  0
    1.8800    2.2400    0.0000 C   0  0
    3.3200    1.7500    0.0000 C   0  0
    3.6400    0.2500    0.0000 C   0  0
    2.5000   -0.7300    0.0000 C   0  0
    1.0400   -0.2000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  8  1  0
 17 12  1  0
 11 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  8  1  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7734

> <plate>
1

> <well>
K10

> <supplier_cmpd_name>
Maprotiline HCl

> <ctcr_id>
3721

> <supplier_cmpd_id>
S2517

> <smiles>
[H+].[Cl-].CNCCCC12CCC(c3ccccc13)c4ccccc24

> <pd_targets>
{CYP2D6,RORC,PMP22,AMPC,KMT2A,MEN1,CYP3A4,LMNA,GAA,CYP2C19,SMN1,FFP,TP53,HTT,MAPK1,SLC6A2,HTR2C,SLC6A3,KDM4E,TSHR,LEF,ADRA1A,HTR2A,SLC6A4,CHRM1,THPO,CYP1A2,ADRA1B,TRPM3,IMPA1,HRH1,KCNJ6,GRIN1,GRIN2A,G
RIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,ADRA2C,HTR2B,DRD3,MTOR,ADRA2B,CHRM4,CHRM5,HTR6,CACNA1C,DRD2,CHRM2,ADRA1D,DRD5,ADRA2A,HRH2,CHRM3,KCNJ5,HTR7,MBTD1,L3MBTL3,L3MBTL1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Unclassified protein","Epigenetic regulator","Other nuclear protein",Transporter,"Membrane receptor","Ion channel","Cytochrome P450","Nuclear receptor",Hydrolase,Reader
,Transferase,Kinase,"Electrochemical transporter","Family A G protein-coupled receptor",Eraser,Protease,"Voltage-gated ion channel","Ligand-gated ion channel","Cytochrome P450 family 2","Nuclear hormo
ne receptor subfamily 1",Bromodomain,"Cytochrome P450 family 3","Methyl-lysine/arginine binding protein","Protein Kinase","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)"
,"Lysine demethylase","Peptide receptor (family A GPCR)","Metallo protease","Cytochrome P450 family 1","Potassium channels","Ionotropic glutamate receptor","Voltage-gated calcium channel","Cytochrome 
P450 family 2D","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Tudor domain","CMGC protein kinase group","SLC06 neurotransmitter transporter fa
mily","Monoamine receptor","Jumonji domain-containing","Glycohormone receptor","Metallo protease MAE clan","Cytochrome P450 family 1A","Inwardly rectifying potassium channel","NMDA receptor","Atypical
 protein kinase group","MBT domain","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P450 2C19","CMGC protein kinase MAPK family","Seroto
nin receptor","Metallo protease M34 family","Adrenergic receptor","Acetylcholine receptor","Cytochrome P450 1A1","Histamine receptor","Dopamine receptor","Atypical protein kinase PIKK family","CMGC pr
otein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Other protein targets","Cytochrome P450","Nuclear hormone receptors","3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers",
"G protein-coupled receptors","Chromatin modifying enzymes","Voltage-gated ion channels","Inositol phosphate turnover","Chromatin-interacting transcriptional repressors","CYP2 family: drug metabolisin
g subset","1F. Retinoic acid-related orphans","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC6 neurotransmitter transporter family","5-Hydroxytryptamine receptors","1.14.11.- Histon
e demethylases","Glycoprotein hormone receptors",Adrenoceptors,"Acetylcholine receptors (muscarinic)","CYP1 family","Transient Receptor Potential channels","Inositol monophosphatase","Histamine recept
ors","Potassium channels","Dopamine receptors",Atypical,"Voltage-gated calcium channels","Methyllysine reader proteins","Mitogen-activated protein kinases (MAP kinases)","Monoamine transporter subfami
ly","Inwardly rectifying potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Developmental Biology","Cell Cycle",Disease,"Metabolism of RNA","Immune System","Signal Transduction","Neuronal System",Hemostasis,"Transport of small mo
lecules","Biological oxidations","RNA Polymerase II Transcription","Nervous system development","Metabolism of lipids",Mitotic,"Diseases of metabolism","Metabolism of non-coding RNA","Cell Cycle Check
points","Innate Immune System","Disorders of transmembrane transporters","Signaling by GPCR","Infectious disease","Transmission across Chemical Synapses","Platelet activation","signaling and aggregati
on","Ion channel transport","Inositol phosphate metabolism","Phase I - Functionalization of compounds","Generic Transcription Pathway","EGR2 and SOX10-mediated initiation of Schwann cell myelination",
"Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Diseases of carbohydrate metabolism","snRNP Assembly","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","SLC transporte
r disorders","GPCR ligand binding","Leishmania infection","Uptake and actions of bacterial toxins","Neurotransmitter clearance","Platelet Aggregation (Plug Formation)","Stimuli-sensing channels","Synt
hesis of IP2",IP,"and Ins in the cytosol","Neurotransmitter receptors and postsynaptic signal transmission","Axon guidance","Cytochrome P450 - arranged by substrate type","Transcriptional regulation b
y RUNX3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Glycogen storage diseases","p53-Dependent G1/S DNA damage checkpoint","Transcriptional Regulation by MECP2","Toll Like Rec
eptor 5 (TLR5) Cascade","Defective SLC6A2 causes orthostatic intolerance (OI)","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Leishmania para
site growth and survival","Uptake and function of anthrax toxins","Serotonin clearance from the synaptic cleft","TRP channels","GABA receptor activation","Transcriptional Regulation by TP53","NCAM sig
naling for neurite out-growth",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Glycogen storage disease type II (GAA)","p53-Dependent G1
 DNA Damage Response","Regulation of MECP2 expression and activity","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania paras
ite infection","GABA B receptor activation","Regulation of TP53 Activity","NCAM1 interactions","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Stabilization 
of p53","MAP kinase activation","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylate
d or N-dealkylated by CYP1A2","Histamine receptors","Activation of GABAB receptors","Dopamine receptors","Regulation of TP53 Expression and Degradation","Regulation of TP53 Activity through Methylatio
n","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","Inhibition  of voltage gated Ca2+ channel
s via Gbeta/gamma subunits","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{SLC6A2}

> <broad_moa>
{"norepinephrine reputake inhibitor","tricyclic antidepressant"}

> <synonyms>
{"Maprotiline hydrochloride",10347-81-6,10347816,"Maprotiline Hcl",Ludiomil,Psymion,"Maprotilline HCl",UNII-7C8J54PVFI,UNII7C8J54PVFI,"Maprotiline (hydrochloride)","Maprotiline Hydrochlorine",7C8J54PV
FI,MLS000069552,MLS000557000,Deprilept,N-Methyl-9,NMethyl9,10-ethanoanthrac,10ethanoanthrac,S2517,SAM001246989,1500373,"Maprotiline HCl",CPD000148117,"MAPROTILINE HYDROCHLORIDE"}

> <pdid>
PD009633

> <targets>
{"Reuptake inhibitor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{71478,657219}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 23  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15  5  1  0
 15  9  1  0
  6 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19  2  1  0
 19 20  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7735

> <plate>
1

> <well>
K11

> <supplier_cmpd_name>
Estrone

> <ctcr_id>
6607

> <supplier_cmpd_id>
S1665

> <smiles>
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O

> <pd_targets>
{MAPT,SERPINA6,HSD17B1,HIF1A,BLM,HSD17B10,CYP3A4,CYP1A2,PGR,ESR1,ESR2,LMNA,NFKB1,PMP22,STS,AR,NFO,CYP19A1,ALOX15,SHBG,HTR2B,SLC6A4,ABCG2,SLCO1A1}

> <pathway_gtopdb>
{"Other cytosolic protein","Secreted protein",Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein","Membrane receptor",Transporter,Oxidoreductase,"Cytochrome P450","Nuclear rec
eptor",Hydrolase,"Family A G protein-coupled receptor","Electrochemical transporter","Primary active transporter","Cytochrome P450 family 3","Cytochrome P450 family 1","Nuclear hormone receptor subfam
ily 3","Cytochrome P450 family 19","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","ATP-binding cassette","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Nuclea
r hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group A","Cytochrome P450 family 19A","Monoamine receptor","SLC06 neurotransmitter transporter family","ABCG subfamily","S
LC21/SLCO family of organic anion transporting polypeptides","Cytochrome P450 3A4","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 g
roup A member 1","Nuclear hormone receptor subfamily 3 group A member 2","Nuclear hormone receptor subfamily 3 group C member 4","Cytochrome P450 19A1","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Cytochrome P450","Nuclear hormone receptors","Eicosanoid turnover","G protein-coupled receptors","SLC superfamily of solute carriers","ATP-binding cassette transporter
 family","CYP3 family","CYP1 family","Steroid hormone receptors",CYP11,CYP17,CYP19,"CYP20 and CYP21 families",Lipoxygenases,"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","
ABCG subfamily","3A. Estrogen receptors","3C. 3-Ketosteroid receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Signal Transduction","Cellular responses to external stimuli","DNA Repair","Gene expression (Transcription)","Cell Cycle","Immune System","Developmental Biology","Transm
ission across Chemical Synapses","Metabolism of lipids","Signaling by GPCR","Cellular responses to stress","DNA Double-Strand Break Repair","Metabolism of amino acids and derivatives","Biological oxid
ations","RNA Polymerase II Transcription","Intracellular signaling by second messengers",Mitotic,"Cytokine Signaling in Immune system","Nervous system development","Abacavir transport and metabolism",
"Neurotransmitter receptors and postsynaptic signal transmission","Metabolism of steroids","GPCR downstream signalling","Cellular response to hypoxia","Homology Directed Repair","Branched-chain amino 
acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Generic Transcription Pathway","PIP3 activates AKT signaling","M Phase","Signal
ing by Interleukins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Sphingolipid metabolism","GPCR ligand binding","Neurotransmitter clearance","Abacavir transmembrane transport","A
ctivation of NMDA receptors and postsynaptic events","Metabolism of steroid hormones","G alpha (i) signalling events","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","HDR th
rough Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Transcriptional regulation by RUNX1","Negative
 regulation of the PI3K/AKT network","Mitotic Metaphase and Anaphase","Interleukin-1 family signaling","Glycosphingolipid metabolism","Transcriptional regulation by RUNX2","Biosynthesis of DPA-derived
 SPMs","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","Post NMDA receptor activation events","Glucocorticoid biosynthesis","Visual phototransduction","HDR through
 Homologous Recombination (HRR)","Biosynthesis of maresins",Xenobiotics,"RUNX1 regulates estrogen receptor mediated transcription",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Mitotic Anaphase","
Interleukin-1 signaling","RUNX2 regulates bone development","Endogenous sterols","Biosynthesis of DPAn-3 SPMs","Amine ligand-binding receptors","Activation of AMPK downstream of NMDARs","The canonical
 retinoid cycle in rods (twilight vision)","Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear 
Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","RUNX2 regulates osteoblast differentiation","Biosynthesis of DPAn-3-derived protectins and resolvins","Serotonin receptors","Pre
synaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ESR1,ESR2}

> <broad_moa>
{"estrogen receptor agonist","estrogenic hormone"}

> <synonyms>
{estrone,53-16-7,53167,folliculin,OESTRONE,Theelin,estrovarin,Estrugenone,"follicular hormone",Hiestrone,Kestrone,Estron,Follicunodis,Disynformon,Folliculine,Glandubolin,Hormestrin,Oestroform,Oestronu
m,Oestroperos,Thelykinin,Femidyn,Folipex,Folisan,Kolpon,S1665,Prestw-914,Estrone}

> <pdid>
PD002339

> <targets>
{Others}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{5870}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  1  0            999 V2000
    7.9729    1.2121    0.0000 Cl  0  5
    2.9938   -0.6197    0.0000 O   0  0
    2.7799    0.8649    0.0000 C   0  0
    1.3863    1.4219    0.0000 C   0  0
    1.1724    2.9066    0.0000 O   0  0
    0.2065    0.4943    0.0000 O   0  0
   -1.1871    1.0507    0.0000 C   0  0  1  0  0  0
   -2.3904   -0.0332    0.0000 C   0  0
   -3.7811    0.4730    0.0000 C   0  0  1  0  0  0
   -2.5225    1.0365    0.0000 C   0  0
   -2.0813    2.2487    0.0000 C   0  0
   -2.7653    3.2639    0.0000 C   0  0  1  0  0  0
   -1.3746    2.7577    0.0000 C   0  0
   -3.9686    2.0630    0.0000 N   0  3
   -5.2189    0.9963    0.0000 C   0  0
   -6.2353    2.0048    0.0000 C   0  0
   -5.6299    3.6680    0.0000 C   0  0
   -4.2031    3.7872    0.0000 C   0  0
    3.9597    1.7926    0.0000 C   0  0
    5.3522    1.2350    0.0000 C   0  0
    6.5314    2.1622    0.0000 C   0  0
    6.3180    3.6469    0.0000 C   0  0
    4.9255    4.2045    0.0000 C   0  0
    3.7463    3.2774    0.0000 C   0  0
    1.6006   -0.0632    0.0000 C   0  0
    2.3096   -1.3851    0.0000 C   0  0
    1.5193   -2.6601    0.0000 C   0  0
    0.0200   -2.6131    0.0000 C   0  0
   -0.6889   -1.2912    0.0000 C   0  0
    0.1014   -0.0163    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  7  6  1  1
  7  8  1  0
  9  8  1  6
  9 10  1  0
 10 11  1  0
 12 11  1  1
 12 13  1  0
 13  7  1  0
 12 14  1  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
  3 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
  3 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
M  CHG  2   1  -1  14   1
M  END
> <name>
Selleck_GPCR

> <id>
7736

> <plate>
1

> <well>
K12

> <supplier_cmpd_name>
Trospium chloride

> <ctcr_id>
7519

> <supplier_cmpd_id>
S2549

> <smiles>
[Cl-].OC(C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]23CCCC3)(c4ccccc4)c5ccccc5

> <pd_targets>
{CHRM1,CHRM2,CHRM3}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"trospium chloride",Sanctura,10405-02-4,10405024,Spasmex,Spasmo-lyt,Spasmolyt,Relaspium,Santura,Uraplex,"Trospium Cl","Sanctura XR","Trospii chloridum","Cloruro de trospio","Spasmo 3","Chlorure de tr
ospium","Trospium (chloride)",IP631,UNII-1E6682427E,UNII1E6682427E,"Trospium chlo",S2549,"Trospium chloride","Trospium chloride"}

> <pdid>
PD010171

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5284631}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  0  0            999 V2000
   15.6025    1.5193    0.0000 C   0  0
   14.3024    0.7712    0.0000 O   0  0
   14.2993   -0.7296    0.0000 C   0  0
   15.5984   -1.4796    0.0000 C   0  0
   15.5984   -2.9796    0.0000 C   0  0
   14.2994   -3.7296    0.0000 C   0  0
   13.0004   -2.9797    0.0000 C   0  0
   13.0002   -1.4796    0.0000 C   0  0
   11.6990   -0.7319    0.0000 O   0  0
   10.4003   -1.4841    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -2.4134   -4.4924    0.0000 C   0  0
   -1.5318   -5.7059    0.0000 C   0  0
   -0.0400   -5.5491    0.0000 C   0  0
    0.5701   -4.1788    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 29 30  1  0
 30 18  1  0
 30 22  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7737

> <plate>
1

> <well>
K13

> <supplier_cmpd_name>
Carvedilol

> <ctcr_id>
1656

> <supplier_cmpd_id>
S1831

> <smiles>
COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRB1,KDM4E,MAPT,GAA,HTR1B,KCNH2,ADRA1A,ADRA1B,HTR1A,MAPK1,HTR4,ADRB2,ADRA1D,KMT2A,APP,RORC,RYR2,FFP,MTOR,HTR2B,SLC6A4,ADRB3,DRD3,ABCB1,SLC22A2,SLC22A1,SLC6A2,DRD2,HTR2C,SLC6A3,S
LC47A1,TLR4,KCNK2,KCNK10,UGT1A1,HTR2A,HTR6,CACNA1C,NDUFC2,VEGFA,NPPB,GJA1,VCAM1,SELE,HIF1A,KCNJ4,KCNJ2,HCRTR2,HCRTR1}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Other cytosolic protein",Enzyme,"Ion channel","Transcription factor",Transporter,"Secreted protein",Adhesion,"Family A G protein-coupled receptor",Eraser,H
ydrolase,"Voltage-gated ion channel",Kinase,Reader,"Nuclear receptor","Ligand-gated ion channel",Transferase,"Electrochemical transporter","Primary active transporter","Small molecule receptor (family
 A GPCR)","Lysine demethylase","Potassium channels","Protein Kinase",Bromodomain,"Nuclear hormone receptor subfamily 1","Ryanodine receptor","SLC superfamily of solute carriers","ATP-binding cassette"
,"Voltage-gated calcium channel","Peptide receptor (family A GPCR)","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium channel","CMGC protein kinase group","Nuclear hormone rece
ptor subfamily 1 group F","Atypical protein kinase group","SLC06 neurotransmitter transporter family","ABCB subfamily","SLC22 family of organic cation and anion transporters","SLC47 family of multidru
g and toxin extrusion transporters","Two-pore domain potassium channel","Inwardly rectifying potassium channel","Short peptide receptor (family A GPCR)","Adrenergic receptor","Serotonin receptor","CMG
C protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Atypical protein kinase PIKK family","Dopamine receptor","Orexin receptor","CMGC protein kinase ERK1","Atypical p
rotein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Chromatin modifying enzymes","3.2.1.- Glycosidases","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Nuclear hormone r
eceptors","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Catalytic receptors","UDP glucuronosyltransferases (UGT)","Other ion channels",Adrenoceptors,"1.14.11.- Histon
e demethylases","5-Hydroxytryptamine receptors","Potassium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","2.1.1.43 Histone methyltransferases (HMTs)","1F. Retinoic acid-related orphans","R
yanodine receptors",Atypical,"SLC6 neurotransmitter transporter family","Dopamine receptors","ABCB subfamily","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and tox
in extrusion transporters","Pattern recognition receptors","Voltage-gated calcium channels","Connexins and Pannexins","Orexin receptors","Voltage-gated potassium channels","Mitogen-activated protein k
inases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Monoamine transporter subfamily","Organic cation transporters (OCT)","Toll-like receptor family","Two P domain po
tassium channels","Inwardly rectifying potassium channels","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction","Muscle contraction","Immune System","Gene expression (Transcription)",Metabolism,"Transport of small molecules","Developmental Biology","Vesicle-media
ted transport",Hemostasis,"Cellular responses to external stimuli","Infectious disease","Transmission across Chemical Synapses","Diseases of metabolism","Signaling by GPCR","Cardiac conduction","Innat
e Immune System","RNA Polymerase II Transcription","Abacavir transport and metabolism","SLC-mediated transmembrane transport","Disorders of transmembrane transporters","Potassium Channels","Nervous sy
stem development","The citric acid (TCA) cycle and respiratory electron transport","Membrane Trafficking","Cytokine Signaling in Immune system","Cell surface interactions at the vascular wall","Cellul
ar responses to stress","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Diseases of carbohydrate metabolism","GPCR ligand binding","Phase 3 - rapid repolarisa
tion","Toll-like Receptor Cascades","Generic Transcription Pathway","Ion homeostasis","Neurotransmitter clearance","Abacavir transmembrane transport","Transport of bile salts and organic acids","metal
 ions and amine compounds","SLC transporter disorders","Tandem pore domain potassium channels","Metabolic disorders of biological oxidation enzymes","Axon guidance","Respiratory electron transport","A
TP synthesis by chemiosmotic coupling","and heat production by uncoupling proteins.","Gap junction trafficking and regulation","Interferon Signaling","Cellular response to hypoxia","Leishmania parasit
e growth and survival","Activation of NMDA receptors and postsynaptic events","Glycogen storage diseases","Class A/1 (Rhodopsin-like receptors)","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional 
regulation by RUNX1","Transcriptional regulation by RUNX3","Transcriptional Regulation by TP53","Serotonin clearance from the synaptic cleft","Organic cation/anion/zwitterion transport","Defective SLC
6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Toll Like Receptor 4 (TLR4) Cascade","TWIK related potassium channel (TREK)","Defective UGT1
A1 causes hyperbilirubinemia","NCAM signaling for neurite out-growth","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","Gap junction trafficking","Interferon gamma sign
aling","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","GABA receptor activation","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor ac
tivation events","Glycogen storage disease type II (GAA)","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","RUNX1 regulates genes involved in megakaryocyte differentiation
 and platelet function","RUNX3 Regulates Immune Response and Cell Migration","Regulation of TP53 Activity","Organic cation transport","MyD88-independent TLR4 cascade","NCAM1 interactions","Complex I b
iogenesis","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","Gap junction assembly","GABA B receptor activation","Peptide ligand-binding receptors","ADORA2B mediated
 anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Serotonin receptors",Adrenoceptors,"MAP kinase activation","TAK1 activates NFkB by phosphorylation and activation of
 IKKs complex","Regulation of TP53 Expression and Degradation","Dopamine receptors","TRIF(TICAM1)-mediated TLR4 signaling","Transport of connexons to the plasma membrane","Activation of GABAB receptor
s","Orexin and neuropeptides FF and QRFP bind to their respective receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","Activation of IRF3/IRF7 mediated b
y TBK1/IKK epsilon","Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","ERK/MAPK targets","ERKs ar
e inactivated"}

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{carvedilol,72956-09-3,72956093,Coreg,Dilatrend,Eucardic,"Carvedilolum (Latin)","BM 14190",Carvedilolum,1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-2-propanol,1(9HCarbazol4yloxy)3((2(
2methoxyphenoxy)ethyl)amino)2propanol,BM-14190,BM14190,"SKF 105517",1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethy,1((9HCarbazol4yl)oxy)3((2(2methoxyphenoxy)ethy,T0342,T0447,S1831,SAM001246736
,1504257,Prestw-1262,"Carvedilol phosphate",Carvedilol,CPD000449280,CARVEDILOL}

> <pdid>
PD001210

> <targets>
{Adrenergic Receptor,Autophagy}

> <classes>
{beta-adrenergic blocker,Neuronal Signaling,Autophagy,GPCR/G Protein}

> <pubchem_cids>
{2585}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 36  0  0  1  0            999 V2000
    1.6391   -7.2459    0.0000 C   0  0
    1.1939   -5.8135    0.0000 C   0  0
    0.7485   -4.3803    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.6873   -2.7330    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8991    0.7525    0.0000 C   0  0
   -5.1969    1.5045    0.0000 C   0  0
   -5.1945    3.0045    0.0000 C   0  0
   -3.8943    3.7525    0.0000 C   0  0
   -2.5965    3.0004    0.0000 C   0  0
   -6.4916    3.7597    0.0000 N   0  0
   -6.4870    5.2597    0.0000 C   0  0
   -7.7931    3.0140    0.0000 C   0  0
  1  2  1  0
  2  3  3  0
  3  4  1  0
  4  5  1  6
  4  6  1  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 12  1  0
 18 19  2  3
 19  9  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22  4  1  0
 22  8  1  0
 22 23  1  6
 20 24  1  6
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 27 30  1  0
 30 31  1  0
 30 32  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7738

> <plate>
1

> <well>
K14

> <supplier_cmpd_name>
Mifepristone

> <ctcr_id>
4858

> <supplier_cmpd_id>
S2606

> <smiles>
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(cc5)N(C)C

> <pd_targets>
{NR3C1,PGR,AR,NR3C2,ABCB1A,ESR1,FTL,BLM,GMNN,LMNA,MAPK1,RORC,NPSR1,CYP3A4,CYP2C8,HTT,NFO,MAPK14,PMP22,ESR2,ALOX15,CYP2C9,NR1I2,MTOR,ADRA2B,ABCB11,OPRM1,OPRK1,FYN,SIGMAR1}

> <pathway_gtopdb>
{"Transcription factor",Transporter,"Other nuclear protein","Unclassified protein",Enzyme,"Membrane receptor","Nuclear receptor","Primary active transporter",Kinase,Protease,"Family A G protein-couple
d receptor","Cytochrome P450",Hydrolase,Oxidoreductase,"Nuclear hormone receptor subfamily 3","ATP-binding cassette","Protein Kinase","Nuclear hormone receptor subfamily 1","Cysteine protease","Peptid
e receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Nuclear hor
mone receptor subfamily 3 group A","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","Cysteine protease CA clan","Short peptide receptor (family A GPCR)","Cytochrome P450 fami
ly 3A","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group I","Atypical protein kinase group","Monoamine receptor","TK protein kinase group","Nuclear hormone receptor subfamily 3 g
roup C member 1","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 2","Nuclear hormon
e receptor subfamily 3 group A member 1","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C1A family","Neuropeptide receptor","Cytochrome P4
50 3A4","Cytochrome P450 2C8","Nuclear hormone receptor subfamily 3 group A member 2","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 1 group I member 2","Atypical protein kinase PIKK family
","Adrenergic receptor","Opioid receptor","Tyrosine protein kinase Src family","CMGC protein kinase ERK1","CMGC protein kinase p38 subfamily","Atypical protein kinase FRAP subfamily","Tyrosine protein
 kinase SrcA"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Other protein targets","Nuclear hormone receptors","ATP-binding cassette transporter family","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","Ei
cosanoid turnover","Catalytic receptors","Sigma receptors","Steroid hormone receptors","ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related orphans","Neuropeptid
e S receptor","CYP3 family","CYP2 family: drug metabolising subset",Lipoxygenases,"1I. Vitamin D receptor-like receptors",Atypical,Adrenoceptors,"Opioid receptors","Receptor kinases","3C. 3-Ketosteroi
d receptors","3A. Estrogen receptors","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","TK: Tyrosine kinase","ERK subfamily","p38 subfa
mily","FRAP subfamily","Non-receptor tyrosine kinases (nRTKs)","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Metabolism of proteins","Vesicle-mediated transport","DNA Repair","Cell Cycle","Immune System",Disease,Metabolism,"Developmental Biology","Signal Transduction","RNA
 Polymerase II Transcription","Post-translational protein modification","Membrane Trafficking","DNA Double-Strand Break Repair",Mitotic,"Innate Immune System","Infectious disease","Metabolism of lipid
s","Biological oxidations","Nervous system development","Intracellular signaling by second messengers","Signaling by GPCR","Generic Transcription Pathway",SUMOylation,"trans-Golgi Network Vesicle Budd
ing","Homology Directed Repair","Mitotic G1 phase and G1/S transition","M Phase","Toll-like Receptor Cascades","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Phase
 I - Functionalization of compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","PIP3 activates AKT signaling","GPCR ligand binding","Metabolism of steroids","GPCR downstream sig
nalling","HIV Infection","SARS-CoV Infections","FOXO-mediated transcription","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX2","Transcriptional regulation by RUNX1","Go
lgi Associated Vesicle Biogenesis","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade
","Transcriptional regulation by RUNX3","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2
","Negative regulation of the PI3K/AKT network","Biosynthesis of DPA-derived SPMs","Transcriptional Regulation by TP53","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","G a
lpha (i) signalling events","Host Interactions of HIV factors","Potential therapeutics for SARS","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","SUMOylation of intrac
ellular receptors","RUNX2 regulates bone development","RUNX1 regulates estrogen receptor mediated transcription","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative complex
","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesi
s of maresins",Xenobiotics,"Regulation of MECP2 expression and activity",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Biosynthesis of DPAn-3 SPMs","Regulation of TP53 Activity","Amine ligand-bind
ing receptors","Synthesis of bile acids and bile salts","Opioid Signalling","MECP2 regulates neuronal receptors and channels","The role of Nef in HIV-1 replication and disease pathogenesis","RUNX2 reg
ulates osteoblast differentiation","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Bi
osynthesis of maresin-like SPMs","CYP2E1 reactions","Biosynthesis of DPAn-3-derived protectins and resolvins","Regulation of TP53 Expression and Degradation",Adrenoceptors,"Synthesis of bile acids and
 bile salts via 7alpha-hydroxycholesterol","G-protein activation","Nef and signal transduction","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) R
eformation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","Activation of the AP-1 family of transcription factors","ERKs are inactivated"}

> <broad_targets>
{AR,NR1I2,NR3C1,PGR}

> <broad_moa>
{"glucocorticoid receptor antagonist","progesterone receptor antagonist"}

> <synonyms>
{mifepristone,84371-65-3,84371653,Mifegyne,Mifeprex,RU-486,RU486,Corlux,Korlym,"RU 486","RU 38486",Mifepriston,RU-38486,RU38486,UNII-320T6RNW1F,UNII320T6RNW1F,MLS000069785,320T6RNW1F,VGX-410C,VGX410C,
CHEBI:50692,VGX-410,VGX410,"Mifepristone, 98",NCGC00025179-05,NCGC0002517905,SMR000058481,Mifepristonum,S2606,SAM001246881,Prestw-299,Mifepristone,CPD000058481}

> <pdid>
PD000351

> <targets>
{Estrogen/progestogen Receptor,Autophagy,Glucocorticoid Receptor,NO Synthase,Progesterone Receptor}

> <classes>
{Endocrinology & Hormones,Autophagy,GPCR/G Protein,Immunology/Inflammation,Others}

> <pubchem_cids>
{55245}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 22  0  0  0  0            999 V2000
   -0.0041   -2.9953    0.0000 C   0  0
    1.2925   -3.7494    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5886   -6.0033    0.0000 C   0  0
    1.2919   -5.2492    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1895   -7.5109    0.0000 C   0  0
    6.4885   -8.2610    0.0000 C   0  0
    7.7875   -7.5110    0.0000 C   0  0
    7.7876   -6.0110    0.0000 C   0  0
    6.4885   -5.2610    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  3 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7739

> <plate>
1

> <well>
K15

> <supplier_cmpd_name>
Tropicamide

> <ctcr_id>
1400

> <supplier_cmpd_id>
S1913

> <smiles>
CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2

> <pd_targets>
{CHRM5,MAPT,BLM,CHRM4,CHRM2,CHRM3,NFO,CYP2C19,CYP2C9,CHRM1,TSHR,HSD17B10,CYP3A4,NFKB1,CYP1A2,LEF,LMNA}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450",Oxidoreductase,Protease,"Small molecule receptor (family
 A GPCR)","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1","Metallo protease","Monoamine receptor","Cytochrome P450 family 2C","Glyco
hormone receptor","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Metallo protease MAE clan","Acetylcholine receptor","Cytochrome P450 2C19","Cytochrome P450 2C9","Cytochrome P450 3A4","Cytoc
hrome P450 1A1","Metallo protease M34 family"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising subset","Glycoprotein hormone receptors","CYP3 family","CYP1 f
amily"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System","DNA Repair",Metabolism,Disease,"Immune System","Cell Cycle","Signaling by GPCR","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Biol
ogical oxidations","Infectious disease","Metabolism of amino acids and derivatives","Metabolism of lipids","Cytokine Signaling in Immune system",Mitotic,"GPCR ligand binding","Neurotransmitter recepto
rs and postsynaptic signal transmission","Homology Directed Repair","Phase I - Functionalization of compounds","Leishmania infection","Branched-chain amino acid catabolism","Biosynthesis of specialize
d proresolving mediators (SPMs)","Signaling by Interleukins","Uptake and actions of bacterial toxins","M Phase","Class A/1 (Rhodopsin-like receptors)","Activation of NMDA receptors and postsynaptic ev
ents","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Biosynthesis of DHA-derive
d SPMs","Interleukin-1 family signaling","Uptake and function of anthrax toxins","Mitotic Metaphase and Anaphase","Amine ligand-binding receptors","Post NMDA receptor activation events","HDR through H
omologous Recombination (HRR)",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","Interleukin-1 signaling","Mitotic Anaphase","Muscarinic acet
ylcholine receptors","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis o
f maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Presynaptic phase of homologous
 DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{1508-75-4,1508754,Mydriacyl,Mydriaticum,N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide,Nethyl3hydroxy2phenylN(pyridin4ylmethyl)propanamide,Tropicamidum,"Ro 1-7683","Ro 17683",N-Ethyl-2-
phenyl-N-(4-pyridylmethyl)hydracrylamide,NEthyl2phenylN(4pyridylmethyl)hydracrylamide,Mydriafair,Tropicacyl,"Minims tropicamide",Bistropamide,Epitro,T1281,S1913,SAM002564235,1500599,Prestw-228,Tropica
mide,CPD000058523,TROPICAMIDE}

> <pdid>
PD002097

> <targets>
{AChR}

> <classes>
{"anticholinergic (opthalmic)","Neuronal Signaling"}

> <pubchem_cids>
{5593}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 31  0  0  0  0            999 V2000
   21.2511   -1.3036    0.0000 H   0  3
   18.7511   -1.3036    0.0000 H   0  3
   16.2511   -1.3036    0.0000 Cl  0  5
   13.7511   -1.3036    0.0000 Cl  0  5
    9.0114   -5.2042    0.0000 C   0  0
    8.2575   -3.9075    0.0000 O   0  0
    9.0031   -2.6049    0.0000 C   0  0
   10.5031   -2.6026    0.0000 C   0  0
   11.2511   -1.3024    0.0000 C   0  0
   10.4991   -0.0045    0.0000 C   0  0
    8.9991   -0.0069    0.0000 C   0  0
    8.2510   -1.3071    0.0000 C   0  0
    6.7502   -1.3070    0.0000 N   0  0
    6.0002   -2.6061    0.0000 C   0  0
    4.5002   -2.6060    0.0000 C   0  0
    3.7501   -1.3070    0.0000 N   0  0
    4.5003   -0.0080    0.0000 C   0  0
    6.0003   -0.0080    0.0000 C   0  0
    2.2493   -1.3039    0.0000 C   0  0
    1.5008   -0.0031    0.0000 C   0  0
    0.0000    0.0000    0.0000 N   0  0
   -0.7540    1.2970    0.0000 C   0  0
   -0.0060    2.5971    0.0000 O   0  0
   -2.2621    1.2970    0.0000 C   0  0
   -3.0162    0.0000    0.0000 C   0  0
   -3.8909    1.2065    0.0000 C   0  0
   -5.3236    0.7390    0.0000 C   0  0
   -5.3236   -0.7540    0.0000 C   0  0
   -3.8909   -1.2065    0.0000 C   0  0
   -2.2621   -1.2970    0.0000 C   0  0
   -0.7540   -1.2970    0.0000 C   0  0
   -0.0060   -2.5971    0.0000 O   0  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 25  1  0
 25 30  1  0
 30 31  1  0
 31 21  1  0
 31 32  2  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7740

> <plate>
1

> <well>
K16

> <supplier_cmpd_name>
BMY 7378

> <ctcr_id>
5822

> <supplier_cmpd_id>
S2691

> <smiles>
[H+].[H+].[Cl-].[Cl-].COc1ccccc1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O

> <pd_targets>
{DRD2,ADRA1A,ADRA1D,HTR2A,HTR2B,HTR2C,CYP3A4,ADRA1B,ADRA2A,ADRA2B,ADRA2C,HTR1A,DRD3,THPO,CYP1A2,DRD1,DRD4,DRD5,KMT2A,MEN1,CHRM1,HTR3A,LMNA}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Unclassified protein","Epigenetic regulator","Ion channel","Other nuclear protein","Family A G protein-coupled receptor","Cytochrome P450",Reader,"Ligand-gated ion channel
","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1",Bromodomain,"5HT3 receptor","Monoamine receptor","Cytochrome P450 family 3A","Cytochrome P450 family 1
A","Dopamine receptor","Adrenergic receptor","Serotonin receptor","Cytochrome P450 3A4","Cytochrome P450 1A1","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Cytochrome P450","Ligand-gated ion channels","Dopamine receptors",Adrenoceptors,"CYP3 family","5-Hydroxytryptamine receptors","CYP1 fam
ily","Acetylcholine receptors (muscarinic)","5-HT<sub>3</sub> receptors"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Hemostasis,"Neuronal System","Cell Cycle","Signaling by GPCR","Metabolism of lipids","Platelet activation","signaling and aggregation","Biological oxidations","Transm
ission across Chemical Synapses",Mitotic,"GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug Formation)","Phase I - Functionalization of compo
unds","Neurotransmitter receptors and postsynaptic signal transmission","M Phase","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate typ
e","Mitotic Metaphase and Anaphase","Amine ligand-binding receptors","Biosynthesis of maresins",Xenobiotics,"Mitotic Anaphase","Dopamine receptors",Adrenoceptors,"Biosynthesis of maresin-like SPMs","S
erotonin receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Refo
rmation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,HTR1A}

> <broad_moa>
{"adrenergic receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{21102-95-4,21102954,"BMY 7378 dihydrochloride","BMY 7378",Bmy-7378,Bmy7378,BMY7378,UNII-KC07KV8T5O,UNIIKC07KV8T5O,KC07KV8T5O,"BMY-7378 HCl","BMY7378 HCl",CHEMBL543741,21102-94-3,21102943,"21102-95-4 
(HCl)","21102954 (HCl)",C17H17ClN4,SR-01000075542,SR01000075542,"BMY7378 dihydrochloride",azaspiro(4.5)decane-7,azaspiro(4.5)decane7,9-di,9di,T3046,S2691}

> <pdid>
PD051724

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{210172,57517921}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 30  0  0  0  0            999 V2000
   10.2288   -7.4986    0.0000 H   0  3
    7.7288   -7.4986    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 N   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 N   0  0
    0.0102   -7.5017    0.0000 C   0  0
    1.3123   -8.2482    0.0000 C   0  0
    1.3177   -9.7490    0.0000 C   0  0
    2.6197  -10.4955    0.0000 N   0  0
    2.6252  -11.9963    0.0000 C   0  0
    1.3274  -12.7485    0.0000 C   0  0
    1.3298  -14.2485    0.0000 C   0  0
    0.0320  -15.0006    0.0000 O   0  0
    2.6300  -14.9964    0.0000 N   0  0
    2.6325  -16.4964    0.0000 C   0  0
    3.9279  -14.2443    0.0000 C   0  0
    5.2281  -14.9922    0.0000 O   0  0
    3.9254  -12.7443    0.0000 N   0  0
    5.2233  -11.9922    0.0000 C   0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  3
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 19  1  0
 27 28  1  0
 14 29  1  0
 29 30  1  0
 30 11  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7741

> <plate>
1

> <well>
K17

> <supplier_cmpd_name>
Urapidil HCl

> <ctcr_id>
2459

> <supplier_cmpd_id>
S2025

> <smiles>
[H+].[Cl-].COc1ccccc1N2CCN(CCCNC3=CC(=O)N(C)C(=O)N3C)CC2

> <pd_targets>
{MAPT,HTR1A,CYP2C9,ADRA1A,ADRA1B,ADRA1D,CHRM1,TSHR,LMNA,CYP2C19,CYP3A4,BLM,PMP22}

> <pathway_gtopdb>
{"Other cytosolic protein","Membrane receptor",Enzyme,"Other nuclear protein","Unclassified protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","
Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Monoamine receptor","Cytochrome P450 family 2C","Glycohormone receptor","Cytochrome P450 family 3A","Serotonin 
receptor","Cytochrome P450 2C9","Adrenergic receptor","Acetylcholine receptor","Cytochrome P450 2C19","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","5-Hydroxytryptamine receptors","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","Glycoprotein hormone 
receptors","CYP3 family"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction",Metabolism,Disease,"Cell Cycle","DNA Repair","Developmental Biology","Transmission across Chemical Synapses","Signaling by GPCR","Biological oxidations","Infec
tious disease",Mitotic,"Metabolism of lipids","DNA Double-Strand Break Repair","Nervous system development","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Pha
se I - Functionalization of compounds","Leishmania infection","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Homology Directed Repair","EGR2 and SOX10-mediated initiation of Sc
hwann cell myelination","Activation of NMDA receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and sur
vival","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Post NMDA receptor activation events","Amine l
igand-binding receptors",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Biosynthesis of maresins","HDR through Homologous Recombination (HRR)","Ac
tivation of AMPK downstream of NMDARs","Serotonin receptors","CYP2E1 reactions","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Re
assembly","Biosynthesis of maresin-like SPMs","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exc
hange"}

> <broad_targets>
{HTR1A}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{AKOS026749783,"Urapidil hydrochloride","Urapidil HCl",64887-14-5,64887145,"Urapidil (hydrochloride)",UNII-PVU92PZO12,UNIIPVU92PZO12,PVU92PZO12,NCGC00094502-01,NCGC0009450201,"Ebrantil (TN)",DSSTox_CI
D_25812,DSSToxCID25812,DSSTox-CID-25812,"DSSTox CID 25812",DSSTox_RID_81149,DSSToxRID81149,DSSTox-RID-81149,"DSSTox RID 81149",DSSTox_GSID_45812,DSSToxGSID45812,DSSTox-GSID-45812,"DSSTox GSID 45812",S
MR000058525,SR-01000075295,SR01000075295,CAS-64887-1,CAS648871,S2025,SAM001247001,Prestw-905,CPD000058525}

> <pdid>
PD013272

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{91981305,167980}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 29  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 O   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    3.9014    2.2508    0.0000 C   0  0
    2.6028    3.0016    0.0000 O   0  0
    5.2007    3.0004    0.0000 O   0  0
   23.0529    0.0861    0.0000 O   0  0
   21.7526   -0.6617    0.0000 C   0  0
   21.7505   -2.1625    0.0000 C   0  0
   22.4962   -3.3728    0.0000 C   0  0
   20.9962   -3.3675    0.0000 C   0  0
   20.4544    0.0914    0.0000 C   0  0
   20.4544    1.5914    0.0000 C   0  0
   19.1553    2.3414    0.0000 C   0  0
   17.8563    1.5914    0.0000 C   0  0
   16.5550    2.3391    0.0000 O   0  0
   15.2563    1.5869    0.0000 C   0  0
   13.9550    2.3346    0.0000 C   0  0
   12.6563    1.5823    0.0000 C   0  0
   11.3550    2.3301    0.0000 C   0  0
   10.0037    1.7090    0.0000 C   0  0
    9.0000    2.8237    0.0000 N   0  0
    9.7499    4.1228    0.0000 C   0  0
   11.2172    3.8109    0.0000 N   0  0
   17.8563    0.0914    0.0000 C   0  0
   19.1553   -0.6586    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 11  1  0
 10 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 22  1  0
 17 27  1  0
 27 28  2  0
 28 14  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7742

> <plate>
1

> <well>
K18

> <supplier_cmpd_name>
Ciproxifan

> <ctcr_id>
7250

> <supplier_cmpd_id>
S2813

> <smiles>
OC(=O)\C=C/C(O)=O.O=C(C1CC1)c2ccc(OCCCc3c[nH]cn3)cc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Ciproxifan maleate",184025-19-2,184025192,"184025 19 2","Ciproxifan (maleate)","FUB 359 maleate salt","(4-(3-(1H-imidazol-5-yl)propoxy)phenyl)(cyclopropyl)methanone maleate","(4(3(1Himidazol5yl)prop
oxy)phenyl)(cyclopropyl)methanone maleate",(,S2813,Ciproxifan}

> <pdid>

> <targets>
{Histamine Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{16219152}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 20  0  0  0  0            999 V2000
    1.8949   -4.8318    0.0000 N   0  0
    1.0157   -3.6164    0.0000 C   0  0
   -0.4763   -3.7706    0.0000 N   0  0
    1.6281   -2.2462    0.0000 N   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -2.6394    0.8543    0.0000 C   0  0
   -3.7533   -0.1515    0.0000 S   0  0
   -5.1816    0.3093    0.0000 C   0  0
   -6.2955   -0.6966    0.0000 C   0  0
   -7.7238   -0.2358    0.0000 C   0  0
   -8.0383    1.2309    0.0000 N   0  0
   -8.8377   -1.2416    0.0000 N   0  0
  -10.2660   -0.7808    0.0000 S   0  0
  -11.6934   -0.3196    0.0000 N   0  0
  -11.3793   -1.7861    0.0000 O   0  0
  -10.5805    0.6858    0.0000 O   0  0
   -0.7500   -1.0323    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  3
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 16 19  2  0
  8 20  1  0
 20  5  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7743

> <plate>
1

> <well>
K19

> <supplier_cmpd_name>
Famotidine

> <ctcr_id>
6597

> <supplier_cmpd_id>
S2078

> <smiles>
NC(N)=Nc1scc(CSCCC(=N)N[S](N)(=O)=O)n1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{famotidine,76824-35-6,76824356,PEPCID,"Pepcid AC",Famodil,Gastridin,Pepcidine,Pepdine,Quamatel,Gaster,Pepdul,"Pepcid RPD",YM-11170,YM11170,"Famotidine (Pepcid)",MK-208,MK208,"MK 208",CHEBI:4975,"YM 1
1170",3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide,3(2Guanidinothiazol4ylmethylthio)N1sulfamoylpropionamide,S2078,SAM001247033,1501003,Prestw-104,Famotidine,CPD000058961,FAMOTIDINE,F
amotidine}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"H2 antihistamine","Neuronal Signaling"}

> <pubchem_cids>
{5702160,5353622,3325}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 20  0  0  0  0            999 V2000
   11.7790   -3.9819    0.0000 H   0  3
    9.2790   -3.9819    0.0000 H   0  3
    6.7790   -3.9819    0.0000 Br  0  5
    4.2790   -3.9819    0.0000 Br  0  5
   -4.5519   -9.7424    0.0000 N   0  0
   -3.3935   -8.7894    0.0000 C   0  0
   -3.6387   -7.3088    0.0000 C   0  0
   -2.4797   -6.3553    0.0000 C   0  0
   -2.7250   -4.8746    0.0000 C   0  0
   -1.5659   -3.9212    0.0000 C   0  0
   -1.8112   -2.4405    0.0000 N   0  0
   -0.6522   -1.4871    0.0000 C   0  0
   -0.8987    0.0000    0.0000 C   0  0
   -2.0541   -1.3755    0.0000 C   0  0
   -0.6052   -0.9721    0.0000 C   0  0
   -0.6052    0.5686    0.0000 C   0  0
    0.4035    1.7790    0.0000 C   0  0
    1.7790    1.2105    0.0000 C   0  0
    1.7607   -0.2751    0.0000 C   0  0
    0.7703   -1.5223    0.0000 C   0  0
    0.3852   -0.6052    0.0000 C   0  0
   -0.8987    1.3205    0.0000 C   0  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 15  1  0
 19 21  1  0
 21 13  1  0
 17 22  1  0
 22 13  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7744

> <plate>
1

> <well>
K20

> <supplier_cmpd_name>
IEM 1754 dihydrobroMide

> <ctcr_id>
3030

> <supplier_cmpd_id>
S2860

> <smiles>
[H+].[H+].[Br-].[Br-].NCCCCCNCC12CC3CC(CC(C3)C1)C2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{GRIA1}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{"IEM 1754 dihydrobroMide",162831-31-4,162831314,"IEM 1754 2HBr","IEM1754 dihydrobromide","IEM 1754","IEM-1754 2HBr","IEM1754 2HBr",IEM1754;IEM-1754,IEM1754;IEM1754,"N-(Tricyclo(3.3.1.13,7)dec-1-ylmet
hyl)-1,5-pentanediamine dihydrobromide","N(Tricyclo(3.3.1.13,7)dec1ylmethyl)1,5pentanediamine dihydrobromide",N'-(1-adamantylmethyl)pentane-,N'(1adamantylmethyl)pentane,S2860}

> <pdid>
PD040989

> <targets>
{GluR,"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9887867,56593248}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 33  0  0  0  0            999 V2000
   -0.7603   -8.0518    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 N   0  0
   -2.6933   -6.3162    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 S   0  0
   -3.8964   -0.7545    0.0000 O   0  0
   -2.5988   -0.0025    0.0000 O   0  0
   -5.2003    1.4932    0.0000 N   0  0
   -6.5504    0.8693    0.0000 C   0  0
   -7.5563    1.9820    0.0000 C   0  0
   -6.8090    3.2826    0.0000 C   0  0
   -5.3412    2.9737    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    8.8133   -0.5100    0.0000 O   0  0
    8.8133   -2.0100    0.0000 C   0  0
    7.5133   -2.7600    0.0000 C   0  0
    6.2133   -2.0100    0.0000 C   0  0
    6.2133   -0.5100    0.0000 O   0  0
    4.9141   -2.7596    0.0000 O   0  0
   10.1133   -2.7600    0.0000 C   0  0
   10.1133   -4.2600    0.0000 O   0  0
   11.4126   -2.0104    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  2  0
 14 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 12 22  1  0
 22 23  2  0
 23  6  1  0
 23  9  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 25 30  1  0
 30 31  1  0
 30 32  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7745

> <plate>
1

> <well>
K21

> <supplier_cmpd_name>
Almotriptan Malate

> <ctcr_id>
3207

> <supplier_cmpd_id>
S2096

> <smiles>
CN(C)CCc1c[nH]c2ccc(C[S](=O)(=O)N3CCCC3)cc12.OC(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Almotriptan malate",181183-52-8,181183528,"Almotriptan maleate","Almotriptan (malate)","LAS 31416 D,L-malate acid","LAS 31416 D,Lmalate acid",CHEBI:53781,PNU-180638E,PNU180638E,"181183-52-8(Almotrip
tan Malate)","181183528(Almotriptan Malate)","PNU 180638E",SR-05000001986,SR05000001986,"Axert (TN)","Almotriptan malate (USP)","Almotriptan mal",T2317,S2096,"Almotriptan Malate"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{123607}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 19 21  0  0  0  0            999 V2000
   -0.4662   -9.6104    0.0000 C   0  0
    0.2883   -8.3139    0.0000 N   0  0
    1.7883   -8.3192    0.0000 C   0  0
    2.5428   -7.0227    0.0000 C   0  0
    1.7974   -5.7210    0.0000 N   0  0
    0.2973   -5.7159    0.0000 C   0  0
   -0.4572   -7.0123    0.0000 C   0  0
    2.5497   -4.4224    0.0000 C   0  0
    4.0497   -4.4250    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
 19 10  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7746

> <plate>
1

> <well>
K22

> <supplier_cmpd_name>
JNJ-7777120

> <ctcr_id>
4407

> <supplier_cmpd_id>
S2905

> <smiles>
CN1CCN(CC1)C(=O)c2[nH]c3ccc(Cl)cc3c2

> <pd_targets>
{HRH4,HRH3,HRH1,HRH2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","A
mine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Histamine receptors","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{HRH4}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{NJ777712,JNJ-7777120,JNJ7777120,459168-41-3,459168413,"JNJ 7777120",1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine,1((5chloro1Hindol2yl)carbonyl)4methylpiperazine,UNII-4H1AU2V37X,UNII4H1AU2V
37X,(5-chloro-1H-indol-2-yl)(4-methylpiperazin-1-yl)methanone,(5chloro1Hindol2yl)(4methylpiperazin1yl)methanone,(5-chloro-1H-indol-2-yl)-(4-methylpiperazin-1-yl)methanone,4H1AU,T2232,S2905}

> <pdid>
PD010521

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{4908365}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 34 36  0  0  1  0            999 V2000
   17.2143   -3.3527    0.0000 Br  0  5
    9.2392   -6.0548    0.0000 N   0  0
    7.9955   -5.2162    0.0000 C   0  0
    7.0969   -5.6549    0.0000 O   0  0
    8.1004   -3.7191    0.0000 C   0  0
    6.7539   -4.3758    0.0000 C   0  0  2  0  0  0
    6.4934   -5.8530    0.0000 C   0  0
    5.0080   -6.0618    0.0000 C   0  0
    4.3719   -4.7174    0.0000 N   0  0
    2.8945   -4.4538    0.0000 C   0  0
    2.3832   -3.0427    0.0000 C   0  0
    0.9057   -2.7791    0.0000 C   0  0
    0.3926   -1.3695    0.0000 C   0  0
   -1.0846   -1.1091    0.0000 C   0  0
   -2.0488   -2.2581    0.0000 C   0  0
   -3.5471   -2.3102    0.0000 O   0  0
   -3.9605   -3.7521    0.0000 C   0  0
   -2.7169   -4.5909    0.0000 C   0  0
   -1.5357   -3.6677    0.0000 C   0  0
   -0.0585   -3.9281    0.0000 C   0  0
    5.4294   -3.6716    0.0000 C   0  0
    6.8560   -2.8800    0.0000 C   0  0
    7.4659   -1.5096    0.0000 C   0  0
    6.5841   -0.2962    0.0000 C   0  0
    5.0923   -0.4532    0.0000 C   0  0
    4.4824   -1.8237    0.0000 C   0  0
    5.3643   -3.0370    0.0000 C   0  0
    9.4497   -3.0618    0.0000 C   0  0
    9.5550   -1.5655    0.0000 C   0  0
   10.9035   -0.9086    0.0000 C   0  0
   12.1467   -1.7480    0.0000 C   0  0
   12.0413   -3.2443    0.0000 C   0  0
   10.6928   -3.9012    0.0000 C   0  0
   14.7143   -3.3527    0.0000 H   0  3
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 15  1  0
 19 20  2  0
 20 12  1  0
  9 21  1  0
 21  6  1  0
  5 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  5 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
M  CHG  2   1  -1  34   1
M  END
> <name>
Selleck_GPCR

> <id>
7747

> <plate>
1

> <well>
L03

> <supplier_cmpd_name>
Darifenacin HBr

> <ctcr_id>
3877

> <supplier_cmpd_id>
S3144

> <smiles>
[Br-].NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5.[H+]

> <pd_targets>
{CHRM2,CHRM1,CHRM3,ADRB1,GPM3,ADRB2,DRD2,CHRM4,CHRM5,KCNH2,KCNE1,KCNQ1,KCND3,SCN5A}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel","Small molecule receptor (family A GPCR)","Potassium channels","Voltage-gated sodium channel","Mono
amine receptor","Voltage-gated potassium channel","Acetylcholine receptor","Adrenergic receptor","Dopamine receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels","Acetylcholine receptors (muscarinic)",Adrenoceptors,"Dopamine receptors","Potassium channels","Voltage-gated sodiu
m channels","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Muscle contraction","Developmental Biology","Signaling by GPCR","Infectious disease","Cardiac conduction","Nervous system development","GPCR ligand binding","Leishmania
 infection","Phase 3 - rapid repolarisation","Phase 1 - inactivation of fast Na+ channels","Axon guidance","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","L1CAM inter
actions","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Interaction between L1 and Ankyrins","Muscarinic acetylcholine receptors","ADORA2B media
ted anti-inflammatory cytokines production","Dopamine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Darifenacin hydrobromide","darifenacin HBr",133099-07-7,133099077,"133099 07 7","Darifenacin (hydrobromide)",Emselex,UNII-CR02EYQ8GV,UNIICR02EYQ8GV,"UNII CR02EYQ8GV",CR02EYQ8GV,CHEBI:31455,"UK-88525
-04 (HYDROBROMIDE)","UK8852504 (HYDROBROMIDE)","UK8852504 (HYD",S3146,S3144,Prestw-1514,"Tripelennamine HCl","Darifenacin HBr"}

> <pdid>
PD009993

> <targets>
{AChR,"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{444030,59800324,60208591}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 34 36  0  0  1  0            999 V2000
   17.2143   -3.3527    0.0000 Br  0  5
    9.2392   -6.0548    0.0000 N   0  0
    7.9955   -5.2162    0.0000 C   0  0
    7.0969   -5.6549    0.0000 O   0  0
    8.1004   -3.7191    0.0000 C   0  0
    6.7539   -4.3758    0.0000 C   0  0  2  0  0  0
    6.4934   -5.8530    0.0000 C   0  0
    5.0080   -6.0618    0.0000 C   0  0
    4.3719   -4.7174    0.0000 N   0  0
    2.8945   -4.4538    0.0000 C   0  0
    2.3832   -3.0427    0.0000 C   0  0
    0.9057   -2.7791    0.0000 C   0  0
    0.3926   -1.3695    0.0000 C   0  0
   -1.0846   -1.1091    0.0000 C   0  0
   -2.0488   -2.2581    0.0000 C   0  0
   -3.5471   -2.3102    0.0000 O   0  0
   -3.9605   -3.7521    0.0000 C   0  0
   -2.7169   -4.5909    0.0000 C   0  0
   -1.5357   -3.6677    0.0000 C   0  0
   -0.0585   -3.9281    0.0000 C   0  0
    5.4294   -3.6716    0.0000 C   0  0
    6.8560   -2.8800    0.0000 C   0  0
    7.4659   -1.5096    0.0000 C   0  0
    6.5841   -0.2962    0.0000 C   0  0
    5.0923   -0.4532    0.0000 C   0  0
    4.4824   -1.8237    0.0000 C   0  0
    5.3643   -3.0370    0.0000 C   0  0
    9.4497   -3.0618    0.0000 C   0  0
    9.5550   -1.5655    0.0000 C   0  0
   10.9035   -0.9086    0.0000 C   0  0
   12.1467   -1.7480    0.0000 C   0  0
   12.0413   -3.2443    0.0000 C   0  0
   10.6928   -3.9012    0.0000 C   0  0
   14.7143   -3.3527    0.0000 H   0  3
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 15  1  0
 19 20  2  0
 20 12  1  0
  9 21  1  0
 21  6  1  0
  5 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  5 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
M  CHG  2   1  -1  34   1
M  END
> <name>
Selleck_GPCR

> <id>
7748

> <plate>
1

> <well>
L04

> <supplier_cmpd_name>
Tripelennamine HCl

> <ctcr_id>
3877

> <supplier_cmpd_id>
S3146

> <smiles>
[Br-].NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5.[H+]

> <pd_targets>
{CHRM2,CHRM1,CHRM3,ADRB1,GPM3,ADRB2,DRD2,CHRM4,CHRM5,KCNH2,KCNE1,KCNQ1,KCND3,SCN5A}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel","Small molecule receptor (family A GPCR)","Potassium channels","Voltage-gated sodium channel","Mono
amine receptor","Voltage-gated potassium channel","Acetylcholine receptor","Adrenergic receptor","Dopamine receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels","Acetylcholine receptors (muscarinic)",Adrenoceptors,"Dopamine receptors","Potassium channels","Voltage-gated sodiu
m channels","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Muscle contraction","Developmental Biology","Signaling by GPCR","Infectious disease","Cardiac conduction","Nervous system development","GPCR ligand binding","Leishmania
 infection","Phase 3 - rapid repolarisation","Phase 1 - inactivation of fast Na+ channels","Axon guidance","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","L1CAM inter
actions","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Interaction between L1 and Ankyrins","Muscarinic acetylcholine receptors","ADORA2B media
ted anti-inflammatory cytokines production","Dopamine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Darifenacin hydrobromide","darifenacin HBr",133099-07-7,133099077,"133099 07 7","Darifenacin (hydrobromide)",Emselex,UNII-CR02EYQ8GV,UNIICR02EYQ8GV,"UNII CR02EYQ8GV",CR02EYQ8GV,CHEBI:31455,"UK-88525
-04 (HYDROBROMIDE)","UK8852504 (HYDROBROMIDE)","UK8852504 (HYD",S3146,S3144,Prestw-1514,"Tripelennamine HCl","Darifenacin HBr"}

> <pdid>
PD009993

> <targets>
{AChR,"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{444030,59800324,60208591}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 14 13  0  0  0  0            999 V2000
    6.3982   -1.8787    0.0000 Cl  0  0
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  2  0
 14  7  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7749

> <plate>
1

> <well>
L05

> <supplier_cmpd_name>
Adrenalone HCl

> <ctcr_id>
6736

> <supplier_cmpd_id>
S3185

> <smiles>
Cl.CNCC(=O)c1ccc(O)c(O)c1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{AKOS026749981,"Adrenalone hydrochloride",62-13-5,62135,"ADRENALONE HCL","Adrenone hydrochloride","Kephrine hydrochloride","Epinephrine ketone hydrochloride","3',4'-Dihydroxy-2-(methylamino)acetopheno
ne hydrochloride","3',4'Dihydroxy2(methylamino)acetophenone hydrochloride",UNII-NN82YWE2IC,UNIINN82YWE2IC,Adrenalone,T0948,S3185,"Adrenalone HCl"}

> <pdid>
PD013683

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{74764544,44722464,66136}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 29  0  0  0  0            999 V2000
    0.2974   -5.7184    0.0000 C   0  0
    1.7974   -5.7210    0.0000 C   0  0
    2.5447   -7.0216    0.0000 O   0  0
    2.5497   -4.4224    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -2.5998    1.4986    0.0000 C   0  0
   -3.8983    0.7460    0.0000 C   0  0
   -5.1983    1.4943    0.0000 O   0  0
   -3.8967   -0.7548    0.0000 C   0  0
   -4.6429   -1.9648    0.0000 C   0  0
   -3.1429   -1.9600    0.0000 C   0  0
   -2.6013    2.9994    0.0000 C   0  0
   -3.9027    3.7455    0.0000 C   0  0
   -3.9073    5.2455    0.0000 C   0  0
   -2.6105    5.9995    0.0000 C   0  0
   -1.3092    5.2535    0.0000 C   0  0
   -1.3046    3.7535    0.0000 C   0  0
   -0.0032    3.0075    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  2  0
 12 13  1  0
 13  5  2  0
 10 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 17  1  0
 14 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 25 26  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7750

> <plate>
1

> <well>
L06

> <supplier_cmpd_name>
Prasugrel

> <ctcr_id>
4087

> <supplier_cmpd_id>
S1258

> <smiles>
CC(=O)Oc1sc2CCN(Cc2c1)C(C(=O)C3CC3)c4ccccc4F

> <pd_targets>
{P2RY12}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Nucleotide-like receptor (family A GPCR)","Purine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","P2Y receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Nucleotide-like (purinergic) receptors","P2Y receptors"}

> <broad_targets>
{P2RY12}

> <broad_moa>
{"purinergic receptor antagonist"}

> <synonyms>
{Prasugrel,150322-43-3,150322433,Effient,Efient,CS-747,CS747,"Prasugrel (Effient)",LY640315,LY-640315,"CS 747","Pcr 4099",CHEBI:87723,"Prasugrel, 98",Prasita,SMR002533665,1189919-49-0,1189919490,"Pras
ugrel (INN:BAN)",NCGC00188690-01,NCGC0018869001,NCGC00188690-02,NCGC0018869002,"HSDB 7995",Prasugrel/Ef,T0230,S1258}

> <pdid>
PD001686

> <targets>
{"P2 Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{6918456}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 22  0  0  0  0            999 V2000
   11.9385   -0.9482    0.0000 Br  0  0
   -1.8778    2.7573    0.0000 C   0  0
   -1.0947    1.4779    0.0000 N   0  0
    0.0000    0.6568    0.0000 C   0  0
   -0.6568   -0.6386    0.0000 C   0  0
   -1.8063   -1.3319    0.0000 C   0  0
   -0.8393    0.0000    0.0000 C   0  0
    0.9488    0.0000    0.0000 C   0  0
    1.8975   -0.8028    0.0000 C   0  0
    1.6421    0.6933    0.0000 C   0  0
    2.6654   -2.0798    0.0000 O   0  0
    4.1661   -2.0555    0.0000 C   0  0
    4.8945   -0.7443    0.0000 O   0  0
    4.9382   -3.3425    0.0000 C   0  0
    4.2098   -4.6537    0.0000 O   0  0
    6.4389   -3.3181    0.0000 C   0  0
    7.2125   -4.6033    0.0000 C   0  0
    8.7123   -4.5759    0.0000 C   0  0
    9.4385   -3.2634    0.0000 C   0  0
    8.6649   -1.9783    0.0000 C   0  0
    7.1652   -2.0056    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  4  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7751

> <plate>
1

> <well>
L07

> <supplier_cmpd_name>
Homatropine Bromide

> <ctcr_id>
131

> <supplier_cmpd_id>
S4025

> <smiles>
Br.CN1C2CCC1CC(C2)OC(=O)C(O)c3ccccc3

> <pd_targets>
{BLM,SMN1,TDP1,CHRM4,CHRM5,CHRM2,CHRM3,CHRM1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor",Reader,Hydrolase,"Family A G protein-coupled receptor","Methyl-lysine/arginine binding protein","Small molecule receptor (family A GPCR)","Tudor doma
in","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"DNA Repair","Metabolism of RNA","Signal Transduction","DNA Double-Strand Break Repair","Metabolism of non-coding RNA","Signaling by GPCR","Homology Directed Repair","snRNP Assembly","Nonhomologous E
nd-Joining (NHEJ)","GPCR ligand binding","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR
)","Amine ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CHRM1}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{S,"HOMATROPINE HYDROBROMIDE","DL-Homatropine hydrobromide","DLHomatropine hydrobromide","Isopto Homatropine",51-56-9,51569,SR-01000075900,SR01000075900,C16H21NO3.HBr,"Tropine mandelate hydrobromide",
"Homatropine HBr",homatropinhydrobromid,SCHEMBL41951,ARONIS24469,Tox21_500,Tox21500,Tox21-500,"Tox21 500",T0177,S4025,Prestw-62,"Homatropine Bromide","Homatropine hydrobromide (R,S)"}

> <pdid>
PD006610

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5821}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 38 40  0  0  1  0            999 V2000
    8.9999   -4.1240    0.0000 Cl  0  0
    6.4992   -0.7414    0.0000 C   0  0
    5.2010   -1.4929    0.0000 N   0  0
    3.8999   -0.7448    0.0000 C   0  0
    3.8977    0.7552    0.0000 O   0  0
    2.6010   -1.4966    0.0000 C   0  0  2  0  0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1953    1.5031    0.0000 O   0  0
   -5.1932    3.0031    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1953   -1.5031    0.0000 O   0  0
   -5.1932   -3.0031    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6060   -6.0003    0.0000 C   0  0
   -2.6060   -7.5003    0.0000 C   0  0
   -1.3070   -8.2503    0.0000 C   0  0
   -0.0080   -7.5003    0.0000 C   0  0
   -0.0079   -6.0003    0.0000 C   0  0
   -1.3071   -9.7511    0.0000 C   0  0
   -2.6056  -10.5019    0.0000 F   0  0
   -0.0078  -10.5008    0.0000 F   0  0
   -1.3064  -11.2511    0.0000 F   0  0
    2.6062   -2.9975    0.0000 C   0  0
    1.3096   -3.7521    0.0000 C   0  0
    1.3147   -5.2521    0.0000 C   0  0
    2.6163   -5.9977    0.0000 C   0  0
    3.9128   -5.2433    0.0000 C   0  0
    3.9077   -3.7433    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  6  4  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  2  0
 15 16  1  0
 16 17  1  0
 15 18  1  0
 18 19  2  0
 19 10  1  0
 19 20  1  0
 20  7  1  0
 20 21  1  1
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
 29 30  1  0
 29 31  1  0
 29 32  1  0
  6 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 33  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7752

> <plate>
1

> <well>
L08

> <supplier_cmpd_name>
Almorexant HCl

> <ctcr_id>
8209

> <supplier_cmpd_id>
S2160

> <smiles>
Cl.CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc3ccc(cc3)C(F)(F)F)c4ccccc4

> <pd_targets>
{HCRTR1,HCRTR2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Orexin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Orexin receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors","Orexin and neuropeptides FF and QRFP bind to their respectiv
e receptors"}

> <broad_targets>
{HCRTR1,HCRTR2}

> <broad_moa>
{"orexin receptor antagonist"}

> <synonyms>
{"Almorexant HCl","Almorexant hydrochloride",913358-93-7,913358937,"Almorexant (hydrochloride)",UNII-O4Z94D9A99,UNIIO4Z94D9A99,O4Z94D9A99,"act-078573 hydrochloride","act078573 hydrochloride","913358-9
3-7(Almorexant HCl),  871224-64-5 (Almorexant).","913358937(Almorexant HCl),  871224645 (Almorexant).",C29H32ClF3N2O3,SCHEMBL1935015,AOB87736,BC,T2613,S2160,Almorexant}

> <pdid>
PD046478

> <targets>
{OX Receptor,Orexin Receptor (OX Receptor)}

> <classes>
{GPCR & G Protein,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{25227440}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 17  0  0  0  0            999 V2000
   21.8999    0.3750    0.0000 Br  0  5
   19.3999    0.3750    0.0000 Br  0  5
    0.0007    0.0004    0.0000 C   0  0
    1.3000    0.7500    0.0000 N   0  3
    1.3000    2.2500    0.0000 C   0  0
    0.0011    1.5002    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0
    7.7999    0.0000    0.0000 C   0  0
    9.0999    0.7500    0.0000 C   0  0
   10.3999    0.0000    0.0000 C   0  0
   11.6999    0.7500    0.0000 C   0  0
   12.9999    0.0000    0.0000 C   0  0
   14.2999    0.7500    0.0000 C   0  0
   15.5999    0.0000    0.0000 N   0  3
   16.8992    0.7496    0.0000 C   0  0
   15.5999   -1.5000    0.0000 C   0  0
   16.8988   -0.7502    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
M  CHG  4   1  -1   2  -1   4   1  17   1
M  END
> <name>
Selleck_GPCR

> <id>
7753

> <plate>
1

> <well>
L09

> <supplier_cmpd_name>
Decamethonium Bromide

> <ctcr_id>
4663

> <supplier_cmpd_id>
S4072

> <smiles>
[Br-].[Br-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C

> <pd_targets>
{NFKB1,ACHE,CHRM1,HSD17B10,LMNA,CHRM2,CHRNA4,HRH3,KDM4E,CHRNB2,APEX1,CHRNA2,CHRNA1,CHRNB1,CHRND,CHRNE,CHRNG}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Membrane receptor","Other nuclear protein","Ion channel","Epigenetic regulator",Hydrolase,"Family A G protein-coupled receptor",Oxidoreductase,"Ligand-gated ion chan
nel",Eraser,"Small molecule receptor (family A GPCR)","Nicotinic acetylcholine receptor","Lysine demethylase","Monoamine receptor","Nicotinic acetylcholine receptor alpha subunit","Jumonji domain-cont
aining","Acetylcholine receptor","Histamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Acetylcholine turnover","G protein-coupled receptors","Ligand-gated ion channels","Chromatin modifying enzymes","Acetylcholine receptors (muscarinic)","Nicotinic ace
tylcholine receptors","Histamine receptors","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Immune System",Metabolism,"Signal Transduction","Cell Cycle","Neuronal System","DNA Repair","Cytokine Signaling in Immune system","Metabolism of lipids","Signaling by GPCR","Metabolism of amino acid
s and derivatives",Mitotic,"Transmission across Chemical Synapses","Base Excision Repair","Signaling by Interleukins","Phospholipid metabolism","GPCR ligand binding","Branched-chain amino acid catabol
ism","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Resolution of Abasic Sites (AP sites)","Interleukin-1 family signaling","Glycerophospholipid biosynthesis","Class A/1 
(Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Acetylcholine binding and downstream events","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Interleukin-1
 signaling","Synthesis of PC","Amine ligand-binding receptors","Mitotic Anaphase","Postsynaptic nicotinic acetylcholine receptors","PCNA-Dependent Long Patch Base Excision Repair","MAP3K8 (TPL2)-depen
dent MAPK1/3 activation","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Histamine receptors","Initia
tion of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CHRNA2,CHRNA3,CHRNA4,CHRNA6}

> <broad_moa>
{"cholinergic receptor antagonist"}

> <synonyms>
{"DECAMETHONIUM BROMIDE",541-22-0,541220,"Decamethonium dibromide","Decamethonium (Bromide)",Syncurine,Decacuran,"Decamethylene bis(trimethylammonium bromide)",UNII-55C6RK944K,UNII55C6RK944K,"Decameth
onium  bromide","Decamethylenebis(trimethylammonium br",T0818,S4072,1505991,Prestw-968,"Decamethonium bromide","Decamethonium Bromide"}

> <pdid>
PD004518

> <targets>
{AChR,nAChR}

> <classes>
{neuromuscular blocker,Neuronal Signaling,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{10921}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 40 42  0  0  0  0            999 V2000
    8.9635   -5.2628    0.0000 O   0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -0.0136   -6.0070    0.0000 N   0  0
   -0.0210   -7.5078    0.0000 S   0  0
   -1.3239   -8.2510    0.0000 O   0  0
   -1.3162   -6.7513    0.0000 O   0  0
    1.2746   -8.2655    0.0000 C   0  0
    1.2663   -9.7654    0.0000 C   0  0
    2.5611  -10.5226    0.0000 C   0  0
    3.8643   -9.7799    0.0000 C   0  0
    3.8726   -8.2799    0.0000 C   0  0
    2.5778   -7.5227    0.0000 C   0  0
    5.1599  -10.5375    0.0000 C   0  0
    5.1525  -12.0375    0.0000 C   0  0
    6.4628   -9.7943    0.0000 C   0  0
    6.4551  -11.2940    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 N   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -3.9020   -3.7404    0.0000 N   0  0
   -2.6004   -2.9949    0.0000 C   0  0
   -2.5984   -1.4941    0.0000 O   0  0
   -3.8966   -0.7411    0.0000 C   0  0
   -3.8946    0.7597    0.0000 C   0  0
   -5.1921    1.5123    0.0000 O   0  0
   -5.2095   -5.9863    0.0000 C   0  0
   -5.2172   -7.4864    0.0000 N   0  0
   -6.5200   -8.2298    0.0000 C   0  0
   -7.8152   -7.4733    0.0000 C   0  0
   -7.8076   -5.9733    0.0000 C   0  0
   -6.5048   -5.2298    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  2  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
 12 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 11  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 28 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 35  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7754

> <plate>
1

> <well>
L10

> <supplier_cmpd_name>
Bosentan Hydrate

> <ctcr_id>
57

> <supplier_cmpd_id>
S3051

> <smiles>
O.COc1ccccc1Oc2c(N[S](=O)(=O)c3ccc(cc3)C(C)(C)C)nc(nc2OCCO)c4ncccn4

> <pd_targets>
{EDNRB,EDNRA,ABCB11,NR1I2,RORC,FFP,ABCC4,ABCC3}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Transcription factor",Enzyme,"Family A G protein-coupled receptor","Primary active transporter","Nuclear receptor",Transferase,"Peptide receptor (family A GPCR)","ATP
-binding cassette","Nuclear hormone receptor subfamily 1","Short peptide receptor (family A GPCR)","ABCB subfamily","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1
 group F","ABCC subfamily","Endothelin receptor","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","ATP-binding cassette transporter family","Nuclear hormone receptors","Endothelin receptors","ABCB subfamily","1I. Vitamin D receptor-like recepto
rs","1F. Retinoic acid-related orphans","ABCC subfamily"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Metabolism of proteins","Gene expression (Transcription)",Hemostasis,"Signaling by GPCR","Metabolism of lipids","Post-translational protein modification","RNA Polyme
rase II Transcription","Platelet activation","signaling and aggregation","GPCR ligand binding","Metabolism of steroids",SUMOylation,"Generic Transcription Pathway","Response to elevated platelet cytos
olic Ca2+","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX3","Platelet degranulation","Pepti
de ligand-binding receptors","Synthesis of bile acids and bile salts","SUMOylation of intracellular receptors","RUNX3 Regulates Immune Response and Cell Migration","Recycling of bile acids and salts",
"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{EDNRA,EDNRB}

> <broad_moa>
{"endothelin receptor antagonist"}

> <synonyms>
{"bosentan monohydrate","Bosentan hydrate",157212-55-0,157212550,"Bosentan (hydrate)",UNII-Q326023R30,UNIIQ326023R30,"Bosentan (USAN:INN:BAN)",Q326023R30,C27H31N5O7S,"Ro 47-0203/029","Ro 470203/029","
Tracleer (TN)","Bosentan (USAN)","Bosentan hydrate (JAN)",MLS004774049,SCHEMBL,T6264,S3051,Bosentan,"Bosentan Hydrate"}

> <pdid>
PD009964

> <targets>
{"Endothelin Receptor","ETA Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{185462}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 29  0  0  1  0            999 V2000
    9.4504    6.4036    0.0000 C   0  0
    9.1445    4.9351    0.0000 C   0  0
   10.2636    3.9363    0.0000 C   0  0
   10.5691    5.4047    0.0000 C   0  0
    7.7193    4.4647    0.0000 N   0  0
    7.4132    2.9954    0.0000 C   0  0
    5.9880    2.5249    0.0000 C   0  0  2  0  0  0
    4.8689    3.5238    0.0000 O   0  0
    5.6819    1.0557    0.0000 C   0  0
    4.2567    0.5852    0.0000 O   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.9531   -1.9978    0.0000 N   0  0
    4.2010   -3.2956    0.0000 S   0  0
    2.7343   -2.9815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   14.3698    3.4294    0.0000 O   0  0
   14.3698    1.9294    0.0000 C   0  0
   13.0705    1.1798    0.0000 O   0  0
   15.6698    1.1794    0.0000 C   0  0
   16.9698    1.9294    0.0000 C   0  0
   16.9712    3.4302    0.0000 C   0  0
   15.6726    4.1810    0.0000 O   0  0
   18.2705    4.1798    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7755

> <plate>
1

> <well>
L11

> <supplier_cmpd_name>
Timolol Maleate

> <ctcr_id>
417

> <supplier_cmpd_id>
S4123

> <smiles>
CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Timolol maleate",26921-17-5,26921175,"Timolol maleate salt","(S)-Timolol maleate","(S)Timolol maleate",Blocadren,"Timolol hydrogen maleate",Timoptic,"(S)-Timolol (Maleate)","(S)Timolol (Maleate)","(
S)-Timolol hydrogen maleate","(S)Timolol hydrogen maleate",Timoptic-XE,TimopticXE,UNII-P8Y54F701R,UNIIP8Y54F701R,"26921-17-5 (maleate)","26921175 (maleate)",MLS000,T0475,S4123,Prestw-948,"Timolol Male
ate"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5281056}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 72 75  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 N   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4007    1.4818    0.0000 C   0  0
  -11.6971    0.7273    0.0000 C   0  0
  -11.6919   -0.7727    0.0000 C   0  0
  -12.9883   -1.5272    0.0000 F   0  0
  -10.3903   -1.5182    0.0000 C   0  0
   -9.0939   -0.7637    0.0000 C   0  0
   -6.4964   -0.7598    0.0000 C   0  0
   -7.7931   -1.5140    0.0000 C   0  0
   -7.7884   -3.0140    0.0000 C   0  0
   -6.4871   -3.7599    0.0000 N   0  0
   -6.4824   -5.2599    0.0000 C   0  0
   -5.1904   -3.0059    0.0000 C   0  0
   -5.1950   -1.5059    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   24.5745   -5.2570    0.0000 C   0  0
   24.5766   -3.7570    0.0000 C   0  0
   25.8770   -3.0093    0.0000 C   0  0
   23.2784   -3.0039    0.0000 C   0  0
   23.2806   -1.5031    0.0000 O   0  0
   21.9824   -0.7500    0.0000 C   0  0
   21.9823    0.7500    0.0000 C   0  0
   20.6833    1.5000    0.0000 C   0  0
   19.3843    0.7500    0.0000 C   0  0
   18.0830    1.4977    0.0000 C   0  0
   16.7843    0.7455    0.0000 N   0  0
   15.4830    1.4932    0.0000 C   0  0
   15.4804    2.9932    0.0000 O   0  0
   14.1843    0.7409    0.0000 N   0  0
   12.8830    1.4887    0.0000 C   0  0
   11.5843    0.7364    0.0000 C   0  0
   10.2826    1.4818    0.0000 C   0  0
    8.9862    0.7273    0.0000 C   0  0
    8.9914   -0.7727    0.0000 C   0  0
    7.6950   -1.5272    0.0000 F   0  0
   10.2930   -1.5182    0.0000 C   0  0
   11.5895   -0.7637    0.0000 C   0  0
   14.1869   -0.7598    0.0000 C   0  0
   12.8902   -1.5140    0.0000 C   0  0
   12.8949   -3.0140    0.0000 C   0  0
   14.1962   -3.7599    0.0000 N   0  0
   14.2009   -5.2599    0.0000 C   0  0
   15.4929   -3.0059    0.0000 C   0  0
   15.4883   -1.5059    0.0000 C   0  0
   19.3843   -0.7500    0.0000 C   0  0
   20.6833   -1.5000    0.0000 C   0  0
   32.2776    0.7416    0.0000 O   0  0
   32.2776   -0.7584    0.0000 C   0  0  2  0  0  0
   30.9776   -1.5084    0.0000 C   0  0  1  0  0  0
   30.9776   -3.0084    0.0000 O   0  0
   29.6776   -0.7584    0.0000 C   0  0
   29.6776    0.7416    0.0000 O   0  0
   28.3783   -1.5080    0.0000 O   0  0
   33.5776   -1.5084    0.0000 C   0  0
   33.5776   -3.0084    0.0000 O   0  0
   34.8769   -0.7588    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 16  1  0
 14 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 23  1  0
  9 30  1  0
 30 31  2  0
 31  6  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  2  0
 43 45  1  0
 45 46  1  0
 46 47  1  0
 47 48  2  0
 48 49  1  0
 49 50  2  0
 50 51  1  0
 50 52  1  0
 52 53  2  0
 53 47  1  0
 45 54  1  0
 54 55  1  0
 55 56  1  0
 56 57  1  0
 57 58  1  0
 57 59  1  0
 59 60  1  0
 60 54  1  0
 40 61  1  0
 61 62  2  0
 62 37  1  0
 64 63  1  1
 64 65  1  0
 65 66  1  1
 65 67  1  0
 67 68  1  0
 67 69  2  0
 64 70  1  0
 70 71  1  0
 70 72  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7756

> <plate>
1

> <well>
L12

> <supplier_cmpd_name>
Pimavanserin

> <ctcr_id>
8210

> <supplier_cmpd_id>
S8183

> <smiles>
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C3CCN(C)CC3)cc1.CC(C)COc4ccc(CNC(=O)N(Cc5ccc(F)cc5)C6CCN(C)CC6)cc4.O[C@H]([C@@H](O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Pimavanserin tartrate",UNII-NA83F1SJSR,UNIINA83F1SJSR,706782-28-7,706782287,Nuplazid,"ACP 103",ACP-103,ACP103,"706782-28-7 (tartrate)","706782287 (tartrate)",NA83F1SJSR,"Pimavanserin tartrate (USAN)
","Nuplazide (TN)","pimavanserin hemitartrate",DTXSID50220958,CHEBI:133014,HMS3886L06,HY-14557A,HY14557A,Pimavans,T6946,S8183,Pimavanserin}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{11672491}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 20  0  0  0  0            999 V2000
   12.9003   -0.3743    0.0000 Cl  0  0
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    7.7998   -2.9895    0.0000 C   0  0
    6.5010   -3.7399    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 12  1  0
 19 20  1  0
 20 21  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7757

> <plate>
1

> <well>
L13

> <supplier_cmpd_name>
MetoclopraMide HCl

> <ctcr_id>
6171

> <supplier_cmpd_id>
S4289

> <smiles>
Cl.CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC

> <pd_targets>
{CYP2D6,AMPC,CYP1A2,DRD2,RAB9A,HTR4,HTR3A,HTR3B,HTR2A,ADRA1A,ADRA1B,ADRA1D,DRD3,HTR2B,HTR2C,HTR3C,HTR3D,HTR3E,LMNA,ADRA2C,CHRM1,HTR6,ESR2,HTR1A,HTR1B,HTR1D,HTR1F,ADRA2A,ADRA2B,ALB,MPO,ALDH1A1,SLC22A1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Cytochrome P450",Hydrolase,"Family A G protein-coupled receptor","Cytochrome P450 family 2","Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","Cytochrom
e P450 family 2D","Cytochrome P450 family 1A","Monoamine receptor","Cytochrome P450 2D6","Cytochrome P450 1A1","Dopamine receptor","Ion channel","Other nuclear protein","Transcription factor","Secrete
d protein",Transporter,"Ligand-gated ion channel","Nuclear receptor",Oxidoreductase,"Electrochemical transporter","5HT3 receptor","Nuclear hormone receptor subfamily 3","SLC superfamily of solute carr
iers","Nuclear hormone receptor subfamily 3 group A","SLC22 family of organic cation and anion transporters","Serotonin receptor","Adrenergic receptor","Acetylcholine receptor","Nuclear hormone recept
or subfamily 3 group A member 2"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","CYP2 family: drug metabolising subset","CYP1 family","Dopamine receptors","Ion channels",Transporters,"Ligand-gated ion channels","N
uclear hormone receptors","1.-.-.- Oxidoreductases","SLC superfamily of solute carriers","5-Hydroxytryptamine receptors","5-HT<sub>3</sub> receptors",Adrenoceptors,"Acetylcholine receptors (muscarinic
)","Steroid hormone receptors","SLC22 family of organic cation and anion transporters","3A. Estrogen receptors","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Biological oxidations","Signaling by GPCR","Phase I - Functionalization of compounds","GPCR ligand binding","Cytochrome P450 - arranged by substrate type","Class A/1
 (Rhodopsin-like receptors)",Xenobiotics,"Amine ligand-binding receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Dopamine receptors",Disease,"Cell Cycle
","Neuronal System","Immune System","Transport of small molecules","Signaling by Rho GTPases","Infectious disease",Mitotic,"Transmission across Chemical Synapses","Intracellular signaling by second me
ssengers","Metabolism of lipids","Innate Immune System","SLC-mediated transmembrane transport","Rho GTPase cycle","Leishmania infection","M Phase","Neurotransmitter receptors and postsynaptic signal t
ransmission","PIP3 activates AKT signaling","Metabolism of steroids","ROS and RNS production in phagocytes","Transport of bile salts and organic acids","metal ions and amine compounds","RHOBTB GTPase 
Cycle","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Negative regulation of the PI3K/AKT network","Bile acid and bile salt metabolism","Events associated with phagocytoly
tic activity of PMN cells","Ethanol oxidation","Organic cation/anion/zwitterion transport","RHOBTB3 ATPase cycle","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase
",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Recycling of bile acids and salts","Organic cation transport","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","Nucle
ar Envelope (NE) Reassembly",Adrenoceptors,"Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CHRM1,DRD2,HTR3A,HTR3B,HTR4}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{"Metoclopramide Base","2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide","2Methoxy4amino5chloroN,Ndimethylaminoethyl)benzamide",AKOS015890642,A823256,4-amino-5-chloro-N-(2-diethylaminoethy
l)-2-methoxy-benzamide,4amino5chloroN(2diethylaminoethyl)2methoxybenzamide,"Metoclopramide hydrochloride",7232-21-5,7232215,Maxolon,"METOCLOPRAMIDE HCL",Meto,S4289,SAM002554911,1500410,Prestw-209,"Met
oclopraMide HCl",CPD000058471,"METOCLOPRAMIDE HYDROCHLORIDE","Metoclopramide monohydrochloride"}

> <pdid>
PD001072

> <targets>
{"Dopamine Receptor"}

> <classes>
{antiemetic,"Neuronal Signaling"}

> <pubchem_cids>
{657384,23659}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 16 18  0  0  0  0            999 V2000
    4.0411   -1.8007    0.0000 C   0  0
    3.2905   -3.0995    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.0390   -4.3998    0.0000 C   0  0
    1.6386   -5.7608    0.0000 C   0  0
    0.5081   -6.7467    0.0000 N   0  0
   -0.7789   -5.9762    0.0000 C   0  0
   -0.4438   -4.5141    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11  3  1  0
  3 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7758

> <plate>
1

> <well>
L15

> <supplier_cmpd_name>
Atipamezole

> <ctcr_id>
8211

> <supplier_cmpd_id>
S4650

> <smiles>
CCC1(Cc2ccccc2C1)c3c[nH]cn3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Atipamezole,104054-27-5,104054275,Antisedan,"MPV 1248",MPV-1248,MPV1248,"4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-1h-imidazole","4(2ethyl2,3dihydro1hinden2yl)1himidazole","1H-Imidazole, 4-(2-ethyl-2,3-d
ihydro-1H-inden-2-yl)-","1HImidazole, 4(2ethyl2,3dihydro1Hinden2yl)",4-(2-Ethyl-2-indanyl)imidazole,4(2Ethyl2indanyl)imidazole,UNII-03N9U5JAF6,UNII03N9U5JAF6,5-(2-ethyl-2,5(2ethyl2,3-dihydro-1H-inden-
2,3dihydro1Hinden2,T6765,S4650,"Atipamezole hydrochloride"}

> <pdid>

> <targets>
{"Adrenergic receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{71310}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 31  0  0  0  0            999 V2000
    6.3830   -0.4464    0.0000 Cl  0  0
    4.9053   -0.7043    0.0000 C   0  0
    4.3898   -2.1129    0.0000 C   0  0
    2.9121   -2.3708    0.0000 C   0  0
    1.9500   -1.2200    0.0000 C   0  0
    2.4655    0.1886    0.0000 C   0  0
    3.9432    0.4465    0.0000 C   0  0
    0.4600   -1.4800    0.0000 C   0  0
   -1.4000   -1.8100    0.0000 C   0  0
   -2.8500   -1.5200    0.0000 C   0  0
   -4.4800   -2.2100    0.0000 C   0  0
   -2.6000   -2.1800    0.0000 C   0  0
   -2.5400   -1.3600    0.0000 C   0  0
   -1.2300   -0.3200    0.0000 C   0  0
   -2.8500   -0.7400    0.0000 C   0  0
    0.4900   -0.6700    0.0000 C   0  0
   -1.2964    1.1627    0.0000 C   0  0
   -2.6255    1.8579    0.0000 O   0  0
   -0.0293    1.9670    0.0000 N   0  0
   -0.0913    3.4665    0.0000 C   0  0
    1.1758    4.2708    0.0000 C   0  0
    1.1160    5.7697    0.0000 C   0  0
    2.3841    6.5709    0.0000 C   0  0
    3.7120    5.8734    0.0000 N   0  0
    3.7719    4.3746    0.0000 C   0  0
    2.5039    3.5733    0.0000 C   0  0
   -1.1200   -2.5800    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
 14 16  1  0
 16  8  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 12 27  1  0
 27  8  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7759

> <plate>
1

> <well>
L17

> <supplier_cmpd_name>
ABC294640

> <ctcr_id>
8212

> <supplier_cmpd_id>
S7174

> <smiles>
Clc1ccc(cc1)C23CC4CC(CC(C4)(C2)C(=O)NCc5ccncc5)C3

> <pd_targets>
{SPHK2}

> <pathway_gtopdb>
{Enzyme}

> <pathway_chembl>
{Enzymes,"Sphingosine 1-phosphate turnover","Sphingosine kinase"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Sphingolipid metabolism","Sphingolipid de novo biosynthesis"}

> <broad_targets>
{SPHK2}

> <broad_moa>
{"sphingosine kinase inhibitor"}

> <synonyms>
{ABC294640,915385-81-8,915385818,Opaganib,ABC-294640,"ABC 294640",3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide,3(4chlorophenyl)N(pyridin4ylmethyl)adamantane1carboxamide,CHEMBL2158
685,UNII-DRG21OQ517,UNIIDRG21OQ517,DRG21OQ517,"Opaganib (ABC294640)",Yeliva,ABC294640Opaganib,GTPL6624,SCHEMBL1548333,CHEBI:12496,T6750,S7174}

> <pdid>
PD021509

> <targets>
{"S1P Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{15604015}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 33 37  0  0  0  0            999 V2000
    2.5447   -7.0216    0.0000 F   0  0
    1.7974   -5.7210    0.0000 C   0  0
    0.2974   -5.7184    0.0000 F   0  0
    1.0449   -7.0186    0.0000 F   0  0
    2.5497   -4.4224    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 N   0  0
    2.5951    3.0039    0.0000 C   0  0
    3.8915    3.7585    0.0000 C   0  0
    3.8863    5.2585    0.0000 C   0  0
    2.5847    6.0040    0.0000 N   0  0
    2.5764    7.5048    0.0000 C   0  0
    1.2730    8.2489    0.0000 C   0  0
    1.2625    9.7489    0.0000 C   0  0
   -0.0417   10.4898    0.0000 C   0  0
   -1.3355    9.7309    0.0000 C   0  0
   -2.7644   10.1845    0.0000 N   0  0
   -3.6377    8.9649    0.0000 C   0  0
   -2.7476    7.7575    0.0000 C   0  0
   -1.3251    8.2309    0.0000 C   0  0
   -0.0209    7.4899    0.0000 C   0  0
   -5.1359    8.9545    0.0000 C   0  0
   -6.6358    8.9442    0.0000 N   0  0
    1.2883    5.2495    0.0000 C   0  0
    1.2934    3.7495    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 S   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 19  1  0
 23 24  2  0
 24 16  1  0
 21 25  1  0
 25 26  3  0
 14 27  1  0
 27 28  1  0
 28 11  1  0
  9 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32  8  1  0
 32 33  1  0
 33  6  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7760

> <plate>
1

> <well>
L19

> <supplier_cmpd_name>
MI-136

> <ctcr_id>
8213

> <supplier_cmpd_id>
S7815

> <smiles>
FC(F)(F)Cc1cc2c(NC3CCN(Cc4ccc5[nH]c(cc5c4)C#N)CC3)ncnc2s1

> <pd_targets>
{MEN1,KMT2A}

> <pathway_gtopdb>
{"Unclassified protein","Epigenetic regulator",Reader,Bromodomain}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","SMAD2/SMAD3:SMAD4 heterotrimer regula
tes transcription"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{I13,MI-136,MI136,1628316-74-4,1628316744,CHEMBL3780497,SCHEMBL16030456,BCP20862,EX-A2339,EXA2339,BDBM50156121,s7815,AKOS027423555,"MI 136; MI136",ZINC220641923,CCG-269451,CCG269451,CS-5526,CS5526,AK4
75093,BS-16079,BS16079,HY-19319,HY19319,Q27454240,3XY,T6889,S7815}

> <pdid>
PD071600

> <targets>
{"Androgen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{86297077}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 23  0  0  0  0            999 V2000
    5.0987    2.2518    0.0000 Br  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 S   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -1.2935    3.7495    0.0000 C   0  0
   -1.2883    5.2495    0.0000 C   0  0
   -2.5848    6.0040    0.0000 C   0  0
   -3.8864    5.2585    0.0000 C   0  0
   -3.8915    3.7585    0.0000 C   0  0
   -5.1938    3.0126    0.0000 N   0  0
   -5.2015    1.5126    0.0000 C   0  0
   -6.5043    0.7691    0.0000 C   0  0
   -7.7996    1.5257    0.0000 N   0  0
   -7.7920    3.0257    0.0000 C   0  0
   -6.4892    3.7691    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 14  1  0
  6 20  1  0
 20 21  1  0
 20 22  2  0
 22  3  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7761

> <plate>
1

> <well>
L21

> <supplier_cmpd_name>
Vortioxetine (Lu AA21004) HBr

> <ctcr_id>
883

> <supplier_cmpd_id>
S8021

> <smiles>
Br.Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1

> <pd_targets>
{HTR6,ADRB1,SLC6A4,HTR1D,HTR1B,HTR1A,HTR7,HTR2A,HTR3A,ADRB2,HTR5A,HTR2C,SLC6A3,HRH1,CYP2C9,CYP3A4,CYP2D6,HRH2,SLC6A2}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Ion channel",Enzyme,"Family A G protein-coupled receptor","Electrochemical transporter","Ligand-gated ion channel","Cytochrome P450","Small molecule receptor (family 
A GPCR)","SLC superfamily of solute carriers","5HT3 receptor","Cytochrome P450 family 2","Cytochrome P450 family 3","Monoamine receptor","SLC06 neurotransmitter transporter family","Cytochrome P450 fa
mily 2C","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Serotonin receptor","Adrenergic receptor","Histamine receptor","Cytochrome P450 2C9","Cytochrome P450 3A4","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,Transporters,"Ion channels",Enzymes,"G protein-coupled receptors","SLC superfamily of solute carriers","Ligand-gated ion channels","Cytochrome P450","5-Hydroxytryptamine receptors",Adrenoce
ptors,"SLC6 neurotransmitter transporter family","5-HT<sub>3</sub> receptors","Histamine receptors","CYP2 family: drug metabolising subset","CYP3 family","Monoamine transporter subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction",Metabolism,"Infectious disease","Transmission across Chemical Synapses","Signaling by GPCR","Disorders of transmembrane transporters","Biological oxida
tions","Metabolism of lipids","Leishmania infection","Neurotransmitter clearance","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","SLC transporter disorders","P
hase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania parasite growth and survival","Serotonin clearance from the synaptic cleft","Class A/1 
(Rhodopsin-like receptors)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Defective SLC6A2 causes
 orthostatic intolerance (OI)","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors",Xenobiotics,"Biosynthesis of maresins","ADORA2B mediated anti-infla
mmatory cytokines production","Serotonin receptors","Histamine receptors","CYP2E1 reactions","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{HTR1A,HTR1B,HTR2A,HTR2C,HTR3A,HTR5A,HTR6,HTR7,SLC6A4}

> <broad_moa>
{"serotonin receptor agonist","serotonin receptor antagonist"}

> <synonyms>
{"Vortioxetine hydrobromide",960203-27-4,960203274,"Vortioxetine HBr","Vortioxetine (Lu AA21004) HBr","Vortioxetine (hydrobromide)",UNII-TKS641KOAY,UNIITKS641KOAY,Brintellix,Trintellix,TKS641KOAY,"Lu 
AA21004 (HBr)","960203-27-4 (HBr)","960203274 (HBr)",CHEBI:76015,B,T2395L,T2395,S8021,Vortioxetine}

> <pdid>
PD012584

> <targets>
{5-HT Receptor,Serotonin Transporter}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{56843850}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 19  0  0  0  0            999 V2000
    8.8915   -4.9368    0.0000 C   0  0
    7.7740   -3.9362    0.0000 C   0  0
    6.3476   -4.4031    0.0000 O   0  0
    5.2295   -3.4020    0.0000 C   0  0
    5.5377   -1.9340    0.0000 O   0  0
    3.8056   -3.8679    0.0000 C   0  0
    3.3372   -5.2929    0.0000 C   0  0
    1.8372   -5.2877    0.0000 N   0  0
    1.3786   -3.8595    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  6  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7762

> <plate>
1

> <well>
M03

> <supplier_cmpd_name>
Etomidate

> <ctcr_id>
3429

> <supplier_cmpd_id>
S1329

> <smiles>
CCOC(=O)c1cncn1C(C)c2ccccc2

> <pd_targets>
{GABRA1,GABRB2,GABRG2,ABCB11,CYP11B1,CHRNA1,CHRNB1,CHRND,CHRNG,CYP11B2,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB3,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,ADRA2B,LEF,CYP1A2,RORC,CYP3A4,CYP2C19,FFP,
LMNA,CYP2C9,AMPC}

> <pathway_gtopdb>
{"Ion channel",Transporter,Enzyme,"Membrane receptor","Transcription factor","Other nuclear protein","Ligand-gated ion channel","Primary active transporter","Cytochrome P450","Family A G protein-coupl
ed receptor",Protease,"Nuclear receptor",Transferase,Hydrolase,"GABA-A receptor","ATP-binding cassette","Cytochrome P450 family 11","Nicotinic acetylcholine receptor","Small molecule receptor (family 
A GPCR)","Metallo protease","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Cytochrome P450 family 2","ABCB subfamily","Cytochrome P450 family 11B","Nicot
inic acetylcholine receptor alpha subunit","Monoamine receptor","Metallo protease MAE clan","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cyto
chrome P450 family 2C","Cytochrome P450 11B1","Cytochrome P450 11B2","Adrenergic receptor","Metallo protease M34 family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","
Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 2C9"}

> <pathway_chembl>
{Transporters,Enzymes,"Ion channels",Receptors,"ATP-binding cassette transporter family","Cytochrome P450","Ligand-gated ion channels","G protein-coupled receptors","Nuclear hormone receptors","ABCB s
ubfamily",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","GABA<sub>A</sub> receptors",Adrenoceptors,"CYP1 family","1F. Retinoic acid-related orphans","CYP3 family","CYP2 family: drug metabolising subset
"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Signal Transduction",Disease,"Gene expression (Transcription)","Cell Cycle","Metabolism of lipids","Biological oxidations","Transmission across Chemical Synapses","Signa
ling by GPCR","Infectious disease","RNA Polymerase II Transcription",Mitotic,"Metabolism of steroids","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal tra
nsmission","GPCR ligand binding","Uptake and actions of bacterial toxins","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Bile acid and bile salt
 metabolism","Cytochrome P450 - arranged by substrate type","GABA receptor activation","Class A/1 (Rhodopsin-like receptors)","Uptake and function of anthrax toxins","Transcriptional regulation by RUN
X3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Synthesis of bile acids and bile salts","Endogenous sterols","Amine ligand-binding receptors",Xenobiotics,"RUNX3 Regulates Immu
ne Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",Adrenoceptors,"Aromatic amines can be N-hydroxylate
d or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA2B,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ}

> <broad_moa>
{"GABA receptor modulator"}

> <synonyms>
{Etomidate,33125-97-2,33125972,Amidate,Ethnor,"Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate","Ethyl 1(1phenylethyl)1Himidazole5carboxylate",Absele,15301-65-2,15301652,C14H16N2O2,Radenarcon,"1H-I
midazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)-","1HImidazole5carboxylic acid, 1(1phenylethyl), ethyl ester, (R)","Amidate (pharmaceutical)",MLS000034952,S,T1089,S1329,SAM002548930,1
505599,CPD000010931,ETOMIDATE}

> <pdid>
PD000355

> <targets>
{"GABA Receptor"}

> <classes>
{sedative,"Neuronal Signaling"}

> <pubchem_cids>
{36339}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 20  0  0  1  0            999 V2000
    6.4995   -3.7442    0.0000 O   0  0
    5.1993   -2.9963    0.0000 C   0  0
    3.9014   -3.7484    0.0000 C   0  0
    2.6012   -3.0004    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    3.8967   -0.7484    0.0000 C   0  0
    5.1969   -1.4963    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  8  5  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 11  1  0
 17 18  1  0
 18  8  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7763

> <plate>
1

> <well>
M04

> <supplier_cmpd_name>
Equol

> <ctcr_id>
7209

> <supplier_cmpd_id>
S2450

> <smiles>
Oc1ccc(cc1)[C@H]2COc3cc(O)ccc3C2

> <pd_targets>
{AR,ESR2}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone recepto
r subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group A member 2"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction","RNA Polymerase II Transcription","Intracellular signaling by second messengers","Generic Transcription Pathway","PIP3 activates AKT signaling"
,"Transcriptional regulation by RUNX2","Negative regulation of the PI3K/AKT network","RUNX2 regulates bone development",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","RUNX2 regulates osteoblast dif
ferentiation"}

> <broad_targets>
{ESR1,ESR2}

> <broad_moa>
{"estrogen receptor agonist"}

> <synonyms>
{Equol,531-95-3,531953,(S)-3-(4-Hydroxyphenyl)chroman-7-ol,(S)3(4Hydroxyphenyl)chroman7ol,(S)-Equol,(S)Equol,(-)-(S)-Equol,()(S)Equol,(-)-Equol,()Equol,S-Equol,SEquol,"(S)-3,4-Dihydro-3-(4-hydroxyphen
yl)-2H-1-benzopyran-7-ol","(S)3,4Dihydro3(4hydroxyphenyl)2H1benzopyran7ol","4',7-Isoflavandiol","4',7Isoflavandiol","4',7-Dihydroxyisoflavan","4',7Dihydroxyisoflavan",UNII-2T6D2HPX7Q,UNII2T6D2HPX7Q,2H
-1-Benzopyran-7-ol,2H1Benzopyran7ol,3,4-dihydro,4dihydro,S2450}

> <pdid>
PD010715

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{91469}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 23  0  0  0  0            999 V2000
    9.9857   -0.0431    0.0000 H   0  3
    7.4857   -0.0431    0.0000 Cl  0  5
    4.9852    2.6764    0.0000 C   0  0
    3.8856    1.6562    0.0000 N   0  0
    4.2194    0.1938    0.0000 C   0  0
    3.1198   -0.8265    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.4522    2.0983    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  7  1  0
 22 17  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7764

> <plate>
1

> <well>
M05

> <supplier_cmpd_name>
Mianserin HCl

> <ctcr_id>
961

> <supplier_cmpd_id>
S1382

> <smiles>
[H+].[Cl-].CN1CCN2C(C1)c3ccccc3Cc4ccccc24

> <pd_targets>
{ADRA1A,ADRA2A,TP53,CYP3A4,HTR6,SLC6A4,HTR7,HTR1B,DRD3,TYR1,HRH1,DRD2,ADRA2C,FFP,HTR2A,HTR2C,CHRM5,ADRA1B,ADRA1D,ADRA2B,KMT2A,MEN1,PMP22,HTR1D,HTR1A,HTR1E,HRH2,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,HTR2B,BLM,
ALD,HPGD,SCN1A,SCN2A,SCN3A,DRD4,HTT,SLC6A2,ABCB11,HTR1F,LMNA,ALDH1A1,LPAR1,CHRM2,CHRM3,CHRM4,CHRM1,HRH4,OPRK1,SLC6A3,DRD1,DRD5,TSHR,CYP2D6,CYP2C9,CYP1A2,KDM4E,CYP2C19}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor",Enzyme,Transporter,"Epigenetic regulator","Unclassified protein","Ion channel","Other nuclear protein","Family A G protein-coupled receptor","Cytochrome P45
0","Electrochemical transporter",Transferase,Reader,"Ligand-gated ion channel","Voltage-gated ion channel","Primary active transporter",Oxidoreductase,"Small molecule receptor (family A GPCR)","Cytoch
rome P450 family 3","SLC superfamily of solute carriers",Bromodomain,"5HT3 receptor","Voltage-gated sodium channel","ATP-binding cassette","Peptide receptor (family A GPCR)","Monoamine receptor","Cyto
chrome P450 family 3A","SLC06 neurotransmitter transporter family","ABCB subfamily","Lipid-like ligand receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Adrenergic receptor","Cytochr
ome P450 3A4","Serotonin receptor","Dopamine receptor","Trace amine receptor","Histamine receptor","Acetylcholine receptor","EDG receptor","Opioid receptor",Eraser,"Cytochrome P450 family 2","Cytochro
me P450 family 1","Lysine demethylase","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Jumonji domain-containing","Cytochrome P450 2D6","Cy
tochrome P450 2C9","Cytochrome P450 1A1","Cytochrome P450 2C19"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Eicosanoid turnover","ATP-binding cassette transporter family","Lig
and-gated ion channels","CYP3 family","5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","Dopamine receptors","Histamine receptors",Adrenoceptors,"Acetylcholine receptors (musc
arinic)","Prostaglandin synthases","ABCB subfamily","5-HT<sub>3</sub> receptors","Lysophospholipid (LPA) receptors","Opioid receptors","Monoamine transporter subfamily","Chromatin modifying enzymes","
Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","CYP1 family","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,"Neuronal System","Signal Transduction","Developmental Biology","DNA Repair","Gene expression (Transcription)","Cell Cycle Checkpoints","Metabolism of lipids","Infecti
ous disease","Transmission across Chemical Synapses","Signaling by GPCR","Nervous system development","DNA Double-Strand Break Repair","RNA Polymerase II Transcription",Mitotic,"Biological oxidations"
,"Disorders of transmembrane transporters","G1/S DNA Damage Checkpoints","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Neurotransmitter clearance","GPCR ligand bi
nding","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Generic Transcription Pathway","Metabolism of steroids","M Phase","Phase I - Functionalization of co
mpounds","SLC transporter disorders","p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Serotonin clearance from the synaptic clef
t","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional Regulation by MECP2","Bile acid and bile salt metabolism","Mito
tic Metaphase and Anaphase","Ethanol oxidation","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","p53-Dependent G1 DNA Damage Re
sponse","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","HDR through Homologous Recombination (HRR)","Biosynthesis of D
-series resolvins","Regulation of MECP2 expression and activity","Synthesis of bile acids and bile salts","Mitotic Anaphase","Lysosphingolipid and LPA receptors","MECP2 regulates neuronal receptors an
d channels","Stabilization of p53","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","Dopamine receptors","Histamine receptors",Adreno
ceptors,"Muscarinic acetylcholine receptors","Homologous DNA Pairing and Strand Exchange","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","Aut
odegradation of the E3 ubiquitin ligase COP1","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","Cytochrome P450 - arranged by substra
te type",Xenobiotics,"CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,HRH1,HRH2,HTR2A,HTR2B,HTR2C,HTR6,HTR7}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{"Mianserin hydrochloride",21535-47-7,21535477,"Mianserin HCl","Mianserine hydrochloride",Tolvon,"ORG GB 94","Mianserin (hydrochloride)","mianserine HCl",MLS000069681,Athymil,Lerivon,SMR000058472,Bolv
idon,MFCD00055072,Tolvin,CHEBI:31843,S,T0783,S1382,2300292,Prestw-99,"MIANSERIN HYDROCHLORIDE"}

> <pdid>
PD009326

> <targets>
{Others}

> <classes>
{"Neuronal Signaling","5HT antagonist"}

> <pubchem_cids>
{68551,657192}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 14 15  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1065    0.0000    0.0000 N   0  0
   -2.7248   -1.2135    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13  8  2  0
 13 14  1  0
 14  5  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7765

> <plate>
1

> <well>
M06

> <supplier_cmpd_name>
Pramipexole

> <ctcr_id>
6377

> <supplier_cmpd_id>
S2460

> <smiles>
CCCN[C@H]1CCc2nc(N)sc2C1

> <pd_targets>
{DRD3,DRD2,SIGMAR1,DRD4,DRD1,DRD5,HTR1A,ADRA2A,HTR2A,HTR7,ADRA2C,HRH2,ADRB2,HTR1B,ADRA2B}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Dopamine receptor","Serotonin receptor","Adrenergic receptor","Histamine rece
ptor"}

> <pathway_chembl>
{Receptors,"Other protein targets","G protein-coupled receptors","Sigma receptors","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","SARS-CoV Infections","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Potential therapeutic
s for SARS","Leishmania parasite growth and survival","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Dopamine receptors","Serotonin receptors",A
drenoceptors,"ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A,HTR1B,HTR1D,HTR2A,HTR2B,HTR2C}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{pramipexole,104632-26-0,104632260,(-)-Pramipexole,()Pramipexole,Sifrol,Mirapexin,Pramipexol,"(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo(d)thiazole-2,6-diamine","(S)N6Propyl4,5,6,7tetrahydrobenzo(d)thiazol
e2,6diamine",Pramipexolum,(S)-Pramipexole,(S)Pramipexole,Mirapex,SUD919CL2Y,U-98528E,U98528E,(S)-2-Amino-4,(S)2Amino4,5,6,7-tetrahydro-6-(propylamino)benzoth,7tetrahydro6(propylamino)benzoth,T1476,S24
60,SAM001247006,Prestw-1316,Pramipexole,CPD000449298}

> <pdid>
PD002907

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{119570}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 31  0  0  0  0            999 V2000
    5.6484   -0.2523    0.0000 Na  0  3
    3.1476   -0.7184    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.5283    2.0123    0.0000 N   0  0
   -3.9246    1.4620    0.0000 C   0  0
   -5.0999    2.3954    0.0000 C   0  0
   -6.4962    1.8451    0.0000 C   0  0
   -7.6715    2.7784    0.0000 C   0  0
   -9.0678    2.2281    0.0000 C   0  0
  -10.2431    3.1615    0.0000 C   0  0
  -11.6394    2.6112    0.0000 C   0  0
  -11.8604    1.1276    0.0000 O   0  5
  -12.8141    3.5440    0.0000 O   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1695   -0.6090    0.0000 C   0  0
   -3.7175   -2.0053    0.0000 C   0  0
   -2.7822   -3.1781    0.0000 C   0  0
   -3.3302   -4.5744    0.0000 Cl  0  0
   -1.2990   -2.9545    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 S   0  0
   -0.1320   -2.7707    0.0000 O   0  0
    2.2485   -1.6245    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 10 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 21  1  0
 27 28  1  0
 28  3  1  0
 28 29  2  0
 28 30  2  0
M  CHG  2   1   1  19  -1
M  END
> <name>
Selleck_GPCR

> <id>
7766

> <plate>
1

> <well>
M07

> <supplier_cmpd_name>
Tianeptine sodium

> <ctcr_id>
1640

> <supplier_cmpd_id>
S1436

> <smiles>
[Na+].CN1c2ccccc2C(NCCCCCCC([O-])=O)c3ccc(Cl)cc3[S]1(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{30123-17-2,30123172,"30123 17 2","Tianeptine sodium salt",Stablon,Coaxil,Tatinol,"Tianeptine (sodium salt)","Tianeptine sodium salt hydrate","(+)-Tianeptine Monosodium Salt","(+)Tianeptine Monosodium
 Salt","(+) Tianeptine Monosodium Salt",S-1574,S1574,"S 1574",169293-32-7,169293327,"169293 32 7",C21H24ClN2NaO4S,UNII-7LI031265R,UNII7LI031265R,"UNII 7LI031265R","30123-17-2 (sodium)","30123172 (sodi
um)","30123 17 2 (sodium)",7LI,T2402,S1436,"Tianeptine sodium"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{23663953}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 20  0  0  0  0            999 V2000
    8.6607   -0.5175    0.0000 H   0  3
    6.1607   -0.5175    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 C   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.4469   -5.2297    0.0000 N   0  0
    2.9152   -5.5365    0.0000 C   0  0
    3.6607   -4.2349    0.0000 C   0  0
    2.6532   -3.1236    0.0000 N   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2985    3.7517    0.0000 C   0  0
   -1.2993    3.7504    0.0000 C   0  0
   -0.0007    4.5008    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  2  0
 11  4  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
  6 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7767

> <plate>
1

> <well>
M08

> <supplier_cmpd_name>
Oxymetazoline hydrochloride

> <ctcr_id>
343

> <supplier_cmpd_id>
S2495

> <smiles>
[H+].[Cl-].Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C

> <pd_targets>
{CYP3A4,CYP2D6,CYP1A2,ADRA1A,ADRA2A,ADRA2B,ADRA2C,ADRA1B,ADRA1D,LMNA,NISCH,TSHR,HTR1A,HTR7,HTR1B,HTR1D,CHRM1,HTR1E,DRD2,HTR2A,HTR2B,LEF,SLC22A1,KMT2A,MEN1,HTR2C,PMP22,BLM,NPSR1,IMPA1,HTR6,CHRM4,CHRM5}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other nuclear protein","Other cytosolic protein",Transporter,"Epigenetic regulator","Unclassified protein","Cytochrome P450","Family A G protein-coupled receptor",Protease
,"Electrochemical transporter",Reader,Hydrolase,"Cytochrome P450 family 3","Cytochrome P450 family 2","Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","Peptide receptor (family A G
PCR)","Metallo protease","SLC superfamily of solute carriers",Bromodomain,"Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Monoamine receptor","Glycohormone recepto
r","Metallo protease MAE clan","SLC22 family of organic cation and anion transporters","Short peptide receptor (family A GPCR)","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 1A1","Adren
ergic receptor","Serotonin receptor","Acetylcholine receptor","Dopamine receptor","Metallo protease M34 family","Neuropeptide receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Inositol phosphate turnover","CYP3 family","CYP2 family: drug metabolising subset"
,"CYP1 family",Adrenoceptors,"Glycoprotein hormone receptors","5-Hydroxytryptamine receptors","Acetylcholine receptors (muscarinic)","Dopamine receptors","SLC22 family of organic cation and anion tran
sporters","Neuropeptide S receptor","Inositol monophosphatase","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Cell Cycle",Disease,"Transport of small molecules","Developmental Biology","DNA Repair","Metabolism of lipids","Biological oxidations","Signaling by GPCR",Mitotic,"I
nfectious disease","SLC-mediated transmembrane transport","Nervous system development","DNA Double-Strand Break Repair","Inositol phosphate metabolism","Biosynthesis of specialized proresolving mediat
ors (SPMs)","Phase I - Functionalization of compounds","GPCR ligand binding","M Phase","Leishmania infection","Uptake and actions of bacterial toxins","Transport of bile salts and organic acids","meta
l ions and amine compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Synthesis of IP2",IP,"and Ins in the cytosol","Biosynthesis of DHA-derived SPMs
","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Uptake and function of anthrax toxin
s","Organic cation/anion/zwitterion transport","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Biosynthesis of maresins",Xenobiotics,"Amine ligand-binding receptors","Mi
totic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Organic cation transport","HDR through Homologous Recombination (HRR)","Biosynthesis of maresin-like SPMs","CYP2E1
 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Serotonin rec
eptors","Muscarinic acetylcholine receptors","Dopamine receptors","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pa
iring and strand exchange"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,HTR1B,HTR1D,HTR2C}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{AKOS015896004,A816594,"Oxymetazoline hydrochloride","Oxymetazoline HCl",2315-02-8,2315028,Afrazine,Ocuclear,"Afrin hydrochloride","Oxymetazoline (hydrochloride)","Sch 9384","Vicks Sinex",UNII-K89MJ0S
5VY,UNIIK89MJ0S5VY,K89MJ0S5VY,MLS000038040,CHEBI:,T0252,S2495,1500453,Prestw-224,"OXYMETAZOLINE HYDROCHLORIDE"}

> <pdid>
PD009632

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"adrenergic agonist","nasal decongestant","Neuronal Signaling"}

> <pubchem_cids>
{51066582,66259,43834307}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 28  0  0  0  0            999 V2000
   10.3802    3.0257    0.0000 C   0  0
   10.3875    1.5257    0.0000 N   0  0
   11.6905    0.7825    0.0000 C   0  0
    9.0919    0.7681    0.0000 C   0  0
    9.0971   -0.7319    0.0000 C   0  0
    7.8007   -1.4864    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 N   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 F   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 F   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.4939    0.7591    0.0000 C   0  0
    7.7903    1.5136    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 12  1  0
 24 17  1  0
  7 25  1  0
 25 26  2  0
 26  4  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7768

> <plate>
1

> <well>
M09

> <supplier_cmpd_name>
SB408124

> <ctcr_id>
5805

> <supplier_cmpd_id>
S1545

> <smiles>
CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1

> <pd_targets>
{KDM4E,MAPT,CYP2C19,LEF,RORC,CYP2D6,CYP3A4,CYP1A2,HCRTR1,CYP2C9,HCRTR2,MAPK1,KMT2A,MEN1,HTR2B,FFP}

> <pathway_gtopdb>
{"Epigenetic regulator","Other cytosolic protein",Enzyme,"Transcription factor","Membrane receptor",Eraser,"Cytochrome P450",Protease,"Nuclear receptor","Family A G protein-coupled receptor",Kinase,Re
ader,Transferase,"Lysine demethylase","Cytochrome P450 family 2","Metallo protease","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Cytochrome P450 family 1","Peptide receptor (fami
ly A GPCR)","Small molecule receptor (family A GPCR)","Cysteine protease","Protein Kinase",Bromodomain,"Jumonji domain-containing","Cytochrome P450 family 2C","Metallo protease MAE clan","Nuclear horm
one receptor subfamily 1 group F","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Short peptide receptor (family A GPCR)","Monoamine receptor","Cysteine protease C
A clan","CMGC protein kinase group","Cytochrome P450 2C19","Metallo protease M34 family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome
 P450 1A1","Orexin receptor","Cytochrome P450 2C9","Dopamine receptor","Cysteine protease C1A family","CMGC protein kinase MAPK family","Serotonin receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","Cytochrome P450","Nuclear hormone receptors","G protein-coupled receptors","Kinases (EC 2.7.x.x)","1.14.11.- Histone demethylases","CYP2 family: drug 
metabolising subset","1F. Retinoic acid-related orphans","CYP3 family","CYP1 family","Orexin receptors","Dopamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","5-Hydroxytryptamine recept
ors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System",Metabolism,Disease,"Gene expression (Transcription)","Signal Transduction","Immune System","Transmission across Chemical Synapses","Biological oxidations","Infectious disease","RNA 
Polymerase II Transcription","Metabolism of lipids","Signaling by GPCR","Innate Immune System","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compoun
ds","Uptake and actions of bacterial toxins","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand binding","Leishmania infection","Toll-like Recepto
r Cascades","Activation of NMDA receptors and postsynaptic events","Cytochrome P450 - arranged by substrate type","Uptake and function of anthrax toxins","Transcriptional regulation by RUNX3","Biosynt
hesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade","Post NMDA receptor activation events",Xenobiotics,"RU
NX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Peptide ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","MyD88 cascade init
iated on plasma membrane","Amine ligand-binding receptors","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-
dealkylated by CYP1A2","Orexin and neuropeptides FF and QRFP bind to their respective receptors","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","Serotonin receptors"
,"MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{HCRTR1,HCRTR2}

> <broad_moa>
{"orexin receptor antagonist"}

> <synonyms>
{SB-408124,SB408124,BCP02343,ZINC3995426,2706AH,ABP000452,BDBM50423648,s1545,"3-(6,8-difluoro-2-methylquinolin-4-yl)-1-(4-(dimethylamino)phenyl)urea","3(6,8difluoro2methylquinolin4yl)1(4(dimethylamino
)phenyl)urea",AKOS024456881,CCG-268112,CCG268112,CS-0350,CS0350,SB19534,NCGC00025330-02,NCGC0002533002,AC-31977,AC31977,AS-73125,AS73125,HY-70068,HY70068,SMR004702996,AB0063495,S1545}

> <pdid>
PD010976

> <targets>
{Others,"OX Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{4331799}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 18  0  0  0  0            999 V2000
    8.7524   -1.1250    0.0000 Cl  0  0
    5.4979    1.0528    0.0000 C   0  0
    6.2524   -0.2436    0.0000 C   0  0
    5.2526   -1.3618    0.0000 N   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    4.0317    0.7359    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16  7  1  0
 16 11  1  0
  5 17  1  0
 17  2  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7769

> <plate>
1

> <well>
M10

> <supplier_cmpd_name>
Naphazoline HCl

> <ctcr_id>
5249

> <supplier_cmpd_id>
S2519

> <smiles>
Cl.C1CN=C(Cc2cccc3ccccc23)N1

> <pd_targets>
{LMNA,ADRA1A,MAPK1,HTR7,ADRA2A,NISCH,MAPT,TAAR1,ADRA2B,ADRA2C,CYP2D6,ADRA1B,ADRA1D,TAAR4}

> <pathway_gtopdb>
{"Other nuclear protein","Membrane receptor",Enzyme,"Other cytosolic protein","Family A G protein-coupled receptor",Kinase,"Cytochrome P450","Small molecule receptor (family A GPCR)","Protein Kinase",
"Cytochrome P450 family 2","Monoamine receptor","CMGC protein kinase group","Cytochrome P450 family 2D","Adrenergic receptor","CMGC protein kinase MAPK family","Serotonin receptor","Trace amine recept
or","Cytochrome P450 2D6","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cytochrome P450",Adrenoceptors,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","5-Hydroxytryptamine receptors","Trace amine rec
eptor","CYP2 family: drug metabolising subset","Orphan and other 7TM receptors","Mitogen-activated protein kinases (MAP kinases)","Class A Orphans","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Signal Transduction","Immune System",Disease,"Neuronal System",Metabolism,Mitotic,"Signaling by GPCR","Innate Immune System","Infectious disease","Transmission across Chemical Synapses"
,"Biological oxidations","M Phase","GPCR ligand binding","Toll-like Receptor Cascades","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionaliza
tion of compounds","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival","Activation of NMDA receptors
 and postsynaptic events","Cytochrome P450 - arranged by substrate type","Mitotic Anaphase","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response fa
vouring Leishmania parasite infection","Post NMDA receptor activation events",Xenobiotics,"Nuclear Envelope (NE) Reassembly",Adrenoceptors,"MAP kinase activation","ADORA2B mediated anti-inflammatory c
ytokines production","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK tar
gets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA2A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{MCULE-8346078401,MCULE8346078401,"NAPHAZOLINE HYDROCHLORIDE",550-99-2,550992,"NAPHAZOLINE HCL",Albalon,"Albalon Liquifilm",Rhinantin,Rhinoperd,Stricylon,Naphcon,Niazol,Rinofug,Vasocon,Opcon,"Clera hy
drochloride","2-(1-Naphthylmethyl)-2-imidazoline hy","2(1Naphthylmethyl)2imidazoline hy",T0446,S2519,SAM002554916,1500424,Prestw-46,"Naphazoline hydrochloride","Naphazoline HCl",CPD000058292}

> <pdid>
PD009276

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"adrenergic agonist","nasal decongestant","Neuronal Signaling"}

> <pubchem_cids>
{43834266,11079,657295,43834388}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 62 67  0  0  0  0            999 V2000
   12.0795   -6.2491    0.0000 O   0  0
   11.5667   -4.8395    0.0000 C   0  0
   10.0888   -4.5777    0.0000 C   0  0
    9.5757   -3.1673    0.0000 O   0  0
    8.0979   -2.9056    0.0000 C   0  0
    7.5847   -1.4952    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 S   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   29.2507   -6.2491    0.0000 O   0  0
   28.7378   -4.8395    0.0000 C   0  0
   27.2600   -4.5777    0.0000 C   0  0
   26.7469   -3.1673    0.0000 O   0  0
   25.2690   -2.9056    0.0000 C   0  0
   24.7559   -1.4952    0.0000 C   0  0
   23.2781   -1.2335    0.0000 N   0  0
   22.7632    0.1754    0.0000 C   0  0
   21.2856    0.4339    0.0000 C   0  0
   20.3195   -0.7186    0.0000 N   0  0
   20.8378   -2.1252    0.0000 C   0  0
   22.3154   -2.3838    0.0000 C   0  0
   18.8564   -0.3846    0.0000 C   0  0
   18.5226    1.0778    0.0000 N   0  0
   17.1711    1.7286    0.0000 C   0  0
   17.2827    3.2255    0.0000 C   0  0
   16.0433    4.0705    0.0000 C   0  0
   14.6919    3.4196    0.0000 C   0  0
   14.5798    1.9238    0.0000 C   0  0
   15.8197    1.0777    0.0000 C   0  0
   15.4859   -0.3847    0.0000 S   0  0
   16.4212   -1.5574    0.0000 C   0  0
   15.6712   -2.8577    0.0000 C   0  0
   16.4212   -4.1567    0.0000 C   0  0
   17.9212   -4.1567    0.0000 C   0  0
   18.6712   -2.8577    0.0000 C   0  0
   17.9212   -1.5574    0.0000 C   0  0
   33.0509    0.7853    0.0000 O   0  0
   33.0509   -0.7147    0.0000 C   0  0
   31.7517   -1.4643    0.0000 O   0  0
   34.3509   -1.4647    0.0000 C   0  0
   35.6509   -0.7147    0.0000 C   0  0
   36.9509   -1.4647    0.0000 C   0  0
   36.9509   -2.9647    0.0000 O   0  0
   38.2502   -0.7151    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  1  0
 10 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 13  1  0
 27 22  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 34  1  0
 37 40  1  0
 40 41  2  3
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 42  1  0
 47 48  1  0
 48 49  1  0
 49 50  2  0
 50 51  1  0
 51 52  2  0
 52 53  1  0
 53 54  2  0
 54 40  1  0
 54 49  1  0
 55 56  1  0
 56 57  2  0
 56 58  1  0
 58 59  2  0
 59 60  1  0
 60 61  1  0
 60 62  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7770

> <plate>
1

> <well>
M11

> <supplier_cmpd_name>
Quetiapine Fumarate

> <ctcr_id>
7478

> <supplier_cmpd_id>
S1763

> <smiles>
OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24.OCCOCCN5CCN(CC5)C6=Nc7ccccc7Sc8ccccc68.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Quetiapine fumarate",111974-72-2,111974722,"Quetiapine hemifumarate",Seroquel,"Seroquel XR","ICI 204,636",ICI-204636,ICI204636,UNII-2S3PL1B6UJ,UNII2S3PL1B6UJ,ZD5077,"ZM 204636","ZM 204,636",2S3PL1B6
UJ,"ICI 204636",MFCD03423782,CHEBI:8708,FK949E,"Quetiapine fumarate (",S1763,"Quetiapine Fumarate"}

> <pdid>

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5281025,25058200}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 34 34  0  0  1  0            999 V2000
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 C   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0  2  0  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    7.7937   -1.5213    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 O   0  0
    2.5893   -6.0044    0.0000 C   0  0
    1.2924   -5.2507    0.0000 C   0  0
    2.5845   -7.5044    0.0000 C   0  0
   14.1943   -1.1310    0.0000 O   0  0
   14.1943   -2.6310    0.0000 C   0  0  2  0  0  0
   12.8943   -3.3810    0.0000 C   0  0  1  0  0  0
   12.8943   -4.8810    0.0000 O   0  0
   11.5943   -2.6310    0.0000 C   0  0
   11.5943   -1.1310    0.0000 O   0  0
   10.2951   -3.3806    0.0000 O   0  0
   15.4943   -3.3810    0.0000 C   0  0
   15.4943   -4.8810    0.0000 O   0  0
   16.7936   -2.6315    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20 14  1  0
 20 21  1  0
  4 22  1  0
 22 23  1  0
 22 24  1  0
 26 25  1  1
 26 27  1  0
 27 28  1  1
 27 29  1  0
 29 30  1  0
 29 31  2  0
 26 32  1  0
 32 33  1  0
 32 34  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7771

> <plate>
1

> <well>
M12

> <supplier_cmpd_name>
Tolterodine tartrate

> <ctcr_id>
7521

> <supplier_cmpd_id>
S2550

> <smiles>
CC(C)N(CC[C@H](c1ccccc1)c2cc(C)ccc2O)C(C)C.O[C@H]([C@@H](O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Tolterodine tartrate",124937-52-6,124937526,"124937 52 6","Detrol LA",Detrol,PNU-200583E,PNU200583E,"PNU 200583E",UNII-5T619TQR3R,UNII5T619TQR3R,"UNII 5T619TQR3R","Tolterodine L-Tartrate","Tolterodi
ne LTartrate","Tolterodine L Tartrate",Kabi-,Kabi,S2550,"Tolterodine tartrate (Detrol LA)"}

> <pdid>

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{443878}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 17  0  0  0  0            999 V2000
    7.5993   -1.6061    0.0000 C   0  0
    8.4849   -2.8168    0.0000 N   0  0
    7.8797   -4.1902    0.0000 C   0  0
    8.7644   -5.4025    0.0000 N   0  0
   10.2567   -5.2435    0.0000 C   0  0
   11.7483   -5.0845    0.0000 N   0  0
    6.3873   -4.3492    0.0000 N   0  0
    5.5026   -3.1368    0.0000 C   0  0
    4.0102   -3.2959    0.0000 C   0  0
    3.1255   -2.0835    0.0000 S   0  0
    1.6332   -2.2426    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 N   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6317   -2.2458    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  3  0
  3  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 12  2  0
 16 17  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7772

> <plate>
1

> <well>
M13

> <supplier_cmpd_name>
Cimetidine

> <ctcr_id>
3832

> <supplier_cmpd_id>
S1845

> <smiles>
CNC(NC#N)=NCCSCc1nc[nH]c1C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{cimetidine,51481-61-9,51481619,Tagamet,Eureceptor,Tametin,Dyspamet,Ulcedine,Acinil,Cimetag,Tratul,Ulcedin,Acibilin,Gastromet,Cimetum,Edalene,Ulcimet,Ulcomet,Cimal,Ulhys,"Tagamet Hb","Cimetidine Hcl",
"Tagamet Hb 200",SKF-92334,SKF92334,Cimetidina,Ulcomedina,Val,902,S1845,SAM002554892,1500684,Prestw-26,Cimetidine,Cimetidine,CPD001370748,CIMETIDINE}

> <pdid>

> <targets>
{""}

> <classes>
{antiulcer,"Neuronal Signaling"}

> <pubchem_cids>
{2756}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 13 11  0  0  0  0            999 V2000
    8.8982   -1.1285    0.0000 H   0  3
    6.3982   -1.1285    0.0000 Br  0  5
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13  7  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7773

> <plate>
1

> <well>
M14

> <supplier_cmpd_name>
Arecoline

> <ctcr_id>
577

> <supplier_cmpd_id>
S2614

> <smiles>
[H+].[Br-].COC(=O)C1=CCCN(C)C1

> <pd_targets>
{CHRM3,CHRM1,CHRM2,CHRM4,CHRM5,LMNA,THRB,MCOLN3,CHRNA4,CHRNB2,CHRNA10,CHRNA2,CHRNA3,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB3,CHRNB4,BLM,CACNA1C}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein","Transcription factor","Ion channel",Enzyme,"Family A G protein-coupled receptor","Nuclear receptor","Voltage-gated ion channel","Ligand-gated ion channel"
,"Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Transient receptor potential channel","Nicotinic acetylcholine receptor","Voltage-gated calcium channel","Monoamine r
eceptor","Nuclear hormone receptor subfamily 1 group A","Nicotinic acetylcholine receptor alpha subunit","Acetylcholine receptor","Nuclear hormone receptor subfamily 1 group A member 2"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Nuclear hormone receptors","Voltage-gated ion channels","Acetylcholine receptors (muscarinic)","1A. Thyroid hormone receptors","Transient Recep
tor Potential channels","Voltage-gated calcium channels"}

> <pathway_reactome>
{"Signal Transduction","Cell Cycle","Metabolism of proteins","Transport of small molecules","DNA Repair","Developmental Biology","Signaling by GPCR",Mitotic,"Post-translational protein modification","
Ion channel transport","DNA Double-Strand Break Repair","Nervous system development","GPCR ligand binding","M Phase",SUMOylation,"Stimuli-sensing channels","Homology Directed Repair","Axon guidance","
Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","SUMO E3 ligases SUMOylate target proteins","TRP channels","HDR through Homologous Recombination (HRR) or Single Strand Annealing
 (SSA)","NCAM signaling for neurite out-growth","Amine ligand-binding receptors","Mitotic Anaphase","SUMOylation of intracellular receptors","HDR through Homologous Recombination (HRR)","NCAM1 interac
tions","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homo
logous DNA pairing and strand exchange"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{"Arecoline hydrobromide",300-08-3,300083,Taeniolin,"Arecoline bromide","ARECOLINE HBr","Methyl 1-Methyl-1,2,5,6-tetrahydropyridine-3-carboxylate hydrobromide","Methyl 1Methyl1,2,5,6tetrahydropyridine
3carboxylate hydrobromide","Arecoline (hydrobromide)",UNII-24S79B9CX7,UNII24S79B9CX7,C8H14BrNO2,24S79B9CX7,MFCD00039041,S2614,1500680,Arecoline,"ARECOLINE HYDROBROMIDE"}

> <pdid>
PD006273

> <targets>
{AChR}

> <classes>
{cathartic,"Neuronal Signaling",hypotensive,"anthelmintic (Cestodes)"}

> <pubchem_cids>
{9301,15487167,91973784,57486785}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 26  0  0  1  0            999 V2000
   -2.1929   -3.7413    0.0000 C   0  0
   -0.7292   -4.0692    0.0000 C   0  0
   -0.2818   -5.5010    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0  1  0  0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  4  2  1  6
  4  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 11  1  0
 17 18  1  6
 17 19  1  0
 19  8  1  0
 19 20  1  6
 20 21  1  0
 21 22  1  0
 22  4  1  0
 22  7  1  0
 22 23  1  6
M  END
> <name>
Selleck_GPCR

> <id>
7774

> <plate>
1

> <well>
M15

> <supplier_cmpd_name>
Pregnenolone

> <ctcr_id>
6794

> <supplier_cmpd_id>
S1914

> <smiles>
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{LMNA,SERPINA6,SHBG,AMPC,G6PD}

> <pathway_gtopdb>
{"Other nuclear protein","Secreted protein",Enzyme,Hydrolase,Oxidoreductase}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Gene expression (Transcription)",Mitotic,"Metabolism of lipids","RNA Polymerase II Transcription","M Phase","Metabolism of steroids","Generic Transcription Pathway","Mitotic 
Metaphase and Anaphase","Metabolism of steroid hormones","Transcriptional Regulation by TP53","Mitotic Anaphase","Glucocorticoid biosynthesis","TP53 Regulates Metabolic Genes","Nuclear Envelope (NE) R
eassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SULT2B1}

> <broad_moa>
{"glutamate receptor modulator"}

> <synonyms>
{RESTW54,"RESTW 54",pregnenolone,145-13-1,145131,"145 13 1",3beta-Hydroxypregn-5-en-20-one,3betaHydroxypregn5en20one,"3beta Hydroxypregn 5 en 20 one",Arthenolone,Pregnetan,Pregneton,Pregnolon,Prenolon
,Regnosone,Skinostelon,5-Pregnen-3beta-ol-20-,5Pregnen3betaol20,S1914,Prestw-546,Pregnenolone}

> <pdid>
PD001701

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{8955}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 22  0  0  1  0            999 V2000
   10.6738   -0.4898    0.0000 Cl  0  5
    5.6730    1.0652    0.0000 N   0  0
    4.2501    0.5904    0.0000 C   0  0
    3.9492   -0.8772    0.0000 C   0  0
    4.9546   -1.9903    0.0000 C   0  0
    4.2067   -3.2906    0.0000 N   0  0
    2.7390   -2.9810    0.0000 C   0  0
    1.6199   -3.9799    0.0000 S   0  0
    2.5987   -1.5004    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 F   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 F   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    8.1738   -0.4898    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9  4  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 13  1  0
 20 21  1  0
 21 10  1  0
M  CHG  2   1  -1  22   1
M  END
> <name>
Selleck_GPCR

> <id>
7775

> <plate>
1

> <well>
M16

> <supplier_cmpd_name>
Nepicastat (SYN-117) HCl

> <ctcr_id>
7590

> <supplier_cmpd_id>
S2695

> <smiles>
[Cl-].NCC1=CNC(=S)N1[C@H]2CCc3c(F)cc(F)cc3C2.[H+]

> <pd_targets>
{DBH}

> <pathway_gtopdb>
{Enzyme,Oxidoreductase}

> <pathway_chembl>
{Enzymes,"Catecholamine turnover"}

> <pathway_reactome>
{Metabolism,"Metabolism of amino acids and derivatives","Metabolism of amine-derived hormones","Catecholamine biosynthesis"}

> <broad_targets>
{DBH}

> <broad_moa>
{"dopamine beta hydroxylase inhibitor"}

> <synonyms>
{"EPICASTAT (SYN117) HC",SMR004702919,"Nepicastat hydrochloride",170151-24-3,170151243,"Nepicastat HCl","Nepicastat (SYN-117) HCl","Nepicastat (SYN117) HCl","Nepicastat hydrochloride anhydrous","Nepic
astat (hydrochloride)",UNII-3WK068D17I,UNII3WK068D17I,"Nepicastat  hydrochloride",3WK068D17I,170151-24-,17015124,T6604,S2695}

> <pdid>
PD007674

> <targets>
{Hydroxylase}

> <classes>
{Metabolism}

> <pubchem_cids>
{9840545}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 34  0  0  1  0            999 V2000
    1.3258   -1.4931    0.0000 C   0  0
    2.6400   -0.7700    0.0000 C   0  0  2  0  0  0
    3.8100   -1.3900    0.0000 C   0  0
    4.1081   -2.8601    0.0000 O   0  0
    4.3800   -0.6900    0.0000 O   0  0
    3.9700    0.2400    0.0000 C   0  0  1  0  0  0
    2.7300    1.5000    0.0000 C   0  0
    0.6600    0.8400    0.0000 C   0  0
   -0.5100    1.5800    0.0000 C   0  0  1  0  0  0
   -1.5200    0.9900    0.0000 C   0  0
   -3.6100    0.9900    0.0000 C   0  0  1  0  0  0
   -5.0763    1.0326    0.0000 C   0  0
   -5.7849    2.3547    0.0000 C   0  0
   -5.8673   -0.2418    0.0000 C   0  0
   -6.5756    1.0802    0.0000 C   0  0
   -0.7600    0.3600    0.0000 C   0  0
   -1.9400   -0.6300    0.0000 C   0  0  1  0  0  0
   -3.3537   -0.1287    0.0000 O   0  0
   -1.7000   -1.8700    0.0000 C   0  0
   -2.6546   -3.0271    0.0000 O   0  0
   -0.6700   -1.8700    0.0000 O   0  0
    0.0000   -0.7300    0.0000 C   0  0  1  0  0  0
    1.1100   -0.8600    0.0000 O   0  0
    1.4800    0.0800    0.0000 C   0  0  2  0  0  0
    1.2700    2.6700    0.0000 C   0  0
    2.4490    3.5973    0.0000 O   0  0
    0.2400    3.0100    0.0000 O   0  0
    2.7300    0.3900    0.0000 C   0  0  1  0  0  0
    1.7607   -0.7548    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  1  6
 12 13  1  0
 12 14  1  0
 12 15  1  0
 11 16  1  0
 16  8  1  0
 16 17  1  0
 17 18  1  6
 17 19  1  0
 19 20  2  0
 19 21  1  0
 22 21  1  6
 22 16  1  0
 22 23  1  0
 24 23  1  1
 24  8  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27  9  1  0
 24 28  1  0
 28  2  1  0
 28  6  1  0
 28 29  1  1
M  END
> <name>
Selleck_GPCR

> <id>
7776

> <plate>
1

> <well>
M17

> <supplier_cmpd_name>
Ginkgolide A

> <ctcr_id>
7167

> <supplier_cmpd_id>
S2026

> <smiles>
C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)C36[C@@H](O)C(=O)O[C@H]6O[C@@]4(C(=O)O5)[C@@]12O

> <pd_targets>
{KMT2A,GLRA1,GLRA2,PTAFR,MEN1}

> <pathway_gtopdb>
{"Epigenetic regulator","Ion channel","Membrane receptor",Reader,"Ligand-gated ion channel","Family A G protein-coupled receptor",Bromodomain,"Glycine receptor","Small molecule receptor (family A GPCR
)","Lipid-like ligand receptor (family A GPCR)","PAF receptor"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"Chromatin modifying enzymes","Ligand-gated ion channels","G protein-coupled receptors","2.1.1.43 Histone methyltransferases (HMTs)","Glycine receptors","Platelet-act
ivating factor receptor"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System","Immune System","RNA Polymerase II Transcription","Transmission across Chemical Synapses","Cytokine Signaling in Immune system","Generic Transcript
ion Pathway","Neurotransmitter receptors and postsynaptic signal transmission","Interferon Signaling","Transcriptional regulation by RUNX1","Interferon gamma signaling","RUNX1 regulates genes involved
 in megakaryocyte differentiation and platelet function"}

> <broad_targets>
{GLRA1,GLRB}

> <broad_moa>
{"GABA receptor antagonist"}

> <synonyms>
{"Ginkgolide A","Ginkgolid A",BN52020,15291-75-5,15291755,CHEBI:5355,MLS006011131,CHEMBL2112174,HMS3884K20,s2026,AKOS024464749,CCG-268742,CCG268742,NCGC00346666-03,NCGC0034666603,SMR002520153,AB015591
82_03,AB0155918203,AB01559182-03,"AB01559182 03",T2749,S2026}

> <pdid>
PD001525

> <targets>
{"GABA Receptor",Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{21725806}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 33  0  0  0  0            999 V2000
    6.4451   -1.8434    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    2.7343   -2.9815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2567    0.5878    0.0000 C   0  0
    3.2235    1.6679    0.0000 C   0  0
    3.6446    3.1076    0.0000 C   0  0
    5.1019    3.4627    0.0000 C   0  0
    5.5231    4.9024    0.0000 I   0  0
    6.1382    2.3782    0.0000 C   0  0
    5.7171    0.9385    0.0000 C   0  0
    4.8054   -4.6666    0.0000 C   0  0
    6.2966   -4.8284    0.0000 O   0  0
    3.9195   -5.8781    0.0000 N   0  0
    4.5250   -7.2514    0.0000 N   0  0
    3.6414   -8.4636    0.0000 C   0  0
    4.2492   -9.8349    0.0000 C   0  0
    5.7408   -9.9941    0.0000 C   0  0
    6.6244   -8.7820    0.0000 C   0  0
    6.0165   -7.4107    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
 12 13  1  0
  5 14  1  0
 14  2  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 25  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7777

> <plate>
1

> <well>
M18

> <supplier_cmpd_name>
AM251

> <ctcr_id>
2683

> <supplier_cmpd_id>
S2819

> <smiles>
Cc1c(nn(c2ccc(Cl)cc2Cl)c1c3ccc(I)cc3)C(=O)NN4CCCCC4

> <pd_targets>
{GPR18,CNR1,CNR2,CYP1A2,LMNA,CYP2D6,CYP2C9,MAPT,CYP2C19,GPR55,NPSR1,CYP3A4,GSP1,KCNH2,FABP1,GSP2,ABCC4,ABCB11,ABCC1,ACHE}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Other cytosolic protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 
1","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Lipid-like ligand receptor (family A GPCR)","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Cytoch
rome P450 family 2C","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Cannabinoid receptor","Cytochrome P450 1A1","Cytochrome P450 2D6","Cytochrome P450 2C9","Cytochrome P450 2C19
","Lysophosphatidylinositol receptor","Neuropeptide receptor","Cytochrome P450 3A4","Ion channel","Auxiliary transport protein",Transporter,"Voltage-gated ion channel","Fatty acid binding protein fami
ly","Primary active transporter",Hydrolase,"Potassium channels","ATP-binding cassette","Voltage-gated potassium channel","ABCC subfamily","ABCB subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Orphan and other 7TM receptors","Cannabinoid receptors","CYP1 family","CYP2 family: drug metabolising subset","Neuropeptide S recept
or","CYP3 family","Class A Orphans","Ion channels","Other protein targets",Transporters,"Voltage-gated ion channels","Fatty acid-binding proteins","ATP-binding cassette transporter family","Acetylchol
ine turnover","Potassium channels","ABCC subfamily","ABCB subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Cell Cycle","Neuronal System",Disease,"Signaling by GPCR","Biological oxidations",Mitotic,"Transmission across Chemical Synapses","Infectious disease","Metabolism of
 lipids","GPCR downstream signalling","Phase I - Functionalization of compounds","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","Biosynthesis of spe
cialized proresolving mediators (SPMs)","G alpha (i) signalling events","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic e
vents","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs",Xenobiotics,"Mitotic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishman
ia parasite infection","Biosynthesis of maresins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Activation of AMPK downstrea
m of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation","Muscle contraction",Hemostasis,"Cardiac co
nduction","Platelet activation","signaling and aggregation","Phase 3 - rapid repolarisation","Regulation of lipid metabolism by PPARalpha","Response to elevated platelet cytosolic Ca2+","Metabolism of
 steroids","Fatty acid metabolism","Phospholipid metabolism","PPARA activates gene expression","Platelet degranulation","Bile acid and bile salt metabolism","Arachidonic acid metabolism","Glycerophosp
holipid biosynthesis","Synthesis of bile acids and bile salts","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Synthesis of PC","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"
}

> <broad_targets>
{CNR1,GPR55}

> <broad_moa>
{"cannabinoid receptor antagonist"}

> <synonyms>
{AM251,183232-66-8,183232668,AM-251,"AM 251",UNII-3I4FA44MAI,UNII3I4FA44MAI,3I4FA44MAI,C22H21Cl2IN4O,CHEMBL285932,CHEBI:90724,MFCD01861181,SMR000466284,SR-01000597360,SR01000597360,"AM 251 (pharmaceut
ical)",Tocris-1117,Tocris1117,CPD000466284,CBiol_001833,CBiol001833,CBiol-001833,"CBiol 001833",BSPBio_001525,BSPBio001525,BSPBio-001525,"BSPBio 001525",KBioGR_000245,KBioGR000245,KBioGR-000245,"KBioG
R 000245",KBioSS_00,KBioSS00,KBioSS-00,"KBioSS 00",S2819,SAM001247081}

> <pdid>
PD003150

> <targets>
{"Cannabinoid Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{2125}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 31 32  0  0  1  0            999 V2000
   13.5422   -0.8074    0.0000 O   0  0
    0.3470    3.9090    0.0000 C   0  0
    1.8104    3.5799    0.0000 C   0  0
    2.2582    2.1474    0.0000 O   0  0
    3.7225    1.8180    0.0000 C   0  0
    4.7389    2.9212    0.0000 O   0  0
    4.1703    0.3856    0.0000 C   0  0  2  0  0  0
    5.6342    0.0546    0.0000 C   0  0
    6.6534    1.1562    0.0000 C   0  0
    8.1173    0.8252    0.0000 C   0  0
    9.1376    1.9248    0.0000 C   0  0
   10.6000    1.5910    0.0000 C   0  0
   11.0422    0.1577    0.0000 C   0  0
   10.0219   -0.9419    0.0000 C   0  0
    8.5595   -0.6081    0.0000 C   0  0
    3.1510   -0.7161    0.0000 N   0  0
    1.6852   -0.3846    0.0000 C   0  0  1  0  0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -3.1695   -0.6090    0.0000 C   0  0
   -3.7175   -2.0053    0.0000 C   0  0
   -2.7822   -3.1781    0.0000 C   0  0
   -1.2990   -2.9545    0.0000 C   0  0  2  0  0  0
   -0.7500   -1.5574    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.4008   -2.9088    0.0000 O   0  0
   -0.3613   -4.1263    0.0000 C   0  0
   -0.9074   -5.5234    0.0000 O   0  0
    1.1217   -3.9013    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  7 16  1  0
 17 16  1  6
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 21  1  0
 26 27  1  0
 27 17  1  0
 27 28  2  0
 25 29  1  6
 29 30  1  0
 29 31  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7778

> <plate>
1

> <well>
M19

> <supplier_cmpd_name>
Cilazapril Monohydrate

> <ctcr_id>
7418

> <supplier_cmpd_id>
S2081

> <smiles>
O.CCOC(=O)[C@H](CCc1ccccc1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(O)=O

> <pd_targets>
{ACE}

> <pathway_gtopdb>
{Enzyme,Protease,"Metallo protease","Metallo protease MAE clan","Metallo protease M2 family"}

> <pathway_chembl>
{Enzymes,"Peptidases and proteinases","MA: Metallo (M) Peptidases","M2: Angiotensin-converting  (ACE and ACE2)"}

> <pathway_reactome>
{"Metabolism of proteins","Peptide hormone metabolism","Metabolism of Angiotensinogen to Angiotensins"}

> <broad_targets>
{ACE}

> <broad_moa>
{"angiotensin converting enzyme inhibitor"}

> <synonyms>
{"CILAZAPRIL MONOHYDRATE",92077-78-6,92077786,"92077 78 6",Justor,"Cilazapril (monohydrate)",UNII-19KW7PI29F,UNII19KW7PI29F,"UNII 19KW7PI29F","Ro 31-2848 monohydrate","Ro 312848 monohydrate","Ro 31 28
48 monohydrate",19KW7PI29F,Inh,S2081,"Cilazapril Monohydrate","Cilazapril Monohydrate"}

> <pdid>
PD009546

> <targets>
{RAAS}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{56329}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 27 29  0  0  0  0            999 V2000
    7.4134   -6.1642    0.0000 C   0  0
    6.8033   -4.7939    0.0000 C   0  0
    5.3361   -4.4820    0.0000 N   0  0
    5.1983   -3.0012    0.0000 C   0  0
    3.8985   -2.2508    0.0000 C   0  0
    2.5988   -1.5004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.5496   -2.3801    0.0000 C   0  0
    6.8527   -0.9111    0.0000 C   0  0
    7.5533   -3.4949    0.0000 N   0  0
    9.0458   -3.3380    0.0000 C   0  0
    9.7542   -2.0214    0.0000 C   0  0
   11.2535   -1.9773    0.0000 C   0  0
   12.0414   -3.2537    0.0000 C   0  0
   13.5417   -3.2127    0.0000 O   0  0
   14.3282   -4.4909    0.0000 C   0  0
   15.8276   -4.4499    0.0000 F   0  0
   13.6144   -5.8102    0.0000 F   0  0
   15.1136   -5.7688    0.0000 F   0  0
   11.3299   -4.5743    0.0000 C   0  0
    9.8306   -4.6184    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  3  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13  7  1  0
  4 14  2  0
 14 15  1  0
 14 16  1  0
 16  2  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
 20 26  1  0
 26 27  2  0
 27 17  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7779

> <plate>
1

> <well>
M20

> <supplier_cmpd_name>
CTEP (RO4956371)

> <ctcr_id>
6049

> <supplier_cmpd_id>
S2861

> <smiles>
Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1c3ccc(OC(F)(F)F)cc3

> <pd_targets>
{KCNH2,GRM5}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor","Voltage-gated ion channel","Family C G protein-coupled receptor","Potassium channels","Small molecule receptor (family C GPCR)","Voltage-gated potassium channel","N
eurotransmitter receptor (family C GPCR)","Metabotropic glutamate receptor"}

> <pathway_chembl>
{"Ion channels",Receptors,"Voltage-gated ion channels","G protein-coupled receptors","Potassium channels","Metabotropic glutamate receptors","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Muscle contraction","Signal Transduction","Cardiac conduction","Signaling by GPCR","Phase 3 - rapid repolarisation","GPCR downstream signalling","G alpha (q) signalling events"}

> <broad_targets>
{GRM5}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{CTEP,871362-31-1,871362311,"mGluR5 inhibitor","CTEP (RO4956371)",CHEMBL3410223,"RO 4956371;mGluR5 inhibitor",(3H)CTEP,RO4956371,C19H13ClF3N3O,SCHEMBL608379,GTPL6408,GTPL6409,DTXSID50469986,EX-A095,EX
A095,HMS3651N19,HMS3884J20,AOB87758,BCP06140,2340AH,BDBM50071375,MF,S2861}

> <pdid>
PD010542

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{11646823}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 30  0  0  1  0            999 V2000
    9.7549    0.2674    0.0000 Cl  0  0
   -2.6395    3.8685    0.0000 O   0  0
   -1.3618    3.0827    0.0000 C   0  0
    0.0000    3.7710    0.0000 C   0  0
    1.0625    3.0827    0.0000 C   0  0
    1.0625    1.6760    0.0000 C   0  0
    2.3045    0.9727    0.0000 C   0  0
    2.3045   -0.4040    0.0000 C   0  0  1  0  0  0
    3.2622   -1.0625    0.0000 N   0  0
    3.2622   -1.9005    0.0000 C   0  0
    0.0000   -1.9005    0.0000 C   0  0
    0.0000   -0.4040    0.0000 C   0  0  1  0  0  0
   -1.3618   -1.1223    0.0000 C   0  0  1  0  0  0
   -2.5589    0.2394    0.0000 O   0  0
   -1.3618    1.6760    0.0000 C   0  0
    0.0000    0.9727    0.0000 C   0  0
   -1.3618   -2.5589    0.0000 C   0  0
   -2.6462   -3.3336    0.0000 O   0  0
    0.0000   -3.2772    0.0000 C   0  0
    1.0774   -2.5589    0.0000 C   0  0
    1.0774   -1.1373    0.0000 C   0  0  1  0  0  0
    2.3821   -1.8775    0.0000 O   0  0
    4.6577   -0.4958    0.0000 C   0  0
    5.8415   -1.4184    0.0000 C   0  0
    7.2549   -1.5708    0.0000 C   0  0
    6.3315   -2.7529    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  1
 12 13  1  0
 13 14  1  6
 14 15  1  0
 15  3  1  0
 15 16  2  0
 16  6  1  0
 16 12  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 12  1  0
 21 22  1  1
  9 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 24  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7780

> <plate>
1

> <well>
M21

> <supplier_cmpd_name>
Naltrexone HCl

> <ctcr_id>
7068

> <supplier_cmpd_id>
S2103

> <smiles>
Cl.Oc1ccc2C[C@H]3N(CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O)CC6CC6

> <pd_targets>
{CHRNA7,OPRK1,OPRM1,OPRD1,CHRNA4,TGR,CYP2D6,SIGMAR1}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Enzyme,"Ligand-gated ion channel","Family A G protein-coupled receptor","Cytochrome P450","Nicotinic acetylcholine receptor","Peptide receptor (family A GPCR)","Cyto
chrome P450 family 2","Nicotinic acetylcholine receptor alpha subunit","Short peptide receptor (family A GPCR)","Cytochrome P450 family 2D","Opioid receptor","Cytochrome P450 2D6"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,"Ligand-gated ion channels","G protein-coupled receptors","Cytochrome P450","Nicotinic acetylcholine receptors","Opioid receptors","CYP2 family: drug metabolising sub
set"}

> <pathway_reactome>
{"Neuronal System","Gene expression (Transcription)","Signal Transduction",Metabolism,"Transmission across Chemical Synapses","RNA Polymerase II Transcription","Signaling by GPCR","Biological oxidatio
ns","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","GPCR downstream signalling","GPCR ligand binding","Phase I - Functionalization of compounds","Ace
tylcholine binding and downstream events","Transcriptional Regulation by MECP2","G alpha (i) signalling events","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","P
ostsynaptic nicotinic acetylcholine receptors","MECP2 regulates neuronal receptors and channels","Opioid Signalling","Peptide ligand-binding receptors",Xenobiotics,"Highly calcium permeable postsynapt
ic nicotinic acetylcholine receptors","G-protein activation","CYP2E1 reactions"}

> <broad_targets>
{OPRD1,OPRK1,OPRM1,SIGMAR1}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{"Naltrexone hydrochloride","Naltrexone Hcl",16676-29-2,16676292,"16676 29 2",Depade,Trexan,Antaxone,ReVia,"Naltrexone (Hydrochloride)","NIH 8503",EN-1639A,EN1639A,"EN 1639A",UNII-Z6375YW9SF,UNIIZ6375
YW9SF,"UNII Z6375YW9SF",Celupan,Nemexin,S2103,SAM002589986,"Naltrexone HCl",CPD000058767}

> <pdid>
PD010071

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5485201,5388998,11760614}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 24  0  0  0  0            999 V2000
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    7.7928   -6.0048    0.0000 C   0  0
    9.0914   -5.2526    0.0000 N   0  0
   10.3927   -6.0004    0.0000 C   0  0
   11.6918   -5.2504    0.0000 C   0  0
   12.9909   -6.0004    0.0000 C   0  0
   12.9909   -7.5004    0.0000 C   0  0
   11.6918   -8.2504    0.0000 C   0  0
   10.3928   -7.5004    0.0000 N   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  1  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 12 21  1  0
 21 22  2  0
 22  9  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7781

> <plate>
1

> <well>
M22

> <supplier_cmpd_name>
WZ811

> <ctcr_id>
5884

> <supplier_cmpd_id>
S2912

> <smiles>
C(Nc1ccccn1)c2ccc(CNc3ccccn3)cc2

> <pd_targets>
{CXCR4}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Chemokine receptor","CXC chemokine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Chemokine receptors"}

> <pathway_reactome>
{Disease,"Infectious disease","HIV Infection","HIV Life Cycle","Early Phase of HIV Life Cycle","Binding and entry of HIV virion"}

> <broad_targets>
{CXCR4}

> <broad_moa>
{"CC chemokine receptor antagonist"}

> <synonyms>
{55778-02-4,55778024,WZ811,"WZ 811",WZ-811,"N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine","N1,N4Di2pyridinyl1,4benzenedimethanamine","N,N'-(1,4-phenylenebis(methylene))bis(pyridin-2-amine)","N,N'(1,4
phenylenebis(methylene))bis(pyridin2amine)",N-((4-((pyridin-2-ylamino)methyl)phenyl)methyl)pyridin-2-amine,N((4((pyridin2ylamino)methyl)phenyl)methyl)pyridin2amine,CHEMBL237830,N,N'-(1,N'(1,4-Phenylen
ebis(methylene)),4Phenylenebis(methylene)),T1739,S2912}

> <pdid>
PD010517

> <targets>
{CXCR}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{11565518}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 29  0  0  1  0            999 V2000
   -1.4188  -10.5751    0.0000 C   0  0
   -1.8661   -9.1434    0.0000 C   0  0
   -0.8500   -8.0388    0.0000 C   0  0
   -1.2977   -6.6063    0.0000 C   0  0
   -0.2816   -5.5018    0.0000 C   0  0
    1.1821   -5.8297    0.0000 O   0  0
   -0.7292   -4.0692    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
 22 12  1  0
 22 23  1  6
 23 24  1  0
 24 25  1  0
 25  8  1  0
 25 11  1  0
 25 26  1  6
M  END
> <name>
Selleck_GPCR

> <id>
7782

> <plate>
1

> <well>
N03

> <supplier_cmpd_name>
Estradiol valerate

> <ctcr_id>
5879

> <supplier_cmpd_id>
S3149

> <smiles>
CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C

> <pd_targets>
{RORC,POLB,SKA,MAPT,LMNA,KMT2A,ATM,ESR1,ESR2}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other cytosolic protein","Other nuclear protein","Epigenetic regulator","Nuclear receptor",Kinase,Reader,"Nuclear hormone receptor subfamily 1",Bromodomain,"Protein Kin
ase","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1 group F","Atypical protein kinase group","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subf
amily 1 group F member 3","Atypical protein kinase PIKK family","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group A member 2"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","1F. Retinoic acid-related orphans","2.1.1.43 Histone methyltransferases (HMTs)",Atypical,"Steroid h
ormone receptors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","3A. Estrogen receptors","Other PIKK family kinases"}

> <pathway_reactome>
{"Gene expression (Transcription)","DNA Repair","Neuronal System","Cell Cycle","Signal Transduction","RNA Polymerase II Transcription","Base Excision Repair","Transmission across Chemical Synapses",Mi
totic,"Cell Cycle Checkpoints","Intracellular signaling by second messengers","Generic Transcription Pathway","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and postsynaptic signa
l transmission","M Phase","G1/S DNA Damage Checkpoints","PIP3 activates AKT signaling","Transcriptional regulation by RUNX3","Resolution of AP sites via the multiple-nucleotide patch replacement pathw
ay","Activation of NMDA receptors and postsynaptic events","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX1","p53-Dependent G1/S DNA damage checkpoint","Negative regulation of the
 PI3K/AKT network","RUNX3 Regulates Immune Response and Cell Migration","PCNA-Dependent Long Patch Base Excision Repair","Post NMDA receptor activation events","Mitotic Anaphase","RUNX1 regulates gene
s involved in megakaryocyte differentiation and platelet function","p53-Dependent G1 DNA Damage Response","RUNX1 regulates estrogen receptor mediated transcription",PI5P,"PP2A and IER3 Regulate PI3K/A
KT Signaling","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Stabilization of p53","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin
 ligase COP1"}

> <broad_targets>
{ESR1}

> <broad_moa>
{"estrogen receptor agonist"}

> <synonyms>
{"estradiol valerate",979-32-8,Delestrogen,"Estradiol 17-valerate","Estradiol valerianate",Estraval,Neofollin,Progynova,Femogex,Progynon-Depot,"Oestradiol valerate",Atladiol,Climaval,Deladiol,Duratrad
,Pharlon,Estate,Dura-estradiol,"Exten strone","Depo estro med",Repo-Estra,"Delestrogen 4X","Estraval PA","Estraval 2X",Estroval-10,"Delahormone unimatic",Depo-Estro-Med,Femogen-L.A.,"Gynogen L.A. 20",
"Gynogen L.A. 40","ESTRADIOL, 17-VALERATE","component of Ditate",UNII-OKG364O896,NSC-17590,"component of Deluteval 2X","17-BETA-ESTRADIOL 17-VALERATE","Estradiol 17.beta.-valerate","component of Mal-O
-Fem L.A",MLS000028449,CHEBI:31561,OKG364O896,MFCD00056541,Cyclocur,Gynokadin,Merimono,Nuvelle,Pelanin,Postoval,Primogyna,Ronfase,SMR000058346,ST075188,"Estradiol Depot",Primogyn-Depot,"beta-Estradiol
 17-valerate","3-Hydroxy-17beta-valeroyloxyestra-1,3,5(10)-trien","17-pentanoyl-estra-1,3,5(10)-triene-3,17beta-diol","Gynogen L.A. 10","(17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl valerate",Valerge
n,"Estradiol 17beta-valerate","Estradiol valerate (VAN)","Estradiol-17-valerate; 1,3,5(10)-Estratriene-3,17b-diol 17-pentanote",estradiol-valerate,"Estradioli valeras","Valerate d'estradiol","CCRIS 55
71","Valerato de estradiol","Estradioli valeras (INN-Latin)",Oestradiol-17b-valerate,"Valerate d'estradiol (INN-French)","EINECS 213-559-2","NSC 17590","Valerato de estradiol (INN-Spanish)",Altadiol,"
Pelanin depot","Gynogen LA","Deladumone (TN)",NCGC00094673-01,"3-Hydroxy-17beta-valeroyloxyestra-1,3,5(10)-triene","Gynogen L.A.10","Estradiol valerate (USP:INN:BAN:JAN)",Opera_ID_444,"Estradiol 17?-v
alerate","B-Estradiol 17-valerate",DSSTox_CID_3004,CHEMBL1511,DSSTox_RID_76827,DSSTox_GSID_23004,SCHEMBL40563,MLS001146931,ARONIS24416,GTPL7655,DTXSID8023004,HMS2232L17,HMS3259C12,HMS3715B21,BCP11918,
EBD28143,"Estra-1,3,5(10)-triene-3,17-diol (17-beta)-, 17-pentanoate","Estra-1,3,5(10)-triene-3,17-diol(17beta)-, 17-pentanoate","Estradiol valerate (JAN/USP/INN)",HY-B0672,NSC17590,ZINC3881556,Tox21_
111312,"Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-pentanoate",LMST02010039,s3149,SBB080821,AKOS005267158,CCG-221130,DB13956,KS-5213,MCULE-6732064308,NC00560,NCGC00018166-02,NCGC00018166-14,CAS-
979-32-8,CPD000058346,AB0106305,B1506,E0876,C12859,D01413,AB00382980_15,124683-EP2295426A1,124683-EP2295427A1,979E328,A845765,SR-01000003061,Q-201506,Q5401768,SR-01000003061-3,"1,3,5(10)-Estratriene-3
,17beta-diol 17-pentanote",BRD-K66766661-001-19-2,"(17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate","(17beta)-3-hydroxyestra-1(10),2,4-trien-17-yl pentanoate","Estra-1,5(10)-triene-3,17-diol (
17.beta.)-, 17-pentanoate",S3149,SAM002564206,Prestw-1473,"Estradiol valerate","Estradiol Valerate"}

> <pdid>
PD002341

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{13791}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 28  0  0  0  0            999 V2000
   15.1894   -0.0057    0.0000 H   0  3
   12.6894   -0.0057    0.0000 H   0  3
   10.1894   -0.0057    0.0000 Cl  0  5
    7.6894   -0.0057    0.0000 Cl  0  5
    5.1873   -7.5109    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5998    1.4986    0.0000 C   0  0
   -3.8983    0.7460    0.0000 C   0  0
   -3.8989   -0.7540    0.0000 C   0  0
   -5.1982   -1.5035    0.0000 C   0  0
   -6.4970   -0.7530    0.0000 C   0  0
   -6.4964    0.7470    0.0000 C   0  0
   -5.1971    1.4965    0.0000 C   0  0
   -2.6013    2.9994    0.0000 C   0  0
   -1.3046    3.7535    0.0000 C   0  0
   -1.3092    5.2535    0.0000 C   0  0
   -2.6105    5.9995    0.0000 C   0  0
   -2.6152    7.4995    0.0000 Cl  0  0
   -3.9073    5.2455    0.0000 C   0  0
   -3.9027    3.7455    0.0000 C   0  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 17 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 30 24  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7783

> <plate>
1

> <well>
N04

> <supplier_cmpd_name>
Flavoxate HCl

> <ctcr_id>
4800

> <supplier_cmpd_id>
S4027

> <smiles>
[H+].[H+].[Cl-].[Cl-].OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3

> <pd_targets>
{KMT2A,MEN1,NS1,CYP3A4,ENV,ALD,ALOX15,HIF1A,FFP,HSD17B10,MAPT,TGR,AMPC,HRH1,DRD2,ADRA1A,ADRA1B,ADRA1D,ABCB11,HTR2A,SLCO1B1,SLCO1B3,KCNH2,CYP2D6}

> <pathway_gtopdb>
{"Epigenetic regulator","Unclassified protein",Enzyme,"Surface antigen","Transcription factor","Other cytosolic protein","Membrane receptor",Transporter,"Ion channel",Reader,"Cytochrome P450",Oxidored
uctase,Protease,Transferase,Hydrolase,"Family A G protein-coupled receptor","Primary active transporter","Electrochemical transporter","Voltage-gated ion channel",Bromodomain,"Cytochrome P450 family 3
","Cysteine protease","Small molecule receptor (family A GPCR)","ATP-binding cassette","SLC superfamily of solute carriers","Potassium channels","Cytochrome P450 family 2","Cytochrome P450 family 3A",
"Cysteine protease CA clan","Monoamine receptor","ABCB subfamily","SLC21/SLCO family of organic anion transporting polypeptides","Voltage-gated potassium channel","Cytochrome P450 family 2D","Cytochro
me P450 3A4","Cysteine protease C1A family","Histamine receptor","Dopamine receptor","Adrenergic receptor","Serotonin receptor","Cytochrome P450 2D6"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","Eicosanoid turnover","G protein-coupled receptors","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Vol
tage-gated ion channels","CYP3 family",Lipoxygenases,"Histamine receptors","Dopamine receptors","ABCB subfamily","5-Hydroxytryptamine receptors","SLCO family of organic anion transporting polypeptides
","Potassium channels","CYP2 family: drug metabolising subset","Voltage-gated potassium channels"}

> <pathway_reactome>
{Metabolism,"Cellular responses to external stimuli","Neuronal System","Signal Transduction","Muscle contraction","Metabolism of lipids","Cellular responses to stress","Metabolism of amino acids and d
erivatives","Transmission across Chemical Synapses","Signaling by GPCR","Cardiac conduction","Biological oxidations","Biosynthesis of specialized proresolving mediators (SPMs)","Cellular response to h
ypoxia","Branched-chain amino acid catabolism","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Metabolism of steroids","Phase 3 - rapid repolarisation","Phase 
I - Functionalization of compounds","Biosynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Activation of NMDA
 receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Cytochrome P450 - arranged by substrate type","Biosynthesis of maresins","Biosynthesis 
of DPAn-3 SPMs","Post NMDA receptor activation events","Amine ligand-binding receptors","Synthesis of bile acids and bile salts","Recycling of bile acids and salts",Xenobiotics,"Biosynthesis of maresi
n-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Activation of AMPK downstream of NMDARs","Histamine receptors","Dopamine receptors","Synthesis of bile acids and bile salts via 
7alpha-hydroxycholesterol","Serotonin receptors","CYP2E1 reactions"}

> <broad_targets>
{HRH1}

> <broad_moa>
{antihistamine}

> <synonyms>
{"Hydroxyzine dihydrochloride",2192-20-3,2192203,"Hydroxyzine hydrochloride","Hydroxyzine 2HCl",Orgatrax,"Hydroxyzine Hcl","Hydroxyzine (dihydrochloride)",MFCD00058200,UNII-5AQ4KXB9U4,UNII5AQ4KXB9U4,U
NII-GF8H55RPZ9,UNIIGF8H55RPZ9,5AQ4KXB9U4,GF8H55RPZ9,"2192-20-3 (2HCl)","2192203 (2HCl)",Arca,T2200,S4026,S4027,Prestw-133,"Flavoxate HCl"}

> <pdid>
PD009966

> <targets>
{AChR,"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{91513,24883432}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 38 39  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
   11.3852    1.8319    0.0000 O   0  0
   11.3852    0.3319    0.0000 C   0  0
   10.0859   -0.4177    0.0000 O   0  0
   12.6852   -0.4181    0.0000 C   0  0
   13.9852    0.3319    0.0000 C   0  0
   15.2851   -0.4181    0.0000 C   0  0
   16.5844    0.3315    0.0000 O   0  0
   15.2851   -1.9181    0.0000 O   0  0
   20.3851    1.8319    0.0000 O   0  0
   20.3851    0.3319    0.0000 C   0  0
   19.0859   -0.4177    0.0000 O   0  0
   21.6851   -0.4181    0.0000 C   0  0
   22.9851    0.3319    0.0000 C   0  0
   24.2851   -0.4181    0.0000 C   0  0
   25.5844    0.3315    0.0000 O   0  0
   24.2851   -1.9181    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  6  1  0
 20 15  1  0
  5 21  1  0
 21 22  1  0
 22  2  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  3
 27 28  1  0
 28 29  2  0
 28 30  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  2  3
 35 36  1  0
 36 37  2  0
 36 38  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7784

> <plate>
1

> <well>
N05

> <supplier_cmpd_name>
Azatadine dimaleate

> <ctcr_id>
6978

> <supplier_cmpd_id>
S3186

> <smiles>
CN1CCC(=C2c3ccccc3CCc4cccnc24)CC1.OC(=O)C=CC(=O)O.OC(=O)C=CC(=O)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{1445763-73-4,1445763734,HMS3604D19,HMS3652A11,AK546698,SW219888-1,SW2198881,Z1625061700,T0236,S3186,"Azatadine Maleate","Azatadine dimaleate"}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{66273}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 19 21  0  0  1  0            999 V2000
   -1.2969  -10.5958    0.0000 C   0  0
   -1.7622   -9.1698    0.0000 C   0  0
   -0.7600   -8.0526    0.0000 C   0  0
    0.7077   -8.3622    0.0000 O   0  0
   -1.2256   -6.6258    0.0000 N   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0  2  0  0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
 18 19  2  0
 19  8  1  0
 19 11  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7785

> <plate>
1

> <well>
N06

> <supplier_cmpd_name>
Ramelteon

> <ctcr_id>
4629

> <supplier_cmpd_id>
S1259

> <smiles>
CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12

> <pd_targets>
{MTNR1A,ABCB11,MTNR1B}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,Enzyme,"Family A G protein-coupled receptor","Primary active transporter",Protease,"Small molecule receptor (family A GPCR)","ATP-binding cassette","Cysteine protease"
,"Monoamine-derivative receptor (family A GPCR)","ABCB subfamily","Cysteine protease CA clan","Melatonin receptor","Cysteine protease C1A family"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","ATP-binding cassette transporter family","Melatonin receptors","ABCB subfamily"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Signaling by GPCR","Metabolism of lipids","GPCR downstream signalling","Metabolism of steroids","G alpha (i) signalling events","Bile acid and bile salt metabolism",
"Synthesis of bile acids and bile salts","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{MTNR1A,MTNR1B}

> <broad_moa>
{"melatonin receptor agonist"}

> <synonyms>
{Ramelteon,196597-26-9,196597269,Rozerem,TAK-375,TAK375,"(S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4-b)furan-8-yl)ethyl)propionamide","(S)N(2(1,6,7,8tetrahydro2Hindeno(5,4b)furan8yl)ethyl)propionamide
",UNII-901AS54I69,UNII901AS54I69,"(S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)propionamide",CHEMBL1218,901AS54I69,N-(2-(,N(2(,T1463,S1259,1505817,RAMELTEON}

> <pdid>
PD000712

> <targets>
{Others}

> <classes>
{"melatonin receptor agonist","GPCR & G Protein"}

> <pubchem_cids>
{208902}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 28  0  0  0  0            999 V2000
   15.1894   -0.0057    0.0000 H   0  3
   12.6894   -0.0057    0.0000 H   0  3
   10.1894   -0.0057    0.0000 Cl  0  5
    7.6894   -0.0057    0.0000 Cl  0  5
    5.1873   -7.5109    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5998    1.4986    0.0000 C   0  0
   -3.8983    0.7460    0.0000 C   0  0
   -3.8989   -0.7540    0.0000 C   0  0
   -5.1982   -1.5035    0.0000 C   0  0
   -6.4970   -0.7530    0.0000 C   0  0
   -6.4964    0.7470    0.0000 C   0  0
   -5.1971    1.4965    0.0000 C   0  0
   -2.6013    2.9994    0.0000 C   0  0
   -1.3046    3.7535    0.0000 C   0  0
   -1.3092    5.2535    0.0000 C   0  0
   -2.6105    5.9995    0.0000 C   0  0
   -2.6152    7.4995    0.0000 Cl  0  0
   -3.9073    5.2455    0.0000 C   0  0
   -3.9027    3.7455    0.0000 C   0  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 17 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 30 24  1  0
M  CHG  4   1   1   2   1   3  -1   4  -1
M  END
> <name>
Selleck_GPCR

> <id>
7786

> <plate>
1

> <well>
N07

> <supplier_cmpd_name>
Hydroxyzine 2HCl

> <ctcr_id>
4800

> <supplier_cmpd_id>
S4026

> <smiles>
[H+].[H+].[Cl-].[Cl-].OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3

> <pd_targets>
{KMT2A,MEN1,NS1,CYP3A4,ENV,ALD,ALOX15,HIF1A,FFP,HSD17B10,MAPT,TGR,AMPC,HRH1,DRD2,ADRA1A,ADRA1B,ADRA1D,ABCB11,HTR2A,SLCO1B1,SLCO1B3,KCNH2,CYP2D6}

> <pathway_gtopdb>
{"Epigenetic regulator","Unclassified protein",Enzyme,"Surface antigen","Transcription factor","Other cytosolic protein","Membrane receptor",Transporter,"Ion channel",Reader,"Cytochrome P450",Oxidored
uctase,Protease,Transferase,Hydrolase,"Family A G protein-coupled receptor","Primary active transporter","Electrochemical transporter","Voltage-gated ion channel",Bromodomain,"Cytochrome P450 family 3
","Cysteine protease","Small molecule receptor (family A GPCR)","ATP-binding cassette","SLC superfamily of solute carriers","Potassium channels","Cytochrome P450 family 2","Cytochrome P450 family 3A",
"Cysteine protease CA clan","Monoamine receptor","ABCB subfamily","SLC21/SLCO family of organic anion transporting polypeptides","Voltage-gated potassium channel","Cytochrome P450 family 2D","Cytochro
me P450 3A4","Cysteine protease C1A family","Histamine receptor","Dopamine receptor","Adrenergic receptor","Serotonin receptor","Cytochrome P450 2D6"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","Eicosanoid turnover","G protein-coupled receptors","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Vol
tage-gated ion channels","CYP3 family",Lipoxygenases,"Histamine receptors","Dopamine receptors","ABCB subfamily","5-Hydroxytryptamine receptors","SLCO family of organic anion transporting polypeptides
","Potassium channels","CYP2 family: drug metabolising subset","Voltage-gated potassium channels"}

> <pathway_reactome>
{Metabolism,"Cellular responses to external stimuli","Neuronal System","Signal Transduction","Muscle contraction","Metabolism of lipids","Cellular responses to stress","Metabolism of amino acids and d
erivatives","Transmission across Chemical Synapses","Signaling by GPCR","Cardiac conduction","Biological oxidations","Biosynthesis of specialized proresolving mediators (SPMs)","Cellular response to h
ypoxia","Branched-chain amino acid catabolism","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Metabolism of steroids","Phase 3 - rapid repolarisation","Phase 
I - Functionalization of compounds","Biosynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Activation of NMDA
 receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Cytochrome P450 - arranged by substrate type","Biosynthesis of maresins","Biosynthesis 
of DPAn-3 SPMs","Post NMDA receptor activation events","Amine ligand-binding receptors","Synthesis of bile acids and bile salts","Recycling of bile acids and salts",Xenobiotics,"Biosynthesis of maresi
n-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Activation of AMPK downstream of NMDARs","Histamine receptors","Dopamine receptors","Synthesis of bile acids and bile salts via 
7alpha-hydroxycholesterol","Serotonin receptors","CYP2E1 reactions"}

> <broad_targets>
{HRH1}

> <broad_moa>
{antihistamine}

> <synonyms>
{"Hydroxyzine dihydrochloride",2192-20-3,2192203,"Hydroxyzine hydrochloride","Hydroxyzine 2HCl",Orgatrax,"Hydroxyzine Hcl","Hydroxyzine (dihydrochloride)",MFCD00058200,UNII-5AQ4KXB9U4,UNII5AQ4KXB9U4,U
NII-GF8H55RPZ9,UNIIGF8H55RPZ9,5AQ4KXB9U4,GF8H55RPZ9,"2192-20-3 (2HCl)","2192203 (2HCl)",Arca,T2200,S4026,S4027,Prestw-133,"Flavoxate HCl"}

> <pdid>
PD009966

> <targets>
{AChR,"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{91513,24883432}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 19 20  0  0  1  0            999 V2000
    7.7003   -1.1250    0.0000 Cl  0  0
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 C   0  0
   -5.1962   -1.5000    0.0000 C   0  0
   -6.4952   -0.7500    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9  8  1  6
  9 10  1  0
 10  5  1  0
 10 11  1  1
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19  9  1  0
 19 13  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7787

> <plate>
1

> <well>
N08

> <supplier_cmpd_name>
PD128907 HCl

> <ctcr_id>
8214

> <supplier_cmpd_id>
S2168

> <smiles>
Cl.CCCN1CCO[C@@H]2[C@@H]1COc3ccc(O)cc23

> <pd_targets>
{DRD3,DRD2,MAPK1,TP53,LEF,CYP2D6,TSHR,CHRM1,CYP3A4,CYP1A2,HTR1A,NFO,LMNA,NPSR1,DRD4}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Dopamine receptor",Enzyme,"Transcription factor","Other nuclear protein",Kina
se,Protease,"Cytochrome P450",Hydrolase,"Protein Kinase","Metallo protease","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1","CMGC pr
otein kinase group","Metallo protease MAE clan","Cytochrome P450 family 2D","Glycohormone receptor","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Short peptide receptor (family A GPCR)","CM
GC protein kinase MAPK family","Metallo protease M34 family","Cytochrome P450 2D6","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 1A1","Serotonin receptor","Neuropeptide receptor","CM
GC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Dopamine receptors",Enzymes,"Kinases (EC 2.7.x.x)","Cytochrome P450","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP2 family: drug metabolising subset","
Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","CYP3 family","CYP1 family","5-Hydroxytryptamine receptors","Neuropeptide S receptor","Mitogen-activated protein kinases (MAP kin
ases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Dopamine receptors","Immune System","Cell Cycle",Disease,Metab
olism,"Innate Immune System","Cell Cycle Checkpoints","Infectious disease","Biological oxidations","Metabolism of lipids",Mitotic,"Toll-like Receptor Cascades","G1/S DNA Damage Checkpoints","Uptake an
d actions of bacterial toxins","Phase I - Functionalization of compounds","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Toll Like Receptor 5 (TLR5) Casc
ade","p53-Dependent G1/S DNA damage checkpoint","Uptake and function of anthrax toxins","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Biosynthesis of DHA-de
rived SPMs","Mitotic Metaphase and Anaphase","MyD88 cascade initiated on plasma membrane","p53-Dependent G1 DNA Damage Response",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite i
nfection","Biosynthesis of maresins","Mitotic Anaphase","MAP kinase activation","Stabilization of p53","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylch
oline receptors","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Serotonin receptors","Nuclear Envelope (NE) Reassembly","MAPK targets/ Nuclear 
events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{DRD2,DRD3}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{"(-)-PD 128907 HYDROCHLORIDE","()PD 128907 HYDROCHLORIDE","PD128907 HCl","(+)-PD 128907 HCl","(+)PD 128907 HCl",C14H19NO3.ClH,DTXSID601017876,2111AH,s2168,CCG-267328,CCG267328,S2168}

> <pdid>
PD047779

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{56972130}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 20  0  0  0  0            999 V2000
   15.4003   -1.1250    0.0000 H   0  3
   12.9003   -1.1250    0.0000 Cl  0  5
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    9.0964    0.7636    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 12  1  0
 21 16  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7788

> <plate>
1

> <well>
N09

> <supplier_cmpd_name>
Propranolol HCl

> <ctcr_id>
2371

> <supplier_cmpd_id>
S4076

> <smiles>
[H+].[Cl-].CC(C)NCC(O)COc1cccc2ccccc12

> <pd_targets>
{PMP22,LMNA,AMPC,APEX1,NFKB1,LEF,HTR2A,HTR2B,HTR2C,CYP2D6,CHRM1,THPO,CYP1A2,HSD17B10,ADRB2,SLC10A1,SCN1A,SCN2A,SCN3A,TSHR,HTR1B,CACNA1S,HTR1A,MAPK1,TP53,CYP2D26,CYP2C9,ADRB1,SLC6A4,SIGMAR1,CACNA1C,CAC
NA1D,ALDH1A1,ADRB3,KCNH2,DRD2,ABCB1,SCN5A,HTR6,SLC22A1,HTR5A,HTR1D,HTR1F}

> <pathway_gtopdb>
{"Unclassified protein","Other nuclear protein",Enzyme,"Other cytosolic protein","Membrane receptor",Transporter,"Ion channel","Transcription factor",Hydrolase,Protease,"Family A G protein-coupled rec
eptor","Cytochrome P450",Oxidoreductase,"Electrochemical transporter","Voltage-gated ion channel",Kinase,"Metallo protease","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Cytoch
rome P450 family 1","SLC superfamily of solute carriers","Voltage-gated sodium channel","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","Protein Kinase","Metallo protease MAE clan",
"Monoamine receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","SLC10 family of sodium-bile acid co-transporters","Glycohormone receptor","CMGC protein kinase group","Cytochrome P450 fam
ily 2C","SLC06 neurotransmitter transporter family","Metallo protease M34 family","Serotonin receptor","Cytochrome P450 2D6","Acetylcholine receptor","Cytochrome P450 1A1","Adrenergic receptor","CMGC 
protein kinase MAPK family","Cytochrome P450 2D2","Cytochrome P450 2C9","CMGC protein kinase ERK1","Primary active transporter","Potassium channels","ATP-binding cassette","Voltage-gated potassium cha
nnel","ABCB subfamily","SLC22 family of organic cation and anion transporters","Dopamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Other protein targets","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Voltage-gated ion channels","Kinases (EC 2.
7.x.x)","Sigma receptors","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","CYP1 family",Adrenoceptors,"SLC10 family of sodium-bile acid co-transporters","Glycoprotein ho
rmone receptors","5-Hydroxytryptamine receptors","Voltage-gated calcium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC6 neurotransmitter transporter family","Mitogen-activated protein 
kinases (MAP kinases)","Monoamine transporter subfamily","ERK subfamily","ATP-binding cassette transporter family","Potassium channels","Dopamine receptors","ABCB subfamily","Voltage-gated sodium chan
nels","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Developmental Biology","Cell Cycle","DNA Repair","Immune System",Disease,Metabolism,"Signal Transduction",Hemostasis,"Neuronal System","Nervous system development",Mitotic,"Base Excision Repair","Cy
tokine Signaling in Immune system","Infectious disease","Biological oxidations","Signaling by GPCR","Platelet activation","signaling and aggregation","Metabolism of amino acids and derivatives","Metab
olism of lipids","Innate Immune System","Cell Cycle Checkpoints","Transmission across Chemical Synapses","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Resolution of Abasi
c Sites (AP sites)","Signaling by Interleukins","Uptake and actions of bacterial toxins","Phase I - Functionalization of compounds","GPCR ligand binding","Platelet Aggregation (Plug Formation)","Branc
hed-chain amino acid catabolism","Leishmania infection","Metabolism of steroids","Axon guidance","Toll-like Receptor Cascades","G1/S DNA Damage Checkpoints","Neurotransmitter clearance","SARS-CoV Infe
ctions","Mitotic Metaphase and Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Interleukin-1 family signaling","Uptake and function of anthrax toxins","Cytoch
rome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Bile acid and bile salt metabolism","NCAM signaling for neurite out-growth","T
oll Like Receptor 5 (TLR5) Cascade","p53-Dependent G1/S DNA damage checkpoint","Serotonin clearance from the synaptic cleft","Potential therapeutics for SARS","Mitotic Anaphase","PCNA-Dependent Long P
atch Base Excision Repair","Interleukin-1 signaling",Xenobiotics,"Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Recycling of bile acids and salt
s","NCAM1 interactions","MyD88 cascade initiated on plasma membrane","p53-Dependent G1 DNA Damage Response","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","CYP2E1 reac
tions","Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","MAP kina
se activation","Stabilization of p53","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MA
PK targets","ERKs are inactivated","Muscle contraction","Transport of small molecules","Cardiac conduction","Abacavir transport and metabolism","SLC-mediated transmembrane transport","Phase 3 - rapid 
repolarisation","Abacavir transmembrane transport","Transport of bile salts and organic acids","metal ions and amine compounds","Ethanol oxidation","L1CAM interactions","Organic cation/anion/zwitterio
n transport","Interaction between L1 and Ankyrins","Organic cation transport","Dopamine receptors"}

> <broad_targets>
{ADRB1,HTR1A,HTR5A,SLC10A1}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Efektolol,"Propranolol hydrochloride",318-98-9,318989,"Propranolol Hcl",Inderal,Anaprilin,Avlocardyl,Berkolol,Caridolol,Herzbase,Inderalici,Naprilin,Pronovan,Dociton,Ikopal,Kemi,"Beta Neg","InnoPran 
XL","Propranolol chloride",Inderex,propranol,S4076,SAM002699889,1505270,"Propranolol HCl",CPD000059167,"PROPRANOLOL HYDROCHLORIDE (+/-)"}

> <pdid>
PD007086

> <targets>
{"Adrenergic Receptor"}

> <classes>
{antianginal,"GPCR & G Protein",antiarrhythmic,antihypertensive}

> <pubchem_cids>
{62882,43834240,25137848}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 38 41  0  0  0  0            999 V2000
    6.6745   -6.6103    0.0000 C   0  0
    7.6412   -5.4633    0.0000 C   0  0
    9.1179   -5.7270    0.0000 C   0  0
   10.0845   -4.5800    0.0000 N   0  0
    9.5745   -3.1693    0.0000 C   0  0
    8.0979   -2.9056    0.0000 C   0  0
    7.5847   -1.4952    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
    1.0157    5.5663    0.0000 Cl  0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
    7.1312   -4.0527    0.0000 C   0  0
   13.8845    1.3531    0.0000 O   0  0
   13.8845   -0.1469    0.0000 C   0  0
   12.5852   -0.8965    0.0000 O   0  0
   15.1845   -0.8969    0.0000 C   0  0
   16.4845   -0.1469    0.0000 C   0  0
   17.7845   -0.8969    0.0000 C   0  0
   17.7845   -2.3969    0.0000 O   0  0
   19.0838   -0.1473    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 11 14  2  3
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 14  1  0
 29 24  1  0
  6 30  2  0
 30  2  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  1  0
 36 38  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7789

> <plate>
1

> <well>
N10

> <supplier_cmpd_name>
Rupatadine Fumarate

> <ctcr_id>
7268

> <supplier_cmpd_id>
S3052

> <smiles>
Cc1cncc(CN2CCC(CC2)=C3c4ccc(Cl)cc4CCc5cccnc35)c1.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"UR-12592 fumarate","UR12592 fumarate",Rupafin,"Rupatadin Fumarate","Rupatadine fumarate",182349-12-8,182349128,"Rupatadine (Fumarate)",UNII-XJ6OT32M93,UNIIXJ6OT32M93,Alergoliber,XJ6OT32M93,"182349-1
2-8 (fumarate)","182349128 (fumarate)",Rupax,MFCD00926499,Rupatall,Tamalis,Wystamm,Ralif,"Rinialer (T",S3052,"Rupatadine Fumarate"}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{6449107}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 14 13  0  0  0  0            999 V2000
    8.8056   -1.8965    0.0000 H   0  3
    6.3056   -1.8965    0.0000 Cl  0  5
    1.8372   -5.2877    0.0000 C   0  0
    3.3372   -5.2929    0.0000 C   0  0
    3.8056   -3.8679    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.3786   -3.8595    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  6 14  1  0
 14  3  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7790

> <plate>
1

> <well>
N11

> <supplier_cmpd_name>
Tolazoline HCl

> <ctcr_id>
3789

> <supplier_cmpd_id>
S4124

> <smiles>
[H+].[Cl-].C1CN=C(Cc2ccccc2)N1

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRA1A,TAAR1,TSHR,CYP2D6,ADRA1B,ADRA1D,LMNA,HTR7,CYP1A2,HRH2,HRH1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P45
0 family 2","Cytochrome P450 family 1","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Adrenergic receptor","Trace amine receptor","Cytochrome P45
0 2D6","Serotonin receptor","Cytochrome P450 1A1","Histamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450",Adrenoceptors,"Trace amine receptor","Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","5-Hydroxytryptamine re
ceptors","CYP1 family","Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,Metabolism,"Cell Cycle","Signaling by GPCR","Infectious disease","Biological oxidations",Mitotic,"GPCR ligand binding","Leishmania infection","Phase I - Functionalizatio
n of compounds","M Phase","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Amine ligand
-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Mitotic Anaphase",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 
reactions","Nuclear Envelope (NE) Reassembly","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Histamine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A,ADRA2A,ADRA2B,ADRA2C,HRH1,HRH2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Tolazoline hydrochloride",59-97-2,59972,"59 97 2","Tolazoline HCl","2-benzyl-4,5-dihydro-1H-imidazole hydrochloride","2benzyl4,5dihydro1Himidazole hydrochloride","2 benzyl 4,5 dihydro 1H imidazole h
ydrochloride","Tolazoline (hydrochloride)",Benzaz,S4127,S4124,SAM002589935,1500580,Prestw-60,"Terbutaline Sulfate",CPD000149600,"TOLAZOLINE HYDROCHLORIDE"}

> <pdid>
PD009716

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein","adrenergic blocker","Neuronal Signaling"}

> <pubchem_cids>
{6048,74764089}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 31 33  0  0  1  0            999 V2000
   -2.9219   -7.3759    0.0000 C   0  0
   -1.4309   -7.5400    0.0000 C   0  0
   -0.5420   -6.3307    0.0000 C   0  0
    0.9498   -6.4949    0.0000 N   0  0
    1.8372   -5.2877    0.0000 C   0  0
    1.3786   -3.8595    0.0000 S   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 O   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0  2  0  0  0
   -5.1937    3.0092    0.0000 O   0  0
   -3.8912    5.2578    0.0000 C   0  0
   -5.1887    6.0105    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8056   -3.8679    0.0000 C   0  0
    5.2311   -3.4009    0.0000 O   0  0
    3.3372   -5.2929    0.0000 N   0  0
    4.2151   -6.5101    0.0000 C   0  0
    3.4940   -7.8274    0.0000 C   0  0
    4.2774   -9.1065    0.0000 C   0  0
    5.7769   -9.0676    0.0000 C   0  0
    6.4930   -7.7496    0.0000 C   0  0
    5.7096   -6.4704    0.0000 C   0  0
    6.4252   -5.1522    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  6
 15 17  1  0
 17 18  1  0
 12 19  1  0
 19 20  1  0
 19 21  2  0
 21  9  1  0
  7 22  1  0
 22 23  2  0
 22 24  1  0
 24  5  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 30 31  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7791

> <plate>
1

> <well>
N12

> <supplier_cmpd_name>
Ponesimod

> <ctcr_id>
8215

> <supplier_cmpd_id>
S8241

> <smiles>
CCC\N=C\1/S\C(=C/c2ccc(OC[C@H](O)CO)c(Cl)c2)\C(=O)N1c3ccccc3C

> <pd_targets>
{S1PR4,S1PR1,S1PR5,S1PR3}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","EDG receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Lysophospholipid (S1P) receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Lysosphingolipid and LPA receptors"}

> <broad_targets>
{S1PR1}

> <broad_moa>
{"sphingosine 1-phosphate receptor agonist"}

> <synonyms>
{Ponesimod,854107-55-4,854107554,UNII-5G7AKV2MKP,UNII5G7AKV2MKP,ACT-128800,ACT128800,CHEMBL1096146,5G7AKV2MKP,"Ponesimod (USAN:INN)","ACT 128800","Ponesimod (USAN/INN)","Ponesimod,ACT-128800","Ponesim
od,ACT128800",GTPL9320,"Ponesimod (ACT-128800)","Ponesimod (ACT128800)",SCHEMBL15477934,SCHEMBL15477937,DTXSID50234631,AM,T3258,S8241}

> <pdid>
PD046939

> <targets>
{S1P Receptor,LPL Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein}

> <pubchem_cids>
{11363176}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 25 25  0  0  0  0            999 V2000
   14.1828   -4.5076    0.0000 Cl  0  0
    5.1937   -3.0093    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    6.4855   -9.7648    0.0000 C   0  0
    7.7846  -10.5149    0.0000 C   0  0
    9.0836   -9.7649    0.0000 C   0  0
   10.3826  -10.5149    0.0000 O   0  0
    9.0836   -8.2649    0.0000 C   0  0
    7.7846   -7.5149    0.0000 C   0  0
   10.3819   -7.5118    0.0000 C   0  0
   11.6822   -8.2596    0.0000 N   0  0
   10.3798   -6.0118    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  3 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 16  1  0
 21 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7792

> <plate>
1

> <well>
N13

> <supplier_cmpd_name>
Labetalol HCl

> <ctcr_id>
6569

> <supplier_cmpd_id>
S4291

> <smiles>
Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(N)=O

> <pd_targets>
{ALDH1A1,HPGD,KDM4E,GAA,ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,RCE1,STE24,LMNA,SMN1,ADRB1,ADRB2,ADRB3,HSD17B10,CYP2D6,SLC6A3,SIGMAR1,HTR1A,HTR2B,SLC6A2}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor","Other nuclear protein",Transporter,Oxidoreductase,Eraser,Hydrolase,"Family A G protein-coupled receptor",Protease,Reader,"Cytochrome P450","Electroc
hemical transporter","Lysine demethylase","Small molecule receptor (family A GPCR)","Metallo protease","Methyl-lysine/arginine binding protein","Cytochrome P450 family 2","SLC superfamily of solute ca
rriers","Jumonji domain-containing","Monoamine receptor","Metallo protease MAE clan","Tudor domain","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Adrenergic receptor","Metal
lo protease M48A subfamily","Cytochrome P450 2D6","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Eicosanoid turnover","Chromatin modifying enzymes","3.2.1.- Glycosidases","G protein-coupled receptors","Cytochrome P450","SLC superfamily of s
olute carriers","Sigma receptors","Prostaglandin synthases","1.14.11.- Histone demethylases",Adrenoceptors,"CYP2 family: drug metabolising subset","SLC6 neurotransmitter transporter family","5-Hydroxy
tryptamine receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Cell Cycle","Metabolism of RNA","Signal Transduction","Biological oxidations","Metabolism of lipids","Diseases of metabolism",Mitotic,"Metabolism of non-coding RNA","Metabolism of
 amino acids and derivatives","Signaling by GPCR","Infectious disease","Disorders of transmembrane transporters","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving me
diators (SPMs)","Diseases of carbohydrate metabolism","M Phase","snRNP Assembly","Branched-chain amino acid catabolism","GPCR ligand binding","Leishmania infection","SLC transporter disorders","SARS-C
oV Infections","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Glycogen storage diseases","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth an
d survival","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Potential therapeutics for SARS","Defective SLC6A2 causes orthostatic into
lerance (OI)","Biosynthesis of D-series resolvins","Glycogen storage disease type II (GAA)","Mitotic Anaphase","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasit
e infection",Xenobiotics,"Nuclear Envelope (NE) Reassembly",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Serotonin receptors","Initiation of Nuclear Enve
lope (NE) Reformation"}

> <broad_targets>
{ADRA1D,ADRB1,ADRB2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{AKOS026749871,"Labetalol hydrochloride",32780-64-6,32780646,"32780 64 6","Labetalol HCL",Amipress,Presdate,"Labetalol (hydrochloride)",Trandate,"ScH 15719W","AH 5158A",UNII-1GEV3BAW9J,UNII1GEV3BAW9J,
"UNII 1GEV3BAW9J",Sch-15719W,Sch15719W,Sch,T0348,S4291,SAM002564217,1503243,Prestw-277,"Labetalol HCl",CPD000058463,"LABETALOL HYDROCHLORIDE"}

> <pdid>
PD009899

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"adrenergic blocker","GPCR & G Protein"}

> <pubchem_cids>
{657196,71412}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 27  0  0  1  0            999 V2000
    0.1423    1.5763    0.0000 C   0  0
    0.0479    0.0793    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    2.8524   -0.2919    0.0000 O   0  0
    3.4192   -2.8384    0.0000 C   0  0
    4.4371   -3.9401    0.0000 C   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  2  0
  7  5  1  1
  7  8  1  0
  8  9  1  6
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 17 16  1  6
 17  7  1  0
 17 11  1  0
  8 18  1  0
 18  3  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21  3  1  0
 21 22  1  1
 21 23  1  0
 23 24  3  0
M  END
> <name>
Selleck_GPCR

> <id>
7793

> <plate>
1

> <well>
N15

> <supplier_cmpd_name>
Etonogestrel

> <ctcr_id>
8216

> <supplier_cmpd_id>
S4673

> <smiles>
CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

> <pd_targets>
{SHBG,PGR}

> <pathway_gtopdb>
{"Secreted protein","Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member
 3"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Metabolism of proteins","Post-translational protein modification",SUMOylation,"SUMO E3 ligases SUMOylate target proteins","SUMOylation of intracellular receptors"}

> <broad_targets>
{ESR1,PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{ETONOGESTREL,Implanon,54048-10-1,54048101,3-Oxodesogestrel,3Oxodesogestrel,nexplanon,3-Ketodesogestrel,3Ketodesogestrel,3-Keto-desogestrel,Org-3236,Org3236,UNII-304GTH6RNH,UNII304GTH6RNH,"ORG 3236",3
04GTH6RNH,CHEBI:50777,"18,19-Dinorpregn-4-en-20-yn-3-one,13-ethyl-17-hydroxy-11-methylene-, (17a)-","18,19Dinorpregn4en20yn3one,13ethyl17hydroxy11methylene, (17a)",etonogestrelum,T2567,S4673,Etonogest
rel}

> <pdid>
PD010119

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{Endocrinology&Hormones}

> <pubchem_cids>
{6917715}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 33 36  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
   -1.3039    3.7494    0.0000 S   0  0
   -2.6017    2.9971    0.0000 O   0  0
   -1.3015    2.2494    0.0000 O   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6076    5.9975    0.0000 C   0  0
   -2.6107    7.4975    0.0000 C   0  0
   -1.3132    8.2502    0.0000 C   0  0
   -0.0126    7.5029    0.0000 C   0  0
   -0.0095    6.0029    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8933   -3.7570    0.0000 C   0  0
   -3.8934   -5.2570    0.0000 C   0  0
   -5.1924   -6.0071    0.0000 C   0  0
   -6.4914   -5.2571    0.0000 C   0  0
   -7.7927   -6.0049    0.0000 C   0  0
   -9.0914   -5.2527    0.0000 N   0  0
   -9.2242   -3.7713    0.0000 C   0  0
  -10.6903   -3.4544    0.0000 C   0  0
  -11.4448   -4.7508    0.0000 C   0  0
  -10.4449   -5.8690    0.0000 C   0  0  2  0  0  0
  -10.7533   -7.3351    0.0000 C   0  0
  -12.1786   -7.8027    0.0000 O   0  0
   -6.4915   -3.7571    0.0000 C   0  0
   -5.1925   -3.0071    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  2  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  4 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 24  1  0
 28 29  1  1
 29 30  1  0
 22 31  1  0
 31 32  2  0
 32 19  1  0
 16 33  2  0
 33  2  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7794

> <plate>
1

> <well>
N17

> <supplier_cmpd_name>
PF-543

> <ctcr_id>
7598

> <supplier_cmpd_id>
S7177

> <smiles>
Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc3ccc(CN4CCC[C@@H]4CO)cc3)c1

> <pd_targets>
{SPHK1,SPHK2}

> <pathway_gtopdb>
{Enzyme}

> <pathway_chembl>
{Enzymes,"Sphingosine 1-phosphate turnover","Sphingosine kinase"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Signaling by Receptor Tyrosine Kinases","Metabolism of lipids","Signaling by VEGF","Sphingolipid metabolism","VEGFA-VEGFR2 Pathway","Sphingolipid de novo biosynthesi
s","VEGFR2 mediated cell proliferation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{PF-543,PF543,1415562-82-1,1415562821,"PF 543",CHEMBL3134157,C27H31NO4S,GTPL6623,SCHEMBL17786131,DTXSID90735359,CHEBI:131144,BCP07072,BDBM50041978,ZINC94568743,CCG-269412,CCG269412,CS-0869,CS0869,SB19
553,"compound 22a (PMID: 22397330)",NCGC00346972-04,NCGC0034697204,HY-15425,HY15425,S7177,SW218168-2,SW2181682}

> <pdid>
PD003318

> <targets>
{"S1P Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{66577038}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 31  0  0  0  0            999 V2000
    5.1965   -1.5117    0.0000 C   0  0
    3.8999   -0.7576    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    7.7905   -6.0071    0.0000 O   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
    1.2941   -3.7520    0.0000 C   0  0
    1.2894   -5.2521    0.0000 C   0  0
   -0.0120   -5.9981    0.0000 C   0  0
   -1.3087   -5.2440    0.0000 C   0  0
   -2.6123   -5.9877    0.0000 O   0  0
   -3.9086   -5.2314    0.0000 C   0  0
   -5.2123   -5.9751    0.0000 C   0  0
   -6.5086   -5.2188    0.0000 N   0  0
   -7.8115   -5.9621    0.0000 C   0  0
   -6.5013   -3.7189    0.0000 C   0  0
   -1.3040   -3.7440    0.0000 C   0  0
   -0.0027   -2.9981    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  3 10  2  3
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
 10 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 21 28  1  0
 28 29  2  0
 29 18  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7795

> <plate>
1

> <well>
N19

> <supplier_cmpd_name>
4-Hydroxytamoxifen

> <ctcr_id>
8217

> <supplier_cmpd_id>
S7827

> <smiles>
CCC(c1ccccc1)=C(c2ccc(O)cc2)c3ccc(OCCN(C)C)cc3

> <pd_targets>
{FFP,NPSR1,MAPT,ESR1,ESR2,PGR,ESRRB,ESRRG,PLD2,AR,LMNA,KMT2A,MEN1,FTL,PLD1,RORC,KDM4E,ESRRA,TP53,CYP3A4,LEF,HIF1A,ALDH1A1,GPER1,REP}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other cytosolic protein","Transcription factor","Other nuclear protein","Epigenetic regulator","Unclassified protein",Transferase,"Family A G protein-coupled receptor","Nu
clear receptor",Hydrolase,Reader,Eraser,"Cytochrome P450",Protease,Oxidoreductase,"Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 3",Bromodomain,"Nuclear hormone receptor subfam
ily 1","Lysine demethylase","Cytochrome P450 family 3","Metallo protease","Small molecule receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group
 A","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group B","Nuclear hormone receptor subfamily 1 group F","Jumonji domain-containing","Cytochrome P450 family 3A"
,"Metallo protease MAE clan","Lipid-like ligand receptor (family A GPCR)","Neuropeptide receptor","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group A 
member 2","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group B member 2","Nuclear hormone receptor subfamily 3 group B member 3","Nuclear hormone recep
tor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 group B member 1","Cytochrome P450 3A4","Metallo protease M34 family","S
teroid-like ligand receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Nuclear hormone receptors","Glycerophospholipid turnover","Chromatin modifying enzymes","Cytochrome P450","Neuropeptide S receptor","Steroid hormone r
eceptors","3B. Estrogen-related receptors","Phosphatidylcholine-specific phospholipase D","1F. Retinoic acid-related orphans","1.14.11.- Histone demethylases","CYP3 family","G protein-coupled estrogen
 receptor","3A. Estrogen receptors","3C. 3-Ketosteroid receptors","Other protein targets","Anti-infective targets","Viral protein targets","Coronavirus (CoV) proteins"}

> <pathway_reactome>
{Disease,"Neuronal System","Gene expression (Transcription)","Signal Transduction","Metabolism of proteins",Metabolism,"Cell Cycle","Vesicle-mediated transport","Cellular responses to external stimuli
","Infectious disease","Transmission across Chemical Synapses","RNA Polymerase II Transcription","Intracellular signaling by second messengers","Post-translational protein modification","Metabolism of
 lipids",Mitotic,"Membrane Trafficking","Cell Cycle Checkpoints","Cellular responses to stress","Biological oxidations","Signaling by GPCR","Leishmania infection","Neurotransmitter receptors and posts
ynaptic signal transmission","Generic Transcription Pathway","PIP3 activates AKT signaling",SUMOylation,"Phospholipid metabolism","M Phase","trans-Golgi Network Vesicle Budding","G1/S DNA Damage Check
points","Biosynthesis of specialized proresolving mediators (SPMs)","Uptake and actions of bacterial toxins","Cellular response to hypoxia","Phase I - Functionalization of compounds","GPCR ligand bind
ing","Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Transcriptional regulation by RUNX1","Negative regulation of the PI3K/AKT network","SUMO E3 ligas
es SUMOylate target proteins","Nuclear Receptor transcription pathway","Glycerophospholipid biosynthesis","Transcriptional regulation by RUNX2","Mitotic Metaphase and Anaphase","Golgi Associated Vesic
le Biogenesis","Transcriptional regulation by RUNX3","p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Uptake and function of anthrax toxins","Oxygen-dependent proline hyd
roxylation of Hypoxia-inducible Factor Alpha","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activa
tion events","RUNX1 regulates estrogen receptor mediated transcription",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","SUMOylation of intracellular receptors","Synthesis of PA","RUNX2 regulates bon
e development","Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","Regulation of RUNX2 expression and activity","p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins","
Peptide ligand-binding receptors","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","RUNX2 regulates osteoblast differentiation","Nuclear Envelope (NE
) Reassembly","Stabilization of p53","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","SARS-CoV Infections","SARS
-CoV-2 Infection","SARS-CoV-2 Genome Replication and Transcription","Replication of the SARS-CoV-2 genome"}

> <broad_targets>
{ESR1}

> <broad_moa>
{"selective estrogen receptor modulator (SERM)"}

> <synonyms>
{HYDROXYTAMOXIFE,Afimoxifene,68392-35-8,68392358,(Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)-phenyl)-2-phenylbut-1-en-1-yl)phenol,(Z)4(1(4(2(Dimethylamino)ethoxy)phenyl)2phenylbut1en1yl)phenol,68047-06-3,68
047063,(Z)-4-(1-(4-(Dimethylaminoethoxy)phenyl)-2-phenyl-1-butenyl)phenol,(Z)4(1(4(Dimethylaminoethoxy)phenyl)2phenyl1butenyl)phenol,174592-47-3,174592473,(E/Z)-4-Hydroxytamoxifen,(E/Z)4Hydroxytamoxif
en,4-(1-(4-(2-(dimethylami,4(1(4(2(dimethylami,T6743,S7827,4-Hydroxytamoxifen}

> <pdid>
PD015621

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{63062}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 31 34  0  0  1  0            999 V2000
    3.8983   -0.7459    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -3.0000    0.0000 O   0  0
    0.0000    3.0008    0.0000 C   0  0
   -1.2979    3.7529    0.0000 C   0  0
   -1.2955    5.2529    0.0000 C   0  0
    0.0047    6.0009    0.0000 C   0  0
    0.0071    7.5009    0.0000 Cl  0  0
    1.3026    5.2488    0.0000 C   0  0
    2.6051    5.9945    0.0000 C   0  0
    3.9026    5.2402    0.0000 C   0  0
    5.2054    5.9836    0.0000 C   0  0
    6.5007    5.2270    0.0000 C   0  0
    6.4931    3.7270    0.0000 C   0  0
    7.7875    2.9674    0.0000 O   0  0
    7.7778    1.4666    0.0000 C   0  0  1  0  0  0
    8.9840    0.5965    0.0000 C   0  0
    8.5083   -0.8261    0.0000 C   0  0
    7.0083   -0.8133    0.0000 O   0  0
    6.5570    0.6172    0.0000 C   0  0
    5.1903    2.9836    0.0000 C   0  0
    3.8951    3.7401    0.0000 C   0  0
    1.3002    3.7488    0.0000 C   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  1  6
  8 10  1  0
 10  3  1  0
 10 11  1  1
  5 12  1  6
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 24 23  1  1
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 24  1  0
 22 29  1  0
 29 30  2  0
 30 19  1  0
 17 31  2  0
 31 12  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7796

> <plate>
1

> <well>
N21

> <supplier_cmpd_name>
Empagliflozin (BI 10773)

> <ctcr_id>
7405

> <supplier_cmpd_id>
S8022

> <smiles>
OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2

> <pd_targets>
{SLC5A2,SLC5A1}

> <pathway_gtopdb>
{Transporter,"Electrochemical transporter","SLC superfamily of solute carriers","SLC05 family of sodium-dependent glucose transporters"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC5 family of sodium-dependent glucose transporters","Hexose transporter family"}

> <pathway_reactome>
{Disease,"Disorders of transmembrane transporters","SLC transporter disorders","Defective SLC5A2 causes renal glucosuria (GLYS1)","Defective SLC5A1 causes congenital glucose/galactose malabsorption (G
GM)"}

> <broad_targets>
{SLC5A1,SLC5A2}

> <broad_moa>
{"sodium/glucose cotransporter inhibitor"}

> <synonyms>
{Empagliflozin,864070-44-0,864070440,"864070 44 0",JARDIANCE,"BI 10773","Empagliflozin (BI 10773)",BI-10773,BI10773,UNII-HDC1R2M35U,UNIIHDC1R2M35U,"UNII HDC1R2M35U",HDC1R2M35U,1-chloro-4-(glucopyranos
-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzen,1chloro4(glucopyranos1yl)2(4(tetrahydrofuran3yloxy)benzyl)benzen,S8022}

> <pdid>
PD009397

> <targets>
{SGLT}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{11949646}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 22 24  0  0  0  0            999 V2000
    5.6396    6.0909    0.0000 C   0  0
    4.2776    5.4624    0.0000 C   0  0
    4.1398    3.9679    0.0000 O   0  0
    2.7771    3.3391    0.0000 C   0  0
    1.5521    4.2048    0.0000 O   0  0
    2.6395    1.8472    0.0000 C   0  0
    3.7691    0.8603    0.0000 N   0  0
    3.1796   -0.5190    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 N   0  0
   -2.5242    2.0130    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1476   -0.7184    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
   -1.5000   -5.4558    0.0000 F   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  6  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 22  9  1  0
 22 16  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7797

> <plate>
1

> <well>
O03

> <supplier_cmpd_name>
Flumazenil

> <ctcr_id>
1295

> <supplier_cmpd_id>
S1332

> <smiles>
CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23

> <pd_targets>
{GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,CYP2C19,GABBR1,ALDH1A1,KMT2A,MEN1,NFO,TSHR,CHRM1,CYP1A2,FFP,RORC}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Membrane receptor","Epigenetic regulator","Transcription factor","Ligand-gated ion channel","Cytochrome P450","Family C G protein-coupled receptor",Oxidoreductase,Reader,Hydrola
se,"Family A G protein-coupled receptor",Transferase,"Nuclear receptor","GABA-A receptor","Cytochrome P450 family 2","Small molecule receptor (family C GPCR)",Bromodomain,"Peptide receptor (family A G
PCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2C","Neurotransmitter receptor (family C GPCR)","Glycohormone 
receptor","Monoamine receptor","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 2C19","GABA-B receptor","Acetylcholine receptor","Cytochrome P450 1A1","Nucle
ar hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Ligand-gated ion channels","Cytochrome P450","G protein-coupled receptors","Nuclear hormone receptors","GABA<sub>A</sub> receptors","CYP2 family: drug metabolising s
ubset","GABA<sub>B</sub> receptors","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","CYP1 family","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Neuronal System",Metabolism,Disease,"Signal Transduction","Gene expression (Transcription)","Transmission across Chemical Synapses","Biological oxidations","Infectious disease","Signaling by GPCR","
RNA Polymerase II Transcription","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Leishmania infection","GPCR ligand binding","Generic Tran
scription Pathway","GABA receptor activation","Cytochrome P450 - arranged by substrate type","Ethanol oxidation","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Trans
criptional regulation by RUNX3",Xenobiotics,"GABA B receptor activation","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","RUNX3 Regulates Immune R
esponse and Cell Migration","CYP2E1 reactions","Activation of GABAB receptors","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Aromatic amines can be N-
hydroxylated or N-dealkylated by CYP1A2","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"}

> <broad_targets>
{GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ}

> <broad_moa>
{"benzodiazepine receptor antagonist"}

> <synonyms>
{flumazenil,78755-81-4,78755814,Anexate,Flumazepil,Romazicon,Lanexat,Mazicon,"Ro 15-1788","Ro 151788",fumazenil,"Flumazenilum (Latin)","Flumazenilo (Spanish)",Flumazenilo,Flumazenilum,(11C)flumazenil,
"Flumazenil (Ro 15-1788)","Flumazenil (Ro 151788)",Ro-15-1788,Ro151788,UNII-40P7XK9392,UNII40P7XK9392,CH,T1240,S1332,SAM001246763,1505701,Flumazenil,CPD000058450,FUMAZENIL}

> <pdid>
PD000330

> <targets>
{"GABA Receptor"}

> <classes>
{"benzodiazepine antagonist","Neuronal Signaling"}

> <pubchem_cids>
{3373}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 12 13  0  0  0  0            999 V2000
    4.2790    0.1284    0.0000 Cl  0  5
   -2.3282    0.4544    0.0000 N   0  3
   -0.8987    0.0000    0.0000 C   0  0
   -2.0541   -1.3755    0.0000 C   0  0
   -0.6052   -0.9721    0.0000 C   0  0
   -0.6052    0.5686    0.0000 C   0  0
    0.4035    1.7790    0.0000 C   0  0
    1.7790    1.2105    0.0000 C   0  0
    1.7607   -0.2751    0.0000 C   0  0
    0.7703   -1.5223    0.0000 C   0  0
    0.3852   -0.6052    0.0000 C   0  0
   -0.8987    1.3205    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
  9 11  1  0
 11  3  1  0
  7 12  1  0
 12  3  1  0
M  CHG  2   1  -1   2   1
M  END
> <name>
Selleck_GPCR

> <id>
7798

> <plate>
1

> <well>
O04

> <supplier_cmpd_name>
Amantadine HCl

> <ctcr_id>
4634

> <supplier_cmpd_id>
S2451

> <smiles>
[Cl-].[NH3+]C12CC3CC(CC(C3)C1)C2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SCHEMBL8907194,AKOS026750102,Symmetrel,"adamantan-1-aminium chloride","adamantan1aminium chloride","adamantan 1 aminium chloride",CHEBI:2619,"1-adamantylammonium chloride","1adamantylammonium chlorid
e","1 adamantylammonium chloride",1-Aminoa,1Aminoa,S2451,SAM002554881,1500110,"Amantadine HCl",CPD001370746,"AMANTADINE HYDROCHLORIDE"}

> <pdid>

> <targets>
{"Dopamine Receptor"}

> <classes>
{"antiparkinsonian; treatment of drug-induced extrapyrimidal reactions",antiviral,"Neuronal Signaling"}

> <pubchem_cids>
{19031614,517422,64150}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 42 43  0  0  0  0            999 V2000
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6131   -7.4988    0.0000 C   0  0
   -3.9147   -8.2443    0.0000 N   0  0
   -5.2111   -7.4898    0.0000 C   0  0
   -5.2060   -5.9898    0.0000 C   0  0
   -3.9043   -5.2443    0.0000 O   0  0
   -3.9230   -9.7451    0.0000 C   0  0
   -5.2264  -10.4892    0.0000 C   0  0
   -5.2368  -11.9892    0.0000 C   0  0
   -6.5410  -12.7302    0.0000 C   0  0
   -7.8349  -11.9712    0.0000 C   0  0
   -9.1390  -12.7122    0.0000 F   0  0
   -7.8245  -10.4712    0.0000 C   0  0
   -6.5203   -9.7302    0.0000 C   0  0
    9.0003   -4.1236    0.0000 O   0  0
    9.0003   -5.6236    0.0000 C   0  0
    7.7010   -6.3731    0.0000 O   0  0
   10.3003   -6.3736    0.0000 C   0  0
   11.6003   -5.6236    0.0000 C   0  0
   12.8989   -6.3744    0.0000 O   0  0
   11.6017   -4.1227    0.0000 C   0  0
   12.9017   -3.3727    0.0000 C   0  0
   14.2003   -4.1236    0.0000 O   0  0
   12.9031   -1.8727    0.0000 O   0  0
   11.6015   -7.1535    0.0000 C   0  0
   10.3028   -7.9041    0.0000 O   0  0
   12.9007   -7.9033    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11  4  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 23  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
 34 40  1  0
 40 41  1  0
 40 42  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7799

> <plate>
1

> <well>
O05

> <supplier_cmpd_name>
Mosapride Citrate

> <ctcr_id>
1324

> <supplier_cmpd_id>
S1385

> <smiles>
CCOc1cc(N)c(Cl)cc1C(=O)NCC2CN(CCO2)Cc3ccc(F)cc3.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Mosapride citrate",112885-42-4,112885424,AS-4370,AS4370,Gasmotin,"Mosapride (citrate)",TAK-370,TAK370,Gasmot,DSSTox_CID_26207,DSSToxCID26207,DSSTox-CID-26207,"DSSTox CID 26207",DSSTox_RID_81436,DSST
oxRID81436,DSSTox-RID-81436,"DSSTox RID 81436",DSSTox_GSID_46207,DSSToxGSID46207,DSSTox-GSID-46207,"DSSTox GSID 46207",CAS-112885-42-4,CAS112885424,C21H25ClFN3O3.C6H8O7,MLS006011997,C27H33ClFN3O10,SCH
EMBL258620,CHEMBL17331,T6597,S1385,SAM001246713,"Mosapride Citrate",CPD000469200}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{119583}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 30 34  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.1884    2.6408    0.0000 C   0  0
   -2.2738    3.8234    0.0000 C   0  0
   -2.8433    5.2111    0.0000 C   0  0
   -4.3298    5.4117    0.0000 N   0  0
   -4.9025    6.7990    0.0000 C   0  0
   -6.3901    6.9976    0.0000 C   0  0
   -6.9628    8.3849    0.0000 C   0  0
   -8.4505    8.5835    0.0000 N   0  0
   -9.4613    7.4925    0.0000 C   0  0
   -9.1791    6.0193    0.0000 O   0  0
  -10.8152    8.1382    0.0000 N   0  0
  -10.6194    9.6245    0.0000 C   0  0
  -11.5936   10.7650    0.0000 C   0  0
  -11.0930   12.1790    0.0000 C   0  0
   -9.6182   12.4525    0.0000 C   0  0
   -8.6439   11.3120    0.0000 C   0  0
   -9.1445    9.8980    0.0000 C   0  0
   -5.2468    4.2247    0.0000 C   0  0
   -4.6773    2.8370    0.0000 C   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1065    0.0000    0.0000 O   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 14  1  0
 23 18  1  0
 10 24  1  0
 24 25  1  0
 25  7  1  0
  6 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29  5  1  0
 29 30  2  0
 30  2  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7800

> <plate>
1

> <well>
O06

> <supplier_cmpd_name>
Domperidone

> <ctcr_id>
5595

> <supplier_cmpd_id>
S2461

> <smiles>
Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1

> <pd_targets>
{DRD2,MAPK1,CYP3A4,CYP1A2,KCNH2,HIF1A,CHRM1,DRD3,CYP2D6,ADRA1A,GLA,ADRA1B,KMT2A,MEN1,AOX1,RXRA,LMNA,NFKB1,GMNN,PMP22,HTR2A,SLC47A2,MTOR,ADRA1D,ADRA2A,OPRK1,HTR2B,SLC22A2,ADRA2C,SLC6A4,SLC47A1,HRH1,OPR
M1,ADRA2B,SLC6A2,HTR2C}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Ion channel","Transcription factor","Epigenetic regulator","Other nuclear protein","Other cytosolic protein","Unclassified protein",Transporter,"Family A G protein-coupled
 receptor",Kinase,"Cytochrome P450","Voltage-gated ion channel",Hydrolase,Reader,Oxidoreductase,"Nuclear receptor","Electrochemical transporter","Small molecule receptor (family A GPCR)","Protein Kina
se","Cytochrome P450 family 3","Cytochrome P450 family 1","Potassium channels","Cytochrome P450 family 2",Bromodomain,"Nuclear hormone receptor subfamily 2","SLC superfamily of solute carriers","Pepti
de receptor (family A GPCR)","Monoamine receptor","CMGC protein kinase group","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Voltage-gated potassium channel","Cytochrome P450 family 2D","Nuc
lear hormone receptor subfamily 2 group B","SLC47 family of multidrug and toxin extrusion transporters","Atypical protein kinase group","Short peptide receptor (family A GPCR)","SLC22 family of organi
c cation and anion transporters","SLC06 neurotransmitter transporter family","Dopamine receptor","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Cytochrome P450 1A1","Acetylcholine receptor",
"Cytochrome P450 2D6","Adrenergic receptor","Nuclear hormone receptor subfamily 2 group B member 1","Serotonin receptor","Atypical protein kinase PIKK family","Opioid receptor","Histamine receptor","C
MGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cytochrome P450","Voltage-gated ion channels","Nuclear hormone receptors","SLC superfamily of solut
e carriers","Dopamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","CYP1 family","Potassium channels","Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising
 subset",Adrenoceptors,"2B. Retinoid X receptors","5-Hydroxytryptamine receptors","SLC47 family of multidrug and toxin extrusion transporters",Atypical,"Opioid receptors","SLC22 family of organic cati
on and anion transporters","SLC6 neurotransmitter transporter family","Histamine receptors","Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Phosphatidyl inositol 
3' kinase-related kinases (PIKK) family","Organic cation transporters (OCT)","Monoamine transporter subfamily","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{"Signal Transduction","Immune System",Metabolism,Disease,"Muscle contraction","Cellular responses to external stimuli","Cell Cycle","Developmental Biology","Transport of small molecules","Gene expres
sion (Transcription)","Neuronal System","Signaling by GPCR","Innate Immune System","Metabolism of lipids","Biological oxidations","Infectious disease","Cardiac conduction","Cellular responses to stres
s","Metabolism of vitamins and cofactors",Mitotic,"Cytokine Signaling in Immune system","Nervous system development","SLC-mediated transmembrane transport","RNA Polymerase II Transcription","Transmiss
ion across Chemical Synapses","Disorders of transmembrane transporters","GPCR ligand binding","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Funct
ionalization of compounds","Leishmania infection","Phase 3 - rapid repolarisation","Cellular response to hypoxia","Sphingolipid metabolism","Metabolism of water-soluble vitamins and cofactors","Metabo
lism of steroids","M Phase","Signaling by Interleukins","Mitotic G1 phase and G1/S transition","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Transport of bile salts and organic aci
ds","metal ions and amine compounds","Generic Transcription Pathway","Neurotransmitter clearance","GPCR downstream signalling","SLC transporter disorders","Class A/1 (Rhodopsin-like receptors)","Toll 
Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Oxygen-dependent proline hydroxylation of H
ypoxia-inducible Factor Alpha","Glycosphingolipid metabolism","Vitamins B6 activation to pyridoxal phosphate","Bile acid and bile salt metabolism","Mitotic Metaphase and Anaphase","Interleukin-1 famil
y signaling","G1/S Transition","Transcriptional Regulation by TP53","Transcriptional Regulation by MECP2","Organic cation/anion/zwitterion transport","Serotonin clearance from the synaptic cleft","G a
lpha (i) signalling events","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresins",Xenobiotics,
"Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of bile acids and bile salts","Mitotic Anaphase","Interleukin-1 signaling","Activation of the pre-replicative complex","
Regulation of TP53 Activity","MECP2 regulates neuronal receptors and channels","Organic cation transport","Opioid Signalling","Dopamine receptors","MAP kinase activation","Biosynthesis of maresin-like
 SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","CYP2E1 reactions",Adrenoceptor
s,"Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Serotonin receptors","Regulation of TP53 Expressio
n and Degradation","Histamine receptors","G-protein activation","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation
","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{DRD2,DRD3}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{RESTW34,domperidone,57808-66-9,57808669,Motilium,Nauzelin,Domperidonum,Domperidona,R-33812,R33812,"R 33,812",NSC299589,"Domperidone (Motilium)",UNII-5587267Z69,UNII5587267Z69,"KW 5338",MLS000069343,C
HEMBL219916,CHEBI:31515,MFCD00069256,NSC-299589,Motinorm,Costi,DSSTox_CID_251,DSSToxCID251,DSSTox-CID-251,"DSSTox CID 251",T0082,S2461,2300212,Prestw-340,Domperidone,Domperidone,DOMPERIDONE}

> <pdid>
PD000066

> <targets>
{"Dopamine Receptor"}

> <classes>
{"dopamine antagonist",antiemetic,"Neuronal Signaling"}

> <pubchem_cids>
{3151}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 18  0  0  0  0            999 V2000
    6.1607   -2.0183    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 S   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 N   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.4469   -5.2297    0.0000 N   0  0
    2.9152   -5.5365    0.0000 C   0  0
    3.6607   -4.2349    0.0000 C   0  0
    2.6532   -3.1236    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  6  1  0
 10 11  1  0
 11  3  2  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7801

> <plate>
1

> <well>
O07

> <supplier_cmpd_name>
Tizanidine HCl

> <ctcr_id>
6452

> <supplier_cmpd_id>
S1437

> <smiles>
Cl.Clc1ccc2nsnc2c1N=C3NCCN3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Tizanidine hydrochloride","Tizanidine Hcl",64461-82-1,64461821,Zanaflex,Sirdalud,"Tizanidine (hydrochloride)",UNII-B53E3NMY5C,UNIIB53E3NMY5C,"DS 103-282","DS 103282",B53E3NMY5C,AN021,"5-Chloro-4-(2-
imidazolin-2-ylamino)-2,1,3-benzothiadiazole hydrochloride","5Chloro4(2imidazolin2ylamino)2,1,3benzothiadiazole hydrochloride",MFCD00798231,64461,S1437,SAM002548961,Prestw-1182,"Tizanidine HCl",CPD000
499584}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{114869,16413927,91980568}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 43 46  0  0  1  0            999 V2000
   10.2003    1.9943    0.0000 Br  0  5
    7.7003    1.9943    0.0000 Br  0  5
    3.8964    0.7545    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    5.1996   -1.4928    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0  1  0  0  0
   -6.5611    2.3779    0.0000 C   0  0
   -3.8971    3.7500    0.0000 C   0  0  1  0  0  0
   -4.2297    5.2071    0.0000 C   0  0
   -5.7225    5.3543    0.0000 C   0  0  1  0  0  0
   -6.3238    3.9802    0.0000 C   0  0  2  0  0  0
   -7.7858    3.6531    0.0000 O   0  0
   -8.8026    4.7570    0.0000 C   0  0
   -8.3548    6.1886    0.0000 C   0  0
  -10.2664    4.4294    0.0000 O   0  0
   -6.4799    6.6470    0.0000 N   0  3
   -7.9799    6.6344    0.0000 C   0  0
   -5.0005    6.6221    0.0000 C   0  0
   -4.2602    7.9267    0.0000 C   0  0
   -5.0198    9.2201    0.0000 C   0  0
   -6.5198    9.2089    0.0000 C   0  0
   -7.2601    7.9043    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0002   -3.0008    0.0000 N   0  3
    1.3008   -3.7481    0.0000 C   0  0
   -1.2638   -2.2315    0.0000 C   0  0
   -2.5620   -2.9829    0.0000 C   0  0
   -2.5603   -4.4829    0.0000 C   0  0
   -1.2604   -5.2315    0.0000 C   0  0
    0.0378   -4.4800    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  7  6  1  6
  7  8  1  0
  9  8  1  1
  9 10  1  0
 10 11  1  0
 12 11  1  6
 12 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 12  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21 16  1  0
 21 22  1  1
 22 23  1  0
 23 24  1  0
 23 25  2  0
 20 26  1  1
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 26  1  0
 13 33  1  0
 33  9  1  0
 33 34  1  1
 33 35  1  0
 35 36  1  0
 36  7  1  0
 36 37  1  1
 37 38  1  0
 37 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 37  1  0
M  CHG  4   1  -1   2  -1  26   1  37   1
M  END
> <name>
Selleck_GPCR

> <id>
7802

> <plate>
1

> <well>
O08

> <supplier_cmpd_name>
Pancuronium dibromide

> <ctcr_id>
4818

> <supplier_cmpd_id>
S2497

> <smiles>
[Br-].[Br-].CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1[N+]6(C)CCCCC6

> <pd_targets>
{RAD52,LMNA,KCNN1,KCNN2,KCNN3,MTOR,CHRNA1,CHRNB1,CHRND,CHRNE,CHRNG,CHRNA2,CHRM2,CHRM3}

> <pathway_gtopdb>
{"Other nuclear protein","Ion channel",Enzyme,"Membrane receptor","Voltage-gated ion channel",Kinase,"Ligand-gated ion channel","Family A G protein-coupled receptor","Potassium channels","Protein Kina
se","Nicotinic acetylcholine receptor","Small molecule receptor (family A GPCR)","Calcium-activated potassium channel","Atypical protein kinase group","Nicotinic acetylcholine receptor alpha subunit",
"Monoamine receptor","Atypical protein kinase PIKK family","Acetylcholine receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"Kinases (EC 2.7.x.x)","Ligand-gated ion channels","G protein-coupled receptors",Atypical,"Nicotinic acetylcholine receptors","Acetylcholine receptors (muscarinic)","
Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"DNA Repair","Cell Cycle","Gene expression (Transcription)","Neuronal System","Signal Transduction","DNA Double-Strand Break Repair",Mitotic,"RNA Polymerase II Transcription","Transmission across Che
mical Synapses","Signaling by GPCR","Homology Directed Repair","M Phase","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","HDR th
rough Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Transcriptional Regulation by TP53","Acetylcholine binding and downstream events","Class A/1 (R
hodopsin-like receptors)","HDR through Single Strand Annealing (SSA)","Mitotic Anaphase","Regulation of TP53 Activity","Postsynaptic nicotinic acetylcholine receptors","Amine ligand-binding receptors"
,"Nuclear Envelope (NE) Reassembly","Regulation of TP53 Expression and Degradation","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Muscarinic acetylcholine receptors","Init
iation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{CHRM2,CHRM3,CHRNA1,CHRNA2}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"PANCURONIUM BROMIDE",Pavulon,15500-66-0,15500660,"Pancuronium dibromide",Mioblock,"ORG NA 97","Pancuronium (dibromide)","Pancuronii bromidum","Bromuro de pancuronio","Bromure de pancuronium",UNII-U9
LY9Y75X2,UNIIU9LY9Y75X2,CHEBI:7908,"ORG-NA 97","ORGNA 97","NA 97",U9LY9Y75X2,Bromure,S2497,Prestw-1034,"Pancuronium bromide"}

> <pdid>
PD009549

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{27350}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 30  0  0  1  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8939   -0.7546    0.0000 C   0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -5.2060    2.9909    0.0000 Cl  0  0
   -5.1852   -3.0098    0.0000 C   0  0  2  0  0  0
   -6.4828   -3.7624    0.0000 O   0  0
   -6.4800   -5.2624    0.0000 C   0  0  2  0  0  0
   -7.7799   -6.0126    0.0000 C   0  0
   -9.0793   -5.2631    0.0000 O   0  0
   -5.1795   -6.0099    0.0000 C   0  0  1  0  0  0
   -5.1767   -7.5099    0.0000 O   0  0
   -3.8819   -5.2575    0.0000 C   0  0  2  0  0  0
   -2.5815   -6.0051    0.0000 O   0  0
   -3.8847   -3.7575    0.0000 C   0  0  1  0  0  0
   -2.5871   -3.0051    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 16 11  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  1
 19 20  1  0
 18 21  1  0
 21 22  1  6
 21 23  1  0
 23 24  1  1
 23 25  1  0
 25 16  1  0
 25 26  1  6
  7 27  1  0
 27 28  2  0
 28  4  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7803

> <plate>
1

> <well>
O09

> <supplier_cmpd_name>
Dapagliflozin

> <ctcr_id>
7142

> <supplier_cmpd_id>
S1548

> <smiles>
CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc1

> <pd_targets>
{SLC5A2,SLC5A1,SLC5A11,SLC5A4}

> <pathway_gtopdb>
{Transporter,"Electrochemical transporter","SLC superfamily of solute carriers","SLC05 family of sodium-dependent glucose transporters"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC5 family of sodium-dependent glucose transporters","Hexose transporter family","Sodium <i>myo</i>-inositol cotransporter transporters"}

> <pathway_reactome>
{Disease,"Transport of small molecules","Disorders of transmembrane transporters","SLC-mediated transmembrane transport","SLC transporter disorders","Transport of bile salts and organic acids","metal 
ions and amine compounds","Cellular hexose transport","Defective SLC5A2 causes renal glucosuria (GLYS1)","Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)","Inositol transporte
rs"}

> <broad_targets>
{SLC5A1,SLC5A2}

> <broad_moa>
{"sodium/glucose cotransporter inhibitor"}

> <synonyms>
{Dapagliflozin,461432-26-8,461432268,BMS-512148,BMS512148,Forxiga,Farxiga,"BMS 512148",UNII-1ULL0QJ8UC,UNII1ULL0QJ8UC,"(1S)-1,5-Anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-D-glucitol","(1S
)1,5Anhydro1C(4chloro3((4ethoxyphenyl)methyl)phenyl)Dglucitol",1ULL0QJ8UC,CHEMBL429910,CHEBI:85078,"Dapagliflozin (USAN:INN)",T4460,T2389,S1548,"Dapagliflozin ((2S)-1,2-propanediol, hydrate)"}

> <pdid>
PD000129

> <targets>
{SGLT}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{9887712}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 22  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0  2  0  0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
   10.2982   -0.0037    0.0000 O   0  0
   10.2982   -1.5037    0.0000 C   0  0  2  0  0  0
    8.9982   -2.2537    0.0000 C   0  0  1  0  0  0
    8.9982   -3.7537    0.0000 O   0  0
    7.6982   -1.5037    0.0000 C   0  0
    7.6982   -0.0037    0.0000 O   0  0
    6.3990   -2.2533    0.0000 O   0  0
   11.5982   -2.2537    0.0000 C   0  0
   11.5982   -3.7537    0.0000 O   0  0
   12.8975   -1.5041    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  1
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
 15 14  1  1
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  0
 18 20  2  0
 15 21  1  0
 21 22  1  0
 21 23  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7804

> <plate>
1

> <well>
O10

> <supplier_cmpd_name>
Epinephrine Bitartrate

> <ctcr_id>
7558

> <supplier_cmpd_id>
S2521

> <smiles>
CNC[C@H](O)c1ccc(O)c(O)c1.O[C@H]([C@@H](O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"L-Epinephrine (Bitartrate)","LEpinephrine (Bitartrate)","Epinephrine bitartrate",51-42-3,51423,"Epinephrine acid tartrate","Adrenaline bitartrate","l-Epinephrine bitartrate","lEpinephrine bitartrate
","adrenaline tartrate",UNII-30Q7KI53AK,UNII30Q7KI53AK,"l-Adrenaline bitartrate","lAdrenaline bitartrate",D02149,30Q7KI53AK,"Epinephrine hydrogen tar",S2521,"Epinephrine Bitartrate","Epinephrine Bitar
trate"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{5815}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 23  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 Cl  0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21  7  1  0
 21 15  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7805

> <plate>
1

> <well>
O11

> <supplier_cmpd_name>
Chlorprothixene

> <ctcr_id>
7158

> <supplier_cmpd_id>
S1771

> <smiles>
CN(C)CC\C=C/1c2ccccc2Sc3ccc(Cl)cc13

> <pd_targets>
{CYP3A4,LMNA,CYP2C19,CYP2D6,FFP,LEF,DRD2,CHRM2,CYP1A2,CHRM1,HTR6,CHRM4,CHRM5,HTR2A,HTR7,CASP1,CHRM3,AMPC,HRH1,ABCB11,PDR5,DRD5,DRD3,SLC22A1,HTR2C,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2B,HTR3A,HTR3B,HTR3C,
HTR3D,HTR3E,HTR4}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor","Cytochrome P450",Transferase,Protease,"Family A G protein-coupled receptor","Cytochrome P450 family 3","Cytochrome P450 family 2","Metallo protease
","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Cysteine protease","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Metallo protease MAE cla
n","Monoamine receptor","Cytochrome P450 family 1A","Cysteine protease CD clan","Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 2D6","Metallo protease M34 family","Dopamine receptor","Ac
etylcholine receptor","Cytochrome P450 1A1","Serotonin receptor","Cysteine protease C14 family",Transporter,Hydrolase,"Primary active transporter","Electrochemical transporter","ATP-binding cassette",
"SLC superfamily of solute carriers","ABCB subfamily","SLC22 family of organic cation and anion transporters","Histamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","Peptidases and proteinases","CYP3 family","CYP2 family: drug metabolising subset","Dopamine receptors","Acetylcholine receptors (mus
carinic)","CYP1 family","5-Hydroxytryptamine receptors","CD: Cysteine (C) Peptidases","C14: Caspase",Transporters,"ATP-binding cassette transporter family","SLC superfamily of solute carriers","Histam
ine receptors","ABCB subfamily","SLC22 family of organic cation and anion transporters","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Cell Cycle",Disease,"Signal Transduction","Gene expression (Transcription)","Metabolism of lipids",Mitotic,"Biological oxidations","Infectious disease","Signaling by GPCR","RNA Polymerase
 II Transcription","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Phase I - Functionalization of compounds","Uptake and actions of bacterial toxins","GPCR ligand binding","Leis
hmania infection","Generic Transcription Pathway","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Cytochrome P450 - arranged by substrate type","Uptake and function of anthrax tox
ins","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Transcriptional Regulation by TP53","Biosynthesis of maresins","Mitotic Anaphase",Xenobiotics,"Amine ligand-bindi
ng receptors","Anti-inflammatory response favouring Leishmania parasite infection","TP53 Regulates Transcription of Cell Death Genes","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassem
bly","CYP2E1 reactions","Dopamine receptors","Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines produ
ction","Serotonin receptors","TP53 Regulates Transcription of Caspase Activators and Caspases","Initiation of Nuclear Envelope (NE) Reformation","Transport of small molecules","SLC-mediated transmembr
ane transport","Metabolism of steroids","Transport of bile salts and organic acids","metal ions and amine compounds","Bile acid and bile salt metabolism","Organic cation/anion/zwitterion transport","S
ynthesis of bile acids and bile salts","Organic cation transport","Histamine receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,HRH1,HTR2A,HTR2B,HTR2C}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{chlorprothixene,113-59-7,113597,Taractan,Truxal,Chlorprothixen,Chlorprotixen,Chlorprotixene,Clorprotixeno,Chlothixen,Iaractan,Rentovet,Traquilan,Vetacalm,Trictal,Truxil,Chlorprothixenum,Paxyl,(Z)-chl
orprothixene,(Z)chlorprothixene,"Ro 4-0403","Ro 40403",UNII-9S7OD60EWP,UNII9S7OD60EWP,N-714,N714,"MK 184",T0074L,T0074,S1771,"Chlorprothixene hydrochloride",Chlorprothixene}

> <pdid>
PD009945

> <targets>
{Others}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{667467}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 29 30  0  0  0  0            999 V2000
   10.9237    0.4742    0.0000 H   0  3
    8.4237    0.4742    0.0000 Cl  0  5
    5.9232   -5.0458    0.0000 C   0  0
    5.0802   -3.8051    0.0000 N   0  0
    5.8323   -2.5073    0.0000 C   0  0
    5.2865   -1.1101    0.0000 C   0  0
    3.8538   -0.6657    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.4987   -3.0043    0.0000 C   0  0
    3.5966   -4.0263    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 C   0  0
    1.3039    3.7494    0.0000 C   0  0
    1.3092    5.2494    0.0000 C   0  0
    2.6108    5.9949    0.0000 C   0  0
    3.9072    5.2405    0.0000 C   0  0
    5.2088    5.9860    0.0000 Cl  0  0
    3.9020    3.7405    0.0000 C   0  0
    2.6004    2.9949    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  4  1  0
  8 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 13 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 27 28  1  0
 28 11  1  0
 28 29  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7806

> <plate>
1

> <well>
O12

> <supplier_cmpd_name>
Azelastine HCl

> <ctcr_id>
6774

> <supplier_cmpd_id>
S2552

> <smiles>
[H+].[Cl-].CN1CCCC(CC1)N2N=C(Cc3ccc(Cl)cc3)c4ccccc4C2=O

> <pd_targets>
{LMNA,CYP3A4,CYP2D6,ADRA1B,ADRA1A,KCNH2,HRH1,CACNA1C,HRH3,HTR2B,ABCB1,CHRM1,HTR2C,HRH2,PLA2G1B,LTC4S}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Membrane receptor","Ion channel",Transporter,"Cytochrome P450","Family A G protein-coupled receptor","Voltage-gated ion channel","Primary active transporter",Hydrolase
,Lyase,"Cytochrome P450 family 3","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Potassium channels","Voltage-gated calcium channel","ATP-binding cassette","Cytochrome P450 fami
ly 3A","Cytochrome P450 family 2D","Monoamine receptor","Voltage-gated potassium channel","ABCB subfamily","Cytochrome P450 3A4","Cytochrome P450 2D6","Adrenergic receptor","Histamine receptor","Serot
onin receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"Cytochrome P450","G protein-coupled receptors","Voltage-gated ion channels","ATP-binding cassette transporter family","Glycerophospholipid turnover","Ei
cosanoid turnover","CYP3 family","CYP2 family: drug metabolising subset",Adrenoceptors,"Potassium channels","Histamine receptors","Voltage-gated calcium channels","5-Hydroxytryptamine receptors","ABCB
 subfamily","Acetylcholine receptors (muscarinic)","Phospholipase A<sub>2</sub>","Leukotriene and lipoxin metabolism","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Signal Transduction","Muscle contraction","Developmental Biology",Disease,Mitotic,"Metabolism of lipids","Biological oxidations","Signaling by GPCR","Cardiac conduction","Ner
vous system development","Abacavir transport and metabolism","Infectious disease","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","GPCR
 ligand binding","Phase 3 - rapid repolarisation","Axon guidance","Abacavir transmembrane transport","Leishmania infection","Phospholipid metabolism","Mitotic Metaphase and Anaphase","Biosynthesis of 
DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","NCAM signaling for neurite out-growth","Leishmania parasite growth and survival","Glycerophosph
olipid biosynthesis","Mitotic Anaphase","Biosynthesis of maresins",Xenobiotics,"Amine ligand-binding receptors","NCAM1 interactions","Anti-inflammatory response favouring Leishmania parasite infection
","Acyl chain remodelling of PC","Biosynthesis of DHA-derived sulfido conjugates","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","CYP2E1 reactions",Adrenoceptors,"Histamine rec
eptors","Serotonin receptors","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin conjugates in tissue regeneration (MCTR)","Initiat
ion of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{"AZELASTINE HYDROCHLORIDE","AZELASTINE HCl",79307-93-0,79307930,Astelin,Optivar,Allergodil,Rhinolast,Azeptin,"Azelastine (hydrochloride)",Astepro,Optilast,W-2979M,W2979M,A-5610,A5610,E-0659,E0659,379
32-96-0,37932960,CHEBI:2951,MFCD00242783,NCGC00095173-01,NCGC0009517301,DSSTox_CID_25945,DSSToxCID25945,DSSTox-CID-25945,"DSSTox CID 25945",DSSTox_RID_81,DSSToxRID81,DSSTox-RID-81,"DSSTox RID 81",T021
1L,S2552,SAM001246645,1505340,Prestw-1130,"Azelastine hydrochloride","Azelastine HCl",CPD000469183}

> <pdid>
PD009611

> <targets>
{Histamine Receptor,SARS-CoV}

> <classes>
{H1 antihistamine (nonsedating),leucotriene synthesis blocker,Neuronal Signaling,Anti-infection,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{54360,50986914}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 33  0  0  1  0            999 V2000
    6.6910   -7.0166    0.0000 C   0  0
    7.4003   -5.6949    0.0000 N   0  3
    8.8853   -5.4831    0.0000 C   0  0
    9.1427   -4.0053    0.0000 C   0  0
    7.8169   -3.3038    0.0000 C   0  0
    6.7615   -4.3518    0.0000 C   0  0  2  0  0  0
    5.2835   -4.0912    0.0000 C   0  0
    4.7693   -2.6812    0.0000 C   0  0
    3.2913   -2.4206    0.0000 O   0  0
    2.7771   -1.0106    0.0000 C   0  0  2  0  0  0
    3.7409    0.1388    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.8128   -2.1606    0.0000 C   0  0
    2.3262   -3.5699    0.0000 C   0  0
    1.3624   -4.7193    0.0000 C   0  0
   -0.1149   -4.4593    0.0000 C   0  0
   -1.0787   -5.6087    0.0000 Cl  0  0
   -0.6283   -3.0499    0.0000 C   0  0
    0.3355   -1.9006    0.0000 C   0  0
   11.3563   -1.6166    0.0000 O   0  0
   11.3563   -3.1166    0.0000 C   0  0
   10.0570   -3.8662    0.0000 O   0  0
   12.6563   -3.8666    0.0000 C   0  0
   13.9563   -3.1166    0.0000 C   0  0
   15.2563   -3.8666    0.0000 C   0  0
   15.2563   -5.3666    0.0000 O   0  5
   16.5556   -3.1171    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  1  1
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 10 18  1  6
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
M  CHG  2   2   1  31  -1
M  END
> <name>
Selleck_GPCR

> <id>
7807

> <plate>
1

> <well>
O13

> <supplier_cmpd_name>
Clemastine Fumarate

> <ctcr_id>
2907

> <supplier_cmpd_id>
S1847

> <smiles>
C[NH+]1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3.OC(=O)/C=C/C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW30,"CLEMASTINE FUMARATE",14976-57-9,14976579,Tavist,Agasten,"Clemastine hydrogen fumarate","Meclastine fumarate",Tavegil,"Clemastine (fumarate)",UNII-19259EGQ3D,UNII19259EGQ3D,CHEBI:3739,Meclopr
odine,Aloginan,Xolamin,19259EGQ3D,"14976-57-9 (FUMARATE)","14976579 (FUMARATE)",Alphamin,Anhistan,C,S1847,1500191,Prestw-306,"Clemastine Fumarate",CLEMASTINE,"Clemastine fumarate"}

> <pdid>

> <targets>
{Histamine Receptor,Autophagy}

> <classes>
{antihistaminic,Neuronal Signaling,Autophagy,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{5281069,6426695}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 22  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3032    3.7490    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 O   0  0
   -5.2003    1.4932    0.0000 N   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8525    1.3572    0.0000 C   0  0
   -8.8524    0.2390    0.0000 C   0  0
  -10.3447    0.3906    0.0000 C   0  0
   -8.0978   -1.0574    0.0000 O   0  0
   -6.6317   -0.7404    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 13  2  0
  8 19  1  0
 19 20  2  0
 20  3  1  0
 20 21  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7808

> <plate>
1

> <well>
O14

> <supplier_cmpd_name>
PNU-120596

> <ctcr_id>
149

> <supplier_cmpd_id>
S2629

> <smiles>
COc1cc(OC)c(NC(=O)Nc2cc(C)on2)cc1Cl

> <pd_targets>
{CHRNA7,KMT2A,MEN1}

> <pathway_gtopdb>
{"Ion channel","Epigenetic regulator","Ligand-gated ion channel",Reader,"Nicotinic acetylcholine receptor",Bromodomain,"Nicotinic acetylcholine receptor alpha subunit"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","Nicotinic acetylcholine receptors"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter receptors and postsynaptic signal transmission","Acetylcholine binding and downstream events","Postsynaptic nicotinic acety
lcholine receptors","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors"}

> <broad_targets>
{CHRNA7}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{NU12059,501925-31-1,501925311,PNU-120596,PNU120596,"1-(5-Chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea","1(5Chloro2,4dimethoxyphenyl)3(5methylisoxazol3yl)urea","PNU 120596","NSC 216666","
N-(5-CHLORO-2,4-DIMETHOXYPHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-UREA","N(5CHLORO2,4DIMETHOXYPHENYL)N'(5METHYL3ISOXAZOLYL)UREA",1-(5-chloro-2,1(5chloro2,4-dimethoxyphenyl)-3-(5-methyl-1,4dimethoxyphenyl)3(
5methyl1,2-oxa,2oxa,T6950,S2629}

> <pdid>
PD010911

> <targets>
{AChR,nAChR}

> <classes>
{Neuronal Signaling,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{311434}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 18 19  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 N   0  0
    1.3039   -3.7494    0.0000 C   0  0
    2.6016   -2.9971    0.0000 O   0  0
    1.3070   -5.2502    0.0000 C   0  0
    2.6078   -5.9988    0.0000 N   0  0
    3.9571   -5.3730    0.0000 C   0  0
    4.9646   -6.4842    0.0000 C   0  0
    4.2192   -7.7859    0.0000 C   0  0
    2.7509   -7.4791    0.0000 C   0  0
    1.6337   -8.4801    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  2  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 17 18  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7809

> <plate>
1

> <well>
O15

> <supplier_cmpd_name>
Nefiracetam

> <ctcr_id>
3469

> <supplier_cmpd_id>
S1969

> <smiles>
Cc1cccc(C)c1NC(=O)CN2CCCC2=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{CHRM1}

> <broad_moa>
{"acetylcholine receptor agonist","benzodiazepine receptor agonist"}

> <synonyms>
{Nefiracetam,77191-36-7,77191367,"N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide","N(2,6dimethylphenyl)2(2oxopyrrolidin1yl)acetamide",Translon,"DM 9384",Motiva,DM-9384,DM9384,UNII-1JK12GX30N
,UNII1JK12GX30N,"1-Pyrrolidineacetamide, N-(2,6-dimethylphenyl)-2-oxo-","1Pyrrolidineacetamide, N(2,6dimethylphenyl)2oxo","N-(2,6-Dimethylphenyl)-2-oxo-1-pyrrolidineacetamide","N(2,6Dimethylphenyl)2ox
o1pyrrolidineacetamide",DZL,T0169,S1969}

> <pdid>
PD002742

> <targets>
{GABA Receptor}

> <classes>
{Neuronal Signaling,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{71157}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 21 23  0  0  0  0            999 V2000
    7.7962   -1.5128    0.0000 C   0  0
    6.4994   -0.7589    0.0000 C   0  0
    6.5044    0.7411    0.0000 C   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.5965   -3.0004    0.0000 N   0  0
    3.8943   -3.7525    0.0000 C   0  0
    3.8919   -5.2525    0.0000 N   0  0
    5.1945   -3.0045    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 F   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10  4  1  0
  6 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 11  1  0
 21 16  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7810

> <plate>
1

> <well>
O16

> <supplier_cmpd_name>
RS-127445

> <ctcr_id>
2925

> <supplier_cmpd_id>
S2698

> <smiles>
CC(C)c1cc(nc(N)n1)c2ccc(F)c3ccccc23

> <pd_targets>
{HTR2A,HTR2B,HTR2C,HTR6,HTR5A,HTR1B,HTR3A}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Family A G protein-coupled receptor","Ligand-gated ion channel","Small molecule receptor (family A GPCR)","5HT3 receptor","Monoamine receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Ligand-gated ion channels","5-Hydroxytryptamine receptors","5-HT<sub>3</sub> receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Neuronal System","Signaling by GPCR","Infectious disease","Transmission across Chemical Synapses","GPCR ligand binding","Leishmania infection","Neurotransmitter recepto
rs and postsynaptic signal transmission","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishma
nia parasite infection","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{HTR2A,HTR2B,HTR2C}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{S12744,CCG-267254,CCG267254,SB19507,NCGC00386190-05,NCGC0038619005,AKOS016007881,RS-127445,RS127445,199864-87-4,199864874,4-(4-fluoronaphthalen-1-yl)-6-isopropylpyrimidin-2-amine,4(4fluoronaphthalen1
yl)6isopropylpyrimidin2amine,"RS 127445",UNII-0JAU3P8OBM,UNII0JAU3P8OBM,"2-Pyrimidinamine, 4-(4-fluoro-1-naphthalenyl)-6-(1-methylethyl)-","2Pyrimidinamine, 4(4fluoro1naphthalenyl)6(1methylethyl)",4-(
4-fluoronaphthalen-,4(4fluoronaphthalen,T6973,S2698}

> <pdid>
PD010880

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{196968}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 27  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.5517    0.8722    0.0000 N   0  0
   -7.5554    1.9869    0.0000 C   0  0
   -6.8054    3.2859    0.0000 C   0  0
   -5.3382    2.9741    0.0000 N   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -0.0060    5.9996    0.0000 O   0  0
   -1.3042    3.7491    0.0000 C   0  0
    6.3987    3.7498    0.0000 C   0  0
    6.3987    2.2498    0.0000 S   0  0
    6.3987    0.7498    0.0000 O   0  0
    5.0994    1.5002    0.0000 O   0  0
    7.6980    1.5002    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 15  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 23 26  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7811

> <plate>
1

> <well>
O17

> <supplier_cmpd_name>
Phentolamine Mesylate

> <ctcr_id>
6302

> <supplier_cmpd_id>
S2038

> <smiles>
Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3.C[S](O)(=O)=O

> <pd_targets>
{BLM,AMPC,FFP,ADRA1A,ADRA1B,ADRA1D,MAPT,ALD,KDM4E,NS1,CYP2D6,TSHR,NFKB1,PMP22,CHRM1,CYP3A4,ADRA2A,ADRA2B,ADRA2C,CYP2C19,HRH1,HTR2A,NISCH,ESR2,HTR7,LMNA,SIGMAR1,DRD2,HTR1B,HTR3A,HTR1A,HTR2C,SCN1A,SCN2A
,SCN3A,SLC22A1,HTR1E,HTR2B,KCNH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other cytosolic protein","Epigenetic regulator","Unclassified protein","Transcription factor","Other nuclear protein","Ion channel",Transporter,Hydrolase,Transferase,"Fami
ly A G protein-coupled receptor",Eraser,"Cytochrome P450","Nuclear receptor","Ligand-gated ion channel","Voltage-gated ion channel","Electrochemical transporter","Small molecule receptor (family A GPC
R)","Lysine demethylase","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 3","5HT3 receptor","Voltage-gated sodium channel",
"SLC superfamily of solute carriers","Potassium channels","Monoamine receptor","Jumonji domain-containing","Cytochrome P450 family 2D","Glycohormone receptor","Cytochrome P450 family 3A","Cytochrome P
450 family 2C","Nuclear hormone receptor subfamily 3 group A","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channel","Adrenergic receptor","Cytochrome P450 2D6","Ace
tylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 2C19","Histamine receptor","Serotonin receptor","Nuclear hormone receptor subfamily 3 group A member 2","Dopamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Ion channels",Transporters,"Chromatin modifying enzymes","Cytochrome P450","G protein-coupled receptors","Nuclear hormone receptors","Sigma receptors","Liga
nd-gated ion channels","SLC superfamily of solute carriers","Voltage-gated ion channels","1.14.11.- Histone demethylases","CYP2 family: drug metabolising subset","Glycoprotein hormone receptors","Acet
ylcholine receptors (muscarinic)","CYP3 family",Adrenoceptors,"Histamine receptors","5-Hydroxytryptamine receptors","Steroid hormone receptors","Dopamine receptors","5-HT<sub>3</sub> receptors","SLC22
 family of organic cation and anion transporters","Potassium channels","3A. Estrogen receptors","Organic cation transporters (OCT)","Voltage-gated potassium channels"}

> <pathway_reactome>
{"DNA Repair","Neuronal System",Metabolism,Disease,"Immune System","Developmental Biology","Signal Transduction","Cell Cycle","Transport of small molecules","Muscle contraction","DNA Double-Strand Bre
ak Repair","Transmission across Chemical Synapses","Biological oxidations","Infectious disease","Cytokine Signaling in Immune system","Nervous system development","Signaling by GPCR","Metabolism of li
pids","Intracellular signaling by second messengers",Mitotic,"SLC-mediated transmembrane transport","Cardiac conduction","Homology Directed Repair","Neurotransmitter receptors and postsynaptic signal 
transmission","Phase I - Functionalization of compounds","Leishmania infection","Signaling by Interleukins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR ligand binding","Bios
ynthesis of specialized proresolving mediators (SPMs)","PIP3 activates AKT signaling","M Phase","SARS-CoV Infections","Transport of bile salts and organic acids","metal ions and amine compounds","Phas
e 3 - rapid repolarisation","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Activation of NMDA receptors and postsynaptic events","Cytochrome P450 - arranged by substrat
e type","Leishmania parasite growth and survival","Interleukin-1 family signaling","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Negative regulation of the PI3K/AKT networ
k","Mitotic Metaphase and Anaphase","Potential therapeutics for SARS","Organic cation/anion/zwitterion transport","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events",Xe
nobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Interleukin-1 signaling","Amine ligand-binding receptors","Biosynthesis of maresins",PI5P,"PP2A and IER3 Regulate PI3K/A
KT Signaling","Mitotic Anaphase","Organic cation transport","Homologous DNA Pairing and Strand Exchange","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","ADORA2B mediated anti-inflammator
y cytokines production","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Histamine receptors","Serotonin receptors",
"Nuclear Envelope (NE) Reassembly","Dopamine receptors","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Phentolamine mesylate",65-28-1,65281,"65 28 1","phentolamine mesilate","Phentolamine methanesulfonate","Phentolamine (mesylate)","Regitine mesylate",OraVerse,"Phentolamine mesylate (USP)",UNII-Y7543
E5K9T,UNIIY7543E5K9T,"UNII Y7543E5K9T","Phentolamine methanesulfonate salt",MLS000069487,Y7543E5,T1275,S2038,"Phentolamine mesilate","Phentolamine Mesylate"}

> <pdid>
PD009843

> <targets>
{"adrenergic receptor","Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{91430,517293}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 26  0  0  1  0            999 V2000
    7.5987    0.1347    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0  1  0  0  0
   -5.3382    2.9741    0.0000 C   0  0
   -6.8054    3.2859    0.0000 C   0  0
   -7.5554    1.9869    0.0000 C   0  0
   -6.5517    0.8722    0.0000 N   0  0
   -6.8519   -0.5956    0.0000 S   0  0
   -5.7292   -1.5903    0.0000 O   0  0
   -5.4290   -0.1209    0.0000 O   0  0
   -8.2754   -1.0713    0.0000 C   0  0
   -8.5750   -2.5411    0.0000 C   0  0
   -9.9976   -3.0165    0.0000 C   0  0
  -11.1207   -2.0222    0.0000 C   0  0
  -10.8211   -0.5524    0.0000 C   0  0
  -11.9442    0.4419    0.0000 O   0  0
   -9.3984   -0.0770    0.0000 C   0  0
    5.0987    0.1347    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  6  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
 15 16  1  0
 16 17  2  0
 16 18  2  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 25 19  1  0
M  CHG  2   1  -1  26   1
M  END
> <name>
Selleck_GPCR

> <id>
7812

> <plate>
1

> <well>
O18

> <supplier_cmpd_name>
SB269970 HCl

> <ctcr_id>
7409

> <supplier_cmpd_id>
S2849

> <smiles>
[Cl-].CC1CCN(CC1)CC[C@H]2CCCN2[S](=O)(=O)c3cccc(O)c3.[H+]

> <pd_targets>
{BLM,NPSR1,LEF,CYP2D6,HTR7,CYP1A2,HTR4,HTR5A,HTR1B,HTR1D,HTR2B,HTR6,HTR1A,DRD2,DRD3}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Family A G protein-coupled receptor",Protease,"Cytochrome P450","Peptide receptor (family A GPCR)","Metallo protease","Cytochrome P450 family 2","Small molecule receptor (
family A GPCR)","Cytochrome P450 family 1","Short peptide receptor (family A GPCR)","Metallo protease MAE clan","Cytochrome P450 family 2D","Monoamine receptor","Cytochrome P450 family 1A","Neuropepti
de receptor","Metallo protease M34 family","Cytochrome P450 2D6","Serotonin receptor","Cytochrome P450 1A1","Dopamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Neuropeptide S receptor","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","CYP1 family","Dopamine receptors"}

> <pathway_reactome>
{"DNA Repair",Disease,Metabolism,"Signal Transduction","DNA Double-Strand Break Repair","Infectious disease","Biological oxidations","Signaling by GPCR","Homology Directed Repair","Leishmania infectio
n","Uptake and actions of bacterial toxins","Phase I - Functionalization of compounds","GPCR ligand binding","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania p
arasite growth and survival","Uptake and function of anthrax toxins","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR)",
"Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Amine ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammatory cytok
ines production","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Serotonin receptors","Dopamine receptors","Presynaptic phase of homologous DNA pairing and stran
d exchange"}

> <broad_targets>
{HTR7}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{261901-57-9,261901579,"SB 269970 hydrochloride","SB-269970 hydrochloride","SB269970 hydrochloride","SB269970 HCl","SB-269970 (hydrochloride)","SB269970 (hydrochloride)","SB 269970A",MFCD03788020,"261
901-57-9 (HCl)","261901579 (HCl)",SR-01000076135,SR01000076135,EU-0101059,EU0101059,C18H29ClN2O3S,C18H28N2O3S.HCl,MLS002153418,"SB 269970 hcl",SCHEMBL2719,S2849}

> <pdid>
PD049223

> <targets>
{5-HT Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{11957684}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 23  0  0  1  0            999 V2000
   12.5577   -0.0006    0.0000 Cl  0  5
    1.2844    3.7485    0.0000 C   0  0
    2.5857    3.0025    0.0000 N   0  0
    2.5914    1.5017    0.0000 C   0  0
    3.8934    0.7553    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0  2  0  0  0
    2.6003   -1.4978    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.2003   -1.4933    0.0000 C   0  0
    5.3453   -2.9734    0.0000 S   0  0
    6.8141   -3.2782    0.0000 C   0  0
    7.5577   -1.9755    0.0000 C   0  0
    6.5486   -0.8657    0.0000 C   0  0
   10.0577   -0.0006    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  8  1  0
 17 12  1  0
  6 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 18  2  0
M  CHG  2   1  -1  23   1
M  END
> <name>
Selleck_GPCR

> <id>
7813

> <plate>
1

> <well>
O19

> <supplier_cmpd_name>
Duloxetine HCl

> <ctcr_id>
276

> <supplier_cmpd_id>
S2084

> <smiles>
[Cl-].CNCC[C@H](Oc1cccc2ccccc12)c3sccc3.[H+]

> <pd_targets>
{HTR2A,KMT2A,HTR6,CYP1A2,CYP3A4,SLC6A2,SLC6A3,SLC6A4,NET,HTT,GAA,CYP2C9,HTR2C,CYP2D6,SHMT2,CYP2C19,KCNH2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,KCND3,SCN5A,KCNE1,KCNQ1}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator",Enzyme,Transporter,"Unclassified protein","Ion channel","Family A G protein-coupled receptor",Reader,"Cytochrome P450","Electrochemical transporter",Hydrola
se,Transferase,"Voltage-gated ion channel","Small molecule receptor (family A GPCR)",Bromodomain,"Cytochrome P450 family 1","Cytochrome P450 family 3","SLC superfamily of solute carriers","Cytochrome 
P450 family 2","Potassium channels","Voltage-gated calcium channel","Voltage-gated sodium channel","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 3A","SLC06 neurotransmitter 
transporter family","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Voltage-gated potassium channel","Serotonin receptor","Cytochrome P450 1A1","Cytochrome P450 3A4","Cytochrome P450 2C9","Cy
tochrome P450 2D6","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","SLC superfamily of solute carriers","3.2.1.- Glycosidases","Voltage-gated 
ion channels","5-Hydroxytryptamine receptors","2.1.1.43 Histone methyltransferases (HMTs)","CYP1 family","CYP3 family","SLC6 neurotransmitter transporter family","CYP2 family: drug metabolising subset
","Potassium channels","Voltage-gated calcium channels","Voltage-gated sodium channels","Monoamine transporter subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)",Disease,Metabolism,"Neuronal System","Muscle contraction","Developmental Biology","Signaling by GPCR","RNA Polymerase II Transcription","Infect
ious disease","Biological oxidations","Metabolism of lipids","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Diseases of metabolism","Metabolism of vitamins and cofa
ctors","Cardiac conduction","Nervous system development","GPCR ligand binding","Generic Transcription Pathway","Leishmania infection","Phase I - Functionalization of compounds","Biosynthesis of specia
lized proresolving mediators (SPMs)","SLC transporter disorders","Neurotransmitter clearance","Diseases of carbohydrate metabolism","Metabolism of water-soluble vitamins and cofactors","Phase 3 - rapi
d repolarisation","Axon guidance","Phase 1 - inactivation of fast Na+ channels","Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX1","Leishmania parasite growth and survival","
Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
","Serotonin clearance from the synaptic cleft","Transcriptional Regulation by MECP2","Glycogen storage diseases","Metabolism of folate and pterines","NCAM signaling for neurite out-growth","L1CAM int
eractions","Amine ligand-binding receptors","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Anti-inflammatory response favouring Leishmania parasite infection"
,Xenobiotics,"Biosynthesis of maresins","Regulation of MECP2 expression and activity","Glycogen storage disease type II (GAA)","NCAM1 interactions","Interaction between L1 and Ankyrins","Serotonin rec
eptors","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","CYP2E1 reactions"}

> <broad_targets>
{HTR2A,HTR2C,HTR6,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"norepinephrine reuptake inhibitor","serotoninâ€“norepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{"DULOXETINE HYDROCHLORIDE",136434-34-9,136434349,"Duloxetine HCl",Cymbalta,"(S)-duloxetine hydrochloride","(S)duloxetine hydrochloride","Duloxetine (hydrochloride)","(S)-Duloxetine HCl","(S)Duloxetin
e HCl",UNII-9044SC542W,UNII9044SC542W,C18H20ClNOS,C18H19NOS.HCl,CPD000469136,"LY248686 HCl",CHEBI:31526,Ariclaim,Xeris,S2084,SAM001246523,1505387}

> <pdid>
PD003013

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{60834,57515987,11966296}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 16 17  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 N   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -1.2948   -3.7517    0.0000 O   0  0
   -3.8933   -3.7570    0.0000 C   0  0
   -3.8934   -5.2570    0.0000 C   0  0
   -5.1924   -6.0071    0.0000 C   0  0
   -6.4914   -5.2571    0.0000 C   0  0
   -6.4915   -3.7571    0.0000 C   0  0
   -5.1925   -3.0071    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  6 16  2  0
 16  2  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7814

> <plate>
1

> <well>
O20

> <supplier_cmpd_name>
VU 0364770

> <ctcr_id>
5355

> <supplier_cmpd_id>
S2862

> <smiles>
Clc1cccc(NC(=O)c2ccccn2)c1

> <pd_targets>
{GRM4,GRM3,GRM5,GRM8,GRM6}

> <pathway_gtopdb>
{"Membrane receptor","Family C G protein-coupled receptor","Small molecule receptor (family C GPCR)","Neurotransmitter receptor (family C GPCR)","Metabotropic glutamate receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Metabotropic glutamate receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR downstream signalling","G alpha (i) signalling events","G alpha (q) signalling events"}

> <broad_targets>
{GRM4}

> <broad_moa>
{"glutamate receptor positive allosteric modulator"}

> <synonyms>
{61350-00-3,61350003,"VU 0364770",VU0364770,N-(3-chlorophenyl)picolinamide,N(3chlorophenyl)picolinamide,N-(3-chlorophenyl)-2-pyridinecarboxamide,N(3chlorophenyl)2pyridinecarboxamide,N-(3-chlorophenyl)
pyridine-2-carboxamide,N(3chlorophenyl)pyridine2carboxamide,C12H9ClN2O,CHEMBL556667,"2-Pyridinecarboxamide, N-(3-chlorophenyl)-","2Pyridinecarboxamide, N(3chlorophenyl)",VU-0364770,cid_836002,cid83600
2,cid-836002,"cid 836002",GTPL6234,SC,T6727,S2862}

> <pdid>
PD010257

> <targets>
{GluR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{836002}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 23 24  0  0  1  0            999 V2000
    9.5862   -3.2909    0.0000 C   0  0
    8.1609   -2.8234    0.0000 C   0  0
    7.8525   -1.3573    0.0000 N   0  0
    8.8523   -0.2390    0.0000 C   0  0
    8.0978    1.0574    0.0000 C   0  0
    6.6317    0.7404    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0  1  0  0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
    0.0000    3.0008    0.0000 S   0  0
   -1.2993    3.7504    0.0000 N   0  0
    1.2985    3.7517    0.0000 O   0  0
   -0.0007    4.5008    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 14 20  1  0
 20 21  1  0
 20 22  2  0
 20 23  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7815

> <plate>
1

> <well>
O21

> <supplier_cmpd_name>
Levosulpiride

> <ctcr_id>
4955

> <supplier_cmpd_id>
S2104

> <smiles>
CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)[S](N)(=O)=O

> <pd_targets>
{CA9,DRD2,CYP1A2,CYP2D6,DRD4,DRD3,CA2,CA1,CYNT,NCE103,1272966,DRD1,DRD5,CA12,CA5A,BLM,CA7,CA3,CA6,CA15,MAPT,CA4,MTCA1,CA5B,MTCA2,ADRA2A,HTR2A,HTR2B,HTR2C,RORC,LMNA,MPO,TSHR,ADRA1A,ADRA1B,ADRA1D}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other cytosolic protein",Lyase,"Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Cytochrome P45
0 family 2","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Dopamine receptor","Cytochrome P450 1A1","Cytochrome P450 2D6","Adrenergic receptor","Transcription factor","O
ther nuclear protein","Nuclear receptor",Oxidoreductase,"Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Glycohormone receptor"
,"Serotonin receptor","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Carbonic anhydrases","G protein-coupled receptors","Cytochrome P450","Dopamine receptors","CYP1 family","CYP2 family: drug metabolising subset",Adrenoceptors,"Nuclear hormone recep
tors","1.-.-.- Oxidoreductases","1F. Retinoic acid-related orphans","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Signal Transduction",Metabolism,"Transport of small molecules","Immune System","DNA Repair","Neuronal System","Cellular responses to stress","Signaling by GP
CR","Biological oxidations","O2/CO2 exchange in erythrocytes","Cytokine Signaling in Immune system","Reversible hydration of carbon dioxide","DNA Double-Strand Break Repair","Transmission across Chemi
cal Synapses","Cellular response to hypoxia","GPCR ligand binding","Phase I - Functionalization of compounds","Erythrocytes take up carbon dioxide and release oxygen","Signaling by Interleukins","Homo
logy Directed Repair","Neurotransmitter receptors and postsynaptic signal transmission","Regulation of gene expression by Hypoxia-inducible Factor","Class A/1 (Rhodopsin-like receptors)","Cytochrome P
450 - arranged by substrate type","Interleukin-12 family signaling","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Activation of NMDA receptors and postsynaptic events"
,"Amine ligand-binding receptors",Xenobiotics,"Interleukin-12 signaling","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events","Dopamine receptors","Aromatic amines can b
e N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Homologous DNA Pairing and Strand Exchange","Activ
ation of AMPK downstream of NMDARs",Adrenoceptors,"Presynaptic phase of homologous DNA pairing and strand exchange","Gene expression (Transcription)","Cell Cycle",Disease,"RNA Polymerase II Transcript
ion",Mitotic,"Innate Immune System","Infectious disease","Generic Transcription Pathway","M Phase","ROS and RNS production in phagocytes","Leishmania infection","Transcriptional regulation by RUNX3","
Mitotic Metaphase and Anaphase","Events associated with phagocytolytic activity of PMN cells","Leishmania parasite growth and survival","RUNX3 Regulates Immune Response and Cell Migration","Mitotic An
aphase","Anti-inflammatory response favouring Leishmania parasite infection","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelop
e (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{NCGC0002485302,Levosulpiride,23672-07-3,23672073,(S)-(-)-sulpiride,(S)()sulpiride,(-)-Sulpiride,()Sulpiride,Levopraid,S-(-)-Sulpiride,S()Sulpiride,Levosulpirida,Levosulpiridum,(S)-sulpiride,(S)sulpir
ide,UNII-JTG7R315LK,UNIIJTG7R315LK,"Levosulpiride (INN)",RV-12309,RV12309,JTG7R315LK,CHEBI:64119,(S)-(-)-N-((1-Ethyl-2-pyrroli,(S)()N((1Ethyl2pyrroli,S2104,SAM001246703,CPD000466366}

> <pdid>
PD000494

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{688272}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 26 27  0  0  1  0            999 V2000
   11.4915   -3.3820    0.0000 Cl  0  5
   -1.3000   -8.2636    0.0000 F   0  0
   -0.0021   -7.5115    0.0000 C   0  0
   -0.0045   -6.0115    0.0000 C   0  0
    1.2934   -5.2595    0.0000 C   0  0
    2.5937   -6.0074    0.0000 C   0  0
    2.5960   -7.5075    0.0000 C   0  0
    1.2981   -8.2595    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0  2  0  0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 N   0  0
    5.1925   -3.0070    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0  1  0  0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    8.9915   -3.3820    0.0000 H   0  3
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  9  6  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 14 15  1  6
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
 24 25  2  0
 25 17  1  0
M  CHG  2   1  -1  26   1
M  END
> <name>
Selleck_GPCR

> <id>
7816

> <plate>
1

> <well>
O22

> <supplier_cmpd_name>
Paroxetine HCl

> <ctcr_id>
4681

> <supplier_cmpd_id>
S3005

> <smiles>
[Cl-].Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3.[H+]

> <pd_targets>
{KMT2A,MEN1,TGR,KCNH2,SLC6A2,HTR1A,HTR2A,HTR3A,SLC6A4,SLC6A3,ADRA1A,CYP3A4,P2RX4,GRK2,MPO,ADRA2A,ADRA2C,CHRM2,CHRM1,CHRM5,ADRA2B,CHRM3,ADRA1B,ADRA1D,NORA,CYP2D6,CHRM4,THPO,CYP1A2,NFKB1,MAPK1,LMNA,TP53
,NET,PMP22,ABCB11,RORC,TACR1,MTOR,SIGMAR1,CACNA1C,CACNA1D,CACNA1F,CACNA1S,ABCB1,ADRB1,ADRB2,ADRB3,DRD2,HRH1,HTR2B,DRD1,DRD5}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Ion channel",Transporter,"Membrane receptor","Unclassified protein","Other cytosolic protein","Other nuclear protein","Transcription factor",Reader,"Voltage-gated ion c
hannel","Electrochemical transporter","Family A G protein-coupled receptor","Ligand-gated ion channel","Cytochrome P450",Kinase,Oxidoreductase,"Primary active transporter","Nuclear receptor",Bromodoma
in,"Potassium channels","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","5HT3 receptor","Cytochrome P450 family 3","P2X receptor","Protein Kinase","Cytochrome P450 famil
y 2","Cytochrome P450 family 1","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","Voltage-gated potassium channel","SLC0
6 neurotransmitter transporter family","Monoamine receptor","Cytochrome P450 family 3A","AGC protein kinase group","Cytochrome P450 family 2D","Cytochrome P450 family 1A","CMGC protein kinase group","
ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Serotonin receptor","Adrenergic receptor","Cytochrome P450 3A4"
,"AGC protein kinase GRK family","Acetylcholine receptor","Cytochrome P450 2D6","Cytochrome P450 1A1","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Neuroki
nin receptor","Atypical protein kinase PIKK family","Dopamine receptor","Histamine receptor","AGC protein kinase BARK subfamily","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Ion channels",Receptors,Transporters,Enzymes,"Other protein targets","Voltage-gated ion channels","G protein-coupled receptors","Ligand-gated ion channels","SLC superfamily of solute carriers","Cyto
chrome P450","Kinases (EC 2.7.x.x)","1.-.-.- Oxidoreductases","ATP-binding cassette transporter family","Nuclear hormone receptors","Sigma receptors","Potassium channels","5-Hydroxytryptamine receptor
s","5-HT<sub>3</sub> receptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"CYP3 family","P2X receptors","AGC: Containing PKA",PKG,"PKC families","Acetylcholine receptors (muscarinic)","
CYP2 family: drug metabolising subset","CYP1 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","ABCB subfamily","1F. Retinoic acid-related orphans","Tachykinin receptors",Atypical,"Dopamine rece
ptors","Histamine receptors","Voltage-gated potassium channels","Monoamine transporter subfamily","G protein-coupled receptor kinases (GRKs)","Mitogen-activated protein kinases (MAP kinases)","Phospha
tidyl inositol 3' kinase-related kinases (PIKK) family","Beta-adrenergic receptor kinases (&beta;ARKs)","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{"Muscle contraction","Signal Transduction","Neuronal System",Disease,Metabolism,"Immune System",Hemostasis,"Cell Cycle","Developmental Biology","Gene expression (Transcription)","Cardiac conduction",
"Signaling by GPCR","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Metabolism of lipids","Infectious disease","Intracellular signaling by second messengers","Innate
 Immune System","Biological oxidations","Platelet activation","signaling and aggregation","Cytokine Signaling in Immune system",Mitotic,"Cell Cycle Checkpoints","Nervous system development","RNA Polym
erase II Transcription","Abacavir transport and metabolism","Phase 3 - rapid repolarisation","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Neurotransmitter c
learance","SLC transporter disorders","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","DAG and IP3 signaling","ROS and RNS production in phagocytes","Phase I - Funct
ionalization of compounds","Platelet Aggregation (Plug Formation)","Signaling by Interleukins","Toll-like Receptor Cascades","M Phase","G1/S DNA Damage Checkpoints","EGR2 and SOX10-mediated initiation
 of Schwann cell myelination","Metabolism of steroids","Generic Transcription Pathway","SARS-CoV Infections","Abacavir transmembrane transport","Class A/1 (Rhodopsin-like receptors)","Serotonin cleara
nce from the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Biosynthesis of DHA-derived SPMs","Cell recruitment (pro-inflammatory response)","CaM pathway","Events a
ssociated with phagocytolytic activity of PMN cells","Defective SLC6A2 causes orthostatic intolerance (OI)","Cytochrome P450 - arranged by substrate type","Interleukin-1 family signaling","Toll Like R
eceptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","p53-Dependent G1/S DNA damage checkpoint","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX3","Transcriptional Regula
tion by TP53","Potential therapeutics for SARS","Amine ligand-binding receptors","Biosynthesis of maresins","Purinergic signaling in leishmaniasis infection","Calmodulin induced events",Xenobiotics,"I
nterleukin-1 signaling","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","p53-Dependent G1 DNA Damage Response","Synthesis of bile acids and bile salts","RUNX3 Regulates Immune Response
 and Cell Migration","Peptide ligand-binding receptors","Regulation of TP53 Activity","Serotonin receptors",Adrenoceptors,"Biosynthesis of maresin-like SPMs","Muscarinic acetylcholine receptors","CYP2
E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","MAP kinase activation","Nuclear Envelope (NE) Reassembly","Stabilization 
of p53","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Tachykinin receptors bind tachykinins","Regulation of TP53 Expression and Degradation","Dopamine receptors","Histamine r
eceptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","E
RK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HTR2A,SLC6A2,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{RESTW85,"Paroxetine hydrochloride","Paroxetine Hcl",78246-49-8,78246498,Paroxat,Paxil,Seroxat,"paroxetine (hydrochloride)",110429-35-1,110429351,Aropax,"Paroxetine hydrochloride (USP)",C19H21ClFNO3,U
NII-3I3T11UD2S,UNII3I3T11UD2S,"Paroxetine hydrochloride hemihydrate",3I3T11UD2S,Paroxe,S3005,S3013,1504085,Prestw-851,"Paroxetine HCl","Plerixafor 8HCl (AMD3100 8HCl)","PAROXETINE HYDROCHLORIDE","Paro
xetine Hydrochloride"}

> <pdid>
PD002925

> <targets>
{CXCR,"5-HT Receptor"}

> <classes>
{"Neuronal Signaling",antidepressant,"GPCR & G Protein"}

> <pubchem_cids>
{10915512,62878,68492682}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 31  0  0  1  0            999 V2000
    3.9026    0.7438    0.0000 C   0  0
    3.8990   -0.7562    0.0000 C   0  0
    5.1965   -1.5088    0.0000 O   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0  1  0  0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8972    3.7500    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0  1  0  0  0
   -5.2920    3.9954    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0  1  0  0  0
   -6.6243    1.0594    0.0000 C   0  0
   -7.4983    2.2785    0.0000 C   0  0
   -6.6089    3.4864    0.0000 C   0  0  2  0  0  0
   -5.5833    4.5643    0.0000 O   0  0
   -5.9846    6.0105    0.0000 C   0  0
   -7.4370    6.3853    0.0000 C   0  0
   -4.9341    7.0812    0.0000 O   0  0
   -8.0656    3.7907    0.0000 C   0  0
   -9.5291    4.1199    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0  2  0  0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  6
 12 14  1  0
 14 15  1  6
 15 16  1  0
 16 17  1  0
 17 12  1  0
 17 18  1  6
 18 19  1  0
 19 20  1  0
 19 21  2  0
 17 22  1  0
 22 23  3  0
 14 24  1  0
 24  9  1  0
 24 25  1  1
 25 26  1  0
 26 27  1  0
 27  8  1  0
 27 28  2  3
 28  5  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7817

> <plate>
1

> <well>
P03

> <supplier_cmpd_name>
Ethynodiol diacetate

> <ctcr_id>
582

> <supplier_cmpd_id>
S3160

> <smiles>
CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(C)=O)C#C)[C@@H]3CCC2=C1

> <pd_targets>
{AR,ABCB11,PGR,RORC,MAOA,ESR1}

> <pathway_gtopdb>
{"Transcription factor",Transporter,Enzyme,"Nuclear receptor","Primary active transporter",Oxidoreductase,"Nuclear hormone receptor subfamily 3","ATP-binding cassette","Nuclear hormone receptor subfam
ily 1","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subfamily
 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 group A member 1"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","ATP-binding cassette transporter family","Catecholamine turnover","Steroid hormone receptors","ABCB subfamily","1F. Retinoic acid-related o
rphans","3C. 3-Ketosteroid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Metabolism of proteins","RNA Polymerase II Transcription","Metabolism of lipids","Biological oxidations","Post-translational protein modification","Gener
ic Transcription Pathway","Metabolism of steroids","Phase I - Functionalization of compounds",SUMOylation,"Transcriptional regulation by RUNX2","Bile acid and bile salt metabolism","Transcriptional re
gulation by RUNX3","Amine Oxidase reactions","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX1","RUNX2 regulates bone development","Synthesis of bile acids and bile salt
s","RUNX3 Regulates Immune Response and Cell Migration","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","SUMOylation of intracellular receptors","RUNX1 regulates estrogen re
ceptor mediated transcription","RUNX2 regulates osteoblast differentiation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{ESR1,PGR}

> <broad_moa>
{}

> <synonyms>
{RESTW90,"RESTW 90","ETHYNODIOL DIACETATE",297-76-7,297767,"297 76 7",Femulen,Continuin,"Ethinodiol diacetate","Etynodiol Acetate","Etynodiol diacetate",Cervicundin,Metrodiol,Luto-metrodiol,Lutometrod
iol,"Luto metrodiol","Metrodiol diacetate","Ovulen 50","SC 11800",19-Nor-17alpha-pregn-4-en-20-yne-3beta,19Nor17alphapregn4en20yne3beta,"19 Nor 17alpha pregn 4 en 20 yne 3beta",17-diol,17diol,"17 diol
",T0996,S3160,Prestw-908,"Ethynodiol diacetate"}

> <pdid>
PD000245

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{9270}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 14 13  0  0  0  0            999 V2000
    8.8056   -1.8965    0.0000 H   0  3
    6.3056   -1.8965    0.0000 Cl  0  5
    1.8372   -5.2877    0.0000 C   0  0
    3.3372   -5.2929    0.0000 C   0  0
    3.8056   -3.8679    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.3786   -3.8595    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  6 14  1  0
 14  3  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7818

> <plate>
1

> <well>
P04

> <supplier_cmpd_name>
Terbutaline Sulfate

> <ctcr_id>
3789

> <supplier_cmpd_id>
S4127

> <smiles>
[H+].[Cl-].C1CN=C(Cc2ccccc2)N1

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRA1A,TAAR1,TSHR,CYP2D6,ADRA1B,ADRA1D,LMNA,HTR7,CYP1A2,HRH2,HRH1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P45
0 family 2","Cytochrome P450 family 1","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Adrenergic receptor","Trace amine receptor","Cytochrome P45
0 2D6","Serotonin receptor","Cytochrome P450 1A1","Histamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450",Adrenoceptors,"Trace amine receptor","Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","5-Hydroxytryptamine re
ceptors","CYP1 family","Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,Metabolism,"Cell Cycle","Signaling by GPCR","Infectious disease","Biological oxidations",Mitotic,"GPCR ligand binding","Leishmania infection","Phase I - Functionalizatio
n of compounds","M Phase","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Amine ligand
-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Mitotic Anaphase",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 
reactions","Nuclear Envelope (NE) Reassembly","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Histamine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A,ADRA2A,ADRA2B,ADRA2C,HRH1,HRH2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Tolazoline hydrochloride",59-97-2,59972,"59 97 2","Tolazoline HCl","2-benzyl-4,5-dihydro-1H-imidazole hydrochloride","2benzyl4,5dihydro1Himidazole hydrochloride","2 benzyl 4,5 dihydro 1H imidazole h
ydrochloride","Tolazoline (hydrochloride)",Benzaz,S4127,S4124,SAM002589935,1500580,Prestw-60,"Terbutaline Sulfate",CPD000149600,"TOLAZOLINE HYDROCHLORIDE"}

> <pdid>
PD009716

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein","adrenergic blocker","Neuronal Signaling"}

> <pubchem_cids>
{6048,74764089}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 39 40  0  0  0  0            999 V2000
    8.8995    2.2439    0.0000 H   0  3
    6.3995    2.2439    0.0000 Cl  0  5
    3.8976   -0.7500    0.0000 C   0  0
    2.5988   -1.5004    0.0000 C   0  0
    3.8982   -2.2498    0.0000 C   0  0
    2.5997   -3.0012    0.0000 C   0  0
    1.3009   -3.7516    0.0000 O   0  0
    3.8988   -3.7512    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  0
   -9.0994    0.7387    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
  -10.3985    2.9886    0.0000 C   0  0
   -9.0995    3.7387    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
  -11.6982    3.7390    0.0000 C   0  0
  -12.9973    4.4890    0.0000 O   0  0
  -12.9977    2.9881    0.0000 C   0  0
  -12.9972    1.4881    0.0000 C   0  0
  -14.2960    0.7377    0.0000 C   0  0
  -15.5953    1.4872    0.0000 C   0  0
  -15.5958    2.9872    0.0000 C   0  0
  -14.2970    3.7377    0.0000 C   0  0
  -11.6978    5.2398    0.0000 C   0  0
  -10.3985    5.9894    0.0000 C   0  0
  -10.3981    7.4894    0.0000 C   0  0
  -11.6969    8.2398    0.0000 C   0  0
  -12.9961    7.4902    0.0000 C   0  0
  -12.9966    5.9902    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  6  8  2  0
  4  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
 23 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 26 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
Selleck_GPCR

> <id>
7819

> <plate>
1

> <well>
P05

> <supplier_cmpd_name>
Fexofenadine HCl

> <ctcr_id>
3216

> <supplier_cmpd_id>
S3208

> <smiles>
[H+].[Cl-].CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4

> <pd_targets>
{BLM,HRH1,KCNH2,LMNA,APEX1,HSD17B10,ALOX15}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel","Other nuclear protein","Family A G protein-coupled receptor","Voltage-gated ion channel",Oxidoreductase,"Small molecule receptor (family A GPCR)","Potassium 
channels","Monoamine receptor","Voltage-gated potassium channel","Histamine receptor"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Eicosanoid turnover","Histamine receptors","Potassium channels",Lipoxygenases,"Voltage-gated potassium cha
nnels"}

> <pathway_reactome>
{"DNA Repair","Signal Transduction","Muscle contraction","Cell Cycle",Metabolism,"DNA Double-Strand Break Repair","Signaling by GPCR","Cardiac conduction",Mitotic,"Base Excision Repair","Metabolism of
 amino acids and derivatives","Metabolism of lipids","Homology Directed Repair","GPCR ligand binding","Phase 3 - rapid repolarisation","M Phase","Resolution of Abasic Sites (AP sites)","Branched-chain
 amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors)"
,"Mitotic Metaphase and Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Biosynthesis of DPA-derived SPMs","HDR through Homologous Recombination (HRR)","Amine 
ligand-binding receptors","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Repair","Biosynthesis of DPAn-3 SPMs","Homologous DNA Pairing and Strand Exchange","Histamine receptors","Nuclear 
Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resolvins","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{138452-21-8,138452218,"138452 21 8",AKOS015896119,AKOS015896444,A807389,"FEXOFENADINE HYDROCHLORIDE",153439-40-8,153439408,"153439 40 8","FEXOFENADINE HCL",Telfast,"Fexofenidine hydrochloride","MDL 1
6,455A","Fexofenadine (hydr",T1470L,T1470,S3208,SAM002700173,1504179,Prestw-1102,"Fexofenadine hydrochloride","Fexofenadine HCl",CPD000718798}

> <pdid>
PD002734

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling","nonsedating H1-antihistamine"}

> <pubchem_cids>
{45108248,63002,16417045}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 28 28  0  0  1  0            999 V2000
   11.5093   -5.2498    0.0000 Cl  0  5
    3.8976   -0.7465    0.0000 C   0  0
    2.5998   -1.4987    0.0000 C   0  0  1  0  0  0
    2.6028   -2.9995    0.0000 N   0  0
    3.9036   -3.7481    0.0000 C   0  0
    3.9065   -5.2490    0.0000 C   0  0
    5.2073   -5.9976    0.0000 C   0  0
    5.2103   -7.4984    0.0000 C   0  0
    6.5093   -8.2486    0.0000 C   0  0
    6.5092   -9.7486    0.0000 C   0  0
    5.2101  -10.4985    0.0000 C   0  0
    3.9111   -9.7485    0.0000 C   0  0
    3.9112   -8.2485    0.0000 C   0  0
    2.6113  -10.4988    0.0000 C   0  0
    2.6103  -11.9988    0.0000 F   0  0
    1.3126   -9.7483    0.0000 F   0  0
    1.3119  -11.2481    0.0000 F   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    9.0093   -5.2498    0.0000 H   0  3
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
  3 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 18  1  0
 27 22  1  0
M  CHG  2   1  -1  28   1
M  END
> <name>
Selleck_GPCR

> <id>
7820

> <plate>
1

> <well>
P06

> <supplier_cmpd_name>
Cinacalcet HCl

> <ctcr_id>
7570

> <supplier_cmpd_id>
S1260

> <smiles>
[Cl-].C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c2cccc3ccccc23.[H+]

> <pd_targets>
{FFP,HTT,GRM5,CYP2D6,CASR,RORC,GLRA1}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor","Transcription factor","Ion channel",Transferase,"Family C G protein-coupled receptor","Cytochrome P450","Nuclear receptor","Ligand-gated ion channel
","Small molecule receptor (family C GPCR)","Cytochrome P450 family 2","Ion receptor (family C GPCR)","Nuclear hormone receptor subfamily 1","Glycine receptor","Neurotransmitter receptor (family C GPC
R)","Cytochrome P450 family 2D","Calcium sensing receptor","Nuclear hormone receptor subfamily 1 group F","Metabotropic glutamate receptor","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 1 
group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Cytochrome P450","Nuclear hormone receptors","Ligand-gated ion channels","Metabotropic glutamate receptors","CYP2 family: drug metaboli
sing subset","Calcium-sensing receptor","1F. Retinoic acid-related orphans","Glycine receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction",Metabolism,"Neuronal System","RNA Polymerase II Transcription","Signaling by GPCR","Biological oxidations","Transmission across Chemical Synaps
es","Generic Transcription Pathway","GPCR downstream signalling","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Transcriptional Regulatio
n by MECP2","G alpha (q) signalling events","Cytochrome P450 - arranged by substrate type","G alpha (i) signalling events","Transcriptional regulation by RUNX3","Regulation of MECP2 expression and act
ivity",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","CYP2E1 reactions"}

> <broad_targets>
{CASR}

> <broad_moa>
{"calcium channel activator"}

> <synonyms>
{SCHEMBL133710,AKOS025117442,"Cinacalcet hydrochloride",364782-34-3,364782343,"Cinacalcet HCl",Sensipar,Mimpara,Regpara,"AMG073 HCl","Cinacalcet (hydrochloride)",UNII-1K860WSG25,UNII1K860WSG25,"AMG 07
3","AMG-073 HCl (Cinacalcet hydrochloride)","AMG073 HCl (Cinacalcet hydrochloride)",CHEBI:48391,1K860WSG25,Parareg,S1260}

> <pdid>
PD009594

> <targets>
{CaSR}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{57504192,156418}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 34 37  0  0  1  0            999 V2000
   11.1152   -3.2053    0.0000 Br  0  5
    3.7318   -5.2025    0.0000 O   0  0
    4.7410   -4.0928    0.0000 C   0  0
    4.2839   -2.6633    0.0000 C   0  0
    5.2931   -1.5536    0.0000 O   0  0
    2.8175   -2.3435    0.0000 O   0  0
    2.3637   -0.9240    0.0000 C   0  0  1  0  0  0
    2.6046    0.4860    0.0000 C   0  0
    1.6757    1.4077    0.0000 N   0  3
    0.6658    0.3038    0.0000 C   0  0
   -0.5991    1.1116    0.0000 C   0  0
   -1.9316    0.4209    0.0000 C   0  0
   -3.1965    1.2287    0.0000 O   0  0
   -4.5289    0.5381    0.0000 C   0  0
   -5.7943    1.3436    0.0000 C   0  0
   -7.1246    0.6506    0.0000 C   0  0
   -7.1896   -0.8480    0.0000 C   0  0
   -5.9243   -1.6536    0.0000 C   0  0
   -4.5940   -0.9606    0.0000 C   0  0
    0.0282    1.4238    0.0000 C   0  0
   -0.2876    0.0215    0.0000 C   0  0
    1.3224    0.1163    0.0000 C   0  0
    2.1818    1.7292    0.0000 C   0  0
    2.2196    2.9020    0.0000 C   0  0
    6.2074   -4.4126    0.0000 C   0  0
    6.7889   -5.7814    0.0000 C   0  0
    8.2814   -5.6324    0.0000 C   0  0
    8.6010   -4.1669    0.0000 C   0  0
    7.3059   -3.4101    0.0000 S   0  0
    3.2746   -3.7738    0.0000 C   0  0
    2.5858   -5.0918    0.0000 C   0  0
    1.1099   -4.8243    0.0000 C   0  0
    0.9082   -3.3379    0.0000 C   0  0
    2.2595   -2.6868    0.0000 S   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  9 20  1  0
 20 21  1  0
 21 22  1  0
 22  7  1  0
 22 23  1  0
 23 24  1  0
 24  9  1  0
  3 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 25  1  0
  3 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 30  1  0
M  CHG  2   1  -1   9   1
M  END
> <name>
Selleck_GPCR

> <id>
7821

> <plate>
1

> <well>
P07

> <supplier_cmpd_name>
Aclidinium Bromide

> <ctcr_id>
7273

> <supplier_cmpd_id>
S4031

> <smiles>
[Br-].OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c4cccs4)c5cccs5

> <pd_targets>
{CHRM1,CHRM5,CHRM3,CHRM2,CHRM4}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Aclidinium bromide",320345-99-1,320345991,Genuair,"Aclidinium (Bromide)","Tudorza Pressair",UNII-UQW7UF9N91,UNIIUQW7UF9N91,"LAS 34273",LAS-W-330,LASW330,LAS-34273,LAS34273,UQW7UF9N91,CHEBI:65344,"LA
S W-330","LAS W330",Bretaris,Eklira,CHEMBL551466,"Aclidinium bromide (USAN:INN)",T2555,S4031,"Aclidinium Bromide"}

> <pdid>
PD009178

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{11519741}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 38 38  0  0  1  0            999 V2000
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 C   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0  2  0  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    7.7960   -1.5190    0.0000 C   0  0
    9.0965   -0.7716    0.0000 O   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6086    1.4995    0.0000 O   0  0
    2.6160    3.0003    0.0000 C   0  0
    3.9189    3.7436    0.0000 O   0  0
    1.3204    3.7579    0.0000 C   0  0
    1.3278    5.2579    0.0000 C   0  0
    0.0175    3.0147    0.0000 C   0  0
    2.5893   -6.0044    0.0000 C   0  0
    1.2924   -5.2507    0.0000 C   0  0
    2.5845   -7.5044    0.0000 C   0  0
   12.8972    0.7483    0.0000 O   0  0
   12.8972   -0.7517    0.0000 C   0  0
   11.5979   -1.5013    0.0000 O   0  0
   14.1972   -1.5017    0.0000 C   0  0
   15.4972   -0.7517    0.0000 C   0  0
   16.7972   -1.5017    0.0000 C   0  0
   16.7972   -3.0017    0.0000 O   0  0
   18.0964   -0.7521    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 19 20  1  0
 20 21  2  0
 21 14  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 25 27  1  0
  4 28  1  0
 28 29  1  0
 28 30  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  1  0
 36 38  2  0
M  END
> <name>
Selleck_GPCR

> <id>
7822

> <plate>
1

> <well>
P08

> <supplier_cmpd_name>
Fesoterodine Fumarate

> <ctcr_id>
7427

> <supplier_cmpd_id>
S2240

> <smiles>
CC(C)N(CC[C@H](c1ccccc1)c2cc(CO)ccc2OC(=O)C(C)C)C(C)C.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Fesoterodine fumarate",286930-03-8,286930038,"286930 03 8",Toviaz,"SPM 907","SPM 8272","Fesoterodine maleate",UNII-EOS72165S7,UNIIEOS72165S7,"UNII EOS72165S7",SPM-907,SPM907,"Fesoterodine (fumarate)
","(R)-Fesoterodine fumarate","(R)Fesoterodine fumarate","(R)Fesoterodine fu",S2240,"Fesoterodine Fumarate","Fesoterodine Fumarate"}

> <pdid>

> <targets>
{AChR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9849808}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 36 40  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 N   0  0
    1.3039    3.7494    0.0000 C   0  0  2  0  0  0
    2.7246    3.6987    0.0000 C   0  0
    1.9792    5.0003    0.0000 C   0  0  1  0  0  0
    1.9603    6.5010    0.0000 C   0  0
    1.0269    7.6485    0.0000 C   0  0
    1.5597    9.0507    0.0000 C   0  0
    3.0405    9.2903    0.0000 C   0  0
    3.5733   10.6924    0.0000 F   0  0
    3.9883    8.1277    0.0000 C   0  0
    5.4691    8.3673    0.0000 F   0  0
    3.4555    6.7255    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 N   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -3.1884   -2.6409    0.0000 C   0  0  2  0  0  0
   -2.2051   -3.7579    0.0000 C   0  0
   -2.9890   -5.0368    0.0000 C   0  0  2  0  0  0
   -2.4129   -6.4199    0.0000 O   0  0
   -0.9247   -6.6138    0.0000 C   0  0
   -0.3476   -7.9993    0.0000 C   0  0
    1.1398   -8.1931    0.0000 O   0  0
   -4.4475   -4.6865    0.0000 C   0  0  1  0  0  0
   -5.5882   -5.6605    0.0000 O   0  0
   -4.5650   -3.1911    0.0000 C   0  0  1  0  0  0
   -5.8390   -2.3993    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  9  8  1  1
  9 10  1  0
 10 11  1  0
 11  9  1  0
 11 12  1  6
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 17 19  2  0
 19 12  1  0
  7 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 24 23  1  6
 24 25  1  0
 25 26  1  0
 26 27  1  6
 27 28  1  0
 28 29  1  0
 29 30  1  0
 26 31  1  0
 31 32  1  1
 31 33  1  0
 33 24  1  0
 33 34  1  1
 23 35  1  0
 35 20  1  0
 35 36  2  0
 36  5  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7823

> <plate>
1

> <well>
P09

> <supplier_cmpd_name>
Ticagrelor

> <ctcr_id>
7280

> <supplier_cmpd_id>
S4079

> <smiles>
CCCSc1nc(N[C@@H]2C[C@H]2c3ccc(F)c(F)c3)c4nnn([C@@H]5C[C@H](OCCO)[C@@H](O)[C@H]5O)c4n1

> <pd_targets>
{SLC29A1,P2RY12}

> <pathway_gtopdb>
{Transporter,"Membrane receptor","Electrochemical transporter","Family A G protein-coupled receptor","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","SLC28 and SLC29 fam
ilies of nucleoside transporters","Nucleotide-like receptor (family A GPCR)","SLC29 Facilitative nucleoside transporter family","Purine receptor"}

> <pathway_chembl>
{Transporters,Receptors,"SLC superfamily of solute carriers","G protein-coupled receptors","SLC28 and SLC29 families of nucleoside transporters","P2Y receptors","SLC29 family"}

> <pathway_reactome>
{"Transport of small molecules","Signal Transduction","SLC-mediated transmembrane transport","Signaling by GPCR","Transport of vitamins",nucleosides,"and related molecules","GPCR ligand binding","Tran
sport of nucleosides and free purine and pyrimidine bases across the plasma membrane","Class A/1 (Rhodopsin-like receptors)","Nucleotide-like (purinergic) receptors","P2Y receptors"}

> <broad_targets>
{P2RY12}

> <broad_moa>
{"purinergic receptor antagonist"}

> <synonyms>
{"Ticagrelor (JAN/USAN/INN)",AR-C126532,ARC126532,cc-291,cc291,Ticagrelor,274693-27-5,274693275,Brilinta,Brilique,AZD6140,AZD-6140,"AZD 6140",AR-C126532XX,ARC126532XX,UNII-GLH0314RVC,UNIIGLH0314RVC,(1
4C)-Ticagrelor,(14C)Ticagrelor,GLH0314RVC,C23H28F2N6O4S,CHEBI:68558,"Ticagrelor (USAN:INN:BAN)","AR-C 126532XX","ARC 126532XX",Bril,S4079}

> <pdid>
PD009197

> <targets>
{"P2 Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{9871419}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 16 16  0  0  0  0            999 V2000
    8.7524   -0.7504    0.0000 Cl  0  0
    2.6030   -2.9977    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    5.2526   -1.3618    0.0000 C   0  0
    6.2524   -0.2436    0.0000 N   0  0
    5.4979    1.0528    0.0000 C   0  0
    4.0317    0.7359    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  4  1  0
  3  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15  9  1  0
 15 16  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7824

> <plate>
1

> <well>
P10

> <supplier_cmpd_name>
Medetomidine HCl

> <ctcr_id>
1298

> <supplier_cmpd_id>
S3060

> <smiles>
Cl.CC(c1c[nH]cn1)c2cccc(C)c2C

> <pd_targets>
{ADRA2B,ADRA2A,ADRA1A,ADRA1D,ADRA2C,NISCH,SLC6A2,MAOB,ADRA1B,MAOA}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Transporter,Enzyme,"Family A G protein-coupled receptor","Electrochemical transporter",Oxidoreductase,"Small molecule receptor (family A GPCR)","SLC supe
rfamily of solute carriers","Monoamine receptor","SLC06 neurotransmitter transporter family","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"G protein-coupled receptors","SLC superfamily of solute carriers","Catecholamine turnover",Adrenoceptors,"SLC6 neurotransmitter transporter family","Monoamine transpor
ter subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,Metabolism,"Signaling by GPCR","Disorders of transmembrane transporters","Biological oxidations","GPCR ligand binding","SLC transporter disorders","Phase I - Functionali
zation of compounds","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine Oxidase reactions","Amine ligand-binding receptors","Biogenic amines are oxida
tively deaminated to aldehydes by MAOA and MAOB",Adrenoceptors}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Medetomidine hydrochloride","Medetomidine HCl",86347-15-1,86347151,"86347 15 1",Domitor,MPV785,"Medetomidine (hydrochloride)","MPV 785","4-(1-(2,3-Dimethylphenyl)ethyl)-1H-imidazole hydrochloride","
4(1(2,3Dimethylphenyl)ethyl)1Himidazole hydrochloride","4 (1 (2,3 Dimethylphenyl)ethyl) 1H imidazole hydrochloride",106807-72-1,106807721,"106807 72 1",CHEBI:48556,MPV-785,4-(1-(2,4(1(2,"4 (1 (2",3-di
methylphenyl,3dimethylphenyl,"3 dimethylphenyl",S3060,S2090,"Dexmedetomidine HCl"}

> <pdid>
PD013841

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"","Neuronal Signaling"}

> <pubchem_cids>
{57515975,68601}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 17 18  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0  1  0  0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  1
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7825

> <plate>
1

> <well>
P11

> <supplier_cmpd_name>
Levodropropizine

> <ctcr_id>
7295

> <supplier_cmpd_id>
S4131

> <smiles>
OC[C@@H](O)CN1CCN(CC1)c2ccccc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{}

> <broad_moa>
{antitussive}

> <synonyms>
{Levodropropizine,99291-25-5,99291255,"(S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol","(S)3(4Phenylpiperazin1yl)propane1,2diol",Levdropropizine,(-)-Dropropizine,()Dropropizine,Levotuss,Danka,Levodrop
ropizina,Levodropropizinum,"(2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol","(2S)3(4phenylpiperazin1yl)propane1,2diol",(S)-(-)-Dropropizine,(S)()Dropropizine,UNII-3O,UNII3O,S4131}

> <pdid>
PD001510

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{65859}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 20 22  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.6924   -4.0811    0.0000 I   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8813   -1.4408    0.0000 C   0  0  2  0  0  0
   -4.8896   -2.5354    0.0000 O   0  0
   -6.2433   -1.8893    0.0000 C   0  0  2  0  0  0
   -7.5587   -2.6066    0.0000 C   0  0
   -7.5961   -4.1061    0.0000 O   0  0
   -6.0471   -0.4022    0.0000 C   0  0  2  0  0  0
   -7.1349    0.6307    0.0000 O   0  0
   -4.5721   -0.1292    0.0000 C   0  0
   -3.9177    1.2205    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11  2  1  0
 11  6  2  0
 12  7  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  6
 15 16  1  0
 14 17  1  0
 17 18  1  6
 17 19  1  0
 19 12  1  0
 19 20  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7826

> <plate>
1

> <well>
P12

> <supplier_cmpd_name>
5-Iodotubercidin

> <ctcr_id>
7696

> <supplier_cmpd_id>
S8314

> <smiles>
Nc1ncnc2n(cc(I)c12)[C@@H]3O[C@H](CO)[C@H](O)C3O

> <pd_targets>
{ADK,MAPK1,ADOK,DOT1L}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator",Transferase,Kinase,Writer,"Protein Kinase","Protein methyltransferase","CMGC protein kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Adenosine turnover","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","CMGC: Containing CDK",MAPK,GSK3,"CLK families","2.1.1.43 Histone methyltransferases (HMTs)","Mitogen-activated prote
in kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Chromatin organization","Metabolism of nucleotides","Innate Immune System","Chromatin modifying enzymes","Nucleotide salvage","Toll-like Receptor Cascades","PKMTs methylat
e histone lysines","Purine salvage","Toll Like Receptor 5 (TLR5) Cascade","MyD88 cascade initiated on plasma membrane","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","E
RK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"NSC 113939",5-ITu,5ITu,7-Deaza-7-iodoadenosine,7Deaza7iodoadenosine,SCHEMBL12618424,HMS3229H07,HMS3403M09,HMS3886B10,"4-Amino-5-iodo-7-(beta-D-ribofuranosyl)pyrrolo(2,3-d)pyrimidine","4Amino5iodo7(b
etaDribofuranosyl)pyrrolo(2,3d)pyrimidine",s8314,CCG-268549,CCG268549,W-202018,W202018,S8314,"EMD 407900",5-Iodotubercidin,407900}

> <pdid>
PD005972

> <targets>
{5-Iodotubercidin,"adenosine receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{16760523}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 44 46  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -1.3070    5.2502    0.0000 N   0  3
   -2.6078    5.9988    0.0000 C   0  0
   -2.6109    7.4996    0.0000 C   0  0
   -3.9118    8.2481    0.0000 C   0  0
   -3.9149    9.7490    0.0000 C   0  0
   -5.2157   10.4975    0.0000 C   0  0
   -5.2188   11.9983    0.0000 C   0  0
   -6.5196   12.7469    0.0000 O   0  0
   -6.5227   14.2477    0.0000 C   0  0
   -7.8235   14.9963    0.0000 C   0  0
   -7.8266   16.4971    0.0000 C   0  0
   -9.1274   17.2456    0.0000 C   0  0
   -9.1305   18.7465    0.0000 C   0  0
  -10.4296   19.4965    0.0000 C   0  0
  -10.4296   20.9965    0.0000 C   0  0
   -9.1306   21.7466    0.0000 C   0  0
   -7.8316   20.9966    0.0000 C   0  0
   -7.8315   19.4966    0.0000 C   0  0
   11.5952    8.2459    0.0000 O   0  0
   10.2961    8.9959    0.0000 C   0  0
   10.2961   10.4959    0.0000 C   0  0
    8.9971   11.2459    0.0000 C   0  0
    7.6981   10.4959    0.0000 C   0  0
    7.6981    8.9959    0.0000 C   0  0
    6.3990    8.2459    0.0000 C   0  0
    6.3990    6.7459    0.0000 C   0  0
    7.6981    5.9959    0.0000 C   0  0
    8.9971    6.7459    0.0000 C   0  0
    8.9971    8.2459    0.0000 C   0  0
   11.5943   11.2490    0.0000 C   0  0
   12.8947   10.5013    0.0000 O   0  5
   11.5922   12.7490    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  5 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 32  1  0
 41 36  1  0
 33 42  1  0
 42 43  1  0
 42 44  2  0
M  CHG  2  13   1  43  -1
M  END
> <name>
Selleck_GPCR

> <id>
7827

> <plate>
1

> <well>
P13

> <supplier_cmpd_name>
Salmeterol Xinafoate

> <ctcr_id>
8218

> <supplier_cmpd_id>
S4296

> <smiles>
OCc1cc(ccc1O)C(O)C[NH2+]CCCCCCOCCCCc2ccccc2.Oc3c(ccc4ccccc34)C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{NCGC00094372-01,NCGC0009437201,NCGC00094372-02,NCGC0009437202,NCGC00094372-04,NCGC0009437204,"salmeterol xinafoate",94749-08-3,94749083,"GR 33343X xinafoate","Salmeterol 1-hydroxy-2-naphthoate","Salm
eterol 1hydroxy2naphthoate","Salmeterol (xinafoate)","GR 33343 G",Salmetedur,SALMETEROLO,Arial,"Serevent diskus",MFCD008,S4296,"Salmeterol Xinafoate"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{56801}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 24 27  0  0  1  0            999 V2000
   -0.6872   -2.7329    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    0.7521   -4.3921    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  1
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 10  1  0
 16 17  1  6
 16 18  1  0
 18  7  1  0
 18 19  1  1
 18 20  1  0
 20 21  1  6
 20 22  1  0
 22 23  1  0
 23  2  1  0
 23  6  1  0
 23 24  1  6
M  END
> <name>
Selleck_GPCR

> <id>
7828

> <plate>
1

> <well>
P15

> <supplier_cmpd_name>
Fluoxymesterone

> <ctcr_id>
8219

> <supplier_cmpd_id>
S4677

> <smiles>
C[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C

> <pd_targets>
{HSD17B10,AR,ESR1,NR3C1,HSD11B2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor",Oxidoreductase,"Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group A","N
uclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","1.-.-.- Oxidoreductases","Steroid hormone receptors","3C. 3-Ketosteroid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Metabolism of lipids","Branched-chain amino acid catabolism","Generic Trans
cription Pathway","Metabolism of steroids","Transcriptional regulation by RUNX2","Transcriptional regulation by RUNX1","FOXO-mediated transcription","Metabolism of steroid hormones","RUNX2 regulates b
one development","RUNX1 regulates estrogen receptor mediated transcription","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Glucocorticoid biosynthesis","RUNX2 regula
tes osteoblast differentiation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{ZINC28643006,S4677,Fluoxymesterone}

> <pdid>
PD009756

> <targets>
{"Androgen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{92852255}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 37 40  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.6523   -5.1712    0.0000 C   0  0
   -3.0999   -4.7779    0.0000 C   0  0
   -2.7066   -3.3304    0.0000 C   0  0
   -4.3985   -5.5180    0.0000 C   0  0
   -4.4064   -7.0180    0.0000 O   0  0
   -5.6938   -4.7616    0.0000 O   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 C   0  0
   -1.3039    3.7494    0.0000 N   0  0
   -1.3070    5.2502    0.0000 O   0  0
   -2.6078    5.9988    0.0000 C   0  0
   -2.6109    7.4996    0.0000 C   0  0
   -3.9100    8.2496    0.0000 C   0  0
   -3.9100    9.7496    0.0000 C   0  0
   -2.6110   10.4997    0.0000 C   0  0
   -2.6111   12.0004    0.0000 C   0  0
   -3.9089   12.7526    0.0000 C   0  0
   -3.9066   14.2526    0.0000 C   0  0
   -2.6064   15.0005    0.0000 C   0  0
   -1.3085   14.2485    0.0000 C   0  0
   -1.3108   12.7485    0.0000 C   0  0
   -1.3119    9.7497    0.0000 C   0  0
   -1.3119    8.2497    0.0000 C   0  0
   -0.0122   10.5002    0.0000 C   0  0
   -0.0113   12.0002    0.0000 F   0  0
    1.2866    9.7498    0.0000 F   0  0
    1.2872   11.2496    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 10  1  0
 12 14  1  0
 14 15  1  0
 14 16  2  0
  5 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 26  1  0
 25 32  1  0
 32 33  2  0
 33 22  1  0
 32 34  1  0
 34 35  1  0
 34 36  1  0
 34 37  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7829

> <plate>
1

> <well>
P17

> <supplier_cmpd_name>
BAF312 (Siponimod)

> <ctcr_id>
8220

> <supplier_cmpd_id>
S7179

> <smiles>
CCc1cc(ccc1CN2CC(C2)C(O)=O)C(/C)=N/OCc3ccc(C4CCCCC4)c(c3)C(F)(F)F

> <pd_targets>
{S1PR5,S1PR3,S1PR1,S1PR4}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","EDG receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Lysophospholipid (S1P) receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Lysosphingolipid and LPA receptors"}

> <broad_targets>
{S1PR1}

> <broad_moa>
{"sphingosine 1-phosphate receptor modulator"}

> <synonyms>
{Siponimod,1230487-00-9,1230487009,"BAF312 (Siponimod)",BAF-312(SiponiMod),BAF312(SiponiMod),BAF-312,BAF312,UNII-RR6P8L282I,UNIIRR6P8L282I,NVP-BAF312-NX,NVPBAF312NX,RR6P8L282I,CHEMBL2336071,"Siponimod
 (INN)","Siponimod (WHO-DD)","Siponimod (WHODD)","Siponimod (USAN)","Siponimod (USAN/INN)","Siponimod (USAN:INN)",SCHEMBL64169,T6403,S7179}

> <pdid>
PD012981

> <targets>
{S1P Receptor,LPL Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein}

> <pubchem_cids>
{44599207}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 44 47  0  0  1  0            999 V2000
    1.5583   -7.2167    0.0000 C   0  0
    1.1096   -5.7854    0.0000 C   0  0
    2.1252   -4.6815    0.0000 C   0  0
   -0.3549   -5.4572    0.0000 C   0  0
   -0.8000   -4.0300    0.0000 C   0  0  2  0  0  0
    0.3200   -2.7700    0.0000 N   0  0
    2.0900   -2.7500    0.0000 C   0  0
    2.5652   -4.1727    0.0000 O   0  0
    3.3700   -1.8100    0.0000 C   0  0  2  0  0  0
    3.3700   -0.3600    0.0000 N   0  0
    4.8800    0.2000    0.0000 C   0  0
    6.0963   -0.6779    0.0000 O   0  0
    4.9300    1.6400    0.0000 C   0  0  2  0  0  0
    6.2900    1.4700    0.0000 C   0  0
    7.0500    2.8100    0.0000 C   0  0
    5.9800    3.9000    0.0000 C   0  0
    4.6300    3.2200    0.0000 N   0  0
    3.1400    3.7500    0.0000 C   0  0
    3.1101    5.2497    0.0000 O   0  0
    1.6200    3.1400    0.0000 C   0  0  1  0  0  0
    0.5383    4.1822    0.0000 C   0  0
    0.8989    5.6391    0.0000 C   0  0
    2.3403    6.0545    0.0000 O   0  0
   -0.1812    6.6799    0.0000 O   0  0
    1.0800    1.5700    0.0000 N   0  0
   -0.7300    1.1200    0.0000 C   0  0
   -1.6553    2.3006    0.0000 O   0  0
   -1.5100   -0.3600    0.0000 C   0  0  1  0  0  0
   -2.9847   -0.0487    0.0000 C   0  0
   -3.4518    1.3776    0.0000 C   0  0
   -2.5637    2.5705    0.0000 C   0  0
   -3.4456    3.7838    0.0000 N   0  0
   -4.8713    3.3200    0.0000 C   0  0
   -6.1705    4.0697    0.0000 C   0  0
   -7.4694    3.3194    0.0000 C   0  0
   -7.4690    1.8194    0.0000 C   0  0
   -6.1698    1.0697    0.0000 C   0  0
   -4.8709    1.8200    0.0000 C   0  0
   -1.4500   -1.9700    0.0000 N   0  0
   -2.7500   -3.3500    0.0000 C   0  0
   -4.2071   -3.7063    0.0000 O   0  0
    4.7272   -2.4536    0.0000 C   0  0
    4.8500   -3.9486    0.0000 C   0  0
    5.9607   -1.6002    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  6
 21 22  1  0
 22 23  1  0
 22 24  2  0
 20 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  6
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 30  1  0
 38 33  1  0
 28 39  1  0
 39 40  1  0
 40  5  1  0
 40 41  2  0
  9 42  1  6
 42 43  1  0
 42 44  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7830

> <plate>
1

> <well>
P19

> <supplier_cmpd_name>
BQ-123

> <ctcr_id>
8221

> <supplier_cmpd_id>
S7883

> <smiles>
CC(C)C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC1=O)C(C)C

> <pd_targets>
{EDNRA,EDNRB,ABCC2}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Family A G protein-coupled receptor","Primary active transporter","Peptide receptor (family A GPCR)","ATP-binding cassette","Short peptide receptor (family A GPCR)","
ABCC subfamily","Endothelin receptor"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","ATP-binding cassette transporter family","Endothelin receptors","ABCC subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Disorders of transmembrane transporters","GPCR ligand binding","ABC transporter disorders","Class A/1 (Rhodopsin-like receptors)","Defective ABCC2 c
auses DJS","Peptide ligand-binding receptors"}

> <broad_targets>
{EDNRA}

> <broad_moa>
{"endothelin receptor antagonist"}

> <synonyms>
{Q12,"Q 12",BQ-123,BQ123,"BQ 123",136553-81-6,136553816,"136553 81 6",Cyclo(D-trp-D-asp-pro-D-val-leu),Cyclo(DtrpDaspproDvalleu),"Cyclo(D trp D asp pro D val leu)",UNII-S2A8YZM151,UNIIS2A8YZM151,"UNII
 S2A8YZM151",CHEBI:2965,CHEMBL314691,S2A8YZM151,c,S7883}

> <pdid>
PD021529

> <targets>
{Endothelin Receptor}

> <classes>
{GPCR & G Protein,GPCR/G Protein}

> <pubchem_cids>
{443289}

$$$$
Selleck_GPCR
  SciTegic11012412592D

 32 34  0  0  0  0            999 V2000
    9.0983   -0.7368    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 N   0  0
    3.8990   -0.7455    0.0000 S   0  0
    3.8964    0.7545    0.0000 O   0  0
    5.1966    0.0070    0.0000 O   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 O   0  0
   -3.8990   -0.7455    0.0000 C   0  0
   -5.2003   -1.4932    0.0000 C   0  0
   -6.4990   -0.7410    0.0000 O   0  0
   -7.8003   -1.4887    0.0000 C   0  0
   -9.0994   -0.7388    0.0000 N   0  0
  -10.3984   -1.4887    0.0000 C   0  0
  -10.3985   -2.9887    0.0000 C   0  0
  -11.6975   -3.7387    0.0000 Br  0  0
   -9.0994   -3.7388    0.0000 C   0  0
   -7.8004   -2.9888    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 C   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 C   0  0
    0.0072   -7.5009    0.0000 Br  0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
 13 25  2  0
 25  9  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 29 31  1  0
 31 32  2  0
 32 26  1  0
M  END
> <name>
Selleck_GPCR

> <id>
7831

> <plate>
1

> <well>
P21

> <supplier_cmpd_name>
Macitentan

> <ctcr_id>
6537

> <supplier_cmpd_id>
S8051

> <smiles>
CCCN[S](=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1c3ccc(Br)cc3

> <pd_targets>
{EDNRA,EDNRB}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Endothelin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Endothelin receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors"}

> <broad_targets>
{EDNRA,EDNRB}

> <broad_moa>
{"endothelin receptor antagonist"}

> <synonyms>
{Macitentan,441798-33-0,441798330,Opsumit,ACT-064992,ACT064992,"ACT 064992",UNII-Z9K9Y9WMVL,UNIIZ9K9Y9WMVL,Z9K9Y9WMVL,CHEBI:76607,Actelion-1,Actelion1,"Macitentan (USAN:INN)",macitentanum,"zlchem 5","
Opsumit (TN)",1258428-05-5,1258428055,"Macitentan (JAN/USAN)",(non-labelled)Macitentan-d7,(nonlabelled)Macitentand7,M,T2561,S8051}

> <pdid>
PD009165

> <targets>
{Endothelin Receptor,Apoptosis}

> <classes>
{GPCR & G Protein,Apoptosis,GPCR/G Protein}

> <pubchem_cids>
{16004692}

$$$$
